data_2mfn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mfn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 121.417 0.627 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -79.69 135.99 36.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.311 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -85.25 139.97 36.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.127 -0.983 . . . . 0.0 109.667 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.82 143.29 95.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.214 1.276 . . . . 0.0 111.943 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.432 ' HB ' ' H ' ' A' ' 7' ' ' GLY . 2.9 p -150.57 -153.29 0.48 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.0 20.12 76.0 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 105.494 -3.043 . . . . 0.0 105.494 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -52.71 127.35 22.86 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.594 0.711 . . . . 0.0 110.09 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 10' ' ' SER . 53.2 t0 -147.83 141.15 25.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.674 ' HG ' ' NE2' ' A' ' 88' ' ' GLN . 81.9 p -111.46 145.89 38.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.956 -1.09 . . . . 0.0 110.255 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 12' ' ' ASP . 80.2 p -169.45 -175.91 2.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.547 -0.721 . . . . 0.0 109.346 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 49.94 44.3 25.38 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -80.03 129.99 36.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.764 -178.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.22 162.06 20.02 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -60.16 -60.01 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.999 -1.063 . . . . 0.0 110.287 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.61 0.14 57.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.957 -1.089 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 14' ' ' THR . 80.0 p -149.64 158.67 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.429 -0.794 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 26.0 p90 -165.54 148.28 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -97.26 149.86 21.58 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.289 -1.507 . . . . 0.0 111.607 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.44 140.44 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -129.83 145.59 51.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.743 -1.223 . . . . 0.0 111.086 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -149.66 158.42 44.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.02 158.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.879 -1.138 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -94.25 136.56 23.36 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.717 -0.614 . . . . 0.0 109.813 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.17 176.15 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.012 1.141 . . . . 0.0 112.407 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -102.54 9.97 39.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.82 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.01 157.22 40.33 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.995 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.48 122.09 11.18 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.74 1.627 . . . . 0.0 112.619 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 29.7 pt -130.03 165.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.295 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.4 p -106.66 -7.99 17.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.24 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.35 -179.18 22.62 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.585 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 16.3 m-85 -125.0 147.53 48.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.194 . . . . 0.0 109.207 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 33' ' ' ILE . 29.4 mm -102.1 126.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.584 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.2 mm -103.78 116.74 48.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.972 -1.08 . . . . 0.0 110.214 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -117.23 131.46 56.84 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.455 ' NE2' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -140.02 149.93 43.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.33 -1.481 . . . . 0.0 111.275 -178.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -169.76 154.92 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.372 -0.83 . . . . 0.0 108.914 179.05 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 42.9 mtt-85 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.599 0.714 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.408 HE21 ' HD2' ' A' ' 49' ' ' ARG . 64.0 tt0 -117.85 112.56 20.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.587 0.708 . . . . 0.0 110.017 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.9 m-20 -124.11 129.96 51.74 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.679 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -118.77 145.18 45.79 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.859 -1.15 . . . . 0.0 109.664 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.52 149.07 72.49 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.963 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.17 157.76 51.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.889 1.059 . . . . 0.0 111.53 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.51 -35.4 98.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 121.363 1.375 . . . . 0.0 112.05 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -70.35 -13.71 62.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.534 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -97.49 120.0 37.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 110.005 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -108.87 -1.25 19.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.592 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.7 p -129.99 137.57 50.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 109.366 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 tt -129.99 130.13 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 m -95.85 119.16 33.84 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.316 -0.865 . . . . 0.0 109.137 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.04 146.04 23.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.0 p -136.35 178.36 7.12 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.581 . . . . 0.0 109.932 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 56.18 44.19 25.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.301 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.6 mt -113.65 152.89 29.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.478 -0.764 . . . . 0.0 109.623 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.644 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 31.4 t-20 -70.11 120.02 75.45 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.117 -0.989 . . . . 0.0 108.733 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 138.82 75.35 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.988 1.125 . . . . 0.0 113.192 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.94 63.34 3.03 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 67' ' ' GLU . 1.1 m -155.04 150.1 26.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.196 -1.179 . . . . 0.0 110.912 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.448 ' N ' HG21 ' A' ' 66' ' ' THR . 11.5 pt-20 -85.73 122.28 29.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.644 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 34.6 m-85 -111.54 139.96 46.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 110.481 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.473 ' CG2' HE22 ' A' ' 87' ' ' GLN . 18.8 t -96.56 120.12 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -120.13 130.02 74.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.43 ' CB ' HG12 ' A' ' 85' ' ' ILE . 88.7 p -118.5 139.91 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.63 129.99 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 73' ' ' ILE . 49.7 mm -119.46 129.26 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.741 -1.224 . . . . 0.0 109.21 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.5 ' CB ' ' OG ' ' A' ' 81' ' ' SER . . . -96.62 127.36 42.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.099 -1.001 . . . . 0.0 109.01 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.82 142.98 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.86 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CG ' ' O ' ' A' ' 76' ' ' ASN . 6.7 t-20 -123.03 37.02 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 108.806 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.6 -94.82 1.82 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -94.71 -6.24 43.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 0.0 110.042 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.55 140.01 49.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.938 -1.101 . . . . 0.0 109.724 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.6 139.96 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.5 ' OG ' ' CB ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -92.54 169.55 10.52 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.19 133.6 44.57 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.225 1.283 . . . . 0.0 112.218 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.1 155.95 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.473 1.449 . . . . 0.0 113.655 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.8 tp -131.82 121.14 23.62 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.43 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.4 mt -128.56 139.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.813 -1.179 . . . . 0.0 110.427 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.55 166.88 26.37 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.473 HE22 ' CG2' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -119.54 137.81 53.58 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.062 -1.257 . . . . 0.0 110.039 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.674 ' NE2' ' HG ' ' A' ' 10' ' ' SER . 62.1 tp60 -134.76 135.95 42.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.714 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.481 ' H ' ' HG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -74.53 136.78 42.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 65' ' ' GLY . 3.7 t . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.52 0.676 . . . . 0.0 110.884 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 94' ' ' ILE . 6.4 mt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.45 -165.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 N-CA-C 109.57 -0.973 . . . . 0.0 109.57 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -157.54 165.6 35.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.51 -1.369 . . . . 0.0 110.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 69.91 37.14 1.83 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.717 -0.614 . . . . 0.0 110.457 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.7 tp -73.05 102.43 3.52 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -150.62 170.04 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.606 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 24.6 t -100.86 135.86 35.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.625 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -104.04 -14.91 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.71 0.767 . . . . 0.0 109.055 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.606 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -139.72 148.23 42.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.49 ' HG ' ' HH ' ' A' ' 182' ' ' TYR . 28.5 t -132.38 119.7 21.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.107 . . . . 0.0 110.793 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.632 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -118.39 153.53 51.83 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -49.97 -42.04 46.38 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.796 1.664 . . . . 0.0 113.479 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -119.1 10.39 12.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.908 -1.12 . . . . 0.0 110.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.632 ' O ' ' OG1' ' A' ' 104' ' ' THR . 76.8 p -152.05 160.94 43.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.823 -1.173 . . . . 0.0 110.209 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' A' ' 107' ' ' SER . 1.5 mt -143.8 155.26 44.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.376 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.531 ' C ' ' CD1' ' A' ' 109' ' ' LEU . 2.1 tm? -99.98 127.21 46.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 109' ' ' LEU . 5.8 pt -110.54 139.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 110.251 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.3 m -138.25 141.94 39.9 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.612 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.603 ' CD2' ' O ' ' A' ' 145' ' ' SER . 43.5 p90 -154.63 159.97 41.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.138 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.83 130.16 32.34 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 109.226 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.93 141.37 96.41 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 120.853 1.035 . . . . 0.0 112.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.87 -162.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.007 1.138 . . . . 0.0 112.379 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.2 17.12 24.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.147 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.0 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.289 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 t -69.97 130.66 42.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.331 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.93 130.01 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.412 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 166' ' ' THR . 26.9 mmt180 -71.71 -45.93 60.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.473 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 11.4 p90 -166.58 167.04 15.79 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-85 -120.4 139.83 52.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 55.4 ttp180 -96.95 130.06 44.32 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.972 -1.08 . . . . 0.0 108.423 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.477 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 62.8 mt -119.25 130.25 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -106.22 146.89 29.73 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.848 0.832 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.771 ' HH ' ' N ' ' A' ' 150' ' ' ASN . 4.6 m-85 -94.6 132.21 39.54 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.73 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.38 117.67 5.46 Favored Glycine 0 C--O 1.206 -1.649 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.672 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--N 1.294 -1.834 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.728 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 126' ' ' TYR . 71.0 mt-30 -109.95 128.64 55.5 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.751 -1.179 . . . . 0.0 108.293 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -119.28 155.46 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.668 -1.27 . . . . 0.0 112.529 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.477 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 54.2 p90 -140.86 151.73 44.54 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.6 p -88.51 165.82 14.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.85 -1.156 . . . . 0.0 111.688 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 142' ' ' GLY . 72.9 t -132.71 95.6 19.57 Favored Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -59.8 44.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 120.787 0.991 . . . . 0.0 112.799 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 35.63 23.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.97 -35.93 74.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -1.152 . . . . 0.0 109.916 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.433 ' HG2' ' HG ' ' A' ' 143' ' ' SER . 10.4 mmtp -139.92 153.68 47.02 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.522 -0.736 . . . . 0.0 109.832 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.603 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 88.6 p -79.9 -9.98 59.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.386 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.414 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 45.5 p -128.15 152.31 48.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.45 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -141.01 169.4 17.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -112.72 139.98 47.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -0.916 . . . . 0.0 108.943 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.594 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 32.9 mm -108.56 120.91 60.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 108.725 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.771 ' N ' ' HH ' ' A' ' 126' ' ' TYR . 73.2 m-20 -124.11 168.68 12.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 32.2 t30 77.15 44.98 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.49 HG21 ' CZ ' ' A' ' 158' ' ' TYR . 68.4 mt -113.01 130.04 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -72.85 121.87 86.14 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.0 109.941 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.03 159.41 42.71 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.27 1.313 . . . . 0.0 113.145 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 23.06 61.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -127.89 133.26 49.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.114 -1.227 . . . . 0.0 109.936 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 54.8 t0 -59.96 140.07 56.98 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.73 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.4 m-85 -132.38 161.52 33.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.681 -1.262 . . . . 0.0 111.057 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 2.4 m -134.28 120.86 20.49 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.7 mt -107.16 120.18 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.154 -1.591 . . . . 0.0 108.97 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.405 ' OG1' ' CB ' ' A' ' 179' ' ' SER . 88.3 m -132.54 149.97 52.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 2.3 pp -143.13 151.22 40.46 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.602 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.0 OUTLIER -120.91 140.01 52.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.66 131.48 49.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.745 -1.222 . . . . 0.0 109.778 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 72.4 t -119.62 121.21 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.366 -0.834 . . . . 0.0 109.797 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 16.5 p . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.1 p -79.94 170.13 16.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.072 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.411 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 mttm -57.03 124.59 66.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.065 -1.022 . . . . 0.0 108.383 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 2.7 Cg_endo -63.34 150.34 88.83 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 120.905 1.07 . . . . 0.0 113.641 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.18 131.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.405 ' CB ' ' OG1' ' A' ' 161' ' ' THR . 80.2 p -130.03 154.12 47.74 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.009 . . . . 0.0 111.811 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.12 159.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -103.09 139.98 37.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.73 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 35.2 t80 -138.11 131.33 30.34 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.902 -1.124 . . . . 0.0 110.494 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.635 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 19.8 pttp -94.09 138.41 32.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 108.93 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.481 HG22 ' CD1' ' A' ' 158' ' ' TYR . 1.3 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.429 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.466 ' C ' ' OG ' ' A' ' 81' ' ' SER . 98.2 mt . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.96 159.27 28.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 6' ' ' THR . 42.7 t -94.29 130.02 35.29 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.886 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.81 72.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.106 1.204 . . . . 0.0 111.788 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -79.55 -153.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.013 -1.054 . . . . 0.0 109.611 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.417 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.94 22.62 78.4 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -58.21 130.28 45.91 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.505 0.669 . . . . 0.0 110.291 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -147.5 123.91 10.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.706 ' CB ' HE21 ' A' ' 88' ' ' GLN . 0.3 OUTLIER -103.23 130.28 50.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 109.876 -179.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' ASP . 88.3 p -154.84 -172.4 4.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.159 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.0 49.89 19.5 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -88.48 126.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.905 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -113.82 162.45 16.32 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.57 69.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 18.8 m120 -97.7 -0.11 46.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.907 -1.121 . . . . 0.0 109.887 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.695 ' O ' ' N ' ' A' ' 14' ' ' THR . 18.1 m -150.47 155.01 38.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.728 ' CD1' ' OE1' ' A' ' 88' ' ' GLN . 28.4 p90 -163.12 150.16 12.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 108.986 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -92.99 143.65 26.03 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.484 -1.385 . . . . 0.0 111.381 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' CE1' ' A' ' 18' ' ' PHE . 2.0 t -116.14 137.19 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.456 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 77.6 m-70 -130.48 149.52 52.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.65 -1.281 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -155.63 160.01 40.08 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.456 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.53 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 120.743 -1.223 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -94.54 132.58 28.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.793 -0.567 . . . . 0.0 109.915 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.68 151.8 67.44 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.998 1.132 . . . . 0.0 112.201 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -65.78 -40.03 91.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.34 147.7 98.84 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.66 138.36 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.426 1.418 . . . . 0.0 112.232 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.671 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 33.3 pt -132.6 168.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.733 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -103.66 -0.47 29.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.407 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.56 -173.62 23.01 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.671 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 44.6 m-85 -130.01 157.06 43.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.226 -1.161 . . . . 0.0 109.506 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.501 HG22 ' HE ' ' A' ' 49' ' ' ARG . 37.2 mm -110.03 130.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.0 mm -117.58 121.2 66.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.927 -1.108 . . . . 0.0 110.403 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.406 HH12 HG13 ' A' ' 73' ' ' ILE . 57.3 mtt180 -121.87 137.4 54.8 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.08 138.77 39.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.618 -1.301 . . . . 0.0 110.849 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -167.74 160.02 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.702 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.849 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.547 0.689 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.541 ' NE2' HH12 ' A' ' 49' ' ' ARG . 14.6 pt20 -120.66 122.02 39.57 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.609 0.719 . . . . 0.0 109.538 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -125.84 125.96 43.71 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.541 HH12 ' NE2' ' A' ' 47' ' ' GLN . 1.9 mmt-85 -108.94 147.3 32.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.108 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.2 m -127.24 147.44 61.96 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 110.175 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.03 159.52 46.14 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 120.955 1.103 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.39 -33.65 97.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 121.383 1.389 . . . . 0.0 111.926 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -69.97 -12.76 61.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.574 -0.704 . . . . 0.0 110.471 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -99.95 110.53 22.86 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -99.57 -1.5 38.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 108.788 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.456 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 78.5 p -138.24 136.07 36.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -129.96 136.62 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 m -100.48 114.63 28.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.48 149.97 23.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 109.556 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.3 p -136.01 177.89 7.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.743 -0.598 . . . . 0.0 109.96 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.9 m120 56.27 46.26 21.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.61 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.0 mt -109.96 153.2 24.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.827 . . . . 0.0 109.063 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -67.47 118.95 61.8 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 0.0 108.508 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 2.6 Cg_endo -62.84 129.83 27.4 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.893 1.062 . . . . 0.0 112.736 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.63 61.33 3.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -142.72 135.51 28.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -1.2 . . . . 0.0 111.464 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -91.03 117.03 29.26 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.718 ' OH ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -133.61 173.78 11.14 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.308 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.63 136.45 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.54 129.94 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -115.93 140.97 48.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 72' ' ' ILE . 48.6 mm -119.95 120.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.406 HG13 HH12 ' A' ' 35' ' ' ARG . 34.2 mm -115.36 129.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 108.666 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.84 129.91 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.751 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.01 159.99 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -140.49 38.45 1.87 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.92 -97.61 1.62 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -99.6 0.03 41.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 110.082 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -111.46 151.68 28.3 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.691 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -129.56 153.93 47.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.466 ' OG ' ' C ' ' A' ' 2' ' ' LEU . 0.1 OUTLIER -107.22 176.8 1.49 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 108.977 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.45 ' CD ' ' HG ' ' A' ' 81' ' ' SER . 3.6 Cg_exo -65.75 131.44 27.53 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.035 1.157 . . . . 0.0 111.628 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.74 140.89 95.1 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.2 1.267 . . . . 0.0 113.384 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.1 tp -119.98 116.73 26.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -128.12 139.94 50.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.7 162.4 26.62 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -110.36 149.61 29.98 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.155 -1.203 . . . . 0.0 109.671 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.728 ' OE1' ' CD1' ' A' ' 18' ' ' PHE . 17.4 tt0 -148.46 156.48 42.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.379 -0.826 . . . . 0.0 108.98 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.522 ' N ' ' HG2' ' A' ' 88' ' ' GLN . . . -121.37 123.62 42.57 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.658 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -73.32 142.89 47.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.48 0.657 . . . . 0.0 110.673 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.1 mt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.78 -170.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 109.946 -0.828 . . . . 0.0 109.946 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 38.2 ttm180 -149.89 160.0 43.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.503 -1.373 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 14.6 t0 72.6 36.22 1.01 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.682 -0.636 . . . . 0.0 110.871 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.433 ' C ' ' CD2' ' A' ' 98' ' ' LEU . 2.2 tt -68.01 102.9 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 97' ' ' ASP . 47.4 mt-10 -149.92 169.65 20.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.334 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.9 t -110.16 131.74 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.44 -0.787 . . . . 0.0 109.605 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -25.26 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.46 -0.775 . . . . 0.0 109.633 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.35 135.94 51.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.607 -0.683 . . . . 0.0 109.158 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.595 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 18.5 t -118.62 116.11 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.142 -0.974 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.611 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -105.66 155.82 37.51 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 121.313 -0.867 . . . . 0.0 108.903 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.61 -35.35 56.53 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.661 1.574 . . . . 0.0 112.931 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.4 p -128.75 16.36 6.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.992 -1.067 . . . . 0.0 110.412 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.611 ' O ' ' OG1' ' A' ' 104' ' ' THR . 29.0 p -158.66 169.34 24.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.806 -1.184 . . . . 0.0 110.01 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -144.81 153.41 41.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.68 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 4.5 tt -101.88 125.66 48.61 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.437 ' CD1' HD11 ' A' ' 124' ' ' ILE . 11.6 pt -114.01 152.12 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.048 -1.033 . . . . 0.0 111.117 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.2 t -147.47 140.31 24.91 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -147.61 160.0 43.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.04 130.16 32.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.73 138.68 84.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.851 1.034 . . . . 0.0 112.167 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.63 -160.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.119 1.213 . . . . 0.0 112.557 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.48 12.24 36.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.01 160.1 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 0.0 109.221 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 84.0 p -68.59 149.96 48.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 109.013 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.454 HG22 ' HH ' ' A' ' 122' ' ' TYR . 54.2 t -131.4 137.32 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -71.51 -53.5 13.66 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 26.4 p90 -167.37 170.32 11.56 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 3.5 m-85 -118.29 135.92 54.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.814 -1.179 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.592 ' NH2' ' CG ' ' A' ' 163' ' ' TYR . 28.5 ttp-105 -98.53 125.04 43.62 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.829 -1.17 . . . . 0.0 107.9 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 85.4 mt -111.17 133.46 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.075 -1.016 . . . . 0.0 110.135 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.44 ' H ' ' HG1' ' A' ' 125' ' ' THR . 3.1 p -105.55 145.12 31.37 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.916 0.865 . . . . 0.0 111.282 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.698 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.3 m-85 -92.41 120.28 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.93 129.65 9.72 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.903 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 . . . . . 0 C--N 1.294 -1.819 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.388 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.443 0.64 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 126' ' ' TYR . 96.8 mm-40 -117.49 138.08 52.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.485 ' OE1' ' NE ' ' A' ' 123' ' ' ARG . 21.9 pt-20 -128.8 160.02 33.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.761 -1.212 . . . . 0.0 112.246 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 50.4 p90 -144.61 157.12 44.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.2 p -87.5 164.94 15.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.901 -1.124 . . . . 0.0 110.939 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 t -128.88 118.3 19.61 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.481 -0.762 . . . . 0.0 110.625 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.3 Cg_exo -59.04 130.47 36.61 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-N 119.273 0.776 . . . . 0.0 111.819 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.72 2.71 2.4 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 141' ' ' PRO . 52.5 m -89.98 -2.9 58.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -1.204 . . . . 0.0 110.113 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -128.81 138.73 52.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.02 -1.05 . . . . 0.0 109.728 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -94.36 -7.39 41.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.189 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.4 p -133.41 153.27 51.75 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.42 ' H ' HG13 ' A' ' 110' ' ' ILE . . . -138.4 175.4 9.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.853 -1.154 . . . . 0.0 109.757 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 t -120.38 146.93 45.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.622 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 32.8 mm -113.16 120.74 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.149 -0.969 . . . . 0.0 109.44 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.698 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 35.6 m120 -123.76 177.51 5.68 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.245 -0.909 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 m120 59.97 46.52 10.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.487 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 4.8 tt -107.68 153.67 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.43 ' N ' ' OH ' ' A' ' 158' ' ' TYR . 13.1 mmtt -97.66 109.97 53.08 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.008 -1.058 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.42 173.16 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.305 1.336 . . . . 0.0 113.036 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.34 27.29 71.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.562 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -152.81 155.81 37.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.981 -1.305 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 48.5 t0 -72.91 155.23 40.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.704 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-85 -142.43 160.02 41.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.858 -1.152 . . . . 0.0 110.774 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.7 m -135.09 120.5 19.13 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.4 mt -105.58 121.58 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.228 -1.545 . . . . 0.0 108.901 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.8 m -129.97 142.05 50.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' A' ' 162' ' ' LEU . 1.4 pp -136.45 152.4 50.53 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.678 -1.209 . . . . 0.0 111.42 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.2 m-85 -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.53 132.61 47.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.699 -1.251 . . . . 0.0 109.541 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.65 124.06 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.634 -0.666 . . . . 0.0 109.694 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.259 0.552 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 85.0 p -79.34 170.0 17.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 108.807 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -56.2 129.06 73.54 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 108.756 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.438 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 2.3 Cg_endo -62.02 144.53 96.32 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.105 1.204 . . . . 0.0 113.217 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.54 128.6 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 81.1 p -123.29 150.04 44.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 111.703 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 39.5 pt -133.85 159.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -104.84 139.33 39.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.947 -1.095 . . . . 0.0 109.002 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.595 ' OH ' ' OG ' ' A' ' 103' ' ' SER . 62.4 t80 -135.33 130.38 34.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.593 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.1 139.99 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 108.946 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.562 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 7.5 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 109.479 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 121.49 0.662 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -74.41 149.22 40.56 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.424 -0.798 . . . . 0.0 108.982 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' THR . 47.5 t -82.5 132.17 53.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.989 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.4 ' O ' HD21 ' A' ' 84' ' ' LEU . 3.0 Cg_endo -59.04 79.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.129 1.22 . . . . 0.0 111.591 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 4' ' ' SER . 1.0 OUTLIER -85.9 -159.56 0.47 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.787 -1.195 . . . . 0.0 110.241 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.24 19.05 72.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 57.3 t80 -59.97 134.83 57.41 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.643 0.735 . . . . 0.0 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 10' ' ' SER . 39.8 t0 -158.98 148.8 19.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 90.0 p -113.98 132.43 55.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.934 -1.104 . . . . 0.0 109.553 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 12' ' ' ASP . 37.3 p -149.22 -175.95 5.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.048 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 11' ' ' SER . 78.2 m-20 47.57 46.94 17.79 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -82.64 127.92 39.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.152 -177.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.681 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.04 161.39 18.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.557 ' H ' ' CB ' ' A' ' 116' ' ' ALA . . . -63.32 -54.37 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.775 -1.203 . . . . 0.0 109.902 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.08 0.01 57.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.052 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 14' ' ' THR . 97.6 p -155.53 158.91 39.23 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.371 -0.831 . . . . 0.0 109.01 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CD1' ' NE2' ' A' ' 88' ' ' GLN . 30.4 p90 -163.02 151.03 13.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 109.529 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 m -95.36 157.1 16.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.54 -1.35 . . . . 0.0 111.518 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.65 ' C ' ' CD2' ' A' ' 21' ' ' HIS . 1.1 t -128.4 160.0 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.65 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.7 m-70 -150.87 154.11 36.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.84 -1.162 . . . . 0.0 110.589 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -153.69 160.01 42.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.509 -0.745 . . . . 0.0 109.19 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -84.63 157.83 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.995 -1.066 . . . . 0.0 109.768 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -99.06 120.44 58.39 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.1 149.71 87.84 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.819 1.013 . . . . 0.0 112.19 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -78.83 -12.39 60.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.187 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.21 150.56 92.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.259 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.82 126.05 20.54 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.323 1.349 . . . . 0.0 112.719 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 28.4 pt -136.52 166.55 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.438 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 p -115.71 -3.31 12.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.9 -175.51 28.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.68 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 55.1 m-85 -131.57 151.36 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -1.199 . . . . 0.0 109.997 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.431 HG22 ' CZ ' ' A' ' 49' ' ' ARG . 1.4 mp -112.71 132.6 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.568 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.2 mm -118.16 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.03 -1.044 . . . . 0.0 110.96 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -119.43 138.4 53.13 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.432 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 8.3 t60 -129.91 139.94 51.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.553 -1.342 . . . . 0.0 111.221 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.442 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 28.8 p-80 -163.61 153.19 14.8 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.3 0.572 . . . . 0.0 109.979 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 0.0 109.338 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.421 0.629 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -121.11 109.91 15.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.0 109.979 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' ILE . 91.7 m-20 -120.79 125.93 48.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.431 ' CZ ' HG22 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -109.27 151.77 26.11 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.01 -1.056 . . . . 0.0 108.731 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.98 145.2 56.76 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.908 -1.12 . . . . 0.0 110.113 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.04 160.4 38.02 Favored 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 120.999 1.133 . . . . 0.0 111.837 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.14 -32.66 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.588 1.525 . . . . 0.0 112.298 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 m -74.84 -10.95 59.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.0 111.101 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.81 117.83 35.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.149 . . . . 0.0 109.872 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -104.14 -0.01 29.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.462 -0.774 . . . . 0.0 109.489 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.7 p -130.94 139.91 50.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.902 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.1 tt -130.04 130.22 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 m -98.94 120.88 40.13 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.173 -0.955 . . . . 0.0 109.979 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.429 HD12 ' ND1' ' A' ' 36' ' ' HIS . 2.9 mt -97.21 138.11 35.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.222 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -123.3 179.48 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 53.74 48.56 21.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.923 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.5 mt -111.54 158.26 19.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.338 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.674 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 10.8 m120 -69.94 129.99 90.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.36 132.66 39.44 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.336 1.357 . . . . 0.0 113.505 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 67.08 65.84 2.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.602 ' N ' ' OG1' ' A' ' 90' ' ' THR . 1.2 m -149.86 151.85 34.15 Favored 'General case' 0 N--CA 1.506 2.341 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.188 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' N ' ' CG2' ' A' ' 66' ' ' THR . 49.6 mp0 -92.66 119.96 32.6 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.674 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 50.0 m-85 -111.23 140.51 45.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.117 -0.99 . . . . 0.0 110.799 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.442 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 15.2 t -92.7 121.42 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.99 125.6 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 109.708 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -99.59 135.33 41.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.673 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 72' ' ' ILE . 48.5 mm -116.51 129.97 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 74' ' ' ALA . 80.4 mt -127.67 160.01 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 110.152 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.497 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -128.54 131.94 48.25 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.1 m -128.31 151.21 34.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.222 -0.924 . . . . 0.0 109.295 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -126.25 33.84 4.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -0.945 . . . . 0.0 108.515 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.83 -89.33 1.27 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 40.7 ttm-85 -89.97 -19.38 24.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -1.061 . . . . 0.0 110.386 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -104.36 150.32 24.6 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 110.788 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -120.63 147.34 45.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.078 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -104.16 160.87 24.66 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.164 -0.96 . . . . 0.0 109.316 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.89 129.96 31.01 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.184 1.256 . . . . 0.0 112.298 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.91 145.25 98.77 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.294 1.329 . . . . 0.0 113.5 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 5' ' ' PRO . 13.3 tp -119.89 119.34 33.21 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -120.02 130.04 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.974 -1.078 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.15 168.79 22.86 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -121.88 147.77 45.58 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 109.889 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.798 ' NE2' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -142.29 159.27 42.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -119.08 135.36 54.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.083 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -73.84 133.6 43.21 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 90' ' ' THR . 39.7 t . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 122.008 0.909 . . . . 0.0 111.547 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.648 ' CD1' ' O ' ' A' ' 176' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.438 ' N ' HG21 ' A' ' 94' ' ' ILE . 3.1 Cg_exo -61.7 -158.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 120.635 0.89 . . . . 0.0 111.205 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.555 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 40.5 ttp180 -154.14 166.69 32.29 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.098 -1.001 . . . . 0.0 109.812 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.555 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 15.7 t0 74.96 35.08 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.503 -0.748 . . . . 0.0 109.831 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.6 107.0 2.36 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -158.51 163.55 36.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.58 139.96 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 pt -118.08 -16.0 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.115 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -140.67 130.04 23.83 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.533 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 6.2 m -117.42 119.76 36.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.019 . . . . 0.0 109.805 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -101.95 158.07 32.48 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.18 -35.56 52.72 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.312 1.341 . . . . 0.0 112.497 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 68.4 p -130.14 18.4 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.031 -1.043 . . . . 0.0 110.245 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.607 ' O ' ' OG1' ' A' ' 104' ' ' THR . 2.4 p -154.16 160.07 41.72 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.877 -1.139 . . . . 0.0 109.91 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -133.38 150.13 51.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 108.653 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.7 tt -105.2 120.09 40.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 108.898 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 124' ' ' ILE . 1.3 pt -99.97 138.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -132.56 133.92 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -145.72 144.89 30.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 1.8 pt-20 -72.3 145.97 88.79 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.934 -1.103 . . . . 0.0 108.575 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.53 136.56 74.97 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 120.962 1.108 . . . . 0.0 111.744 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.31 -163.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 120.332 0.688 . . . . 0.0 111.364 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.557 ' CB ' ' H ' ' A' ' 15' ' ' ALA . . . -113.74 11.68 18.15 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.221 -0.924 . . . . 0.0 108.986 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 33.1 m -129.97 159.99 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -71.16 133.06 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.933 . . . . 0.0 108.789 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 t -122.78 134.59 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.074 . . . . 0.0 110.266 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.3 -52.29 16.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.473 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 14.1 p90 -166.84 170.11 12.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.5 m-85 -122.15 143.87 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.963 . . . . 0.0 108.412 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.606 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 54.6 ttt-85 -103.71 126.04 50.58 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.692 -1.255 . . . . 0.0 107.906 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.471 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 50.2 mt -116.56 144.1 25.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.48 ' CG2' ' NH2' ' A' ' 123' ' ' ARG . 36.0 p -118.31 144.49 45.8 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.832 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.735 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.9 m-85 -87.9 131.36 34.61 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.52 115.25 4.66 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.922 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.496 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 34.2 mt-10 . . . . . 0 C--N 1.299 -1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.532 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 83.6 mt-30 -117.95 136.61 53.38 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.265 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.606 ' CD ' ' HE ' ' A' ' 123' ' ' ARG . 10.6 pt-20 -123.17 144.32 49.43 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.261 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 52.2 p90 -138.49 158.87 43.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.0 p -94.25 167.0 11.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.905 -1.122 . . . . 0.0 111.54 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 142' ' ' GLY . 98.0 t -135.17 85.64 33.1 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.5 Cg_exo -58.87 50.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 120.996 1.131 . . . . 0.0 113.162 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 34.95 24.54 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 141' ' ' PRO . 79.6 p -61.64 -39.98 93.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -1.18 . . . . 0.0 109.763 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -145.58 171.13 15.14 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.112 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 99.5 p -84.35 -1.17 55.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.581 -0.699 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.446 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 68.4 p -130.73 151.31 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 108.993 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.424 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -126.78 148.92 49.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.972 -1.08 . . . . 0.0 109.79 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 m -94.02 143.19 26.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.11 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.593 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 37.3 mm -115.19 121.33 66.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.735 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 14.3 m120 -127.11 170.0 12.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.703 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 19.0 m120 68.34 48.6 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.0 109.816 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.463 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 2.0 tt -113.74 147.34 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -95.45 111.13 54.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.848 -1.157 . . . . 0.0 109.654 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.95 163.37 28.63 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.061 1.174 . . . . 0.0 112.705 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.96 72.49 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.569 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -146.36 146.79 30.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.31 . . . . 0.0 109.917 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 55.3 t0 -70.01 151.52 45.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.588 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.8 OUTLIER -138.1 173.16 11.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.86 -1.15 . . . . 0.0 111.225 -178.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -141.34 111.52 6.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.81 124.03 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.3 -1.5 . . . . 0.0 109.462 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.453 HG23 ' CE1' ' A' ' 163' ' ' TYR . 25.9 m -124.81 139.92 53.4 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.617 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.552 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -119.67 136.5 54.38 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -178.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 162' ' ' LEU . 51.0 m-85 -121.65 141.45 51.11 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 175' ' ' SER . . . -103.61 123.64 47.33 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 62.8 t -110.36 119.93 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.004 . . . . 0.0 109.84 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.453 -0.78 . . . . 0.0 108.949 179.367 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.563 0.697 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.471 ' HG ' ' HB2' ' A' ' 164' ' ' ALA . 1.4 p -105.19 160.31 15.18 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.648 ' O ' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -39.07 100.1 0.21 Allowed Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 121.088 -1.007 . . . . 0.0 110.148 -178.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.495 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.5 Cg_exo -62.69 159.27 37.85 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 121.818 1.679 . . . . 0.0 114.751 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.0 t -124.22 130.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 80.2 p -120.26 150.19 41.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.757 -1.215 . . . . 0.0 110.933 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.28 161.14 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.225 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -104.33 128.72 52.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 108.601 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.533 ' OH ' ' OG ' ' A' ' 103' ' ' SER . 60.5 t80 -123.59 128.32 49.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 110.382 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -100.83 138.1 38.34 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.34 -0.85 . . . . 0.0 109.044 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.569 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.481 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -80.0 124.99 29.2 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 109.199 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.54 ' OG ' ' OG ' ' A' ' 81' ' ' SER . 53.5 m -78.75 146.9 69.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.483 ' O ' ' CG2' ' A' ' 6' ' ' THR . 3.0 Cg_exo -57.6 157.98 21.28 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 120.983 1.122 . . . . 0.0 111.681 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 5' ' ' PRO . 21.2 p -156.2 -144.36 0.13 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 109.646 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.14 19.47 24.01 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 105.249 -3.14 . . . . 0.0 105.249 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 6' ' ' THR . 59.6 t80 -54.91 130.03 39.8 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.83 0.824 . . . . 0.0 110.805 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 10' ' ' SER . 60.6 t0 -158.67 141.3 14.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 41.2 m -106.85 140.35 39.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.608 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 12' ' ' ASP . 60.8 p -152.98 -176.44 5.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' SER . 74.7 m-20 50.01 46.22 24.63 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.581 ' CD1' HE21 ' A' ' 88' ' ' GLN . 1.0 OUTLIER -82.19 123.4 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.733 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.2 161.98 17.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.02 -57.61 12.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.813 -1.179 . . . . 0.0 110.049 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -91.1 -0.01 57.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.937 -1.102 . . . . 0.0 110.012 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 38.5 t -151.36 155.73 39.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.685 ' CZ ' ' OE1' ' A' ' 88' ' ' GLN . 20.5 p90 -162.9 145.76 10.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -94.78 151.11 19.52 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.463 -1.398 . . . . 0.0 111.531 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.1 134.83 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.401 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 49.9 m-70 -129.23 149.6 50.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.643 -1.286 . . . . 0.0 111.0 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -154.1 159.39 41.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -0.78 . . . . 0.0 109.175 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.36 155.66 3.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.044 -1.035 . . . . 0.0 109.941 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.464 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -87.14 135.41 34.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.849 -0.532 . . . . 0.0 109.751 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.79 -179.5 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 120.962 1.108 . . . . 0.0 112.139 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.53 12.46 26.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.722 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.2 158.33 38.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.015 . . . . 0.0 109.647 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HB2' HD22 ' A' ' 76' ' ' ASN . 2.9 Cg_endo -56.54 130.3 39.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.777 1.651 . . . . 0.0 112.554 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 39.5 pt -138.92 170.02 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.395 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.469 ' HG1' ' N ' ' A' ' 77' ' ' GLY . 24.1 p -117.98 0.27 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.715 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.43 -178.18 24.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 51.2 m-85 -130.14 151.29 50.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -1.13 . . . . 0.0 109.516 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.46 HD11 ' NH1' ' A' ' 49' ' ' ARG . 28.4 mm -110.01 129.99 63.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.519 ' O ' ' O ' ' A' ' 48' ' ' ASP . 1.9 mm -113.55 120.56 63.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.812 -1.18 . . . . 0.0 109.935 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -116.67 131.53 56.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -121.8 139.11 54.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.285 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -168.62 147.3 4.2 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.093 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 108.74 178.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.864 0.84 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -112.83 113.51 25.62 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.519 ' O ' ' O ' ' A' ' 34' ' ' ILE . 85.6 m-20 -113.7 123.24 49.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.151 -0.968 . . . . 0.0 108.653 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 49' ' ' ARG . 0.4 OUTLIER -108.69 144.47 36.43 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.025 -1.047 . . . . 0.0 108.956 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.1 m -128.13 149.99 72.62 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.037 -1.04 . . . . 0.0 110.203 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.53 160.1 41.34 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.123 1.216 . . . . 0.0 111.724 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.92 -35.97 97.69 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.364 1.376 . . . . 0.0 112.38 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -70.23 -12.02 61.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 110.867 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -101.85 121.21 41.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.015 -1.053 . . . . 0.0 110.113 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -108.75 -0.0 20.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.61 -0.681 . . . . 0.0 109.699 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.401 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 57.3 p -130.34 139.95 50.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.183 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.4 tt -130.75 139.92 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.9 m -106.9 131.49 53.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.248 -0.908 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.509 ' O ' ' OG ' ' A' ' 17' ' ' SER . 4.2 mt -112.07 148.08 34.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.806 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.4 p -135.06 179.66 6.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.862 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 57.47 40.72 26.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.368 -0.832 . . . . 0.0 109.539 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.6 mt -107.31 156.83 18.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.4 -0.813 . . . . 0.0 109.409 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.576 ' H ' ' HH ' ' A' ' 68' ' ' TYR . 22.8 m120 -69.99 120.21 76.46 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 108.618 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.59 129.38 27.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 120.835 1.024 . . . . 0.0 112.966 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 76.17 60.76 3.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.442 HG21 ' N ' ' A' ' 67' ' ' GLU . 1.2 m -145.47 152.02 39.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -1.125 . . . . 0.0 110.336 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.442 ' N ' HG21 ' A' ' 66' ' ' THR . 3.8 pt-20 -88.78 119.99 29.78 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HH ' ' H ' ' A' ' 63' ' ' ASN . 38.4 m-85 -112.72 139.98 47.88 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.057 -1.027 . . . . 0.0 110.617 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.99 121.35 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.0 121.59 67.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.0 p -100.88 140.99 34.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 111.604 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 72' ' ' ILE . 49.7 mm -119.78 120.0 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.92 130.0 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.088 . . . . 0.0 109.612 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.4 139.42 30.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.91 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.0 139.45 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.135 -0.978 . . . . 0.0 109.615 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.417 HD22 ' HB2' ' A' ' 28' ' ' PRO . 41.7 t-20 -121.51 37.67 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 108.779 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.469 ' N ' ' HG1' ' A' ' 30' ' ' THR . . . 95.27 -100.66 2.58 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -91.63 -0.18 57.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.167 . . . . 0.0 110.325 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.26 141.57 48.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.06 . . . . 0.0 109.513 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.12 138.78 53.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.729 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.54 ' OG ' ' OG ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -83.85 163.33 49.29 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' OG ' ' A' ' 4' ' ' SER . 3.1 Cg_exo -57.54 135.08 67.5 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 121.336 1.358 . . . . 0.0 111.945 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.93 130.93 40.75 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.251 1.301 . . . . 0.0 113.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 tp -107.32 119.99 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -125.28 134.19 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.993 -1.067 . . . . 0.0 111.146 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.52 164.83 24.87 Favored Glycine 0 N--CA 1.479 1.542 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -114.69 131.11 56.85 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.921 -1.34 . . . . 0.0 110.084 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.685 ' OE1' ' CZ ' ' A' ' 18' ' ' PHE . 18.6 tm0? -123.87 128.32 49.3 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' O ' ' NE2' ' A' ' 88' ' ' GLN . . . -101.45 131.56 47.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.471 ' H ' ' HG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -74.43 136.65 42.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.679 ' O ' ' N ' ' A' ' 65' ' ' GLY . 3.9 t . . . . . 0 C--N 1.302 -1.471 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.447 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 94' ' ' ILE . 6.7 mt . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.24 159.63 21.99 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 120.332 0.688 . . . . 0.0 110.541 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -120.57 172.5 7.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.826 -1.171 . . . . 0.0 110.959 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.59 39.99 29.59 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.7 tp -72.15 92.9 1.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.765 -1.209 . . . . 0.0 107.849 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.49 170.69 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.654 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -104.68 139.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.62 -15.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.258 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.3 134.79 34.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 99.87 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 110.334 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.602 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -81.93 156.8 69.67 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -49.03 -43.93 34.44 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.466 1.444 . . . . 0.0 112.95 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 44.2 p -124.36 18.4 8.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.602 ' O ' ' OG1' ' A' ' 104' ' ' THR . 37.7 p -153.76 165.77 34.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.862 -1.149 . . . . 0.0 109.898 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.9 OUTLIER -140.69 154.22 46.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.561 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 8.5 tt -104.96 119.99 40.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 110' ' ' ILE . 5.2 pt -106.68 145.99 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.987 . . . . 0.0 110.616 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 95.7 p -144.79 149.99 36.43 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.44 0.638 . . . . 0.0 109.778 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.606 ' CE2' ' O ' ' A' ' 145' ' ' SER . 43.8 p90 -149.84 154.87 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -76.0 134.67 71.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.065 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 127.92 26.17 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.771 0.981 . . . . 0.0 111.948 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.22 -178.22 0.19 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.058 1.172 . . . . 0.0 112.613 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.37 10.26 41.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.84 . . . . 0.0 109.467 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -71.7 138.73 48.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.01 135.9 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.468 -0.77 . . . . 0.0 109.079 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.691 ' NH1' ' O ' ' A' ' 166' ' ' THR . 80.6 mmt-85 -71.18 -51.45 24.73 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.774 -1.204 . . . . 0.0 107.947 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.451 ' CE2' HG23 ' A' ' 139' ' ' THR . 6.5 p90 -167.52 174.57 7.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 17.4 m-85 -120.18 139.43 52.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.165 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 37.0 ttp-105 -100.46 129.96 46.48 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.484 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 16.6 mt -124.02 151.96 29.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.783 -1.198 . . . . 0.0 110.859 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.458 ' N ' HG21 ' A' ' 124' ' ' ILE . 25.4 p -126.13 141.14 52.06 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.093 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.733 ' HH ' ' N ' ' A' ' 150' ' ' ASN . 6.5 m-85 -84.11 129.54 34.9 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -109.17 131.01 10.3 Favored Glycine 0 N--CA 1.483 1.803 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.247 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.51 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.531 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 22.2 mm100 -111.92 129.87 56.03 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.355 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -107.86 133.86 51.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.546 -0.721 . . . . 0.0 111.323 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.484 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 41.5 p90 -141.64 157.52 44.98 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.451 HG23 ' CE2' ' A' ' 121' ' ' TYR . 3.2 p -98.21 167.44 10.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.785 -1.197 . . . . 0.0 111.525 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 88.1 t -132.18 118.68 16.3 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -57.6 127.99 27.53 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.507 0.804 . . . . 0.0 112.268 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.26 -4.55 0.83 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 141' ' ' PRO . 89.6 p -89.73 -0.05 57.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -1.233 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -124.88 132.96 53.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.889 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 97.7 p -93.13 0.05 57.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.474 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 15.1 p -139.12 158.12 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.451 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -139.95 169.95 16.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.819 -1.176 . . . . 0.0 109.916 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -118.92 142.59 47.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 109.391 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 31.4 mm -110.21 120.43 61.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.889 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.733 ' N ' ' HH ' ' A' ' 126' ' ' TYR . 25.2 m120 -123.04 172.94 8.16 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -0.941 . . . . 0.0 110.283 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 61.1 49.82 5.38 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.728 0.775 . . . . 0.0 109.107 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.479 HG13 ' CE2' ' A' ' 158' ' ' TYR . 5.2 tt -108.98 153.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.75 110.02 55.63 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 110.147 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.43 170.04 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.156 1.237 . . . . 0.0 112.492 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.98 20.03 75.89 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.48 150.8 36.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.043 -1.269 . . . . 0.0 109.701 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.643 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.3 t0 -70.02 153.12 43.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.728 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -140.89 159.89 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.611 -1.306 . . . . 0.0 110.55 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.473 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 46.9 m -132.94 119.99 20.86 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 79.6 mt -106.74 120.74 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.348 -1.47 . . . . 0.0 108.668 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.452 HG23 ' CE1' ' A' ' 163' ' ' TYR . 94.2 m -120.02 130.2 54.61 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.944 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.607 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -115.87 138.22 51.37 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.696 0.76 . . . . 0.0 110.83 -178.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.6 m-85 -117.47 157.38 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.56 135.79 54.99 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.795 -1.19 . . . . 0.0 110.176 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.06 120.0 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' THR . . . . . 0.691 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.338 0.589 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 81.9 p -80.64 169.15 18.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -56.29 121.3 41.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.504 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.0 Cg_exo -61.38 154.02 61.74 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 120.929 1.086 . . . . 0.0 114.162 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.64 129.97 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 85.0 p -121.13 156.64 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.439 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.0 pt -139.57 165.76 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.343 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -112.69 129.95 56.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.97 . . . . 0.0 108.963 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.513 ' CE1' HD23 ' A' ' 108' ' ' LEU . 54.7 t80 -124.98 118.52 26.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.026 . . . . 0.0 109.974 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.64 140.02 29.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.514 -179.839 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.434 ' O ' ' CD ' ' A' ' 82' ' ' PRO . 86.0 mt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.409 0.623 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -79.97 130.11 35.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -84.83 149.79 54.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.473 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.75 146.19 86.7 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.173 1.249 . . . . 0.0 112.105 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' N ' ' A' ' 8' ' ' PHE . 17.8 p -143.54 -150.65 0.32 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.044 -1.035 . . . . 0.0 109.601 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.96 19.18 49.84 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 105.0 -3.24 . . . . 0.0 105.0 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' N ' ' C ' ' A' ' 6' ' ' THR . 63.6 t80 -54.51 134.93 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.478 -0.861 . . . . 0.0 110.863 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.9 t0 -157.97 147.57 19.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.7 m -116.81 135.23 53.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 12' ' ' ASP . 77.3 p -152.05 -171.02 3.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 11' ' ' SER . 81.5 m-20 50.0 41.62 23.45 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.453 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -78.39 130.84 35.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.051 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.56 162.73 24.27 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -58.81 -60.08 4.42 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.026 -1.046 . . . . 0.0 110.279 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -91.49 -0.0 57.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.896 -1.127 . . . . 0.0 109.993 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 98.4 p -148.92 155.81 41.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.464 ' CD1' ' HG3' ' A' ' 88' ' ' GLN . 18.7 p90 -165.04 144.67 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 108.687 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -96.89 150.62 20.54 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.361 -1.462 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.01 132.4 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.423 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 63.4 m-70 -125.43 143.54 50.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.821 -1.175 . . . . 0.0 110.657 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -147.79 152.98 38.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -0.767 . . . . 0.0 109.211 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.01 142.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.108 -0.995 . . . . 0.0 110.492 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.03 137.06 79.28 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.838 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.58 -164.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.991 1.127 . . . . 0.0 112.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -112.38 17.86 19.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.939 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.73 150.21 49.9 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.909 -1.119 . . . . 0.0 109.951 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.48 127.1 23.42 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.485 1.456 . . . . 0.0 112.604 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 43.0 pt -133.4 170.02 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.2 p -106.08 -7.06 18.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 0.0 109.213 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.12 176.38 23.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 44.5 m-85 -119.99 145.54 46.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -1.199 . . . . 0.0 109.132 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 33' ' ' ILE . 38.1 mm -102.04 128.87 54.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 120.953 -1.092 . . . . 0.0 108.304 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.8 mm -110.06 118.94 58.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.139 -0.975 . . . . 0.0 110.101 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.71 HH12 ' NE2' ' A' ' 47' ' ' GLN . 33.7 mmt180 -108.33 127.88 54.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.474 ' ND1' ' C ' ' A' ' 36' ' ' HIS . 2.2 t-80 -119.98 135.71 54.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.856 -1.152 . . . . 0.0 110.715 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.443 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 29.4 p-80 -167.94 149.96 5.49 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.618 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.059 179.481 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.586 0.708 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.71 ' NE2' HH12 ' A' ' 35' ' ' ARG . 97.5 mt-30 -105.64 116.51 32.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -117.87 127.53 53.95 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.557 ' HE ' ' NH2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -121.45 148.55 44.27 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 109.693 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.0 m -133.14 138.46 31.7 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.135 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 166.12 11.58 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 120.926 1.084 . . . . 0.0 111.709 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.45 -36.28 94.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.466 1.444 . . . . 0.0 112.428 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -70.37 -11.05 60.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 110.777 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -102.79 120.02 39.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.088 -1.007 . . . . 0.0 110.04 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -109.71 -4.9 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.515 -0.741 . . . . 0.0 109.465 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.423 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 59.7 p -130.16 138.76 50.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.2 tt -130.0 130.01 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.36 -0.838 . . . . 0.0 108.746 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.4 m -100.24 133.31 44.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.14 145.5 40.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -132.63 -178.73 5.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.726 -0.609 . . . . 0.0 109.85 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.1 m120 57.39 40.4 27.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.7 155.15 19.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.49 -0.756 . . . . 0.0 109.087 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.649 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 15.9 m120 -69.99 120.63 79.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.976 -1.078 . . . . 0.0 108.561 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -61.5 125.13 16.07 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 120.921 1.081 . . . . 0.0 112.889 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 83.4 58.68 2.25 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -146.1 154.01 41.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.957 -1.32 . . . . 0.0 110.96 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' A' ' 66' ' ' THR . 98.0 mt-10 -89.96 118.72 29.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.649 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 43.2 m-85 -110.1 140.02 44.61 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 110.119 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.0 t -102.84 121.42 53.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.92 122.33 69.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 108.961 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -96.34 134.56 39.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 110.703 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 84' ' ' LEU . 50.3 mm -117.06 124.47 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 74' ' ' ALA . 60.3 mt -130.04 162.06 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.458 ' N ' HG23 ' A' ' 73' ' ' ILE . . . -121.4 136.57 54.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.655 -0.653 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.537 ' O ' ' OG1' ' A' ' 30' ' ' THR . 15.6 m -131.12 140.19 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 109.562 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' A' ' 29' ' ' ILE . 23.5 t-20 -124.58 41.88 3.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.012 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.01 -103.68 2.53 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.23 -0.04 44.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -104.56 155.77 18.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -128.08 153.17 47.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.419 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -108.86 171.84 4.16 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.83 . . . . 0.0 109.088 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' A' ' 2' ' ' LEU . 3.2 Cg_exo -61.85 126.35 18.7 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.21 1.273 . . . . 0.0 111.634 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.58 126.34 19.63 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.066 1.177 . . . . 0.0 113.472 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 72' ' ' ILE . 26.8 tp -106.15 120.04 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mt -125.01 139.3 51.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.998 -1.064 . . . . 0.0 110.36 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.21 152.49 21.47 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -109.75 129.93 55.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.429 -1.042 . . . . 0.0 109.54 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.54 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -123.55 129.79 51.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 88' ' ' GLN . . . -100.01 129.63 46.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.131 -0.981 . . . . 0.0 109.939 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.36 134.99 42.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.468 0.651 . . . . 0.0 109.975 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.58 178.2 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 N-CA-C 109.653 -0.941 . . . . 0.0 109.653 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -142.09 172.02 13.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.463 -1.398 . . . . 0.0 110.631 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.0 40.16 19.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.897 -0.502 . . . . 0.0 110.781 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.3 tp -72.7 93.29 1.63 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -147.92 169.97 18.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 51.2 t -96.98 133.83 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 110.711 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.19 -28.74 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.987 0.899 . . . . 0.0 108.664 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -135.28 134.93 40.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.471 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -121.48 126.57 49.58 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.854 -1.154 . . . . 0.0 110.812 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.634 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -112.39 157.59 39.66 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.6 -40.05 46.2 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.602 1.534 . . . . 0.0 113.27 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -120.69 9.97 10.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.891 -1.131 . . . . 0.0 110.546 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.634 ' C ' ' HG1' ' A' ' 104' ' ' THR . 80.1 p -154.01 162.27 41.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.658 -1.276 . . . . 0.0 110.77 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -144.61 152.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.474 -0.766 . . . . 0.0 109.01 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 5.4 tt -102.81 120.19 40.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.224 -0.922 . . . . 0.0 108.548 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.4 pt -102.81 146.95 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 110.707 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.3 p -139.96 149.23 43.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -154.06 160.02 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.544 -0.723 . . . . 0.0 109.614 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -86.22 143.96 37.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.13 137.49 75.73 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.054 1.17 . . . . 0.0 112.283 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.03 -166.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.016 1.144 . . . . 0.0 112.294 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.45 -1.68 24.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 109.606 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 164.19 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 109.707 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.7 m -68.76 150.01 48.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.363 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.9 t -134.56 141.54 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.822 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 61.3 mmt-85 -71.12 -51.03 27.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.522 ' OH ' ' NH2' ' A' ' 123' ' ' ARG . 7.9 p90 -166.48 179.29 5.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -120.02 139.94 51.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.717 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.679 ' NE ' ' OE2' ' A' ' 137' ' ' GLU . 36.3 ttm180 -106.12 124.7 49.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 30.5 mt -119.98 146.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.008 -1.058 . . . . 0.0 110.65 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -118.52 149.47 41.25 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.005 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.59 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 5.6 m-85 -93.12 136.37 33.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.55 118.41 5.5 Favored Glycine 0 N--CA 1.481 1.644 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.126 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--N 1.295 -1.798 0 O-C-N 121.411 -1.052 . . . . 0.0 108.786 177.473 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.528 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 10.7 mt-30 -102.45 123.03 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.951 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.679 ' OE2' ' NE ' ' A' ' 123' ' ' ARG . 80.4 tt0 -100.0 129.97 46.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 111.558 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 45.3 p90 -134.97 143.82 47.07 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.463 HG23 ' CE2' ' A' ' 121' ' ' TYR . 2.2 p -84.7 168.26 15.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.982 -1.074 . . . . 0.0 111.156 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 79.3 t -142.78 128.74 10.44 Favored Pre-proline 0 N--CA 1.485 1.285 0 O-C-N 121.751 -0.593 . . . . 0.0 109.416 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.99 150.65 62.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 120.621 0.881 . . . . 0.0 112.287 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.14 -8.46 69.77 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -89.98 -0.04 57.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -1.213 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -106.96 125.09 50.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.943 -1.098 . . . . 0.0 110.282 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -93.26 -5.39 49.93 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.6 p -142.93 159.8 41.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -140.84 167.63 21.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.728 -1.233 . . . . 0.0 109.883 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -117.95 136.69 53.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.59 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 32.8 mm -109.46 123.21 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 108.625 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.565 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 68.0 m-20 -124.01 170.02 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.133 -0.979 . . . . 0.0 109.761 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 39.8 m-20 71.69 49.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.361 0.6 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.472 HG21 ' CZ ' ' A' ' 158' ' ' TYR . 79.4 mt -115.58 130.72 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 0.0 109.393 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 184' ' ' THR . 22.4 mttm -73.95 118.86 72.82 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.056 -1.028 . . . . 0.0 109.795 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.0 167.28 16.31 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.31 1.34 . . . . 0.0 113.288 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 184' ' ' THR . . . 60.0 28.16 65.81 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.675 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -140.0 139.27 36.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.932 -1.334 . . . . 0.0 110.492 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -59.95 140.23 56.86 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -134.74 159.16 42.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.315 -1.491 . . . . 0.0 110.058 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.539 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 66.9 m -130.22 119.99 23.78 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 160' ' ' ILE . 48.5 mm -108.26 123.63 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.194 -1.566 . . . . 0.0 108.273 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.464 HG21 ' CE1' ' A' ' 163' ' ' TYR . 86.6 m -127.61 140.02 52.37 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.172 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.584 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -122.37 137.77 54.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.683 0.754 . . . . 0.0 110.394 -178.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.554 ' N ' ' CD1' ' A' ' 162' ' ' LEU . 1.4 m-85 -122.94 153.43 39.73 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.18 55.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.839 -1.163 . . . . 0.0 109.47 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.2 t -111.61 120.04 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.851 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 41.1 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.728 0.775 . . . . 0.0 109.225 179.696 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.9 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 46.1 p -79.4 169.98 17.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 119.48 42.0 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.521 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.3 Cg_exo -61.14 148.12 93.76 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 120.779 0.986 . . . . 0.0 114.074 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.9 120.12 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 86.2 p -112.56 153.43 27.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 111.461 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.2 pt -134.73 160.03 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -110.62 133.13 53.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 108.621 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.609 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 60.7 t80 -139.14 126.57 21.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.018 -1.051 . . . . 0.0 110.154 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.609 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 66.2 mttm -84.71 147.59 26.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.376 -0.828 . . . . 0.0 109.013 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.675 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 1.1 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.395 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.462 0.648 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.79 130.21 34.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.419 -0.8 . . . . 0.0 108.939 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.454 ' HA ' ' HG ' ' A' ' 81' ' ' SER . 94.0 p -69.96 146.66 95.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.03 . . . . 0.0 109.735 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.436 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 2.6 Cg_endo -60.75 116.31 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.179 1.253 . . . . 0.0 111.877 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -120.0 -155.75 0.63 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.923 -1.111 . . . . 0.0 109.66 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.66 20.02 75.35 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.444 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 64.4 t80 -53.07 133.18 38.8 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.755 0.788 . . . . 0.0 110.695 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 10' ' ' SER . 57.1 t0 -148.52 145.77 28.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 88' ' ' GLN . 47.6 t -129.11 145.2 51.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.979 -1.076 . . . . 0.0 110.295 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 12' ' ' ASP . 9.9 p -172.75 -162.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 11' ' ' SER . 72.6 m-20 49.39 40.08 17.84 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -80.12 132.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.938 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.683 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 164.09 20.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' H ' ' HB2' ' A' ' 116' ' ' ALA . . . -58.51 -59.09 5.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.706 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.475 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 31.7 m120 -92.52 -0.51 57.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.969 -1.082 . . . . 0.0 109.817 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.683 ' O ' ' N ' ' A' ' 14' ' ' THR . 90.0 p -151.4 156.49 40.8 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.581 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 32.4 p90 -161.89 148.33 13.77 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.433 HG23 ' NE2' ' A' ' 21' ' ' HIS . 4.4 m -102.36 151.33 22.39 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.112 -1.617 . . . . 0.0 111.956 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.444 ' CG1' ' CZ ' ' A' ' 8' ' ' PHE . 1.6 t -120.54 138.66 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.457 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 77.1 m-70 -127.49 141.22 51.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.844 -1.16 . . . . 0.0 110.838 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -149.97 156.24 41.36 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.91 159.39 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.03 -1.044 . . . . 0.0 109.842 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -88.69 140.19 29.65 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.69 179.28 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.921 1.081 . . . . 0.0 112.453 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.96 10.01 42.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.899 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.61 150.66 46.0 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.075 -1.015 . . . . 0.0 109.854 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.65 127.97 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.555 1.504 . . . . 0.0 112.684 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.737 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.2 pt -131.66 170.43 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.5 p -105.61 -3.29 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 109.855 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.34 174.29 14.21 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.737 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 13.0 m-85 -121.89 149.93 42.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.246 -1.15 . . . . 0.0 109.239 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.432 ' CG2' ' HG3' ' A' ' 49' ' ' ARG . 6.0 mt -115.15 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 120.984 -1.072 . . . . 0.0 108.579 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' O ' ' A' ' 48' ' ' ASP . 1.3 mm -107.4 119.61 57.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.181 -0.949 . . . . 0.0 110.783 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -110.0 129.61 55.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.697 ' CE1' ' OD2' ' A' ' 48' ' ' ASP . 40.7 p-80 -134.13 148.61 50.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.51 -1.369 . . . . 0.0 111.339 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -162.85 151.14 14.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 109.457 179.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.493 ' CB ' ' CE1' ' A' ' 36' ' ' HIS . 84.3 mtt-85 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 121.394 0.616 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 92.2 mm-40 -120.52 129.21 53.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.528 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.697 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 99.3 m-20 -141.29 117.56 10.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.432 ' HG3' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -109.43 142.06 40.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.891 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.3 137.03 29.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.12 160.18 31.42 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.772 0.981 . . . . 0.0 111.624 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.96 -33.8 96.1 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.502 1.468 . . . . 0.0 111.991 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.3 p -70.04 -10.35 58.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 110.354 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -103.88 120.59 41.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -106.92 -7.46 17.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.457 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 53.2 p -129.98 138.52 50.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 109.231 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 tt -130.01 132.83 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.432 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.5 m -99.73 120.0 39.03 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.468 ' CD2' ' OD2' ' A' ' 48' ' ' ASP . 7.6 mt -93.19 143.53 26.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.263 -0.898 . . . . 0.0 109.81 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.5 p -130.1 178.81 6.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.797 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.71 43.04 19.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.79 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 43.3 mt -109.99 153.63 24.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.599 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.9 m-80 -69.98 126.72 92.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.998 . . . . 0.0 108.655 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 2.5 Cg_endo -64.76 132.16 31.75 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 120.709 0.939 . . . . 0.0 112.368 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.87 62.14 3.08 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.433 HG23 ' CD1' ' A' ' 68' ' ' TYR . 1.1 m -148.48 152.99 37.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.322 -1.105 . . . . 0.0 110.525 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' A' ' 66' ' ' THR . 98.7 mt-10 -91.45 120.0 31.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.599 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 30.8 m-85 -108.82 148.16 30.99 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 110.57 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -110.04 125.77 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.27 129.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.915 -1.115 . . . . 0.0 110.335 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.408 ' CB ' HG12 ' A' ' 85' ' ' ILE . 78.6 p -115.22 139.99 49.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 110.728 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.6 mm -109.18 129.99 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.3 mm -119.9 123.15 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.047 . . . . 0.0 108.929 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB1' ' HG ' ' A' ' 81' ' ' SER . . . -93.5 132.69 37.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.972 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 m -129.9 140.02 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -121.58 43.4 2.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.97 -97.09 1.88 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.565 ' H ' ' CD ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -102.17 0.01 33.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -1.195 . . . . 0.0 109.299 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -112.4 151.26 30.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -124.64 153.12 42.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 109.493 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.454 ' HG ' ' HA ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -106.25 170.16 6.1 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 109.239 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.5 Cg_exo -59.74 125.39 17.65 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.223 1.282 . . . . 0.0 112.007 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.76 143.32 99.37 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.223 1.282 . . . . 0.0 113.383 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.436 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 24.9 tp -119.76 128.09 53.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -127.71 140.03 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 120.841 -1.162 . . . . 0.0 110.926 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.11 161.67 27.2 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -115.9 136.76 52.74 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.092 -1.24 . . . . 0.0 110.284 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.591 ' CD ' ' CB ' ' A' ' 10' ' ' SER . 98.2 mm-40 -130.2 139.03 50.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.77 137.47 48.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.419 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -79.68 140.11 37.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.1 t . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 121.504 0.669 . . . . 0.0 111.28 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.473 0.178 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.68 81.31 0.14 Allowed 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 120.798 0.998 . . . . 0.0 110.668 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.495 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 28.5 ttp-105 -62.76 165.78 6.22 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.501 -0.749 . . . . 0.0 111.118 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.495 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 95.1 m-20 64.96 42.28 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.062 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.9 tp -79.86 103.6 9.87 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -150.06 170.03 19.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.939 -1.101 . . . . 0.0 110.255 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 54.0 t -103.85 139.14 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.369 -0.832 . . . . 0.0 109.643 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.67 -10.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.62 130.84 28.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 p -114.81 98.5 6.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.673 ' HG1' ' H ' ' A' ' 107' ' ' SER . 1.2 p -88.41 151.12 48.01 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.321 -0.862 . . . . 0.0 109.089 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.37 -30.7 53.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.348 1.365 . . . . 0.0 113.001 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.8 p -129.02 12.89 6.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.906 -1.121 . . . . 0.0 110.718 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.673 ' H ' ' HG1' ' A' ' 104' ' ' THR . 14.6 p -159.85 161.93 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.82 -1.175 . . . . 0.0 110.027 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -135.67 153.93 51.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 5.4 tt -102.8 119.96 39.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 108.769 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 110' ' ' ILE . 2.6 pt -107.37 135.85 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 m -136.35 140.03 42.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -144.04 157.14 44.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.389 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.03 127.34 92.45 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.477 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.76 125.89 16.34 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 120.684 0.923 . . . . 0.0 111.654 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.03 176.39 0.74 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 120.831 1.021 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.44 ' HB2' ' H ' ' A' ' 15' ' ' ALA . . . -108.39 24.92 12.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.651 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.0 160.1 41.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.1 m -67.63 130.02 41.73 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.0 109.029 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.31 132.08 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.609 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -71.71 -53.5 13.31 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 8.1 p90 -167.27 170.29 11.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 5.5 m-85 -115.98 137.64 51.93 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 53.8 ttp180 -100.41 123.02 44.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.747 -1.221 . . . . 0.0 108.219 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.484 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 69.0 mt -110.26 139.82 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.005 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.5 p -115.59 137.22 52.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.375 -0.828 . . . . 0.0 110.796 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.715 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.9 m-85 -84.11 124.17 30.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.25 126.6 8.3 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.724 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.466 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 22.2 mt-10 . . . . . 0 C--N 1.295 -1.769 0 O-C-N 121.711 -0.876 . . . . 0.0 108.723 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 121.38 0.61 . . . . 0.0 110.314 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.536 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 96.9 mt-30 -119.82 104.36 10.14 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.121 -1.031 . . . . 0.0 108.554 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -86.89 140.79 29.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 0.0 112.084 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.484 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 39.8 p90 -143.9 150.01 37.76 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.7 p -89.56 168.72 11.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.933 -1.105 . . . . 0.0 111.459 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 19.6 t -134.14 126.81 18.75 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.747 -0.595 . . . . 0.0 109.649 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.64 155.7 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.291 0.782 . . . . 0.0 111.809 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.91 -0.31 81.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.7 p -99.96 2.29 43.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.059 -1.259 . . . . 0.0 110.422 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -112.48 128.57 56.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.821 -1.175 . . . . 0.0 110.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.2 m -94.74 -6.43 43.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.0 p -139.59 157.04 46.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.461 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -137.48 160.02 40.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.629 -1.294 . . . . 0.0 110.653 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.457 ' CG2' HD22 ' A' ' 150' ' ' ASN . 6.0 m -106.11 142.39 35.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.608 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 34.8 mm -114.47 120.07 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.715 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 8.8 m120 -122.05 173.81 7.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.236 -0.915 . . . . 0.0 109.798 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.3 46.26 2.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.037 . . . . 0.0 109.478 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.49 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 2.7 tt -110.43 153.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -98.29 109.98 54.49 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.966 -1.084 . . . . 0.0 110.488 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.46 154.43 74.34 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.075 1.183 . . . . 0.0 112.546 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.02 15.46 78.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.554 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . -137.91 149.06 45.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 49.5 t0 -69.92 150.81 46.34 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.5 m-85 -139.34 164.11 30.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.895 -1.128 . . . . 0.0 110.929 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.471 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.9 m -136.48 115.4 12.26 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.75 121.98 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.363 -1.46 . . . . 0.0 108.612 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.8 m -132.34 148.52 52.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.076 -1.015 . . . . 0.0 110.104 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 2.3 pp -140.65 152.51 45.45 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.973 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 2.5 m-85 -120.07 139.24 52.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.16 124.37 45.49 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 70.5 t -106.32 120.73 57.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.0 p . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.167 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 85.5 p -74.31 162.15 29.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.199 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -62.12 134.31 94.45 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.059 -1.026 . . . . 0.0 108.716 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 134.42 61.14 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.245 1.297 . . . . 0.0 113.424 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.83 129.99 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 92.4 p -128.09 159.33 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.052 -1.03 . . . . 0.0 112.201 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 44.4 pt -138.8 160.06 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -107.41 130.15 54.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.092 . . . . 0.0 109.195 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.512 ' CE2' HD23 ' A' ' 108' ' ' LEU . 65.7 t80 -122.5 129.94 52.53 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.95 139.23 35.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 3.2 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.184 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -83.39 109.99 17.77 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 109.073 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.434 ' HA ' ' HG ' ' A' ' 81' ' ' SER . 91.9 p -70.02 150.05 96.28 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.256 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.77 149.7 67.16 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.077 1.185 . . . . 0.0 111.669 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 7' ' ' GLY . 0.7 OUTLIER -152.68 -158.16 0.87 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 69.96 21.54 76.83 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 105.93 -2.868 . . . . 0.0 105.93 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -50.41 130.07 22.92 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.712 0.768 . . . . 0.0 110.359 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 10' ' ' SER . 52.1 t0 -155.59 149.64 25.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.547 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.8 m -121.97 140.97 51.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.964 -1.085 . . . . 0.0 110.133 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 12' ' ' ASP . 78.0 p -157.2 -173.91 4.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.094 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.05 42.55 24.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -78.01 124.83 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.935 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.692 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.89 162.45 17.32 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.34 -59.33 5.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.867 -1.146 . . . . 0.0 109.824 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.474 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 28.9 m120 -87.15 -10.79 51.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 14' ' ' THR . 48.8 m -139.96 155.26 47.21 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.636 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.627 ' CE2' ' OE1' ' A' ' 88' ' ' GLN . 15.1 p90 -161.46 142.01 10.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 108.779 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -91.16 154.02 19.63 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.443 -1.411 . . . . 0.0 111.777 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 t -124.35 139.31 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -129.68 141.25 50.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.819 -1.175 . . . . 0.0 110.93 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -148.44 160.02 43.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.02 156.11 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 120.81 -1.181 . . . . 0.0 110.346 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.445 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -99.21 124.4 45.2 Favored Pre-proline 0 C--N 1.299 -1.629 0 O-C-N 121.874 -0.516 . . . . 0.0 109.997 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HD2' ' HH ' ' A' ' 32' ' ' TYR . 2.9 Cg_endo -61.26 163.66 16.73 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.973 1.116 . . . . 0.0 112.244 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -92.06 -1.41 57.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.83 151.76 74.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.14 120.59 8.59 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.344 1.362 . . . . 0.0 112.332 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.618 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 25.5 pt -135.74 164.4 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.91 -7.36 15.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.028 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.87 175.37 19.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 18.4 m-85 -120.0 139.99 51.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.24 . . . . 0.0 109.163 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 33' ' ' ILE . 34.9 mm -91.17 120.09 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.7 mm -97.15 107.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 110.12 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -105.46 120.0 40.5 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.697 -1.252 . . . . 0.0 107.673 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.45 ' NE2' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -120.04 136.57 54.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.974 -1.079 . . . . 0.0 110.334 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -160.0 160.24 33.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 179.695 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.282 0.563 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -102.09 120.5 40.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.878 . . . . 0.0 109.293 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -126.0 140.19 52.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -130.05 146.94 51.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.903 -1.123 . . . . 0.0 109.606 -178.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.5 145.79 45.33 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.94 162.56 25.25 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.032 1.155 . . . . 0.0 111.925 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.28 -34.09 97.95 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.576 1.518 . . . . 0.0 112.314 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.5 t -69.99 -19.73 63.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.589 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -96.06 115.19 27.05 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -107.62 0.48 22.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 p -129.98 134.39 47.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.403 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.26 136.11 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 109.723 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.2 m -99.97 122.23 42.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.309 -0.869 . . . . 0.0 109.649 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.48 145.47 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.761 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -132.97 -178.66 5.06 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.434 0.635 . . . . 0.0 110.277 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 51.54 49.66 20.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.355 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.45 HD23 ' NE2' ' A' ' 36' ' ' HIS . 42.4 mt -116.5 153.68 31.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 109.286 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -70.0 123.32 88.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 108.598 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 2.6 Cg_endo -62.49 133.67 44.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.876 1.051 . . . . 0.0 112.717 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.66 62.26 2.9 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 m -147.42 148.92 31.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -1.12 . . . . 0.0 110.982 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' OE2' ' NE2' ' A' ' 87' ' ' GLN . 86.5 tt0 -90.13 119.0 30.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -109.92 152.75 25.43 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.194 -0.941 . . . . 0.0 110.814 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.02 121.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.51 129.98 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.758 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.427 ' CB ' HG12 ' A' ' 85' ' ' ILE . 93.8 p -116.84 137.88 51.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 0.0 110.741 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -112.77 121.85 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.3 mm -112.12 129.99 66.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.854 -1.154 . . . . 0.0 109.252 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.469 ' HB1' ' HG ' ' A' ' 81' ' ' SER . . . -95.61 123.12 39.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.987 . . . . 0.0 109.026 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.39 133.08 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.56 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -115.84 35.81 4.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.3 -103.06 2.49 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -90.33 0.03 57.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -1.141 . . . . 0.0 110.341 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.52 141.37 48.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.907 -1.121 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.98 140.5 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.814 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.469 ' HG ' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -94.05 167.87 12.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.837 . . . . 0.0 109.234 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -58.68 129.99 34.95 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.468 1.445 . . . . 0.0 112.085 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.0 151.9 68.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.396 1.397 . . . . 0.0 113.698 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.2 tp -125.41 111.91 15.68 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.427 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.7 mt -120.41 129.92 75.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 120.868 -1.145 . . . . 0.0 110.91 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.68 175.98 19.42 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.605 ' NE2' ' OE2' ' A' ' 67' ' ' GLU . 27.7 mt-30 -125.94 137.25 53.69 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.483 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.627 ' OE1' ' CE2' ' A' ' 18' ' ' PHE . 12.4 tm0? -130.92 130.68 43.79 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.618 ' C ' ' NE2' ' A' ' 88' ' ' GLN . . . -99.04 131.6 44.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.918 -1.114 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.41 135.8 42.39 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' A' ' 65' ' ' GLY . 18.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.5 mt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.17 -166.34 0.1 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 109.926 -0.836 . . . . 0.0 109.926 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -152.74 162.17 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.594 -1.316 . . . . 0.0 110.513 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.61 40.04 20.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.812 -0.555 . . . . 0.0 110.902 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.1 tp -73.08 96.79 2.24 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.73 -1.231 . . . . 0.0 107.792 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -151.76 169.81 21.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.679 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 43.2 t -96.23 139.38 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.165 -0.959 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -108.6 -11.89 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.853 0.835 . . . . 0.0 108.768 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.605 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -147.18 150.7 35.44 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -129.83 130.01 44.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.838 -1.164 . . . . 0.0 110.271 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.43 157.97 39.78 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.26 -40.93 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 121.434 1.423 . . . . 0.0 112.656 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.9 p -129.97 19.96 5.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.058 -1.026 . . . . 0.0 110.197 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.595 ' O ' ' OG1' ' A' ' 104' ' ' THR . 5.5 p -153.46 169.83 22.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.873 -1.142 . . . . 0.0 110.011 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.532 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -143.88 155.39 44.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.33 -0.857 . . . . 0.0 109.699 -179.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.426 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 25.1 tp -103.99 120.51 41.21 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.449 ' CD1' HD11 ' A' ' 124' ' ' ILE . 3.3 pt -107.59 146.95 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 111.321 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.8 p -141.11 144.22 34.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.469 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 42.3 p90 -150.74 159.99 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.73 140.58 22.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.2 134.52 56.33 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.028 1.152 . . . . 0.0 111.803 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.64 -171.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 120.954 1.103 . . . . 0.0 112.335 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.33 -1.44 29.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.09 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 m -129.96 160.04 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.476 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 152.28 44.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.478 HG13 ' CZ ' ' A' ' 122' ' ' TYR . 48.9 t -130.04 133.81 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.916 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.446 ' CG ' ' O ' ' A' ' 165' ' ' VAL . 11.6 ptm180 -72.49 -48.04 43.81 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.417 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.473 ' CE1' HG23 ' A' ' 139' ' ' THR . 2.2 p90 -166.96 162.53 15.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.904 -1.122 . . . . 0.0 110.036 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.607 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 m-85 -122.52 151.11 41.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.512 ' NE ' ' HB2' ' A' ' 163' ' ' TYR . 17.2 ptt180 -109.85 129.64 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.794 -1.191 . . . . 0.0 108.193 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.487 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 83.9 mt -112.4 145.57 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.951 . . . . 0.0 109.546 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -122.07 142.7 50.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 0.0 110.967 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.68 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.1 m-85 -84.57 130.0 34.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.692 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.21 135.34 12.77 Favored Glycine 0 N--CA 1.479 1.566 0 C-N-CA 120.216 -0.993 . . . . 0.0 110.93 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 . . . . . 0 C--N 1.295 -1.786 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.702 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.477 ' HB2' ' CG ' ' A' ' 126' ' ' TYR . 15.7 mt-30 -99.61 115.28 29.04 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.561 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -104.86 140.0 38.77 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.87 0.843 . . . . 0.0 111.979 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 42.8 p90 -145.91 151.96 38.69 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.473 HG23 ' CE1' ' A' ' 121' ' ' TYR . 2.7 p -84.33 160.16 20.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.941 -1.1 . . . . 0.0 111.453 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 122' ' ' TYR . 89.0 t -120.2 119.04 31.02 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.67 109.52 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.73 0.953 . . . . 0.0 111.821 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -50.09 -10.27 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 141' ' ' PRO . 80.1 p -69.99 -19.22 63.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 110.136 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -122.03 140.74 52.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.7 m -90.02 -1.14 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.469 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 63.4 p -132.85 159.12 40.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.448 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -143.37 166.36 24.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.792 -1.192 . . . . 0.0 110.203 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 149' ' ' ILE . 2.5 m -112.16 149.12 32.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.439 -0.788 . . . . 0.0 109.151 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.623 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 33.1 mm -117.62 123.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.68 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 31.2 m120 -125.49 170.08 11.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.024 -1.048 . . . . 0.0 110.013 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 80.8 m-20 65.64 46.7 2.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.589 0.709 . . . . 0.0 109.562 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.459 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 3.7 tt -108.32 149.79 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -98.02 110.04 54.15 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.25 174.69 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.187 1.258 . . . . 0.0 112.853 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.97 26.42 74.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.678 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -157.21 159.08 37.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.927 -1.337 . . . . 0.0 110.068 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.8 t0 -77.94 144.39 36.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.692 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -130.77 158.17 40.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.828 -1.17 . . . . 0.0 110.272 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.462 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 63.7 m -130.24 118.92 22.1 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.91 119.79 49.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.364 -1.46 . . . . 0.0 108.775 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.5 m -127.08 140.85 51.99 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.661 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.575 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 1.5 pp -139.09 152.42 47.49 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.335 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 0.8 OUTLIER -119.96 141.82 49.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.467 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -99.46 137.17 38.34 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.582 -1.324 . . . . 0.0 110.19 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.446 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 62.2 t -110.02 120.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.435 0.636 . . . . 0.0 110.026 -179.41 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.42 0.628 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.5 p -83.02 172.77 12.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.181 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 133.33 87.97 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.024 -1.048 . . . . 0.0 108.464 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.02 145.77 97.59 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.338 1.359 . . . . 0.0 113.846 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.54 129.66 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 93.1 p -126.34 155.83 41.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.943 -1.098 . . . . 0.0 111.52 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.2 pt -139.17 164.19 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -113.1 129.91 56.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 109.403 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.532 ' CE1' HD23 ' A' ' 108' ' ' LEU . 60.8 t80 -124.59 122.02 36.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.891 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 43.9 mmtt -84.61 149.54 25.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.907 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.678 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 9.0 p . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.059 -1.025 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.01 137.23 36.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.394 -0.816 . . . . 0.0 109.098 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 t -78.06 133.28 65.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.3 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 3.3 Cg_exo -57.22 90.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 120.967 1.111 . . . . 0.0 112.064 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -92.26 -158.54 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 109.904 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 22.11 66.82 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.468 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 56.0 t80 -57.75 132.4 53.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.82 0.819 . . . . 0.0 110.752 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.7 t0 -154.11 142.08 20.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 75.0 p -117.74 140.0 50.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.907 -1.121 . . . . 0.0 109.846 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 12' ' ' ASP . 58.7 p -158.6 -176.6 5.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.8 m-20 49.93 48.41 21.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.478 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -85.32 121.1 36.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.384 -177.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -112.76 162.7 15.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.04 -56.58 19.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.792 -1.193 . . . . 0.0 110.524 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -92.07 -0.03 57.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.85 -1.156 . . . . 0.0 109.93 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.7 ' O ' ' N ' ' A' ' 14' ' ' THR . 37.2 t -150.87 151.55 32.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.694 ' CE2' ' OH ' ' A' ' 68' ' ' TYR . 23.3 p90 -160.97 145.94 14.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 108.829 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -93.16 148.03 22.37 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.507 -1.37 . . . . 0.0 111.489 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -121.52 142.56 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.421 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 72.3 m-70 -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.807 -1.183 . . . . 0.0 110.808 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -154.02 157.55 39.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.494 -0.754 . . . . 0.0 109.084 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.06 158.83 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 120.875 -1.141 . . . . 0.0 110.0 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -89.28 148.6 41.05 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 109.9 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.58 178.72 0.61 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.279 1.319 . . . . 0.0 112.456 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -103.82 7.1 37.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.21 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.72 157.55 51.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.85 136.29 75.6 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.676 1.584 . . . . 0.0 112.591 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 40.7 pt -139.97 170.06 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 p -106.42 -0.84 23.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -173.85 23.15 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 37.1 m-85 -128.36 151.15 49.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -1.207 . . . . 0.0 109.419 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HE ' ' A' ' 49' ' ' ARG . 31.9 mm -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -0.949 . . . . 0.0 108.48 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.9 mm -113.91 123.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.008 -1.057 . . . . 0.0 110.315 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.569 HH12 ' NE2' ' A' ' 47' ' ' GLN . 83.0 mtt-85 -123.24 130.92 53.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.607 ' NE2' ' CB ' ' A' ' 46' ' ' ARG . 20.5 p-80 -130.76 129.4 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.559 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -159.99 159.92 32.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 109.32 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.409 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.607 ' CB ' ' NE2' ' A' ' 36' ' ' HIS . 22.5 mmm180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.328 0.585 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.569 ' NE2' HH12 ' A' ' 35' ' ' ARG . 99.4 mt-30 -120.82 109.96 15.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.793 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' ILE . 94.5 m-20 -121.98 129.99 52.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.197 -0.94 . . . . 0.0 108.673 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.533 ' CD ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -113.56 141.22 47.43 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.325 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.95 147.66 46.82 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.28 159.98 44.54 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 120.844 1.029 . . . . 0.0 111.552 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 2.7 Cg_endo -57.96 -37.85 94.44 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.583 1.522 . . . . 0.0 112.563 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 m -70.05 -12.49 61.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.872 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -100.07 115.43 29.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.922 -1.112 . . . . 0.0 109.888 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -103.06 -4.11 25.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.486 -0.758 . . . . 0.0 108.983 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.421 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 19.4 p -130.33 135.92 48.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.772 . . . . 0.0 109.245 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.0 tt -132.43 133.75 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.096 -1.003 . . . . 0.0 110.361 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -95.74 109.99 22.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.585 ' O ' ' OG ' ' A' ' 17' ' ' SER . 5.6 mt -85.63 148.81 25.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.129 -0.982 . . . . 0.0 109.814 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.4 p -135.05 177.73 7.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.74 -0.6 . . . . 0.0 109.596 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m120 57.33 45.43 20.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.5 mt -111.68 150.03 30.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.414 HD21 ' C ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -62.09 116.95 25.01 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.21 131.71 35.61 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 120.868 1.045 . . . . 0.0 112.932 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.45 62.91 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -142.38 130.72 22.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 110.887 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -87.14 122.52 31.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.694 ' OH ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -139.82 175.45 9.56 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.615 -1.234 . . . . 0.0 110.863 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.12 129.08 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.71 123.19 68.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.415 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.1 p -111.19 142.36 43.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 0.0 111.586 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mm -119.88 119.98 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.1 mm -113.66 119.97 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.91 -1.119 . . . . 0.0 108.809 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.67 130.13 34.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 108.686 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.8 147.55 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 110.061 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -128.51 40.05 3.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.06 -100.81 2.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 ptt-85 -90.34 -5.96 55.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -1.19 . . . . 0.0 110.242 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -112.31 143.48 43.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.97 -1.082 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -127.3 130.54 49.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 110.42 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -76.12 152.53 84.24 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.56 140.03 45.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 120.746 0.964 . . . . 0.0 111.765 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.89 146.22 80.2 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.561 1.508 . . . . 0.0 114.076 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 20.0 tp -122.08 121.74 37.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.415 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -133.2 140.55 46.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 O-C-N 120.846 -1.159 . . . . 0.0 111.379 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.33 162.57 27.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -110.84 141.88 43.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.037 -1.273 . . . . 0.0 110.165 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.586 ' OE1' ' OG ' ' A' ' 10' ' ' SER . 67.5 tp60 -145.21 158.46 43.82 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.5 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . -124.19 127.12 47.26 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.858 -1.151 . . . . 0.0 111.03 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.11 142.57 45.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.523 0.677 . . . . 0.0 110.907 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.3 mt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.42 -159.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 N-CA-C 109.896 -0.848 . . . . 0.0 109.896 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 15.9 ttp180 -160.01 160.57 33.45 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.664 -1.273 . . . . 0.0 111.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 98.2 m-20 59.95 43.84 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.439 HD21 ' CD2' ' A' ' 162' ' ' LEU . 41.2 tp -72.06 112.73 8.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 120.491 -1.381 . . . . 0.0 107.41 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -157.14 169.38 24.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.4 t -104.95 133.41 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CG2' ' OG ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -98.39 -30.0 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.703 0.763 . . . . 0.0 109.427 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.97 144.55 47.46 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 p -122.32 119.06 29.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 110.164 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -97.18 156.58 36.13 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.1 -46.2 26.46 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.564 1.509 . . . . 0.0 112.918 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.8 p -121.09 15.86 11.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.677 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.63 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 4.8 p -149.97 164.29 35.87 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.093 -1.004 . . . . 0.0 109.669 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.532 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -139.43 150.0 44.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.628 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 1.9 tt -99.02 122.64 42.55 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.109 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 147' ' ' ALA . 0.8 OUTLIER -106.99 141.26 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 0.0 110.872 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 101' ' ' ILE . 9.5 p -142.74 136.49 28.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.58 -0.7 . . . . 0.0 109.362 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.436 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 34.7 p90 -145.31 156.96 44.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.316 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.62 137.92 54.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.616 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.41 132.04 39.03 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 120.916 1.078 . . . . 0.0 112.099 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.94 -159.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 120.932 1.088 . . . . 0.0 112.256 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.44 2.92 45.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.01 160.0 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.098 -1.001 . . . . 0.0 109.819 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.4 t -74.55 135.36 42.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.442 ' HB ' ' CZ ' ' A' ' 122' ' ' TYR . 22.6 t -109.99 135.01 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -71.15 -45.94 62.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.487 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 12.1 p90 -166.29 162.37 17.27 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.424 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-85 -119.98 138.08 53.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 108.596 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.442 ' NE ' ' HB3' ' A' ' 137' ' ' GLU . 13.6 tpt180 -95.46 121.58 37.29 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 89.9 mt -110.0 132.36 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.144 -0.973 . . . . 0.0 110.322 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -113.17 144.76 42.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.689 . . . . 0.0 111.436 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.7 m-85 -87.93 136.61 32.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.695 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.7 128.7 9.4 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.161 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 . . . . . 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.814 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.485 ' HB2' ' CG ' ' A' ' 126' ' ' TYR . 15.0 mt-30 -94.39 112.69 24.48 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.344 -1.342 . . . . 0.0 108.373 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.442 ' HB3' ' NE ' ' A' ' 123' ' ' ARG . 21.5 mp0 -102.41 140.17 37.04 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.988 0.899 . . . . 0.0 112.715 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.503 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 41.9 p90 -143.16 153.87 43.3 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 p -88.62 163.1 15.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.663 -1.273 . . . . 0.0 112.092 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.629 ' O ' ' N ' ' A' ' 142' ' ' GLY . 27.9 t -123.85 105.35 32.44 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.2 Cg_exo -59.86 35.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.672 0.915 . . . . 0.0 112.76 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 30.69 30.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.697 ' N ' ' O ' ' A' ' 141' ' ' PRO . 81.4 p -69.41 -33.6 73.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -1.21 . . . . 0.0 109.698 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -146.17 176.38 9.78 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.563 -0.711 . . . . 0.0 110.107 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 92.7 p -90.03 0.01 57.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.722 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.436 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 19.8 p -136.22 150.96 49.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.471 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -148.05 177.49 9.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 108.945 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.626 ' CG2' ' N ' ' A' ' 149' ' ' ILE . 43.8 m -122.61 167.07 13.86 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.062 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.63 ' O ' ' CB ' ' A' ' 107' ' ' SER . 85.8 mt -123.92 130.52 73.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 110.01 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.582 ' O ' ' OH ' ' A' ' 126' ' ' TYR . 30.3 m120 -123.32 172.67 8.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.6 m120 61.42 40.36 14.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.0 110.323 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.49 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 3.4 tt -97.78 168.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 108.707 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.473 ' HB3' ' HH ' ' A' ' 158' ' ' TYR . 5.2 tptm -110.73 100.08 44.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 120.925 -1.109 . . . . 0.0 109.36 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.71 164.15 30.31 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.396 1.397 . . . . 0.0 113.015 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.98 19.52 69.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.48 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -149.72 156.76 42.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.29 . . . . 0.0 110.186 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.688 ' OD2' ' NZ ' ' A' ' 183' ' ' LYS . 61.9 t0 -70.0 151.14 45.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.6 OUTLIER -141.95 159.28 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.505 -1.372 . . . . 0.0 110.328 -179.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.495 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 20.4 m -130.49 123.17 29.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -103.39 120.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.131 -1.606 . . . . 0.0 109.666 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.7 m -131.36 141.86 49.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.445 ' H ' HD21 ' A' ' 162' ' ' LEU . 2.3 pt? -135.18 154.79 51.5 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.4 m-85 -120.02 140.6 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -108.04 125.74 51.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.752 -1.218 . . . . 0.0 109.768 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.487 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 90.1 t -114.5 127.54 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.524 0.678 . . . . 0.0 109.691 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.3 p -66.34 152.6 44.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.066 -1.021 . . . . 0.0 108.458 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -49.34 137.03 16.12 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.844 -1.16 . . . . 0.0 108.825 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.53 142.29 97.56 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.165 1.243 . . . . 0.0 112.916 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 129.23 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 64.8 p -126.06 150.82 47.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.034 -1.041 . . . . 0.0 111.992 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 48.0 pt -134.8 160.05 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -97.87 140.28 32.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.873 -1.142 . . . . 0.0 109.48 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.532 ' CE1' HD23 ' A' ' 108' ' ' LEU . 58.3 t80 -137.52 119.35 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 109.62 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.688 ' NZ ' ' OD2' ' A' ' 157' ' ' ASP . 71.3 mmtt -89.4 133.86 34.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.248 -0.907 . . . . 0.0 108.765 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.48 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 3.1 p . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 0.0 109.427 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 81' ' ' SER . 84.9 mt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.13 130.1 36.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.486 ' HG ' ' HB3' ' A' ' 81' ' ' SER . 73.8 m -76.57 144.07 73.08 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 109.514 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.509 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 2.6 Cg_endo -58.87 110.16 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.171 . . . . 0.0 111.377 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.1 -155.29 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 109.772 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.02 23.7 76.93 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 105.108 -3.197 . . . . 0.0 105.108 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.437 ' CZ ' HG11 ' A' ' 20' ' ' VAL . 54.1 t80 -50.56 130.03 23.34 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.561 -0.819 . . . . 0.0 110.88 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.6 t0 -142.96 137.44 29.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.572 ' OG ' ' OE1' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -119.57 138.0 53.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 0.0 110.202 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' ASP . 91.5 p -167.2 -166.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.726 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.443 ' CB ' ' HG1' ' A' ' 19' ' ' THR . 95.2 m-20 48.7 43.68 20.93 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.754 ' CD1' HE21 ' A' ' 88' ' ' GLN . 1.0 OUTLIER -76.92 129.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.21 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.38 161.12 21.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 -59.99 4.5 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 110.218 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -90.06 0.02 57.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.869 -1.144 . . . . 0.0 109.062 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 14' ' ' THR . 86.0 p -149.47 159.2 44.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.093 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 18' ' ' PHE . 16.9 p90 -163.77 148.27 10.49 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.443 ' HG1' ' CB ' ' A' ' 12' ' ' ASP . 2.0 m -101.37 150.29 23.17 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.115 -1.616 . . . . 0.0 112.286 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.437 HG11 ' CZ ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -119.18 139.06 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -129.33 139.99 51.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.773 -1.204 . . . . 0.0 110.816 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 35.9 p90 -150.25 155.45 39.74 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -87.32 157.24 3.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.868 -1.145 . . . . 0.0 109.985 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -93.12 137.02 23.87 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.95 176.01 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 120.827 1.018 . . . . 0.0 111.892 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -103.3 15.55 28.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.311 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.87 155.75 47.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.09 131.27 40.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.614 1.543 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.0 pt -140.01 170.64 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.246 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 46.9 p -108.41 -10.15 15.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 109.841 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.89 178.27 23.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.624 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 25.8 m-85 -123.14 145.14 48.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 109.232 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.494 HD11 HG22 ' A' ' 33' ' ' ILE . 42.3 mm -100.7 128.01 53.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 120.88 -1.138 . . . . 0.0 108.123 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.618 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.2 mm -109.29 110.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.112 -0.992 . . . . 0.0 110.421 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -105.69 121.49 44.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.474 ' CD2' ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -118.76 135.09 54.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.808 -1.182 . . . . 0.0 110.861 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -160.05 159.0 31.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.597 -0.689 . . . . 0.0 109.586 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 108.547 179.337 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 mmt180 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.427 0.632 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -100.51 117.06 33.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.469 -0.769 . . . . 0.0 109.372 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -123.08 133.25 54.31 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.474 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -127.43 150.12 49.78 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.816 -1.177 . . . . 0.0 109.871 -178.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.433 ' CG1' HD11 ' A' ' 57' ' ' ILE . 34.4 m -135.15 145.96 56.33 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.17 160.08 46.58 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 120.924 1.083 . . . . 0.0 111.256 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.81 -31.5 91.83 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.243 1.296 . . . . 0.0 112.172 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.3 m -72.5 -11.42 60.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.546 -0.721 . . . . 0.0 111.255 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -103.94 120.0 40.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.839 -1.163 . . . . 0.0 109.461 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.431 ' C ' ' OD1' ' A' ' 55' ' ' ASN . 46.3 p-10 -102.49 -1.96 29.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.3 p -134.72 138.18 44.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' CG1' ' A' ' 50' ' ' VAL . 4.9 tt -131.55 134.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.705 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -102.5 119.8 39.45 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.339 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.461 HD21 ' CG ' ' A' ' 36' ' ' HIS . 1.1 mt -89.29 148.97 23.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 108.977 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -131.31 177.55 7.39 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.514 0.673 . . . . 0.0 110.019 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.4 m120 55.2 45.5 25.74 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.3 mt -109.94 152.87 25.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.175 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.473 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 95.1 m-20 -68.67 120.48 75.99 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.325 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.95 133.99 50.66 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 121.068 1.179 . . . . 0.0 113.49 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.7 63.05 2.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.2 m -148.57 156.36 42.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -1.16 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' N ' ' CG2' ' A' ' 66' ' ' THR . 8.8 pt-20 -99.31 120.02 38.88 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.473 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 77.3 m-85 -110.19 153.77 24.3 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 111.039 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -109.97 120.73 61.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.02 125.9 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.932 -1.105 . . . . 0.0 109.826 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 p -104.88 136.14 44.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 110.839 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mm -112.05 121.03 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.11 129.98 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.965 -1.084 . . . . 0.0 109.594 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.65 132.54 36.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.339 -0.851 . . . . 0.0 109.543 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.484 ' O ' ' OG1' ' A' ' 30' ' ' THR . 16.5 m -128.6 137.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.442 ' HA ' ' HG1' ' A' ' 30' ' ' THR . 45.8 t-20 -119.96 41.93 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.17 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.63 -92.4 1.71 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.94 -0.0 40.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -1.106 . . . . 0.0 110.581 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.33 152.85 37.27 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.016 -1.053 . . . . 0.0 109.631 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -131.87 160.0 36.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 110.001 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.556 ' OG ' ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -110.93 172.17 3.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.239 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.453 ' CD ' ' HG ' ' A' ' 81' ' ' SER . 3.1 Cg_exo -61.78 132.74 41.39 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.391 1.394 . . . . 0.0 112.417 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.17 128.28 25.88 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.182 1.255 . . . . 0.0 113.074 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.509 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 20.4 tp -106.9 121.37 44.3 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -119.98 133.39 66.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.932 -1.105 . . . . 0.0 110.868 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.82 155.39 21.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -110.99 136.17 50.4 Favored 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.204 -1.174 . . . . 0.0 110.054 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.754 HE21 ' CD1' ' A' ' 13' ' ' ILE . 51.6 tt0 -137.6 143.53 41.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.43 149.55 37.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.979 -1.076 . . . . 0.0 111.594 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.424 ' H ' ' HG1' ' A' ' 90' ' ' THR . 0.5 OUTLIER -85.77 136.47 33.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 65' ' ' GLY . 20.8 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.466 0.65 . . . . 0.0 110.045 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 94' ' ' ILE . 3.1 mt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -57.42 -171.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.283 0.655 . . . . 0.0 110.988 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.491 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 53.0 ttt85 -146.67 160.65 41.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.725 -1.234 . . . . 0.0 110.92 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.491 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 25.0 t0 72.55 34.88 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.856 -0.527 . . . . 0.0 111.456 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.519 ' C ' ' CD2' ' A' ' 98' ' ' LEU . 2.2 tt -65.28 102.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.498 -1.376 . . . . 0.0 107.663 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.58 157.97 44.15 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.939 -1.101 . . . . 0.0 110.549 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.96 137.3 21.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.3 pt -123.72 -13.21 6.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -142.63 130.01 21.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.5 t -115.03 117.67 31.24 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -108.6 157.96 35.23 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.07 -40.74 33.98 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 121.509 1.473 . . . . 0.0 112.781 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.6 p -130.01 20.02 5.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 110.22 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.613 ' O ' ' OG1' ' A' ' 104' ' ' THR . 18.9 p -153.41 165.37 36.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.889 -1.132 . . . . 0.0 110.285 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 107' ' ' SER . 1.2 mt -141.49 157.26 45.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.9 tp -104.8 127.55 52.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.084 -1.01 . . . . 0.0 108.381 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 147' ' ' ALA . 2.0 pt -109.77 135.3 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 110.703 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.6 m -126.86 132.51 50.94 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 42.5 p90 -143.02 157.5 44.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 109.596 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -95.11 142.06 24.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.368 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.29 136.44 68.34 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 120.952 1.101 . . . . 0.0 112.034 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.38 -163.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 120.984 1.123 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.24 1.6 56.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 109.187 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.98 160.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.702 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.4 p -69.63 157.38 37.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 108.584 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.446 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 23.8 t -129.91 130.0 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 110.146 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -73.16 -42.97 62.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.472 ' CE2' HG23 ' A' ' 139' ' ' THR . 1.5 p90 -166.57 163.45 16.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.117 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-85 -120.0 142.76 48.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 108.771 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.468 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 1.2 mtp180 -99.36 127.34 45.37 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.509 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 35.7 mt -110.01 130.0 63.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.813 -1.179 . . . . 0.0 109.834 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.421 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 76.9 p -106.56 140.37 39.55 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.962 0.887 . . . . 0.0 111.58 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.628 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 5.8 m-85 -91.43 127.48 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.737 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -99.57 117.17 5.79 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.423 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 C--N 1.293 -1.855 0 O-C-N 121.541 -0.976 . . . . 0.0 109.197 179.319 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.513 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 93.3 mm-40 -109.38 121.53 45.38 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.611 -1.236 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -109.77 140.57 43.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.865 . . . . 0.0 111.617 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.509 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 43.0 p90 -139.6 150.0 44.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.481 ' H ' ' HG1' ' A' ' 139' ' ' THR . 4.1 p -86.19 163.57 17.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.112 -0.993 . . . . 0.0 111.463 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 142' ' ' GLY . 7.2 t -129.99 112.45 17.27 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.703 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.35 35.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.728 0.952 . . . . 0.0 112.719 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 140' ' ' VAL . . . 35.03 24.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 141' ' ' PRO . 28.8 t -66.39 -40.02 89.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.059 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -134.3 175.64 9.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.841 0.829 . . . . 0.0 110.546 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 52.5 m -94.62 0.0 54.81 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -136.83 150.92 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 108.844 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.462 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -141.73 162.92 34.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 109.847 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.4 t -100.56 148.37 24.89 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 108.98 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.628 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 48.5 mm -116.62 120.03 63.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.619 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 78.8 m-20 -120.06 173.91 6.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.19 -0.943 . . . . 0.0 110.306 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.7 t30 65.92 40.0 4.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 109.56 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.506 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 2.3 tt -100.66 146.54 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.764 ' H ' ' HH ' ' A' ' 158' ' ' TYR . 24.0 tttp -99.95 109.43 56.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.987 -1.071 . . . . 0.0 110.123 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.55 172.64 11.09 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.129 1.22 . . . . 0.0 112.485 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.608 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.34 20.86 77.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.677 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -148.65 156.75 42.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.317 . . . . 0.0 109.763 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.9 t0 -69.97 147.27 50.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.764 ' HH ' ' H ' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -138.0 156.87 47.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.79 -1.194 . . . . 0.0 110.515 -178.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.5 m -134.58 118.03 16.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.18 124.91 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.343 -1.473 . . . . 0.0 109.357 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.469 HG21 ' N ' ' A' ' 162' ' ' LEU . 99.8 m -130.83 142.83 50.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.0 110.439 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.469 ' N ' HG21 ' A' ' 161' ' ' THR . 80.3 mt -107.83 142.13 38.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.645 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 24.7 m-85 -119.98 140.02 51.59 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.94 129.93 55.44 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.94 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 121' ' ' TYR . 62.4 t -115.37 122.55 69.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.51 0.672 . . . . 0.0 110.045 -178.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.358 0.599 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 49.1 p -72.07 160.69 32.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 176' ' ' LYS . 18.3 mmtm -57.73 130.57 82.12 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 108.435 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.435 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.1 Cg_endo -61.12 134.66 53.93 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.195 1.263 . . . . 0.0 113.664 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 161' ' ' THR . 2.0 t -100.29 126.83 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.438 ' CB ' ' OG1' ' A' ' 161' ' ' THR . 79.1 p -122.69 145.25 48.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.057 -1.027 . . . . 0.0 112.187 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.61 159.97 42.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -104.13 135.78 44.98 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.85 -1.156 . . . . 0.0 109.502 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.478 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 65.7 t80 -130.2 109.67 10.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.39 136.22 33.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.077 -1.014 . . . . 0.0 108.99 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.677 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 2.5 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.371 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.799 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -79.49 140.63 37.24 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' THR . 66.5 m -76.77 140.67 67.65 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.391 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.426 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 2.9 Cg_endo -57.76 78.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.133 1.222 . . . . 0.0 111.71 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.516 ' H ' ' HG1' ' A' ' 6' ' ' THR . 0.9 OUTLIER -81.55 -152.02 0.09 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.425 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.0 22.95 77.31 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 106.207 -2.757 . . . . 0.0 106.207 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -57.78 130.0 44.44 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.623 0.725 . . . . 0.0 110.141 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.8 t0 -156.6 147.25 21.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 39.1 t -121.49 141.85 50.63 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.03 -1.043 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 12' ' ' ASP . 22.9 p -155.64 -171.54 3.81 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.4 m-20 49.63 39.94 18.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.426 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -76.49 130.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.42 160.81 27.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -59.67 -60.0 4.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 110.229 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -89.27 0.06 57.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.978 -1.076 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 14' ' ' THR . 47.5 t -149.33 154.62 39.26 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.429 ' N ' ' HG ' ' A' ' 17' ' ' SER . 12.6 p90 -165.12 141.01 5.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.405 HG23 ' NE2' ' A' ' 21' ' ' HIS . 3.1 m -91.24 150.09 21.49 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.449 -1.407 . . . . 0.0 111.301 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -119.98 138.44 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.419 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 68.9 m-70 -128.59 144.33 51.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.934 -1.104 . . . . 0.0 110.965 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -145.28 160.02 42.14 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.9 159.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.855 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.454 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -97.59 132.73 24.61 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.55 -178.46 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.003 1.135 . . . . 0.0 112.711 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -103.86 -0.75 28.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.15 151.68 38.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.088 -1.007 . . . . 0.0 109.729 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 2.9 Cg_endo -57.38 126.31 21.6 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.411 1.408 . . . . 0.0 112.29 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.56 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 19.6 pt -130.04 164.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.408 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -99.98 -1.79 36.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.515 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.9 -172.69 23.56 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 42.6 m-85 -128.45 156.84 42.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.24 128.08 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 mm -111.61 118.14 56.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.944 -1.098 . . . . 0.0 110.653 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -112.07 129.41 56.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.513 ' C ' ' CD2' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -124.01 141.29 52.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.781 -1.2 . . . . 0.0 110.982 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 46.9 p-80 -165.1 166.88 18.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.063 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.582 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.545 0.688 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.643 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -121.86 117.73 27.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.0 109.855 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' ILE . 85.9 m-20 -123.15 119.1 29.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.756 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -104.44 141.68 35.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.095 -1.003 . . . . 0.0 109.424 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.33 147.85 59.0 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.46 159.92 45.38 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 120.853 1.035 . . . . 0.0 111.516 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.85 -35.17 99.05 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.488 1.459 . . . . 0.0 112.402 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -69.95 -16.75 63.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.894 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -100.03 117.19 33.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.031 -1.043 . . . . 0.0 109.478 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -104.31 -0.08 28.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.419 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 51.6 p -132.85 138.4 47.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.249 -0.907 . . . . 0.0 109.799 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.5 tt -130.05 134.9 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.048 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.8 m -99.81 120.27 39.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.517 ' O ' ' OG ' ' A' ' 17' ' ' SER . 7.2 mt -97.45 140.75 31.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.274 -0.891 . . . . 0.0 109.568 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.1 p -132.63 179.42 6.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.686 . . . . 0.0 109.943 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.91 39.97 29.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.483 -0.761 . . . . 0.0 109.576 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.0 mt -107.21 149.34 27.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 0.0 109.104 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.537 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 87.7 m-20 -60.82 116.4 18.33 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.96 -1.087 . . . . 0.0 108.363 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 131.97 37.2 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.035 1.157 . . . . 0.0 113.401 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.31 62.82 2.24 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -150.55 157.52 43.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -1.224 . . . . 0.0 110.662 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 66' ' ' THR . 99.0 mt-10 -92.24 120.05 32.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.537 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 44.2 m-85 -110.84 148.71 31.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.157 -0.964 . . . . 0.0 110.996 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.46 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 62.7 t -110.04 124.34 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.9 124.85 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 p -108.4 134.81 50.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 111.195 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 72' ' ' ILE . 24.6 mm -114.5 117.3 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.5 mp -111.8 125.46 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 108.443 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.8 127.82 39.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.46 129.96 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.876 . . . . 0.0 109.116 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 52.3 t30 -111.64 34.82 3.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.865 . . . . 0.0 109.341 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.17 -87.05 1.52 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.79 -6.01 56.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -1.108 . . . . 0.0 110.393 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -131.12 150.05 52.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 60.0 mp0 -126.67 129.96 49.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.96 160.01 81.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.207 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.46 142.03 98.35 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.221 1.28 . . . . 0.0 111.969 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.99 136.99 78.61 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.239 1.293 . . . . 0.0 113.048 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 tp -115.77 121.29 42.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.95 130.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.947 -1.096 . . . . 0.0 111.074 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.08 160.44 22.49 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.004 -2.439 . . . . 0.0 107.004 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -118.54 137.88 52.91 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.04 -1.27 . . . . 0.0 110.033 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -139.3 139.29 37.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -102.24 133.68 46.73 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 110.77 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.34 140.06 41.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.651 . . . . 0.0 110.484 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . 0.455 ' O ' ' N ' ' A' ' 96' ' ' ARG . 2.0 mt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 96' ' ' ARG . 2.5 Cg_endo -65.89 62.13 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.824 1.016 . . . . 0.0 111.124 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.509 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 44.5 ttm105 -40.58 163.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 110.367 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.509 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.9 m-20 63.1 40.62 8.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.904 -0.497 . . . . 0.0 111.246 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.0 tp -79.97 104.09 10.3 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.835 -1.166 . . . . 0.0 107.887 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -158.64 166.58 31.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.021 . . . . 0.0 110.121 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 25.3 t -89.07 140.02 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.443 ' CD1' ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -114.14 -9.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -147.62 158.8 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.3 t -134.77 127.93 31.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.965 -1.084 . . . . 0.0 110.423 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.624 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.55 158.68 38.0 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -48.92 -32.68 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.485 1.456 . . . . 0.0 112.914 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -139.21 20.26 2.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 109.862 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.624 ' O ' ' OG1' ' A' ' 104' ' ' THR . 6.1 p -153.15 167.5 29.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.022 . . . . 0.0 110.067 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.443 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 30.6 tp -105.27 121.63 44.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 108.795 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 110' ' ' ILE . 3.1 pt -102.95 143.94 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.482 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 97' ' ' ASP . 36.3 t -136.73 140.0 42.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.704 -0.622 . . . . 0.0 109.756 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.695 ' CD2' ' O ' ' A' ' 145' ' ' SER . 48.8 p90 -144.37 156.99 44.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.564 -0.71 . . . . 0.0 109.303 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.96 130.45 89.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.67 118.59 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 120.937 1.091 . . . . 0.0 112.247 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.06 168.01 11.44 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 120.864 1.043 . . . . 0.0 111.995 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.01 28.12 8.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.829 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.97 159.99 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.5 t -70.86 129.96 40.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.326 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 122' ' ' TYR . 39.9 t -129.98 130.44 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -70.95 -51.27 26.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.488 ' CE2' HG23 ' A' ' 139' ' ' THR . 15.3 p90 -167.14 170.49 11.77 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.598 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 3.7 m-85 -120.03 139.86 51.86 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 108.47 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -98.7 126.85 44.44 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.5 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 44.9 mt -118.55 130.84 72.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.872 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.5 p -101.55 146.54 27.53 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.088 0.947 . . . . 0.0 111.527 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.721 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 3.3 m-85 -92.05 128.07 37.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.727 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.27 122.99 7.08 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.873 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--N 1.295 -1.779 0 O-C-N 121.617 -0.931 . . . . 0.0 108.535 178.742 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.523 0.678 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.519 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 28.3 mt-30 -125.23 131.77 53.08 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.1 pm0 -113.36 148.66 35.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.913 -1.117 . . . . 0.0 111.991 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.5 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 49.9 p90 -139.96 150.82 44.97 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.488 HG23 ' CE2' ' A' ' 121' ' ' TYR . 15.1 p -88.32 166.09 14.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.032 . . . . 0.0 111.634 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLY . 54.2 t -136.97 95.24 12.19 Favored Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.681 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -60.05 47.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 120.909 1.073 . . . . 0.0 113.243 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 33.98 26.98 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 141' ' ' PRO . 94.5 p -62.99 -39.98 96.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.452 ' HG2' ' N ' ' A' ' 145' ' ' SER . 19.0 tttt -146.12 165.24 29.7 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.889 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.695 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 79.4 p -78.97 -2.85 42.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.68 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.449 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 58.7 p -129.45 150.58 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 108.831 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.446 ' H ' HG13 ' A' ' 110' ' ' ILE . . . -132.39 161.57 33.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.101 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.45 HG21 ' N ' ' A' ' 149' ' ' ILE . 5.7 m -104.24 147.1 27.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.437 -0.789 . . . . 0.0 109.437 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.611 ' CG2' ' HH ' ' A' ' 126' ' ' TYR . 40.5 mm -117.92 119.98 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.721 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 10.6 m120 -121.87 176.83 5.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 110.463 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.93 50.05 5.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.809 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.458 HG13 ' CE2' ' A' ' 158' ' ' TYR . 2.6 tt -114.81 149.22 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.087 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -94.18 111.96 55.47 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 109.974 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.24 156.37 63.46 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.171 1.247 . . . . 0.0 112.945 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.663 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.02 23.69 76.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.1 137.1 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.059 -1.26 . . . . 0.0 109.706 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 53.7 t0 -60.04 140.01 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.727 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -134.28 172.07 13.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.866 -1.146 . . . . 0.0 111.055 -178.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -146.44 124.63 12.18 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 69.9 mt -111.61 125.95 68.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 120.296 -1.502 . . . . 0.0 109.155 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.437 HG23 ' CE1' ' A' ' 163' ' ' TYR . 21.9 m -124.44 141.05 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.371 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -124.05 140.49 52.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 111.427 -177.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 162' ' ' LEU . 7.0 m-85 -124.78 152.49 43.78 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.64 131.49 54.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.816 -1.177 . . . . 0.0 109.875 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.02 130.02 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.549 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 109.945 -179.884 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.2 p -80.08 170.03 17.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 108.47 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -63.57 118.42 44.28 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.1 Cg_exo -61.98 150.59 85.72 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.034 1.156 . . . . 0.0 113.393 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.73 131.05 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 97.4 p -117.2 154.03 31.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.09 -1.006 . . . . 0.0 111.475 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 48.3 pt -137.58 164.69 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -111.32 138.78 47.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.171 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.509 ' CE2' HD23 ' A' ' 108' ' ' LEU . 64.9 t80 -136.05 126.85 27.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.072 -1.017 . . . . 0.0 109.952 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -100.82 129.24 46.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.281 -0.887 . . . . 0.0 108.834 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.3 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.253 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.854 0 N-CA-C 119.456 2.542 . . . . 0.0 119.456 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt -125.98 139.63 53.28 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.24 -1.153 . . . . 0.0 109.327 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -79.69 135.99 36.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.311 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -85.25 139.97 36.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.127 -0.983 . . . . 0.0 109.667 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -57.82 143.29 95.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.214 1.276 . . . . 0.0 111.943 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.432 ' HB ' ' H ' ' A' ' 7' ' ' GLY . 2.9 p -150.57 -153.29 0.48 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.0 20.12 76.0 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 105.494 -3.043 . . . . 0.0 105.494 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -52.71 127.35 22.86 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.594 0.711 . . . . 0.0 110.09 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 10' ' ' SER . 53.2 t0 -147.83 141.15 25.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.674 ' HG ' ' NE2' ' A' ' 88' ' ' GLN . 81.9 p -111.46 145.89 38.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.956 -1.09 . . . . 0.0 110.255 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 12' ' ' ASP . 80.2 p -169.45 -175.91 2.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.547 -0.721 . . . . 0.0 109.346 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 49.94 44.3 25.38 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -80.03 129.99 36.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.764 -178.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.22 162.06 20.02 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -60.16 -60.01 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.999 -1.063 . . . . 0.0 110.287 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.61 0.14 57.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.957 -1.089 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 14' ' ' THR . 80.0 p -149.64 158.67 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.429 -0.794 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.481 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 26.0 p90 -165.54 148.28 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -97.26 149.86 21.58 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.289 -1.507 . . . . 0.0 111.607 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.4 t -122.44 140.44 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -129.83 145.59 51.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.743 -1.223 . . . . 0.0 111.086 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.8 p90 -149.66 158.42 44.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.02 158.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.879 -1.138 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -94.25 136.56 23.36 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.717 -0.614 . . . . 0.0 109.813 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.17 176.15 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.012 1.141 . . . . 0.0 112.407 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -102.54 9.97 39.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.82 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -112.01 157.22 40.33 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.995 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.48 122.09 11.18 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.74 1.627 . . . . 0.0 112.619 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 29.7 pt -130.03 165.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.295 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.4 p -106.66 -7.99 17.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.24 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.35 -179.18 22.62 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.585 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 16.3 m-85 -125.0 147.53 48.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.194 . . . . 0.0 109.207 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 33' ' ' ILE . 29.4 mm -102.1 126.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.584 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.2 mm -103.78 116.74 48.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.972 -1.08 . . . . 0.0 110.214 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -117.23 131.46 56.84 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.455 ' NE2' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -140.02 149.93 43.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.33 -1.481 . . . . 0.0 111.275 -178.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -169.76 154.92 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.459 ' H ' ' HB3' ' A' ' 41' ' ' SER . . . -85.04 162.66 19.24 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.372 -0.83 . . . . 0.0 108.914 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -59.97 -39.98 87.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.937 -1.102 . . . . 0.0 108.697 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 44.0 m170 -90.75 21.32 4.14 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.385 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.459 ' HB3' ' H ' ' A' ' 38' ' ' ALA . 85.2 p -74.3 168.77 18.99 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.342 -0.849 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.682 ' C ' ' H ' ' A' ' 44' ' ' ARG . 49.0 t -74.35 149.98 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.797 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -47.94 -0.46 0.01 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.682 ' H ' ' C ' ' A' ' 42' ' ' VAL . 13.6 mtp180 -114.41 91.72 25.31 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.236 . . . . 0.0 109.236 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.59 152.72 80.71 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.308 1.338 . . . . 0.0 112.334 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.455 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 42.9 mtt-85 -73.68 151.93 40.61 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.218 -0.926 . . . . 0.0 109.745 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.408 HE21 ' HD2' ' A' ' 49' ' ' ARG . 64.0 tt0 -117.85 112.56 20.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.587 0.708 . . . . 0.0 110.017 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.9 m-20 -124.11 129.96 51.74 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.679 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -118.77 145.18 45.79 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.859 -1.15 . . . . 0.0 109.664 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.52 149.07 72.49 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.963 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.17 157.76 51.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.889 1.059 . . . . 0.0 111.53 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.51 -35.4 98.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 121.363 1.375 . . . . 0.0 112.05 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -70.35 -13.71 62.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.534 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -97.49 120.0 37.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 110.005 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.3 p-10 -108.87 -1.25 19.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.592 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.7 p -129.99 137.57 50.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 109.366 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.6 tt -129.99 130.13 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 m -95.85 119.16 33.84 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.316 -0.865 . . . . 0.0 109.137 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.2 mt -93.04 146.04 23.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.0 p -136.35 178.36 7.12 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.581 . . . . 0.0 109.932 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 56.18 44.19 25.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.301 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 14.6 mt -113.65 152.89 29.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.478 -0.764 . . . . 0.0 109.623 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.644 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 31.4 t-20 -70.11 120.02 75.45 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.117 -0.989 . . . . 0.0 108.733 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 138.82 75.35 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.988 1.125 . . . . 0.0 113.192 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.94 63.34 3.03 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 67' ' ' GLU . 1.1 m -155.04 150.1 26.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.196 -1.179 . . . . 0.0 110.912 -179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.448 ' N ' HG21 ' A' ' 66' ' ' THR . 11.5 pt-20 -85.73 122.28 29.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.644 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 34.6 m-85 -111.54 139.96 46.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 110.481 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.473 ' CG2' HE22 ' A' ' 87' ' ' GLN . 18.8 t -96.56 120.12 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.4 t -120.13 130.02 74.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.43 ' CB ' HG12 ' A' ' 85' ' ' ILE . 88.7 p -118.5 139.91 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.63 129.99 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.46 HG22 HD11 ' A' ' 73' ' ' ILE . 49.7 mm -119.46 129.26 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.741 -1.224 . . . . 0.0 109.21 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.5 ' CB ' ' OG ' ' A' ' 81' ' ' SER . . . -96.62 127.36 42.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.099 -1.001 . . . . 0.0 109.01 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.82 142.98 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.86 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CG ' ' O ' ' A' ' 76' ' ' ASN . 6.7 t-20 -123.03 37.02 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 108.806 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.6 -94.82 1.82 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -94.71 -6.24 43.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 0.0 110.042 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.55 140.01 49.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.938 -1.101 . . . . 0.0 109.724 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.6 139.96 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.5 ' OG ' ' CB ' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -92.54 169.55 10.52 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.19 133.6 44.57 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.225 1.283 . . . . 0.0 112.218 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.1 155.95 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.473 1.449 . . . . 0.0 113.655 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.8 tp -131.82 121.14 23.62 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.43 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.4 mt -128.56 139.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.813 -1.179 . . . . 0.0 110.427 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.55 166.88 26.37 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.473 HE22 ' CG2' ' A' ' 69' ' ' VAL . 0.1 OUTLIER -119.54 137.81 53.58 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.062 -1.257 . . . . 0.0 110.039 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.674 ' NE2' ' HG ' ' A' ' 10' ' ' SER . 62.1 tp60 -134.76 135.95 42.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.714 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.481 ' H ' ' HG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -74.53 136.78 42.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 65' ' ' GLY . 3.7 t -43.47 171.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.52 0.676 . . . . 0.0 110.884 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 68.3 m -108.58 140.25 42.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.535 -0.728 . . . . 0.0 109.224 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.4 -40.04 96.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.0 110.738 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 94' ' ' ILE . 6.4 mt -69.97 139.55 88.06 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.02 -1.05 . . . . 0.0 109.618 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.45 -165.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 N-CA-C 109.57 -0.973 . . . . 0.0 109.57 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -157.54 165.6 35.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.51 -1.369 . . . . 0.0 110.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 69.91 37.14 1.83 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.717 -0.614 . . . . 0.0 110.457 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 46.7 tp -73.05 102.43 3.52 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -150.62 170.04 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.606 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 24.6 t -100.86 135.86 35.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.625 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.453 HD11 HG22 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -104.04 -14.91 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.71 0.767 . . . . 0.0 109.055 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.606 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -139.72 148.23 42.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.49 ' HG ' ' HH ' ' A' ' 182' ' ' TYR . 28.5 t -132.38 119.7 21.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.107 . . . . 0.0 110.793 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.632 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -118.39 153.53 51.83 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -49.97 -42.04 46.38 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.796 1.664 . . . . 0.0 113.479 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -119.1 10.39 12.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.908 -1.12 . . . . 0.0 110.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.632 ' O ' ' OG1' ' A' ' 104' ' ' THR . 76.8 p -152.05 160.94 43.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.823 -1.173 . . . . 0.0 110.209 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' A' ' 107' ' ' SER . 1.5 mt -143.8 155.26 44.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.376 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.531 ' C ' ' CD1' ' A' ' 109' ' ' LEU . 2.1 tm? -99.98 127.21 46.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.469 ' N ' HD12 ' A' ' 109' ' ' LEU . 5.8 pt -110.54 139.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 110.251 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 53.3 m -138.25 141.94 39.9 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.612 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.603 ' CD2' ' O ' ' A' ' 145' ' ' SER . 43.5 p90 -154.63 159.97 41.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.138 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.83 130.16 32.34 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 109.226 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.93 141.37 96.41 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 120.853 1.035 . . . . 0.0 112.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.87 -162.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.007 1.138 . . . . 0.0 112.379 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -104.2 17.12 24.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.147 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.0 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.289 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 t -69.97 130.66 42.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.331 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.1 t -115.93 130.01 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.412 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 166' ' ' THR . 26.9 mmt180 -71.71 -45.93 60.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.473 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 11.4 p90 -166.58 167.04 15.79 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.614 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-85 -120.4 139.83 52.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.444 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 55.4 ttp180 -96.95 130.06 44.32 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.972 -1.08 . . . . 0.0 108.423 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.477 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 62.8 mt -119.25 130.25 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -106.22 146.89 29.73 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.848 0.832 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.771 ' HH ' ' N ' ' A' ' 150' ' ' ASN . 4.6 m-85 -94.6 132.21 39.54 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.73 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.38 117.67 5.46 Favored Glycine 0 C--O 1.206 -1.649 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.672 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.609 ' O ' ' C ' ' A' ' 129' ' ' THR . 40.9 mt-10 -108.67 142.3 39.37 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.72 ' OG1' ' N ' ' A' ' 130' ' ' GLY . 1.1 p -21.37 -89.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.551 -0.718 . . . . 0.0 111.432 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.72 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . -79.76 -11.96 84.08 Favored Glycine 0 N--CA 1.495 2.594 0 O-C-N 120.918 -1.114 . . . . 0.0 110.679 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.12 47.6 0.18 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.562 ' N ' ' O ' ' A' ' 130' ' ' GLY . 40.2 t30 -59.99 -40.03 87.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.511 -0.994 . . . . 0.0 109.584 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.525 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 0.3 OUTLIER -99.22 -51.08 0.2 Allowed Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 121.426 -0.796 . . . . 0.0 110.117 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.525 ' CD ' ' N ' ' A' ' 133' ' ' SER . 3.0 Cg_endo -65.91 44.33 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.219 1.279 . . . . 0.0 112.674 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 133' ' ' SER . 0.8 OUTLIER -68.76 154.37 8.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.537 -0.727 . . . . 0.0 109.534 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 126' ' ' TYR . 71.0 mt-30 -109.95 128.64 55.5 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.751 -1.179 . . . . 0.0 108.293 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -119.28 155.46 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.668 -1.27 . . . . 0.0 112.529 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.477 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 54.2 p90 -140.86 151.73 44.54 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.6 p -88.51 165.82 14.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.85 -1.156 . . . . 0.0 111.688 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 142' ' ' GLY . 72.9 t -132.71 95.6 19.57 Favored Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -59.8 44.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 120.787 0.991 . . . . 0.0 112.799 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 35.63 23.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.97 -35.93 74.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -1.152 . . . . 0.0 109.916 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' HG2' ' HG ' ' A' ' 143' ' ' SER . 10.4 mmtp -139.92 153.68 47.02 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.522 -0.736 . . . . 0.0 109.832 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.603 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 88.6 p -79.9 -9.98 59.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.386 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.414 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 45.5 p -128.15 152.31 48.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.45 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -141.01 169.4 17.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -112.72 139.98 47.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -0.916 . . . . 0.0 108.943 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.594 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 32.9 mm -108.56 120.91 60.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 108.725 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.771 ' N ' ' HH ' ' A' ' 126' ' ' TYR . 73.2 m-20 -124.11 168.68 12.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 32.2 t30 77.15 44.98 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.49 HG21 ' CZ ' ' A' ' 158' ' ' TYR . 68.4 mt -113.01 130.04 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -72.85 121.87 86.14 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.0 109.941 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.03 159.41 42.71 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.27 1.313 . . . . 0.0 113.145 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 23.06 61.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.422 ' CB ' ' CG2' ' A' ' 129' ' ' THR . . . -127.89 133.26 49.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.114 -1.227 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 54.8 t0 -59.96 140.07 56.98 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.73 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.4 m-85 -132.38 161.52 33.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.681 -1.262 . . . . 0.0 111.057 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 2.4 m -134.28 120.86 20.49 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.7 mt -107.16 120.18 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.154 -1.591 . . . . 0.0 108.97 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.405 ' OG1' ' CB ' ' A' ' 179' ' ' SER . 88.3 m -132.54 149.97 52.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 2.3 pp -143.13 151.22 40.46 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.602 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.0 OUTLIER -120.91 140.01 52.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.66 131.48 49.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.745 -1.222 . . . . 0.0 109.778 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 72.4 t -119.62 121.21 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.366 -0.834 . . . . 0.0 109.797 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.531 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 16.5 p -108.52 -65.3 1.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.531 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -73.9 140.82 28.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -150.02 153.68 36.9 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.22 -1.165 . . . . 0.0 109.404 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.66 -86.79 1.36 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.572 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -73.59 -46.42 47.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -1.14 . . . . 0.0 111.074 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.8 m -135.61 71.63 64.84 Favored Pre-proline 0 C--N 1.293 -1.874 0 O-C-N 121.295 -0.878 . . . . 0.0 110.489 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.34 99.03 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 121.467 1.445 . . . . 0.0 111.828 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -123.0 147.6 46.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.02 -1.05 . . . . 0.0 110.165 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 24.4 p -123.1 149.37 44.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.416 -0.803 . . . . 0.0 109.185 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.1 p -79.94 170.13 16.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.072 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.411 ' O ' HD12 ' A' ' 94' ' ' ILE . 2.8 mttm -57.03 124.59 66.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.065 -1.022 . . . . 0.0 108.383 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 2.7 Cg_endo -63.34 150.34 88.83 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 120.905 1.07 . . . . 0.0 113.641 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.9 t -116.18 131.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.405 ' CB ' ' OG1' ' A' ' 161' ' ' THR . 80.2 p -130.03 154.12 47.74 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.009 . . . . 0.0 111.811 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.12 159.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -103.09 139.98 37.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.73 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 35.2 t80 -138.11 131.33 30.34 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.902 -1.124 . . . . 0.0 110.494 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.635 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 19.8 pttp -94.09 138.41 32.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 108.93 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.481 HG22 ' CD1' ' A' ' 158' ' ' TYR . 1.3 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.429 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.9 0 N-CA-C 119.456 2.543 . . . . 0.0 119.456 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.466 ' C ' ' OG ' ' A' ' 81' ' ' SER . 98.2 mt -133.14 143.5 49.29 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.252 -1.146 . . . . 0.0 109.234 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.96 159.27 28.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 6' ' ' THR . 42.7 t -94.29 130.02 35.29 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.886 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.81 72.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.106 1.204 . . . . 0.0 111.788 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -79.55 -153.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.013 -1.054 . . . . 0.0 109.611 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.417 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.94 22.62 78.4 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 -177.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -58.21 130.28 45.91 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.505 0.669 . . . . 0.0 110.291 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -147.5 123.91 10.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.706 ' CB ' HE21 ' A' ' 88' ' ' GLN . 0.3 OUTLIER -103.23 130.28 50.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 109.876 -179.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' ASP . 88.3 p -154.84 -172.4 4.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.159 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.0 49.89 19.5 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.505 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -88.48 126.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.905 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -113.82 162.45 16.32 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.96 -51.57 69.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.463 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 18.8 m120 -97.7 -0.11 46.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.907 -1.121 . . . . 0.0 109.887 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.695 ' O ' ' N ' ' A' ' 14' ' ' THR . 18.1 m -150.47 155.01 38.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.728 ' CD1' ' OE1' ' A' ' 88' ' ' GLN . 28.4 p90 -163.12 150.16 12.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 108.986 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -92.99 143.65 26.03 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.484 -1.385 . . . . 0.0 111.381 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' CE1' ' A' ' 18' ' ' PHE . 2.0 t -116.14 137.19 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.456 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 77.6 m-70 -130.48 149.52 52.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.65 -1.281 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 36.6 p90 -155.63 160.01 40.08 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.456 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.53 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 120.743 -1.223 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -94.54 132.58 28.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.793 -0.567 . . . . 0.0 109.915 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.68 151.8 67.44 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.998 1.132 . . . . 0.0 112.201 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -65.78 -40.03 91.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.34 147.7 98.84 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.66 138.36 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.426 1.418 . . . . 0.0 112.232 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.671 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 33.3 pt -132.6 168.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.733 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -103.66 -0.47 29.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.407 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.56 -173.62 23.01 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.671 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 44.6 m-85 -130.01 157.06 43.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.226 -1.161 . . . . 0.0 109.506 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.501 HG22 ' HE ' ' A' ' 49' ' ' ARG . 37.2 mm -110.03 130.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.0 mm -117.58 121.2 66.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.927 -1.108 . . . . 0.0 110.403 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.406 HH12 HG13 ' A' ' 73' ' ' ILE . 57.3 mtt180 -121.87 137.4 54.8 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.08 138.77 39.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.618 -1.301 . . . . 0.0 110.849 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -167.74 160.02 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.702 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . -83.33 154.56 24.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.849 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.479 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 13.3 pt-20 -64.54 -29.98 71.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.913 . . . . 0.0 109.051 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.479 ' CD2' ' HG3' ' A' ' 39' ' ' GLU . 90.4 m-70 -105.03 18.01 23.12 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 93.9 p -74.73 167.11 22.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 109.409 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.697 ' O ' ' N ' ' A' ' 44' ' ' ARG . 13.9 m -73.95 158.49 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -58.28 33.94 0.02 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 42' ' ' VAL . 68.3 mtt180 -122.17 55.49 6.4 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.844 -1.386 . . . . 0.0 110.476 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 44' ' ' ARG . 2.7 Cg_endo -57.77 126.15 20.89 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.502 1.468 . . . . 0.0 112.355 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -74.2 149.99 40.59 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.136 -0.978 . . . . 0.0 110.177 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.541 ' NE2' HH12 ' A' ' 49' ' ' ARG . 14.6 pt20 -120.66 122.02 39.57 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.609 0.719 . . . . 0.0 109.538 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -125.84 125.96 43.71 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.541 HH12 ' NE2' ' A' ' 47' ' ' GLN . 1.9 mmt-85 -108.94 147.3 32.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.108 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.2 m -127.24 147.44 61.96 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 110.175 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.03 159.52 46.14 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 120.955 1.103 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.39 -33.65 97.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 121.383 1.389 . . . . 0.0 111.926 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -69.97 -12.76 61.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.574 -0.704 . . . . 0.0 110.471 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -99.95 110.53 22.86 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -99.57 -1.5 38.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 108.788 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.456 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 78.5 p -138.24 136.07 36.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.2 tt -129.96 136.62 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 m -100.48 114.63 28.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 11.1 mt -88.48 149.97 23.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 109.556 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 27.3 p -136.01 177.89 7.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.743 -0.598 . . . . 0.0 109.96 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.9 m120 56.27 46.26 21.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.61 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.0 mt -109.96 153.2 24.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.827 . . . . 0.0 109.063 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -67.47 118.95 61.8 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 0.0 108.508 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.463 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 2.6 Cg_endo -62.84 129.83 27.4 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.893 1.062 . . . . 0.0 112.736 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.63 61.33 3.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -142.72 135.51 28.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -1.2 . . . . 0.0 111.464 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -91.03 117.03 29.26 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.718 ' OH ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -133.61 173.78 11.14 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.308 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.63 136.45 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.54 129.94 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -115.93 140.97 48.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.478 HG22 HD11 ' A' ' 72' ' ' ILE . 48.6 mm -119.95 120.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.406 HG13 HH12 ' A' ' 35' ' ' ARG . 34.2 mm -115.36 129.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 108.666 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -92.84 129.91 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.751 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.01 159.99 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -140.49 38.45 1.87 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.92 -97.61 1.62 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -99.6 0.03 41.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 110.082 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -111.46 151.68 28.3 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.691 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -129.56 153.93 47.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.466 ' OG ' ' C ' ' A' ' 2' ' ' LEU . 0.1 OUTLIER -107.22 176.8 1.49 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 108.977 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.45 ' CD ' ' HG ' ' A' ' 81' ' ' SER . 3.6 Cg_exo -65.75 131.44 27.53 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.035 1.157 . . . . 0.0 111.628 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.74 140.89 95.1 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.2 1.267 . . . . 0.0 113.384 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.1 tp -119.98 116.73 26.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -128.12 139.94 50.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.7 162.4 26.62 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -110.36 149.61 29.98 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.155 -1.203 . . . . 0.0 109.671 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.728 ' OE1' ' CD1' ' A' ' 18' ' ' PHE . 17.4 tt0 -148.46 156.48 42.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.379 -0.826 . . . . 0.0 108.98 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.522 ' N ' ' HG2' ' A' ' 88' ' ' GLN . . . -121.37 123.62 42.57 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.658 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.407 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -73.32 142.89 47.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -61.77 154.42 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.48 0.657 . . . . 0.0 110.673 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.8 p -83.51 151.62 25.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.425 -0.797 . . . . 0.0 109.815 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.54 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 53.2 t0 -81.16 -20.14 41.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.446 -0.784 . . . . 0.0 110.769 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.1 mt -81.53 140.84 48.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.876 -1.14 . . . . 0.0 109.527 -179.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.78 -170.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 109.946 -0.828 . . . . 0.0 109.946 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.464 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 38.2 ttm180 -149.89 160.0 43.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.503 -1.373 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.464 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 14.6 t0 72.6 36.22 1.01 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.682 -0.636 . . . . 0.0 110.871 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.433 ' C ' ' CD2' ' A' ' 98' ' ' LEU . 2.2 tt -68.01 102.9 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 97' ' ' ASP . 47.4 mt-10 -149.92 169.65 20.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.334 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.9 t -110.16 131.74 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.44 -0.787 . . . . 0.0 109.605 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -25.26 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.46 -0.775 . . . . 0.0 109.633 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -127.35 135.94 51.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.607 -0.683 . . . . 0.0 109.158 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.595 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 18.5 t -118.62 116.11 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.142 -0.974 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.611 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -105.66 155.82 37.51 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 121.313 -0.867 . . . . 0.0 108.903 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.61 -35.35 56.53 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.661 1.574 . . . . 0.0 112.931 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 56.4 p -128.75 16.36 6.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.992 -1.067 . . . . 0.0 110.412 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.611 ' O ' ' OG1' ' A' ' 104' ' ' THR . 29.0 p -158.66 169.34 24.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.806 -1.184 . . . . 0.0 110.01 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -144.81 153.41 41.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.68 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 4.5 tt -101.88 125.66 48.61 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.437 ' CD1' HD11 ' A' ' 124' ' ' ILE . 11.6 pt -114.01 152.12 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.048 -1.033 . . . . 0.0 111.117 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.2 t -147.47 140.31 24.91 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -147.61 160.0 43.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.04 130.16 32.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.73 138.68 84.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.851 1.034 . . . . 0.0 112.167 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.63 -160.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.119 1.213 . . . . 0.0 112.557 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.48 12.24 36.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.01 160.1 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 0.0 109.221 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 84.0 p -68.59 149.96 48.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 109.013 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.454 HG22 ' HH ' ' A' ' 122' ' ' TYR . 54.2 t -131.4 137.32 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -71.51 -53.5 13.66 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 26.4 p90 -167.37 170.32 11.56 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 3.5 m-85 -118.29 135.92 54.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.814 -1.179 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.592 ' NH2' ' CG ' ' A' ' 163' ' ' TYR . 28.5 ttp-105 -98.53 125.04 43.62 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.829 -1.17 . . . . 0.0 107.9 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.482 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 85.4 mt -111.17 133.46 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.075 -1.016 . . . . 0.0 110.135 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.44 ' H ' ' HG1' ' A' ' 125' ' ' THR . 3.1 p -105.55 145.12 31.37 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.916 0.865 . . . . 0.0 111.282 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.698 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.3 m-85 -92.41 120.28 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.93 129.65 9.72 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.903 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 130' ' ' GLY . 56.9 mt-10 -106.24 163.24 12.97 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.596 ' C ' ' O ' ' A' ' 128' ' ' GLU . 0.8 OUTLIER -28.91 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.0 109.766 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . 104.32 31.77 4.52 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.33 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.58 -90.08 0.39 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -133.29 22.45 4.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -1.156 . . . . 0.0 109.497 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.6 t -106.84 119.25 51.99 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.885 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.1 155.74 54.19 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.879 1.052 . . . . 0.0 112.355 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m -73.62 150.33 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.908 . . . . 0.0 109.754 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.554 ' O ' ' N ' ' A' ' 126' ' ' TYR . 96.8 mm-40 -117.49 138.08 52.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.485 ' OE1' ' NE ' ' A' ' 123' ' ' ARG . 21.9 pt-20 -128.8 160.02 33.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.761 -1.212 . . . . 0.0 112.246 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.482 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 50.4 p90 -144.61 157.12 44.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.2 p -87.5 164.94 15.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.901 -1.124 . . . . 0.0 110.939 -178.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.455 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 t -128.88 118.3 19.61 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.481 -0.762 . . . . 0.0 110.625 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.485 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.3 Cg_exo -59.04 130.47 36.61 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-N 119.273 0.776 . . . . 0.0 111.819 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.72 2.71 2.4 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 141' ' ' PRO . 52.5 m -89.98 -2.9 58.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -1.204 . . . . 0.0 110.113 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -128.81 138.73 52.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.02 -1.05 . . . . 0.0 109.728 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -94.36 -7.39 41.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.189 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.4 p -133.41 153.27 51.75 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.42 ' H ' HG13 ' A' ' 110' ' ' ILE . . . -138.4 175.4 9.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.853 -1.154 . . . . 0.0 109.757 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 t -120.38 146.93 45.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.622 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 32.8 mm -113.16 120.74 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.149 -0.969 . . . . 0.0 109.44 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.698 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 35.6 m120 -123.76 177.51 5.68 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.245 -0.909 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 m120 59.97 46.52 10.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.487 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 4.8 tt -107.68 153.67 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' N ' ' OH ' ' A' ' 158' ' ' TYR . 13.1 mmtt -97.66 109.97 53.08 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.008 -1.058 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.42 173.16 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.305 1.336 . . . . 0.0 113.036 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.34 27.29 71.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.562 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -152.81 155.81 37.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.981 -1.305 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 48.5 t0 -72.91 155.23 40.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.704 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-85 -142.43 160.02 41.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.858 -1.152 . . . . 0.0 110.774 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.7 m -135.09 120.5 19.13 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.4 mt -105.58 121.58 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.228 -1.545 . . . . 0.0 108.901 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.8 m -129.97 142.05 50.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.434 ' CD1' ' C ' ' A' ' 162' ' ' LEU . 1.4 pp -136.45 152.4 50.53 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.678 -1.209 . . . . 0.0 111.42 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.2 m-85 -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.53 132.61 47.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.699 -1.251 . . . . 0.0 109.541 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.65 124.06 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 2.8 p -123.13 -65.38 1.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.634 -0.666 . . . . 0.0 109.694 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.617 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -23.24 142.11 0.01 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -121.71 132.84 54.85 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.393 -1.063 . . . . 0.0 109.258 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 142.98 -151.68 23.37 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -91.46 -0.44 57.62 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.326 -1.103 . . . . 0.0 109.382 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.0 m -131.76 74.32 77.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.975 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.13 108.66 1.18 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.581 1.521 . . . . 0.0 111.724 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.99 150.04 25.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.374 -0.829 . . . . 0.0 109.779 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.1 p -126.2 148.89 49.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.356 -0.84 . . . . 0.0 109.606 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 85.0 p -79.34 170.0 17.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 108.807 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 6.2 mttm -56.2 129.06 73.54 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 108.756 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.438 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 2.3 Cg_endo -62.02 144.53 96.32 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.105 1.204 . . . . 0.0 113.217 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -113.54 128.6 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 81.1 p -123.29 150.04 44.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 111.703 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 39.5 pt -133.85 159.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -104.84 139.33 39.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.947 -1.095 . . . . 0.0 109.002 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.595 ' OH ' ' OG ' ' A' ' 103' ' ' SER . 62.4 t80 -135.33 130.38 34.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.593 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.1 139.99 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 108.946 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.562 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 7.5 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 109.479 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.867 0 N-CA-C 119.344 2.497 . . . . 0.0 119.344 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.1 mt -120.02 133.68 55.47 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.201 -1.176 . . . . 0.0 109.313 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -74.41 149.22 40.56 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.424 -0.798 . . . . 0.0 108.982 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' THR . 47.5 t -82.5 132.17 53.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.989 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.4 ' O ' HD21 ' A' ' 84' ' ' LEU . 3.0 Cg_endo -59.04 79.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.129 1.22 . . . . 0.0 111.591 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 4' ' ' SER . 1.0 OUTLIER -85.9 -159.56 0.47 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.787 -1.195 . . . . 0.0 110.241 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.24 19.05 72.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 -177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 57.3 t80 -59.97 134.83 57.41 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.643 0.735 . . . . 0.0 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 10' ' ' SER . 39.8 t0 -158.98 148.8 19.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 90.0 p -113.98 132.43 55.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.934 -1.104 . . . . 0.0 109.553 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 12' ' ' ASP . 37.3 p -149.22 -175.95 5.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.048 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 11' ' ' SER . 78.2 m-20 47.57 46.94 17.79 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -82.64 127.92 39.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.152 -177.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.681 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.04 161.39 18.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.557 ' H ' ' CB ' ' A' ' 116' ' ' ALA . . . -63.32 -54.37 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.775 -1.203 . . . . 0.0 109.902 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.08 0.01 57.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.052 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 14' ' ' THR . 97.6 p -155.53 158.91 39.23 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.371 -0.831 . . . . 0.0 109.01 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CD1' ' NE2' ' A' ' 88' ' ' GLN . 30.4 p90 -163.02 151.03 13.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 109.529 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 m -95.36 157.1 16.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.54 -1.35 . . . . 0.0 111.518 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.65 ' C ' ' CD2' ' A' ' 21' ' ' HIS . 1.1 t -128.4 160.0 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.65 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.7 m-70 -150.87 154.11 36.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.84 -1.162 . . . . 0.0 110.589 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -153.69 160.01 42.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.509 -0.745 . . . . 0.0 109.19 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -84.63 157.83 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.995 -1.066 . . . . 0.0 109.768 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -99.06 120.44 58.39 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.1 149.71 87.84 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.819 1.013 . . . . 0.0 112.19 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -78.83 -12.39 60.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.187 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -72.21 150.56 92.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.259 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.82 126.05 20.54 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.323 1.349 . . . . 0.0 112.719 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 28.4 pt -136.52 166.55 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.438 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 p -115.71 -3.31 12.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.9 -175.51 28.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.68 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 55.1 m-85 -131.57 151.36 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -1.199 . . . . 0.0 109.997 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.431 HG22 ' CZ ' ' A' ' 49' ' ' ARG . 1.4 mp -112.71 132.6 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.568 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.2 mm -118.16 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.03 -1.044 . . . . 0.0 110.96 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -119.43 138.4 53.13 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.432 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 8.3 t60 -129.91 139.94 51.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.553 -1.342 . . . . 0.0 111.221 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.442 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 28.8 p-80 -163.61 153.19 14.8 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.3 0.572 . . . . 0.0 109.979 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.526 ' O ' ' OG ' ' A' ' 41' ' ' SER . . . -95.93 149.68 21.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 0.0 109.338 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.03 -39.39 85.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 109.438 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -83.17 0.08 46.93 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.511 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' A' ' 38' ' ' ALA . 70.0 p -91.79 124.76 36.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.99 -1.069 . . . . 0.0 109.803 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.405 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 39.6 t -99.96 -10.04 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.68 174.35 6.79 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.02 132.41 88.45 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.26 -1.141 . . . . 0.0 109.326 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.65 136.75 77.6 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.859 1.04 . . . . 0.0 111.889 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -73.73 156.62 37.7 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.131 -0.981 . . . . 0.0 109.994 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -121.11 109.91 15.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.0 109.979 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' ILE . 91.7 m-20 -120.79 125.93 48.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.431 ' CZ ' HG22 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -109.27 151.77 26.11 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.01 -1.056 . . . . 0.0 108.731 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.8 m -130.98 145.2 56.76 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.908 -1.12 . . . . 0.0 110.113 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.04 160.4 38.02 Favored 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 120.999 1.133 . . . . 0.0 111.837 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.14 -32.66 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.588 1.525 . . . . 0.0 112.298 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 m -74.84 -10.95 59.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.0 111.101 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.81 117.83 35.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.149 . . . . 0.0 109.872 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -104.14 -0.01 29.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.462 -0.774 . . . . 0.0 109.489 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.7 p -130.94 139.91 50.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.902 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.1 tt -130.04 130.22 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 m -98.94 120.88 40.13 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.173 -0.955 . . . . 0.0 109.979 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.429 HD12 ' ND1' ' A' ' 36' ' ' HIS . 2.9 mt -97.21 138.11 35.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.222 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -123.3 179.48 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 53.74 48.56 21.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.923 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 55.5 mt -111.54 158.26 19.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.338 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.674 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 10.8 m120 -69.94 129.99 90.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.36 132.66 39.44 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.336 1.357 . . . . 0.0 113.505 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 67.08 65.84 2.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.602 ' N ' ' OG1' ' A' ' 90' ' ' THR . 1.2 m -149.86 151.85 34.15 Favored 'General case' 0 N--CA 1.506 2.341 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.188 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' N ' ' CG2' ' A' ' 66' ' ' THR . 49.6 mp0 -92.66 119.96 32.6 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.674 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 50.0 m-85 -111.23 140.51 45.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.117 -0.99 . . . . 0.0 110.799 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.442 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 15.2 t -92.7 121.42 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.99 125.6 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 109.708 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -99.59 135.33 41.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.673 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.423 HG21 HD11 ' A' ' 72' ' ' ILE . 48.5 mm -116.51 129.97 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.497 ' CG2' ' N ' ' A' ' 74' ' ' ALA . 80.4 mt -127.67 160.01 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 110.152 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.497 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -128.54 131.94 48.25 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.1 m -128.31 151.21 34.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.222 -0.924 . . . . 0.0 109.295 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -126.25 33.84 4.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -0.945 . . . . 0.0 108.515 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.83 -89.33 1.27 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.421 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 40.7 ttm-85 -89.97 -19.38 24.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -1.061 . . . . 0.0 110.386 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -104.36 150.32 24.6 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 110.788 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -120.63 147.34 45.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.078 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -104.16 160.87 24.66 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.164 -0.96 . . . . 0.0 109.316 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.89 129.96 31.01 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.184 1.256 . . . . 0.0 112.298 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.91 145.25 98.77 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.294 1.329 . . . . 0.0 113.5 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.4 HD21 ' O ' ' A' ' 5' ' ' PRO . 13.3 tp -119.89 119.34 33.21 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -120.02 130.04 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.974 -1.078 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.15 168.79 22.86 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -121.88 147.77 45.58 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 109.889 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.798 ' NE2' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -142.29 159.27 42.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -119.08 135.36 54.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.083 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -73.84 133.6 43.21 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.136 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 90' ' ' THR . 39.7 t -37.21 171.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.008 0.909 . . . . 0.0 111.547 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.539 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 1.4 t -105.36 153.62 21.41 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 49.7 t0 -59.99 -40.02 87.72 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.473 -0.767 . . . . 0.0 110.243 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.648 ' CD1' ' O ' ' A' ' 176' ' ' LYS . 0.5 OUTLIER -72.62 143.67 85.2 Favored Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 118.116 -1.434 . . . . 0.0 109.115 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.438 ' N ' HG21 ' A' ' 94' ' ' ILE . 3.1 Cg_exo -61.7 -158.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 120.635 0.89 . . . . 0.0 111.205 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.555 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 40.5 ttp180 -154.14 166.69 32.29 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.098 -1.001 . . . . 0.0 109.812 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.555 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 15.7 t0 74.96 35.08 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.503 -0.748 . . . . 0.0 109.831 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 44.3 tp -67.6 107.0 2.36 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -158.51 163.55 36.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.58 139.96 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 pt -118.08 -16.0 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.115 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -140.67 130.04 23.83 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.533 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 6.2 m -117.42 119.76 36.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.019 . . . . 0.0 109.805 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -101.95 158.07 32.48 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.18 -35.56 52.72 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.312 1.341 . . . . 0.0 112.497 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 68.4 p -130.14 18.4 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.031 -1.043 . . . . 0.0 110.245 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.607 ' O ' ' OG1' ' A' ' 104' ' ' THR . 2.4 p -154.16 160.07 41.72 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.877 -1.139 . . . . 0.0 109.91 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.496 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -133.38 150.13 51.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 108.653 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 4.7 tt -105.2 120.09 40.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 108.898 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.432 ' CD1' HD11 ' A' ' 124' ' ' ILE . 1.3 pt -99.97 138.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.5 t -132.56 133.92 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -145.72 144.89 30.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.414 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 1.8 pt-20 -72.3 145.97 88.79 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.934 -1.103 . . . . 0.0 108.575 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.53 136.56 74.97 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 120.962 1.108 . . . . 0.0 111.744 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.31 -163.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 120.332 0.688 . . . . 0.0 111.364 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.557 ' CB ' ' H ' ' A' ' 15' ' ' ALA . . . -113.74 11.68 18.15 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.221 -0.924 . . . . 0.0 108.986 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 33.1 m -129.97 159.99 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -71.16 133.06 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.933 . . . . 0.0 108.789 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 14.6 t -122.78 134.59 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.074 . . . . 0.0 110.266 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.468 ' HD2' ' NH2' ' A' ' 168' ' ' ARG . 0.8 OUTLIER -72.3 -52.29 16.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.473 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 14.1 p90 -166.84 170.11 12.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.638 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.5 m-85 -122.15 143.87 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.963 . . . . 0.0 108.412 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.606 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 54.6 ttt-85 -103.71 126.04 50.58 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.692 -1.255 . . . . 0.0 107.906 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.471 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 50.2 mt -116.56 144.1 25.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.48 ' CG2' ' NH2' ' A' ' 123' ' ' ARG . 36.0 p -118.31 144.49 45.8 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.832 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.735 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.9 m-85 -87.9 131.36 34.61 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.52 115.25 4.66 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.922 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.496 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 34.2 mt-10 -109.97 98.67 7.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 9.1 p -60.33 -39.62 87.7 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.653 -1.28 . . . . 0.0 109.765 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -50.95 -39.09 39.67 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.32 10.13 74.81 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 121.139 -1.212 . . . . 0.0 110.494 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.473 ' OD1' ' NZ ' ' A' ' 153' ' ' LYS . 15.1 t-20 -60.0 -39.97 87.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.859 -1.377 . . . . 0.0 109.162 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.7 m -136.15 149.82 69.25 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.25 166.79 6.86 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.106 1.204 . . . . 0.0 112.266 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m -60.02 152.53 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.203 -0.935 . . . . 0.0 108.582 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.532 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 83.6 mt-30 -117.95 136.61 53.38 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.265 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.606 ' CD ' ' HE ' ' A' ' 123' ' ' ARG . 10.6 pt-20 -123.17 144.32 49.43 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.261 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 52.2 p90 -138.49 158.87 43.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.0 p -94.25 167.0 11.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.905 -1.122 . . . . 0.0 111.54 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.587 ' O ' ' N ' ' A' ' 142' ' ' GLY . 98.0 t -135.17 85.64 33.1 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.5 Cg_exo -58.87 50.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 120.996 1.131 . . . . 0.0 113.162 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.587 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 34.95 24.54 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 141' ' ' PRO . 79.6 p -61.64 -39.98 93.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -1.18 . . . . 0.0 109.763 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -145.58 171.13 15.14 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.112 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 99.5 p -84.35 -1.17 55.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.581 -0.699 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.446 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 68.4 p -130.73 151.31 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 108.993 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -126.78 148.92 49.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.972 -1.08 . . . . 0.0 109.79 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 m -94.02 143.19 26.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.11 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.593 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 37.3 mm -115.19 121.33 66.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.735 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 14.3 m120 -127.11 170.0 12.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.703 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 19.0 m120 68.34 48.6 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.0 109.816 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.463 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 2.0 tt -113.74 147.34 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.473 ' NZ ' ' OD1' ' A' ' 132' ' ' ASN . 2.6 ttpt -95.45 111.13 54.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.848 -1.157 . . . . 0.0 109.654 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.95 163.37 28.63 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.061 1.174 . . . . 0.0 112.705 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.96 72.49 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.569 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -146.36 146.79 30.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.31 . . . . 0.0 109.917 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 55.3 t0 -70.01 151.52 45.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.588 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.8 OUTLIER -138.1 173.16 11.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.86 -1.15 . . . . 0.0 111.225 -178.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -141.34 111.52 6.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.81 124.03 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.3 -1.5 . . . . 0.0 109.462 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.453 HG23 ' CE1' ' A' ' 163' ' ' TYR . 25.9 m -124.81 139.92 53.4 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.617 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.552 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -119.67 136.5 54.38 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -178.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 162' ' ' LEU . 51.0 m-85 -121.65 141.45 51.11 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.471 ' HB2' ' HG ' ' A' ' 175' ' ' SER . . . -103.61 123.64 47.33 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 62.8 t -110.36 119.93 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.004 . . . . 0.0 109.84 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 p -96.41 -43.62 7.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.453 -0.78 . . . . 0.0 108.949 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -92.12 164.64 28.63 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.468 ' NH2' ' HD2' ' A' ' 120' ' ' ARG . 61.8 mtt180 -114.87 -109.98 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.093 -1.24 . . . . 0.0 110.337 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.41 -28.68 39.02 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -72.72 -44.46 61.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.981 -1.305 . . . . 0.0 109.871 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.457 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 75.6 m -141.47 66.31 23.03 Favored Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 121.56 -0.713 . . . . 0.0 109.674 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 171' ' ' SER . 2.8 Cg_endo -65.74 82.61 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.673 1.582 . . . . 0.0 112.421 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.86 139.66 52.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.28 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.2 p -101.9 167.04 10.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -0.973 . . . . 0.0 109.825 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.471 ' HG ' ' HB2' ' A' ' 164' ' ' ALA . 1.4 p -105.19 160.31 15.18 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.648 ' O ' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -39.07 100.1 0.21 Allowed Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 121.088 -1.007 . . . . 0.0 110.148 -178.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.495 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.5 Cg_exo -62.69 159.27 37.85 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 121.818 1.679 . . . . 0.0 114.751 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 59.0 t -124.22 130.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 80.2 p -120.26 150.19 41.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.757 -1.215 . . . . 0.0 110.933 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.28 161.14 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.225 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -104.33 128.72 52.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 108.601 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.533 ' OH ' ' OG ' ' A' ' 103' ' ' SER . 60.5 t80 -123.59 128.32 49.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 110.382 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -100.83 138.1 38.34 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.34 -0.85 . . . . 0.0 109.044 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.569 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.481 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.865 0 N-CA-C 119.404 2.522 . . . . 0.0 119.404 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.2 mt -129.98 145.74 51.65 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.262 -1.14 . . . . 0.0 109.08 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -80.0 124.99 29.2 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 109.199 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.54 ' OG ' ' OG ' ' A' ' 81' ' ' SER . 53.5 m -78.75 146.9 69.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' O ' ' CG2' ' A' ' 6' ' ' THR . 3.0 Cg_exo -57.6 157.98 21.28 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 120.983 1.122 . . . . 0.0 111.681 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 5' ' ' PRO . 21.2 p -156.2 -144.36 0.13 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 109.646 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.14 19.47 24.01 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 105.249 -3.14 . . . . 0.0 105.249 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 6' ' ' THR . 59.6 t80 -54.91 130.03 39.8 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.83 0.824 . . . . 0.0 110.805 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 10' ' ' SER . 60.6 t0 -158.67 141.3 14.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 41.2 m -106.85 140.35 39.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.608 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 12' ' ' ASP . 60.8 p -152.98 -176.44 5.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' SER . 74.7 m-20 50.01 46.22 24.63 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.581 ' CD1' HE21 ' A' ' 88' ' ' GLN . 1.0 OUTLIER -82.19 123.4 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.733 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.2 161.98 17.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.02 -57.61 12.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.813 -1.179 . . . . 0.0 110.049 -178.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -91.1 -0.01 57.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.937 -1.102 . . . . 0.0 110.012 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 38.5 t -151.36 155.73 39.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.685 ' CZ ' ' OE1' ' A' ' 88' ' ' GLN . 20.5 p90 -162.9 145.76 10.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -94.78 151.11 19.52 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.463 -1.398 . . . . 0.0 111.531 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.9 t -120.1 134.83 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.401 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 49.9 m-70 -129.23 149.6 50.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.643 -1.286 . . . . 0.0 111.0 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 40.4 p90 -154.1 159.39 41.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -0.78 . . . . 0.0 109.175 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.36 155.66 3.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.044 -1.035 . . . . 0.0 109.941 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.464 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -87.14 135.41 34.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.849 -0.532 . . . . 0.0 109.751 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.79 -179.5 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 120.962 1.108 . . . . 0.0 112.139 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.53 12.46 26.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.722 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -113.2 158.33 38.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.015 . . . . 0.0 109.647 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.417 ' HB2' HD22 ' A' ' 76' ' ' ASN . 2.9 Cg_endo -56.54 130.3 39.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.777 1.651 . . . . 0.0 112.554 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 39.5 pt -138.92 170.02 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.395 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.469 ' HG1' ' N ' ' A' ' 77' ' ' GLY . 24.1 p -117.98 0.27 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.715 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.43 -178.18 24.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 51.2 m-85 -130.14 151.29 50.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -1.13 . . . . 0.0 109.516 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.46 HD11 ' NH1' ' A' ' 49' ' ' ARG . 28.4 mm -110.01 129.99 63.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.519 ' O ' ' O ' ' A' ' 48' ' ' ASP . 1.9 mm -113.55 120.56 63.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.812 -1.18 . . . . 0.0 109.935 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -116.67 131.53 56.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -121.8 139.11 54.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.285 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -168.62 147.3 4.2 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.093 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.484 ' H ' HG22 ' A' ' 42' ' ' VAL . . . -82.45 167.72 18.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 108.74 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -72.66 -97.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.959 -1.088 . . . . 0.0 110.59 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -73.49 -39.96 64.46 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.363 0.601 . . . . 0.0 111.386 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.41 ' O ' ' CB ' ' A' ' 38' ' ' ALA . 1.4 p -101.48 96.87 7.43 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.257 -0.902 . . . . 0.0 110.425 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.484 HG22 ' H ' ' A' ' 38' ' ' ALA . 9.0 p -143.43 140.24 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.588 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.15 -87.36 0.71 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -120.04 114.63 33.59 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.215 -1.168 . . . . 0.0 109.651 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.75 95.47 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 120.732 0.955 . . . . 0.0 111.614 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -75.35 155.0 36.97 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.299 -0.876 . . . . 0.0 111.404 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -112.83 113.51 25.62 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.519 ' O ' ' O ' ' A' ' 34' ' ' ILE . 85.6 m-20 -113.7 123.24 49.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.151 -0.968 . . . . 0.0 108.653 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.481 HH11 ' HG3' ' A' ' 49' ' ' ARG . 0.4 OUTLIER -108.69 144.47 36.43 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.025 -1.047 . . . . 0.0 108.956 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.1 m -128.13 149.99 72.62 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.037 -1.04 . . . . 0.0 110.203 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.53 160.1 41.34 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.123 1.216 . . . . 0.0 111.724 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.92 -35.97 97.69 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.364 1.376 . . . . 0.0 112.38 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -70.23 -12.02 61.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 110.867 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -101.85 121.21 41.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.015 -1.053 . . . . 0.0 110.113 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -108.75 -0.0 20.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.61 -0.681 . . . . 0.0 109.699 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.401 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 57.3 p -130.34 139.95 50.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.183 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 6.4 tt -130.75 139.92 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.9 m -106.9 131.49 53.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.248 -0.908 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.509 ' O ' ' OG ' ' A' ' 17' ' ' SER . 4.2 mt -112.07 148.08 34.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.806 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.4 p -135.06 179.66 6.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.862 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 57.47 40.72 26.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.368 -0.832 . . . . 0.0 109.539 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 44.6 mt -107.31 156.83 18.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.4 -0.813 . . . . 0.0 109.409 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.576 ' H ' ' HH ' ' A' ' 68' ' ' TYR . 22.8 m120 -69.99 120.21 76.46 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 108.618 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.59 129.38 27.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 120.835 1.024 . . . . 0.0 112.966 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 76.17 60.76 3.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.442 HG21 ' N ' ' A' ' 67' ' ' GLU . 1.2 m -145.47 152.02 39.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -1.125 . . . . 0.0 110.336 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.442 ' N ' HG21 ' A' ' 66' ' ' THR . 3.8 pt-20 -88.78 119.99 29.78 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HH ' ' H ' ' A' ' 63' ' ' ASN . 38.4 m-85 -112.72 139.98 47.88 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.057 -1.027 . . . . 0.0 110.617 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.99 121.35 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.0 121.59 67.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.0 p -100.88 140.99 34.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 111.604 -179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 72' ' ' ILE . 49.7 mm -119.78 120.0 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.92 130.0 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.088 . . . . 0.0 109.612 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.4 139.42 30.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.91 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.0 139.45 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.135 -0.978 . . . . 0.0 109.615 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.417 HD22 ' HB2' ' A' ' 28' ' ' PRO . 41.7 t-20 -121.51 37.67 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 108.779 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.469 ' N ' ' HG1' ' A' ' 30' ' ' THR . . . 95.27 -100.66 2.58 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -91.63 -0.18 57.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.167 . . . . 0.0 110.325 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.26 141.57 48.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.06 . . . . 0.0 109.513 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.12 138.78 53.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.729 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.54 ' OG ' ' OG ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -83.85 163.33 49.29 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' OG ' ' A' ' 4' ' ' SER . 3.1 Cg_exo -57.54 135.08 67.5 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 121.336 1.358 . . . . 0.0 111.945 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.93 130.93 40.75 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.251 1.301 . . . . 0.0 113.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.5 tp -107.32 119.99 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -125.28 134.19 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.993 -1.067 . . . . 0.0 111.146 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.52 164.83 24.87 Favored Glycine 0 N--CA 1.479 1.542 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -114.69 131.11 56.85 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.921 -1.34 . . . . 0.0 110.084 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.685 ' OE1' ' CZ ' ' A' ' 18' ' ' PHE . 18.6 tm0? -123.87 128.32 49.3 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' O ' ' NE2' ' A' ' 88' ' ' GLN . . . -101.45 131.56 47.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.471 ' H ' ' HG1' ' A' ' 90' ' ' THR . 0.0 OUTLIER -74.43 136.65 42.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.679 ' O ' ' N ' ' A' ' 65' ' ' GLY . 3.9 t -45.72 166.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.447 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.404 ' HB2' ' HE ' ' A' ' 96' ' ' ARG . 70.0 m -118.48 143.74 46.5 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.05 -39.91 87.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.277 -0.89 . . . . 0.0 108.656 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 94' ' ' ILE . 6.7 mt -66.67 138.93 95.67 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.424 -0.797 . . . . 0.0 109.015 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.24 159.63 21.99 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 120.332 0.688 . . . . 0.0 110.541 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.404 ' HE ' ' HB2' ' A' ' 92' ' ' SER . 24.0 mmt180 -120.57 172.5 7.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.826 -1.171 . . . . 0.0 110.959 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.59 39.99 29.59 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 41.7 tp -72.15 92.9 1.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.765 -1.209 . . . . 0.0 107.849 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.49 170.69 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.654 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -104.68 139.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.1 pt -107.62 -15.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.258 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.3 134.79 34.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 99.87 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 110.334 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.602 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -81.93 156.8 69.67 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -49.03 -43.93 34.44 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.466 1.444 . . . . 0.0 112.95 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 44.2 p -124.36 18.4 8.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.602 ' O ' ' OG1' ' A' ' 104' ' ' THR . 37.7 p -153.76 165.77 34.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.862 -1.149 . . . . 0.0 109.898 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.513 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.9 OUTLIER -140.69 154.22 46.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.561 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.445 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 8.5 tt -104.96 119.99 40.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 110' ' ' ILE . 5.2 pt -106.68 145.99 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.987 . . . . 0.0 110.616 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 95.7 p -144.79 149.99 36.43 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.44 0.638 . . . . 0.0 109.778 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.606 ' CE2' ' O ' ' A' ' 145' ' ' SER . 43.8 p90 -149.84 154.87 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -76.0 134.67 71.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.065 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 127.92 26.17 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.771 0.981 . . . . 0.0 111.948 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.22 -178.22 0.19 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.058 1.172 . . . . 0.0 112.613 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.37 10.26 41.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.84 . . . . 0.0 109.467 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -71.7 138.73 48.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.01 135.9 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.468 -0.77 . . . . 0.0 109.079 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.691 ' NH1' ' O ' ' A' ' 166' ' ' THR . 80.6 mmt-85 -71.18 -51.45 24.73 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.774 -1.204 . . . . 0.0 107.947 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.451 ' CE2' HG23 ' A' ' 139' ' ' THR . 6.5 p90 -167.52 174.57 7.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 17.4 m-85 -120.18 139.43 52.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.165 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 37.0 ttp-105 -100.46 129.96 46.48 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.484 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 16.6 mt -124.02 151.96 29.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.783 -1.198 . . . . 0.0 110.859 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.458 ' N ' HG21 ' A' ' 124' ' ' ILE . 25.4 p -126.13 141.14 52.06 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.093 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.733 ' HH ' ' N ' ' A' ' 150' ' ' ASN . 6.5 m-85 -84.11 129.54 34.9 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -109.17 131.01 10.3 Favored Glycine 0 N--CA 1.483 1.803 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.247 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.546 ' O ' ' C ' ' A' ' 129' ' ' THR . 61.4 mt-10 -105.78 158.1 16.97 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 130' ' ' GLY . 0.9 OUTLIER -31.37 -64.23 0.15 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.247 -0.908 . . . . 0.0 110.242 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.602 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . -60.02 -40.01 96.44 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . 77.48 -33.12 1.59 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.477 ' H ' ' C ' ' A' ' 130' ' ' GLY . 25.9 t-20 -71.1 -19.94 62.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -1.027 . . . . 0.0 108.429 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.423 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -62.33 166.82 6.18 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 3.0 Cg_exo -57.21 87.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 121.652 1.568 . . . . 0.0 112.796 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -55.61 160.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.279 -0.888 . . . . 0.0 108.933 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.531 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 22.2 mm100 -111.92 129.87 56.03 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.355 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 65.4 tt0 -107.86 133.86 51.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.546 -0.721 . . . . 0.0 111.323 -178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.484 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 41.5 p90 -141.64 157.52 44.98 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.451 HG23 ' CE2' ' A' ' 121' ' ' TYR . 3.2 p -98.21 167.44 10.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.785 -1.197 . . . . 0.0 111.525 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 88.1 t -132.18 118.68 16.3 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.488 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -57.6 127.99 27.53 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.507 0.804 . . . . 0.0 112.268 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.26 -4.55 0.83 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.488 ' H ' ' C ' ' A' ' 141' ' ' PRO . 89.6 p -89.73 -0.05 57.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -1.233 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -124.88 132.96 53.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.889 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 97.7 p -93.13 0.05 57.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.474 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 15.1 p -139.12 158.12 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.451 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -139.95 169.95 16.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.819 -1.176 . . . . 0.0 109.916 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -118.92 142.59 47.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 109.391 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 31.4 mm -110.21 120.43 61.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.889 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.733 ' N ' ' HH ' ' A' ' 126' ' ' TYR . 25.2 m120 -123.04 172.94 8.16 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -0.941 . . . . 0.0 110.283 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 61.1 49.82 5.38 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.728 0.775 . . . . 0.0 109.107 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.479 HG13 ' CE2' ' A' ' 158' ' ' TYR . 5.2 tt -108.98 153.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.75 110.02 55.63 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 110.147 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.43 170.04 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.156 1.237 . . . . 0.0 112.492 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.98 20.03 75.89 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -146.48 150.8 36.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.043 -1.269 . . . . 0.0 109.701 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.643 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.3 t0 -70.02 153.12 43.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.728 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -140.89 159.89 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.611 -1.306 . . . . 0.0 110.55 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.473 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 46.9 m -132.94 119.99 20.86 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 79.6 mt -106.74 120.74 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.348 -1.47 . . . . 0.0 108.668 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.452 HG23 ' CE1' ' A' ' 163' ' ' TYR . 94.2 m -120.02 130.2 54.61 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.944 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.607 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 0.1 OUTLIER -115.87 138.22 51.37 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.696 0.76 . . . . 0.0 110.83 -178.436 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.51 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.6 m-85 -117.47 157.38 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.56 135.79 54.99 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.795 -1.19 . . . . 0.0 110.176 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.2 t -110.06 120.0 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.691 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.8 p -110.67 -42.58 4.02 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -54.06 -153.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 72.5 mtm180 -139.49 170.06 16.61 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.289 -1.124 . . . . 0.0 108.801 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -47.36 -32.02 6.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -72.36 -39.95 67.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -1.114 . . . . 0.0 109.136 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.9 m -133.15 70.0 78.08 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 121.777 -0.577 . . . . 0.0 109.688 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.06 98.57 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.517 1.478 . . . . 0.0 112.279 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -114.2 148.36 37.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.602 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.5 p -133.77 146.3 50.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.653 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 81.9 p -80.64 169.15 18.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 176' ' ' LYS . 0.2 OUTLIER -56.29 121.3 41.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.504 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.0 Cg_exo -61.38 154.02 61.74 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 120.929 1.086 . . . . 0.0 114.162 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.64 129.97 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 85.0 p -121.13 156.64 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.439 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 47.0 pt -139.57 165.76 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.343 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -112.69 129.95 56.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.97 . . . . 0.0 108.963 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.513 ' CE1' HD23 ' A' ' 108' ' ' LEU . 54.7 t80 -124.98 118.52 26.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.026 . . . . 0.0 109.974 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.64 140.02 29.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.514 -179.839 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.838 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.434 ' O ' ' CD ' ' A' ' 82' ' ' PRO . 86.0 mt -120.17 131.13 54.89 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.226 -1.161 . . . . 0.0 109.344 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -79.97 130.11 35.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -84.83 149.79 54.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.473 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.75 146.19 86.7 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.173 1.249 . . . . 0.0 112.105 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' N ' ' A' ' 8' ' ' PHE . 17.8 p -143.54 -150.65 0.32 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.044 -1.035 . . . . 0.0 109.601 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.96 19.18 49.84 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 105.0 -3.24 . . . . 0.0 105.0 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' N ' ' C ' ' A' ' 6' ' ' THR . 63.6 t80 -54.51 134.93 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.478 -0.861 . . . . 0.0 110.863 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.9 t0 -157.97 147.57 19.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.7 m -116.81 135.23 53.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 12' ' ' ASP . 77.3 p -152.05 -171.02 3.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 11' ' ' SER . 81.5 m-20 50.0 41.62 23.45 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.453 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -78.39 130.84 35.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.051 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.56 162.73 24.27 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -58.81 -60.08 4.42 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.026 -1.046 . . . . 0.0 110.279 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -91.49 -0.0 57.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.896 -1.127 . . . . 0.0 109.993 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 98.4 p -148.92 155.81 41.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.464 ' CD1' ' HG3' ' A' ' 88' ' ' GLN . 18.7 p90 -165.04 144.67 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 108.687 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -96.89 150.62 20.54 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.361 -1.462 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.01 132.4 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.423 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 63.4 m-70 -125.43 143.54 50.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.821 -1.175 . . . . 0.0 110.657 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 44.5 p90 -147.79 152.98 38.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -0.767 . . . . 0.0 109.211 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.01 142.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.108 -0.995 . . . . 0.0 110.492 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.03 137.06 79.28 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.838 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.58 -164.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.991 1.127 . . . . 0.0 112.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -112.38 17.86 19.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.939 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.73 150.21 49.9 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.909 -1.119 . . . . 0.0 109.951 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.48 127.1 23.42 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.485 1.456 . . . . 0.0 112.604 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 43.0 pt -133.4 170.02 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.537 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.2 p -106.08 -7.06 18.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 0.0 109.213 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.12 176.38 23.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 44.5 m-85 -119.99 145.54 46.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -1.199 . . . . 0.0 109.132 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.454 HG22 HD11 ' A' ' 33' ' ' ILE . 38.1 mm -102.04 128.87 54.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 120.953 -1.092 . . . . 0.0 108.304 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.8 mm -110.06 118.94 58.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.139 -0.975 . . . . 0.0 110.101 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.71 HH12 ' NE2' ' A' ' 47' ' ' GLN . 33.7 mmt180 -108.33 127.88 54.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.474 ' ND1' ' C ' ' A' ' 36' ' ' HIS . 2.2 t-80 -119.98 135.71 54.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.856 -1.152 . . . . 0.0 110.715 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.443 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 29.4 p-80 -167.94 149.96 5.49 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.618 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -86.61 168.48 13.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.059 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.582 ' OE2' ' OE1' ' A' ' 67' ' ' GLU . 14.6 mt-10 -59.95 -48.28 82.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 110.444 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -136.04 36.96 2.8 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.335 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 p -74.58 150.09 39.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.748 -1.22 . . . . 0.0 109.381 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.35 -39.95 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.867 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.35 139.92 25.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.96 151.08 96.27 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.33 -1.1 . . . . 0.0 109.463 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.19 119.13 6.02 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.352 1.368 . . . . 0.0 112.113 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -85.28 153.32 22.67 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.71 ' NE2' HH12 ' A' ' 35' ' ' ARG . 97.5 mt-30 -105.64 116.51 32.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -117.87 127.53 53.95 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.557 ' HE ' ' NH2' ' A' ' 35' ' ' ARG . 0.0 OUTLIER -121.45 148.55 44.27 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 109.693 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.0 m -133.14 138.46 31.7 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.135 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 166.12 11.58 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 120.926 1.084 . . . . 0.0 111.709 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.45 -36.28 94.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.466 1.444 . . . . 0.0 112.428 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -70.37 -11.05 60.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 110.777 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -102.79 120.02 39.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.088 -1.007 . . . . 0.0 110.04 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -109.71 -4.9 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.515 -0.741 . . . . 0.0 109.465 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.423 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 59.7 p -130.16 138.76 50.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 9.2 tt -130.0 130.01 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.36 -0.838 . . . . 0.0 108.746 178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.4 m -100.24 133.31 44.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.14 145.5 40.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -132.63 -178.73 5.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.726 -0.609 . . . . 0.0 109.85 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.1 m120 57.39 40.4 27.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.7 155.15 19.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.49 -0.756 . . . . 0.0 109.087 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.649 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 15.9 m120 -69.99 120.63 79.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.976 -1.078 . . . . 0.0 108.561 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -61.5 125.13 16.07 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 120.921 1.081 . . . . 0.0 112.889 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 83.4 58.68 2.25 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -146.1 154.01 41.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.957 -1.32 . . . . 0.0 110.96 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.582 ' OE1' ' OE2' ' A' ' 39' ' ' GLU . 98.0 mt-10 -89.96 118.72 29.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.649 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 43.2 m-85 -110.1 140.02 44.61 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 110.119 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.0 t -102.84 121.42 53.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.92 122.33 69.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 108.961 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -96.34 134.56 39.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 110.703 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.514 ' N ' ' O ' ' A' ' 84' ' ' LEU . 50.3 mm -117.06 124.47 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.458 HG23 ' N ' ' A' ' 74' ' ' ALA . 60.3 mt -130.04 162.06 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.458 ' N ' HG23 ' A' ' 73' ' ' ILE . . . -121.4 136.57 54.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.655 -0.653 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.537 ' O ' ' OG1' ' A' ' 30' ' ' THR . 15.6 m -131.12 140.19 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 109.562 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.419 HD21 ' HA ' ' A' ' 29' ' ' ILE . 23.5 t-20 -124.58 41.88 3.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.012 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.01 -103.68 2.53 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.23 -0.04 44.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -104.56 155.77 18.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -128.08 153.17 47.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.419 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -108.86 171.84 4.16 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.83 . . . . 0.0 109.088 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' CD ' ' O ' ' A' ' 2' ' ' LEU . 3.2 Cg_exo -61.85 126.35 18.7 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.21 1.273 . . . . 0.0 111.634 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.58 126.34 19.63 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.066 1.177 . . . . 0.0 113.472 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.514 ' O ' ' N ' ' A' ' 72' ' ' ILE . 26.8 tp -106.15 120.04 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mt -125.01 139.3 51.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.998 -1.064 . . . . 0.0 110.36 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.21 152.49 21.47 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -109.75 129.93 55.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.429 -1.042 . . . . 0.0 109.54 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.54 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -123.55 129.79 51.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 88' ' ' GLN . . . -100.01 129.63 46.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.131 -0.981 . . . . 0.0 109.939 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.36 134.99 42.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.8 t -41.71 155.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.468 0.651 . . . . 0.0 109.975 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.1 p -105.16 23.72 13.19 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.224 1.011 . . . . 0.0 109.155 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 58.62 14.61 3.18 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.498 179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 20.3 mt -104.46 138.44 19.52 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.724 -1.235 . . . . 0.0 109.774 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.58 178.2 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 N-CA-C 109.653 -0.941 . . . . 0.0 109.653 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -142.09 172.02 13.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.463 -1.398 . . . . 0.0 110.631 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.0 40.16 19.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.897 -0.502 . . . . 0.0 110.781 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.3 tp -72.7 93.29 1.63 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -147.92 169.97 18.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 51.2 t -96.98 133.83 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 110.711 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -98.19 -28.74 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.987 0.899 . . . . 0.0 108.664 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -135.28 134.93 40.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.471 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -121.48 126.57 49.58 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.854 -1.154 . . . . 0.0 110.812 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.634 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -112.39 157.59 39.66 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.6 -40.05 46.2 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.602 1.534 . . . . 0.0 113.27 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -120.69 9.97 10.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.891 -1.131 . . . . 0.0 110.546 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.634 ' C ' ' HG1' ' A' ' 104' ' ' THR . 80.1 p -154.01 162.27 41.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.658 -1.276 . . . . 0.0 110.77 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -144.61 152.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.474 -0.766 . . . . 0.0 109.01 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 5.4 tt -102.81 120.19 40.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.224 -0.922 . . . . 0.0 108.548 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 6.4 pt -102.81 146.95 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 110.707 -179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.3 p -139.96 149.23 43.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -154.06 160.02 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.544 -0.723 . . . . 0.0 109.614 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -86.22 143.96 37.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.13 137.49 75.73 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.054 1.17 . . . . 0.0 112.283 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.03 -166.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.016 1.144 . . . . 0.0 112.294 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.45 -1.68 24.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 109.606 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 164.19 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 109.707 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.7 m -68.76 150.01 48.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.363 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 19.9 t -134.56 141.54 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.822 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.701 HH21 ' HE ' ' A' ' 168' ' ' ARG . 61.3 mmt-85 -71.12 -51.03 27.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.522 ' OH ' ' NH2' ' A' ' 123' ' ' ARG . 7.9 p90 -166.48 179.29 5.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -120.02 139.94 51.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.717 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.679 ' NE ' ' OE2' ' A' ' 137' ' ' GLU . 36.3 ttm180 -106.12 124.7 49.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.478 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 30.5 mt -119.98 146.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.008 -1.058 . . . . 0.0 110.65 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -118.52 149.47 41.25 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.005 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.59 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 5.6 m-85 -93.12 136.37 33.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.55 118.41 5.5 Favored Glycine 0 N--CA 1.481 1.644 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.126 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 129' ' ' THR . 45.4 mt-10 -109.4 144.66 37.31 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.411 -1.052 . . . . 0.0 108.786 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.584 ' O ' ' O ' ' A' ' 128' ' ' GLU . 0.8 OUTLIER -33.08 157.95 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.139 -0.975 . . . . 0.0 110.118 179.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.565 ' O ' ' N ' ' A' ' 133' ' ' SER . . . 69.23 90.65 0.07 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . -45.05 -24.09 0.75 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 130' ' ' GLY . 42.3 p-10 -76.66 -10.01 59.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.458 -1.025 . . . . 0.0 109.199 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.565 ' N ' ' O ' ' A' ' 130' ' ' GLY . 68.0 m -73.08 139.09 79.19 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.803 . . . . 0.0 109.425 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.37 146.08 91.25 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.166 1.244 . . . . 0.0 112.82 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.35 150.75 6.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.446 -0.784 . . . . 0.0 109.252 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.528 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 10.7 mt-30 -102.45 123.03 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.951 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.679 ' OE2' ' NE ' ' A' ' 123' ' ' ARG . 80.4 tt0 -100.0 129.97 46.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 111.558 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.478 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 45.3 p90 -134.97 143.82 47.07 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.463 HG23 ' CE2' ' A' ' 121' ' ' TYR . 2.2 p -84.7 168.26 15.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.982 -1.074 . . . . 0.0 111.156 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 79.3 t -142.78 128.74 10.44 Favored Pre-proline 0 N--CA 1.485 1.285 0 O-C-N 121.751 -0.593 . . . . 0.0 109.416 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.99 150.65 62.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 120.621 0.881 . . . . 0.0 112.287 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.14 -8.46 69.77 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -89.98 -0.04 57.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -1.213 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -106.96 125.09 50.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.943 -1.098 . . . . 0.0 110.282 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -93.26 -5.39 49.93 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.6 p -142.93 159.8 41.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -140.84 167.63 21.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.728 -1.233 . . . . 0.0 109.883 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -117.95 136.69 53.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.59 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 32.8 mm -109.46 123.21 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 108.625 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.565 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 68.0 m-20 -124.01 170.02 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.133 -0.979 . . . . 0.0 109.761 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 39.8 m-20 71.69 49.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.361 0.6 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.472 HG21 ' CZ ' ' A' ' 158' ' ' TYR . 79.4 mt -115.58 130.72 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 0.0 109.393 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 184' ' ' THR . 22.4 mttm -73.95 118.86 72.82 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.056 -1.028 . . . . 0.0 109.795 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.0 167.28 16.31 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.31 1.34 . . . . 0.0 113.288 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 184' ' ' THR . . . 60.0 28.16 65.81 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.675 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -140.0 139.27 36.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.932 -1.334 . . . . 0.0 110.492 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.556 ' N ' HG21 ' A' ' 129' ' ' THR . 44.8 t0 -59.95 140.23 56.86 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -134.74 159.16 42.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.315 -1.491 . . . . 0.0 110.058 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.539 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 66.9 m -130.22 119.99 23.78 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 160' ' ' ILE . 48.5 mm -108.26 123.63 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.194 -1.566 . . . . 0.0 108.273 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.464 HG21 ' CE1' ' A' ' 163' ' ' TYR . 86.6 m -127.61 140.02 52.37 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.172 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.584 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -122.37 137.77 54.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.683 0.754 . . . . 0.0 110.394 -178.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.554 ' N ' ' CD1' ' A' ' 162' ' ' LEU . 1.4 m-85 -122.94 153.43 39.73 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.18 55.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.839 -1.163 . . . . 0.0 109.47 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 63.2 t -111.61 120.04 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.851 -179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.424 ' O ' ' O ' ' A' ' 167' ' ' GLY . 41.1 p -104.69 -50.07 3.38 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.728 0.775 . . . . 0.0 109.225 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -57.75 -160.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.701 ' HE ' HH21 ' A' ' 120' ' ' ARG . 87.5 mtt180 -137.13 178.55 7.0 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.429 -1.042 . . . . 0.0 108.99 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -49.01 -29.61 8.64 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.46 -39.99 70.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.217 -1.167 . . . . 0.0 108.87 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 53.2 m -136.0 69.21 64.15 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.02 87.66 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.684 1.589 . . . . 0.0 112.587 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.26 138.67 44.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.9 p -129.49 150.63 50.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.315 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 46.1 p -79.4 169.98 17.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 119.48 42.0 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.521 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.3 Cg_exo -61.14 148.12 93.76 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 120.779 0.986 . . . . 0.0 114.074 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.9 120.12 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 86.2 p -112.56 153.43 27.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 111.461 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 42.2 pt -134.73 160.03 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -110.62 133.13 53.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 108.621 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.609 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 60.7 t80 -139.14 126.57 21.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.018 -1.051 . . . . 0.0 110.154 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.609 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 66.2 mttm -84.71 147.59 26.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.376 -0.828 . . . . 0.0 109.013 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.675 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 1.1 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.395 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.388 2.515 . . . . 0.0 119.388 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.9 mt -119.99 130.6 54.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.236 -1.155 . . . . 0.0 109.565 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.79 130.21 34.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.419 -0.8 . . . . 0.0 108.939 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.454 ' HA ' ' HG ' ' A' ' 81' ' ' SER . 94.0 p -69.96 146.66 95.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.03 . . . . 0.0 109.735 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 2.6 Cg_endo -60.75 116.31 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.179 1.253 . . . . 0.0 111.877 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -120.0 -155.75 0.63 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.923 -1.111 . . . . 0.0 109.66 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.66 20.02 75.35 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.444 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 64.4 t80 -53.07 133.18 38.8 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.755 0.788 . . . . 0.0 110.695 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 10' ' ' SER . 57.1 t0 -148.52 145.77 28.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 88' ' ' GLN . 47.6 t -129.11 145.2 51.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.979 -1.076 . . . . 0.0 110.295 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 12' ' ' ASP . 9.9 p -172.75 -162.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 11' ' ' SER . 72.6 m-20 49.39 40.08 17.84 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.49 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -80.12 132.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.938 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.683 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 164.09 20.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' H ' ' HB2' ' A' ' 116' ' ' ALA . . . -58.51 -59.09 5.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.706 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.475 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 31.7 m120 -92.52 -0.51 57.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.969 -1.082 . . . . 0.0 109.817 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.683 ' O ' ' N ' ' A' ' 14' ' ' THR . 90.0 p -151.4 156.49 40.8 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.581 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.49 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 32.4 p90 -161.89 148.33 13.77 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.433 HG23 ' NE2' ' A' ' 21' ' ' HIS . 4.4 m -102.36 151.33 22.39 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.112 -1.617 . . . . 0.0 111.956 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.444 ' CG1' ' CZ ' ' A' ' 8' ' ' PHE . 1.6 t -120.54 138.66 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.457 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 77.1 m-70 -127.49 141.22 51.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.844 -1.16 . . . . 0.0 110.838 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -149.97 156.24 41.36 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.91 159.39 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.03 -1.044 . . . . 0.0 109.842 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -88.69 140.19 29.65 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.69 179.28 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.921 1.081 . . . . 0.0 112.453 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.96 10.01 42.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.899 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -116.61 150.66 46.0 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.075 -1.015 . . . . 0.0 109.854 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.65 127.97 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.555 1.504 . . . . 0.0 112.684 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.737 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.2 pt -131.66 170.43 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.5 p -105.61 -3.29 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 109.855 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.34 174.29 14.21 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.737 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 13.0 m-85 -121.89 149.93 42.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.246 -1.15 . . . . 0.0 109.239 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.432 ' CG2' ' HG3' ' A' ' 49' ' ' ARG . 6.0 mt -115.15 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 120.984 -1.072 . . . . 0.0 108.579 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.572 ' O ' ' O ' ' A' ' 48' ' ' ASP . 1.3 mm -107.4 119.61 57.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.181 -0.949 . . . . 0.0 110.783 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -110.0 129.61 55.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.697 ' CE1' ' OD2' ' A' ' 48' ' ' ASP . 40.7 p-80 -134.13 148.61 50.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.51 -1.369 . . . . 0.0 111.339 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.453 ' HB2' ' HG ' ' A' ' 41' ' ' SER . 35.9 p-80 -162.85 151.14 14.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.6 165.26 20.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 109.457 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -60.0 -36.73 77.82 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.967 0.889 . . . . 0.0 109.397 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -88.55 19.38 3.94 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.072 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.453 ' HG ' ' HB2' ' A' ' 37' ' ' HIS . 86.5 p -74.51 169.74 17.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.351 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.65 ' C ' ' H ' ' A' ' 44' ' ' ARG . 15.7 m -106.47 -177.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.59 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.66 14.6 0.03 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.65 ' H ' ' C ' ' A' ' 42' ' ' VAL . 20.3 mtt180 -122.05 71.19 31.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.913 -1.345 . . . . 0.0 110.096 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.01 150.32 84.74 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.312 1.341 . . . . 0.0 112.222 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.493 ' CB ' ' CE1' ' A' ' 36' ' ' HIS . 84.3 mtt-85 -74.51 157.65 35.15 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.19 -0.944 . . . . 0.0 109.873 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 92.2 mm-40 -120.52 129.21 53.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.528 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.697 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 99.3 m-20 -141.29 117.56 10.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.432 ' HG3' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -109.43 142.06 40.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.891 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.3 137.03 29.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.12 160.18 31.42 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.772 0.981 . . . . 0.0 111.624 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.96 -33.8 96.1 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.502 1.468 . . . . 0.0 111.991 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.3 p -70.04 -10.35 58.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 110.354 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -103.88 120.59 41.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -106.92 -7.46 17.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.457 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 53.2 p -129.98 138.52 50.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 109.231 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.8 tt -130.01 132.83 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.432 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.5 m -99.73 120.0 39.03 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.468 ' CD2' ' OD2' ' A' ' 48' ' ' ASP . 7.6 mt -93.19 143.53 26.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.263 -0.898 . . . . 0.0 109.81 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.5 p -130.1 178.81 6.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.797 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.71 43.04 19.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.79 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 68' ' ' TYR . 43.3 mt -109.99 153.63 24.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.599 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.9 m-80 -69.98 126.72 92.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.998 . . . . 0.0 108.655 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.475 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 2.5 Cg_endo -64.76 132.16 31.75 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 120.709 0.939 . . . . 0.0 112.368 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.87 62.14 3.08 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.433 HG23 ' CD1' ' A' ' 68' ' ' TYR . 1.1 m -148.48 152.99 37.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.322 -1.105 . . . . 0.0 110.525 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' A' ' 66' ' ' THR . 98.7 mt-10 -91.45 120.0 31.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.599 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 30.8 m-85 -108.82 148.16 30.99 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 110.57 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -110.04 125.77 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.27 129.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.915 -1.115 . . . . 0.0 110.335 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.408 ' CB ' HG12 ' A' ' 85' ' ' ILE . 78.6 p -115.22 139.99 49.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 110.728 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.6 mm -109.18 129.99 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 38.3 mm -119.9 123.15 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.047 . . . . 0.0 108.929 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.412 ' HB1' ' HG ' ' A' ' 81' ' ' SER . . . -93.5 132.69 37.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.972 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 m -129.9 140.02 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -121.58 43.4 2.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.97 -97.09 1.88 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.565 ' H ' ' CD ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -102.17 0.01 33.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -1.195 . . . . 0.0 109.299 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -112.4 151.26 30.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -124.64 153.12 42.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 109.493 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.454 ' HG ' ' HA ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -106.25 170.16 6.1 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 109.239 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.419 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.5 Cg_exo -59.74 125.39 17.65 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.223 1.282 . . . . 0.0 112.007 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -60.76 143.32 99.37 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.223 1.282 . . . . 0.0 113.383 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.436 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 24.9 tp -119.76 128.09 53.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.408 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -127.71 140.03 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 120.841 -1.162 . . . . 0.0 110.926 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.11 161.67 27.2 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -115.9 136.76 52.74 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.092 -1.24 . . . . 0.0 110.284 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.591 ' CD ' ' CB ' ' A' ' 10' ' ' SER . 98.2 mm-40 -130.2 139.03 50.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.77 137.47 48.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.419 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -79.68 140.11 37.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.1 t -55.33 170.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.504 0.669 . . . . 0.0 111.28 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.423 ' H ' HG11 ' A' ' 91' ' ' VAL . 22.8 t -97.69 138.5 34.99 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.525 -0.734 . . . . 0.0 110.007 -179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD2' ' CB ' ' A' ' 64' ' ' PRO . 95.9 m-20 -69.95 -40.08 75.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.361 -0.837 . . . . 0.0 112.244 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 2.1 mt -72.8 140.23 80.95 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.635 -1.29 . . . . 0.0 110.71 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.68 81.31 0.14 Allowed 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 120.798 0.998 . . . . 0.0 110.668 177.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.495 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 28.5 ttp-105 -62.76 165.78 6.22 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.501 -0.749 . . . . 0.0 111.118 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.495 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 95.1 m-20 64.96 42.28 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.062 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.9 tp -79.86 103.6 9.87 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -150.06 170.03 19.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.939 -1.101 . . . . 0.0 110.255 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 54.0 t -103.85 139.14 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.369 -0.832 . . . . 0.0 109.643 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.67 -10.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.62 130.84 28.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 p -114.81 98.5 6.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.673 ' HG1' ' H ' ' A' ' 107' ' ' SER . 1.2 p -88.41 151.12 48.01 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.321 -0.862 . . . . 0.0 109.089 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.37 -30.7 53.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.348 1.365 . . . . 0.0 113.001 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 27.8 p -129.02 12.89 6.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.906 -1.121 . . . . 0.0 110.718 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.673 ' H ' ' HG1' ' A' ' 104' ' ' THR . 14.6 p -159.85 161.93 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.82 -1.175 . . . . 0.0 110.027 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -135.67 153.93 51.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.403 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 5.4 tt -102.8 119.96 39.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 108.769 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 110' ' ' ILE . 2.6 pt -107.37 135.85 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.9 m -136.35 140.03 42.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -144.04 157.14 44.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.389 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.03 127.34 92.45 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.477 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.76 125.89 16.34 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 120.684 0.923 . . . . 0.0 111.654 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.03 176.39 0.74 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 120.831 1.021 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.44 ' HB2' ' H ' ' A' ' 15' ' ' ALA . . . -108.39 24.92 12.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.651 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.0 160.1 41.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.1 m -67.63 130.02 41.73 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.0 109.029 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.31 132.08 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.609 -179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -71.71 -53.5 13.31 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.434 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 8.1 p90 -167.27 170.29 11.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 5.5 m-85 -115.98 137.64 51.93 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.449 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 53.8 ttp180 -100.41 123.02 44.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.747 -1.221 . . . . 0.0 108.219 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.484 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 69.0 mt -110.26 139.82 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.005 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.5 p -115.59 137.22 52.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.375 -0.828 . . . . 0.0 110.796 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.715 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.9 m-85 -84.11 124.17 30.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.25 126.6 8.3 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.724 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.617 ' O ' ' C ' ' A' ' 129' ' ' THR . 22.2 mt-10 -106.85 161.17 14.93 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.711 -0.876 . . . . 0.0 108.723 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.617 ' C ' ' O ' ' A' ' 128' ' ' GLU . 1.0 OUTLIER -17.26 -64.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.949 -0.47 . . . . 0.0 110.831 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.564 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . 138.12 13.96 0.76 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.799 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -61.95 -72.86 0.58 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -100.52 0.01 38.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.366 -1.079 . . . . 0.0 108.269 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.657 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 1.1 t 66.78 40.17 0.24 Allowed Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.708 -0.62 . . . . 0.0 111.035 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 133' ' ' SER . 2.4 Cg_endo -59.25 86.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 120.742 0.961 . . . . 0.0 111.573 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -93.24 138.03 21.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.871 -1.143 . . . . 0.0 110.314 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.536 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 96.9 mt-30 -119.82 104.36 10.14 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.121 -1.031 . . . . 0.0 108.554 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -86.89 140.79 29.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 0.0 112.084 -178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.484 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 39.8 p90 -143.9 150.01 37.76 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.7 p -89.56 168.72 11.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.933 -1.105 . . . . 0.0 111.459 -177.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.434 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 19.6 t -134.14 126.81 18.75 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.747 -0.595 . . . . 0.0 109.649 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.64 155.7 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.291 0.782 . . . . 0.0 111.809 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.91 -0.31 81.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.7 p -99.96 2.29 43.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.059 -1.259 . . . . 0.0 110.422 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -112.48 128.57 56.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.821 -1.175 . . . . 0.0 110.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.2 m -94.74 -6.43 43.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.0 p -139.59 157.04 46.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.461 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -137.48 160.02 40.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.629 -1.294 . . . . 0.0 110.653 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.457 ' CG2' HD22 ' A' ' 150' ' ' ASN . 6.0 m -106.11 142.39 35.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.608 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 34.8 mm -114.47 120.07 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.715 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 8.8 m120 -122.05 173.81 7.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.236 -0.915 . . . . 0.0 109.798 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.3 46.26 2.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.037 . . . . 0.0 109.478 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.49 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 2.7 tt -110.43 153.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -98.29 109.98 54.49 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.966 -1.084 . . . . 0.0 110.488 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.46 154.43 74.34 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.075 1.183 . . . . 0.0 112.546 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.02 15.46 78.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.554 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . -137.91 149.06 45.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 49.5 t0 -69.92 150.81 46.34 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.5 m-85 -139.34 164.11 30.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.895 -1.128 . . . . 0.0 110.929 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.471 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.9 m -136.48 115.4 12.26 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.75 121.98 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.363 -1.46 . . . . 0.0 108.612 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.8 m -132.34 148.52 52.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.076 -1.015 . . . . 0.0 110.104 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 2.3 pp -140.65 152.51 45.45 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.973 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 2.5 m-85 -120.07 139.24 52.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -100.16 124.37 45.49 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 70.5 t -106.32 120.73 57.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 19.0 p -121.85 136.58 54.94 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -94.35 126.41 8.67 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.499 -1.334 . . . . 0.0 109.981 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.602 ' H ' ' HA ' ' A' ' 172' ' ' PRO . 78.1 mtt180 -103.98 7.9 36.65 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.4 -1.059 . . . . 0.0 109.255 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 122.5 -124.49 5.72 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.7 -15.23 61.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -1.126 . . . . 0.0 109.354 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -128.05 88.51 52.77 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.543 -0.723 . . . . 0.0 109.156 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.602 ' HA ' ' H ' ' A' ' 168' ' ' ARG . 3.2 Cg_exo -62.24 -174.94 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.09 1.193 . . . . 0.0 111.954 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -156.26 159.99 39.38 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.275 -0.89 . . . . 0.0 110.607 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.3 p -134.74 140.12 45.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 0.0 109.013 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 85.5 p -74.31 162.15 29.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.199 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -62.12 134.31 94.45 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.059 -1.026 . . . . 0.0 108.716 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 134.42 61.14 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.245 1.297 . . . . 0.0 113.424 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.83 129.99 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 92.4 p -128.09 159.33 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.052 -1.03 . . . . 0.0 112.201 -177.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 44.4 pt -138.8 160.06 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -107.41 130.15 54.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.092 . . . . 0.0 109.195 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.512 ' CE2' HD23 ' A' ' 108' ' ' LEU . 65.7 t80 -122.5 129.94 52.53 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.95 139.23 35.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.554 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 3.2 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.184 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.83 0 N-CA-C 119.367 2.507 . . . . 0.0 119.367 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.7 mt -117.99 136.75 53.32 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.276 -1.132 . . . . 0.0 108.933 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -83.39 109.99 17.77 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 109.073 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.434 ' HA ' ' HG ' ' A' ' 81' ' ' SER . 91.9 p -70.02 150.05 96.28 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.256 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.77 149.7 67.16 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.077 1.185 . . . . 0.0 111.669 179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 7' ' ' GLY . 0.7 OUTLIER -152.68 -158.16 0.87 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 69.96 21.54 76.83 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 105.93 -2.868 . . . . 0.0 105.93 -177.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -50.41 130.07 22.92 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.712 0.768 . . . . 0.0 110.359 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 10' ' ' SER . 52.1 t0 -155.59 149.64 25.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.547 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.8 m -121.97 140.97 51.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.964 -1.085 . . . . 0.0 110.133 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 12' ' ' ASP . 78.0 p -157.2 -173.91 4.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.094 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.05 42.55 24.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.437 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -78.01 124.83 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.935 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.692 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.89 162.45 17.32 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.552 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.34 -59.33 5.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.867 -1.146 . . . . 0.0 109.824 -179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.474 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 28.9 m120 -87.15 -10.79 51.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 14' ' ' THR . 48.8 m -139.96 155.26 47.21 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.636 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.627 ' CE2' ' OE1' ' A' ' 88' ' ' GLN . 15.1 p90 -161.46 142.01 10.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 108.779 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -91.16 154.02 19.63 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.443 -1.411 . . . . 0.0 111.777 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 t -124.35 139.31 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -129.68 141.25 50.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.819 -1.175 . . . . 0.0 110.93 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 39.4 p90 -148.44 160.02 43.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.02 156.11 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 120.81 -1.181 . . . . 0.0 110.346 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.445 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -99.21 124.4 45.2 Favored Pre-proline 0 C--N 1.299 -1.629 0 O-C-N 121.874 -0.516 . . . . 0.0 109.997 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HD2' ' HH ' ' A' ' 32' ' ' TYR . 2.9 Cg_endo -61.26 163.66 16.73 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.973 1.116 . . . . 0.0 112.244 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -92.06 -1.41 57.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.83 151.76 74.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.14 120.59 8.59 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.344 1.362 . . . . 0.0 112.332 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.618 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 25.5 pt -135.74 164.4 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.91 -7.36 15.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.028 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.87 175.37 19.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 18.4 m-85 -120.0 139.99 51.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.24 . . . . 0.0 109.163 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.462 HG22 HD11 ' A' ' 33' ' ' ILE . 34.9 mm -91.17 120.09 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.7 mm -97.15 107.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 110.12 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -105.46 120.0 40.5 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.697 -1.252 . . . . 0.0 107.673 177.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.45 ' NE2' HD23 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -120.04 136.57 54.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.974 -1.079 . . . . 0.0 110.334 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -160.0 160.24 33.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -88.71 -171.71 3.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -50.98 -87.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.086 -1.009 . . . . 0.0 109.104 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -141.17 27.6 1.93 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.463 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.1 p -74.37 -13.51 60.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.668 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG23 ' H ' ' A' ' 44' ' ' ARG . 11.7 p -137.57 139.98 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.99 -3.34 76.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.451 ' H ' HG23 ' A' ' 42' ' ' VAL . 3.2 mmm180 -120.1 96.91 49.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.316 -1.108 . . . . 0.0 109.701 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.04 137.88 64.48 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 120.869 1.046 . . . . 0.0 111.881 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -76.15 134.79 39.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.251 -0.905 . . . . 0.0 109.895 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -102.09 120.5 40.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.878 . . . . 0.0 109.293 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -126.0 140.19 52.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.486 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -130.05 146.94 51.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.903 -1.123 . . . . 0.0 109.606 -178.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.0 m -139.5 145.79 45.33 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.94 162.56 25.25 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.032 1.155 . . . . 0.0 111.925 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.28 -34.09 97.95 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.576 1.518 . . . . 0.0 112.314 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.5 t -69.99 -19.73 63.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.589 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -96.06 115.19 27.05 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -107.62 0.48 22.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 p -129.98 134.39 47.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.403 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 7.3 tt -130.26 136.11 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 109.723 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.2 m -99.97 122.23 42.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.309 -0.869 . . . . 0.0 109.649 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 12.6 mt -95.48 145.47 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.761 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -132.97 -178.66 5.06 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.434 0.635 . . . . 0.0 110.277 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 51.54 49.66 20.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.355 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.45 HD23 ' NE2' ' A' ' 36' ' ' HIS . 42.4 mt -116.5 153.68 31.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 109.286 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -70.0 123.32 88.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 108.598 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HD3' ' ND2' ' A' ' 16' ' ' ASN . 2.6 Cg_endo -62.49 133.67 44.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.876 1.051 . . . . 0.0 112.717 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.66 62.26 2.9 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 m -147.42 148.92 31.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -1.12 . . . . 0.0 110.982 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' OE2' ' NE2' ' A' ' 87' ' ' GLN . 86.5 tt0 -90.13 119.0 30.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -109.92 152.75 25.43 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.194 -0.941 . . . . 0.0 110.814 -178.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.02 121.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.51 129.98 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.758 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.427 ' CB ' HG12 ' A' ' 85' ' ' ILE . 93.8 p -116.84 137.88 51.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 0.0 110.741 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -112.77 121.85 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.3 mm -112.12 129.99 66.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.854 -1.154 . . . . 0.0 109.252 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.469 ' HB1' ' HG ' ' A' ' 81' ' ' SER . . . -95.61 123.12 39.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.987 . . . . 0.0 109.026 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.3 m -124.39 133.08 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.56 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -115.84 35.81 4.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.3 -103.06 2.49 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -90.33 0.03 57.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -1.141 . . . . 0.0 110.341 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.52 141.37 48.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.907 -1.121 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.98 140.5 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.814 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.469 ' HG ' ' HB1' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -94.05 167.87 12.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.837 . . . . 0.0 109.234 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -58.68 129.99 34.95 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.468 1.445 . . . . 0.0 112.085 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.0 151.9 68.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.396 1.397 . . . . 0.0 113.698 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.2 tp -125.41 111.91 15.68 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.427 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.7 mt -120.41 129.92 75.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 120.868 -1.145 . . . . 0.0 110.91 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.68 175.98 19.42 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.605 ' NE2' ' OE2' ' A' ' 67' ' ' GLU . 27.7 mt-30 -125.94 137.25 53.69 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.483 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.627 ' OE1' ' CE2' ' A' ' 18' ' ' PHE . 12.4 tm0? -130.92 130.68 43.79 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.618 ' C ' ' NE2' ' A' ' 88' ' ' GLN . . . -99.04 131.6 44.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.918 -1.114 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.41 135.8 42.39 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.599 ' O ' ' N ' ' A' ' 65' ' ' GLY . 18.6 t -43.8 171.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.429 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 58.2 m -113.59 149.67 34.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.56 -0.713 . . . . 0.0 109.377 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.571 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 57.4 t0 -69.99 -16.02 63.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.86 . . . . 0.0 109.774 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 8.5 mt -59.14 140.35 87.49 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 110.589 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.17 -166.34 0.1 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 109.926 -0.836 . . . . 0.0 109.926 176.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -152.74 162.17 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.594 -1.316 . . . . 0.0 110.513 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.61 40.04 20.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.812 -0.555 . . . . 0.0 110.902 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 50.1 tp -73.08 96.79 2.24 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.73 -1.231 . . . . 0.0 107.792 178.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -151.76 169.81 21.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.679 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 43.2 t -96.23 139.38 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.165 -0.959 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -108.6 -11.89 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.853 0.835 . . . . 0.0 108.768 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.605 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -147.18 150.7 35.44 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -129.83 130.01 44.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.838 -1.164 . . . . 0.0 110.271 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.43 157.97 39.78 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.26 -40.93 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 121.434 1.423 . . . . 0.0 112.656 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 40.9 p -129.97 19.96 5.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.058 -1.026 . . . . 0.0 110.197 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.595 ' O ' ' OG1' ' A' ' 104' ' ' THR . 5.5 p -153.46 169.83 22.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.873 -1.142 . . . . 0.0 110.011 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.532 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -143.88 155.39 44.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.33 -0.857 . . . . 0.0 109.699 -179.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.426 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 25.1 tp -103.99 120.51 41.21 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.449 ' CD1' HD11 ' A' ' 124' ' ' ILE . 3.3 pt -107.59 146.95 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 111.321 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.8 p -141.11 144.22 34.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.469 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 42.3 p90 -150.74 159.99 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.73 140.58 22.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.2 134.52 56.33 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.028 1.152 . . . . 0.0 111.803 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.64 -171.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 120.954 1.103 . . . . 0.0 112.335 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -77.33 -1.44 29.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.09 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 23.4 m -129.96 160.04 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.476 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 152.28 44.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.478 HG13 ' CZ ' ' A' ' 122' ' ' TYR . 48.9 t -130.04 133.81 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.916 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.446 ' CG ' ' O ' ' A' ' 165' ' ' VAL . 11.6 ptm180 -72.49 -48.04 43.81 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.417 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.473 ' CE1' HG23 ' A' ' 139' ' ' THR . 2.2 p90 -166.96 162.53 15.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.904 -1.122 . . . . 0.0 110.036 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.607 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 m-85 -122.52 151.11 41.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.512 ' NE ' ' HB2' ' A' ' 163' ' ' TYR . 17.2 ptt180 -109.85 129.64 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.794 -1.191 . . . . 0.0 108.193 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.487 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 83.9 mt -112.4 145.57 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.951 . . . . 0.0 109.546 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.1 p -122.07 142.7 50.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 0.0 110.967 -179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.68 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.1 m-85 -84.57 130.0 34.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.692 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.21 135.34 12.77 Favored Glycine 0 N--CA 1.479 1.566 0 C-N-CA 120.216 -0.993 . . . . 0.0 110.93 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.603 ' O ' ' C ' ' A' ' 129' ' ' THR . 60.0 mt-10 -105.79 151.83 23.98 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.739 ' OG1' ' N ' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -25.31 -86.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.583 -0.698 . . . . 0.0 110.355 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.739 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . -83.52 -80.02 1.03 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 133' ' ' SER . . . 161.01 -85.33 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 131' ' ' GLY . 12.7 m120 39.95 19.79 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.338 -1.096 . . . . 0.0 108.709 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 131' ' ' GLY . 0.7 OUTLIER -168.18 148.95 4.55 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.471 -0.768 . . . . 0.0 109.186 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.12 155.28 40.45 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.183 1.255 . . . . 0.0 112.57 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.3 m -86.96 166.09 2.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.477 ' HB2' ' CG ' ' A' ' 126' ' ' TYR . 15.7 mt-30 -99.61 115.28 29.04 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.561 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -104.86 140.0 38.77 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.87 0.843 . . . . 0.0 111.979 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.487 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 42.8 p90 -145.91 151.96 38.69 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.473 HG23 ' CE1' ' A' ' 121' ' ' TYR . 2.7 p -84.33 160.16 20.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.941 -1.1 . . . . 0.0 111.453 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 122' ' ' TYR . 89.0 t -120.2 119.04 31.02 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.519 ' C ' ' H ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.67 109.52 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.73 0.953 . . . . 0.0 111.821 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -50.09 -10.27 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.519 ' H ' ' C ' ' A' ' 141' ' ' PRO . 80.1 p -69.99 -19.22 63.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 110.136 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -122.03 140.74 52.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.7 m -90.02 -1.14 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.469 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 63.4 p -132.85 159.12 40.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.448 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -143.37 166.36 24.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.792 -1.192 . . . . 0.0 110.203 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 149' ' ' ILE . 2.5 m -112.16 149.12 32.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.439 -0.788 . . . . 0.0 109.151 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.623 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 33.1 mm -117.62 123.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.68 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 31.2 m120 -125.49 170.08 11.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.024 -1.048 . . . . 0.0 110.013 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 80.8 m-20 65.64 46.7 2.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.589 0.709 . . . . 0.0 109.562 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.459 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 3.7 tt -108.32 149.79 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -98.02 110.04 54.15 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -67.25 174.69 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.187 1.258 . . . . 0.0 112.853 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.97 26.42 74.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.678 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -157.21 159.08 37.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.927 -1.337 . . . . 0.0 110.068 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.8 t0 -77.94 144.39 36.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.692 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -130.77 158.17 40.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.828 -1.17 . . . . 0.0 110.272 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.462 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 63.7 m -130.24 118.92 22.1 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.91 119.79 49.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.364 -1.46 . . . . 0.0 108.775 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.5 m -127.08 140.85 51.99 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.661 -179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.575 ' C ' ' CD1' ' A' ' 162' ' ' LEU . 1.5 pp -139.09 152.42 47.49 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.335 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.591 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 0.8 OUTLIER -119.96 141.82 49.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.467 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -99.46 137.17 38.34 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.582 -1.324 . . . . 0.0 110.19 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.446 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 62.2 t -110.02 120.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.3 p -115.21 -48.86 2.79 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.435 0.636 . . . . 0.0 110.026 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -49.91 157.87 1.66 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -130.02 130.43 44.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.391 -1.064 . . . . 0.0 109.406 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 147.82 -165.31 28.85 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -73.13 -30.78 63.85 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.408 -1.054 . . . . 0.0 109.179 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 52.5 m -129.98 76.06 78.64 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.7 -0.625 . . . . 0.0 109.352 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -63.93 -160.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.658 1.572 . . . . 0.0 112.486 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -136.15 158.95 43.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.354 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.1 p -133.39 149.65 51.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.132 -0.98 . . . . 0.0 109.89 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.5 p -83.02 172.77 12.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.181 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.26 133.33 87.97 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.024 -1.048 . . . . 0.0 108.464 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.02 145.77 97.59 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.338 1.359 . . . . 0.0 113.846 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.54 129.66 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 93.1 p -126.34 155.83 41.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.943 -1.098 . . . . 0.0 111.52 -177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 27.2 pt -139.17 164.19 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -113.1 129.91 56.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 109.403 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.532 ' CE1' HD23 ' A' ' 108' ' ' LEU . 60.8 t80 -124.59 122.02 36.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.891 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 43.9 mmtt -84.61 149.54 25.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.907 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.678 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 9.0 p . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.059 -1.025 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.797 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.0 mt -129.96 143.94 51.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.213 -1.169 . . . . 0.0 109.159 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.01 137.23 36.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.394 -0.816 . . . . 0.0 109.098 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 t -78.06 133.28 65.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.3 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.441 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 3.3 Cg_exo -57.22 90.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 120.967 1.111 . . . . 0.0 112.064 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -92.26 -158.54 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 109.904 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 22.11 66.82 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.468 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 56.0 t80 -57.75 132.4 53.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.82 0.819 . . . . 0.0 110.752 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.7 t0 -154.11 142.08 20.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 75.0 p -117.74 140.0 50.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.907 -1.121 . . . . 0.0 109.846 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 12' ' ' ASP . 58.7 p -158.6 -176.6 5.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.8 m-20 49.93 48.41 21.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.478 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -85.32 121.1 36.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.384 -177.478 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -112.76 162.7 15.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.04 -56.58 19.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.792 -1.193 . . . . 0.0 110.524 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -92.07 -0.03 57.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.85 -1.156 . . . . 0.0 109.93 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.7 ' O ' ' N ' ' A' ' 14' ' ' THR . 37.2 t -150.87 151.55 32.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.694 ' CE2' ' OH ' ' A' ' 68' ' ' TYR . 23.3 p90 -160.97 145.94 14.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 108.829 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.6 m -93.16 148.03 22.37 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.507 -1.37 . . . . 0.0 111.489 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 8' ' ' PHE . 0.1 OUTLIER -121.52 142.56 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.421 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 72.3 m-70 -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.807 -1.183 . . . . 0.0 110.808 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 42.9 p90 -154.02 157.55 39.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.494 -0.754 . . . . 0.0 109.084 179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.457 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.06 158.83 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 120.875 -1.141 . . . . 0.0 110.0 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -89.28 148.6 41.05 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 109.9 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.58 178.72 0.61 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.279 1.319 . . . . 0.0 112.456 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -103.82 7.1 37.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.21 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -119.72 157.55 51.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -56.85 136.29 75.6 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.676 1.584 . . . . 0.0 112.591 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 40.7 pt -139.97 170.06 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 p -106.42 -0.84 23.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -173.85 23.15 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 37.1 m-85 -128.36 151.15 49.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -1.207 . . . . 0.0 109.419 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.477 HG22 ' HE ' ' A' ' 49' ' ' ARG . 31.9 mm -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -0.949 . . . . 0.0 108.48 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.465 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.9 mm -113.91 123.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.008 -1.057 . . . . 0.0 110.315 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.569 HH12 ' NE2' ' A' ' 47' ' ' GLN . 83.0 mtt-85 -123.24 130.92 53.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.607 ' NE2' ' CB ' ' A' ' 46' ' ' ARG . 20.5 p-80 -130.76 129.4 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.559 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -159.99 159.92 32.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 109.32 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.546 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -82.38 157.94 23.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -59.99 -40.04 87.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.402 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -86.25 -0.02 54.83 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.329 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 38' ' ' ALA . 88.9 p -110.04 116.65 31.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.996 -1.065 . . . . 0.0 109.695 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.0 m -138.8 1.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.927 . . . . 0.0 109.509 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.35 -65.28 2.73 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 -121.51 79.99 38.23 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.172 -1.193 . . . . 0.0 109.853 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.07 140.65 79.78 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.412 1.408 . . . . 0.0 112.29 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.607 ' CB ' ' NE2' ' A' ' 36' ' ' HIS . 22.5 mmm180 -81.3 135.96 35.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.785 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.569 ' NE2' HH12 ' A' ' 35' ' ' ARG . 99.4 mt-30 -120.82 109.96 15.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.793 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' ILE . 94.5 m-20 -121.98 129.99 52.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.197 -0.94 . . . . 0.0 108.673 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.533 ' CD ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -113.56 141.22 47.43 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.325 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.1 m -120.95 147.66 46.82 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.28 159.98 44.54 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 120.844 1.029 . . . . 0.0 111.552 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 2.7 Cg_endo -57.96 -37.85 94.44 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.583 1.522 . . . . 0.0 112.563 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 m -70.05 -12.49 61.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.872 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -100.07 115.43 29.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.922 -1.112 . . . . 0.0 109.888 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -103.06 -4.11 25.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.486 -0.758 . . . . 0.0 108.983 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.421 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 19.4 p -130.33 135.92 48.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.772 . . . . 0.0 109.245 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 8.0 tt -132.43 133.75 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.096 -1.003 . . . . 0.0 110.361 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -95.74 109.99 22.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.585 ' O ' ' OG ' ' A' ' 17' ' ' SER . 5.6 mt -85.63 148.81 25.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.129 -0.982 . . . . 0.0 109.814 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.4 p -135.05 177.73 7.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.74 -0.6 . . . . 0.0 109.596 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m120 57.33 45.43 20.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 48.5 mt -111.68 150.03 30.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.414 HD21 ' C ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -62.09 116.95 25.01 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.21 131.71 35.61 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 120.868 1.045 . . . . 0.0 112.932 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.45 62.91 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -142.38 130.72 22.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 110.887 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -87.14 122.52 31.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 177.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.694 ' OH ' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -139.82 175.45 9.56 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.615 -1.234 . . . . 0.0 110.863 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.4 t -109.12 129.08 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.71 123.19 68.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.415 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.1 p -111.19 142.36 43.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 0.0 111.586 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 49.3 mm -119.88 119.98 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.1 mm -113.66 119.97 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.91 -1.119 . . . . 0.0 108.809 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -85.67 130.13 34.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 108.686 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.8 147.55 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 110.061 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -128.51 40.05 3.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.06 -100.81 2.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 ptt-85 -90.34 -5.96 55.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -1.19 . . . . 0.0 110.242 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -112.31 143.48 43.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.97 -1.082 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -127.3 130.54 49.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 110.42 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.7 m -76.12 152.53 84.24 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.56 140.03 45.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 120.746 0.964 . . . . 0.0 111.765 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.89 146.22 80.2 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.561 1.508 . . . . 0.0 114.076 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.441 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 20.0 tp -122.08 121.74 37.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.415 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -133.2 140.55 46.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 O-C-N 120.846 -1.159 . . . . 0.0 111.379 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.33 162.57 27.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -110.84 141.88 43.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.037 -1.273 . . . . 0.0 110.165 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.586 ' OE1' ' OG ' ' A' ' 10' ' ' SER . 67.5 tp60 -145.21 158.46 43.82 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.5 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . -124.19 127.12 47.26 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.858 -1.151 . . . . 0.0 111.03 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.11 142.57 45.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -62.62 161.07 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.523 0.677 . . . . 0.0 110.907 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.5 m -88.87 138.5 31.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.576 -0.702 . . . . 0.0 110.016 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.563 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 54.1 t0 -70.23 -27.03 64.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 110.542 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 10.3 mt -60.06 140.53 90.65 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.0 110.067 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.42 -159.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 N-CA-C 109.896 -0.848 . . . . 0.0 109.896 177.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 15.9 ttp180 -160.01 160.57 33.45 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.664 -1.273 . . . . 0.0 111.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 98.2 m-20 59.95 43.84 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.439 HD21 ' CD2' ' A' ' 162' ' ' LEU . 41.2 tp -72.06 112.73 8.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 120.491 -1.381 . . . . 0.0 107.41 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -157.14 169.38 24.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 53.4 t -104.95 133.41 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CG2' ' OG ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -98.39 -30.0 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.703 0.763 . . . . 0.0 109.427 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.97 144.55 47.46 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 p -122.32 119.06 29.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 110.164 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -97.18 156.58 36.13 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.1 -46.2 26.46 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.564 1.509 . . . . 0.0 112.918 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 64.8 p -121.09 15.86 11.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.677 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.63 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 4.8 p -149.97 164.29 35.87 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.093 -1.004 . . . . 0.0 109.669 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.532 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -139.43 150.0 44.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.628 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.419 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 1.9 tt -99.02 122.64 42.55 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.109 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.471 ' CG1' ' O ' ' A' ' 147' ' ' ALA . 0.8 OUTLIER -106.99 141.26 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 0.0 110.872 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 101' ' ' ILE . 9.5 p -142.74 136.49 28.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.58 -0.7 . . . . 0.0 109.362 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.436 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 34.7 p90 -145.31 156.96 44.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.316 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.62 137.92 54.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.616 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.41 132.04 39.03 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 120.916 1.078 . . . . 0.0 112.099 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.94 -159.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 120.932 1.088 . . . . 0.0 112.256 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.44 2.92 45.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 24.0 m -130.01 160.0 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.098 -1.001 . . . . 0.0 109.819 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.4 t -74.55 135.36 42.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.442 ' HB ' ' CZ ' ' A' ' 122' ' ' TYR . 22.6 t -109.99 135.01 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.565 ' CB ' ' HE ' ' A' ' 168' ' ' ARG . 23.9 mmt180 -71.15 -45.94 62.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.487 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 12.1 p90 -166.29 162.37 17.27 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.424 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-85 -119.98 138.08 53.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 108.596 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' NE ' ' HB3' ' A' ' 137' ' ' GLU . 13.6 tpt180 -95.46 121.58 37.29 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.503 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 89.9 mt -110.0 132.36 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.144 -0.973 . . . . 0.0 110.322 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 3.1 p -113.17 144.76 42.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.689 . . . . 0.0 111.436 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.625 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.7 m-85 -87.93 136.61 32.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.695 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.7 128.7 9.4 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.161 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' GLY . 55.6 mt-10 -108.92 147.66 31.86 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.513 ' C ' ' O ' ' A' ' 128' ' ' GLU . 1.0 OUTLIER -39.56 -20.01 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.885 -1.134 . . . . 0.0 109.057 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . -108.04 58.57 0.4 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . -39.96 -20.04 0.02 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 130' ' ' GLY . 47.0 t-20 -59.98 -40.03 87.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.168 -1.195 . . . . 0.0 108.88 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.9 m -70.41 150.98 95.75 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.93 124.18 15.62 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.334 1.356 . . . . 0.0 112.99 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 17.1 m -69.02 162.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.404 -0.81 . . . . 0.0 108.853 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.485 ' HB2' ' CG ' ' A' ' 126' ' ' TYR . 15.0 mt-30 -94.39 112.69 24.48 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.344 -1.342 . . . . 0.0 108.373 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.442 ' HB3' ' NE ' ' A' ' 123' ' ' ARG . 21.5 mp0 -102.41 140.17 37.04 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.988 0.899 . . . . 0.0 112.715 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.503 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 41.9 p90 -143.16 153.87 43.3 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 p -88.62 163.1 15.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.663 -1.273 . . . . 0.0 112.092 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.629 ' O ' ' N ' ' A' ' 142' ' ' GLY . 27.9 t -123.85 105.35 32.44 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.2 Cg_exo -59.86 35.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.672 0.915 . . . . 0.0 112.76 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 30.69 30.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.697 ' N ' ' O ' ' A' ' 141' ' ' PRO . 81.4 p -69.41 -33.6 73.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -1.21 . . . . 0.0 109.698 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -146.17 176.38 9.78 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.563 -0.711 . . . . 0.0 110.107 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 92.7 p -90.03 0.01 57.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.722 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.436 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 19.8 p -136.22 150.96 49.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.471 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -148.05 177.49 9.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 108.945 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.626 ' CG2' ' N ' ' A' ' 149' ' ' ILE . 43.8 m -122.61 167.07 13.86 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.062 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.63 ' O ' ' CB ' ' A' ' 107' ' ' SER . 85.8 mt -123.92 130.52 73.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 110.01 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.582 ' O ' ' OH ' ' A' ' 126' ' ' TYR . 30.3 m120 -123.32 172.67 8.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.6 m120 61.42 40.36 14.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.0 110.323 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.49 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 3.4 tt -97.78 168.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 108.707 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.473 ' HB3' ' HH ' ' A' ' 158' ' ' TYR . 5.2 tptm -110.73 100.08 44.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 120.925 -1.109 . . . . 0.0 109.36 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -66.71 164.15 30.31 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.396 1.397 . . . . 0.0 113.015 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.98 19.52 69.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.48 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -149.72 156.76 42.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.29 . . . . 0.0 110.186 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.688 ' OD2' ' NZ ' ' A' ' 183' ' ' LYS . 61.9 t0 -70.0 151.14 45.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.6 OUTLIER -141.95 159.28 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.505 -1.372 . . . . 0.0 110.328 -179.188 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.495 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 20.4 m -130.49 123.17 29.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -103.39 120.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.131 -1.606 . . . . 0.0 109.666 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.7 m -131.36 141.86 49.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.445 ' H ' HD21 ' A' ' 162' ' ' LEU . 2.3 pt? -135.18 154.79 51.5 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.4 m-85 -120.02 140.6 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -108.04 125.74 51.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.752 -1.218 . . . . 0.0 109.768 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.487 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 90.1 t -114.5 127.54 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.662 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 1.4 p -121.29 -69.3 0.85 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.524 0.678 . . . . 0.0 109.691 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.662 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -57.21 121.37 25.13 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.565 ' HE ' ' CB ' ' A' ' 120' ' ' ARG . 53.9 mtt180 -119.89 12.9 12.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.394 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -77.28 -133.7 0.62 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.01 0.63 57.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -1.061 . . . . 0.0 109.546 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.0 m -130.01 71.2 82.26 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.787 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.58 105.19 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.67 1.58 . . . . 0.0 111.903 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.96 140.75 50.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.177 -0.952 . . . . 0.0 109.912 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 79.2 p -119.89 144.1 47.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.394 -0.816 . . . . 0.0 108.956 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.3 p -66.34 152.6 44.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.066 -1.021 . . . . 0.0 108.458 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 mmtm -49.34 137.03 16.12 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.844 -1.16 . . . . 0.0 108.825 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.53 142.29 97.56 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.165 1.243 . . . . 0.0 112.916 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 129.23 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 64.8 p -126.06 150.82 47.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.034 -1.041 . . . . 0.0 111.992 -177.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 48.0 pt -134.8 160.05 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -97.87 140.28 32.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.873 -1.142 . . . . 0.0 109.48 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.532 ' CE1' HD23 ' A' ' 108' ' ' LEU . 58.3 t80 -137.52 119.35 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 109.62 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.688 ' NZ ' ' OD2' ' A' ' 157' ' ' ASP . 71.3 mmtt -89.4 133.86 34.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.248 -0.907 . . . . 0.0 108.765 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.48 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 3.1 p . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 0.0 109.427 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.811 0 N-CA-C 119.384 2.514 . . . . 0.0 119.384 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 81' ' ' SER . 84.9 mt -123.72 136.81 54.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.262 -1.14 . . . . 0.0 109.241 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.13 130.1 36.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.486 ' HG ' ' HB3' ' A' ' 81' ' ' SER . 73.8 m -76.57 144.07 73.08 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 109.514 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.509 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 2.6 Cg_endo -58.87 110.16 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.171 . . . . 0.0 111.377 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.1 -155.29 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 109.772 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.02 23.7 76.93 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 105.108 -3.197 . . . . 0.0 105.108 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.437 ' CZ ' HG11 ' A' ' 20' ' ' VAL . 54.1 t80 -50.56 130.03 23.34 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.561 -0.819 . . . . 0.0 110.88 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.6 t0 -142.96 137.44 29.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.572 ' OG ' ' OE1' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -119.57 138.0 53.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 0.0 110.202 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' ASP . 91.5 p -167.2 -166.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.726 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.443 ' CB ' ' HG1' ' A' ' 19' ' ' THR . 95.2 m-20 48.7 43.68 20.93 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.754 ' CD1' HE21 ' A' ' 88' ' ' GLN . 1.0 OUTLIER -76.92 129.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.21 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.38 161.12 21.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.84 -59.99 4.5 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 110.218 -178.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -90.06 0.02 57.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.869 -1.144 . . . . 0.0 109.062 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 14' ' ' THR . 86.0 p -149.47 159.2 44.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.093 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.457 ' C ' ' CD1' ' A' ' 18' ' ' PHE . 16.9 p90 -163.77 148.27 10.49 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.443 ' HG1' ' CB ' ' A' ' 12' ' ' ASP . 2.0 m -101.37 150.29 23.17 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.115 -1.616 . . . . 0.0 112.286 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.437 HG11 ' CZ ' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -119.18 139.06 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -129.33 139.99 51.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.773 -1.204 . . . . 0.0 110.816 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 35.9 p90 -150.25 155.45 39.74 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -87.32 157.24 3.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.868 -1.145 . . . . 0.0 109.985 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -93.12 137.02 23.87 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.95 176.01 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 120.827 1.018 . . . . 0.0 111.892 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -103.3 15.55 28.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.311 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.87 155.75 47.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.09 131.27 40.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.614 1.543 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.0 pt -140.01 170.64 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.246 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 46.9 p -108.41 -10.15 15.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 109.841 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.89 178.27 23.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.624 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 25.8 m-85 -123.14 145.14 48.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 109.232 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.494 HD11 HG22 ' A' ' 33' ' ' ILE . 42.3 mm -100.7 128.01 53.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 120.88 -1.138 . . . . 0.0 108.123 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.618 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.2 mm -109.29 110.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.112 -0.992 . . . . 0.0 110.421 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -105.69 121.49 44.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.474 ' CD2' ' HB2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -118.76 135.09 54.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.808 -1.182 . . . . 0.0 110.861 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -160.05 159.0 31.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.597 -0.689 . . . . 0.0 109.586 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -94.39 139.6 30.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 108.547 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.576 ' OE2' ' OE1' ' A' ' 67' ' ' GLU . 21.9 pt-20 -62.12 -26.19 68.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.022 -1.049 . . . . 0.0 109.79 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -93.25 2.14 56.75 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.505 -0.747 . . . . 0.0 110.029 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 98.1 p -78.99 158.4 27.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.099 -1.0 . . . . 0.0 109.833 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.53 -0.99 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -0.839 . . . . 0.0 109.362 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.24 -177.37 50.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -70.02 133.04 88.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 0.0 109.476 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.86 135.56 69.77 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.202 1.268 . . . . 0.0 112.649 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.474 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 mmt180 -73.51 136.73 44.14 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -100.51 117.06 33.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.469 -0.769 . . . . 0.0 109.372 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -123.08 133.25 54.31 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.474 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -127.43 150.12 49.78 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.816 -1.177 . . . . 0.0 109.871 -178.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.433 ' CG1' HD11 ' A' ' 57' ' ' ILE . 34.4 m -135.15 145.96 56.33 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.17 160.08 46.58 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 120.924 1.083 . . . . 0.0 111.256 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.81 -31.5 91.83 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.243 1.296 . . . . 0.0 112.172 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.3 m -72.5 -11.42 60.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.546 -0.721 . . . . 0.0 111.255 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -103.94 120.0 40.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.839 -1.163 . . . . 0.0 109.461 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.431 ' C ' ' OD1' ' A' ' 55' ' ' ASN . 46.3 p-10 -102.49 -1.96 29.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.3 p -134.72 138.18 44.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.433 HD11 ' CG1' ' A' ' 50' ' ' VAL . 4.9 tt -131.55 134.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.705 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -102.5 119.8 39.45 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.339 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.461 HD21 ' CG ' ' A' ' 36' ' ' HIS . 1.1 mt -89.29 148.97 23.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 108.977 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -131.31 177.55 7.39 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.514 0.673 . . . . 0.0 110.019 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.4 m120 55.2 45.5 25.74 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 56.3 mt -109.94 152.87 25.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.175 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.473 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 95.1 m-20 -68.67 120.48 75.99 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.325 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.95 133.99 50.66 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 121.068 1.179 . . . . 0.0 113.49 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.7 63.05 2.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.2 m -148.57 156.36 42.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -1.16 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' OE1' ' OE2' ' A' ' 39' ' ' GLU . 8.8 pt-20 -99.31 120.02 38.88 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.473 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 77.3 m-85 -110.19 153.77 24.3 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 111.039 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -109.97 120.73 61.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.2 t -120.02 125.9 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.932 -1.105 . . . . 0.0 109.826 -178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 p -104.88 136.14 44.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 110.839 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.2 mm -112.05 121.03 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.11 129.98 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.965 -1.084 . . . . 0.0 109.594 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -91.65 132.54 36.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.339 -0.851 . . . . 0.0 109.543 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.484 ' O ' ' OG1' ' A' ' 30' ' ' THR . 16.5 m -128.6 137.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.442 ' HA ' ' HG1' ' A' ' 30' ' ' THR . 45.8 t-20 -119.96 41.93 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.17 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.63 -92.4 1.71 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.94 -0.0 40.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -1.106 . . . . 0.0 110.581 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.33 152.85 37.27 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.016 -1.053 . . . . 0.0 109.631 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -131.87 160.0 36.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 110.001 -179.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.556 ' OG ' ' O ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -110.93 172.17 3.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.239 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.453 ' CD ' ' HG ' ' A' ' 81' ' ' SER . 3.1 Cg_exo -61.78 132.74 41.39 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.391 1.394 . . . . 0.0 112.417 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.17 128.28 25.88 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.182 1.255 . . . . 0.0 113.074 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.509 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 20.4 tp -106.9 121.37 44.3 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -119.98 133.39 66.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.932 -1.105 . . . . 0.0 110.868 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.82 155.39 21.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -110.99 136.17 50.4 Favored 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.204 -1.174 . . . . 0.0 110.054 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.754 HE21 ' CD1' ' A' ' 13' ' ' ILE . 51.6 tt0 -137.6 143.53 41.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.43 149.55 37.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.979 -1.076 . . . . 0.0 111.594 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.424 ' H ' ' HG1' ' A' ' 90' ' ' THR . 0.5 OUTLIER -85.77 136.47 33.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.687 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 65' ' ' GLY . 20.8 t -51.13 173.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.466 0.65 . . . . 0.0 110.045 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.44 ' H ' ' CG1' ' A' ' 91' ' ' VAL . 68.6 m -100.86 141.35 33.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.413 -0.805 . . . . 0.0 109.158 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.568 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 57.9 t0 -71.47 -12.05 61.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.092 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 94' ' ' ILE . 3.1 mt -77.87 139.26 61.77 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.017 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -57.42 -171.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.283 0.655 . . . . 0.0 110.988 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.491 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 53.0 ttt85 -146.67 160.65 41.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.725 -1.234 . . . . 0.0 110.92 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.491 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 25.0 t0 72.55 34.88 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.856 -0.527 . . . . 0.0 111.456 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.519 ' C ' ' CD2' ' A' ' 98' ' ' LEU . 2.2 tt -65.28 102.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.498 -1.376 . . . . 0.0 107.663 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -142.58 157.97 44.15 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.939 -1.101 . . . . 0.0 110.549 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.2 p -89.96 137.3 21.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.3 pt -123.72 -13.21 6.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -142.63 130.01 21.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.5 t -115.03 117.67 31.24 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.613 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -108.6 157.96 35.23 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.07 -40.74 33.98 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 121.509 1.473 . . . . 0.0 112.781 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.6 p -130.01 20.02 5.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 110.22 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.613 ' O ' ' OG1' ' A' ' 104' ' ' THR . 18.9 p -153.41 165.37 36.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.889 -1.132 . . . . 0.0 110.285 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 107' ' ' SER . 1.2 mt -141.49 157.26 45.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 23.9 tp -104.8 127.55 52.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.084 -1.01 . . . . 0.0 108.381 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.462 ' CG1' ' O ' ' A' ' 147' ' ' ALA . 2.0 pt -109.77 135.3 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 110.703 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 52.6 m -126.86 132.51 50.94 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 42.5 p90 -143.02 157.5 44.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 109.596 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -95.11 142.06 24.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.368 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.29 136.44 68.34 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 120.952 1.101 . . . . 0.0 112.034 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.38 -163.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 120.984 1.123 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -91.24 1.6 56.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 109.187 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.436 ' CG2' ' OD1' ' A' ' 93' ' ' ASP . 33.1 m -129.98 160.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.702 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.4 p -69.63 157.38 37.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 108.584 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.446 ' CB ' ' CZ ' ' A' ' 122' ' ' TYR . 23.8 t -129.91 130.0 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 110.146 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -73.16 -42.97 62.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.472 ' CE2' HG23 ' A' ' 139' ' ' THR . 1.5 p90 -166.57 163.45 16.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.117 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.588 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-85 -120.0 142.76 48.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 108.771 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.468 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 1.2 mtp180 -99.36 127.34 45.37 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.509 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 35.7 mt -110.01 130.0 63.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.813 -1.179 . . . . 0.0 109.834 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.421 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 76.9 p -106.56 140.37 39.55 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.962 0.887 . . . . 0.0 111.58 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.628 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 5.8 m-85 -91.43 127.48 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.737 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -99.57 117.17 5.79 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.423 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -109.21 64.86 0.61 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.541 -0.976 . . . . 0.0 109.197 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -74.08 146.72 43.41 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.982 -1.074 . . . . 0.0 109.839 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.94 -9.96 75.52 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -119.67 -8.47 9.02 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.07 29.44 6.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.274 -1.133 . . . . 0.0 108.801 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 17.7 m -97.77 151.51 37.63 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.371 -0.831 . . . . 0.0 109.35 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.36 140.11 87.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.327 1.351 . . . . 0.0 112.475 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.5 m -69.76 150.2 10.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.341 -0.85 . . . . 0.0 109.156 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.513 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 93.3 mm-40 -109.38 121.53 45.38 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.611 -1.236 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -109.77 140.57 43.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.865 . . . . 0.0 111.617 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.509 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 43.0 p90 -139.6 150.0 44.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.481 ' H ' ' HG1' ' A' ' 139' ' ' THR . 4.1 p -86.19 163.57 17.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.112 -0.993 . . . . 0.0 111.463 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.549 ' C ' ' H ' ' A' ' 142' ' ' GLY . 7.2 t -129.99 112.45 17.27 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.703 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.35 35.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.728 0.952 . . . . 0.0 112.719 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 140' ' ' VAL . . . 35.03 24.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 141' ' ' PRO . 28.8 t -66.39 -40.02 89.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.059 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -134.3 175.64 9.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.841 0.829 . . . . 0.0 110.546 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 52.5 m -94.62 0.0 54.81 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -136.83 150.92 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 108.844 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -141.73 162.92 34.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 109.847 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.4 t -100.56 148.37 24.89 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 108.98 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.628 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 48.5 mm -116.62 120.03 63.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.619 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 78.8 m-20 -120.06 173.91 6.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.19 -0.943 . . . . 0.0 110.306 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.7 t30 65.92 40.0 4.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 109.56 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.506 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 2.3 tt -100.66 146.54 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.764 ' H ' ' HH ' ' A' ' 158' ' ' TYR . 24.0 tttp -99.95 109.43 56.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.987 -1.071 . . . . 0.0 110.123 -179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -68.55 172.64 11.09 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.129 1.22 . . . . 0.0 112.485 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.608 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.34 20.86 77.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.677 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -148.65 156.75 42.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.317 . . . . 0.0 109.763 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.9 t0 -69.97 147.27 50.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.764 ' HH ' ' H ' ' A' ' 153' ' ' LYS . 0.3 OUTLIER -138.0 156.87 47.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.79 -1.194 . . . . 0.0 110.515 -178.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.5 m -134.58 118.03 16.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.18 124.91 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.343 -1.473 . . . . 0.0 109.357 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.469 HG21 ' N ' ' A' ' 162' ' ' LEU . 99.8 m -130.83 142.83 50.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.0 110.439 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.469 ' N ' HG21 ' A' ' 161' ' ' THR . 80.3 mt -107.83 142.13 38.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.645 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 24.7 m-85 -119.98 140.02 51.59 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.94 129.93 55.44 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.94 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.434 HG22 ' CZ ' ' A' ' 121' ' ' TYR . 62.4 t -115.37 122.55 69.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.741 ' HG1' ' H ' ' A' ' 167' ' ' GLY . 9.7 p -129.82 -61.73 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.51 0.672 . . . . 0.0 110.045 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.741 ' H ' ' HG1' ' A' ' 166' ' ' THR . . . -25.4 131.77 0.02 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -111.22 124.96 53.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.45 -1.029 . . . . 0.0 109.271 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 157.24 -168.72 34.16 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -76.42 -5.13 45.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.429 -1.042 . . . . 0.0 109.31 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.4 m -130.04 76.45 78.03 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -0.847 . . . . 0.0 109.536 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.03 106.59 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.563 1.509 . . . . 0.0 112.172 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.97 154.79 23.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.464 -0.773 . . . . 0.0 109.692 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 66.7 p -125.63 147.27 49.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.722 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 49.1 p -72.07 160.69 32.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.412 ' HD3' ' N ' ' A' ' 176' ' ' LYS . 18.3 mmtm -57.73 130.57 82.12 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 108.435 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.435 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.1 Cg_endo -61.12 134.66 53.93 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.195 1.263 . . . . 0.0 113.664 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.459 ' O ' ' CG2' ' A' ' 161' ' ' THR . 2.0 t -100.29 126.83 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.438 ' CB ' ' OG1' ' A' ' 161' ' ' THR . 79.1 p -122.69 145.25 48.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.057 -1.027 . . . . 0.0 112.187 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.8 pt -130.61 159.97 42.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -104.13 135.78 44.98 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.85 -1.156 . . . . 0.0 109.502 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.478 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 65.7 t80 -130.2 109.67 10.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.39 136.22 33.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.077 -1.014 . . . . 0.0 108.99 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.677 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 2.5 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.371 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' C ' ' CD1' ' A' ' 2' ' ' LEU . . . . . . . . 1 N--CA 1.529 4.835 0 N-CA-C 119.396 2.518 . . . . 0.0 119.396 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.799 ' H ' ' CD2' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -112.95 157.64 21.23 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.246 -1.149 . . . . 0.0 108.809 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -79.49 140.63 37.24 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' THR . 66.5 m -76.77 140.67 67.65 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.391 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.426 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 2.9 Cg_endo -57.76 78.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.133 1.222 . . . . 0.0 111.71 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.516 ' H ' ' HG1' ' A' ' 6' ' ' THR . 0.9 OUTLIER -81.55 -152.02 0.09 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.397 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.0 22.95 77.31 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 106.207 -2.757 . . . . 0.0 106.207 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -57.78 130.0 44.44 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.623 0.725 . . . . 0.0 110.141 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.8 t0 -156.6 147.25 21.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 39.1 t -121.49 141.85 50.63 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.03 -1.043 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 12' ' ' ASP . 22.9 p -155.64 -171.54 3.81 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.4 m-20 49.63 39.94 18.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.426 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -76.49 130.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.42 160.81 27.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.652 ' CB ' ' OD1' ' A' ' 93' ' ' ASP . . . -59.67 -60.0 4.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 110.229 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -89.27 0.06 57.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.978 -1.076 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 14' ' ' THR . 47.5 t -149.33 154.62 39.26 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.429 ' N ' ' HG ' ' A' ' 17' ' ' SER . 12.6 p90 -165.12 141.01 5.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.405 HG23 ' NE2' ' A' ' 21' ' ' HIS . 3.1 m -91.24 150.09 21.49 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.449 -1.407 . . . . 0.0 111.301 -178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.409 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -119.98 138.44 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.419 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 68.9 m-70 -128.59 144.33 51.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.934 -1.104 . . . . 0.0 110.965 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 41.1 p90 -145.28 160.02 42.14 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.454 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.9 159.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.855 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.454 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -97.59 132.73 24.61 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.55 -178.46 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.003 1.135 . . . . 0.0 112.711 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -103.86 -0.75 28.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.15 151.68 38.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.088 -1.007 . . . . 0.0 109.729 -179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 2.9 Cg_endo -57.38 126.31 21.6 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.411 1.408 . . . . 0.0 112.29 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.56 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 19.6 pt -130.04 164.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.408 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -99.98 -1.79 36.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.515 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.9 -172.69 23.56 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 42.6 m-85 -128.45 156.84 42.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.24 128.08 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.48 ' N ' ' O ' ' A' ' 48' ' ' ASP . 1.6 mm -111.61 118.14 56.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.944 -1.098 . . . . 0.0 110.653 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -112.07 129.41 56.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.513 ' C ' ' CD2' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -124.01 141.29 52.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.781 -1.2 . . . . 0.0 110.982 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 46.9 p-80 -165.1 166.88 18.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.063 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.83 138.56 37.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -63.43 -20.34 65.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 109.431 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -75.8 -10.01 59.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.597 -0.689 . . . . 0.0 109.776 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 82.2 p -138.71 150.01 45.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.025 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 43' ' ' GLY . 12.7 t -136.79 2.96 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.436 -0.79 . . . . 0.0 109.384 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 42' ' ' VAL . . . -44.81 -99.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.427 ' HB2' HH21 ' A' ' 44' ' ' ARG . 32.9 mtm-85 -117.06 100.43 53.3 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.2 -1.176 . . . . 0.0 109.68 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -64.85 138.22 56.88 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.166 1.244 . . . . 0.0 112.196 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -73.61 152.86 40.4 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.097 -1.002 . . . . 0.0 110.155 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -121.86 117.73 27.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.0 109.855 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 34' ' ' ILE . 85.9 m-20 -123.15 119.1 29.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.756 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -104.44 141.68 35.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.095 -1.003 . . . . 0.0 109.424 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.9 m -125.33 147.85 59.0 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.46 159.92 45.38 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 120.853 1.035 . . . . 0.0 111.516 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.85 -35.17 99.05 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.488 1.459 . . . . 0.0 112.402 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -69.95 -16.75 63.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.894 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -100.03 117.19 33.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.031 -1.043 . . . . 0.0 109.478 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -104.31 -0.08 28.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.419 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 51.6 p -132.85 138.4 47.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.249 -0.907 . . . . 0.0 109.799 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.5 tt -130.05 134.9 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.048 179.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.8 m -99.81 120.27 39.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.517 ' O ' ' OG ' ' A' ' 17' ' ' SER . 7.2 mt -97.45 140.75 31.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.274 -0.891 . . . . 0.0 109.568 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.1 p -132.63 179.42 6.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.686 . . . . 0.0 109.943 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.91 39.97 29.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.483 -0.761 . . . . 0.0 109.576 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 21.0 mt -107.21 149.34 27.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 0.0 109.104 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.537 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 87.7 m-20 -60.82 116.4 18.33 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.96 -1.087 . . . . 0.0 108.363 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 131.97 37.2 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.035 1.157 . . . . 0.0 113.401 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.31 62.82 2.24 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -150.55 157.52 43.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -1.224 . . . . 0.0 110.662 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 66' ' ' THR . 99.0 mt-10 -92.24 120.05 32.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.537 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 44.2 m-85 -110.84 148.71 31.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.157 -0.964 . . . . 0.0 110.996 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.46 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 62.7 t -110.04 124.34 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.9 124.85 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 p -108.4 134.81 50.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 111.195 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.41 HD11 HG22 ' A' ' 72' ' ' ILE . 24.6 mm -114.5 117.3 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.51 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.5 mp -111.8 125.46 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 108.443 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.8 127.82 39.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.46 129.96 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.876 . . . . 0.0 109.116 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 52.3 t30 -111.64 34.82 3.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.865 . . . . 0.0 109.341 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.17 -87.05 1.52 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.79 -6.01 56.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -1.108 . . . . 0.0 110.393 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 100.0 mt-10 -131.12 150.05 52.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 60.0 mp0 -126.67 129.96 49.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.96 160.01 81.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.207 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.46 142.03 98.35 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.221 1.28 . . . . 0.0 111.969 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.99 136.99 78.61 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.239 1.293 . . . . 0.0 113.048 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 26.2 tp -115.77 121.29 42.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.95 130.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.947 -1.096 . . . . 0.0 111.074 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.08 160.44 22.49 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.004 -2.439 . . . . 0.0 107.004 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -118.54 137.88 52.91 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.04 -1.27 . . . . 0.0 110.033 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -139.3 139.29 37.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -102.24 133.68 46.73 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 110.77 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.34 140.06 41.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -60.19 153.16 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.651 . . . . 0.0 110.484 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.428 ' HG ' HH22 ' A' ' 96' ' ' ARG . 89.9 p -84.11 159.97 21.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.418 -0.801 . . . . 0.0 109.079 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.652 ' OD1' ' CB ' ' A' ' 15' ' ' ALA . 89.1 m-20 -105.62 -13.77 15.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.135 -0.978 . . . . 0.0 111.28 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.455 ' O ' ' N ' ' A' ' 96' ' ' ARG . 2.0 mt -80.05 138.13 53.17 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 120.662 -1.274 . . . . 0.0 110.496 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 96' ' ' ARG . 2.5 Cg_endo -65.89 62.13 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.824 1.016 . . . . 0.0 111.124 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.509 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 44.5 ttm105 -40.58 163.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 110.367 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.509 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.9 m-20 63.1 40.62 8.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.904 -0.497 . . . . 0.0 111.246 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 49.0 tp -79.97 104.09 10.3 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.835 -1.166 . . . . 0.0 107.887 178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -158.64 166.58 31.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.021 . . . . 0.0 110.121 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 25.3 t -89.07 140.02 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.443 ' CD1' ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -114.14 -9.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -147.62 158.8 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.3 t -134.77 127.93 31.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.965 -1.084 . . . . 0.0 110.423 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.624 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.55 158.68 38.0 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -48.92 -32.68 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.485 1.456 . . . . 0.0 112.914 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 3.0 p -139.21 20.26 2.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 109.862 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.624 ' O ' ' OG1' ' A' ' 104' ' ' THR . 6.1 p -153.15 167.5 29.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.022 . . . . 0.0 110.067 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.443 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 30.6 tp -105.27 121.63 44.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 108.795 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.508 HG22 HD11 ' A' ' 110' ' ' ILE . 3.1 pt -102.95 143.94 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.482 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 97' ' ' ASP . 36.3 t -136.73 140.0 42.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.704 -0.622 . . . . 0.0 109.756 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.695 ' CD2' ' O ' ' A' ' 145' ' ' SER . 48.8 p90 -144.37 156.99 44.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.564 -0.71 . . . . 0.0 109.303 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.96 130.45 89.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.67 118.59 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 120.937 1.091 . . . . 0.0 112.247 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.06 168.01 11.44 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 120.864 1.043 . . . . 0.0 111.995 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -107.01 28.12 8.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.829 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.97 159.99 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.5 t -70.86 129.96 40.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.326 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.47 HG12 ' CZ ' ' A' ' 122' ' ' TYR . 39.9 t -129.98 130.44 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -70.95 -51.27 26.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.488 ' CE2' HG23 ' A' ' 139' ' ' THR . 15.3 p90 -167.14 170.49 11.77 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.598 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 3.7 m-85 -120.03 139.86 51.86 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 108.47 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -98.7 126.85 44.44 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.5 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 44.9 mt -118.55 130.84 72.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.872 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.5 p -101.55 146.54 27.53 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.088 0.947 . . . . 0.0 111.527 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.721 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 3.3 m-85 -92.05 128.07 37.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.727 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.27 122.99 7.08 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.873 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.591 ' O ' ' C ' ' A' ' 129' ' ' THR . 43.4 mt-10 -105.75 157.45 17.43 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.617 -0.931 . . . . 0.0 108.535 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.644 ' HG1' ' H ' ' A' ' 130' ' ' GLY . 1.0 OUTLIER -22.8 -62.27 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.7 -0.625 . . . . 0.0 110.709 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.644 ' H ' ' HG1' ' A' ' 129' ' ' THR . . . 142.91 24.28 0.18 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.675 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.21 -81.68 0.09 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 133' ' ' SER . 80.8 m-20 -102.96 -1.98 28.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -1.118 . . . . 0.0 108.549 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.687 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 1.6 p 75.51 35.04 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.657 -0.652 . . . . 0.0 111.668 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 133' ' ' SER . 2.5 Cg_endo -60.17 50.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 120.724 0.949 . . . . 0.0 112.464 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 133' ' ' SER . 1.7 m -57.11 143.47 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.804 -1.185 . . . . 0.0 109.517 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.519 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 28.3 mt-30 -125.23 131.77 53.08 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.449 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.1 pm0 -113.36 148.66 35.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.913 -1.117 . . . . 0.0 111.991 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.5 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 49.9 p90 -139.96 150.82 44.97 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.488 HG23 ' CE2' ' A' ' 121' ' ' TYR . 15.1 p -88.32 166.09 14.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.032 . . . . 0.0 111.634 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLY . 54.2 t -136.97 95.24 12.19 Favored Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.681 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -60.05 47.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 120.909 1.073 . . . . 0.0 113.243 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 33.98 26.98 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 141' ' ' PRO . 94.5 p -62.99 -39.98 96.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.452 ' HG2' ' N ' ' A' ' 145' ' ' SER . 19.0 tttt -146.12 165.24 29.7 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.889 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.695 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 79.4 p -78.97 -2.85 42.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.68 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.449 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 58.7 p -129.45 150.58 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 108.831 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.446 ' H ' HG13 ' A' ' 110' ' ' ILE . . . -132.39 161.57 33.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.101 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.45 HG21 ' N ' ' A' ' 149' ' ' ILE . 5.7 m -104.24 147.1 27.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.437 -0.789 . . . . 0.0 109.437 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.611 ' CG2' ' HH ' ' A' ' 126' ' ' TYR . 40.5 mm -117.92 119.98 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.721 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 10.6 m120 -121.87 176.83 5.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 110.463 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.93 50.05 5.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.809 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.458 HG13 ' CE2' ' A' ' 158' ' ' TYR . 2.6 tt -114.81 149.22 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.087 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -94.18 111.96 55.47 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 109.974 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.24 156.37 63.46 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.171 1.247 . . . . 0.0 112.945 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.663 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.02 23.69 76.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -136.1 137.1 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.059 -1.26 . . . . 0.0 109.706 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 53.7 t0 -60.04 140.01 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.727 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -134.28 172.07 13.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.866 -1.146 . . . . 0.0 111.055 -178.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -146.44 124.63 12.18 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 69.9 mt -111.61 125.95 68.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 120.296 -1.502 . . . . 0.0 109.155 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.437 HG23 ' CE1' ' A' ' 163' ' ' TYR . 21.9 m -124.44 141.05 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.371 179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.533 ' CD1' ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -124.05 140.49 52.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 111.427 -177.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.533 ' N ' ' CD1' ' A' ' 162' ' ' LEU . 7.0 m-85 -124.78 152.49 43.78 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.64 131.49 54.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.816 -1.177 . . . . 0.0 109.875 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.02 130.02 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.549 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.633 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 2.8 p -116.73 -70.75 0.77 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 109.945 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.633 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -70.58 143.01 36.23 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.473 ' HG2' HH11 ' A' ' 168' ' ' ARG . 75.9 mtp85 -134.3 136.33 43.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -1.08 . . . . 0.0 109.088 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 149.67 -148.65 20.16 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -74.35 -14.3 60.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -1.138 . . . . 0.0 109.116 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.9 m -132.44 75.23 74.29 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.555 -0.716 . . . . 0.0 109.496 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.4 -177.68 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.429 1.419 . . . . 0.0 111.905 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -155.45 126.9 7.29 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.472 -0.768 . . . . 0.0 109.962 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 p -132.55 141.93 48.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 108.991 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.2 p -80.08 170.03 17.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 108.47 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -63.57 118.42 44.28 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.1 Cg_exo -61.98 150.59 85.72 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.034 1.156 . . . . 0.0 113.393 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.9 t -120.73 131.05 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 97.4 p -117.2 154.03 31.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.09 -1.006 . . . . 0.0 111.475 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 48.3 pt -137.58 164.69 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -111.32 138.78 47.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.171 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.509 ' CE2' HD23 ' A' ' 108' ' ' LEU . 64.9 t80 -136.05 126.85 27.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.072 -1.017 . . . . 0.0 109.952 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -100.82 129.24 46.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.281 -0.887 . . . . 0.0 108.834 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.3 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.253 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 121.417 0.627 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -79.69 135.99 36.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.311 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -85.25 139.97 36.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.127 -0.983 . . . . 0.0 109.667 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.687 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_exo -57.82 143.29 95.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.214 1.276 . . . . 0.0 111.943 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 p -150.57 -153.29 0.48 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 20.12 76.0 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 105.494 -3.043 . . . . 0.0 105.494 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -52.71 127.35 22.86 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.594 0.711 . . . . 0.0 110.09 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 10' ' ' SER . 53.2 t0 -147.83 141.15 25.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.624 ' CB ' ' OE1' ' A' ' 88' ' ' GLN . 81.9 p -111.46 145.89 38.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.956 -1.09 . . . . 0.0 110.255 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 12' ' ' ASP . 80.2 p -169.45 -175.91 2.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.547 -0.721 . . . . 0.0 109.346 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 49.94 44.3 25.38 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -80.03 129.99 36.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.764 -178.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.22 162.06 20.02 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.137 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.812 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.16 -60.01 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.999 -1.063 . . . . 0.0 110.287 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.61 0.14 57.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.957 -1.089 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 14' ' ' THR . 80.0 p -149.64 158.67 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.429 -0.794 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.684 ' CE2' HG22 ' A' ' 20' ' ' VAL . 26.0 p90 -165.54 148.28 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -97.26 149.86 21.58 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.289 -1.507 . . . . 0.0 111.607 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 18' ' ' PHE . 1.4 t -122.44 140.44 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -129.83 145.59 51.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.743 -1.223 . . . . 0.0 111.086 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 46.8 p90 -149.66 158.42 44.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.02 158.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.879 -1.138 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -94.25 136.56 23.36 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.717 -0.614 . . . . 0.0 109.813 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 2.8 Cg_endo -59.17 176.15 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.012 1.141 . . . . 0.0 112.407 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -102.54 9.97 39.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.82 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -112.01 157.22 40.33 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.995 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.8 Cg_endo -57.48 122.09 11.18 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.74 1.627 . . . . 0.0 112.619 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 29.7 pt -130.03 165.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.295 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 76' ' ' ASN . 70.4 p -106.66 -7.99 17.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.24 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.35 -179.18 22.62 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.585 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 16.3 m-85 -125.0 147.53 48.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.194 . . . . 0.0 109.207 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' HG3' ' A' ' 49' ' ' ARG . 29.4 mm -102.1 126.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.589 HD11 HG22 ' A' ' 50' ' ' VAL . 3.2 mm -103.78 116.74 48.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.972 -1.08 . . . . 0.0 110.214 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -117.23 131.46 56.84 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.613 ' HB2' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.02 149.93 43.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.33 -1.481 . . . . 0.0 111.275 -178.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -169.76 154.92 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.372 -0.83 . . . . 0.0 108.914 179.05 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.477 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 42.9 mtt-85 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.599 0.714 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -117.85 112.56 20.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.587 0.708 . . . . 0.0 110.017 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.9 m-20 -124.11 129.96 51.74 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.697 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -118.77 145.18 45.79 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.859 -1.15 . . . . 0.0 109.664 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 HD11 ' A' ' 34' ' ' ILE . 27.1 m -131.52 149.07 72.49 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.963 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.17 157.76 51.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.889 1.059 . . . . 0.0 111.53 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.51 -35.4 98.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 121.363 1.375 . . . . 0.0 112.05 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -70.35 -13.71 62.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.534 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -97.49 120.0 37.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 110.005 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.401 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 30.3 p-10 -108.87 -1.25 19.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.592 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.7 p -129.99 137.57 50.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 109.366 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.562 HD13 HG21 ' A' ' 34' ' ' ILE . 8.6 tt -129.99 130.13 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 m -95.85 119.16 33.84 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.316 -0.865 . . . . 0.0 109.137 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' ' 62' ' ' LEU . 12.2 mt -93.04 146.04 23.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.0 p -136.35 178.36 7.12 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.581 . . . . 0.0 109.932 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 56.18 44.19 25.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.301 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.753 HD11 ' HB3' ' A' ' 59' ' ' LEU . 14.6 mt -113.65 152.89 29.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.478 -0.764 . . . . 0.0 109.623 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.644 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 31.4 t-20 -70.11 120.02 75.45 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.117 -0.989 . . . . 0.0 108.733 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.812 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 138.82 75.35 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.988 1.125 . . . . 0.0 113.192 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.94 63.34 3.03 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -155.04 150.1 26.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.196 -1.179 . . . . 0.0 110.912 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 11.5 pt-20 -85.73 122.28 29.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.644 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 34.6 m-85 -111.54 139.96 46.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 110.481 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.545 HG22 ' OE1' ' A' ' 87' ' ' GLN . 18.8 t -96.56 120.12 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 36' ' ' HIS . 47.4 t -120.13 130.02 74.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.437 ' CB ' HG12 ' A' ' 85' ' ' ILE . 88.7 p -118.5 139.91 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.63 129.99 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.46 129.26 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.741 -1.224 . . . . 0.0 109.21 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.756 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -96.62 127.36 42.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.099 -1.001 . . . . 0.0 109.01 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.82 142.98 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.86 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CG ' ' O ' ' A' ' 76' ' ' ASN . 6.7 t-20 -123.03 37.02 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 108.806 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.6 -94.82 1.82 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -94.71 -6.24 43.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 0.0 110.042 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.55 140.01 49.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.938 -1.101 . . . . 0.0 109.724 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.6 139.96 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.756 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -92.54 169.55 10.52 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.19 133.6 44.57 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.225 1.283 . . . . 0.0 112.218 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.1 155.95 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.473 1.449 . . . . 0.0 113.655 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 5' ' ' PRO . 17.8 tp -131.82 121.14 23.62 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.4 mt -128.56 139.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.813 -1.179 . . . . 0.0 110.427 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.55 166.88 26.37 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.545 ' OE1' HG22 ' A' ' 69' ' ' VAL . 13.2 mm-40 -119.54 137.81 53.58 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.062 -1.257 . . . . 0.0 110.039 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.624 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 62.1 tp60 -134.76 135.95 42.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.714 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.53 136.78 42.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.762 HG11 ' HB2' ' A' ' 116' ' ' ALA . 3.7 t . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.52 0.676 . . . . 0.0 110.884 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.479 HG21 HG23 ' A' ' 178' ' ' VAL . 6.4 mt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.45 -165.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 N-CA-C 109.57 -0.973 . . . . 0.0 109.57 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -157.54 165.6 35.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.51 -1.369 . . . . 0.0 110.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 69.91 37.14 1.83 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.717 -0.614 . . . . 0.0 110.457 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.495 HD13 ' CD2' ' A' ' 162' ' ' LEU . 46.7 tp -73.05 102.43 3.52 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -150.62 170.04 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.606 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 24.6 t -100.86 135.86 35.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.625 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -104.04 -14.91 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.71 0.767 . . . . 0.0 109.055 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -139.72 148.23 42.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.437 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 28.5 t -132.38 119.7 21.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.107 . . . . 0.0 110.793 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -118.39 153.53 51.83 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -49.97 -42.04 46.38 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.796 1.664 . . . . 0.0 113.479 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -119.1 10.39 12.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.908 -1.12 . . . . 0.0 110.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.073 ' O ' HD23 ' A' ' 108' ' ' LEU . 76.8 p -152.05 160.94 43.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.823 -1.173 . . . . 0.0 110.209 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.073 HD23 ' O ' ' A' ' 107' ' ' SER . 1.5 mt -143.8 155.26 44.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.376 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.827 HD13 ' N ' ' A' ' 110' ' ' ILE . 2.1 tm? -99.98 127.21 46.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.827 ' N ' HD13 ' A' ' 109' ' ' LEU . 5.8 pt -110.54 139.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 110.251 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.554 ' HA ' HG22 ' A' ' 146' ' ' THR . 53.3 m -138.25 141.94 39.9 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.612 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.603 ' CD2' ' O ' ' A' ' 145' ' ' SER . 43.5 p90 -154.63 159.97 41.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.138 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.83 130.16 32.34 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 109.226 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.93 141.37 96.41 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 120.853 1.035 . . . . 0.0 112.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.87 -162.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.007 1.138 . . . . 0.0 112.379 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.762 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -104.2 17.12 24.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.147 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.0 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.289 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 t -69.97 130.66 42.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.331 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.645 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 41.1 t -115.93 130.01 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.412 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 166' ' ' THR . 26.9 mmt180 -71.71 -45.93 60.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.48 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 11.4 p90 -166.58 167.04 15.79 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.645 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -120.4 139.83 52.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 55.4 ttp180 -96.95 130.06 44.32 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.972 -1.08 . . . . 0.0 108.423 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.527 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 62.8 mt -119.25 130.25 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -106.22 146.89 29.73 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.848 0.832 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.681 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.6 m-85 -94.6 132.21 39.54 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.73 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.38 117.67 5.46 Favored Glycine 0 C--O 1.206 -1.649 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.672 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--N 1.294 -1.834 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.728 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 126' ' ' TYR . 71.0 mt-30 -109.95 128.64 55.5 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.751 -1.179 . . . . 0.0 108.293 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -119.28 155.46 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.668 -1.27 . . . . 0.0 112.529 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 54.2 p90 -140.86 151.73 44.54 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.6 p -88.51 165.82 14.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.85 -1.156 . . . . 0.0 111.688 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 142' ' ' GLY . 72.9 t -132.71 95.6 19.57 Favored Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -59.8 44.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 120.787 0.991 . . . . 0.0 112.799 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 35.63 23.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.97 -35.93 74.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -1.152 . . . . 0.0 109.916 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -139.92 153.68 47.02 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.522 -0.736 . . . . 0.0 109.832 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.603 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 88.6 p -79.9 -9.98 59.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.386 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 111' ' ' SER . 45.5 p -128.15 152.31 48.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.733 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -141.01 169.4 17.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -112.72 139.98 47.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -0.916 . . . . 0.0 108.943 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 110' ' ' ILE . 32.9 mm -108.56 120.91 60.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 108.725 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.681 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 73.2 m-20 -124.11 168.68 12.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 32.2 t30 77.15 44.98 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.935 HG23 ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -113.01 130.04 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -72.85 121.87 86.14 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.0 109.941 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.03 159.41 42.71 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.27 1.313 . . . . 0.0 113.145 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 23.06 61.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 184' ' ' THR . . . -127.89 133.26 49.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.114 -1.227 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 54.8 t0 -59.96 140.07 56.98 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.935 ' CE2' HG23 ' A' ' 152' ' ' ILE . 1.4 m-85 -132.38 161.52 33.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.681 -1.262 . . . . 0.0 111.057 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.547 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 2.4 m -134.28 120.86 20.49 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.664 HD11 HD12 ' A' ' 108' ' ' LEU . 6.7 mt -107.16 120.18 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.154 -1.591 . . . . 0.0 108.97 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 179' ' ' SER . 88.3 m -132.54 149.97 52.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.495 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.3 pp -143.13 151.22 40.46 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.602 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.0 OUTLIER -120.91 140.01 52.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.66 131.48 49.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.745 -1.222 . . . . 0.0 109.778 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 72.4 t -119.62 121.21 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.366 -0.834 . . . . 0.0 109.797 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 16.5 p . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.1 p -79.94 170.13 16.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.072 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -57.03 124.59 66.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.065 -1.022 . . . . 0.0 108.383 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.482 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 2.7 Cg_endo -63.34 150.34 88.83 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 120.905 1.07 . . . . 0.0 113.641 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.479 HG23 HG21 ' A' ' 94' ' ' ILE . 1.9 t -116.18 131.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 161' ' ' THR . 80.2 p -130.03 154.12 47.74 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.009 . . . . 0.0 111.811 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.12 159.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -103.09 139.98 37.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.73 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 35.2 t80 -138.11 131.33 30.34 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.902 -1.124 . . . . 0.0 110.494 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.635 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 19.8 pttp -94.09 138.41 32.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 108.93 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 156' ' ' ALA . 1.3 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.429 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' A' ' 81' ' ' SER . 98.2 mt . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.96 159.27 28.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' THR . 42.7 t -94.29 130.02 35.29 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.886 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.549 ' CD ' ' HB2' ' A' ' 74' ' ' ALA . 2.8 Cg_endo -58.81 72.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.106 1.204 . . . . 0.0 111.788 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -79.55 -153.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.013 -1.054 . . . . 0.0 109.611 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.94 22.62 78.4 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -58.21 130.28 45.91 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.505 0.669 . . . . 0.0 110.291 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -147.5 123.91 10.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.23 130.28 50.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 109.876 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' ASP . 88.3 p -154.84 -172.4 4.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.159 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.0 49.89 19.5 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -88.48 126.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.905 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -113.82 162.45 16.32 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.123 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -59.96 -51.57 69.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -97.7 -0.11 46.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.907 -1.121 . . . . 0.0 109.887 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.695 ' O ' ' N ' ' A' ' 14' ' ' THR . 18.1 m -150.47 155.01 38.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.878 ' CD1' ' NE2' ' A' ' 88' ' ' GLN . 28.4 p90 -163.12 150.16 12.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 108.986 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -92.99 143.65 26.03 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.484 -1.385 . . . . 0.0 111.381 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.841 HG22 ' CE1' ' A' ' 18' ' ' PHE . 2.0 t -116.14 137.19 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.482 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 77.6 m-70 -130.48 149.52 52.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.65 -1.281 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.447 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 36.6 p90 -155.63 160.01 40.08 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.53 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 120.743 -1.223 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' N ' HG13 ' A' ' 23' ' ' VAL . . . -94.54 132.58 28.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.793 -0.567 . . . . 0.0 109.915 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HG2' HG21 ' A' ' 29' ' ' ILE . 2.9 Cg_endo -59.68 151.8 67.44 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.998 1.132 . . . . 0.0 112.201 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -65.78 -40.03 91.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.34 147.7 98.84 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.66 138.36 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.426 1.418 . . . . 0.0 112.232 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.671 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 33.3 pt -132.6 168.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.733 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -103.66 -0.47 29.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.407 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.56 -173.62 23.01 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.671 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 44.6 m-85 -130.01 157.06 43.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.226 -1.161 . . . . 0.0 109.506 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.611 ' C ' HD13 ' A' ' 34' ' ' ILE . 37.2 mm -110.03 130.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.689 HG23 ' CD1' ' A' ' 72' ' ' ILE . 2.0 mm -117.58 121.2 66.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.927 -1.108 . . . . 0.0 110.403 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.434 HH12 HG13 ' A' ' 73' ' ' ILE . 57.3 mtt180 -121.87 137.4 54.8 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.08 138.77 39.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.618 -1.301 . . . . 0.0 110.849 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -167.74 160.02 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.702 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.849 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.547 0.689 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.452 ' CD ' HH22 ' A' ' 49' ' ' ARG . 3.0 pt20 -120.66 122.02 39.57 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.609 0.719 . . . . 0.0 109.538 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -125.84 125.96 43.71 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.56 ' HD2' HG23 ' A' ' 33' ' ' ILE . 1.9 mmt-85 -108.94 147.3 32.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.108 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.701 ' CG1' HD12 ' A' ' 57' ' ' ILE . 28.2 m -127.24 147.44 61.96 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 110.175 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.03 159.52 46.14 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 120.955 1.103 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.39 -33.65 97.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 121.383 1.389 . . . . 0.0 111.926 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -69.97 -12.76 61.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.574 -0.704 . . . . 0.0 110.471 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -99.95 110.53 22.86 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -99.57 -1.5 38.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 108.788 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.482 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 78.5 p -138.24 136.07 36.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.701 HD12 ' CG1' ' A' ' 50' ' ' VAL . 7.2 tt -129.96 136.62 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 m -100.48 114.63 28.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.478 ' HB3' HD11 ' A' ' 62' ' ' LEU . 11.1 mt -88.48 149.97 23.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 109.556 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.427 HG22 ' OG ' ' A' ' 17' ' ' SER . 27.3 p -136.01 177.89 7.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.743 -0.598 . . . . 0.0 109.96 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.9 m120 56.27 46.26 21.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.61 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 59' ' ' LEU . 44.0 mt -109.96 153.2 24.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.827 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -67.47 118.95 61.8 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 0.0 108.508 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.699 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.6 Cg_endo -62.84 129.83 27.4 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.893 1.062 . . . . 0.0 112.736 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.63 61.33 3.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -142.72 135.51 28.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -1.2 . . . . 0.0 111.464 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 89' ' ' ALA . 99.1 mt-10 -91.03 117.03 29.26 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.731 ' OH ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -133.61 173.78 11.14 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.308 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.63 136.45 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.54 129.94 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -115.93 140.97 48.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.689 ' CD1' HG23 ' A' ' 34' ' ' ILE . 48.6 mm -119.95 120.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.434 HG13 HH12 ' A' ' 35' ' ' ARG . 34.2 mm -115.36 129.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 108.666 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -92.84 129.91 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.751 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.01 159.99 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -140.49 38.45 1.87 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.92 -97.61 1.62 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -99.6 0.03 41.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 110.082 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -111.46 151.68 28.3 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.691 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -129.56 153.93 47.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -107.22 176.8 1.49 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 108.977 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 81' ' ' SER . 3.6 Cg_exo -65.75 131.44 27.53 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.035 1.157 . . . . 0.0 111.628 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.74 140.89 95.1 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.2 1.267 . . . . 0.0 113.384 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.1 tp -119.98 116.73 26.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -128.12 139.94 50.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.7 162.4 26.62 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -110.36 149.61 29.98 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.155 -1.203 . . . . 0.0 109.671 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.878 ' NE2' ' CD1' ' A' ' 18' ' ' PHE . 31.7 tt0 -148.46 156.48 42.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.379 -0.826 . . . . 0.0 108.98 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' N ' ' HG2' ' A' ' 88' ' ' GLN . . . -121.37 123.62 42.57 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.658 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.731 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.32 142.89 47.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.48 0.657 . . . . 0.0 110.673 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 178' ' ' VAL . 3.1 mt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD2' HG22 ' A' ' 94' ' ' ILE . 3.6 Cg_exo -58.78 -170.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 109.946 -0.828 . . . . 0.0 109.946 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 38.2 ttm180 -149.89 160.0 43.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.503 -1.373 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.479 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 14.6 t0 72.6 36.22 1.01 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.682 -0.636 . . . . 0.0 110.871 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.664 HD22 HD13 ' A' ' 180' ' ' ILE . 2.2 tt -68.01 102.9 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 97' ' ' ASP . 47.4 mt-10 -149.92 169.65 20.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.334 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.9 t -110.16 131.74 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.44 -0.787 . . . . 0.0 109.605 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -25.26 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.46 -0.775 . . . . 0.0 109.633 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -127.35 135.94 51.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.607 -0.683 . . . . 0.0 109.158 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.595 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 18.5 t -118.62 116.11 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.142 -0.974 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -105.66 155.82 37.51 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 121.313 -0.867 . . . . 0.0 108.903 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.61 -35.35 56.53 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.661 1.574 . . . . 0.0 112.931 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.481 ' C ' HG22 ' A' ' 152' ' ' ILE . 56.4 p -128.75 16.36 6.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.992 -1.067 . . . . 0.0 110.412 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.079 ' O ' HD23 ' A' ' 108' ' ' LEU . 29.0 p -158.66 169.34 24.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.806 -1.184 . . . . 0.0 110.01 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.079 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -144.81 153.41 41.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.68 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 110' ' ' ILE . 4.5 tt -101.88 125.66 48.61 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.713 HD11 ' HB3' ' A' ' 147' ' ' ALA . 11.6 pt -114.01 152.12 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.048 -1.033 . . . . 0.0 111.117 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.2 t -147.47 140.31 24.91 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -147.61 160.0 43.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.04 130.16 32.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.73 138.68 84.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.851 1.034 . . . . 0.0 112.167 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.63 -160.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.119 1.213 . . . . 0.0 112.557 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.48 12.24 36.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 33.2 m -130.01 160.1 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 0.0 109.221 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 84.0 p -68.59 149.96 48.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 109.013 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.4 137.32 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -71.51 -53.5 13.66 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CE2' HG22 ' A' ' 139' ' ' THR . 26.4 p90 -167.37 170.32 11.56 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 3.5 m-85 -118.29 135.92 54.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.814 -1.179 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.592 ' NH2' ' CG ' ' A' ' 163' ' ' TYR . 28.5 ttp-105 -98.53 125.04 43.62 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.829 -1.17 . . . . 0.0 107.9 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.589 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 85.4 mt -111.17 133.46 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.075 -1.016 . . . . 0.0 110.135 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 137' ' ' GLU . 3.1 p -105.55 145.12 31.37 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.916 0.865 . . . . 0.0 111.282 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.698 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.3 m-85 -92.41 120.28 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.93 129.65 9.72 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.903 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 . . . . . 0 C--N 1.294 -1.819 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.388 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.443 0.64 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 126' ' ' TYR . 96.8 mm-40 -117.49 138.08 52.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.734 ' HB3' HG22 ' A' ' 125' ' ' THR . 21.9 pt-20 -128.8 160.02 33.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.761 -1.212 . . . . 0.0 112.246 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 50.4 p90 -144.61 157.12 44.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.475 HG22 ' CE2' ' A' ' 121' ' ' TYR . 7.2 p -87.5 164.94 15.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.901 -1.124 . . . . 0.0 110.939 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 t -128.88 118.3 19.61 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.481 -0.762 . . . . 0.0 110.625 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.3 Cg_exo -59.04 130.47 36.61 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-N 119.273 0.776 . . . . 0.0 111.819 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.72 2.71 2.4 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 141' ' ' PRO . 52.5 m -89.98 -2.9 58.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -1.204 . . . . 0.0 110.113 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -128.81 138.73 52.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.02 -1.05 . . . . 0.0 109.728 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -94.36 -7.39 41.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.189 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.4 p -133.41 153.27 51.75 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.713 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -138.4 175.4 9.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.853 -1.154 . . . . 0.0 109.757 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 t -120.38 146.93 45.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.689 HD11 HD13 ' A' ' 110' ' ' ILE . 32.8 mm -113.16 120.74 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.149 -0.969 . . . . 0.0 109.44 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.698 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 35.6 m120 -123.76 177.51 5.68 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.245 -0.909 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 59.97 46.52 10.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.493 HG12 ' CZ ' ' A' ' 158' ' ' TYR . 4.8 tt -107.68 153.67 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.43 ' N ' ' OH ' ' A' ' 158' ' ' TYR . 13.1 mmtt -97.66 109.97 53.08 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.008 -1.058 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.43 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.4 Cg_endo -68.42 173.16 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.305 1.336 . . . . 0.0 113.036 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.34 27.29 71.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.81 155.81 37.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.981 -1.305 . . . . 0.0 109.975 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 48.5 t0 -72.91 155.23 40.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.704 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-85 -142.43 160.02 41.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.858 -1.152 . . . . 0.0 110.774 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.473 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.7 m -135.09 120.5 19.13 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 108' ' ' LEU . 98.4 mt -105.58 121.58 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.228 -1.545 . . . . 0.0 108.901 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 125' ' ' THR . 50.8 m -129.97 142.05 50.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 162' ' ' LEU . 1.4 pp -136.45 152.4 50.53 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.678 -1.209 . . . . 0.0 111.42 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.2 m-85 -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.53 132.61 47.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.699 -1.251 . . . . 0.0 109.541 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.65 124.06 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.634 -0.666 . . . . 0.0 109.694 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.259 0.552 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 85.0 p -79.34 170.0 17.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 108.807 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.454 ' HB2' HD11 ' A' ' 94' ' ' ILE . 6.2 mttm -56.2 129.06 73.54 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 108.756 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.3 Cg_endo -62.02 144.53 96.32 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.105 1.204 . . . . 0.0 113.217 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 94' ' ' ILE . 2.1 t -113.54 128.6 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 81.1 p -123.29 150.04 44.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 111.703 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.664 HD13 HD22 ' A' ' 98' ' ' LEU . 39.5 pt -133.85 159.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -104.84 139.33 39.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.947 -1.095 . . . . 0.0 109.002 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.604 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 62.4 t80 -135.33 130.38 34.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.593 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.1 139.99 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 108.946 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 109.479 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 121.49 0.662 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -74.41 149.22 40.56 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.424 -0.798 . . . . 0.0 108.982 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' THR . 47.5 t -82.5 132.17 53.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.989 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_endo -59.04 79.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.129 1.22 . . . . 0.0 111.591 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 4' ' ' SER . 1.0 OUTLIER -85.9 -159.56 0.47 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.787 -1.195 . . . . 0.0 110.241 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 79.24 19.05 72.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.572 ' HB2' HD21 ' A' ' 84' ' ' LEU . 57.3 t80 -59.97 134.83 57.41 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.643 0.735 . . . . 0.0 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 10' ' ' SER . 39.8 t0 -158.98 148.8 19.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 90.0 p -113.98 132.43 55.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.934 -1.104 . . . . 0.0 109.553 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 12' ' ' ASP . 37.3 p -149.22 -175.95 5.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.048 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 11' ' ' SER . 78.2 m-20 47.57 46.94 17.79 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.791 HG22 HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -82.64 127.92 39.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.152 -177.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.681 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.04 161.39 18.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.764 ' H ' ' HB1' ' A' ' 116' ' ' ALA . . . -63.32 -54.37 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.775 -1.203 . . . . 0.0 109.902 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.08 0.01 57.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.052 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 14' ' ' THR . 97.6 p -155.53 158.91 39.23 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.371 -0.831 . . . . 0.0 109.01 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CD1' ' NE2' ' A' ' 88' ' ' GLN . 30.4 p90 -163.02 151.03 13.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 109.529 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 m -95.36 157.1 16.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.54 -1.35 . . . . 0.0 111.518 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.65 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.1 t -128.4 160.0 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.65 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.7 m-70 -150.87 154.11 36.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.84 -1.162 . . . . 0.0 110.589 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 47.4 p90 -153.69 160.01 42.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.509 -0.745 . . . . 0.0 109.19 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -84.63 157.83 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.995 -1.066 . . . . 0.0 109.768 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 23' ' ' VAL . . . -99.06 120.44 58.39 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.1 149.71 87.84 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.819 1.013 . . . . 0.0 112.19 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -78.83 -12.39 60.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.187 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -72.21 150.56 92.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.259 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.82 126.05 20.54 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.323 1.349 . . . . 0.0 112.719 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 28.4 pt -136.52 166.55 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.438 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 p -115.71 -3.31 12.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.9 -175.51 28.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.68 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 55.1 m-85 -131.57 151.36 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -1.199 . . . . 0.0 109.997 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 32' ' ' TYR . 1.4 mp -112.71 132.6 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 72' ' ' ILE . 2.2 mm -118.16 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.03 -1.044 . . . . 0.0 110.96 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -119.43 138.4 53.13 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.432 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 8.3 t60 -129.91 139.94 51.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.553 -1.342 . . . . 0.0 111.221 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.446 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 28.8 p-80 -163.61 153.19 14.8 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.3 0.572 . . . . 0.0 109.979 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.899 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 0.0 109.338 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.421 0.629 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -121.11 109.91 15.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.0 109.979 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' ILE . 91.7 m-20 -120.79 125.93 48.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.541 ' NH1' HG23 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -109.27 151.77 26.11 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.01 -1.056 . . . . 0.0 108.731 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.599 HG22 HD11 ' A' ' 34' ' ' ILE . 27.8 m -130.98 145.2 56.76 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.908 -1.12 . . . . 0.0 110.113 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.04 160.4 38.02 Favored 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 120.999 1.133 . . . . 0.0 111.837 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.14 -32.66 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.588 1.525 . . . . 0.0 112.298 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 m -74.84 -10.95 59.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.0 111.101 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.81 117.83 35.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.149 . . . . 0.0 109.872 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -104.14 -0.01 29.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.462 -0.774 . . . . 0.0 109.489 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.7 p -130.94 139.91 50.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.902 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 9.1 tt -130.04 130.22 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 m -98.94 120.88 40.13 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.173 -0.955 . . . . 0.0 109.979 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.9 mt -97.21 138.11 35.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.222 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -123.3 179.48 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 53.74 48.56 21.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.923 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 59' ' ' LEU . 55.5 mt -111.54 158.26 19.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.338 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.674 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 75.7 m-20 -69.94 129.99 90.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.36 132.66 39.44 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.336 1.357 . . . . 0.0 113.505 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 67.08 65.84 2.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.602 ' N ' ' OG1' ' A' ' 90' ' ' THR . 1.2 m -149.86 151.85 34.15 Favored 'General case' 0 N--CA 1.506 2.341 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.188 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 49.6 mp0 -92.66 119.96 32.6 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.899 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 50.0 m-85 -111.23 140.51 45.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.117 -0.99 . . . . 0.0 110.799 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.446 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 15.2 t -92.7 121.42 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.99 125.6 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 109.708 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -99.59 135.33 41.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.673 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.662 HD13 HG23 ' A' ' 34' ' ' ILE . 48.5 mm -116.51 129.97 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 74' ' ' ALA . 80.4 mt -127.67 160.01 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 110.152 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.553 ' N ' HG22 ' A' ' 73' ' ' ILE . . . -128.54 131.94 48.25 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.1 m -128.31 151.21 34.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.222 -0.924 . . . . 0.0 109.295 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -126.25 33.84 4.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -0.945 . . . . 0.0 108.515 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.83 -89.33 1.27 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 40.7 ttm-85 -89.97 -19.38 24.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -1.061 . . . . 0.0 110.386 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -104.36 150.32 24.6 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 110.788 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -120.63 147.34 45.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.078 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -104.16 160.87 24.66 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.164 -0.96 . . . . 0.0 109.316 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.89 129.96 31.01 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.184 1.256 . . . . 0.0 112.298 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.91 145.25 98.77 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.294 1.329 . . . . 0.0 113.5 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 8' ' ' PHE . 13.3 tp -119.89 119.34 33.21 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -120.02 130.04 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.974 -1.078 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.15 168.79 22.86 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -121.88 147.77 45.58 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 109.889 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.798 ' NE2' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -142.29 159.27 42.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -119.08 135.36 54.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.083 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -73.84 133.6 43.21 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.136 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.791 HG23 HG22 ' A' ' 13' ' ' ILE . 39.7 t . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 122.008 0.909 . . . . 0.0 111.547 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 176' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.698 ' HD2' HG23 ' A' ' 94' ' ' ILE . 3.1 Cg_exo -61.7 -158.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 120.635 0.89 . . . . 0.0 111.205 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.555 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 40.5 ttp180 -154.14 166.69 32.29 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.098 -1.001 . . . . 0.0 109.812 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.555 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 15.7 t0 74.96 35.08 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.503 -0.748 . . . . 0.0 109.831 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD13 HD23 ' A' ' 162' ' ' LEU . 44.3 tp -67.6 107.0 2.36 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -158.51 163.55 36.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.58 139.96 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 pt -118.08 -16.0 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.115 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -140.67 130.04 23.83 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.468 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 6.2 m -117.42 119.76 36.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.019 . . . . 0.0 109.805 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.604 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -101.95 158.07 32.48 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.18 -35.56 52.72 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.312 1.341 . . . . 0.0 112.497 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.425 ' C ' HG22 ' A' ' 152' ' ' ILE . 68.4 p -130.14 18.4 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.031 -1.043 . . . . 0.0 110.245 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.607 ' O ' HD23 ' A' ' 108' ' ' LEU . 2.4 p -154.16 160.07 41.72 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.877 -1.139 . . . . 0.0 109.91 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.802 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -133.38 150.13 51.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 108.653 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 110' ' ' ILE . 4.7 tt -105.2 120.09 40.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 108.898 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.3 pt -99.97 138.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.683 ' HA ' HG22 ' A' ' 146' ' ' THR . 32.5 t -132.56 133.92 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -145.72 144.89 30.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 1.8 pt-20 -72.3 145.97 88.79 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.934 -1.103 . . . . 0.0 108.575 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.53 136.56 74.97 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 120.962 1.108 . . . . 0.0 111.744 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.31 -163.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 120.332 0.688 . . . . 0.0 111.364 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.764 ' HB1' ' H ' ' A' ' 15' ' ' ALA . . . -113.74 11.68 18.15 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.221 -0.924 . . . . 0.0 108.986 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 33.1 m -129.97 159.99 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -71.16 133.06 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.933 . . . . 0.0 108.789 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.666 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 14.6 t -122.78 134.59 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.074 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.3 -52.29 16.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 14.1 p90 -166.84 170.11 12.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.5 m-85 -122.15 143.87 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.963 . . . . 0.0 108.412 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.629 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 54.6 ttt-85 -103.71 126.04 50.58 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.692 -1.255 . . . . 0.0 107.906 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.674 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 50.2 mt -116.56 144.1 25.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.521 HG22 HH21 ' A' ' 123' ' ' ARG . 36.0 p -118.31 144.49 45.8 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.832 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.735 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.9 m-85 -87.9 131.36 34.61 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.52 115.25 4.66 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.922 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 34.2 mt-10 . . . . . 0 C--N 1.299 -1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.63 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 83.6 mt-30 -117.95 136.61 53.38 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.265 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.629 ' CD ' ' HE ' ' A' ' 123' ' ' ARG . 10.6 pt-20 -123.17 144.32 49.43 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.261 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.674 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 52.2 p90 -138.49 158.87 43.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 121' ' ' TYR . 4.0 p -94.25 167.0 11.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.905 -1.122 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 142' ' ' GLY . 98.0 t -135.17 85.64 33.1 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.5 Cg_exo -58.87 50.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 120.996 1.131 . . . . 0.0 113.162 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 34.95 24.54 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 141' ' ' PRO . 79.6 p -61.64 -39.98 93.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -1.18 . . . . 0.0 109.763 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -145.58 171.13 15.14 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.112 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 99.5 p -84.35 -1.17 55.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.581 -0.699 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 111' ' ' SER . 68.4 p -130.73 151.31 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 108.993 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -126.78 148.92 49.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.972 -1.08 . . . . 0.0 109.79 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 m -94.02 143.19 26.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.11 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.608 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 37.3 mm -115.19 121.33 66.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.735 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 33.4 m-80 -127.11 170.0 12.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.703 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 19.0 m120 68.34 48.6 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.0 109.816 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.574 ' CD1' HD11 ' A' ' 108' ' ' LEU . 2.0 tt -113.74 147.34 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -95.45 111.13 54.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.848 -1.157 . . . . 0.0 109.654 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.429 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 2.8 Cg_endo -64.95 163.37 28.63 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.061 1.174 . . . . 0.0 112.705 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.96 72.49 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 184' ' ' THR . . . -146.36 146.79 30.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.31 . . . . 0.0 109.917 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 55.3 t0 -70.01 151.52 45.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.588 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.8 OUTLIER -138.1 173.16 11.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.86 -1.15 . . . . 0.0 111.225 -178.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -141.34 111.52 6.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.81 124.03 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.3 -1.5 . . . . 0.0 109.462 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -124.81 139.92 53.4 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.617 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 1.027 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -119.67 136.5 54.38 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -178.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 1.027 ' N ' HD12 ' A' ' 162' ' ' LEU . 51.0 m-85 -121.65 141.45 51.11 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.758 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -103.61 123.64 47.33 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 62.8 t -110.36 119.93 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.004 . . . . 0.0 109.84 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.453 -0.78 . . . . 0.0 108.949 179.367 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.563 0.697 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.758 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 1.4 p -105.19 160.31 15.18 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.857 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -39.07 100.1 0.21 Allowed Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 121.088 -1.007 . . . . 0.0 110.148 -178.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.5 Cg_exo -62.69 159.27 37.85 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 121.818 1.679 . . . . 0.0 114.751 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.487 HG23 HG21 ' A' ' 94' ' ' ILE . 59.0 t -124.22 130.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 80.2 p -120.26 150.19 41.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.757 -1.215 . . . . 0.0 110.933 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.28 161.14 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.225 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -104.33 128.72 52.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 108.601 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.802 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 60.5 t80 -123.59 128.32 49.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 110.382 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -100.83 138.1 38.34 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.34 -0.85 . . . . 0.0 109.044 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.7 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.481 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -80.0 124.99 29.2 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 109.199 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.54 ' HG ' ' HG ' ' A' ' 81' ' ' SER . 53.5 m -78.75 146.9 69.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.783 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_exo -57.6 157.98 21.28 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 120.983 1.122 . . . . 0.0 111.681 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 5' ' ' PRO . 21.2 p -156.2 -144.36 0.13 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 109.646 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.14 19.47 24.01 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 105.249 -3.14 . . . . 0.0 105.249 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 6' ' ' THR . 59.6 t80 -54.91 130.03 39.8 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.83 0.824 . . . . 0.0 110.805 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 10' ' ' SER . 60.6 t0 -158.67 141.3 14.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 41.2 m -106.85 140.35 39.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.608 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 12' ' ' ASP . 60.8 p -152.98 -176.44 5.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' SER . 74.7 m-20 50.01 46.22 24.63 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.735 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -82.19 123.4 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.733 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.2 161.98 17.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.02 -57.61 12.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.813 -1.179 . . . . 0.0 110.049 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -91.1 -0.01 57.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.937 -1.102 . . . . 0.0 110.012 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 38.5 t -151.36 155.73 39.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.837 ' CZ ' ' NE2' ' A' ' 88' ' ' GLN . 20.5 p90 -162.9 145.76 10.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -94.78 151.11 19.52 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.463 -1.398 . . . . 0.0 111.531 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -120.1 134.83 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.417 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 49.9 m-70 -129.23 149.6 50.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.643 -1.286 . . . . 0.0 111.0 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 40.4 p90 -154.1 159.39 41.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -0.78 . . . . 0.0 109.175 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.36 155.66 3.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.044 -1.035 . . . . 0.0 109.941 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.14 135.41 34.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.849 -0.532 . . . . 0.0 109.751 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.79 -179.5 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 120.962 1.108 . . . . 0.0 112.139 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.53 12.46 26.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.722 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -113.2 158.33 38.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.015 . . . . 0.0 109.647 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.9 Cg_endo -56.54 130.3 39.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.777 1.651 . . . . 0.0 112.554 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 39.5 pt -138.92 170.02 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.395 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 p -117.98 0.27 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.715 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.43 -178.18 24.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 51.2 m-85 -130.14 151.29 50.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -1.13 . . . . 0.0 109.516 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.762 HG23 ' HD2' ' A' ' 49' ' ' ARG . 28.4 mm -110.01 129.99 63.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.671 HG21 HG21 ' A' ' 57' ' ' ILE . 1.9 mm -113.55 120.56 63.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.812 -1.18 . . . . 0.0 109.935 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -116.67 131.53 56.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.459 ' CE1' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -121.8 139.11 54.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.285 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -168.62 147.3 4.2 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.093 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.494 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 108.74 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.864 0.84 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -112.83 113.51 25.62 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.519 ' O ' ' O ' ' A' ' 34' ' ' ILE . 85.6 m-20 -113.7 123.24 49.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.151 -0.968 . . . . 0.0 108.653 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.762 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -108.69 144.47 36.43 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.025 -1.047 . . . . 0.0 108.956 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.662 HG22 HD11 ' A' ' 34' ' ' ILE . 32.1 m -128.13 149.99 72.62 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.037 -1.04 . . . . 0.0 110.203 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.53 160.1 41.34 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.123 1.216 . . . . 0.0 111.724 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.92 -35.97 97.69 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.364 1.376 . . . . 0.0 112.38 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -70.23 -12.02 61.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 110.867 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -101.85 121.21 41.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.015 -1.053 . . . . 0.0 110.113 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -108.75 -0.0 20.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.61 -0.681 . . . . 0.0 109.699 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.417 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 57.3 p -130.34 139.95 50.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.183 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.671 HG21 HG21 ' A' ' 34' ' ' ILE . 6.4 tt -130.75 139.92 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.9 m -106.9 131.49 53.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.248 -0.908 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 62' ' ' LEU . 4.2 mt -112.07 148.08 34.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.806 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.4 p -135.06 179.66 6.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.862 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 57.47 40.72 26.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.368 -0.832 . . . . 0.0 109.539 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 59' ' ' LEU . 44.6 mt -107.31 156.83 18.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.4 -0.813 . . . . 0.0 109.409 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -69.99 120.21 76.46 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 108.618 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.695 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.9 Cg_endo -61.59 129.38 27.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 120.835 1.024 . . . . 0.0 112.966 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 76.17 60.76 3.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.2 m -145.47 152.02 39.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -1.125 . . . . 0.0 110.336 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 3.8 pt-20 -88.78 119.99 29.78 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 38.4 m-85 -112.72 139.98 47.88 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.057 -1.027 . . . . 0.0 110.617 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.99 121.35 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.0 121.59 67.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.405 ' CB ' HG12 ' A' ' 85' ' ' ILE . 13.0 p -100.88 140.99 34.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.623 ' CD1' HG23 ' A' ' 34' ' ' ILE . 49.7 mm -119.78 120.0 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.92 130.0 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.088 . . . . 0.0 109.612 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -93.4 139.42 30.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.91 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.0 139.45 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.135 -0.978 . . . . 0.0 109.615 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.448 HD21 ' HB2' ' A' ' 28' ' ' PRO . 41.7 t-20 -121.51 37.67 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 108.779 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.27 -100.66 2.58 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -91.63 -0.18 57.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.167 . . . . 0.0 110.325 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.26 141.57 48.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.06 . . . . 0.0 109.513 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.12 138.78 53.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.729 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -83.85 163.33 49.29 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' OG ' ' A' ' 4' ' ' SER . 3.1 Cg_exo -57.54 135.08 67.5 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 121.336 1.358 . . . . 0.0 111.945 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.93 130.93 40.75 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.251 1.301 . . . . 0.0 113.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 5' ' ' PRO . 19.5 tp -107.32 119.99 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.405 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -125.28 134.19 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.993 -1.067 . . . . 0.0 111.146 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.52 164.83 24.87 Favored Glycine 0 N--CA 1.479 1.542 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -114.69 131.11 56.85 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.921 -1.34 . . . . 0.0 110.084 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.837 ' NE2' ' CZ ' ' A' ' 18' ' ' PHE . 1.2 tm0? -123.87 128.32 49.3 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -101.45 131.56 47.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.173 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.43 136.65 42.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.735 HG23 HG22 ' A' ' 13' ' ' ILE . 3.9 t . . . . . 0 C--N 1.302 -1.471 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.447 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.514 HG21 HG23 ' A' ' 178' ' ' VAL . 6.7 mt . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HG2' HD21 ' A' ' 162' ' ' LEU . 3.3 Cg_exo -59.24 159.63 21.99 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 120.332 0.688 . . . . 0.0 110.541 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -120.57 172.5 7.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.826 -1.171 . . . . 0.0 110.959 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.59 39.99 29.59 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.668 HD13 HD23 ' A' ' 162' ' ' LEU . 41.7 tp -72.15 92.9 1.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.765 -1.209 . . . . 0.0 107.849 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.49 170.69 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.654 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -104.68 139.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 101' ' ' ILE . 1.1 pt -107.62 -15.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.258 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.3 134.79 34.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 99.87 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 110.334 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.704 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -81.93 156.8 69.67 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -49.03 -43.93 34.44 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.466 1.444 . . . . 0.0 112.95 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 152' ' ' ILE . 44.2 p -124.36 18.4 8.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.039 ' O ' HD23 ' A' ' 108' ' ' LEU . 37.7 p -153.76 165.77 34.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.862 -1.149 . . . . 0.0 109.898 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -140.69 154.22 46.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.561 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.487 HD23 ' C ' ' A' ' 109' ' ' LEU . 8.5 tt -104.96 119.99 40.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 147' ' ' ALA . 5.2 pt -106.68 145.99 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.987 . . . . 0.0 110.616 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 95.7 p -144.79 149.99 36.43 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.44 0.638 . . . . 0.0 109.778 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.606 ' CE2' ' O ' ' A' ' 145' ' ' SER . 43.8 p90 -149.84 154.87 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -76.0 134.67 71.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.065 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 127.92 26.17 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.771 0.981 . . . . 0.0 111.948 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.22 -178.22 0.19 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.058 1.172 . . . . 0.0 112.613 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 91' ' ' VAL . . . -100.37 10.26 41.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.84 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -71.7 138.73 48.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.01 135.9 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.468 -0.77 . . . . 0.0 109.079 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.691 ' NH1' ' O ' ' A' ' 166' ' ' THR . 80.6 mmt-85 -71.18 -51.45 24.73 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.774 -1.204 . . . . 0.0 107.947 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CE2' HG22 ' A' ' 139' ' ' THR . 6.5 p90 -167.52 174.57 7.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 17.4 m-85 -120.18 139.43 52.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.165 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 37.0 ttp-105 -100.46 129.96 46.48 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.72 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 16.6 mt -124.02 151.96 29.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.783 -1.198 . . . . 0.0 110.859 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 25.4 p -126.13 141.14 52.06 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.093 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.679 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.5 m-85 -84.11 129.54 34.9 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -109.17 131.01 10.3 Favored Glycine 0 N--CA 1.483 1.803 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.247 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.51 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.627 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 22.2 mm100 -111.92 129.87 56.03 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.355 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 123' ' ' ARG . 65.4 tt0 -107.86 133.86 51.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.546 -0.721 . . . . 0.0 111.323 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.72 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 41.5 p90 -141.64 157.52 44.98 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.595 HG22 ' CE2' ' A' ' 121' ' ' TYR . 3.2 p -98.21 167.44 10.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.785 -1.197 . . . . 0.0 111.525 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 124' ' ' ILE . 88.1 t -132.18 118.68 16.3 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -57.6 127.99 27.53 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.507 0.804 . . . . 0.0 112.268 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.26 -4.55 0.83 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 141' ' ' PRO . 89.6 p -89.73 -0.05 57.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -1.233 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -124.88 132.96 53.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.889 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 97.7 p -93.13 0.05 57.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.477 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 15.1 p -139.12 158.12 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.661 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -139.95 169.95 16.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.819 -1.176 . . . . 0.0 109.916 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -118.92 142.59 47.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 109.391 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 31.4 mm -110.21 120.43 61.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.889 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.679 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 69.8 m-20 -123.04 172.94 8.16 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -0.941 . . . . 0.0 110.283 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 61.1 49.82 5.38 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.728 0.775 . . . . 0.0 109.107 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 106' ' ' THR . 5.2 tt -108.98 153.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.75 110.02 55.63 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 110.147 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 2.5 Cg_endo -68.43 170.04 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.156 1.237 . . . . 0.0 112.492 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.98 20.03 75.89 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.547 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -146.48 150.8 36.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.043 -1.269 . . . . 0.0 109.701 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.643 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.3 t0 -70.02 153.12 43.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.728 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -140.89 159.89 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.611 -1.306 . . . . 0.0 110.55 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 46.9 m -132.94 119.99 20.86 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.815 HD11 HD12 ' A' ' 108' ' ' LEU . 79.6 mt -106.74 120.74 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.348 -1.47 . . . . 0.0 108.668 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 94.2 m -120.02 130.2 54.61 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.944 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.99 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -115.87 138.22 51.37 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.696 0.76 . . . . 0.0 110.83 -178.436 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.99 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.6 m-85 -117.47 157.38 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.56 135.79 54.99 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.795 -1.19 . . . . 0.0 110.176 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.59 HG21 ' CE1' ' A' ' 121' ' ' TYR . 63.2 t -110.06 120.0 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.691 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.338 0.589 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 81.9 p -80.64 169.15 18.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.505 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -56.29 121.3 41.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.0 Cg_exo -61.38 154.02 61.74 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 120.929 1.086 . . . . 0.0 114.162 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.514 HG23 HG21 ' A' ' 94' ' ' ILE . 2.1 t -117.64 129.97 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 85.0 p -121.13 156.64 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.439 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.655 HG21 ' O ' ' A' ' 98' ' ' LEU . 47.0 pt -139.57 165.76 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.343 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -112.69 129.95 56.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.97 . . . . 0.0 108.963 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CE1' HG22 ' A' ' 184' ' ' THR . 54.7 t80 -124.98 118.52 26.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.026 . . . . 0.0 109.974 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.64 140.02 29.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.552 HG22 ' CE1' ' A' ' 182' ' ' TYR . 4.8 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.434 ' O ' ' CD ' ' A' ' 82' ' ' PRO . 86.0 mt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.409 0.623 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -79.97 130.11 35.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -84.83 149.79 54.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.02 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.75 146.19 86.7 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.173 1.249 . . . . 0.0 112.105 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' N ' ' A' ' 8' ' ' PHE . 17.8 p -143.54 -150.65 0.32 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.044 -1.035 . . . . 0.0 109.601 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.96 19.18 49.84 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 105.0 -3.24 . . . . 0.0 105.0 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' N ' ' C ' ' A' ' 6' ' ' THR . 63.6 t80 -54.51 134.93 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.478 -0.861 . . . . 0.0 110.863 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.9 t0 -157.97 147.57 19.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.7 m -116.81 135.23 53.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 12' ' ' ASP . 77.3 p -152.05 -171.02 3.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 11' ' ' SER . 81.5 m-20 50.0 41.62 23.45 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -78.39 130.84 35.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.051 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.56 162.73 24.27 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.749 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.81 -60.08 4.42 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.026 -1.046 . . . . 0.0 110.279 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -91.49 -0.0 57.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.896 -1.127 . . . . 0.0 109.993 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 98.4 p -148.92 155.81 41.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CE1' HG22 ' A' ' 20' ' ' VAL . 18.7 p90 -165.04 144.67 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 108.687 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -96.89 150.62 20.54 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.361 -1.462 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.628 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -120.01 132.4 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 63.4 m-70 -125.43 143.54 50.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.821 -1.175 . . . . 0.0 110.657 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 44.5 p90 -147.79 152.98 38.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -0.767 . . . . 0.0 109.211 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.01 142.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.108 -0.995 . . . . 0.0 110.492 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.03 137.06 79.28 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.838 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.58 -164.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.991 1.127 . . . . 0.0 112.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -112.38 17.86 19.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.939 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -119.73 150.21 49.9 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.909 -1.119 . . . . 0.0 109.951 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.48 127.1 23.42 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.485 1.456 . . . . 0.0 112.604 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 43.0 pt -133.4 170.02 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.2 p -106.08 -7.06 18.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 0.0 109.213 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.12 176.38 23.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 44.5 m-85 -119.99 145.54 46.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -1.199 . . . . 0.0 109.132 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.656 HG23 ' HG3' ' A' ' 49' ' ' ARG . 38.1 mm -102.04 128.87 54.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 120.953 -1.092 . . . . 0.0 108.304 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.8 mm -110.06 118.94 58.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.139 -0.975 . . . . 0.0 110.101 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.596 ' NH2' ' HE ' ' A' ' 49' ' ' ARG . 33.7 mmt180 -108.33 127.88 54.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.474 ' ND1' ' C ' ' A' ' 36' ' ' HIS . 2.2 t-80 -119.98 135.71 54.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.856 -1.152 . . . . 0.0 110.715 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.449 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 29.4 p-80 -167.94 149.96 5.49 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.618 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.059 179.481 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.586 0.708 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.413 ' OE1' ' NH1' ' A' ' 35' ' ' ARG . 21.8 mt-30 -105.64 116.51 32.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -117.87 127.53 53.95 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.656 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -121.45 148.55 44.27 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 109.693 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 34' ' ' ILE . 33.0 m -133.14 138.46 31.7 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.135 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 166.12 11.58 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 120.926 1.084 . . . . 0.0 111.709 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.45 -36.28 94.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.466 1.444 . . . . 0.0 112.428 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -70.37 -11.05 60.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 110.777 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -102.79 120.02 39.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.088 -1.007 . . . . 0.0 110.04 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -109.71 -4.9 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.515 -0.741 . . . . 0.0 109.465 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.461 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 59.7 p -130.16 138.76 50.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.592 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 9.2 tt -130.0 130.01 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.36 -0.838 . . . . 0.0 108.746 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.4 m -100.24 133.31 44.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.14 145.5 40.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -132.63 -178.73 5.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.726 -0.609 . . . . 0.0 109.85 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 57.39 40.4 27.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.7 155.15 19.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.49 -0.756 . . . . 0.0 109.087 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.649 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 15.9 m120 -69.99 120.63 79.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.976 -1.078 . . . . 0.0 108.561 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.749 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -61.5 125.13 16.07 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 120.921 1.081 . . . . 0.0 112.889 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 83.4 58.68 2.25 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -146.1 154.01 41.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.957 -1.32 . . . . 0.0 110.96 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' A' ' 66' ' ' THR . 98.0 mt-10 -89.96 118.72 29.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.649 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 43.2 m-85 -110.1 140.02 44.61 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 110.119 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.0 t -102.84 121.42 53.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.92 122.33 69.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 108.961 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -96.34 134.56 39.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 110.703 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 34' ' ' ILE . 50.3 mm -117.06 124.47 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.564 HG22 ' N ' ' A' ' 74' ' ' ALA . 60.3 mt -130.04 162.06 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -121.4 136.57 54.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.655 -0.653 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' OG1' ' A' ' 30' ' ' THR . 15.6 m -131.12 140.19 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 109.562 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -124.58 41.88 3.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.012 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.01 -103.68 2.53 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.23 -0.04 44.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -104.56 155.77 18.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -128.08 153.17 47.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -108.86 171.84 4.16 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.83 . . . . 0.0 109.088 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -61.85 126.35 18.7 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.21 1.273 . . . . 0.0 111.634 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.58 126.34 19.63 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.066 1.177 . . . . 0.0 113.472 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.02 HD22 ' O ' ' A' ' 5' ' ' PRO . 26.8 tp -106.15 120.04 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mt -125.01 139.3 51.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.998 -1.064 . . . . 0.0 110.36 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.21 152.49 21.47 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -109.75 129.93 55.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.429 -1.042 . . . . 0.0 109.54 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.54 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -123.55 129.79 51.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 88' ' ' GLN . . . -100.01 129.63 46.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.131 -0.981 . . . . 0.0 109.939 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.36 134.99 42.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.468 0.651 . . . . 0.0 109.975 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 94' ' ' ILE . 20.3 mt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.58 178.2 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 N-CA-C 109.653 -0.941 . . . . 0.0 109.653 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -142.09 172.02 13.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.463 -1.398 . . . . 0.0 110.631 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.0 40.16 19.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.897 -0.502 . . . . 0.0 110.781 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.635 HD13 HD23 ' A' ' 162' ' ' LEU . 42.3 tp -72.7 93.29 1.63 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -147.92 169.97 18.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 51.2 t -96.98 133.83 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 110.711 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.414 HG12 ' N ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -98.19 -28.74 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.987 0.899 . . . . 0.0 108.664 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' N ' HG12 ' A' ' 101' ' ' ILE . . . -135.28 134.93 40.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.471 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -121.48 126.57 49.58 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.854 -1.154 . . . . 0.0 110.812 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -112.39 157.59 39.66 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.6 -40.05 46.2 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.602 1.534 . . . . 0.0 113.27 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -120.69 9.97 10.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.891 -1.131 . . . . 0.0 110.546 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.042 ' O ' HD23 ' A' ' 108' ' ' LEU . 80.1 p -154.01 162.27 41.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.658 -1.276 . . . . 0.0 110.77 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -144.61 152.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.474 -0.766 . . . . 0.0 109.01 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.531 HD23 ' C ' ' A' ' 109' ' ' LEU . 5.4 tt -102.81 120.19 40.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.224 -0.922 . . . . 0.0 108.548 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 147' ' ' ALA . 6.4 pt -102.81 146.95 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 110.707 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.3 p -139.96 149.23 43.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -154.06 160.02 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.544 -0.723 . . . . 0.0 109.614 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -86.22 143.96 37.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.13 137.49 75.73 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.054 1.17 . . . . 0.0 112.283 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.03 -166.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.016 1.144 . . . . 0.0 112.294 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.45 -1.68 24.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 109.606 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 164.19 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 109.707 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.7 m -68.76 150.01 48.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.363 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 166' ' ' THR . 19.9 t -134.56 141.54 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.822 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 166' ' ' THR . 61.3 mmt-85 -71.12 -51.03 27.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.731 ' CE2' HG22 ' A' ' 139' ' ' THR . 7.9 p90 -166.48 179.29 5.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -120.02 139.94 51.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.717 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.679 ' NE ' ' OE2' ' A' ' 137' ' ' GLU . 36.3 ttm180 -106.12 124.7 49.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 30.5 mt -119.98 146.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.008 -1.058 . . . . 0.0 110.65 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -118.52 149.47 41.25 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.005 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.627 ' HB2' ' H ' ' A' ' 136' ' ' GLN . 5.6 m-85 -93.12 136.37 33.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.55 118.41 5.5 Favored Glycine 0 N--CA 1.481 1.644 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.126 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--N 1.295 -1.798 0 O-C-N 121.411 -1.052 . . . . 0.0 108.786 177.473 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.627 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 43.2 mt-30 -102.45 123.03 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.951 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.679 ' OE2' ' NE ' ' A' ' 123' ' ' ARG . 80.4 tt0 -100.0 129.97 46.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 111.558 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 45.3 p90 -134.97 143.82 47.07 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.731 HG22 ' CE2' ' A' ' 121' ' ' TYR . 2.2 p -84.7 168.26 15.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.982 -1.074 . . . . 0.0 111.156 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 124' ' ' ILE . 79.3 t -142.78 128.74 10.44 Favored Pre-proline 0 N--CA 1.485 1.285 0 O-C-N 121.751 -0.593 . . . . 0.0 109.416 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.99 150.65 62.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 120.621 0.881 . . . . 0.0 112.287 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.14 -8.46 69.77 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -89.98 -0.04 57.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -1.213 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -106.96 125.09 50.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.943 -1.098 . . . . 0.0 110.282 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -93.26 -5.39 49.93 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.6 p -142.93 159.8 41.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -140.84 167.63 21.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.728 -1.233 . . . . 0.0 109.883 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -117.95 136.69 53.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.599 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 32.8 mm -109.46 123.21 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 108.625 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.565 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 68.0 m-20 -124.01 170.02 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.133 -0.979 . . . . 0.0 109.761 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 39.8 m-20 71.69 49.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.361 0.6 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.923 HG23 ' CE2' ' A' ' 158' ' ' TYR . 79.4 mt -115.58 130.72 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 0.0 109.393 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 184' ' ' THR . 22.4 mttm -73.95 118.86 72.82 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.056 -1.028 . . . . 0.0 109.795 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.0 167.28 16.31 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.31 1.34 . . . . 0.0 113.288 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 184' ' ' THR . . . 60.0 28.16 65.81 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 184' ' ' THR . . . -140.0 139.27 36.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.932 -1.334 . . . . 0.0 110.492 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -59.95 140.23 56.86 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.923 ' CE2' HG23 ' A' ' 152' ' ' ILE . 0.7 OUTLIER -134.74 159.16 42.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.315 -1.491 . . . . 0.0 110.058 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.624 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 66.9 m -130.22 119.99 23.78 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.26 123.63 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.194 -1.566 . . . . 0.0 108.273 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.525 HG22 ' CE1' ' A' ' 163' ' ' TYR . 86.6 m -127.61 140.02 52.37 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.172 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 1.077 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -122.37 137.77 54.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.683 0.754 . . . . 0.0 110.394 -178.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 1.077 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.4 m-85 -122.94 153.43 39.73 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.18 55.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.839 -1.163 . . . . 0.0 109.47 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.404 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 63.2 t -111.61 120.04 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.851 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 119' ' ' VAL . 41.1 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.728 0.775 . . . . 0.0 109.225 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.9 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 46.1 p -79.4 169.98 17.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 119.48 42.0 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.527 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.3 Cg_exo -61.14 148.12 93.76 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 120.779 0.986 . . . . 0.0 114.074 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.9 120.12 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 86.2 p -112.56 153.43 27.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 111.461 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 98' ' ' LEU . 42.2 pt -134.73 160.03 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -110.62 133.13 53.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 108.621 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.609 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 60.7 t80 -139.14 126.57 21.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.018 -1.051 . . . . 0.0 110.154 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.609 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 66.2 mttm -84.71 147.59 26.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.376 -0.828 . . . . 0.0 109.013 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 155' ' ' GLY . 1.1 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.395 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.462 0.648 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.79 130.21 34.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.419 -0.8 . . . . 0.0 108.939 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.0 p -69.96 146.66 95.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.03 . . . . 0.0 109.735 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.862 ' O ' HD22 ' A' ' 84' ' ' LEU . 2.6 Cg_endo -60.75 116.31 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.179 1.253 . . . . 0.0 111.877 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -120.0 -155.75 0.63 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.923 -1.111 . . . . 0.0 109.66 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.66 20.02 75.35 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.512 ' HB2' HD21 ' A' ' 84' ' ' LEU . 64.4 t80 -53.07 133.18 38.8 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.755 0.788 . . . . 0.0 110.695 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 10' ' ' SER . 57.1 t0 -148.52 145.77 28.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 88' ' ' GLN . 47.6 t -129.11 145.2 51.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.979 -1.076 . . . . 0.0 110.295 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 12' ' ' ASP . 9.9 p -172.75 -162.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 11' ' ' SER . 72.6 m-20 49.39 40.08 17.84 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.514 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -80.12 132.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.938 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.683 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 164.09 20.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.51 -59.09 5.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.706 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -92.52 -0.51 57.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.969 -1.082 . . . . 0.0 109.817 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.683 ' O ' ' N ' ' A' ' 14' ' ' THR . 90.0 p -151.4 156.49 40.8 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.581 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 32.4 p90 -161.89 148.33 13.77 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -102.36 151.33 22.39 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.112 -1.617 . . . . 0.0 111.956 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.483 HG22 ' HE1' ' A' ' 18' ' ' PHE . 1.6 t -120.54 138.66 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.474 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 77.1 m-70 -127.49 141.22 51.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.844 -1.16 . . . . 0.0 110.838 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.8 p90 -149.97 156.24 41.36 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.91 159.39 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.03 -1.044 . . . . 0.0 109.842 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -88.69 140.19 29.65 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.69 179.28 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.921 1.081 . . . . 0.0 112.453 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.96 10.01 42.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.899 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -116.61 150.66 46.0 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.075 -1.015 . . . . 0.0 109.854 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.65 127.97 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.555 1.504 . . . . 0.0 112.684 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.737 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.2 pt -131.66 170.43 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.5 p -105.61 -3.29 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 109.855 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.34 174.29 14.21 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.737 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 13.0 m-85 -121.89 149.93 42.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.246 -1.15 . . . . 0.0 109.239 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.833 HG23 ' HG3' ' A' ' 49' ' ' ARG . 6.0 mt -115.15 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 120.984 -1.072 . . . . 0.0 108.579 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.8 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.3 mm -107.4 119.61 57.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.181 -0.949 . . . . 0.0 110.783 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -110.0 129.61 55.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.697 ' CE1' ' OD2' ' A' ' 48' ' ' ASP . 40.7 p-80 -134.13 148.61 50.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.51 -1.369 . . . . 0.0 111.339 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -162.85 151.14 14.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 109.457 179.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.508 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 84.3 mtt-85 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 121.394 0.616 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 92.2 mm-40 -120.52 129.21 53.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.528 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.697 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 99.3 m-20 -141.29 117.56 10.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.833 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -109.43 142.06 40.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.891 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.583 HG11 ' HB ' ' A' ' 57' ' ' ILE . 35.4 m -126.3 137.03 29.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.12 160.18 31.42 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.772 0.981 . . . . 0.0 111.624 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.96 -33.8 96.1 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.502 1.468 . . . . 0.0 111.991 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.3 p -70.04 -10.35 58.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 110.354 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -103.88 120.59 41.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -106.92 -7.46 17.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.474 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 53.2 p -129.98 138.52 50.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 109.231 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.583 ' HB ' HG11 ' A' ' 50' ' ' VAL . 5.8 tt -130.01 132.83 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.5 m -99.73 120.0 39.03 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.491 HD21 ' OD2' ' A' ' 48' ' ' ASP . 7.6 mt -93.19 143.53 26.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.263 -0.898 . . . . 0.0 109.81 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.5 p -130.1 178.81 6.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.797 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.71 43.04 19.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.79 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 59' ' ' LEU . 43.3 mt -109.99 153.63 24.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.599 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 6.5 m120 -69.98 126.72 92.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.998 . . . . 0.0 108.655 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.718 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.5 Cg_endo -64.76 132.16 31.75 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 120.709 0.939 . . . . 0.0 112.368 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.87 62.14 3.08 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -148.48 152.99 37.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.322 -1.105 . . . . 0.0 110.525 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' A' ' 66' ' ' THR . 98.7 mt-10 -91.45 120.0 31.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.599 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 30.8 m-85 -108.82 148.16 30.99 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 110.57 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -110.04 125.77 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.27 129.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.915 -1.115 . . . . 0.0 110.335 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' HG12 ' A' ' 85' ' ' ILE . 78.6 p -115.22 139.99 49.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 110.728 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 34' ' ' ILE . 6.6 mm -109.18 129.99 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 38.3 mm -119.9 123.15 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.047 . . . . 0.0 108.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -93.5 132.69 37.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.972 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 m -129.9 140.02 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -121.58 43.4 2.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.97 -97.09 1.88 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.646 ' H ' ' CD ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -102.17 0.01 33.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -1.195 . . . . 0.0 109.299 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -112.4 151.26 30.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -124.64 153.12 42.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 109.493 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -106.25 170.16 6.1 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 109.239 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.5 Cg_exo -59.74 125.39 17.65 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.223 1.282 . . . . 0.0 112.007 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 2.9 Cg_endo -60.76 143.32 99.37 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.223 1.282 . . . . 0.0 113.383 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 5' ' ' PRO . 24.9 tp -119.76 128.09 53.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.412 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -127.71 140.03 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 120.841 -1.162 . . . . 0.0 110.926 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.11 161.67 27.2 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -115.9 136.76 52.74 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.092 -1.24 . . . . 0.0 110.284 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.591 ' CD ' ' CB ' ' A' ' 10' ' ' SER . 98.2 mm-40 -130.2 139.03 50.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -110.77 137.47 48.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -79.68 140.11 37.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.1 t . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 121.504 0.669 . . . . 0.0 111.28 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.539 HG23 ' HD2' ' A' ' 95' ' ' PRO . 2.1 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.473 0.178 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.7 Cg_endo -63.68 81.31 0.14 Allowed 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 120.798 0.998 . . . . 0.0 110.668 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.498 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 28.5 ttp-105 -62.76 165.78 6.22 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.501 -0.749 . . . . 0.0 111.118 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.1 m-20 64.96 42.28 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.062 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.523 ' O ' HG21 ' A' ' 180' ' ' ILE . 54.9 tp -79.86 103.6 9.87 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -150.06 170.03 19.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.939 -1.101 . . . . 0.0 110.255 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 54.0 t -103.85 139.14 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.369 -0.832 . . . . 0.0 109.643 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.67 -10.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -138.62 130.84 28.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 p -114.81 98.5 6.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.656 ' OG1' ' N ' ' A' ' 107' ' ' SER . 1.2 p -88.41 151.12 48.01 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.321 -0.862 . . . . 0.0 109.089 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.37 -30.7 53.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.348 1.365 . . . . 0.0 113.001 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.441 ' C ' HG22 ' A' ' 152' ' ' ILE . 27.8 p -129.02 12.89 6.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.906 -1.121 . . . . 0.0 110.718 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.944 ' O ' HD23 ' A' ' 108' ' ' LEU . 14.6 p -159.85 161.93 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.82 -1.175 . . . . 0.0 110.027 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.944 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -135.67 153.93 51.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 109' ' ' LEU . 5.4 tt -102.8 119.96 39.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 108.769 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 147' ' ' ALA . 2.6 pt -107.37 135.85 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 146' ' ' THR . 52.9 m -136.35 140.03 42.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -144.04 157.14 44.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.389 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.03 127.34 92.45 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.477 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.76 125.89 16.34 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 120.684 0.923 . . . . 0.0 111.654 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.03 176.39 0.74 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 120.831 1.021 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -108.39 24.92 12.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.651 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.0 160.1 41.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.1 m -67.63 130.02 41.73 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.0 109.029 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 166' ' ' THR . 57.5 t -126.31 132.08 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.609 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -71.71 -53.5 13.31 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.585 ' CE2' HG22 ' A' ' 139' ' ' THR . 8.1 p90 -167.27 170.29 11.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 5.5 m-85 -115.98 137.64 51.93 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 53.8 ttp180 -100.41 123.02 44.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.747 -1.221 . . . . 0.0 108.219 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.597 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 69.0 mt -110.26 139.82 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.005 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.794 HG22 ' HG2' ' A' ' 137' ' ' GLU . 19.5 p -115.59 137.22 52.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.375 -0.828 . . . . 0.0 110.796 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.715 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.9 m-85 -84.11 124.17 30.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.25 126.6 8.3 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.724 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 22.2 mt-10 . . . . . 0 C--N 1.295 -1.769 0 O-C-N 121.711 -0.876 . . . . 0.0 108.723 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 121.38 0.61 . . . . 0.0 110.314 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.647 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 96.9 mt-30 -119.82 104.36 10.14 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.121 -1.031 . . . . 0.0 108.554 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.794 ' HG2' HG22 ' A' ' 125' ' ' THR . 98.9 mt-10 -86.89 140.79 29.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 0.0 112.084 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 39.8 p90 -143.9 150.01 37.76 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.585 HG22 ' CE2' ' A' ' 121' ' ' TYR . 16.7 p -89.56 168.72 11.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.933 -1.105 . . . . 0.0 111.459 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 19.6 t -134.14 126.81 18.75 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.747 -0.595 . . . . 0.0 109.649 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.64 155.7 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.291 0.782 . . . . 0.0 111.809 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.91 -0.31 81.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.7 p -99.96 2.29 43.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.059 -1.259 . . . . 0.0 110.422 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -112.48 128.57 56.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.821 -1.175 . . . . 0.0 110.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.2 m -94.74 -6.43 43.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 111' ' ' SER . 48.0 p -139.59 157.04 46.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -137.48 160.02 40.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.629 -1.294 . . . . 0.0 110.653 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.0 m -106.11 142.39 35.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.608 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 34.8 mm -114.47 120.07 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.715 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 53.5 m-20 -122.05 173.81 7.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.236 -0.915 . . . . 0.0 109.798 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.3 46.26 2.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.037 . . . . 0.0 109.478 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 158' ' ' TYR . 2.7 tt -110.43 153.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -98.29 109.98 54.49 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.966 -1.084 . . . . 0.0 110.488 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.46 154.43 74.34 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.075 1.183 . . . . 0.0 112.546 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.02 15.46 78.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.496 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . -137.91 149.06 45.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 49.5 t0 -69.92 150.81 46.34 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.5 m-85 -139.34 164.11 30.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.895 -1.128 . . . . 0.0 110.929 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.9 m -136.48 115.4 12.26 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.75 121.98 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.363 -1.46 . . . . 0.0 108.612 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.428 HG23 ' HB3' ' A' ' 179' ' ' SER . 62.8 m -132.34 148.52 52.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.076 -1.015 . . . . 0.0 110.104 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 2.3 pp -140.65 152.51 45.45 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.973 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 2.5 m-85 -120.07 139.24 52.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -100.16 124.37 45.49 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 70.5 t -106.32 120.73 57.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 119' ' ' VAL . 19.0 p . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 85.5 p -74.31 162.15 29.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.199 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 94' ' ' ILE . 7.0 mttm -62.12 134.31 94.45 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.059 -1.026 . . . . 0.0 108.716 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 134.42 61.14 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.245 1.297 . . . . 0.0 113.424 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.83 129.99 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.428 ' HB3' HG23 ' A' ' 161' ' ' THR . 92.4 p -128.09 159.33 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.052 -1.03 . . . . 0.0 112.201 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.523 HG21 ' O ' ' A' ' 98' ' ' LEU . 44.4 pt -138.8 160.06 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -107.41 130.15 54.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.092 . . . . 0.0 109.195 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.503 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 65.7 t80 -122.5 129.94 52.53 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.95 139.23 35.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 3.2 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.184 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -83.39 109.99 17.77 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 109.073 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.9 p -70.02 150.05 96.28 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.256 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.592 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.77 149.7 67.16 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.077 1.185 . . . . 0.0 111.669 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -152.68 -158.16 0.87 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.96 21.54 76.83 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 105.93 -2.868 . . . . 0.0 105.93 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -50.41 130.07 22.92 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.712 0.768 . . . . 0.0 110.359 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 10' ' ' SER . 52.1 t0 -155.59 149.64 25.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.547 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.8 m -121.97 140.97 51.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.964 -1.085 . . . . 0.0 110.133 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 12' ' ' ASP . 78.0 p -157.2 -173.91 4.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.094 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.05 42.55 24.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.783 HG22 HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -78.01 124.83 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.935 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.692 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.89 162.45 17.32 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.552 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.756 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.34 -59.33 5.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.867 -1.146 . . . . 0.0 109.824 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -87.15 -10.79 51.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.859 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 14' ' ' THR . 48.8 m -139.96 155.26 47.21 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.636 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.775 ' CE2' ' NE2' ' A' ' 88' ' ' GLN . 15.1 p90 -161.46 142.01 10.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 108.779 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -91.16 154.02 19.63 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.443 -1.411 . . . . 0.0 111.777 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.688 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.8 t -124.35 139.31 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -129.68 141.25 50.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.819 -1.175 . . . . 0.0 110.93 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.4 p90 -148.44 160.02 43.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.02 156.11 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 120.81 -1.181 . . . . 0.0 110.346 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.21 124.4 45.2 Favored Pre-proline 0 C--N 1.299 -1.629 0 O-C-N 121.874 -0.516 . . . . 0.0 109.997 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.26 163.66 16.73 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.973 1.116 . . . . 0.0 112.244 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -92.06 -1.41 57.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -79.83 151.76 74.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.14 120.59 8.59 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.344 1.362 . . . . 0.0 112.332 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 27' ' ' ALA . 25.5 pt -135.74 164.4 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.91 -7.36 15.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.028 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.87 175.37 19.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 18.4 m-85 -120.0 139.99 51.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.24 . . . . 0.0 109.163 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.738 HG23 ' HG3' ' A' ' 49' ' ' ARG . 34.9 mm -91.17 120.09 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 57' ' ' ILE . 3.7 mm -97.15 107.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 110.12 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 68.3 mtm180 -105.46 120.0 40.5 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.697 -1.252 . . . . 0.0 107.673 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CD2' HD22 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -120.04 136.57 54.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.974 -1.079 . . . . 0.0 110.334 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -160.0 160.24 33.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.661 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.282 0.563 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.09 120.5 40.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.878 . . . . 0.0 109.293 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -126.0 140.19 52.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.738 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -130.05 146.94 51.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.903 -1.123 . . . . 0.0 109.606 -178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 34' ' ' ILE . 29.0 m -139.5 145.79 45.33 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.94 162.56 25.25 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.032 1.155 . . . . 0.0 111.925 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.28 -34.09 97.95 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.576 1.518 . . . . 0.0 112.314 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.5 t -69.99 -19.73 63.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.589 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -96.06 115.19 27.05 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -107.62 0.48 22.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 p -129.98 134.39 47.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.403 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 34' ' ' ILE . 7.3 tt -130.26 136.11 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 109.723 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.2 m -99.97 122.23 42.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.309 -0.869 . . . . 0.0 109.649 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.829 ' HB3' HD11 ' A' ' 62' ' ' LEU . 12.6 mt -95.48 145.47 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.761 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -132.97 -178.66 5.06 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.434 0.635 . . . . 0.0 110.277 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 51.54 49.66 20.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.355 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.829 HD11 ' HB3' ' A' ' 59' ' ' LEU . 42.4 mt -116.5 153.68 31.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 109.286 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -70.0 123.32 88.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 108.598 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.756 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.6 Cg_endo -62.49 133.67 44.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.876 1.051 . . . . 0.0 112.717 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.66 62.26 2.9 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 m -147.42 148.92 31.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -1.12 . . . . 0.0 110.982 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.455 ' OE2' ' OE1' ' A' ' 87' ' ' GLN . 86.5 tt0 -90.13 119.0 30.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.661 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 37.9 m-85 -109.92 152.75 25.43 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.194 -0.941 . . . . 0.0 110.814 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.02 121.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.51 129.98 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.758 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 85' ' ' ILE . 93.8 p -116.84 137.88 51.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 0.0 110.741 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -112.77 121.85 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.3 mm -112.12 129.99 66.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.854 -1.154 . . . . 0.0 109.252 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -95.61 123.12 39.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.987 . . . . 0.0 109.026 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 75' ' ' VAL . 33.3 m -124.39 133.08 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.56 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -115.84 35.81 4.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.3 -103.06 2.49 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -90.33 0.03 57.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -1.141 . . . . 0.0 110.341 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.52 141.37 48.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.907 -1.121 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.98 140.5 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.814 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -94.05 167.87 12.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.837 . . . . 0.0 109.234 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -58.68 129.99 34.95 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.468 1.445 . . . . 0.0 112.085 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.0 151.9 68.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.396 1.397 . . . . 0.0 113.698 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 5' ' ' PRO . 28.2 tp -125.41 111.91 15.68 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.436 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.7 mt -120.41 129.92 75.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 120.868 -1.145 . . . . 0.0 110.91 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.68 175.98 19.42 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.455 ' OE1' ' OE2' ' A' ' 67' ' ' GLU . 92.6 mt-30 -125.94 137.25 53.69 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.483 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.775 ' NE2' ' CE2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -130.92 130.68 43.79 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.468 ' C ' ' OE1' ' A' ' 88' ' ' GLN . . . -99.04 131.6 44.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.918 -1.114 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.41 135.8 42.39 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.783 HG23 HG22 ' A' ' 13' ' ' ILE . 18.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 176' ' ' LYS . 8.5 mt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.6 Cg_endo -66.17 -166.34 0.1 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 109.926 -0.836 . . . . 0.0 109.926 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -152.74 162.17 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.594 -1.316 . . . . 0.0 110.513 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.61 40.04 20.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.812 -0.555 . . . . 0.0 110.902 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.782 ' O ' HG21 ' A' ' 180' ' ' ILE . 50.1 tp -73.08 96.79 2.24 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.73 -1.231 . . . . 0.0 107.792 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -151.76 169.81 21.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.679 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 43.2 t -96.23 139.38 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.165 -0.959 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.752 HD11 ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -108.6 -11.89 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.853 0.835 . . . . 0.0 108.768 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.605 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -147.18 150.7 35.44 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -129.83 130.01 44.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.838 -1.164 . . . . 0.0 110.271 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.43 157.97 39.78 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.26 -40.93 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 121.434 1.423 . . . . 0.0 112.656 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.501 ' C ' HG22 ' A' ' 152' ' ' ILE . 40.9 p -129.97 19.96 5.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.058 -1.026 . . . . 0.0 110.197 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.053 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.5 p -153.46 169.83 22.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.873 -1.142 . . . . 0.0 110.011 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -143.88 155.39 44.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.33 -0.857 . . . . 0.0 109.699 -179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.752 ' CD2' HD11 ' A' ' 101' ' ' ILE . 25.1 tp -103.99 120.51 41.21 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 147' ' ' ALA . 3.3 pt -107.59 146.95 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 111.321 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.8 p -141.11 144.22 34.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.468 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 42.3 p90 -150.74 159.99 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.73 140.58 22.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.2 134.52 56.33 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.028 1.152 . . . . 0.0 111.803 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.64 -171.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 120.954 1.103 . . . . 0.0 112.335 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.761 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -77.33 -1.44 29.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.09 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 23.4 m -129.96 160.04 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.476 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 152.28 44.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' A' ' 122' ' ' TYR . 48.9 t -130.04 133.81 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.916 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HD3' HG12 ' A' ' 165' ' ' VAL . 11.6 ptm180 -72.49 -48.04 43.81 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.417 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.698 ' CE1' HG22 ' A' ' 139' ' ' THR . 2.2 p90 -166.96 162.53 15.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.904 -1.122 . . . . 0.0 110.036 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.607 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 m-85 -122.52 151.11 41.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.527 ' NE ' ' HB2' ' A' ' 163' ' ' TYR . 17.2 ptt180 -109.85 129.64 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.794 -1.191 . . . . 0.0 108.193 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.623 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 83.9 mt -112.4 145.57 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.951 . . . . 0.0 109.546 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.621 HG22 ' HG2' ' A' ' 137' ' ' GLU . 1.1 p -122.07 142.7 50.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.68 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.1 m-85 -84.57 130.0 34.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.692 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.21 135.34 12.77 Favored Glycine 0 N--CA 1.479 1.566 0 C-N-CA 120.216 -0.993 . . . . 0.0 110.93 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 . . . . . 0 C--N 1.295 -1.786 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.702 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.567 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 61.6 mt-30 -99.61 115.28 29.04 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.561 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.621 ' HG2' HG22 ' A' ' 125' ' ' THR . 95.1 mt-10 -104.86 140.0 38.77 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.87 0.843 . . . . 0.0 111.979 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 42.8 p90 -145.91 151.96 38.69 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.698 HG22 ' CE1' ' A' ' 121' ' ' TYR . 2.7 p -84.33 160.16 20.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.941 -1.1 . . . . 0.0 111.453 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 122' ' ' TYR . 89.0 t -120.2 119.04 31.02 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.67 109.52 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.73 0.953 . . . . 0.0 111.821 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -50.09 -10.27 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.99 -19.22 63.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 110.136 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -122.03 140.74 52.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.7 m -90.02 -1.14 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.468 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 63.4 p -132.85 159.12 40.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.729 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -143.37 166.36 24.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.792 -1.192 . . . . 0.0 110.203 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.5 m -112.16 149.12 32.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.439 -0.788 . . . . 0.0 109.151 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.623 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 33.1 mm -117.62 123.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.68 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 31.2 m120 -125.49 170.08 11.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.024 -1.048 . . . . 0.0 110.013 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 80.8 m-20 65.64 46.7 2.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.589 0.709 . . . . 0.0 109.562 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.501 HG22 ' C ' ' A' ' 106' ' ' THR . 3.7 tt -108.32 149.79 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -98.02 110.04 54.15 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.411 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.4 Cg_endo -67.25 174.69 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.187 1.258 . . . . 0.0 112.853 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.97 26.42 74.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' A' ' 184' ' ' THR . . . -157.21 159.08 37.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.927 -1.337 . . . . 0.0 110.068 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.8 t0 -77.94 144.39 36.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.692 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -130.77 158.17 40.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.828 -1.17 . . . . 0.0 110.272 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 63.7 m -130.24 118.92 22.1 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 108' ' ' LEU . 76.2 mt -100.91 119.79 49.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.364 -1.46 . . . . 0.0 108.775 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 179' ' ' SER . 21.5 m -127.08 140.85 51.99 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.661 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.825 ' C ' HD12 ' A' ' 162' ' ' LEU . 1.5 pp -139.09 152.42 47.49 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.335 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' HD12 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -119.96 141.82 49.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.46 137.17 38.34 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.582 -1.324 . . . . 0.0 110.19 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.662 HG12 ' HD3' ' A' ' 120' ' ' ARG . 62.2 t -110.02 120.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.435 0.636 . . . . 0.0 110.026 -179.41 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.42 0.628 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.5 p -83.02 172.77 12.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.181 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.673 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -59.26 133.33 87.97 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.024 -1.048 . . . . 0.0 108.464 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.02 145.77 97.59 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.338 1.359 . . . . 0.0 113.846 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.54 129.66 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 161' ' ' THR . 93.1 p -126.34 155.83 41.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.943 -1.098 . . . . 0.0 111.52 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 98' ' ' LEU . 27.2 pt -139.17 164.19 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -113.1 129.91 56.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 109.403 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 60.8 t80 -124.59 122.02 36.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.891 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 43.9 mmtt -84.61 149.54 25.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.907 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.526 ' OG1' ' OXT' ' A' ' 184' ' ' THR . 9.0 p . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.059 -1.025 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.01 137.23 36.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.394 -0.816 . . . . 0.0 109.098 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 t -78.06 133.28 65.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.3 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.57 ' CD ' ' HB2' ' A' ' 74' ' ' ALA . 3.3 Cg_exo -57.22 90.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 120.967 1.111 . . . . 0.0 112.064 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -92.26 -158.54 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 109.904 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 22.11 66.82 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.468 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 56.0 t80 -57.75 132.4 53.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.82 0.819 . . . . 0.0 110.752 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.7 t0 -154.11 142.08 20.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 75.0 p -117.74 140.0 50.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.907 -1.121 . . . . 0.0 109.846 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 12' ' ' ASP . 58.7 p -158.6 -176.6 5.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.8 m-20 49.93 48.41 21.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -85.32 121.1 36.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.384 -177.478 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -112.76 162.7 15.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.04 -56.58 19.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.792 -1.193 . . . . 0.0 110.524 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -92.07 -0.03 57.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.85 -1.156 . . . . 0.0 109.93 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.7 ' O ' ' N ' ' A' ' 14' ' ' THR . 37.2 t -150.87 151.55 32.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.663 ' CD2' ' OH ' ' A' ' 68' ' ' TYR . 23.3 p90 -160.97 145.94 14.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 108.829 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 12' ' ' ASP . 3.6 m -93.16 148.03 22.37 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.507 -1.37 . . . . 0.0 111.489 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -121.52 142.56 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.438 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 72.3 m-70 -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.807 -1.183 . . . . 0.0 110.808 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.536 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 42.9 p90 -154.02 157.55 39.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.494 -0.754 . . . . 0.0 109.084 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.06 158.83 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 120.875 -1.141 . . . . 0.0 110.0 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -89.28 148.6 41.05 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 109.9 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.612 ' HG2' HG21 ' A' ' 29' ' ' ILE . 2.5 Cg_endo -61.58 178.72 0.61 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.279 1.319 . . . . 0.0 112.456 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -103.82 7.1 37.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.21 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -119.72 157.55 51.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.9 Cg_endo -56.85 136.29 75.6 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.676 1.584 . . . . 0.0 112.591 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 40.7 pt -139.97 170.06 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 p -106.42 -0.84 23.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -173.85 23.15 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 37.1 m-85 -128.36 151.15 49.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -1.207 . . . . 0.0 109.419 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.861 HG23 ' HE ' ' A' ' 49' ' ' ARG . 31.9 mm -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -0.949 . . . . 0.0 108.48 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.709 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.9 mm -113.91 123.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.008 -1.057 . . . . 0.0 110.315 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.479 ' NH1' HH21 ' A' ' 49' ' ' ARG . 83.0 mtt-85 -123.24 130.92 53.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.607 ' NE2' ' CB ' ' A' ' 46' ' ' ARG . 20.5 p-80 -130.76 129.4 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.559 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -159.99 159.92 32.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 109.32 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.607 ' CB ' ' NE2' ' A' ' 36' ' ' HIS . 22.5 mmm180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.328 0.585 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -120.82 109.96 15.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.793 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' ILE . 94.5 m-20 -121.98 129.99 52.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.197 -0.94 . . . . 0.0 108.673 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.861 ' HE ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -113.56 141.22 47.43 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.325 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.795 ' CG1' HD12 ' A' ' 57' ' ' ILE . 33.1 m -120.95 147.66 46.82 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.28 159.98 44.54 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 120.844 1.029 . . . . 0.0 111.552 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.505 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 2.7 Cg_endo -57.96 -37.85 94.44 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.583 1.522 . . . . 0.0 112.563 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 m -70.05 -12.49 61.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.872 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -100.07 115.43 29.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.922 -1.112 . . . . 0.0 109.888 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -103.06 -4.11 25.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.486 -0.758 . . . . 0.0 108.983 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.438 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 19.4 p -130.33 135.92 48.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.772 . . . . 0.0 109.245 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.795 HD12 ' CG1' ' A' ' 50' ' ' VAL . 8.0 tt -132.43 133.75 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.096 -1.003 . . . . 0.0 110.361 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -95.74 109.99 22.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 17' ' ' SER . 5.6 mt -85.63 148.81 25.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.129 -0.982 . . . . 0.0 109.814 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.4 p -135.05 177.73 7.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.74 -0.6 . . . . 0.0 109.596 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m120 57.33 45.43 20.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 59' ' ' LEU . 48.5 mt -111.68 150.03 30.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.09 116.95 25.01 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.625 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.21 131.71 35.61 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 120.868 1.045 . . . . 0.0 112.932 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.45 62.91 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -142.38 130.72 22.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 110.887 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 67' ' ' GLU . 21.2 pt-20 -87.14 122.52 31.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.663 ' OH ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -139.82 175.45 9.56 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.615 -1.234 . . . . 0.0 110.863 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 87' ' ' GLN . 62.4 t -109.12 129.08 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.71 123.19 68.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.419 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.1 p -111.19 142.36 43.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 0.0 111.586 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.709 ' CD1' HG23 ' A' ' 34' ' ' ILE . 49.3 mm -119.88 119.98 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.1 mm -113.66 119.97 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.91 -1.119 . . . . 0.0 108.809 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.821 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -85.67 130.13 34.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 108.686 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.8 147.55 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 110.061 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -128.51 40.05 3.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.06 -100.81 2.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 ptt-85 -90.34 -5.96 55.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -1.19 . . . . 0.0 110.242 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -112.31 143.48 43.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.97 -1.082 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -127.3 130.54 49.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 110.42 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.821 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 15.7 m -76.12 152.53 84.24 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.56 140.03 45.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 120.746 0.964 . . . . 0.0 111.765 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.89 146.22 80.2 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.561 1.508 . . . . 0.0 114.076 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 5' ' ' PRO . 20.0 tp -122.08 121.74 37.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.419 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -133.2 140.55 46.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 O-C-N 120.846 -1.159 . . . . 0.0 111.379 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.33 162.57 27.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.446 ' HG2' HG22 ' A' ' 69' ' ' VAL . 77.1 mt-30 -110.84 141.88 43.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.037 -1.273 . . . . 0.0 110.165 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.542 ' OE1' ' OG ' ' A' ' 10' ' ' SER . 67.5 tp60 -145.21 158.46 43.82 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.534 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . -124.19 127.12 47.26 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.858 -1.151 . . . . 0.0 111.03 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.638 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.11 142.57 45.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.523 0.677 . . . . 0.0 110.907 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 176' ' ' LYS . 10.3 mt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.493 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.8 Cg_endo -64.42 -159.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 N-CA-C 109.896 -0.848 . . . . 0.0 109.896 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 15.9 ttp180 -160.01 160.57 33.45 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.664 -1.273 . . . . 0.0 111.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 98.2 m-20 59.95 43.84 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.631 HD22 ' CD2' ' A' ' 162' ' ' LEU . 41.2 tp -72.06 112.73 8.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 120.491 -1.381 . . . . 0.0 107.41 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -157.14 169.38 24.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 109' ' ' LEU . 53.4 t -104.95 133.41 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CG2' ' OG ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -98.39 -30.0 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.703 0.763 . . . . 0.0 109.427 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.97 144.55 47.46 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 p -122.32 119.06 29.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 110.164 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -97.18 156.58 36.13 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.1 -46.2 26.46 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.564 1.509 . . . . 0.0 112.918 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 154' ' ' PRO . 64.8 p -121.09 15.86 11.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.677 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.035 ' O ' HD23 ' A' ' 108' ' ' LEU . 4.8 p -149.97 164.29 35.87 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.093 -1.004 . . . . 0.0 109.669 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.035 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -139.43 150.0 44.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.628 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 110' ' ' ILE . 1.9 tt -99.02 122.64 42.55 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.109 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.506 ' N ' HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -106.99 141.26 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 0.0 110.872 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 101' ' ' ILE . 9.5 p -142.74 136.49 28.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.58 -0.7 . . . . 0.0 109.362 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.442 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 34.7 p90 -145.31 156.96 44.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.316 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.62 137.92 54.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.616 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.41 132.04 39.03 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 120.916 1.078 . . . . 0.0 112.099 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.94 -159.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 120.932 1.088 . . . . 0.0 112.256 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.44 2.92 45.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 24.0 m -130.01 160.0 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.098 -1.001 . . . . 0.0 109.819 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.4 t -74.55 135.36 42.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 122' ' ' TYR . 22.6 t -109.99 135.01 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -71.15 -45.94 62.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.496 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 12.1 p90 -166.29 162.37 17.27 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.424 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-85 -119.98 138.08 53.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 108.596 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 137' ' ' GLU . 13.6 tpt180 -95.46 121.58 37.29 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 89.9 mt -110.0 132.36 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.144 -0.973 . . . . 0.0 110.322 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 ' CG ' ' A' ' 137' ' ' GLU . 3.1 p -113.17 144.76 42.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.689 . . . . 0.0 111.436 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.776 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.7 m-85 -87.93 136.61 32.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.695 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.7 128.7 9.4 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.161 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 . . . . . 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.814 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.411 HG23 ' OE2' ' A' ' 137' ' ' GLU . 17.1 m . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.514 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 53.6 mt-30 -94.39 112.69 24.48 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.344 -1.342 . . . . 0.0 108.373 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.466 ' HB3' ' NE ' ' A' ' 123' ' ' ARG . 21.5 mp0 -102.41 140.17 37.04 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.988 0.899 . . . . 0.0 112.715 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 41.9 p90 -143.16 153.87 43.3 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 p -88.62 163.1 15.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.663 -1.273 . . . . 0.0 112.092 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.629 ' O ' ' N ' ' A' ' 142' ' ' GLY . 27.9 t -123.85 105.35 32.44 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.2 Cg_exo -59.86 35.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.672 0.915 . . . . 0.0 112.76 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 30.69 30.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.697 ' N ' ' O ' ' A' ' 141' ' ' PRO . 81.4 p -69.41 -33.6 73.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -1.21 . . . . 0.0 109.698 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -146.17 176.38 9.78 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.563 -0.711 . . . . 0.0 110.107 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 92.7 p -90.03 0.01 57.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.722 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.442 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 19.8 p -136.22 150.96 49.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.471 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -148.05 177.49 9.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 108.945 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.741 HG22 ' N ' ' A' ' 149' ' ' ILE . 43.8 m -122.61 167.07 13.86 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.062 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.776 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 85.8 mt -123.92 130.52 73.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 110.01 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.464 ' O ' ' OH ' ' A' ' 126' ' ' TYR . 68.7 m-20 -123.32 172.67 8.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 61.42 40.36 14.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.0 110.323 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.49 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 3.4 tt -97.78 168.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 108.707 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -110.73 100.08 44.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 120.925 -1.109 . . . . 0.0 109.36 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.534 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.8 Cg_endo -66.71 164.15 30.31 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.396 1.397 . . . . 0.0 113.015 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.98 19.52 69.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.688 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -149.72 156.76 42.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.29 . . . . 0.0 110.186 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.688 ' OD2' ' NZ ' ' A' ' 183' ' ' LYS . 61.9 t0 -70.0 151.14 45.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.6 OUTLIER -141.95 159.28 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.505 -1.372 . . . . 0.0 110.328 -179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 20.4 m -130.49 123.17 29.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -103.39 120.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.131 -1.606 . . . . 0.0 109.666 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 179' ' ' SER . 22.7 m -131.36 141.86 49.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.631 ' CD2' HD22 ' A' ' 98' ' ' LEU . 2.3 pt? -135.18 154.79 51.5 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.4 m-85 -120.02 140.6 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -108.04 125.74 51.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.752 -1.218 . . . . 0.0 109.768 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 90.1 t -114.5 127.54 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.524 0.678 . . . . 0.0 109.691 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.3 p -66.34 152.6 44.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.066 -1.021 . . . . 0.0 108.458 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.67 ' HB2' HD11 ' A' ' 94' ' ' ILE . 1.8 mmtm -49.34 137.03 16.12 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.844 -1.16 . . . . 0.0 108.825 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.53 142.29 97.56 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.165 1.243 . . . . 0.0 112.916 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 129.23 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 161' ' ' THR . 64.8 p -126.06 150.82 47.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.034 -1.041 . . . . 0.0 111.992 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.575 HG23 HD23 ' A' ' 98' ' ' LEU . 48.0 pt -134.8 160.05 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -97.87 140.28 32.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.873 -1.142 . . . . 0.0 109.48 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.651 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 58.3 t80 -137.52 119.35 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 109.62 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.688 ' NZ ' ' OD2' ' A' ' 157' ' ' ASP . 71.3 mmtt -89.4 133.86 34.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.248 -0.907 . . . . 0.0 108.765 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.688 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 3.1 p . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 0.0 109.427 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 81' ' ' SER . 84.9 mt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.13 130.1 36.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.8 m -76.57 144.07 73.08 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 109.514 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.778 ' O ' HD22 ' A' ' 84' ' ' LEU . 2.6 Cg_endo -58.87 110.16 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.171 . . . . 0.0 111.377 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.1 -155.29 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 109.772 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.02 23.7 76.93 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 105.108 -3.197 . . . . 0.0 105.108 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 54.1 t80 -50.56 130.03 23.34 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.561 -0.819 . . . . 0.0 110.88 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.6 t0 -142.96 137.44 29.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.572 ' OG ' ' OE1' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -119.57 138.0 53.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 0.0 110.202 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' ASP . 91.5 p -167.2 -166.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.726 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.2 m-20 48.7 43.68 20.93 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.805 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -76.92 129.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.21 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.38 161.12 21.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.84 -59.99 4.5 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 110.218 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -90.06 0.02 57.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.869 -1.144 . . . . 0.0 109.062 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 14' ' ' THR . 86.0 p -149.47 159.2 44.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.093 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.494 ' CE1' HG22 ' A' ' 20' ' ' VAL . 16.9 p90 -163.77 148.27 10.49 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -101.37 150.29 23.17 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.115 -1.616 . . . . 0.0 112.286 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.494 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -119.18 139.06 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -129.33 139.99 51.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.773 -1.204 . . . . 0.0 110.816 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 35.9 p90 -150.25 155.45 39.74 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -87.32 157.24 3.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.868 -1.145 . . . . 0.0 109.985 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.401 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -93.12 137.02 23.87 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.95 176.01 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 120.827 1.018 . . . . 0.0 111.892 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -103.3 15.55 28.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.311 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.87 155.75 47.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.09 131.27 40.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.614 1.543 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.0 pt -140.01 170.64 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.246 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 46.9 p -108.41 -10.15 15.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 109.841 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.89 178.27 23.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.624 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 25.8 m-85 -123.14 145.14 48.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 109.232 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.67 HG23 ' HG3' ' A' ' 49' ' ' ARG . 42.3 mm -100.7 128.01 53.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 120.88 -1.138 . . . . 0.0 108.123 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.618 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.2 mm -109.29 110.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.112 -0.992 . . . . 0.0 110.421 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -105.69 121.49 44.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.494 ' CG ' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -118.76 135.09 54.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.808 -1.182 . . . . 0.0 110.861 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -160.05 159.0 31.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.597 -0.689 . . . . 0.0 109.586 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 108.547 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 mmt180 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.427 0.632 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -100.51 117.06 33.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.469 -0.769 . . . . 0.0 109.372 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -123.08 133.25 54.31 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.67 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -127.43 150.12 49.78 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.816 -1.177 . . . . 0.0 109.871 -178.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 HD11 ' A' ' 34' ' ' ILE . 34.4 m -135.15 145.96 56.33 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.17 160.08 46.58 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 120.924 1.083 . . . . 0.0 111.256 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.81 -31.5 91.83 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.243 1.296 . . . . 0.0 112.172 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.3 m -72.5 -11.42 60.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.546 -0.721 . . . . 0.0 111.255 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -103.94 120.0 40.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.839 -1.163 . . . . 0.0 109.461 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.431 ' C ' ' OD1' ' A' ' 55' ' ' ASN . 46.3 p-10 -102.49 -1.96 29.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.3 p -134.72 138.18 44.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.439 HD12 ' CG1' ' A' ' 50' ' ' VAL . 4.9 tt -131.55 134.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.705 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -102.5 119.8 39.45 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.339 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.5 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.1 mt -89.29 148.97 23.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 108.977 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -131.31 177.55 7.39 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.514 0.673 . . . . 0.0 110.019 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.4 m120 55.2 45.5 25.74 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.5 HD11 ' CB ' ' A' ' 59' ' ' LEU . 56.3 mt -109.94 152.87 25.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.473 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 95.1 m-20 -68.67 120.48 75.99 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.325 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.781 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.8 Cg_endo -60.95 133.99 50.66 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 121.068 1.179 . . . . 0.0 113.49 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.7 63.05 2.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.2 m -148.57 156.36 42.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -1.16 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' N ' ' CG2' ' A' ' 66' ' ' THR . 8.8 pt-20 -99.31 120.02 38.88 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.473 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 77.3 m-85 -110.19 153.77 24.3 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 111.039 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -109.97 120.73 61.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 36' ' ' HIS . 60.2 t -120.02 125.9 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.932 -1.105 . . . . 0.0 109.826 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 p -104.88 136.14 44.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 110.839 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.753 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.2 mm -112.05 121.03 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -119.11 129.98 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.965 -1.084 . . . . 0.0 109.594 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.74 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -91.65 132.54 36.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.339 -0.851 . . . . 0.0 109.543 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG12 ' HG2' ' A' ' 80' ' ' GLU . 16.5 m -128.6 137.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -119.96 41.93 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.63 -92.4 1.71 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.94 -0.0 40.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -1.106 . . . . 0.0 110.581 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.33 152.85 37.27 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.016 -1.053 . . . . 0.0 109.631 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.559 ' HG2' HG12 ' A' ' 75' ' ' VAL . 99.1 mt-10 -131.87 160.0 36.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 110.001 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.74 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -110.93 172.17 3.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.239 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.1 Cg_exo -61.78 132.74 41.39 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.391 1.394 . . . . 0.0 112.417 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.17 128.28 25.88 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.182 1.255 . . . . 0.0 113.074 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 5' ' ' PRO . 20.4 tp -106.9 121.37 44.3 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -119.98 133.39 66.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.932 -1.105 . . . . 0.0 110.868 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.82 155.39 21.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -110.99 136.17 50.4 Favored 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.204 -1.174 . . . . 0.0 110.054 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.792 HE21 ' CD1' ' A' ' 13' ' ' ILE . 51.6 tt0 -137.6 143.53 41.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.43 149.55 37.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.979 -1.076 . . . . 0.0 111.594 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 136.47 33.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.805 HG23 HG22 ' A' ' 13' ' ' ILE . 20.8 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.466 0.65 . . . . 0.0 110.045 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.769 HG21 HG23 ' A' ' 178' ' ' VAL . 3.1 mt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.473 ' HD2' HG22 ' A' ' 94' ' ' ILE . 3.7 Cg_exo -57.42 -171.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.283 0.655 . . . . 0.0 110.988 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.491 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 53.0 ttt85 -146.67 160.65 41.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.725 -1.234 . . . . 0.0 110.92 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.491 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 25.0 t0 72.55 34.88 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.856 -0.527 . . . . 0.0 111.456 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.647 HD22 HD13 ' A' ' 180' ' ' ILE . 2.2 tt -65.28 102.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.498 -1.376 . . . . 0.0 107.663 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.466 ' N ' HD23 ' A' ' 98' ' ' LEU . 98.8 mt-10 -142.58 157.97 44.15 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.939 -1.101 . . . . 0.0 110.549 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 100' ' ' VAL . 3.2 p -89.96 137.3 21.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.61 HD11 ' CD2' ' A' ' 109' ' ' LEU . 47.3 pt -123.72 -13.21 6.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -142.63 130.01 21.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.5 t -115.03 117.67 31.24 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.687 ' CB ' ' HG ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -108.6 157.96 35.23 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.07 -40.74 33.98 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 121.509 1.473 . . . . 0.0 112.781 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.562 ' C ' HG22 ' A' ' 152' ' ' ILE . 69.6 p -130.01 20.02 5.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 110.22 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.065 ' O ' HD23 ' A' ' 108' ' ' LEU . 18.9 p -153.41 165.37 36.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.889 -1.132 . . . . 0.0 110.285 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.065 HD23 ' O ' ' A' ' 107' ' ' SER . 1.2 mt -141.49 157.26 45.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.61 ' CD2' HD11 ' A' ' 101' ' ' ILE . 23.9 tp -104.8 127.55 52.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.084 -1.01 . . . . 0.0 108.381 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.488 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.0 pt -109.77 135.3 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 110.703 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 146' ' ' THR . 52.6 m -126.86 132.51 50.94 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 42.5 p90 -143.02 157.5 44.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 109.596 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -95.11 142.06 24.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.368 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.29 136.44 68.34 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 120.952 1.101 . . . . 0.0 112.034 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.38 -163.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 120.984 1.123 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -91.24 1.6 56.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 109.187 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.632 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 33.1 m -129.98 160.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.702 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.4 p -69.63 157.38 37.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 108.584 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.602 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 23.8 t -129.91 130.0 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 110.146 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -73.16 -42.97 62.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.762 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 -166.57 163.45 16.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.117 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.602 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -120.0 142.76 48.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 108.771 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.48 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 1.2 mtp180 -99.36 127.34 45.37 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.7 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 35.7 mt -110.01 130.0 63.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.813 -1.179 . . . . 0.0 109.834 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.421 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 76.9 p -106.56 140.37 39.55 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.962 0.887 . . . . 0.0 111.58 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.702 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 5.8 m-85 -91.43 127.48 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.737 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -99.57 117.17 5.79 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.423 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 C--N 1.293 -1.855 0 O-C-N 121.541 -0.976 . . . . 0.0 109.197 179.319 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.624 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 93.3 mm-40 -109.38 121.53 45.38 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.611 -1.236 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 86.5 tt0 -109.77 140.57 43.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.865 . . . . 0.0 111.617 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.7 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 43.0 p90 -139.6 150.0 44.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.762 HG22 ' CE2' ' A' ' 121' ' ' TYR . 4.1 p -86.19 163.57 17.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.112 -0.993 . . . . 0.0 111.463 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 142' ' ' GLY . 7.2 t -129.99 112.45 17.27 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.703 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.35 35.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.728 0.952 . . . . 0.0 112.719 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.56 ' H ' HG12 ' A' ' 140' ' ' VAL . . . 35.03 24.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 141' ' ' PRO . 28.8 t -66.39 -40.02 89.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.059 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -134.3 175.64 9.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.841 0.829 . . . . 0.0 110.546 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 52.5 m -94.62 0.0 54.81 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 111' ' ' SER . 17.9 p -136.83 150.92 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 108.844 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.462 ' H ' HG13 ' A' ' 110' ' ' ILE . . . -141.73 162.92 34.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 109.847 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.4 t -100.56 148.37 24.89 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 108.98 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.702 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 48.5 mm -116.62 120.03 63.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.619 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 78.8 m-20 -120.06 173.91 6.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.19 -0.943 . . . . 0.0 110.306 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.7 t30 65.92 40.0 4.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 109.56 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.562 HG22 ' C ' ' A' ' 106' ' ' THR . 2.3 tt -100.66 146.54 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -99.95 109.43 56.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.987 -1.071 . . . . 0.0 110.123 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 2.5 Cg_endo -68.55 172.64 11.09 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.129 1.22 . . . . 0.0 112.485 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.608 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.34 20.86 77.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 184' ' ' THR . . . -148.65 156.75 42.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.317 . . . . 0.0 109.763 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.9 t0 -69.97 147.27 50.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.737 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -138.0 156.87 47.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.79 -1.194 . . . . 0.0 110.515 -178.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.5 m -134.58 118.03 16.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.18 124.91 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.343 -1.473 . . . . 0.0 109.357 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 178' ' ' VAL . 99.8 m -130.83 142.83 50.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.0 110.439 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 80.3 mt -107.83 142.13 38.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.645 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 24.7 m-85 -119.98 140.02 51.59 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.94 129.93 55.44 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.94 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 62.4 t -115.37 122.55 69.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' THR . . . . . 0.55 HG22 ' HA ' ' A' ' 119' ' ' VAL . 9.7 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.51 0.672 . . . . 0.0 110.045 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.358 0.599 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 49.1 p -72.07 160.69 32.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 94' ' ' ILE . 18.3 mmtm -57.73 130.57 82.12 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 108.435 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.435 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.1 Cg_endo -61.12 134.66 53.93 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.195 1.263 . . . . 0.0 113.664 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.901 ' O ' HG23 ' A' ' 161' ' ' THR . 2.0 t -100.29 126.83 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.438 ' CB ' ' OG1' ' A' ' 161' ' ' THR . 79.1 p -122.69 145.25 48.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.057 -1.027 . . . . 0.0 112.187 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.647 HD13 HD22 ' A' ' 98' ' ' LEU . 15.8 pt -130.61 159.97 42.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -104.13 135.78 44.98 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.85 -1.156 . . . . 0.0 109.502 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.442 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 65.7 t80 -130.2 109.67 10.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.39 136.22 33.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.077 -1.014 . . . . 0.0 108.99 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.371 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.976 HD13 ' N ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -79.49 140.63 37.24 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' THR . 66.5 m -76.77 140.67 67.65 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.391 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 2.9 Cg_endo -57.76 78.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.133 1.222 . . . . 0.0 111.71 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -81.55 -152.02 0.09 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.397 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.0 22.95 77.31 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 106.207 -2.757 . . . . 0.0 106.207 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -57.78 130.0 44.44 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.623 0.725 . . . . 0.0 110.141 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.8 t0 -156.6 147.25 21.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 39.1 t -121.49 141.85 50.63 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.03 -1.043 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 12' ' ' ASP . 22.9 p -155.64 -171.54 3.81 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.4 m-20 49.63 39.94 18.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.45 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -76.49 130.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.42 160.81 27.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.598 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -59.67 -60.0 4.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 110.229 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -89.27 0.06 57.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.978 -1.076 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 14' ' ' THR . 47.5 t -149.33 154.62 39.26 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.802 ' CE1' HG22 ' A' ' 20' ' ' VAL . 12.6 p90 -165.12 141.01 5.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -91.24 150.09 21.49 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.449 -1.407 . . . . 0.0 111.301 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.802 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -119.98 138.44 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.436 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 68.9 m-70 -128.59 144.33 51.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.934 -1.104 . . . . 0.0 110.965 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 41.1 p90 -145.28 160.02 42.14 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.9 159.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.855 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -97.59 132.73 24.61 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.55 -178.46 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.003 1.135 . . . . 0.0 112.711 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -103.86 -0.75 28.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -103.15 151.68 38.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.088 -1.007 . . . . 0.0 109.729 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 2.9 Cg_endo -57.38 126.31 21.6 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.411 1.408 . . . . 0.0 112.29 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.56 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 19.6 pt -130.04 164.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.408 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -99.98 -1.79 36.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.515 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.9 -172.69 23.56 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 42.6 m-85 -128.45 156.84 42.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.739 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -114.24 128.08 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.739 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.6 mm -111.61 118.14 56.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.944 -1.098 . . . . 0.0 110.653 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -112.07 129.41 56.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.51 ' CE1' HD22 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -124.01 141.29 52.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.781 -1.2 . . . . 0.0 110.982 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 46.9 p-80 -165.1 166.88 18.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.063 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.582 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.545 0.688 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.643 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -121.86 117.73 27.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.0 109.855 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' ILE . 85.9 m-20 -123.15 119.1 29.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.783 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -104.44 141.68 35.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.095 -1.003 . . . . 0.0 109.424 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 34' ' ' ILE . 30.9 m -125.33 147.85 59.0 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.46 159.92 45.38 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 120.853 1.035 . . . . 0.0 111.516 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.85 -35.17 99.05 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.488 1.459 . . . . 0.0 112.402 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -69.95 -16.75 63.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.894 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -100.03 117.19 33.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.031 -1.043 . . . . 0.0 109.478 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -104.31 -0.08 28.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.436 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 51.6 p -132.85 138.4 47.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.249 -0.907 . . . . 0.0 109.799 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.505 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 5.5 tt -130.05 134.9 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.048 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.8 m -99.81 120.27 39.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 62' ' ' LEU . 7.2 mt -97.45 140.75 31.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.274 -0.891 . . . . 0.0 109.568 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.1 p -132.63 179.42 6.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.686 . . . . 0.0 109.943 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.91 39.97 29.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.483 -0.761 . . . . 0.0 109.576 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 59' ' ' LEU . 21.0 mt -107.21 149.34 27.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 0.0 109.104 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.537 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 87.7 m-20 -60.82 116.4 18.33 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.96 -1.087 . . . . 0.0 108.363 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 131.97 37.2 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.035 1.157 . . . . 0.0 113.401 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.31 62.82 2.24 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -150.55 157.52 43.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -1.224 . . . . 0.0 110.662 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 66' ' ' THR . 99.0 mt-10 -92.24 120.05 32.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.537 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 44.2 m-85 -110.84 148.71 31.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.157 -0.964 . . . . 0.0 110.996 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.465 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 62.7 t -110.04 124.34 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.9 124.85 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 p -108.4 134.81 50.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 111.195 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.718 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.6 mm -114.5 117.3 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.5 mp -111.8 125.46 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 108.443 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -93.8 127.82 39.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 80' ' ' GLU . 3.1 m -117.46 129.96 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.876 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 52.3 t30 -111.64 34.82 3.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.865 . . . . 0.0 109.341 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.17 -87.05 1.52 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.79 -6.01 56.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -1.108 . . . . 0.0 110.393 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' HD11 ' A' ' 2' ' ' LEU . 100.0 mt-10 -131.12 150.05 52.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.495 ' HG3' HG12 ' A' ' 75' ' ' VAL . 60.0 mp0 -126.67 129.96 49.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.704 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -74.96 160.01 81.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.207 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.46 142.03 98.35 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.221 1.28 . . . . 0.0 111.969 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.99 136.99 78.61 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.239 1.293 . . . . 0.0 113.048 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 5' ' ' PRO . 26.2 tp -115.77 121.29 42.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.95 130.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.947 -1.096 . . . . 0.0 111.074 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.08 160.44 22.49 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.004 -2.439 . . . . 0.0 107.004 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.444 ' HG2' HG22 ' A' ' 69' ' ' VAL . 73.5 mt-30 -118.54 137.88 52.91 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.04 -1.27 . . . . 0.0 110.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -139.3 139.29 37.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -102.24 133.68 46.73 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 110.77 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.34 140.06 41.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.651 . . . . 0.0 110.484 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ARG . 2.0 mt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.591 ' HG2' HD21 ' A' ' 162' ' ' LEU . 2.5 Cg_endo -65.89 62.13 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.824 1.016 . . . . 0.0 111.124 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 44.5 ttm105 -40.58 163.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 110.367 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.525 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.9 m-20 63.1 40.62 8.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.904 -0.497 . . . . 0.0 111.246 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.554 HD13 HD23 ' A' ' 162' ' ' LEU . 49.0 tp -79.97 104.09 10.3 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.835 -1.166 . . . . 0.0 107.887 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -158.64 166.58 31.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.021 . . . . 0.0 110.121 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 25.3 t -89.07 140.02 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.773 HD11 ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -114.14 -9.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . . . -147.62 158.8 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.3 t -134.77 127.93 31.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.965 -1.084 . . . . 0.0 110.423 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.738 ' CB ' ' HG ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.55 158.68 38.0 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -48.92 -32.68 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.485 1.456 . . . . 0.0 112.914 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.595 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.0 p -139.21 20.26 2.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 109.862 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.07 ' O ' HD23 ' A' ' 108' ' ' LEU . 6.1 p -153.15 167.5 29.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.022 . . . . 0.0 110.067 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.07 HD23 ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.773 ' CD2' HD11 ' A' ' 101' ' ' ILE . 30.6 tp -105.27 121.63 44.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 108.795 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 147' ' ' ALA . 3.1 pt -102.95 143.94 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.482 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 146' ' ' THR . 36.3 t -136.73 140.0 42.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.704 -0.622 . . . . 0.0 109.756 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.695 ' CD2' ' O ' ' A' ' 145' ' ' SER . 48.8 p90 -144.37 156.99 44.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.564 -0.71 . . . . 0.0 109.303 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.96 130.45 89.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.67 118.59 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 120.937 1.091 . . . . 0.0 112.247 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.06 168.01 11.44 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 120.864 1.043 . . . . 0.0 111.995 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.49 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -107.01 28.12 8.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.829 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.97 159.99 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.5 t -70.86 129.96 40.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.326 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.713 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 39.9 t -129.98 130.44 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -70.95 -51.27 26.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 139' ' ' THR . 15.3 p90 -167.14 170.49 11.77 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.713 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 3.7 m-85 -120.03 139.86 51.86 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 108.47 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -98.7 126.85 44.44 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.607 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 44.9 mt -118.55 130.84 72.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.872 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 137' ' ' GLU . 12.5 p -101.55 146.54 27.53 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.088 0.947 . . . . 0.0 111.527 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.721 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 3.3 m-85 -92.05 128.07 37.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.727 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.27 122.99 7.08 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.873 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--N 1.295 -1.779 0 O-C-N 121.617 -0.931 . . . . 0.0 108.535 178.742 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.523 0.678 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.638 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 78.7 mt-30 -125.23 131.77 53.08 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.1 pm0 -113.36 148.66 35.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.913 -1.117 . . . . 0.0 111.991 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 49.9 p90 -139.96 150.82 44.97 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.41 HG22 ' CE2' ' A' ' 121' ' ' TYR . 15.1 p -88.32 166.09 14.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.032 . . . . 0.0 111.634 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLY . 54.2 t -136.97 95.24 12.19 Favored Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.681 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -60.05 47.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 120.909 1.073 . . . . 0.0 113.243 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 33.98 26.98 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 141' ' ' PRO . 94.5 p -62.99 -39.98 96.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' A' ' 145' ' ' SER . 19.0 tttt -146.12 165.24 29.7 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.889 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.695 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 79.4 p -78.97 -2.85 42.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.68 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 111' ' ' SER . 58.7 p -129.45 150.58 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 108.831 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -132.39 161.57 33.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.101 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 m -104.24 147.1 27.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.437 -0.789 . . . . 0.0 109.437 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.599 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 40.5 mm -117.92 119.98 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.721 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 68.2 m-20 -121.87 176.83 5.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 110.463 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.93 50.05 5.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.809 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.595 HG22 ' C ' ' A' ' 106' ' ' THR . 2.6 tt -114.81 149.22 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.087 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -94.18 111.96 55.47 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 109.974 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.24 156.37 63.46 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.171 1.247 . . . . 0.0 112.945 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.663 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.02 23.69 76.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 184' ' ' THR . . . -136.1 137.1 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.059 -1.26 . . . . 0.0 109.706 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 53.7 t0 -60.04 140.01 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.727 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -134.28 172.07 13.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.866 -1.146 . . . . 0.0 111.055 -178.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -146.44 124.63 12.18 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.815 HD11 HD12 ' A' ' 108' ' ' LEU . 69.9 mt -111.61 125.95 68.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 120.296 -1.502 . . . . 0.0 109.155 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.9 m -124.44 141.05 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.371 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 1.047 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -124.05 140.49 52.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 111.427 -177.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 1.047 ' N ' HD12 ' A' ' 162' ' ' LEU . 7.0 m-85 -124.78 152.49 43.78 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.64 131.49 54.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.816 -1.177 . . . . 0.0 109.875 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.02 130.02 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.549 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 109.945 -179.884 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.2 p -80.08 170.03 17.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 108.47 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -63.57 118.42 44.28 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.1 Cg_exo -61.98 150.59 85.72 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.034 1.156 . . . . 0.0 113.393 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.468 HG12 HD23 ' A' ' 98' ' ' LEU . 2.9 t -120.73 131.05 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 97.4 p -117.2 154.03 31.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.09 -1.006 . . . . 0.0 111.475 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 98' ' ' LEU . 48.3 pt -137.58 164.69 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -111.32 138.78 47.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.171 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.47 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 64.9 t80 -136.05 126.85 27.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.072 -1.017 . . . . 0.0 109.952 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -100.82 129.24 46.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.281 -0.887 . . . . 0.0 108.834 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.3 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.253 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.854 0 N-CA-C 119.456 2.542 . . . . 0.0 119.456 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt -125.98 139.63 53.28 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.24 -1.153 . . . . 0.0 109.327 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -79.69 135.99 36.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.311 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -85.25 139.97 36.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.127 -0.983 . . . . 0.0 109.667 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.687 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_exo -57.82 143.29 95.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.214 1.276 . . . . 0.0 111.943 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 p -150.57 -153.29 0.48 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 20.12 76.0 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 105.494 -3.043 . . . . 0.0 105.494 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -52.71 127.35 22.86 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.594 0.711 . . . . 0.0 110.09 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 10' ' ' SER . 53.2 t0 -147.83 141.15 25.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.624 ' CB ' ' OE1' ' A' ' 88' ' ' GLN . 81.9 p -111.46 145.89 38.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.956 -1.09 . . . . 0.0 110.255 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 12' ' ' ASP . 80.2 p -169.45 -175.91 2.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.547 -0.721 . . . . 0.0 109.346 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 49.94 44.3 25.38 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -80.03 129.99 36.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.764 -178.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.22 162.06 20.02 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.812 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.16 -60.01 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.999 -1.063 . . . . 0.0 110.287 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.61 0.14 57.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.957 -1.089 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 14' ' ' THR . 80.0 p -149.64 158.67 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.429 -0.794 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.684 ' CE2' HG22 ' A' ' 20' ' ' VAL . 26.0 p90 -165.54 148.28 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -97.26 149.86 21.58 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.289 -1.507 . . . . 0.0 111.607 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 18' ' ' PHE . 1.4 t -122.44 140.44 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -129.83 145.59 51.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.743 -1.223 . . . . 0.0 111.086 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 46.8 p90 -149.66 158.42 44.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.02 158.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.879 -1.138 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -94.25 136.56 23.36 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.717 -0.614 . . . . 0.0 109.813 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 2.8 Cg_endo -59.17 176.15 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.012 1.141 . . . . 0.0 112.407 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -102.54 9.97 39.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.82 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -112.01 157.22 40.33 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.995 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.8 Cg_endo -57.48 122.09 11.18 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.74 1.627 . . . . 0.0 112.619 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 29.7 pt -130.03 165.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.295 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 76' ' ' ASN . 70.4 p -106.66 -7.99 17.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.24 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.35 -179.18 22.62 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.585 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 16.3 m-85 -125.0 147.53 48.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.194 . . . . 0.0 109.207 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' HG3' ' A' ' 49' ' ' ARG . 29.4 mm -102.1 126.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.589 HD11 HG22 ' A' ' 50' ' ' VAL . 3.2 mm -103.78 116.74 48.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.972 -1.08 . . . . 0.0 110.214 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -117.23 131.46 56.84 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.613 ' HB2' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.02 149.93 43.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.33 -1.481 . . . . 0.0 111.275 -178.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -169.76 154.92 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' H ' ' HB3' ' A' ' 41' ' ' SER . . . -85.04 162.66 19.24 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.372 -0.83 . . . . 0.0 108.914 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -59.97 -39.98 87.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.937 -1.102 . . . . 0.0 108.697 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 44.0 m170 -90.75 21.32 4.14 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.385 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' A' ' 38' ' ' ALA . 85.2 p -74.3 168.77 18.99 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.342 -0.849 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.679 ' O ' ' N ' ' A' ' 44' ' ' ARG . 49.0 t -74.35 149.98 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.797 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -47.94 -0.46 0.01 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.679 ' N ' ' O ' ' A' ' 42' ' ' VAL . 13.6 mtp180 -114.41 91.72 25.31 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.236 . . . . 0.0 109.236 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.59 152.72 80.71 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.308 1.338 . . . . 0.0 112.334 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.477 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 42.9 mtt-85 -73.68 151.93 40.61 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.218 -0.926 . . . . 0.0 109.745 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -117.85 112.56 20.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.587 0.708 . . . . 0.0 110.017 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.9 m-20 -124.11 129.96 51.74 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.697 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -118.77 145.18 45.79 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.859 -1.15 . . . . 0.0 109.664 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 HD11 ' A' ' 34' ' ' ILE . 27.1 m -131.52 149.07 72.49 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.963 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.17 157.76 51.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.889 1.059 . . . . 0.0 111.53 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.51 -35.4 98.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 121.363 1.375 . . . . 0.0 112.05 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -70.35 -13.71 62.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.534 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -97.49 120.0 37.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 110.005 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.401 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 30.3 p-10 -108.87 -1.25 19.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.592 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.7 p -129.99 137.57 50.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 109.366 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.562 HD13 HG21 ' A' ' 34' ' ' ILE . 8.6 tt -129.99 130.13 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 m -95.85 119.16 33.84 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.316 -0.865 . . . . 0.0 109.137 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' ' 62' ' ' LEU . 12.2 mt -93.04 146.04 23.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.0 p -136.35 178.36 7.12 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.581 . . . . 0.0 109.932 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 56.18 44.19 25.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.301 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.753 HD11 ' HB3' ' A' ' 59' ' ' LEU . 14.6 mt -113.65 152.89 29.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.478 -0.764 . . . . 0.0 109.623 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.644 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 31.4 t-20 -70.11 120.02 75.45 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.117 -0.989 . . . . 0.0 108.733 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.812 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 138.82 75.35 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.988 1.125 . . . . 0.0 113.192 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.94 63.34 3.03 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -155.04 150.1 26.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.196 -1.179 . . . . 0.0 110.912 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 11.5 pt-20 -85.73 122.28 29.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.644 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 34.6 m-85 -111.54 139.96 46.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 110.481 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.545 HG22 ' OE1' ' A' ' 87' ' ' GLN . 18.8 t -96.56 120.12 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 36' ' ' HIS . 47.4 t -120.13 130.02 74.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.437 ' CB ' HG12 ' A' ' 85' ' ' ILE . 88.7 p -118.5 139.91 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.63 129.99 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.46 129.26 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.741 -1.224 . . . . 0.0 109.21 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.756 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -96.62 127.36 42.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.099 -1.001 . . . . 0.0 109.01 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.82 142.98 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.86 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CG ' ' O ' ' A' ' 76' ' ' ASN . 6.7 t-20 -123.03 37.02 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 108.806 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.6 -94.82 1.82 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -94.71 -6.24 43.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 0.0 110.042 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.55 140.01 49.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.938 -1.101 . . . . 0.0 109.724 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.6 139.96 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.756 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -92.54 169.55 10.52 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.19 133.6 44.57 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.225 1.283 . . . . 0.0 112.218 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.1 155.95 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.473 1.449 . . . . 0.0 113.655 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 5' ' ' PRO . 17.8 tp -131.82 121.14 23.62 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.4 mt -128.56 139.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.813 -1.179 . . . . 0.0 110.427 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.55 166.88 26.37 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.545 ' OE1' HG22 ' A' ' 69' ' ' VAL . 13.2 mm-40 -119.54 137.81 53.58 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.062 -1.257 . . . . 0.0 110.039 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.624 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 62.1 tp60 -134.76 135.95 42.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.714 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.53 136.78 42.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.762 HG11 ' HB2' ' A' ' 116' ' ' ALA . 3.7 t -43.47 171.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.52 0.676 . . . . 0.0 110.884 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 91' ' ' VAL . 68.3 m -108.58 140.25 42.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.535 -0.728 . . . . 0.0 109.224 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.4 -40.04 96.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.0 110.738 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.479 HG21 HG23 ' A' ' 178' ' ' VAL . 6.4 mt -69.97 139.55 88.06 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.02 -1.05 . . . . 0.0 109.618 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.45 -165.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 N-CA-C 109.57 -0.973 . . . . 0.0 109.57 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -157.54 165.6 35.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.51 -1.369 . . . . 0.0 110.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 69.91 37.14 1.83 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.717 -0.614 . . . . 0.0 110.457 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.495 HD13 ' CD2' ' A' ' 162' ' ' LEU . 46.7 tp -73.05 102.43 3.52 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -150.62 170.04 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.606 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 24.6 t -100.86 135.86 35.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.625 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -104.04 -14.91 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.71 0.767 . . . . 0.0 109.055 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -139.72 148.23 42.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.437 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 28.5 t -132.38 119.7 21.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.107 . . . . 0.0 110.793 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -118.39 153.53 51.83 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -49.97 -42.04 46.38 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.796 1.664 . . . . 0.0 113.479 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -119.1 10.39 12.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.908 -1.12 . . . . 0.0 110.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.073 ' O ' HD23 ' A' ' 108' ' ' LEU . 76.8 p -152.05 160.94 43.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.823 -1.173 . . . . 0.0 110.209 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.073 HD23 ' O ' ' A' ' 107' ' ' SER . 1.5 mt -143.8 155.26 44.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.376 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.827 HD13 ' N ' ' A' ' 110' ' ' ILE . 2.1 tm? -99.98 127.21 46.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.827 ' N ' HD13 ' A' ' 109' ' ' LEU . 5.8 pt -110.54 139.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 110.251 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.554 ' HA ' HG22 ' A' ' 146' ' ' THR . 53.3 m -138.25 141.94 39.9 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.612 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.603 ' CD2' ' O ' ' A' ' 145' ' ' SER . 43.5 p90 -154.63 159.97 41.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.138 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.83 130.16 32.34 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 109.226 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.93 141.37 96.41 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 120.853 1.035 . . . . 0.0 112.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.87 -162.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.007 1.138 . . . . 0.0 112.379 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.762 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -104.2 17.12 24.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.147 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.0 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.289 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 t -69.97 130.66 42.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.331 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.645 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 41.1 t -115.93 130.01 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.412 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 166' ' ' THR . 26.9 mmt180 -71.71 -45.93 60.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.48 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 11.4 p90 -166.58 167.04 15.79 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.645 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -120.4 139.83 52.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 55.4 ttp180 -96.95 130.06 44.32 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.972 -1.08 . . . . 0.0 108.423 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.527 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 62.8 mt -119.25 130.25 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -106.22 146.89 29.73 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.848 0.832 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.681 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.6 m-85 -94.6 132.21 39.54 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.73 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.38 117.67 5.46 Favored Glycine 0 C--O 1.206 -1.649 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.672 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.609 ' O ' ' C ' ' A' ' 129' ' ' THR . 40.9 mt-10 -108.67 142.3 39.37 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.913 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.1 p -21.37 -89.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.551 -0.718 . . . . 0.0 111.432 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.72 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . -79.76 -11.96 84.08 Favored Glycine 0 N--CA 1.495 2.594 0 O-C-N 120.918 -1.114 . . . . 0.0 110.679 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.12 47.6 0.18 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 130' ' ' GLY . 40.2 t30 -59.99 -40.03 87.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.511 -0.994 . . . . 0.0 109.584 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.605 ' O ' HG13 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -99.22 -51.08 0.2 Allowed Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 121.426 -0.796 . . . . 0.0 110.117 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 133' ' ' SER . 3.0 Cg_endo -65.91 44.33 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.219 1.279 . . . . 0.0 112.674 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 133' ' ' SER . 0.8 OUTLIER -68.76 154.37 8.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.537 -0.727 . . . . 0.0 109.534 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 126' ' ' TYR . 71.0 mt-30 -109.95 128.64 55.5 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.751 -1.179 . . . . 0.0 108.293 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -119.28 155.46 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.668 -1.27 . . . . 0.0 112.529 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 54.2 p90 -140.86 151.73 44.54 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.6 p -88.51 165.82 14.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.85 -1.156 . . . . 0.0 111.688 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 142' ' ' GLY . 72.9 t -132.71 95.6 19.57 Favored Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -59.8 44.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 120.787 0.991 . . . . 0.0 112.799 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 35.63 23.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.97 -35.93 74.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -1.152 . . . . 0.0 109.916 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -139.92 153.68 47.02 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.522 -0.736 . . . . 0.0 109.832 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.603 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 88.6 p -79.9 -9.98 59.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.386 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 111' ' ' SER . 45.5 p -128.15 152.31 48.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.733 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -141.01 169.4 17.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -112.72 139.98 47.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -0.916 . . . . 0.0 108.943 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 110' ' ' ILE . 32.9 mm -108.56 120.91 60.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 108.725 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.681 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 73.2 m-20 -124.11 168.68 12.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 32.2 t30 77.15 44.98 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.935 HG23 ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -113.01 130.04 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -72.85 121.87 86.14 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.0 109.941 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.03 159.41 42.71 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.27 1.313 . . . . 0.0 113.145 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 23.06 61.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.913 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . -127.89 133.26 49.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.114 -1.227 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 54.8 t0 -59.96 140.07 56.98 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.935 ' CE2' HG23 ' A' ' 152' ' ' ILE . 1.4 m-85 -132.38 161.52 33.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.681 -1.262 . . . . 0.0 111.057 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.547 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 2.4 m -134.28 120.86 20.49 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.664 HD11 HD12 ' A' ' 108' ' ' LEU . 6.7 mt -107.16 120.18 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.154 -1.591 . . . . 0.0 108.97 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 179' ' ' SER . 88.3 m -132.54 149.97 52.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.495 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.3 pp -143.13 151.22 40.46 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.602 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.0 OUTLIER -120.91 140.01 52.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.66 131.48 49.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.745 -1.222 . . . . 0.0 109.778 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 72.4 t -119.62 121.21 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.366 -0.834 . . . . 0.0 109.797 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.531 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 16.5 p -108.52 -65.3 1.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.531 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -73.9 140.82 28.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -150.02 153.68 36.9 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.22 -1.165 . . . . 0.0 109.404 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.66 -86.79 1.36 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.572 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -73.59 -46.42 47.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -1.14 . . . . 0.0 111.074 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.8 m -135.61 71.63 64.84 Favored Pre-proline 0 C--N 1.293 -1.874 0 O-C-N 121.295 -0.878 . . . . 0.0 110.489 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.34 99.03 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 121.467 1.445 . . . . 0.0 111.828 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -123.0 147.6 46.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.02 -1.05 . . . . 0.0 110.165 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 24.4 p -123.1 149.37 44.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.416 -0.803 . . . . 0.0 109.185 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.1 p -79.94 170.13 16.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.072 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -57.03 124.59 66.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.065 -1.022 . . . . 0.0 108.383 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.482 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 2.7 Cg_endo -63.34 150.34 88.83 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 120.905 1.07 . . . . 0.0 113.641 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.479 HG23 HG21 ' A' ' 94' ' ' ILE . 1.9 t -116.18 131.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 161' ' ' THR . 80.2 p -130.03 154.12 47.74 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.009 . . . . 0.0 111.811 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.12 159.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -103.09 139.98 37.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.73 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 35.2 t80 -138.11 131.33 30.34 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.902 -1.124 . . . . 0.0 110.494 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.635 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 19.8 pttp -94.09 138.41 32.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 108.93 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 156' ' ' ALA . 1.3 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.429 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.9 0 N-CA-C 119.456 2.543 . . . . 0.0 119.456 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' A' ' 81' ' ' SER . 98.2 mt -133.14 143.5 49.29 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.252 -1.146 . . . . 0.0 109.234 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.96 159.27 28.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' THR . 42.7 t -94.29 130.02 35.29 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.886 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.549 ' CD ' ' HB2' ' A' ' 74' ' ' ALA . 2.8 Cg_endo -58.81 72.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.106 1.204 . . . . 0.0 111.788 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -79.55 -153.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.013 -1.054 . . . . 0.0 109.611 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.94 22.62 78.4 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -58.21 130.28 45.91 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.505 0.669 . . . . 0.0 110.291 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -147.5 123.91 10.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -103.23 130.28 50.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 109.876 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' ASP . 88.3 p -154.84 -172.4 4.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.159 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.0 49.89 19.5 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -88.48 126.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.905 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -113.82 162.45 16.32 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.123 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -59.96 -51.57 69.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 -97.7 -0.11 46.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.907 -1.121 . . . . 0.0 109.887 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.695 ' O ' ' N ' ' A' ' 14' ' ' THR . 18.1 m -150.47 155.01 38.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.878 ' CD1' ' NE2' ' A' ' 88' ' ' GLN . 28.4 p90 -163.12 150.16 12.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 108.986 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -92.99 143.65 26.03 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.484 -1.385 . . . . 0.0 111.381 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.841 HG22 ' CE1' ' A' ' 18' ' ' PHE . 2.0 t -116.14 137.19 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.482 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 77.6 m-70 -130.48 149.52 52.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.65 -1.281 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 36.6 p90 -155.63 160.01 40.08 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.53 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 120.743 -1.223 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' N ' HG13 ' A' ' 23' ' ' VAL . . . -94.54 132.58 28.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.793 -0.567 . . . . 0.0 109.915 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HG2' HG21 ' A' ' 29' ' ' ILE . 2.9 Cg_endo -59.68 151.8 67.44 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.998 1.132 . . . . 0.0 112.201 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -65.78 -40.03 91.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.34 147.7 98.84 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.66 138.36 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.426 1.418 . . . . 0.0 112.232 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.671 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 33.3 pt -132.6 168.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.733 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -103.66 -0.47 29.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.407 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.56 -173.62 23.01 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.671 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 44.6 m-85 -130.01 157.06 43.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.226 -1.161 . . . . 0.0 109.506 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.611 ' C ' HD13 ' A' ' 34' ' ' ILE . 37.2 mm -110.03 130.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.689 HG23 ' CD1' ' A' ' 72' ' ' ILE . 2.0 mm -117.58 121.2 66.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.927 -1.108 . . . . 0.0 110.403 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.434 HH12 HG13 ' A' ' 73' ' ' ILE . 57.3 mtt180 -121.87 137.4 54.8 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.08 138.77 39.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.618 -1.301 . . . . 0.0 110.849 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -167.74 160.02 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.702 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' A' ' 41' ' ' SER . . . -83.33 154.56 24.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.849 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -64.54 -29.98 71.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.913 . . . . 0.0 109.051 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -105.03 18.01 23.12 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.661 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 93.9 p -74.73 167.11 22.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 109.409 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.697 ' O ' ' N ' ' A' ' 44' ' ' ARG . 13.9 m -73.95 158.49 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.437 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -58.28 33.94 0.02 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 42' ' ' VAL . 68.3 mtt180 -122.17 55.49 6.4 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.844 -1.386 . . . . 0.0 110.476 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 44' ' ' ARG . 2.7 Cg_endo -57.77 126.15 20.89 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.502 1.468 . . . . 0.0 112.355 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -74.2 149.99 40.59 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.136 -0.978 . . . . 0.0 110.177 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.452 ' CD ' HH22 ' A' ' 49' ' ' ARG . 3.0 pt20 -120.66 122.02 39.57 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.609 0.719 . . . . 0.0 109.538 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -125.84 125.96 43.71 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.56 ' HD2' HG23 ' A' ' 33' ' ' ILE . 1.9 mmt-85 -108.94 147.3 32.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.108 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.701 ' CG1' HD12 ' A' ' 57' ' ' ILE . 28.2 m -127.24 147.44 61.96 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 110.175 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.03 159.52 46.14 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 120.955 1.103 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.39 -33.65 97.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 121.383 1.389 . . . . 0.0 111.926 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -69.97 -12.76 61.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.574 -0.704 . . . . 0.0 110.471 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -99.95 110.53 22.86 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -99.57 -1.5 38.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 108.788 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.482 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 78.5 p -138.24 136.07 36.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.701 HD12 ' CG1' ' A' ' 50' ' ' VAL . 7.2 tt -129.96 136.62 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 m -100.48 114.63 28.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.478 ' HB3' HD11 ' A' ' 62' ' ' LEU . 11.1 mt -88.48 149.97 23.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 109.556 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.427 HG22 ' OG ' ' A' ' 17' ' ' SER . 27.3 p -136.01 177.89 7.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.743 -0.598 . . . . 0.0 109.96 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.9 m120 56.27 46.26 21.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.61 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 59' ' ' LEU . 44.0 mt -109.96 153.2 24.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.827 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -67.47 118.95 61.8 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 0.0 108.508 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.699 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.6 Cg_endo -62.84 129.83 27.4 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.893 1.062 . . . . 0.0 112.736 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.63 61.33 3.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -142.72 135.51 28.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -1.2 . . . . 0.0 111.464 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 89' ' ' ALA . 99.1 mt-10 -91.03 117.03 29.26 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.731 ' OH ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -133.61 173.78 11.14 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.308 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.63 136.45 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.54 129.94 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -115.93 140.97 48.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.689 ' CD1' HG23 ' A' ' 34' ' ' ILE . 48.6 mm -119.95 120.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.434 HG13 HH12 ' A' ' 35' ' ' ARG . 34.2 mm -115.36 129.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 108.666 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -92.84 129.91 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.751 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.01 159.99 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -140.49 38.45 1.87 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.92 -97.61 1.62 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -99.6 0.03 41.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 110.082 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -111.46 151.68 28.3 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.691 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -129.56 153.93 47.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -107.22 176.8 1.49 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 108.977 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 81' ' ' SER . 3.6 Cg_exo -65.75 131.44 27.53 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.035 1.157 . . . . 0.0 111.628 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.74 140.89 95.1 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.2 1.267 . . . . 0.0 113.384 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.1 tp -119.98 116.73 26.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -128.12 139.94 50.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.7 162.4 26.62 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -110.36 149.61 29.98 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.155 -1.203 . . . . 0.0 109.671 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.878 ' NE2' ' CD1' ' A' ' 18' ' ' PHE . 31.7 tt0 -148.46 156.48 42.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.379 -0.826 . . . . 0.0 108.98 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' N ' ' HG2' ' A' ' 88' ' ' GLN . . . -121.37 123.62 42.57 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.658 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.731 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.32 142.89 47.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -61.77 154.42 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.48 0.657 . . . . 0.0 110.673 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.8 p -83.51 151.62 25.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.425 -0.797 . . . . 0.0 109.815 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.54 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 53.2 t0 -81.16 -20.14 41.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.446 -0.784 . . . . 0.0 110.769 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 178' ' ' VAL . 3.1 mt -81.53 140.84 48.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.876 -1.14 . . . . 0.0 109.527 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD2' HG22 ' A' ' 94' ' ' ILE . 3.6 Cg_exo -58.78 -170.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 109.946 -0.828 . . . . 0.0 109.946 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 38.2 ttm180 -149.89 160.0 43.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.503 -1.373 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.479 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 14.6 t0 72.6 36.22 1.01 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.682 -0.636 . . . . 0.0 110.871 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.664 HD22 HD13 ' A' ' 180' ' ' ILE . 2.2 tt -68.01 102.9 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 97' ' ' ASP . 47.4 mt-10 -149.92 169.65 20.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.334 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.9 t -110.16 131.74 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.44 -0.787 . . . . 0.0 109.605 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -25.26 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.46 -0.775 . . . . 0.0 109.633 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -127.35 135.94 51.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.607 -0.683 . . . . 0.0 109.158 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.595 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 18.5 t -118.62 116.11 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.142 -0.974 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -105.66 155.82 37.51 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 121.313 -0.867 . . . . 0.0 108.903 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.61 -35.35 56.53 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.661 1.574 . . . . 0.0 112.931 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.481 ' C ' HG22 ' A' ' 152' ' ' ILE . 56.4 p -128.75 16.36 6.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.992 -1.067 . . . . 0.0 110.412 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.079 ' O ' HD23 ' A' ' 108' ' ' LEU . 29.0 p -158.66 169.34 24.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.806 -1.184 . . . . 0.0 110.01 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.079 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -144.81 153.41 41.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.68 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 110' ' ' ILE . 4.5 tt -101.88 125.66 48.61 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.713 HD11 ' HB3' ' A' ' 147' ' ' ALA . 11.6 pt -114.01 152.12 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.048 -1.033 . . . . 0.0 111.117 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.2 t -147.47 140.31 24.91 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -147.61 160.0 43.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.04 130.16 32.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.73 138.68 84.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.851 1.034 . . . . 0.0 112.167 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.63 -160.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.119 1.213 . . . . 0.0 112.557 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.48 12.24 36.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 33.2 m -130.01 160.1 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 0.0 109.221 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 84.0 p -68.59 149.96 48.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 109.013 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.4 137.32 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -71.51 -53.5 13.66 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CE2' HG22 ' A' ' 139' ' ' THR . 26.4 p90 -167.37 170.32 11.56 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.595 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 3.5 m-85 -118.29 135.92 54.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.814 -1.179 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.592 ' NH2' ' CG ' ' A' ' 163' ' ' TYR . 28.5 ttp-105 -98.53 125.04 43.62 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.829 -1.17 . . . . 0.0 107.9 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.589 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 85.4 mt -111.17 133.46 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.075 -1.016 . . . . 0.0 110.135 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 137' ' ' GLU . 3.1 p -105.55 145.12 31.37 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.916 0.865 . . . . 0.0 111.282 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.698 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.3 m-85 -92.41 120.28 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.93 129.65 9.72 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.903 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 130' ' ' GLY . 56.9 mt-10 -106.24 163.24 12.97 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.734 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -28.91 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.0 109.766 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . 104.32 31.77 4.52 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.33 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.58 -90.08 0.39 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -133.29 22.45 4.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -1.156 . . . . 0.0 109.497 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.6 t -106.84 119.25 51.99 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.885 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.1 155.74 54.19 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.879 1.052 . . . . 0.0 112.355 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.408 HG13 ' H ' ' A' ' 135' ' ' VAL . 1.4 m -73.62 150.33 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.908 . . . . 0.0 109.754 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 126' ' ' TYR . 96.8 mm-40 -117.49 138.08 52.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.734 ' HB3' HG22 ' A' ' 125' ' ' THR . 21.9 pt-20 -128.8 160.02 33.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.761 -1.212 . . . . 0.0 112.246 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 50.4 p90 -144.61 157.12 44.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.475 HG22 ' CE2' ' A' ' 121' ' ' TYR . 7.2 p -87.5 164.94 15.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.901 -1.124 . . . . 0.0 110.939 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 t -128.88 118.3 19.61 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.481 -0.762 . . . . 0.0 110.625 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.3 Cg_exo -59.04 130.47 36.61 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-N 119.273 0.776 . . . . 0.0 111.819 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.72 2.71 2.4 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 141' ' ' PRO . 52.5 m -89.98 -2.9 58.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -1.204 . . . . 0.0 110.113 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -128.81 138.73 52.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.02 -1.05 . . . . 0.0 109.728 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -94.36 -7.39 41.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.189 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.4 p -133.41 153.27 51.75 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.713 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -138.4 175.4 9.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.853 -1.154 . . . . 0.0 109.757 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 t -120.38 146.93 45.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.689 HD11 HD13 ' A' ' 110' ' ' ILE . 32.8 mm -113.16 120.74 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.149 -0.969 . . . . 0.0 109.44 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.698 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 35.6 m120 -123.76 177.51 5.68 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.245 -0.909 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 59.97 46.52 10.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.493 HG12 ' CZ ' ' A' ' 158' ' ' TYR . 4.8 tt -107.68 153.67 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' N ' ' OH ' ' A' ' 158' ' ' TYR . 13.1 mmtt -97.66 109.97 53.08 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.008 -1.058 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.43 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.4 Cg_endo -68.42 173.16 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.305 1.336 . . . . 0.0 113.036 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.34 27.29 71.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.734 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . -152.81 155.81 37.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.981 -1.305 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 48.5 t0 -72.91 155.23 40.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.704 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-85 -142.43 160.02 41.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.858 -1.152 . . . . 0.0 110.774 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.473 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.7 m -135.09 120.5 19.13 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 108' ' ' LEU . 98.4 mt -105.58 121.58 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.228 -1.545 . . . . 0.0 108.901 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 125' ' ' THR . 50.8 m -129.97 142.05 50.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 162' ' ' LEU . 1.4 pp -136.45 152.4 50.53 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.678 -1.209 . . . . 0.0 111.42 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.2 m-85 -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.53 132.61 47.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.699 -1.251 . . . . 0.0 109.541 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.65 124.06 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 2.8 p -123.13 -65.38 1.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.634 -0.666 . . . . 0.0 109.694 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.617 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -23.24 142.11 0.01 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -121.71 132.84 54.85 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.393 -1.063 . . . . 0.0 109.258 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 142.98 -151.68 23.37 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -91.46 -0.44 57.62 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.326 -1.103 . . . . 0.0 109.382 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.0 m -131.76 74.32 77.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.975 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.13 108.66 1.18 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.581 1.521 . . . . 0.0 111.724 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.99 150.04 25.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.374 -0.829 . . . . 0.0 109.779 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.1 p -126.2 148.89 49.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.356 -0.84 . . . . 0.0 109.606 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 85.0 p -79.34 170.0 17.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 108.807 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.454 ' HB2' HD11 ' A' ' 94' ' ' ILE . 6.2 mttm -56.2 129.06 73.54 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 108.756 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.3 Cg_endo -62.02 144.53 96.32 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.105 1.204 . . . . 0.0 113.217 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 94' ' ' ILE . 2.1 t -113.54 128.6 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 81.1 p -123.29 150.04 44.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 111.703 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.664 HD13 HD22 ' A' ' 98' ' ' LEU . 39.5 pt -133.85 159.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -104.84 139.33 39.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.947 -1.095 . . . . 0.0 109.002 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.604 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 62.4 t80 -135.33 130.38 34.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.593 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.1 139.99 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 108.946 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 109.479 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.867 0 N-CA-C 119.344 2.497 . . . . 0.0 119.344 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.1 mt -120.02 133.68 55.47 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.201 -1.176 . . . . 0.0 109.313 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -74.41 149.22 40.56 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.424 -0.798 . . . . 0.0 108.982 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' THR . 47.5 t -82.5 132.17 53.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.989 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_endo -59.04 79.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.129 1.22 . . . . 0.0 111.591 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 4' ' ' SER . 1.0 OUTLIER -85.9 -159.56 0.47 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.787 -1.195 . . . . 0.0 110.241 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 79.24 19.05 72.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.572 ' HB2' HD21 ' A' ' 84' ' ' LEU . 57.3 t80 -59.97 134.83 57.41 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.643 0.735 . . . . 0.0 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 10' ' ' SER . 39.8 t0 -158.98 148.8 19.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 90.0 p -113.98 132.43 55.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.934 -1.104 . . . . 0.0 109.553 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 12' ' ' ASP . 37.3 p -149.22 -175.95 5.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.048 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 11' ' ' SER . 78.2 m-20 47.57 46.94 17.79 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.791 HG22 HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -82.64 127.92 39.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.152 -177.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.681 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.04 161.39 18.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.764 ' H ' ' HB1' ' A' ' 116' ' ' ALA . . . -63.32 -54.37 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.775 -1.203 . . . . 0.0 109.902 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.08 0.01 57.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.052 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 14' ' ' THR . 97.6 p -155.53 158.91 39.23 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.371 -0.831 . . . . 0.0 109.01 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CD1' ' NE2' ' A' ' 88' ' ' GLN . 30.4 p90 -163.02 151.03 13.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 109.529 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 m -95.36 157.1 16.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.54 -1.35 . . . . 0.0 111.518 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.65 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.1 t -128.4 160.0 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.65 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.7 m-70 -150.87 154.11 36.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.84 -1.162 . . . . 0.0 110.589 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 47.4 p90 -153.69 160.01 42.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.509 -0.745 . . . . 0.0 109.19 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -84.63 157.83 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.995 -1.066 . . . . 0.0 109.768 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 23' ' ' VAL . . . -99.06 120.44 58.39 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.1 149.71 87.84 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.819 1.013 . . . . 0.0 112.19 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -78.83 -12.39 60.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.187 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -72.21 150.56 92.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.259 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.82 126.05 20.54 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.323 1.349 . . . . 0.0 112.719 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 28.4 pt -136.52 166.55 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.438 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 p -115.71 -3.31 12.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.9 -175.51 28.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.68 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 55.1 m-85 -131.57 151.36 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -1.199 . . . . 0.0 109.997 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 32' ' ' TYR . 1.4 mp -112.71 132.6 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 72' ' ' ILE . 2.2 mm -118.16 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.03 -1.044 . . . . 0.0 110.96 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -119.43 138.4 53.13 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.432 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 8.3 t60 -129.91 139.94 51.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.553 -1.342 . . . . 0.0 111.221 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.446 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 28.8 p-80 -163.61 153.19 14.8 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.3 0.572 . . . . 0.0 109.979 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.899 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -95.93 149.68 21.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 0.0 109.338 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.03 -39.39 85.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 109.438 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -83.17 0.08 46.93 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.511 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.524 ' OG ' ' O ' ' A' ' 38' ' ' ALA . 70.0 p -91.79 124.76 36.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.99 -1.069 . . . . 0.0 109.803 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 42' ' ' VAL . 39.6 t -99.96 -10.04 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.68 174.35 6.79 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.02 132.41 88.45 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.26 -1.141 . . . . 0.0 109.326 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.65 136.75 77.6 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.859 1.04 . . . . 0.0 111.889 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -73.73 156.62 37.7 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.131 -0.981 . . . . 0.0 109.994 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -121.11 109.91 15.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.0 109.979 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' ILE . 91.7 m-20 -120.79 125.93 48.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.541 ' NH1' HG23 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -109.27 151.77 26.11 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.01 -1.056 . . . . 0.0 108.731 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.599 HG22 HD11 ' A' ' 34' ' ' ILE . 27.8 m -130.98 145.2 56.76 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.908 -1.12 . . . . 0.0 110.113 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.04 160.4 38.02 Favored 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 120.999 1.133 . . . . 0.0 111.837 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.14 -32.66 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.588 1.525 . . . . 0.0 112.298 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 m -74.84 -10.95 59.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.0 111.101 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.81 117.83 35.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.149 . . . . 0.0 109.872 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -104.14 -0.01 29.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.462 -0.774 . . . . 0.0 109.489 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.7 p -130.94 139.91 50.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.902 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 9.1 tt -130.04 130.22 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 m -98.94 120.88 40.13 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.173 -0.955 . . . . 0.0 109.979 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.9 mt -97.21 138.11 35.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.222 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -123.3 179.48 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 53.74 48.56 21.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.923 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 59' ' ' LEU . 55.5 mt -111.54 158.26 19.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.338 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.674 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 75.7 m-20 -69.94 129.99 90.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.36 132.66 39.44 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.336 1.357 . . . . 0.0 113.505 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 67.08 65.84 2.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.602 ' N ' ' OG1' ' A' ' 90' ' ' THR . 1.2 m -149.86 151.85 34.15 Favored 'General case' 0 N--CA 1.506 2.341 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.188 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 49.6 mp0 -92.66 119.96 32.6 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.899 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 50.0 m-85 -111.23 140.51 45.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.117 -0.99 . . . . 0.0 110.799 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.446 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 15.2 t -92.7 121.42 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.99 125.6 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 109.708 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -99.59 135.33 41.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.673 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.662 HD13 HG23 ' A' ' 34' ' ' ILE . 48.5 mm -116.51 129.97 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 74' ' ' ALA . 80.4 mt -127.67 160.01 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 110.152 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.553 ' N ' HG22 ' A' ' 73' ' ' ILE . . . -128.54 131.94 48.25 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.1 m -128.31 151.21 34.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.222 -0.924 . . . . 0.0 109.295 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -126.25 33.84 4.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -0.945 . . . . 0.0 108.515 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.83 -89.33 1.27 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 78' ' ' ARG . 40.7 ttm-85 -89.97 -19.38 24.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -1.061 . . . . 0.0 110.386 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -104.36 150.32 24.6 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 110.788 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -120.63 147.34 45.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.078 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -104.16 160.87 24.66 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.164 -0.96 . . . . 0.0 109.316 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.89 129.96 31.01 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.184 1.256 . . . . 0.0 112.298 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.91 145.25 98.77 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.294 1.329 . . . . 0.0 113.5 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 8' ' ' PHE . 13.3 tp -119.89 119.34 33.21 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -120.02 130.04 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.974 -1.078 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.15 168.79 22.86 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -121.88 147.77 45.58 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 109.889 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.798 ' NE2' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -142.29 159.27 42.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -119.08 135.36 54.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.083 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -73.84 133.6 43.21 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.136 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.791 HG23 HG22 ' A' ' 13' ' ' ILE . 39.7 t -37.21 171.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.008 0.909 . . . . 0.0 111.547 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.744 ' N ' HG12 ' A' ' 91' ' ' VAL . 1.4 t -105.36 153.62 21.41 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 49.7 t0 -59.99 -40.02 87.72 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.473 -0.767 . . . . 0.0 110.243 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 176' ' ' LYS . 0.5 OUTLIER -72.62 143.67 85.2 Favored Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 118.116 -1.434 . . . . 0.0 109.115 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.698 ' HD2' HG23 ' A' ' 94' ' ' ILE . 3.1 Cg_exo -61.7 -158.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 120.635 0.89 . . . . 0.0 111.205 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.555 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 40.5 ttp180 -154.14 166.69 32.29 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.098 -1.001 . . . . 0.0 109.812 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.555 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 15.7 t0 74.96 35.08 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.503 -0.748 . . . . 0.0 109.831 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD13 HD23 ' A' ' 162' ' ' LEU . 44.3 tp -67.6 107.0 2.36 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -158.51 163.55 36.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.58 139.96 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 pt -118.08 -16.0 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.115 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -140.67 130.04 23.83 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.468 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 6.2 m -117.42 119.76 36.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.019 . . . . 0.0 109.805 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.604 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -101.95 158.07 32.48 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.18 -35.56 52.72 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.312 1.341 . . . . 0.0 112.497 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.425 ' C ' HG22 ' A' ' 152' ' ' ILE . 68.4 p -130.14 18.4 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.031 -1.043 . . . . 0.0 110.245 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.607 ' O ' HD23 ' A' ' 108' ' ' LEU . 2.4 p -154.16 160.07 41.72 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.877 -1.139 . . . . 0.0 109.91 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.802 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -133.38 150.13 51.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 108.653 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 110' ' ' ILE . 4.7 tt -105.2 120.09 40.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 108.898 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.3 pt -99.97 138.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.683 ' HA ' HG22 ' A' ' 146' ' ' THR . 32.5 t -132.56 133.92 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -145.72 144.89 30.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 1.8 pt-20 -72.3 145.97 88.79 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.934 -1.103 . . . . 0.0 108.575 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.53 136.56 74.97 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 120.962 1.108 . . . . 0.0 111.744 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.31 -163.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 120.332 0.688 . . . . 0.0 111.364 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.764 ' HB1' ' H ' ' A' ' 15' ' ' ALA . . . -113.74 11.68 18.15 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.221 -0.924 . . . . 0.0 108.986 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 33.1 m -129.97 159.99 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -71.16 133.06 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.933 . . . . 0.0 108.789 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.666 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 14.6 t -122.78 134.59 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.074 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.477 ' HD2' ' NH2' ' A' ' 168' ' ' ARG . 0.8 OUTLIER -72.3 -52.29 16.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.413 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 14.1 p90 -166.84 170.11 12.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.5 m-85 -122.15 143.87 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.963 . . . . 0.0 108.412 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.629 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 54.6 ttt-85 -103.71 126.04 50.58 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.692 -1.255 . . . . 0.0 107.906 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.674 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 50.2 mt -116.56 144.1 25.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.521 HG22 HH21 ' A' ' 123' ' ' ARG . 36.0 p -118.31 144.49 45.8 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.832 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.735 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.9 m-85 -87.9 131.36 34.61 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.52 115.25 4.66 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.922 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 34.2 mt-10 -109.97 98.67 7.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.459 ' H ' HG23 ' A' ' 129' ' ' THR . 9.1 p -60.33 -39.62 87.7 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.653 -1.28 . . . . 0.0 109.765 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -50.95 -39.09 39.67 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.32 10.13 74.81 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 121.139 -1.212 . . . . 0.0 110.494 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -60.0 -39.97 87.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.859 -1.377 . . . . 0.0 109.162 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.7 m -136.15 149.82 69.25 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.25 166.79 6.86 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.106 1.204 . . . . 0.0 112.266 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m -60.02 152.53 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.203 -0.935 . . . . 0.0 108.582 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.63 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 83.6 mt-30 -117.95 136.61 53.38 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.265 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.629 ' CD ' ' HE ' ' A' ' 123' ' ' ARG . 10.6 pt-20 -123.17 144.32 49.43 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.261 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.674 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 52.2 p90 -138.49 158.87 43.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 121' ' ' TYR . 4.0 p -94.25 167.0 11.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.905 -1.122 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 142' ' ' GLY . 98.0 t -135.17 85.64 33.1 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.5 Cg_exo -58.87 50.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 120.996 1.131 . . . . 0.0 113.162 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 34.95 24.54 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 141' ' ' PRO . 79.6 p -61.64 -39.98 93.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -1.18 . . . . 0.0 109.763 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -145.58 171.13 15.14 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.112 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 99.5 p -84.35 -1.17 55.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.581 -0.699 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 111' ' ' SER . 68.4 p -130.73 151.31 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 108.993 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -126.78 148.92 49.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.972 -1.08 . . . . 0.0 109.79 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.8 m -94.02 143.19 26.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.11 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.608 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 37.3 mm -115.19 121.33 66.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.735 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 33.4 m-80 -127.11 170.0 12.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.703 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 19.0 m120 68.34 48.6 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.0 109.816 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.574 ' CD1' HD11 ' A' ' 108' ' ' LEU . 2.0 tt -113.74 147.34 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -95.45 111.13 54.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.848 -1.157 . . . . 0.0 109.654 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.429 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 2.8 Cg_endo -64.95 163.37 28.63 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.061 1.174 . . . . 0.0 112.705 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.96 72.49 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 184' ' ' THR . . . -146.36 146.79 30.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.31 . . . . 0.0 109.917 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 55.3 t0 -70.01 151.52 45.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.588 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.8 OUTLIER -138.1 173.16 11.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.86 -1.15 . . . . 0.0 111.225 -178.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -141.34 111.52 6.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.81 124.03 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.3 -1.5 . . . . 0.0 109.462 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -124.81 139.92 53.4 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.617 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 1.027 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -119.67 136.5 54.38 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -178.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 1.027 ' N ' HD12 ' A' ' 162' ' ' LEU . 51.0 m-85 -121.65 141.45 51.11 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.758 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -103.61 123.64 47.33 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 62.8 t -110.36 119.93 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.004 . . . . 0.0 109.84 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 p -96.41 -43.62 7.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.453 -0.78 . . . . 0.0 108.949 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 165' ' ' VAL . . . -92.12 164.64 28.63 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.477 ' NH2' ' HD2' ' A' ' 120' ' ' ARG . 61.8 mtt180 -114.87 -109.98 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.093 -1.24 . . . . 0.0 110.337 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.41 -28.68 39.02 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -72.72 -44.46 61.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.981 -1.305 . . . . 0.0 109.871 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.463 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 75.6 m -141.47 66.31 23.03 Favored Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 121.56 -0.713 . . . . 0.0 109.674 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 171' ' ' SER . 2.8 Cg_endo -65.74 82.61 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.673 1.582 . . . . 0.0 112.421 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.86 139.66 52.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.28 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.2 p -101.9 167.04 10.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -0.973 . . . . 0.0 109.825 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.758 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 1.4 p -105.19 160.31 15.18 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.857 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -39.07 100.1 0.21 Allowed Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 121.088 -1.007 . . . . 0.0 110.148 -178.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.5 Cg_exo -62.69 159.27 37.85 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 121.818 1.679 . . . . 0.0 114.751 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.487 HG23 HG21 ' A' ' 94' ' ' ILE . 59.0 t -124.22 130.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 80.2 p -120.26 150.19 41.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.757 -1.215 . . . . 0.0 110.933 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.28 161.14 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.225 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -104.33 128.72 52.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 108.601 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.802 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 60.5 t80 -123.59 128.32 49.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 110.382 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -100.83 138.1 38.34 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.34 -0.85 . . . . 0.0 109.044 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.7 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.481 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.865 0 N-CA-C 119.404 2.522 . . . . 0.0 119.404 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.2 mt -129.98 145.74 51.65 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.262 -1.14 . . . . 0.0 109.08 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -80.0 124.99 29.2 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 109.199 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.54 ' HG ' ' HG ' ' A' ' 81' ' ' SER . 53.5 m -78.75 146.9 69.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.783 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_exo -57.6 157.98 21.28 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 120.983 1.122 . . . . 0.0 111.681 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 5' ' ' PRO . 21.2 p -156.2 -144.36 0.13 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 109.646 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.14 19.47 24.01 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 105.249 -3.14 . . . . 0.0 105.249 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 6' ' ' THR . 59.6 t80 -54.91 130.03 39.8 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.83 0.824 . . . . 0.0 110.805 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 10' ' ' SER . 60.6 t0 -158.67 141.3 14.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 41.2 m -106.85 140.35 39.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.608 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 12' ' ' ASP . 60.8 p -152.98 -176.44 5.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' SER . 74.7 m-20 50.01 46.22 24.63 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.735 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -82.19 123.4 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.733 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.2 161.98 17.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.02 -57.61 12.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.813 -1.179 . . . . 0.0 110.049 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -91.1 -0.01 57.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.937 -1.102 . . . . 0.0 110.012 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 38.5 t -151.36 155.73 39.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.837 ' CZ ' ' NE2' ' A' ' 88' ' ' GLN . 20.5 p90 -162.9 145.76 10.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -94.78 151.11 19.52 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.463 -1.398 . . . . 0.0 111.531 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -120.1 134.83 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.417 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 49.9 m-70 -129.23 149.6 50.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.643 -1.286 . . . . 0.0 111.0 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 40.4 p90 -154.1 159.39 41.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -0.78 . . . . 0.0 109.175 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.36 155.66 3.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.044 -1.035 . . . . 0.0 109.941 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.14 135.41 34.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.849 -0.532 . . . . 0.0 109.751 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.79 -179.5 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 120.962 1.108 . . . . 0.0 112.139 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.53 12.46 26.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.722 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -113.2 158.33 38.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.015 . . . . 0.0 109.647 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.9 Cg_endo -56.54 130.3 39.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.777 1.651 . . . . 0.0 112.554 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 39.5 pt -138.92 170.02 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.395 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 p -117.98 0.27 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.715 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.43 -178.18 24.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 51.2 m-85 -130.14 151.29 50.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -1.13 . . . . 0.0 109.516 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.762 HG23 ' HD2' ' A' ' 49' ' ' ARG . 28.4 mm -110.01 129.99 63.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.671 HG21 HG21 ' A' ' 57' ' ' ILE . 1.9 mm -113.55 120.56 63.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.812 -1.18 . . . . 0.0 109.935 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -116.67 131.53 56.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.459 ' CE1' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -121.8 139.11 54.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.285 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -168.62 147.3 4.2 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.093 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . -82.45 167.72 18.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 108.74 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -72.66 -97.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.959 -1.088 . . . . 0.0 110.59 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -73.49 -39.96 64.46 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.363 0.601 . . . . 0.0 111.386 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 1.4 p -101.48 96.87 7.43 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.257 -0.902 . . . . 0.0 110.425 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.49 ' CG2' ' H ' ' A' ' 38' ' ' ALA . 9.0 p -143.43 140.24 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.588 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.15 -87.36 0.71 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -120.04 114.63 33.59 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.215 -1.168 . . . . 0.0 109.651 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.75 95.47 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 120.732 0.955 . . . . 0.0 111.614 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -75.35 155.0 36.97 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.299 -0.876 . . . . 0.0 111.404 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -112.83 113.51 25.62 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.519 ' O ' ' O ' ' A' ' 34' ' ' ILE . 85.6 m-20 -113.7 123.24 49.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.151 -0.968 . . . . 0.0 108.653 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.762 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -108.69 144.47 36.43 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.025 -1.047 . . . . 0.0 108.956 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.662 HG22 HD11 ' A' ' 34' ' ' ILE . 32.1 m -128.13 149.99 72.62 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.037 -1.04 . . . . 0.0 110.203 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.53 160.1 41.34 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.123 1.216 . . . . 0.0 111.724 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.92 -35.97 97.69 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.364 1.376 . . . . 0.0 112.38 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -70.23 -12.02 61.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 110.867 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -101.85 121.21 41.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.015 -1.053 . . . . 0.0 110.113 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -108.75 -0.0 20.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.61 -0.681 . . . . 0.0 109.699 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.417 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 57.3 p -130.34 139.95 50.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.183 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.671 HG21 HG21 ' A' ' 34' ' ' ILE . 6.4 tt -130.75 139.92 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.9 m -106.9 131.49 53.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.248 -0.908 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 62' ' ' LEU . 4.2 mt -112.07 148.08 34.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.806 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.4 p -135.06 179.66 6.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.862 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 57.47 40.72 26.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.368 -0.832 . . . . 0.0 109.539 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 59' ' ' LEU . 44.6 mt -107.31 156.83 18.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.4 -0.813 . . . . 0.0 109.409 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -69.99 120.21 76.46 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 108.618 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.695 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.9 Cg_endo -61.59 129.38 27.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 120.835 1.024 . . . . 0.0 112.966 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 76.17 60.76 3.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.2 m -145.47 152.02 39.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -1.125 . . . . 0.0 110.336 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 3.8 pt-20 -88.78 119.99 29.78 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.494 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 38.4 m-85 -112.72 139.98 47.88 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.057 -1.027 . . . . 0.0 110.617 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.99 121.35 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.0 121.59 67.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.405 ' CB ' HG12 ' A' ' 85' ' ' ILE . 13.0 p -100.88 140.99 34.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.623 ' CD1' HG23 ' A' ' 34' ' ' ILE . 49.7 mm -119.78 120.0 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.92 130.0 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.088 . . . . 0.0 109.612 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -93.4 139.42 30.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.91 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.0 139.45 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.135 -0.978 . . . . 0.0 109.615 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.448 HD21 ' HB2' ' A' ' 28' ' ' PRO . 41.7 t-20 -121.51 37.67 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 108.779 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.27 -100.66 2.58 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -91.63 -0.18 57.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.167 . . . . 0.0 110.325 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.26 141.57 48.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.06 . . . . 0.0 109.513 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.12 138.78 53.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.729 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -83.85 163.33 49.29 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' OG ' ' A' ' 4' ' ' SER . 3.1 Cg_exo -57.54 135.08 67.5 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 121.336 1.358 . . . . 0.0 111.945 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.93 130.93 40.75 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.251 1.301 . . . . 0.0 113.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 5' ' ' PRO . 19.5 tp -107.32 119.99 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.405 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -125.28 134.19 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.993 -1.067 . . . . 0.0 111.146 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.52 164.83 24.87 Favored Glycine 0 N--CA 1.479 1.542 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -114.69 131.11 56.85 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.921 -1.34 . . . . 0.0 110.084 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.837 ' NE2' ' CZ ' ' A' ' 18' ' ' PHE . 1.2 tm0? -123.87 128.32 49.3 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -101.45 131.56 47.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.173 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.43 136.65 42.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.735 HG23 HG22 ' A' ' 13' ' ' ILE . 3.9 t -45.72 166.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.447 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 91' ' ' VAL . 70.0 m -118.48 143.74 46.5 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.05 -39.91 87.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.277 -0.89 . . . . 0.0 108.656 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.514 HG21 HG23 ' A' ' 178' ' ' VAL . 6.7 mt -66.67 138.93 95.67 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.424 -0.797 . . . . 0.0 109.015 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HG2' HD21 ' A' ' 162' ' ' LEU . 3.3 Cg_exo -59.24 159.63 21.99 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 120.332 0.688 . . . . 0.0 110.541 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HE ' ' HB2' ' A' ' 92' ' ' SER . 24.0 mmt180 -120.57 172.5 7.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.826 -1.171 . . . . 0.0 110.959 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.59 39.99 29.59 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.668 HD13 HD23 ' A' ' 162' ' ' LEU . 41.7 tp -72.15 92.9 1.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.765 -1.209 . . . . 0.0 107.849 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.49 170.69 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.654 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -104.68 139.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 101' ' ' ILE . 1.1 pt -107.62 -15.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.258 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.3 134.79 34.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 99.87 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 110.334 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.704 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -81.93 156.8 69.67 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -49.03 -43.93 34.44 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.466 1.444 . . . . 0.0 112.95 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 152' ' ' ILE . 44.2 p -124.36 18.4 8.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.039 ' O ' HD23 ' A' ' 108' ' ' LEU . 37.7 p -153.76 165.77 34.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.862 -1.149 . . . . 0.0 109.898 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -140.69 154.22 46.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.561 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.487 HD23 ' C ' ' A' ' 109' ' ' LEU . 8.5 tt -104.96 119.99 40.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 147' ' ' ALA . 5.2 pt -106.68 145.99 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.987 . . . . 0.0 110.616 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 95.7 p -144.79 149.99 36.43 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.44 0.638 . . . . 0.0 109.778 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.606 ' CE2' ' O ' ' A' ' 145' ' ' SER . 43.8 p90 -149.84 154.87 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -76.0 134.67 71.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.065 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 127.92 26.17 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.771 0.981 . . . . 0.0 111.948 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.22 -178.22 0.19 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.058 1.172 . . . . 0.0 112.613 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 91' ' ' VAL . . . -100.37 10.26 41.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.84 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -71.7 138.73 48.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.01 135.9 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.468 -0.77 . . . . 0.0 109.079 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.691 ' NH1' ' O ' ' A' ' 166' ' ' THR . 80.6 mmt-85 -71.18 -51.45 24.73 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.774 -1.204 . . . . 0.0 107.947 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CE2' HG22 ' A' ' 139' ' ' THR . 6.5 p90 -167.52 174.57 7.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 17.4 m-85 -120.18 139.43 52.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.165 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 37.0 ttp-105 -100.46 129.96 46.48 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.72 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 16.6 mt -124.02 151.96 29.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.783 -1.198 . . . . 0.0 110.859 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 25.4 p -126.13 141.14 52.06 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.093 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.679 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.5 m-85 -84.11 129.54 34.9 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -109.17 131.01 10.3 Favored Glycine 0 N--CA 1.483 1.803 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.247 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.546 ' O ' ' C ' ' A' ' 129' ' ' THR . 61.4 mt-10 -105.78 158.1 16.97 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.84 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -31.37 -64.23 0.15 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.247 -0.908 . . . . 0.0 110.242 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.602 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . -60.02 -40.01 96.44 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . 77.48 -33.12 1.59 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 130' ' ' GLY . 25.9 t-20 -71.1 -19.94 62.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -1.027 . . . . 0.0 108.429 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.437 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -62.33 166.82 6.18 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 3.0 Cg_exo -57.21 87.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 121.652 1.568 . . . . 0.0 112.796 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.418 ' H ' HG13 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -55.61 160.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.279 -0.888 . . . . 0.0 108.933 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.627 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 83.5 mm-40 -111.92 129.87 56.03 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.355 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 123' ' ' ARG . 65.4 tt0 -107.86 133.86 51.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.546 -0.721 . . . . 0.0 111.323 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.72 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 41.5 p90 -141.64 157.52 44.98 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.595 HG22 ' CE2' ' A' ' 121' ' ' TYR . 3.2 p -98.21 167.44 10.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.785 -1.197 . . . . 0.0 111.525 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 124' ' ' ILE . 88.1 t -132.18 118.68 16.3 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -57.6 127.99 27.53 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.507 0.804 . . . . 0.0 112.268 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.26 -4.55 0.83 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 141' ' ' PRO . 89.6 p -89.73 -0.05 57.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -1.233 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -124.88 132.96 53.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.889 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 97.7 p -93.13 0.05 57.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.477 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 15.1 p -139.12 158.12 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.661 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -139.95 169.95 16.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.819 -1.176 . . . . 0.0 109.916 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -118.92 142.59 47.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 109.391 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 31.4 mm -110.21 120.43 61.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.889 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.679 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 69.8 m-20 -123.04 172.94 8.16 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -0.941 . . . . 0.0 110.283 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 61.1 49.82 5.38 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.728 0.775 . . . . 0.0 109.107 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 106' ' ' THR . 5.2 tt -108.98 153.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.75 110.02 55.63 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 110.147 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 2.5 Cg_endo -68.43 170.04 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.156 1.237 . . . . 0.0 112.492 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.98 20.03 75.89 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.84 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . -146.48 150.8 36.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.043 -1.269 . . . . 0.0 109.701 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.643 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.3 t0 -70.02 153.12 43.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.728 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -140.89 159.89 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.611 -1.306 . . . . 0.0 110.55 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 46.9 m -132.94 119.99 20.86 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.815 HD11 HD12 ' A' ' 108' ' ' LEU . 79.6 mt -106.74 120.74 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.348 -1.47 . . . . 0.0 108.668 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 94.2 m -120.02 130.2 54.61 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.944 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.99 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -115.87 138.22 51.37 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.696 0.76 . . . . 0.0 110.83 -178.436 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.99 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.6 m-85 -117.47 157.38 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.56 135.79 54.99 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.795 -1.19 . . . . 0.0 110.176 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.59 HG21 ' CE1' ' A' ' 121' ' ' TYR . 63.2 t -110.06 120.0 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.691 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.8 p -110.67 -42.58 4.02 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -54.06 -153.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.406 ' HG2' ' NE ' ' A' ' 120' ' ' ARG . 72.5 mtm180 -139.49 170.06 16.61 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.289 -1.124 . . . . 0.0 108.801 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -47.36 -32.02 6.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -72.36 -39.95 67.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -1.114 . . . . 0.0 109.136 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.9 m -133.15 70.0 78.08 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 121.777 -0.577 . . . . 0.0 109.688 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.06 98.57 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.517 1.478 . . . . 0.0 112.279 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -114.2 148.36 37.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.602 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.5 p -133.77 146.3 50.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.653 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 81.9 p -80.64 169.15 18.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.505 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -56.29 121.3 41.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.0 Cg_exo -61.38 154.02 61.74 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 120.929 1.086 . . . . 0.0 114.162 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.514 HG23 HG21 ' A' ' 94' ' ' ILE . 2.1 t -117.64 129.97 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 85.0 p -121.13 156.64 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.439 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.655 HG21 ' O ' ' A' ' 98' ' ' LEU . 47.0 pt -139.57 165.76 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.343 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -112.69 129.95 56.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.97 . . . . 0.0 108.963 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CE1' HG22 ' A' ' 184' ' ' THR . 54.7 t80 -124.98 118.52 26.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.026 . . . . 0.0 109.974 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.64 140.02 29.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.552 HG22 ' CE1' ' A' ' 182' ' ' TYR . 4.8 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.838 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.434 ' O ' ' CD ' ' A' ' 82' ' ' PRO . 86.0 mt -120.17 131.13 54.89 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.226 -1.161 . . . . 0.0 109.344 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -79.97 130.11 35.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -84.83 149.79 54.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.02 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.75 146.19 86.7 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.173 1.249 . . . . 0.0 112.105 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' N ' ' A' ' 8' ' ' PHE . 17.8 p -143.54 -150.65 0.32 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.044 -1.035 . . . . 0.0 109.601 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.96 19.18 49.84 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 105.0 -3.24 . . . . 0.0 105.0 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' N ' ' C ' ' A' ' 6' ' ' THR . 63.6 t80 -54.51 134.93 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.478 -0.861 . . . . 0.0 110.863 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.9 t0 -157.97 147.57 19.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.7 m -116.81 135.23 53.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 12' ' ' ASP . 77.3 p -152.05 -171.02 3.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 11' ' ' SER . 81.5 m-20 50.0 41.62 23.45 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -78.39 130.84 35.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.051 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.56 162.73 24.27 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.749 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.81 -60.08 4.42 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.026 -1.046 . . . . 0.0 110.279 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -91.49 -0.0 57.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.896 -1.127 . . . . 0.0 109.993 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 98.4 p -148.92 155.81 41.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CE1' HG22 ' A' ' 20' ' ' VAL . 18.7 p90 -165.04 144.67 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 108.687 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -96.89 150.62 20.54 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.361 -1.462 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.628 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -120.01 132.4 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 63.4 m-70 -125.43 143.54 50.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.821 -1.175 . . . . 0.0 110.657 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 44.5 p90 -147.79 152.98 38.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -0.767 . . . . 0.0 109.211 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.01 142.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.108 -0.995 . . . . 0.0 110.492 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.03 137.06 79.28 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.838 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.58 -164.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.991 1.127 . . . . 0.0 112.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -112.38 17.86 19.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.939 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -119.73 150.21 49.9 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.909 -1.119 . . . . 0.0 109.951 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.48 127.1 23.42 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.485 1.456 . . . . 0.0 112.604 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 43.0 pt -133.4 170.02 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.2 p -106.08 -7.06 18.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 0.0 109.213 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.12 176.38 23.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 44.5 m-85 -119.99 145.54 46.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -1.199 . . . . 0.0 109.132 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.656 HG23 ' HG3' ' A' ' 49' ' ' ARG . 38.1 mm -102.04 128.87 54.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 120.953 -1.092 . . . . 0.0 108.304 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.8 mm -110.06 118.94 58.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.139 -0.975 . . . . 0.0 110.101 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.596 ' NH2' ' HE ' ' A' ' 49' ' ' ARG . 33.7 mmt180 -108.33 127.88 54.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.474 ' ND1' ' C ' ' A' ' 36' ' ' HIS . 2.2 t-80 -119.98 135.71 54.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.856 -1.152 . . . . 0.0 110.715 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.449 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 29.4 p-80 -167.94 149.96 5.49 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.618 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.596 ' HB3' ' CB ' ' A' ' 41' ' ' SER . . . -86.61 168.48 13.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.059 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.582 ' OE2' ' OE1' ' A' ' 67' ' ' GLU . 14.6 mt-10 -59.95 -48.28 82.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 110.444 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -136.04 36.96 2.8 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.335 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.596 ' CB ' ' HB3' ' A' ' 38' ' ' ALA . 14.8 p -74.58 150.09 39.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.748 -1.22 . . . . 0.0 109.381 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.35 -39.95 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.867 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.35 139.92 25.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.96 151.08 96.27 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.33 -1.1 . . . . 0.0 109.463 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.19 119.13 6.02 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.352 1.368 . . . . 0.0 112.113 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -85.28 153.32 22.67 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.413 ' OE1' ' NH1' ' A' ' 35' ' ' ARG . 21.8 mt-30 -105.64 116.51 32.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -117.87 127.53 53.95 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.656 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -121.45 148.55 44.27 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 109.693 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 34' ' ' ILE . 33.0 m -133.14 138.46 31.7 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.135 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 166.12 11.58 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 120.926 1.084 . . . . 0.0 111.709 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.45 -36.28 94.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.466 1.444 . . . . 0.0 112.428 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -70.37 -11.05 60.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 110.777 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -102.79 120.02 39.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.088 -1.007 . . . . 0.0 110.04 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -109.71 -4.9 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.515 -0.741 . . . . 0.0 109.465 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.461 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 59.7 p -130.16 138.76 50.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.592 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 9.2 tt -130.0 130.01 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.36 -0.838 . . . . 0.0 108.746 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.4 m -100.24 133.31 44.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.14 145.5 40.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -132.63 -178.73 5.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.726 -0.609 . . . . 0.0 109.85 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 57.39 40.4 27.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.7 155.15 19.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.49 -0.756 . . . . 0.0 109.087 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.649 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 15.9 m120 -69.99 120.63 79.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.976 -1.078 . . . . 0.0 108.561 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.749 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -61.5 125.13 16.07 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 120.921 1.081 . . . . 0.0 112.889 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 83.4 58.68 2.25 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -146.1 154.01 41.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.957 -1.32 . . . . 0.0 110.96 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.582 ' OE1' ' OE2' ' A' ' 39' ' ' GLU . 98.0 mt-10 -89.96 118.72 29.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.649 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 43.2 m-85 -110.1 140.02 44.61 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 110.119 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.0 t -102.84 121.42 53.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.92 122.33 69.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 108.961 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -96.34 134.56 39.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 110.703 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 34' ' ' ILE . 50.3 mm -117.06 124.47 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.564 HG22 ' N ' ' A' ' 74' ' ' ALA . 60.3 mt -130.04 162.06 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -121.4 136.57 54.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.655 -0.653 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' OG1' ' A' ' 30' ' ' THR . 15.6 m -131.12 140.19 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 109.562 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -124.58 41.88 3.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.012 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.01 -103.68 2.53 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.23 -0.04 44.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -104.56 155.77 18.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -128.08 153.17 47.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -108.86 171.84 4.16 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.83 . . . . 0.0 109.088 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -61.85 126.35 18.7 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.21 1.273 . . . . 0.0 111.634 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.58 126.34 19.63 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.066 1.177 . . . . 0.0 113.472 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.02 HD22 ' O ' ' A' ' 5' ' ' PRO . 26.8 tp -106.15 120.04 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mt -125.01 139.3 51.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.998 -1.064 . . . . 0.0 110.36 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.21 152.49 21.47 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -109.75 129.93 55.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.429 -1.042 . . . . 0.0 109.54 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.54 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -123.55 129.79 51.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 88' ' ' GLN . . . -100.01 129.63 46.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.131 -0.981 . . . . 0.0 109.939 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.36 134.99 42.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.8 t -41.71 155.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.468 0.651 . . . . 0.0 109.975 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 94' ' ' ILE . 28.1 p -105.16 23.72 13.19 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.224 1.011 . . . . 0.0 109.155 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' HG13 ' A' ' 117' ' ' VAL . 96.1 m-20 58.62 14.61 3.18 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 94' ' ' ILE . 20.3 mt -104.46 138.44 19.52 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.724 -1.235 . . . . 0.0 109.774 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.58 178.2 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 N-CA-C 109.653 -0.941 . . . . 0.0 109.653 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -142.09 172.02 13.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.463 -1.398 . . . . 0.0 110.631 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.0 40.16 19.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.897 -0.502 . . . . 0.0 110.781 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.635 HD13 HD23 ' A' ' 162' ' ' LEU . 42.3 tp -72.7 93.29 1.63 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -147.92 169.97 18.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 51.2 t -96.98 133.83 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 110.711 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.414 HG12 ' N ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -98.19 -28.74 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.987 0.899 . . . . 0.0 108.664 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' N ' HG12 ' A' ' 101' ' ' ILE . . . -135.28 134.93 40.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.471 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -121.48 126.57 49.58 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.854 -1.154 . . . . 0.0 110.812 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -112.39 157.59 39.66 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.6 -40.05 46.2 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.602 1.534 . . . . 0.0 113.27 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -120.69 9.97 10.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.891 -1.131 . . . . 0.0 110.546 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.042 ' O ' HD23 ' A' ' 108' ' ' LEU . 80.1 p -154.01 162.27 41.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.658 -1.276 . . . . 0.0 110.77 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -144.61 152.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.474 -0.766 . . . . 0.0 109.01 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.531 HD23 ' C ' ' A' ' 109' ' ' LEU . 5.4 tt -102.81 120.19 40.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.224 -0.922 . . . . 0.0 108.548 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 147' ' ' ALA . 6.4 pt -102.81 146.95 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 110.707 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.3 p -139.96 149.23 43.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -154.06 160.02 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.544 -0.723 . . . . 0.0 109.614 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -86.22 143.96 37.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.13 137.49 75.73 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.054 1.17 . . . . 0.0 112.283 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.03 -166.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.016 1.144 . . . . 0.0 112.294 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.45 -1.68 24.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 109.606 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.427 HG13 ' OD1' ' A' ' 93' ' ' ASP . 34.6 m -130.05 164.19 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 109.707 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.7 m -68.76 150.01 48.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.363 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 166' ' ' THR . 19.9 t -134.56 141.54 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.822 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.735 HH21 ' HE ' ' A' ' 168' ' ' ARG . 61.3 mmt-85 -71.12 -51.03 27.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.731 ' CE2' HG22 ' A' ' 139' ' ' THR . 7.9 p90 -166.48 179.29 5.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -120.02 139.94 51.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.717 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.679 ' NE ' ' OE2' ' A' ' 137' ' ' GLU . 36.3 ttm180 -106.12 124.7 49.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 30.5 mt -119.98 146.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.008 -1.058 . . . . 0.0 110.65 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -118.52 149.47 41.25 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.005 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.627 ' HB2' ' H ' ' A' ' 136' ' ' GLN . 5.6 m-85 -93.12 136.37 33.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.55 118.41 5.5 Favored Glycine 0 N--CA 1.481 1.644 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.126 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 129' ' ' THR . 45.4 mt-10 -109.4 144.66 37.31 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.411 -1.052 . . . . 0.0 108.786 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.599 HG23 ' N ' ' A' ' 157' ' ' ASP . 0.8 OUTLIER -33.08 157.95 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.139 -0.975 . . . . 0.0 110.118 179.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' SER . . . 69.23 90.65 0.07 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . -45.05 -24.09 0.75 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 130' ' ' GLY . 42.3 p-10 -76.66 -10.01 59.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.458 -1.025 . . . . 0.0 109.199 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 130' ' ' GLY . 68.0 m -73.08 139.09 79.19 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.803 . . . . 0.0 109.425 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.37 146.08 91.25 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.166 1.244 . . . . 0.0 112.82 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.35 150.75 6.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.446 -0.784 . . . . 0.0 109.252 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.627 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 43.2 mt-30 -102.45 123.03 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.951 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.679 ' OE2' ' NE ' ' A' ' 123' ' ' ARG . 80.4 tt0 -100.0 129.97 46.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 111.558 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 45.3 p90 -134.97 143.82 47.07 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.731 HG22 ' CE2' ' A' ' 121' ' ' TYR . 2.2 p -84.7 168.26 15.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.982 -1.074 . . . . 0.0 111.156 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 124' ' ' ILE . 79.3 t -142.78 128.74 10.44 Favored Pre-proline 0 N--CA 1.485 1.285 0 O-C-N 121.751 -0.593 . . . . 0.0 109.416 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.99 150.65 62.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 120.621 0.881 . . . . 0.0 112.287 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.14 -8.46 69.77 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -89.98 -0.04 57.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -1.213 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -106.96 125.09 50.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.943 -1.098 . . . . 0.0 110.282 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -93.26 -5.39 49.93 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.6 p -142.93 159.8 41.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -140.84 167.63 21.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.728 -1.233 . . . . 0.0 109.883 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -117.95 136.69 53.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.599 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 32.8 mm -109.46 123.21 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 108.625 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.565 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 68.0 m-20 -124.01 170.02 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.133 -0.979 . . . . 0.0 109.761 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 39.8 m-20 71.69 49.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.361 0.6 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.923 HG23 ' CE2' ' A' ' 158' ' ' TYR . 79.4 mt -115.58 130.72 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 0.0 109.393 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 184' ' ' THR . 22.4 mttm -73.95 118.86 72.82 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.056 -1.028 . . . . 0.0 109.795 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.0 167.28 16.31 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.31 1.34 . . . . 0.0 113.288 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 184' ' ' THR . . . 60.0 28.16 65.81 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 184' ' ' THR . . . -140.0 139.27 36.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.932 -1.334 . . . . 0.0 110.492 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.599 ' N ' HG23 ' A' ' 129' ' ' THR . 44.8 t0 -59.95 140.23 56.86 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.923 ' CE2' HG23 ' A' ' 152' ' ' ILE . 0.7 OUTLIER -134.74 159.16 42.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.315 -1.491 . . . . 0.0 110.058 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.624 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 66.9 m -130.22 119.99 23.78 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.26 123.63 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.194 -1.566 . . . . 0.0 108.273 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.525 HG22 ' CE1' ' A' ' 163' ' ' TYR . 86.6 m -127.61 140.02 52.37 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.172 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 1.077 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -122.37 137.77 54.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.683 0.754 . . . . 0.0 110.394 -178.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 1.077 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.4 m-85 -122.94 153.43 39.73 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.18 55.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.839 -1.163 . . . . 0.0 109.47 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.404 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 63.2 t -111.61 120.04 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.851 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 119' ' ' VAL . 41.1 p -104.69 -50.07 3.38 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.728 0.775 . . . . 0.0 109.225 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -57.75 -160.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.735 ' HE ' HH21 ' A' ' 120' ' ' ARG . 87.5 mtt180 -137.13 178.55 7.0 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.429 -1.042 . . . . 0.0 108.99 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -49.01 -29.61 8.64 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.46 -39.99 70.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.217 -1.167 . . . . 0.0 108.87 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 53.2 m -136.0 69.21 64.15 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.02 87.66 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.684 1.589 . . . . 0.0 112.587 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.26 138.67 44.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.9 p -129.49 150.63 50.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.315 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 46.1 p -79.4 169.98 17.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 119.48 42.0 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.527 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.3 Cg_exo -61.14 148.12 93.76 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 120.779 0.986 . . . . 0.0 114.074 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.9 120.12 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 86.2 p -112.56 153.43 27.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 111.461 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 98' ' ' LEU . 42.2 pt -134.73 160.03 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -110.62 133.13 53.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 108.621 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.609 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 60.7 t80 -139.14 126.57 21.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.018 -1.051 . . . . 0.0 110.154 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.609 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 66.2 mttm -84.71 147.59 26.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.376 -0.828 . . . . 0.0 109.013 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 155' ' ' GLY . 1.1 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.395 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.388 2.515 . . . . 0.0 119.388 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.9 mt -119.99 130.6 54.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.236 -1.155 . . . . 0.0 109.565 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.79 130.21 34.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.419 -0.8 . . . . 0.0 108.939 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.0 p -69.96 146.66 95.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.03 . . . . 0.0 109.735 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.862 ' O ' HD22 ' A' ' 84' ' ' LEU . 2.6 Cg_endo -60.75 116.31 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.179 1.253 . . . . 0.0 111.877 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -120.0 -155.75 0.63 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.923 -1.111 . . . . 0.0 109.66 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.66 20.02 75.35 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.512 ' HB2' HD21 ' A' ' 84' ' ' LEU . 64.4 t80 -53.07 133.18 38.8 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.755 0.788 . . . . 0.0 110.695 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 10' ' ' SER . 57.1 t0 -148.52 145.77 28.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 88' ' ' GLN . 47.6 t -129.11 145.2 51.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.979 -1.076 . . . . 0.0 110.295 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 12' ' ' ASP . 9.9 p -172.75 -162.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 11' ' ' SER . 72.6 m-20 49.39 40.08 17.84 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.514 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -80.12 132.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.938 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.683 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 164.09 20.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.51 -59.09 5.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.706 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -92.52 -0.51 57.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.969 -1.082 . . . . 0.0 109.817 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.683 ' O ' ' N ' ' A' ' 14' ' ' THR . 90.0 p -151.4 156.49 40.8 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.581 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 32.4 p90 -161.89 148.33 13.77 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -102.36 151.33 22.39 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.112 -1.617 . . . . 0.0 111.956 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.483 HG22 ' HE1' ' A' ' 18' ' ' PHE . 1.6 t -120.54 138.66 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.474 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 77.1 m-70 -127.49 141.22 51.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.844 -1.16 . . . . 0.0 110.838 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.8 p90 -149.97 156.24 41.36 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.91 159.39 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.03 -1.044 . . . . 0.0 109.842 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -88.69 140.19 29.65 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.69 179.28 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.921 1.081 . . . . 0.0 112.453 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.96 10.01 42.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.899 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -116.61 150.66 46.0 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.075 -1.015 . . . . 0.0 109.854 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.65 127.97 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.555 1.504 . . . . 0.0 112.684 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.737 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.2 pt -131.66 170.43 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.5 p -105.61 -3.29 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 109.855 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.34 174.29 14.21 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.737 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 13.0 m-85 -121.89 149.93 42.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.246 -1.15 . . . . 0.0 109.239 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.833 HG23 ' HG3' ' A' ' 49' ' ' ARG . 6.0 mt -115.15 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 120.984 -1.072 . . . . 0.0 108.579 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.8 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.3 mm -107.4 119.61 57.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.181 -0.949 . . . . 0.0 110.783 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -110.0 129.61 55.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.697 ' CE1' ' OD2' ' A' ' 48' ' ' ASP . 40.7 p-80 -134.13 148.61 50.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.51 -1.369 . . . . 0.0 111.339 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -162.85 151.14 14.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.6 165.26 20.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 109.457 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -60.0 -36.73 77.82 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.967 0.889 . . . . 0.0 109.397 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -88.55 19.38 3.94 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.072 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.5 p -74.51 169.74 17.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.351 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.634 ' C ' ' H ' ' A' ' 44' ' ' ARG . 15.7 m -106.47 -177.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.59 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.66 14.6 0.03 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.634 ' H ' ' C ' ' A' ' 42' ' ' VAL . 20.3 mtt180 -122.05 71.19 31.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.913 -1.345 . . . . 0.0 110.096 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.01 150.32 84.74 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.312 1.341 . . . . 0.0 112.222 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.508 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 84.3 mtt-85 -74.51 157.65 35.15 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.19 -0.944 . . . . 0.0 109.873 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 92.2 mm-40 -120.52 129.21 53.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.528 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.697 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 99.3 m-20 -141.29 117.56 10.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.833 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -109.43 142.06 40.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.891 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.583 HG11 ' HB ' ' A' ' 57' ' ' ILE . 35.4 m -126.3 137.03 29.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.12 160.18 31.42 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.772 0.981 . . . . 0.0 111.624 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.96 -33.8 96.1 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.502 1.468 . . . . 0.0 111.991 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.3 p -70.04 -10.35 58.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 110.354 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -103.88 120.59 41.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -106.92 -7.46 17.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.474 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 53.2 p -129.98 138.52 50.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 109.231 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.583 ' HB ' HG11 ' A' ' 50' ' ' VAL . 5.8 tt -130.01 132.83 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.5 m -99.73 120.0 39.03 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.491 HD21 ' OD2' ' A' ' 48' ' ' ASP . 7.6 mt -93.19 143.53 26.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.263 -0.898 . . . . 0.0 109.81 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.5 p -130.1 178.81 6.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.797 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.71 43.04 19.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.79 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 59' ' ' LEU . 43.3 mt -109.99 153.63 24.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.599 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 6.5 m120 -69.98 126.72 92.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.998 . . . . 0.0 108.655 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.718 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.5 Cg_endo -64.76 132.16 31.75 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 120.709 0.939 . . . . 0.0 112.368 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.87 62.14 3.08 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -148.48 152.99 37.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.322 -1.105 . . . . 0.0 110.525 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' A' ' 66' ' ' THR . 98.7 mt-10 -91.45 120.0 31.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.599 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 30.8 m-85 -108.82 148.16 30.99 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 110.57 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -110.04 125.77 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.27 129.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.915 -1.115 . . . . 0.0 110.335 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' HG12 ' A' ' 85' ' ' ILE . 78.6 p -115.22 139.99 49.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 110.728 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 34' ' ' ILE . 6.6 mm -109.18 129.99 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 38.3 mm -119.9 123.15 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.047 . . . . 0.0 108.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -93.5 132.69 37.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.972 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 m -129.9 140.02 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -121.58 43.4 2.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.97 -97.09 1.88 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.646 ' H ' ' CD ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -102.17 0.01 33.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -1.195 . . . . 0.0 109.299 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -112.4 151.26 30.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -124.64 153.12 42.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 109.493 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -106.25 170.16 6.1 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 109.239 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.5 Cg_exo -59.74 125.39 17.65 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.223 1.282 . . . . 0.0 112.007 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 2.9 Cg_endo -60.76 143.32 99.37 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.223 1.282 . . . . 0.0 113.383 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 5' ' ' PRO . 24.9 tp -119.76 128.09 53.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.412 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -127.71 140.03 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 120.841 -1.162 . . . . 0.0 110.926 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.11 161.67 27.2 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -115.9 136.76 52.74 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.092 -1.24 . . . . 0.0 110.284 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.591 ' CD ' ' CB ' ' A' ' 10' ' ' SER . 98.2 mm-40 -130.2 139.03 50.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -110.77 137.47 48.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -79.68 140.11 37.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.1 t -55.33 170.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.504 0.669 . . . . 0.0 111.28 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.8 t -97.69 138.5 34.99 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.525 -0.734 . . . . 0.0 110.007 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD2' ' CB ' ' A' ' 64' ' ' PRO . 95.9 m-20 -69.95 -40.08 75.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.361 -0.837 . . . . 0.0 112.244 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.539 HG23 ' HD2' ' A' ' 95' ' ' PRO . 2.1 mt -72.8 140.23 80.95 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.635 -1.29 . . . . 0.0 110.71 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.7 Cg_endo -63.68 81.31 0.14 Allowed 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 120.798 0.998 . . . . 0.0 110.668 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.498 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 28.5 ttp-105 -62.76 165.78 6.22 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.501 -0.749 . . . . 0.0 111.118 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.1 m-20 64.96 42.28 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.062 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.523 ' O ' HG21 ' A' ' 180' ' ' ILE . 54.9 tp -79.86 103.6 9.87 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -150.06 170.03 19.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.939 -1.101 . . . . 0.0 110.255 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 54.0 t -103.85 139.14 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.369 -0.832 . . . . 0.0 109.643 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.67 -10.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -138.62 130.84 28.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 p -114.81 98.5 6.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.656 ' OG1' ' N ' ' A' ' 107' ' ' SER . 1.2 p -88.41 151.12 48.01 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.321 -0.862 . . . . 0.0 109.089 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.37 -30.7 53.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.348 1.365 . . . . 0.0 113.001 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.441 ' C ' HG22 ' A' ' 152' ' ' ILE . 27.8 p -129.02 12.89 6.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.906 -1.121 . . . . 0.0 110.718 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.944 ' O ' HD23 ' A' ' 108' ' ' LEU . 14.6 p -159.85 161.93 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.82 -1.175 . . . . 0.0 110.027 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.944 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -135.67 153.93 51.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.57 HD23 ' C ' ' A' ' 109' ' ' LEU . 5.4 tt -102.8 119.96 39.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 108.769 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 147' ' ' ALA . 2.6 pt -107.37 135.85 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 146' ' ' THR . 52.9 m -136.35 140.03 42.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -144.04 157.14 44.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.389 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.03 127.34 92.45 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.477 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.76 125.89 16.34 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 120.684 0.923 . . . . 0.0 111.654 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.03 176.39 0.74 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 120.831 1.021 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -108.39 24.92 12.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.651 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.0 160.1 41.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.1 m -67.63 130.02 41.73 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.0 109.029 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 166' ' ' THR . 57.5 t -126.31 132.08 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.609 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -71.71 -53.5 13.31 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.585 ' CE2' HG22 ' A' ' 139' ' ' THR . 8.1 p90 -167.27 170.29 11.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.564 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 5.5 m-85 -115.98 137.64 51.93 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 53.8 ttp180 -100.41 123.02 44.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.747 -1.221 . . . . 0.0 108.219 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.597 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 69.0 mt -110.26 139.82 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.005 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.794 HG22 ' HG2' ' A' ' 137' ' ' GLU . 19.5 p -115.59 137.22 52.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.375 -0.828 . . . . 0.0 110.796 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.715 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.9 m-85 -84.11 124.17 30.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.25 126.6 8.3 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.724 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.617 ' O ' ' C ' ' A' ' 129' ' ' THR . 22.2 mt-10 -106.85 161.17 14.93 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.711 -0.876 . . . . 0.0 108.723 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.633 HG22 ' HB1' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -17.26 -64.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.949 -0.47 . . . . 0.0 110.831 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.564 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . 138.12 13.96 0.76 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.799 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -61.95 -72.86 0.58 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -100.52 0.01 38.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.366 -1.079 . . . . 0.0 108.269 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.657 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 1.1 t 66.78 40.17 0.24 Allowed Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.708 -0.62 . . . . 0.0 111.035 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 133' ' ' SER . 2.4 Cg_endo -59.25 86.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 120.742 0.961 . . . . 0.0 111.573 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -93.24 138.03 21.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.871 -1.143 . . . . 0.0 110.314 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.647 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 96.9 mt-30 -119.82 104.36 10.14 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.121 -1.031 . . . . 0.0 108.554 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.794 ' HG2' HG22 ' A' ' 125' ' ' THR . 98.9 mt-10 -86.89 140.79 29.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 0.0 112.084 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 39.8 p90 -143.9 150.01 37.76 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.585 HG22 ' CE2' ' A' ' 121' ' ' TYR . 16.7 p -89.56 168.72 11.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.933 -1.105 . . . . 0.0 111.459 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 19.6 t -134.14 126.81 18.75 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.747 -0.595 . . . . 0.0 109.649 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.64 155.7 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.291 0.782 . . . . 0.0 111.809 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.91 -0.31 81.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.7 p -99.96 2.29 43.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.059 -1.259 . . . . 0.0 110.422 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -112.48 128.57 56.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.821 -1.175 . . . . 0.0 110.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.2 m -94.74 -6.43 43.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 111' ' ' SER . 48.0 p -139.59 157.04 46.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -137.48 160.02 40.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.629 -1.294 . . . . 0.0 110.653 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.0 m -106.11 142.39 35.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.608 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 34.8 mm -114.47 120.07 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.715 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 53.5 m-20 -122.05 173.81 7.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.236 -0.915 . . . . 0.0 109.798 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.3 46.26 2.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.037 . . . . 0.0 109.478 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 158' ' ' TYR . 2.7 tt -110.43 153.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -98.29 109.98 54.49 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.966 -1.084 . . . . 0.0 110.488 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.46 154.43 74.34 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.075 1.183 . . . . 0.0 112.546 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.02 15.46 78.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' A' ' 129' ' ' THR . . . -137.91 149.06 45.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 49.5 t0 -69.92 150.81 46.34 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.5 m-85 -139.34 164.11 30.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.895 -1.128 . . . . 0.0 110.929 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.9 m -136.48 115.4 12.26 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.75 121.98 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.363 -1.46 . . . . 0.0 108.612 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.428 HG23 ' HB3' ' A' ' 179' ' ' SER . 62.8 m -132.34 148.52 52.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.076 -1.015 . . . . 0.0 110.104 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 2.3 pp -140.65 152.51 45.45 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.973 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 2.5 m-85 -120.07 139.24 52.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -100.16 124.37 45.49 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 70.5 t -106.32 120.73 57.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 119' ' ' VAL . 19.0 p -121.85 136.58 54.94 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -94.35 126.41 8.67 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.499 -1.334 . . . . 0.0 109.981 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.636 ' H ' ' HA ' ' A' ' 172' ' ' PRO . 78.1 mtt180 -103.98 7.9 36.65 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.4 -1.059 . . . . 0.0 109.255 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 122.5 -124.49 5.72 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.7 -15.23 61.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -1.126 . . . . 0.0 109.354 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -128.05 88.51 52.77 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.543 -0.723 . . . . 0.0 109.156 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.636 ' HA ' ' H ' ' A' ' 168' ' ' ARG . 3.2 Cg_exo -62.24 -174.94 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.09 1.193 . . . . 0.0 111.954 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -156.26 159.99 39.38 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.275 -0.89 . . . . 0.0 110.607 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.3 p -134.74 140.12 45.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 0.0 109.013 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 85.5 p -74.31 162.15 29.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.199 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 94' ' ' ILE . 7.0 mttm -62.12 134.31 94.45 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.059 -1.026 . . . . 0.0 108.716 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 134.42 61.14 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.245 1.297 . . . . 0.0 113.424 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.83 129.99 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.428 ' HB3' HG23 ' A' ' 161' ' ' THR . 92.4 p -128.09 159.33 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.052 -1.03 . . . . 0.0 112.201 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.523 HG21 ' O ' ' A' ' 98' ' ' LEU . 44.4 pt -138.8 160.06 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -107.41 130.15 54.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.092 . . . . 0.0 109.195 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.503 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 65.7 t80 -122.5 129.94 52.53 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.95 139.23 35.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 3.2 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.184 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.83 0 N-CA-C 119.367 2.507 . . . . 0.0 119.367 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.7 mt -117.99 136.75 53.32 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.276 -1.132 . . . . 0.0 108.933 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -83.39 109.99 17.77 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 109.073 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.9 p -70.02 150.05 96.28 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.256 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.592 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.77 149.7 67.16 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.077 1.185 . . . . 0.0 111.669 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -152.68 -158.16 0.87 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.96 21.54 76.83 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 105.93 -2.868 . . . . 0.0 105.93 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -50.41 130.07 22.92 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.712 0.768 . . . . 0.0 110.359 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 10' ' ' SER . 52.1 t0 -155.59 149.64 25.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.547 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.8 m -121.97 140.97 51.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.964 -1.085 . . . . 0.0 110.133 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 12' ' ' ASP . 78.0 p -157.2 -173.91 4.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.094 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.05 42.55 24.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.783 HG22 HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -78.01 124.83 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.935 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.692 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.89 162.45 17.32 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.552 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.756 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.34 -59.33 5.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.867 -1.146 . . . . 0.0 109.824 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 -87.15 -10.79 51.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.859 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 14' ' ' THR . 48.8 m -139.96 155.26 47.21 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.636 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.775 ' CE2' ' NE2' ' A' ' 88' ' ' GLN . 15.1 p90 -161.46 142.01 10.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 108.779 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -91.16 154.02 19.63 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.443 -1.411 . . . . 0.0 111.777 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.688 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.8 t -124.35 139.31 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -129.68 141.25 50.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.819 -1.175 . . . . 0.0 110.93 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.4 p90 -148.44 160.02 43.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.02 156.11 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 120.81 -1.181 . . . . 0.0 110.346 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.21 124.4 45.2 Favored Pre-proline 0 C--N 1.299 -1.629 0 O-C-N 121.874 -0.516 . . . . 0.0 109.997 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.26 163.66 16.73 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.973 1.116 . . . . 0.0 112.244 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -92.06 -1.41 57.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -79.83 151.76 74.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.14 120.59 8.59 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.344 1.362 . . . . 0.0 112.332 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 27' ' ' ALA . 25.5 pt -135.74 164.4 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.91 -7.36 15.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.028 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.87 175.37 19.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 18.4 m-85 -120.0 139.99 51.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.24 . . . . 0.0 109.163 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.738 HG23 ' HG3' ' A' ' 49' ' ' ARG . 34.9 mm -91.17 120.09 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 57' ' ' ILE . 3.7 mm -97.15 107.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 110.12 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 68.3 mtm180 -105.46 120.0 40.5 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.697 -1.252 . . . . 0.0 107.673 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CD2' HD22 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -120.04 136.57 54.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.974 -1.079 . . . . 0.0 110.334 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -160.0 160.24 33.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.661 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -88.71 -171.71 3.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -50.98 -87.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.086 -1.009 . . . . 0.0 109.104 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -141.17 27.6 1.93 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.463 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.1 p -74.37 -13.51 60.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.668 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.934 HG22 ' H ' ' A' ' 44' ' ' ARG . 11.7 p -137.57 139.98 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.99 -3.34 76.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.934 ' H ' HG22 ' A' ' 42' ' ' VAL . 3.2 mmm180 -120.1 96.91 49.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.316 -1.108 . . . . 0.0 109.701 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.04 137.88 64.48 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 120.869 1.046 . . . . 0.0 111.881 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -76.15 134.79 39.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.251 -0.905 . . . . 0.0 109.895 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -102.09 120.5 40.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.878 . . . . 0.0 109.293 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -126.0 140.19 52.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.738 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -130.05 146.94 51.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.903 -1.123 . . . . 0.0 109.606 -178.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 34' ' ' ILE . 29.0 m -139.5 145.79 45.33 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.94 162.56 25.25 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.032 1.155 . . . . 0.0 111.925 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.28 -34.09 97.95 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.576 1.518 . . . . 0.0 112.314 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.5 t -69.99 -19.73 63.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.589 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -96.06 115.19 27.05 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -107.62 0.48 22.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 p -129.98 134.39 47.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.403 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 34' ' ' ILE . 7.3 tt -130.26 136.11 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 109.723 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.2 m -99.97 122.23 42.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.309 -0.869 . . . . 0.0 109.649 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.829 ' HB3' HD11 ' A' ' 62' ' ' LEU . 12.6 mt -95.48 145.47 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.761 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -132.97 -178.66 5.06 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.434 0.635 . . . . 0.0 110.277 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 51.54 49.66 20.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.355 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.829 HD11 ' HB3' ' A' ' 59' ' ' LEU . 42.4 mt -116.5 153.68 31.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 109.286 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -70.0 123.32 88.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 108.598 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.756 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.6 Cg_endo -62.49 133.67 44.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.876 1.051 . . . . 0.0 112.717 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.66 62.26 2.9 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 m -147.42 148.92 31.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -1.12 . . . . 0.0 110.982 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.455 ' OE2' ' OE1' ' A' ' 87' ' ' GLN . 86.5 tt0 -90.13 119.0 30.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.661 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 37.9 m-85 -109.92 152.75 25.43 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.194 -0.941 . . . . 0.0 110.814 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.02 121.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.51 129.98 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.758 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 85' ' ' ILE . 93.8 p -116.84 137.88 51.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 0.0 110.741 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -112.77 121.85 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.3 mm -112.12 129.99 66.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.854 -1.154 . . . . 0.0 109.252 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -95.61 123.12 39.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.987 . . . . 0.0 109.026 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 75' ' ' VAL . 33.3 m -124.39 133.08 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.56 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -115.84 35.81 4.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.3 -103.06 2.49 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -90.33 0.03 57.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -1.141 . . . . 0.0 110.341 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.52 141.37 48.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.907 -1.121 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.98 140.5 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.814 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -94.05 167.87 12.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.837 . . . . 0.0 109.234 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -58.68 129.99 34.95 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.468 1.445 . . . . 0.0 112.085 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.0 151.9 68.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.396 1.397 . . . . 0.0 113.698 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 5' ' ' PRO . 28.2 tp -125.41 111.91 15.68 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.436 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.7 mt -120.41 129.92 75.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 120.868 -1.145 . . . . 0.0 110.91 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.68 175.98 19.42 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.455 ' OE1' ' OE2' ' A' ' 67' ' ' GLU . 92.6 mt-30 -125.94 137.25 53.69 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.483 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.775 ' NE2' ' CE2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -130.92 130.68 43.79 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.468 ' C ' ' OE1' ' A' ' 88' ' ' GLN . . . -99.04 131.6 44.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.918 -1.114 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.41 135.8 42.39 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.783 HG23 HG22 ' A' ' 13' ' ' ILE . 18.6 t -43.8 171.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.63 ' N ' HG12 ' A' ' 91' ' ' VAL . 58.2 m -113.59 149.67 34.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.56 -0.713 . . . . 0.0 109.377 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.706 ' OD2' HG21 ' A' ' 166' ' ' THR . 57.4 t0 -69.99 -16.02 63.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.86 . . . . 0.0 109.774 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 176' ' ' LYS . 8.5 mt -59.14 140.35 87.49 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 110.589 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.6 Cg_endo -66.17 -166.34 0.1 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 109.926 -0.836 . . . . 0.0 109.926 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -152.74 162.17 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.594 -1.316 . . . . 0.0 110.513 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.61 40.04 20.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.812 -0.555 . . . . 0.0 110.902 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.782 ' O ' HG21 ' A' ' 180' ' ' ILE . 50.1 tp -73.08 96.79 2.24 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.73 -1.231 . . . . 0.0 107.792 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -151.76 169.81 21.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.679 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 43.2 t -96.23 139.38 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.165 -0.959 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.752 HD11 ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -108.6 -11.89 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.853 0.835 . . . . 0.0 108.768 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.605 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -147.18 150.7 35.44 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -129.83 130.01 44.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.838 -1.164 . . . . 0.0 110.271 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.43 157.97 39.78 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.26 -40.93 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 121.434 1.423 . . . . 0.0 112.656 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.501 ' C ' HG22 ' A' ' 152' ' ' ILE . 40.9 p -129.97 19.96 5.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.058 -1.026 . . . . 0.0 110.197 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.053 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.5 p -153.46 169.83 22.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.873 -1.142 . . . . 0.0 110.011 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -143.88 155.39 44.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.33 -0.857 . . . . 0.0 109.699 -179.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.752 ' CD2' HD11 ' A' ' 101' ' ' ILE . 25.1 tp -103.99 120.51 41.21 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 147' ' ' ALA . 3.3 pt -107.59 146.95 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 111.321 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.8 p -141.11 144.22 34.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.468 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 42.3 p90 -150.74 159.99 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.73 140.58 22.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.2 134.52 56.33 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.028 1.152 . . . . 0.0 111.803 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.64 -171.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 120.954 1.103 . . . . 0.0 112.335 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.761 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -77.33 -1.44 29.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.09 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 23.4 m -129.96 160.04 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.476 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 152.28 44.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' A' ' 122' ' ' TYR . 48.9 t -130.04 133.81 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.916 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HD3' HG12 ' A' ' 165' ' ' VAL . 11.6 ptm180 -72.49 -48.04 43.81 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.417 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.698 ' CE1' HG22 ' A' ' 139' ' ' THR . 2.2 p90 -166.96 162.53 15.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.904 -1.122 . . . . 0.0 110.036 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.607 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 1.3 m-85 -122.52 151.11 41.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.527 ' NE ' ' HB2' ' A' ' 163' ' ' TYR . 17.2 ptt180 -109.85 129.64 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.794 -1.191 . . . . 0.0 108.193 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.623 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 83.9 mt -112.4 145.57 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.951 . . . . 0.0 109.546 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.621 HG22 ' HG2' ' A' ' 137' ' ' GLU . 1.1 p -122.07 142.7 50.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.68 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.1 m-85 -84.57 130.0 34.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.692 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.21 135.34 12.77 Favored Glycine 0 N--CA 1.479 1.566 0 C-N-CA 120.216 -0.993 . . . . 0.0 110.93 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.603 ' O ' ' C ' ' A' ' 129' ' ' THR . 60.0 mt-10 -105.79 151.83 23.98 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.798 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -25.31 -86.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.583 -0.698 . . . . 0.0 110.355 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.739 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . -83.52 -80.02 1.03 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 133' ' ' SER . . . 161.01 -85.33 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 131' ' ' GLY . 69.5 m-20 39.95 19.79 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.338 -1.096 . . . . 0.0 108.709 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 131' ' ' GLY . 0.7 OUTLIER -168.18 148.95 4.55 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.471 -0.768 . . . . 0.0 109.186 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.12 155.28 40.45 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.183 1.255 . . . . 0.0 112.57 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 135' ' ' VAL . 31.3 m -86.96 166.09 2.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.567 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 61.6 mt-30 -99.61 115.28 29.04 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.561 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.621 ' HG2' HG22 ' A' ' 125' ' ' THR . 95.1 mt-10 -104.86 140.0 38.77 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.87 0.843 . . . . 0.0 111.979 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 42.8 p90 -145.91 151.96 38.69 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.698 HG22 ' CE1' ' A' ' 121' ' ' TYR . 2.7 p -84.33 160.16 20.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.941 -1.1 . . . . 0.0 111.453 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 122' ' ' TYR . 89.0 t -120.2 119.04 31.02 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.67 109.52 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.73 0.953 . . . . 0.0 111.821 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -50.09 -10.27 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.99 -19.22 63.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 110.136 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -122.03 140.74 52.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.7 m -90.02 -1.14 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.468 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 63.4 p -132.85 159.12 40.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.729 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -143.37 166.36 24.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.792 -1.192 . . . . 0.0 110.203 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.5 m -112.16 149.12 32.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.439 -0.788 . . . . 0.0 109.151 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.623 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 33.1 mm -117.62 123.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.68 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 31.2 m120 -125.49 170.08 11.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.024 -1.048 . . . . 0.0 110.013 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 80.8 m-20 65.64 46.7 2.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.589 0.709 . . . . 0.0 109.562 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.501 HG22 ' C ' ' A' ' 106' ' ' THR . 3.7 tt -108.32 149.79 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -98.02 110.04 54.15 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.411 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.4 Cg_endo -67.25 174.69 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.187 1.258 . . . . 0.0 112.853 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.97 26.42 74.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.798 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . -157.21 159.08 37.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.927 -1.337 . . . . 0.0 110.068 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.8 t0 -77.94 144.39 36.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.692 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -130.77 158.17 40.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.828 -1.17 . . . . 0.0 110.272 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 63.7 m -130.24 118.92 22.1 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 108' ' ' LEU . 76.2 mt -100.91 119.79 49.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.364 -1.46 . . . . 0.0 108.775 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 179' ' ' SER . 21.5 m -127.08 140.85 51.99 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.661 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.825 ' C ' HD12 ' A' ' 162' ' ' LEU . 1.5 pp -139.09 152.42 47.49 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.335 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' HD12 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -119.96 141.82 49.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.46 137.17 38.34 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.582 -1.324 . . . . 0.0 110.19 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.662 HG12 ' HD3' ' A' ' 120' ' ' ARG . 62.2 t -110.02 120.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.706 HG21 ' OD2' ' A' ' 93' ' ' ASP . 24.3 p -115.21 -48.86 2.79 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.435 0.636 . . . . 0.0 110.026 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -49.91 157.87 1.66 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -130.02 130.43 44.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.391 -1.064 . . . . 0.0 109.406 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 147.82 -165.31 28.85 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -73.13 -30.78 63.85 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.408 -1.054 . . . . 0.0 109.179 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 52.5 m -129.98 76.06 78.64 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.7 -0.625 . . . . 0.0 109.352 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -63.93 -160.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.658 1.572 . . . . 0.0 112.486 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -136.15 158.95 43.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.354 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.1 p -133.39 149.65 51.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.132 -0.98 . . . . 0.0 109.89 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.5 p -83.02 172.77 12.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.181 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.673 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -59.26 133.33 87.97 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.024 -1.048 . . . . 0.0 108.464 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.02 145.77 97.59 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.338 1.359 . . . . 0.0 113.846 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.54 129.66 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 161' ' ' THR . 93.1 p -126.34 155.83 41.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.943 -1.098 . . . . 0.0 111.52 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 98' ' ' LEU . 27.2 pt -139.17 164.19 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -113.1 129.91 56.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 109.403 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 60.8 t80 -124.59 122.02 36.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.891 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 43.9 mmtt -84.61 149.54 25.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.907 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.526 ' OG1' ' OXT' ' A' ' 184' ' ' THR . 9.0 p . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.059 -1.025 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.797 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.0 mt -129.96 143.94 51.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.213 -1.169 . . . . 0.0 109.159 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.01 137.23 36.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.394 -0.816 . . . . 0.0 109.098 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 t -78.06 133.28 65.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.3 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' CD ' ' HB2' ' A' ' 74' ' ' ALA . 3.3 Cg_exo -57.22 90.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 120.967 1.111 . . . . 0.0 112.064 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -92.26 -158.54 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 109.904 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 22.11 66.82 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.468 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 56.0 t80 -57.75 132.4 53.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.82 0.819 . . . . 0.0 110.752 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.7 t0 -154.11 142.08 20.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 75.0 p -117.74 140.0 50.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.907 -1.121 . . . . 0.0 109.846 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 12' ' ' ASP . 58.7 p -158.6 -176.6 5.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.8 m-20 49.93 48.41 21.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -85.32 121.1 36.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.384 -177.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -112.76 162.7 15.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.04 -56.58 19.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.792 -1.193 . . . . 0.0 110.524 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -92.07 -0.03 57.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.85 -1.156 . . . . 0.0 109.93 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.7 ' O ' ' N ' ' A' ' 14' ' ' THR . 37.2 t -150.87 151.55 32.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.663 ' CD2' ' OH ' ' A' ' 68' ' ' TYR . 23.3 p90 -160.97 145.94 14.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 108.829 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 12' ' ' ASP . 3.6 m -93.16 148.03 22.37 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.507 -1.37 . . . . 0.0 111.489 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -121.52 142.56 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.438 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 72.3 m-70 -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.807 -1.183 . . . . 0.0 110.808 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.536 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 42.9 p90 -154.02 157.55 39.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.494 -0.754 . . . . 0.0 109.084 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.06 158.83 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 120.875 -1.141 . . . . 0.0 110.0 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -89.28 148.6 41.05 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 109.9 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.612 ' HG2' HG21 ' A' ' 29' ' ' ILE . 2.5 Cg_endo -61.58 178.72 0.61 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.279 1.319 . . . . 0.0 112.456 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -103.82 7.1 37.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.21 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -119.72 157.55 51.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.9 Cg_endo -56.85 136.29 75.6 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.676 1.584 . . . . 0.0 112.591 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 40.7 pt -139.97 170.06 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 p -106.42 -0.84 23.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -173.85 23.15 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 37.1 m-85 -128.36 151.15 49.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -1.207 . . . . 0.0 109.419 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.861 HG23 ' HE ' ' A' ' 49' ' ' ARG . 31.9 mm -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -0.949 . . . . 0.0 108.48 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.709 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.9 mm -113.91 123.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.008 -1.057 . . . . 0.0 110.315 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.479 ' NH1' HH21 ' A' ' 49' ' ' ARG . 83.0 mtt-85 -123.24 130.92 53.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.607 ' NE2' ' CB ' ' A' ' 46' ' ' ARG . 20.5 p-80 -130.76 129.4 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.559 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -159.99 159.92 32.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 109.32 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.546 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -82.38 157.94 23.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.545 ' HG2' HG23 ' A' ' 69' ' ' VAL . 12.9 mt-10 -59.99 -40.04 87.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.402 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -86.25 -0.02 54.83 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.329 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 38' ' ' ALA . 88.9 p -110.04 116.65 31.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.996 -1.065 . . . . 0.0 109.695 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.0 m -138.8 1.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.927 . . . . 0.0 109.509 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.35 -65.28 2.73 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 -121.51 79.99 38.23 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.172 -1.193 . . . . 0.0 109.853 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.07 140.65 79.78 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.412 1.408 . . . . 0.0 112.29 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.607 ' CB ' ' NE2' ' A' ' 36' ' ' HIS . 22.5 mmm180 -81.3 135.96 35.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.785 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -120.82 109.96 15.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.793 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' ILE . 94.5 m-20 -121.98 129.99 52.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.197 -0.94 . . . . 0.0 108.673 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.861 ' HE ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -113.56 141.22 47.43 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.325 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.795 ' CG1' HD12 ' A' ' 57' ' ' ILE . 33.1 m -120.95 147.66 46.82 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.28 159.98 44.54 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 120.844 1.029 . . . . 0.0 111.552 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.505 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 2.7 Cg_endo -57.96 -37.85 94.44 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.583 1.522 . . . . 0.0 112.563 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 m -70.05 -12.49 61.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.872 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -100.07 115.43 29.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.922 -1.112 . . . . 0.0 109.888 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -103.06 -4.11 25.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.486 -0.758 . . . . 0.0 108.983 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.438 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 19.4 p -130.33 135.92 48.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.772 . . . . 0.0 109.245 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.795 HD12 ' CG1' ' A' ' 50' ' ' VAL . 8.0 tt -132.43 133.75 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.096 -1.003 . . . . 0.0 110.361 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -95.74 109.99 22.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 17' ' ' SER . 5.6 mt -85.63 148.81 25.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.129 -0.982 . . . . 0.0 109.814 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.4 p -135.05 177.73 7.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.74 -0.6 . . . . 0.0 109.596 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m120 57.33 45.43 20.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 59' ' ' LEU . 48.5 mt -111.68 150.03 30.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -62.09 116.95 25.01 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.625 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.21 131.71 35.61 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 120.868 1.045 . . . . 0.0 112.932 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.45 62.91 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -142.38 130.72 22.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 110.887 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 67' ' ' GLU . 21.2 pt-20 -87.14 122.52 31.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.663 ' OH ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -139.82 175.45 9.56 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.615 -1.234 . . . . 0.0 110.863 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.545 HG23 ' HG2' ' A' ' 39' ' ' GLU . 62.4 t -109.12 129.08 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.71 123.19 68.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.419 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.1 p -111.19 142.36 43.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 0.0 111.586 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.709 ' CD1' HG23 ' A' ' 34' ' ' ILE . 49.3 mm -119.88 119.98 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.1 mm -113.66 119.97 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.91 -1.119 . . . . 0.0 108.809 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.821 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -85.67 130.13 34.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 108.686 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.8 147.55 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 110.061 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -128.51 40.05 3.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.06 -100.81 2.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 ptt-85 -90.34 -5.96 55.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -1.19 . . . . 0.0 110.242 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -112.31 143.48 43.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.97 -1.082 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -127.3 130.54 49.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 110.42 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.821 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 15.7 m -76.12 152.53 84.24 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.56 140.03 45.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 120.746 0.964 . . . . 0.0 111.765 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.89 146.22 80.2 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.561 1.508 . . . . 0.0 114.076 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 5' ' ' PRO . 20.0 tp -122.08 121.74 37.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.419 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -133.2 140.55 46.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 O-C-N 120.846 -1.159 . . . . 0.0 111.379 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.33 162.57 27.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.446 ' HG2' HG22 ' A' ' 69' ' ' VAL . 77.1 mt-30 -110.84 141.88 43.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.037 -1.273 . . . . 0.0 110.165 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.542 ' OE1' ' OG ' ' A' ' 10' ' ' SER . 67.5 tp60 -145.21 158.46 43.82 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.534 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . -124.19 127.12 47.26 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.858 -1.151 . . . . 0.0 111.03 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.638 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.11 142.57 45.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -62.62 161.07 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.523 0.677 . . . . 0.0 110.907 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.5 m -88.87 138.5 31.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.576 -0.702 . . . . 0.0 110.016 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.563 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 54.1 t0 -70.23 -27.03 64.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 110.542 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 176' ' ' LYS . 10.3 mt -60.06 140.53 90.65 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.0 110.067 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.493 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.8 Cg_endo -64.42 -159.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 N-CA-C 109.896 -0.848 . . . . 0.0 109.896 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 15.9 ttp180 -160.01 160.57 33.45 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.664 -1.273 . . . . 0.0 111.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 98.2 m-20 59.95 43.84 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.631 HD22 ' CD2' ' A' ' 162' ' ' LEU . 41.2 tp -72.06 112.73 8.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 120.491 -1.381 . . . . 0.0 107.41 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -157.14 169.38 24.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 109' ' ' LEU . 53.4 t -104.95 133.41 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CG2' ' OG ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -98.39 -30.0 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.703 0.763 . . . . 0.0 109.427 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.97 144.55 47.46 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 p -122.32 119.06 29.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 110.164 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -97.18 156.58 36.13 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.1 -46.2 26.46 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.564 1.509 . . . . 0.0 112.918 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 154' ' ' PRO . 64.8 p -121.09 15.86 11.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.677 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.035 ' O ' HD23 ' A' ' 108' ' ' LEU . 4.8 p -149.97 164.29 35.87 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.093 -1.004 . . . . 0.0 109.669 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.035 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -139.43 150.0 44.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.628 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 110' ' ' ILE . 1.9 tt -99.02 122.64 42.55 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.109 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.506 ' N ' HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -106.99 141.26 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 0.0 110.872 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 101' ' ' ILE . 9.5 p -142.74 136.49 28.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.58 -0.7 . . . . 0.0 109.362 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.442 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 34.7 p90 -145.31 156.96 44.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.316 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.62 137.92 54.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.616 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.41 132.04 39.03 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 120.916 1.078 . . . . 0.0 112.099 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.94 -159.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 120.932 1.088 . . . . 0.0 112.256 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.44 2.92 45.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 24.0 m -130.01 160.0 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.098 -1.001 . . . . 0.0 109.819 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.4 t -74.55 135.36 42.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 122' ' ' TYR . 22.6 t -109.99 135.01 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.596 ' CB ' ' HE ' ' A' ' 168' ' ' ARG . 23.9 mmt180 -71.15 -45.94 62.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.496 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 12.1 p90 -166.29 162.37 17.27 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.424 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.582 ' N ' ' CD1' ' A' ' 122' ' ' TYR . 2.7 m-85 -119.98 138.08 53.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 108.596 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 137' ' ' GLU . 13.6 tpt180 -95.46 121.58 37.29 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 89.9 mt -110.0 132.36 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.144 -0.973 . . . . 0.0 110.322 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 ' CG ' ' A' ' 137' ' ' GLU . 3.1 p -113.17 144.76 42.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.689 . . . . 0.0 111.436 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.776 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.7 m-85 -87.93 136.61 32.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.695 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.7 128.7 9.4 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.161 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' GLY . 55.6 mt-10 -108.92 147.66 31.86 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.656 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -39.56 -20.01 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.885 -1.134 . . . . 0.0 109.057 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . -108.04 58.57 0.4 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . -39.96 -20.04 0.02 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 130' ' ' GLY . 47.0 t-20 -59.98 -40.03 87.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.168 -1.195 . . . . 0.0 108.88 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.9 m -70.41 150.98 95.75 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.93 124.18 15.62 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.334 1.356 . . . . 0.0 112.99 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.411 HG23 ' OE2' ' A' ' 137' ' ' GLU . 17.1 m -69.02 162.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.404 -0.81 . . . . 0.0 108.853 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.514 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 53.6 mt-30 -94.39 112.69 24.48 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.344 -1.342 . . . . 0.0 108.373 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.466 ' HB3' ' NE ' ' A' ' 123' ' ' ARG . 21.5 mp0 -102.41 140.17 37.04 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.988 0.899 . . . . 0.0 112.715 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 41.9 p90 -143.16 153.87 43.3 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 p -88.62 163.1 15.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.663 -1.273 . . . . 0.0 112.092 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.629 ' O ' ' N ' ' A' ' 142' ' ' GLY . 27.9 t -123.85 105.35 32.44 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.2 Cg_exo -59.86 35.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.672 0.915 . . . . 0.0 112.76 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 30.69 30.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.697 ' N ' ' O ' ' A' ' 141' ' ' PRO . 81.4 p -69.41 -33.6 73.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -1.21 . . . . 0.0 109.698 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -146.17 176.38 9.78 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.563 -0.711 . . . . 0.0 110.107 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 92.7 p -90.03 0.01 57.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.722 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.442 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 19.8 p -136.22 150.96 49.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.471 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -148.05 177.49 9.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 108.945 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.741 HG22 ' N ' ' A' ' 149' ' ' ILE . 43.8 m -122.61 167.07 13.86 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.062 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.776 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 85.8 mt -123.92 130.52 73.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 110.01 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.464 ' O ' ' OH ' ' A' ' 126' ' ' TYR . 68.7 m-20 -123.32 172.67 8.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 56.2 m-20 61.42 40.36 14.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.0 110.323 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.49 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 3.4 tt -97.78 168.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 108.707 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -110.73 100.08 44.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 120.925 -1.109 . . . . 0.0 109.36 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.534 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.8 Cg_endo -66.71 164.15 30.31 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.396 1.397 . . . . 0.0 113.015 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.98 19.52 69.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.688 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -149.72 156.76 42.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.29 . . . . 0.0 110.186 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.688 ' OD2' ' NZ ' ' A' ' 183' ' ' LYS . 61.9 t0 -70.0 151.14 45.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.6 OUTLIER -141.95 159.28 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.505 -1.372 . . . . 0.0 110.328 -179.188 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 20.4 m -130.49 123.17 29.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -103.39 120.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.131 -1.606 . . . . 0.0 109.666 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 179' ' ' SER . 22.7 m -131.36 141.86 49.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.631 ' CD2' HD22 ' A' ' 98' ' ' LEU . 2.3 pt? -135.18 154.79 51.5 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.4 m-85 -120.02 140.6 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -108.04 125.74 51.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.752 -1.218 . . . . 0.0 109.768 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 90.1 t -114.5 127.54 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.662 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 1.4 p -121.29 -69.3 0.85 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.524 0.678 . . . . 0.0 109.691 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.662 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -57.21 121.37 25.13 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.596 ' HE ' ' CB ' ' A' ' 120' ' ' ARG . 53.9 mtt180 -119.89 12.9 12.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.394 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -77.28 -133.7 0.62 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.01 0.63 57.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -1.061 . . . . 0.0 109.546 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.0 m -130.01 71.2 82.26 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.787 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.58 105.19 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.67 1.58 . . . . 0.0 111.903 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.96 140.75 50.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.177 -0.952 . . . . 0.0 109.912 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 79.2 p -119.89 144.1 47.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.394 -0.816 . . . . 0.0 108.956 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.3 p -66.34 152.6 44.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.066 -1.021 . . . . 0.0 108.458 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.67 ' HB2' HD11 ' A' ' 94' ' ' ILE . 1.8 mmtm -49.34 137.03 16.12 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.844 -1.16 . . . . 0.0 108.825 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.53 142.29 97.56 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.165 1.243 . . . . 0.0 112.916 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 129.23 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 161' ' ' THR . 64.8 p -126.06 150.82 47.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.034 -1.041 . . . . 0.0 111.992 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.575 HG23 HD23 ' A' ' 98' ' ' LEU . 48.0 pt -134.8 160.05 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -97.87 140.28 32.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.873 -1.142 . . . . 0.0 109.48 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.651 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 58.3 t80 -137.52 119.35 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 109.62 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.688 ' NZ ' ' OD2' ' A' ' 157' ' ' ASP . 71.3 mmtt -89.4 133.86 34.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.248 -0.907 . . . . 0.0 108.765 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.688 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 3.1 p . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 0.0 109.427 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.811 0 N-CA-C 119.384 2.514 . . . . 0.0 119.384 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 81' ' ' SER . 84.9 mt -123.72 136.81 54.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.262 -1.14 . . . . 0.0 109.241 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.13 130.1 36.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.8 m -76.57 144.07 73.08 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 109.514 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.778 ' O ' HD22 ' A' ' 84' ' ' LEU . 2.6 Cg_endo -58.87 110.16 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.171 . . . . 0.0 111.377 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.1 -155.29 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 109.772 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.02 23.7 76.93 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 105.108 -3.197 . . . . 0.0 105.108 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 54.1 t80 -50.56 130.03 23.34 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.561 -0.819 . . . . 0.0 110.88 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.6 t0 -142.96 137.44 29.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.572 ' OG ' ' OE1' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -119.57 138.0 53.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 0.0 110.202 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' ASP . 91.5 p -167.2 -166.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.726 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.2 m-20 48.7 43.68 20.93 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.805 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -76.92 129.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.21 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.38 161.12 21.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.84 -59.99 4.5 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 110.218 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -90.06 0.02 57.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.869 -1.144 . . . . 0.0 109.062 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 14' ' ' THR . 86.0 p -149.47 159.2 44.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.093 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.494 ' CE1' HG22 ' A' ' 20' ' ' VAL . 16.9 p90 -163.77 148.27 10.49 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -101.37 150.29 23.17 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.115 -1.616 . . . . 0.0 112.286 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.494 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -119.18 139.06 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -129.33 139.99 51.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.773 -1.204 . . . . 0.0 110.816 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 35.9 p90 -150.25 155.45 39.74 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -87.32 157.24 3.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.868 -1.145 . . . . 0.0 109.985 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -93.12 137.02 23.87 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.95 176.01 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 120.827 1.018 . . . . 0.0 111.892 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -103.3 15.55 28.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.311 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.87 155.75 47.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.09 131.27 40.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.614 1.543 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.0 pt -140.01 170.64 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.246 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 46.9 p -108.41 -10.15 15.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 109.841 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.89 178.27 23.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.624 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 25.8 m-85 -123.14 145.14 48.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 109.232 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.67 HG23 ' HG3' ' A' ' 49' ' ' ARG . 42.3 mm -100.7 128.01 53.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 120.88 -1.138 . . . . 0.0 108.123 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.618 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.2 mm -109.29 110.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.112 -0.992 . . . . 0.0 110.421 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -105.69 121.49 44.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.494 ' CG ' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -118.76 135.09 54.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.808 -1.182 . . . . 0.0 110.861 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -160.05 159.0 31.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.597 -0.689 . . . . 0.0 109.586 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 41' ' ' SER . . . -94.39 139.6 30.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 108.547 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.576 ' OE2' ' OE1' ' A' ' 67' ' ' GLU . 21.9 pt-20 -62.12 -26.19 68.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.022 -1.049 . . . . 0.0 109.79 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.523 ' NE2' HG23 ' A' ' 66' ' ' THR . 18.6 p80 -93.25 2.14 56.75 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.505 -0.747 . . . . 0.0 110.029 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 98.1 p -78.99 158.4 27.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.099 -1.0 . . . . 0.0 109.833 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.53 -0.99 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -0.839 . . . . 0.0 109.362 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.24 -177.37 50.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -70.02 133.04 88.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 0.0 109.476 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.86 135.56 69.77 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.202 1.268 . . . . 0.0 112.649 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 mmt180 -73.51 136.73 44.14 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -100.51 117.06 33.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.469 -0.769 . . . . 0.0 109.372 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -123.08 133.25 54.31 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.67 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -127.43 150.12 49.78 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.816 -1.177 . . . . 0.0 109.871 -178.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 HD11 ' A' ' 34' ' ' ILE . 34.4 m -135.15 145.96 56.33 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.17 160.08 46.58 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 120.924 1.083 . . . . 0.0 111.256 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.81 -31.5 91.83 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.243 1.296 . . . . 0.0 112.172 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.3 m -72.5 -11.42 60.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.546 -0.721 . . . . 0.0 111.255 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -103.94 120.0 40.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.839 -1.163 . . . . 0.0 109.461 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.431 ' C ' ' OD1' ' A' ' 55' ' ' ASN . 46.3 p-10 -102.49 -1.96 29.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.3 p -134.72 138.18 44.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.439 HD12 ' CG1' ' A' ' 50' ' ' VAL . 4.9 tt -131.55 134.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.705 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -102.5 119.8 39.45 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.339 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.5 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.1 mt -89.29 148.97 23.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 108.977 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -131.31 177.55 7.39 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.514 0.673 . . . . 0.0 110.019 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.4 m120 55.2 45.5 25.74 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.5 HD11 ' CB ' ' A' ' 59' ' ' LEU . 56.3 mt -109.94 152.87 25.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.473 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 95.1 m-20 -68.67 120.48 75.99 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.325 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.781 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.8 Cg_endo -60.95 133.99 50.66 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 121.068 1.179 . . . . 0.0 113.49 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.7 63.05 2.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.523 HG23 ' NE2' ' A' ' 40' ' ' HIS . 1.2 m -148.57 156.36 42.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -1.16 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' OE1' ' OE2' ' A' ' 39' ' ' GLU . 8.8 pt-20 -99.31 120.02 38.88 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.473 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 77.3 m-85 -110.19 153.77 24.3 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 111.039 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -109.97 120.73 61.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 36' ' ' HIS . 60.2 t -120.02 125.9 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.932 -1.105 . . . . 0.0 109.826 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 p -104.88 136.14 44.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 110.839 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.753 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.2 mm -112.05 121.03 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -119.11 129.98 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.965 -1.084 . . . . 0.0 109.594 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.74 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -91.65 132.54 36.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.339 -0.851 . . . . 0.0 109.543 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG12 ' HG2' ' A' ' 80' ' ' GLU . 16.5 m -128.6 137.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -119.96 41.93 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.63 -92.4 1.71 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.94 -0.0 40.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -1.106 . . . . 0.0 110.581 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.33 152.85 37.27 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.016 -1.053 . . . . 0.0 109.631 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.559 ' HG2' HG12 ' A' ' 75' ' ' VAL . 99.1 mt-10 -131.87 160.0 36.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 110.001 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.74 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -110.93 172.17 3.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.239 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.1 Cg_exo -61.78 132.74 41.39 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.391 1.394 . . . . 0.0 112.417 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.17 128.28 25.88 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.182 1.255 . . . . 0.0 113.074 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 5' ' ' PRO . 20.4 tp -106.9 121.37 44.3 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -119.98 133.39 66.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.932 -1.105 . . . . 0.0 110.868 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.82 155.39 21.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -110.99 136.17 50.4 Favored 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.204 -1.174 . . . . 0.0 110.054 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.792 HE21 ' CD1' ' A' ' 13' ' ' ILE . 51.6 tt0 -137.6 143.53 41.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.43 149.55 37.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.979 -1.076 . . . . 0.0 111.594 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 136.47 33.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.805 HG23 HG22 ' A' ' 13' ' ' ILE . 20.8 t -51.13 173.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.466 0.65 . . . . 0.0 110.045 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.635 ' N ' HG12 ' A' ' 91' ' ' VAL . 68.6 m -100.86 141.35 33.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.413 -0.805 . . . . 0.0 109.158 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.568 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 57.9 t0 -71.47 -12.05 61.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.092 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.769 HG21 HG23 ' A' ' 178' ' ' VAL . 3.1 mt -77.87 139.26 61.77 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.017 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.473 ' HD2' HG22 ' A' ' 94' ' ' ILE . 3.7 Cg_exo -57.42 -171.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.283 0.655 . . . . 0.0 110.988 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.491 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 53.0 ttt85 -146.67 160.65 41.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.725 -1.234 . . . . 0.0 110.92 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.491 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 25.0 t0 72.55 34.88 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.856 -0.527 . . . . 0.0 111.456 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.647 HD22 HD13 ' A' ' 180' ' ' ILE . 2.2 tt -65.28 102.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.498 -1.376 . . . . 0.0 107.663 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.466 ' N ' HD23 ' A' ' 98' ' ' LEU . 98.8 mt-10 -142.58 157.97 44.15 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.939 -1.101 . . . . 0.0 110.549 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 100' ' ' VAL . 3.2 p -89.96 137.3 21.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.61 HD11 ' CD2' ' A' ' 109' ' ' LEU . 47.3 pt -123.72 -13.21 6.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -142.63 130.01 21.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.5 t -115.03 117.67 31.24 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.687 ' CB ' ' HG ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -108.6 157.96 35.23 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.07 -40.74 33.98 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 121.509 1.473 . . . . 0.0 112.781 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.562 ' C ' HG22 ' A' ' 152' ' ' ILE . 69.6 p -130.01 20.02 5.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 110.22 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.065 ' O ' HD23 ' A' ' 108' ' ' LEU . 18.9 p -153.41 165.37 36.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.889 -1.132 . . . . 0.0 110.285 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.065 HD23 ' O ' ' A' ' 107' ' ' SER . 1.2 mt -141.49 157.26 45.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.61 ' CD2' HD11 ' A' ' 101' ' ' ILE . 23.9 tp -104.8 127.55 52.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.084 -1.01 . . . . 0.0 108.381 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.488 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.0 pt -109.77 135.3 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 110.703 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 146' ' ' THR . 52.6 m -126.86 132.51 50.94 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 42.5 p90 -143.02 157.5 44.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 109.596 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -95.11 142.06 24.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.368 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.29 136.44 68.34 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 120.952 1.101 . . . . 0.0 112.034 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.38 -163.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 120.984 1.123 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -91.24 1.6 56.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 109.187 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.632 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 33.1 m -129.98 160.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.702 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.4 p -69.63 157.38 37.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 108.584 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.602 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 23.8 t -129.91 130.0 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 110.146 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -73.16 -42.97 62.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.762 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 -166.57 163.45 16.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.117 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.602 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -120.0 142.76 48.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 108.771 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.48 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 1.2 mtp180 -99.36 127.34 45.37 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.7 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 35.7 mt -110.01 130.0 63.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.813 -1.179 . . . . 0.0 109.834 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.421 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 76.9 p -106.56 140.37 39.55 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.962 0.887 . . . . 0.0 111.58 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.702 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 5.8 m-85 -91.43 127.48 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.737 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -99.57 117.17 5.79 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.423 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 133' ' ' SER . 42.7 mt-10 -109.21 64.86 0.61 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.541 -0.976 . . . . 0.0 109.197 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -74.08 146.72 43.41 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.982 -1.074 . . . . 0.0 109.839 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.94 -9.96 75.52 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -119.67 -8.47 9.02 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 m-20 52.07 29.44 6.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.274 -1.133 . . . . 0.0 108.801 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.403 ' HB2' ' OE1' ' A' ' 128' ' ' GLU . 17.7 m -97.77 151.51 37.63 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.371 -0.831 . . . . 0.0 109.35 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.36 140.11 87.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.327 1.351 . . . . 0.0 112.475 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.412 ' H ' HG13 ' A' ' 135' ' ' VAL . 2.5 m -69.76 150.2 10.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.341 -0.85 . . . . 0.0 109.156 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.624 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 93.3 mm-40 -109.38 121.53 45.38 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.611 -1.236 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 86.5 tt0 -109.77 140.57 43.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.865 . . . . 0.0 111.617 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.7 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 43.0 p90 -139.6 150.0 44.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.762 HG22 ' CE2' ' A' ' 121' ' ' TYR . 4.1 p -86.19 163.57 17.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.112 -0.993 . . . . 0.0 111.463 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 142' ' ' GLY . 7.2 t -129.99 112.45 17.27 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.703 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.35 35.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.728 0.952 . . . . 0.0 112.719 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.56 ' H ' HG12 ' A' ' 140' ' ' VAL . . . 35.03 24.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 141' ' ' PRO . 28.8 t -66.39 -40.02 89.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.059 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -134.3 175.64 9.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.841 0.829 . . . . 0.0 110.546 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 52.5 m -94.62 0.0 54.81 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 111' ' ' SER . 17.9 p -136.83 150.92 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 108.844 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' H ' HG13 ' A' ' 110' ' ' ILE . . . -141.73 162.92 34.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 109.847 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.4 t -100.56 148.37 24.89 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 108.98 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.702 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 48.5 mm -116.62 120.03 63.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.619 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 78.8 m-20 -120.06 173.91 6.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.19 -0.943 . . . . 0.0 110.306 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.7 t30 65.92 40.0 4.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 109.56 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.562 HG22 ' C ' ' A' ' 106' ' ' THR . 2.3 tt -100.66 146.54 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -99.95 109.43 56.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.987 -1.071 . . . . 0.0 110.123 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 2.5 Cg_endo -68.55 172.64 11.09 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.129 1.22 . . . . 0.0 112.485 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.608 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.34 20.86 77.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 184' ' ' THR . . . -148.65 156.75 42.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.317 . . . . 0.0 109.763 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.9 t0 -69.97 147.27 50.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.737 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -138.0 156.87 47.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.79 -1.194 . . . . 0.0 110.515 -178.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.5 m -134.58 118.03 16.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.18 124.91 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.343 -1.473 . . . . 0.0 109.357 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 178' ' ' VAL . 99.8 m -130.83 142.83 50.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.0 110.439 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 80.3 mt -107.83 142.13 38.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.645 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 24.7 m-85 -119.98 140.02 51.59 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.94 129.93 55.44 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.94 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 62.4 t -115.37 122.55 69.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.57 ' O ' ' C ' ' A' ' 167' ' ' GLY . 9.7 p -129.82 -61.73 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.51 0.672 . . . . 0.0 110.045 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.57 ' C ' ' O ' ' A' ' 166' ' ' THR . . . -25.4 131.77 0.02 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -111.22 124.96 53.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.45 -1.029 . . . . 0.0 109.271 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 157.24 -168.72 34.16 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -76.42 -5.13 45.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.429 -1.042 . . . . 0.0 109.31 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.4 m -130.04 76.45 78.03 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -0.847 . . . . 0.0 109.536 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.03 106.59 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.563 1.509 . . . . 0.0 112.172 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.97 154.79 23.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.464 -0.773 . . . . 0.0 109.692 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 66.7 p -125.63 147.27 49.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.722 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 49.1 p -72.07 160.69 32.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 94' ' ' ILE . 18.3 mmtm -57.73 130.57 82.12 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 108.435 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.435 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.1 Cg_endo -61.12 134.66 53.93 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.195 1.263 . . . . 0.0 113.664 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.901 ' O ' HG23 ' A' ' 161' ' ' THR . 2.0 t -100.29 126.83 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.438 ' CB ' ' OG1' ' A' ' 161' ' ' THR . 79.1 p -122.69 145.25 48.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.057 -1.027 . . . . 0.0 112.187 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.647 HD13 HD22 ' A' ' 98' ' ' LEU . 15.8 pt -130.61 159.97 42.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -104.13 135.78 44.98 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.85 -1.156 . . . . 0.0 109.502 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.442 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 65.7 t80 -130.2 109.67 10.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.39 136.22 33.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.077 -1.014 . . . . 0.0 108.99 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.371 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.945 ' C ' HD13 ' A' ' 2' ' ' LEU . . . . . . . . 1 N--CA 1.529 4.835 0 N-CA-C 119.396 2.518 . . . . 0.0 119.396 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 1.019 ' H ' HD22 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -112.95 157.64 21.23 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.246 -1.149 . . . . 0.0 108.809 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -79.49 140.63 37.24 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' THR . 66.5 m -76.77 140.67 67.65 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.391 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 2.9 Cg_endo -57.76 78.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.133 1.222 . . . . 0.0 111.71 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -81.55 -152.02 0.09 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.397 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.0 22.95 77.31 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 106.207 -2.757 . . . . 0.0 106.207 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -57.78 130.0 44.44 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.623 0.725 . . . . 0.0 110.141 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.8 t0 -156.6 147.25 21.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 39.1 t -121.49 141.85 50.63 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.03 -1.043 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 12' ' ' ASP . 22.9 p -155.64 -171.54 3.81 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.4 m-20 49.63 39.94 18.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.45 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -76.49 130.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.42 160.81 27.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.652 ' CB ' ' OD1' ' A' ' 93' ' ' ASP . . . -59.67 -60.0 4.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 110.229 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -89.27 0.06 57.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.978 -1.076 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 14' ' ' THR . 47.5 t -149.33 154.62 39.26 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.802 ' CE1' HG22 ' A' ' 20' ' ' VAL . 12.6 p90 -165.12 141.01 5.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -91.24 150.09 21.49 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.449 -1.407 . . . . 0.0 111.301 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.802 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -119.98 138.44 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.436 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 68.9 m-70 -128.59 144.33 51.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.934 -1.104 . . . . 0.0 110.965 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 41.1 p90 -145.28 160.02 42.14 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.9 159.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.855 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -97.59 132.73 24.61 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.55 -178.46 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.003 1.135 . . . . 0.0 112.711 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -103.86 -0.75 28.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -103.15 151.68 38.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.088 -1.007 . . . . 0.0 109.729 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 2.9 Cg_endo -57.38 126.31 21.6 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.411 1.408 . . . . 0.0 112.29 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.56 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 19.6 pt -130.04 164.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.408 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -99.98 -1.79 36.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.515 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.9 -172.69 23.56 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 42.6 m-85 -128.45 156.84 42.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.739 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -114.24 128.08 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.739 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.6 mm -111.61 118.14 56.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.944 -1.098 . . . . 0.0 110.653 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -112.07 129.41 56.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.51 ' CE1' HD22 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -124.01 141.29 52.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.781 -1.2 . . . . 0.0 110.982 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 46.9 p-80 -165.1 166.88 18.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.063 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.83 138.56 37.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -63.43 -20.34 65.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 109.431 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -75.8 -10.01 59.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.597 -0.689 . . . . 0.0 109.776 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 82.2 p -138.71 150.01 45.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.025 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 43' ' ' GLY . 12.7 t -136.79 2.96 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.436 -0.79 . . . . 0.0 109.384 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 42' ' ' VAL . . . -44.81 -99.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' HB2' HH21 ' A' ' 44' ' ' ARG . 32.9 mtm-85 -117.06 100.43 53.3 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.2 -1.176 . . . . 0.0 109.68 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -64.85 138.22 56.88 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.166 1.244 . . . . 0.0 112.196 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -73.61 152.86 40.4 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.097 -1.002 . . . . 0.0 110.155 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -121.86 117.73 27.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.0 109.855 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' ILE . 85.9 m-20 -123.15 119.1 29.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.783 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -104.44 141.68 35.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.095 -1.003 . . . . 0.0 109.424 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 34' ' ' ILE . 30.9 m -125.33 147.85 59.0 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.46 159.92 45.38 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 120.853 1.035 . . . . 0.0 111.516 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.85 -35.17 99.05 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.488 1.459 . . . . 0.0 112.402 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -69.95 -16.75 63.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.894 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -100.03 117.19 33.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.031 -1.043 . . . . 0.0 109.478 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -104.31 -0.08 28.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.436 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 51.6 p -132.85 138.4 47.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.249 -0.907 . . . . 0.0 109.799 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.505 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 5.5 tt -130.05 134.9 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.048 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.8 m -99.81 120.27 39.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 62' ' ' LEU . 7.2 mt -97.45 140.75 31.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.274 -0.891 . . . . 0.0 109.568 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.1 p -132.63 179.42 6.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.686 . . . . 0.0 109.943 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.91 39.97 29.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.483 -0.761 . . . . 0.0 109.576 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 59' ' ' LEU . 21.0 mt -107.21 149.34 27.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 0.0 109.104 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.537 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 87.7 m-20 -60.82 116.4 18.33 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.96 -1.087 . . . . 0.0 108.363 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 131.97 37.2 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.035 1.157 . . . . 0.0 113.401 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.31 62.82 2.24 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -150.55 157.52 43.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -1.224 . . . . 0.0 110.662 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 66' ' ' THR . 99.0 mt-10 -92.24 120.05 32.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.537 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 44.2 m-85 -110.84 148.71 31.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.157 -0.964 . . . . 0.0 110.996 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.465 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 62.7 t -110.04 124.34 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.9 124.85 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 p -108.4 134.81 50.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 111.195 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.718 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.6 mm -114.5 117.3 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.5 mp -111.8 125.46 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 108.443 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -93.8 127.82 39.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 80' ' ' GLU . 3.1 m -117.46 129.96 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.876 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 52.3 t30 -111.64 34.82 3.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.865 . . . . 0.0 109.341 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.17 -87.05 1.52 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.79 -6.01 56.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -1.108 . . . . 0.0 110.393 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' HD11 ' A' ' 2' ' ' LEU . 100.0 mt-10 -131.12 150.05 52.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.495 ' HG3' HG12 ' A' ' 75' ' ' VAL . 60.0 mp0 -126.67 129.96 49.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.704 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -74.96 160.01 81.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.207 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.46 142.03 98.35 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.221 1.28 . . . . 0.0 111.969 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.99 136.99 78.61 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.239 1.293 . . . . 0.0 113.048 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 5' ' ' PRO . 26.2 tp -115.77 121.29 42.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.95 130.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.947 -1.096 . . . . 0.0 111.074 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.08 160.44 22.49 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.004 -2.439 . . . . 0.0 107.004 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.444 ' HG2' HG22 ' A' ' 69' ' ' VAL . 73.5 mt-30 -118.54 137.88 52.91 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.04 -1.27 . . . . 0.0 110.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -139.3 139.29 37.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -102.24 133.68 46.73 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 110.77 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.34 140.06 41.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -60.19 153.16 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.651 . . . . 0.0 110.484 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -84.11 159.97 21.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.418 -0.801 . . . . 0.0 109.079 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.652 ' OD1' ' CB ' ' A' ' 15' ' ' ALA . 89.1 m-20 -105.62 -13.77 15.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.135 -0.978 . . . . 0.0 111.28 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ARG . 2.0 mt -80.05 138.13 53.17 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 120.662 -1.274 . . . . 0.0 110.496 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.591 ' HG2' HD21 ' A' ' 162' ' ' LEU . 2.5 Cg_endo -65.89 62.13 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.824 1.016 . . . . 0.0 111.124 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 44.5 ttm105 -40.58 163.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 110.367 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.525 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.9 m-20 63.1 40.62 8.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.904 -0.497 . . . . 0.0 111.246 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.554 HD13 HD23 ' A' ' 162' ' ' LEU . 49.0 tp -79.97 104.09 10.3 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.835 -1.166 . . . . 0.0 107.887 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -158.64 166.58 31.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.021 . . . . 0.0 110.121 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 25.3 t -89.07 140.02 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.773 HD11 ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -114.14 -9.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . . . -147.62 158.8 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.3 t -134.77 127.93 31.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.965 -1.084 . . . . 0.0 110.423 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.738 ' CB ' ' HG ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.55 158.68 38.0 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -48.92 -32.68 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.485 1.456 . . . . 0.0 112.914 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.595 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.0 p -139.21 20.26 2.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 109.862 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.07 ' O ' HD23 ' A' ' 108' ' ' LEU . 6.1 p -153.15 167.5 29.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.022 . . . . 0.0 110.067 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.07 HD23 ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.773 ' CD2' HD11 ' A' ' 101' ' ' ILE . 30.6 tp -105.27 121.63 44.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 108.795 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 147' ' ' ALA . 3.1 pt -102.95 143.94 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.482 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 146' ' ' THR . 36.3 t -136.73 140.0 42.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.704 -0.622 . . . . 0.0 109.756 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.695 ' CD2' ' O ' ' A' ' 145' ' ' SER . 48.8 p90 -144.37 156.99 44.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.564 -0.71 . . . . 0.0 109.303 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.96 130.45 89.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.67 118.59 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 120.937 1.091 . . . . 0.0 112.247 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.06 168.01 11.44 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 120.864 1.043 . . . . 0.0 111.995 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.49 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -107.01 28.12 8.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.829 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.97 159.99 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.5 t -70.86 129.96 40.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.326 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.713 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 39.9 t -129.98 130.44 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -70.95 -51.27 26.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 139' ' ' THR . 15.3 p90 -167.14 170.49 11.77 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.713 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 3.7 m-85 -120.03 139.86 51.86 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 108.47 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -98.7 126.85 44.44 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.607 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 44.9 mt -118.55 130.84 72.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.872 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 137' ' ' GLU . 12.5 p -101.55 146.54 27.53 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.088 0.947 . . . . 0.0 111.527 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.721 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 3.3 m-85 -92.05 128.07 37.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.727 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.27 122.99 7.08 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.873 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.591 ' O ' ' C ' ' A' ' 129' ' ' THR . 43.4 mt-10 -105.75 157.45 17.43 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.617 -0.931 . . . . 0.0 108.535 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.591 ' C ' ' O ' ' A' ' 128' ' ' GLU . 1.0 OUTLIER -22.8 -62.27 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.7 -0.625 . . . . 0.0 110.709 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . 142.91 24.28 0.18 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.675 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.21 -81.68 0.09 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 133' ' ' SER . 80.8 m-20 -102.96 -1.98 28.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -1.118 . . . . 0.0 108.549 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.687 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 1.6 p 75.51 35.04 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.657 -0.652 . . . . 0.0 111.668 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 133' ' ' SER . 2.5 Cg_endo -60.17 50.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 120.724 0.949 . . . . 0.0 112.464 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.601 ' N ' ' O ' ' A' ' 133' ' ' SER . 1.7 m -57.11 143.47 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.804 -1.185 . . . . 0.0 109.517 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.638 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 78.7 mt-30 -125.23 131.77 53.08 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' H ' ' CD ' ' A' ' 137' ' ' GLU . 1.1 pm0 -113.36 148.66 35.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.913 -1.117 . . . . 0.0 111.991 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 49.9 p90 -139.96 150.82 44.97 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.41 HG22 ' CE2' ' A' ' 121' ' ' TYR . 15.1 p -88.32 166.09 14.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.032 . . . . 0.0 111.634 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLY . 54.2 t -136.97 95.24 12.19 Favored Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.681 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -60.05 47.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 120.909 1.073 . . . . 0.0 113.243 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 33.98 26.98 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 141' ' ' PRO . 94.5 p -62.99 -39.98 96.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' A' ' 145' ' ' SER . 19.0 tttt -146.12 165.24 29.7 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.889 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.695 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 79.4 p -78.97 -2.85 42.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.68 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 111' ' ' SER . 58.7 p -129.45 150.58 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 108.831 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -132.39 161.57 33.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.101 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 m -104.24 147.1 27.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.437 -0.789 . . . . 0.0 109.437 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.599 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 40.5 mm -117.92 119.98 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.721 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 68.2 m-20 -121.87 176.83 5.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 110.463 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.93 50.05 5.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.809 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.595 HG22 ' C ' ' A' ' 106' ' ' THR . 2.6 tt -114.81 149.22 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.087 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -94.18 111.96 55.47 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 109.974 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.24 156.37 63.46 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.171 1.247 . . . . 0.0 112.945 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.663 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.02 23.69 76.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 184' ' ' THR . . . -136.1 137.1 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.059 -1.26 . . . . 0.0 109.706 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 53.7 t0 -60.04 140.01 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.727 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -134.28 172.07 13.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.866 -1.146 . . . . 0.0 111.055 -178.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -146.44 124.63 12.18 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.815 HD11 HD12 ' A' ' 108' ' ' LEU . 69.9 mt -111.61 125.95 68.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 120.296 -1.502 . . . . 0.0 109.155 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.9 m -124.44 141.05 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.371 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 1.047 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -124.05 140.49 52.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 111.427 -177.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 1.047 ' N ' HD12 ' A' ' 162' ' ' LEU . 7.0 m-85 -124.78 152.49 43.78 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.64 131.49 54.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.816 -1.177 . . . . 0.0 109.875 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.02 130.02 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.549 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.633 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 2.8 p -116.73 -70.75 0.77 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 109.945 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.633 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -70.58 143.01 36.23 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.484 ' HG2' HH11 ' A' ' 168' ' ' ARG . 75.9 mtp85 -134.3 136.33 43.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -1.08 . . . . 0.0 109.088 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 149.67 -148.65 20.16 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -74.35 -14.3 60.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -1.138 . . . . 0.0 109.116 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.9 m -132.44 75.23 74.29 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.555 -0.716 . . . . 0.0 109.496 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.4 -177.68 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.429 1.419 . . . . 0.0 111.905 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -155.45 126.9 7.29 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.472 -0.768 . . . . 0.0 109.962 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 p -132.55 141.93 48.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 108.991 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.2 p -80.08 170.03 17.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 108.47 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -63.57 118.42 44.28 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.1 Cg_exo -61.98 150.59 85.72 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.034 1.156 . . . . 0.0 113.393 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.468 HG12 HD23 ' A' ' 98' ' ' LEU . 2.9 t -120.73 131.05 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 97.4 p -117.2 154.03 31.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.09 -1.006 . . . . 0.0 111.475 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 98' ' ' LEU . 48.3 pt -137.58 164.69 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -111.32 138.78 47.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.171 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.47 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 64.9 t80 -136.05 126.85 27.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.072 -1.017 . . . . 0.0 109.952 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -100.82 129.24 46.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.281 -0.887 . . . . 0.0 108.834 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.3 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.253 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 121.417 0.627 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -79.69 135.99 36.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.311 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -85.25 139.97 36.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.127 -0.983 . . . . 0.0 109.667 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.687 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_exo -57.82 143.29 95.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.214 1.276 . . . . 0.0 111.943 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 p -150.57 -153.29 0.48 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 20.12 76.0 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 105.494 -3.043 . . . . 0.0 105.494 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -52.71 127.35 22.86 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.594 0.711 . . . . 0.0 110.09 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 10' ' ' SER . 53.2 t0 -147.83 141.15 25.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.624 ' CB ' ' OE1' ' A' ' 88' ' ' GLN . 81.9 p -111.46 145.89 38.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.956 -1.09 . . . . 0.0 110.255 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 12' ' ' ASP . 80.2 p -169.45 -175.91 2.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.547 -0.721 . . . . 0.0 109.346 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 49.94 44.3 25.38 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -80.03 129.99 36.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.764 -178.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.22 162.06 20.02 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.812 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.16 -60.01 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.999 -1.063 . . . . 0.0 110.287 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.61 0.14 57.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.957 -1.089 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 14' ' ' THR . 80.0 p -149.64 158.67 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.429 -0.794 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.684 ' CE2' HG22 ' A' ' 20' ' ' VAL . 26.0 p90 -165.54 148.28 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -97.26 149.86 21.58 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.289 -1.507 . . . . 0.0 111.607 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 18' ' ' PHE . 1.4 t -122.44 140.44 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -129.83 145.59 51.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.743 -1.223 . . . . 0.0 111.086 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 46.8 p90 -149.66 158.42 44.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.02 158.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.879 -1.138 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -94.25 136.56 23.36 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.717 -0.614 . . . . 0.0 109.813 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 2.8 Cg_endo -59.17 176.15 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.012 1.141 . . . . 0.0 112.407 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -102.54 9.97 39.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.82 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -112.01 157.22 40.33 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.995 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.8 Cg_endo -57.48 122.09 11.18 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.74 1.627 . . . . 0.0 112.619 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 29.7 pt -130.03 165.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.295 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 76' ' ' ASN . 70.4 p -106.66 -7.99 17.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.24 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.35 -179.18 22.62 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.585 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 16.3 m-85 -125.0 147.53 48.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.194 . . . . 0.0 109.207 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' HG3' ' A' ' 49' ' ' ARG . 29.4 mm -102.1 126.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.589 HD11 HG22 ' A' ' 50' ' ' VAL . 3.2 mm -103.78 116.74 48.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.972 -1.08 . . . . 0.0 110.214 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -117.23 131.46 56.84 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.613 ' HB2' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.02 149.93 43.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.33 -1.481 . . . . 0.0 111.275 -178.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -169.76 154.92 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.372 -0.83 . . . . 0.0 108.914 179.05 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.477 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 42.9 mtt-85 . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.599 0.714 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.435 HE21 ' HD2' ' A' ' 49' ' ' ARG . 64.0 tt0 -117.85 112.56 20.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.587 0.708 . . . . 0.0 110.017 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.9 m-20 -124.11 129.96 51.74 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.697 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -118.77 145.18 45.79 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.859 -1.15 . . . . 0.0 109.664 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 HD11 ' A' ' 34' ' ' ILE . 27.1 m -131.52 149.07 72.49 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.963 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.17 157.76 51.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.889 1.059 . . . . 0.0 111.53 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.51 -35.4 98.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 121.363 1.375 . . . . 0.0 112.05 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -70.35 -13.71 62.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.534 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -97.49 120.0 37.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 110.005 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.401 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 30.3 p-10 -108.87 -1.25 19.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.592 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.7 p -129.99 137.57 50.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 109.366 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.562 HD13 HG21 ' A' ' 34' ' ' ILE . 8.6 tt -129.99 130.13 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 m -95.85 119.16 33.84 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.316 -0.865 . . . . 0.0 109.137 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' ' 62' ' ' LEU . 12.2 mt -93.04 146.04 23.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.0 p -136.35 178.36 7.12 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.581 . . . . 0.0 109.932 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 56.18 44.19 25.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.301 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.753 HD11 ' HB3' ' A' ' 59' ' ' LEU . 14.6 mt -113.65 152.89 29.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.478 -0.764 . . . . 0.0 109.623 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.644 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 31.4 t-20 -70.11 120.02 75.45 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.117 -0.989 . . . . 0.0 108.733 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.812 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 138.82 75.35 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.988 1.125 . . . . 0.0 113.192 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.94 63.34 3.03 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -155.04 150.1 26.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.196 -1.179 . . . . 0.0 110.912 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 11.5 pt-20 -85.73 122.28 29.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.644 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 34.6 m-85 -111.54 139.96 46.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 110.481 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.776 HG22 HE22 ' A' ' 87' ' ' GLN . 18.8 t -96.56 120.12 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 36' ' ' HIS . 47.4 t -120.13 130.02 74.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.437 ' CB ' HG12 ' A' ' 85' ' ' ILE . 88.7 p -118.5 139.91 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.63 129.99 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.46 129.26 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.741 -1.224 . . . . 0.0 109.21 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.756 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -96.62 127.36 42.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.099 -1.001 . . . . 0.0 109.01 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.82 142.98 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.86 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CG ' ' O ' ' A' ' 76' ' ' ASN . 6.7 t-20 -123.03 37.02 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 108.806 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.6 -94.82 1.82 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -94.71 -6.24 43.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 0.0 110.042 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.55 140.01 49.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.938 -1.101 . . . . 0.0 109.724 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.6 139.96 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.756 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -92.54 169.55 10.52 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.19 133.6 44.57 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.225 1.283 . . . . 0.0 112.218 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.1 155.95 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.473 1.449 . . . . 0.0 113.655 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 5' ' ' PRO . 17.8 tp -131.82 121.14 23.62 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.4 mt -128.56 139.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.813 -1.179 . . . . 0.0 110.427 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.55 166.88 26.37 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.776 HE22 HG22 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -119.54 137.81 53.58 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.062 -1.257 . . . . 0.0 110.039 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.624 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 62.1 tp60 -134.76 135.95 42.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.714 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.53 136.78 42.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.762 HG11 ' HB2' ' A' ' 116' ' ' ALA . 3.7 t . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.52 0.676 . . . . 0.0 110.884 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.479 HG21 HG23 ' A' ' 178' ' ' VAL . 6.4 mt . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.45 -165.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 N-CA-C 109.57 -0.973 . . . . 0.0 109.57 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -157.54 165.6 35.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.51 -1.369 . . . . 0.0 110.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 69.91 37.14 1.83 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.717 -0.614 . . . . 0.0 110.457 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.495 HD13 ' CD2' ' A' ' 162' ' ' LEU . 46.7 tp -73.05 102.43 3.52 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -150.62 170.04 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.606 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 24.6 t -100.86 135.86 35.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.625 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -104.04 -14.91 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.71 0.767 . . . . 0.0 109.055 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -139.72 148.23 42.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.437 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 28.5 t -132.38 119.7 21.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.107 . . . . 0.0 110.793 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -118.39 153.53 51.83 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -49.97 -42.04 46.38 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.796 1.664 . . . . 0.0 113.479 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -119.1 10.39 12.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.908 -1.12 . . . . 0.0 110.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.073 ' O ' HD23 ' A' ' 108' ' ' LEU . 76.8 p -152.05 160.94 43.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.823 -1.173 . . . . 0.0 110.209 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.073 HD23 ' O ' ' A' ' 107' ' ' SER . 1.5 mt -143.8 155.26 44.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.376 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.827 HD13 ' N ' ' A' ' 110' ' ' ILE . 2.1 tm? -99.98 127.21 46.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.827 ' N ' HD13 ' A' ' 109' ' ' LEU . 5.8 pt -110.54 139.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 110.251 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.554 ' HA ' HG22 ' A' ' 146' ' ' THR . 53.3 m -138.25 141.94 39.9 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.612 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.603 ' CD2' ' O ' ' A' ' 145' ' ' SER . 43.5 p90 -154.63 159.97 41.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.138 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.83 130.16 32.34 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 109.226 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.93 141.37 96.41 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 120.853 1.035 . . . . 0.0 112.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.87 -162.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.007 1.138 . . . . 0.0 112.379 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.762 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -104.2 17.12 24.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.147 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.0 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.289 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 t -69.97 130.66 42.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.331 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.645 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 41.1 t -115.93 130.01 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.412 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 166' ' ' THR . 26.9 mmt180 -71.71 -45.93 60.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.48 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 11.4 p90 -166.58 167.04 15.79 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.645 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -120.4 139.83 52.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 55.4 ttp180 -96.95 130.06 44.32 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.972 -1.08 . . . . 0.0 108.423 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.527 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 62.8 mt -119.25 130.25 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -106.22 146.89 29.73 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.848 0.832 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.681 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.6 m-85 -94.6 132.21 39.54 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.73 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.38 117.67 5.46 Favored Glycine 0 C--O 1.206 -1.649 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.672 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 . . . . . 0 C--N 1.294 -1.834 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.728 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.484 1.227 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 126' ' ' TYR . 71.0 mt-30 -109.95 128.64 55.5 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.751 -1.179 . . . . 0.0 108.293 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -119.28 155.46 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.668 -1.27 . . . . 0.0 112.529 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 54.2 p90 -140.86 151.73 44.54 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.6 p -88.51 165.82 14.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.85 -1.156 . . . . 0.0 111.688 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 142' ' ' GLY . 72.9 t -132.71 95.6 19.57 Favored Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -59.8 44.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 120.787 0.991 . . . . 0.0 112.799 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 35.63 23.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.97 -35.93 74.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -1.152 . . . . 0.0 109.916 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -139.92 153.68 47.02 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.522 -0.736 . . . . 0.0 109.832 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.603 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 88.6 p -79.9 -9.98 59.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.386 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 111' ' ' SER . 45.5 p -128.15 152.31 48.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.733 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -141.01 169.4 17.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -112.72 139.98 47.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -0.916 . . . . 0.0 108.943 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 110' ' ' ILE . 32.9 mm -108.56 120.91 60.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 108.725 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.681 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 73.2 m-20 -124.11 168.68 12.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 32.2 t30 77.15 44.98 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.935 HG23 ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -113.01 130.04 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -72.85 121.87 86.14 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.0 109.941 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.03 159.41 42.71 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.27 1.313 . . . . 0.0 113.145 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 23.06 61.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 184' ' ' THR . . . -127.89 133.26 49.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.114 -1.227 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 54.8 t0 -59.96 140.07 56.98 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.935 ' CE2' HG23 ' A' ' 152' ' ' ILE . 1.4 m-85 -132.38 161.52 33.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.681 -1.262 . . . . 0.0 111.057 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.547 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 2.4 m -134.28 120.86 20.49 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.664 HD11 HD12 ' A' ' 108' ' ' LEU . 6.7 mt -107.16 120.18 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.154 -1.591 . . . . 0.0 108.97 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 179' ' ' SER . 88.3 m -132.54 149.97 52.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.495 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.3 pp -143.13 151.22 40.46 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.602 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.0 OUTLIER -120.91 140.01 52.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.66 131.48 49.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.745 -1.222 . . . . 0.0 109.778 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 72.4 t -119.62 121.21 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.366 -0.834 . . . . 0.0 109.797 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.468 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 16.5 p . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 24.4 p . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.1 p -79.94 170.13 16.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.072 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -57.03 124.59 66.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.065 -1.022 . . . . 0.0 108.383 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.482 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 2.7 Cg_endo -63.34 150.34 88.83 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 120.905 1.07 . . . . 0.0 113.641 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.479 HG23 HG21 ' A' ' 94' ' ' ILE . 1.9 t -116.18 131.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 161' ' ' THR . 80.2 p -130.03 154.12 47.74 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.009 . . . . 0.0 111.811 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.12 159.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -103.09 139.98 37.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.73 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 35.2 t80 -138.11 131.33 30.34 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.902 -1.124 . . . . 0.0 110.494 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.635 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 19.8 pttp -94.09 138.41 32.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 108.93 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 156' ' ' ALA . 1.3 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.429 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' A' ' 81' ' ' SER . 98.2 mt . . . . . 0 N--CA 1.487 1.387 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.96 159.27 28.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' THR . 42.7 t -94.29 130.02 35.29 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.886 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.549 ' CD ' ' HB2' ' A' ' 74' ' ' ALA . 2.8 Cg_endo -58.81 72.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.106 1.204 . . . . 0.0 111.788 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -79.55 -153.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.013 -1.054 . . . . 0.0 109.611 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.94 22.62 78.4 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -58.21 130.28 45.91 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.505 0.669 . . . . 0.0 110.291 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -147.5 123.91 10.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.739 ' CB ' HE21 ' A' ' 88' ' ' GLN . 0.3 OUTLIER -103.23 130.28 50.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 109.876 -179.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' ASP . 88.3 p -154.84 -172.4 4.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.159 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.0 49.89 19.5 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -88.48 126.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.905 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -113.82 162.45 16.32 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -59.96 -51.57 69.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 18.8 m120 -97.7 -0.11 46.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.907 -1.121 . . . . 0.0 109.887 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.695 ' O ' ' N ' ' A' ' 14' ' ' THR . 18.1 m -150.47 155.01 38.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.841 ' CE1' HG22 ' A' ' 20' ' ' VAL . 28.4 p90 -163.12 150.16 12.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 108.986 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -92.99 143.65 26.03 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.484 -1.385 . . . . 0.0 111.381 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.841 HG22 ' CE1' ' A' ' 18' ' ' PHE . 2.0 t -116.14 137.19 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.482 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 77.6 m-70 -130.48 149.52 52.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.65 -1.281 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.447 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 36.6 p90 -155.63 160.01 40.08 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.53 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 120.743 -1.223 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.41 ' N ' HG13 ' A' ' 23' ' ' VAL . . . -94.54 132.58 28.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.793 -0.567 . . . . 0.0 109.915 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HG2' HG21 ' A' ' 29' ' ' ILE . 2.9 Cg_endo -59.68 151.8 67.44 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.998 1.132 . . . . 0.0 112.201 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -65.78 -40.03 91.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.34 147.7 98.84 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.66 138.36 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.426 1.418 . . . . 0.0 112.232 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.671 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 33.3 pt -132.6 168.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.733 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -103.66 -0.47 29.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.407 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.56 -173.62 23.01 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.671 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 44.6 m-85 -130.01 157.06 43.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.226 -1.161 . . . . 0.0 109.506 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.611 ' C ' HD13 ' A' ' 34' ' ' ILE . 37.2 mm -110.03 130.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.689 HG23 ' CD1' ' A' ' 72' ' ' ILE . 2.0 mm -117.58 121.2 66.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.927 -1.108 . . . . 0.0 110.403 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.434 HH12 HG13 ' A' ' 73' ' ' ILE . 57.3 mtt180 -121.87 137.4 54.8 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.08 138.77 39.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.618 -1.301 . . . . 0.0 110.849 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -167.74 160.02 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.702 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.467 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.849 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 . . . . . 0 N--CA 1.48 1.038 0 CA-C-O 121.547 0.689 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.559 ' NE2' HH12 ' A' ' 49' ' ' ARG . 14.6 pt20 -120.66 122.02 39.57 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.609 0.719 . . . . 0.0 109.538 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -125.84 125.96 43.71 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.56 ' HD2' HG23 ' A' ' 33' ' ' ILE . 1.9 mmt-85 -108.94 147.3 32.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.108 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.701 ' CG1' HD12 ' A' ' 57' ' ' ILE . 28.2 m -127.24 147.44 61.96 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 110.175 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.03 159.52 46.14 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 120.955 1.103 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.39 -33.65 97.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 121.383 1.389 . . . . 0.0 111.926 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -69.97 -12.76 61.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.574 -0.704 . . . . 0.0 110.471 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -99.95 110.53 22.86 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -99.57 -1.5 38.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 108.788 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.482 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 78.5 p -138.24 136.07 36.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.701 HD12 ' CG1' ' A' ' 50' ' ' VAL . 7.2 tt -129.96 136.62 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 m -100.48 114.63 28.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.478 ' HB3' HD11 ' A' ' 62' ' ' LEU . 11.1 mt -88.48 149.97 23.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 109.556 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.427 HG22 ' OG ' ' A' ' 17' ' ' SER . 27.3 p -136.01 177.89 7.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.743 -0.598 . . . . 0.0 109.96 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.9 m120 56.27 46.26 21.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.61 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 59' ' ' LEU . 44.0 mt -109.96 153.2 24.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.827 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.424 ' H ' HD22 ' A' ' 63' ' ' ASN . 2.3 m-80 -67.47 118.95 61.8 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 0.0 108.508 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.699 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.6 Cg_endo -62.84 129.83 27.4 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.893 1.062 . . . . 0.0 112.736 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.63 61.33 3.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -142.72 135.51 28.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -1.2 . . . . 0.0 111.464 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 89' ' ' ALA . 99.1 mt-10 -91.03 117.03 29.26 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.731 ' OH ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -133.61 173.78 11.14 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.308 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.63 136.45 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.54 129.94 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -115.93 140.97 48.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.689 ' CD1' HG23 ' A' ' 34' ' ' ILE . 48.6 mm -119.95 120.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.434 HG13 HH12 ' A' ' 35' ' ' ARG . 34.2 mm -115.36 129.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 108.666 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -92.84 129.91 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.751 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.01 159.99 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -140.49 38.45 1.87 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.92 -97.61 1.62 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -99.6 0.03 41.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 110.082 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -111.46 151.68 28.3 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.691 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -129.56 153.93 47.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -107.22 176.8 1.49 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 108.977 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 81' ' ' SER . 3.6 Cg_exo -65.75 131.44 27.53 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.035 1.157 . . . . 0.0 111.628 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.74 140.89 95.1 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.2 1.267 . . . . 0.0 113.384 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.1 tp -119.98 116.73 26.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -128.12 139.94 50.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.7 162.4 26.62 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -110.36 149.61 29.98 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.155 -1.203 . . . . 0.0 109.671 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.739 HE21 ' CB ' ' A' ' 10' ' ' SER . 17.4 tt0 -148.46 156.48 42.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.379 -0.826 . . . . 0.0 108.98 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' N ' ' HG2' ' A' ' 88' ' ' GLN . . . -121.37 123.62 42.57 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.658 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.731 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.32 142.89 47.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.808 0 CA-C-O 121.48 0.657 . . . . 0.0 110.673 -179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 178' ' ' VAL . 3.1 mt . . . . . 0 N--CA 1.492 1.643 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD2' HG22 ' A' ' 94' ' ' ILE . 3.6 Cg_exo -58.78 -170.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 109.946 -0.828 . . . . 0.0 109.946 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 38.2 ttm180 -149.89 160.0 43.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.503 -1.373 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.479 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 14.6 t0 72.6 36.22 1.01 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.682 -0.636 . . . . 0.0 110.871 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.664 HD22 HD13 ' A' ' 180' ' ' ILE . 2.2 tt -68.01 102.9 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 97' ' ' ASP . 47.4 mt-10 -149.92 169.65 20.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.334 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.9 t -110.16 131.74 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.44 -0.787 . . . . 0.0 109.605 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -25.26 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.46 -0.775 . . . . 0.0 109.633 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -127.35 135.94 51.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.607 -0.683 . . . . 0.0 109.158 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.595 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 18.5 t -118.62 116.11 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.142 -0.974 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -105.66 155.82 37.51 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 121.313 -0.867 . . . . 0.0 108.903 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.61 -35.35 56.53 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.661 1.574 . . . . 0.0 112.931 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.481 ' C ' HG22 ' A' ' 152' ' ' ILE . 56.4 p -128.75 16.36 6.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.992 -1.067 . . . . 0.0 110.412 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.079 ' O ' HD23 ' A' ' 108' ' ' LEU . 29.0 p -158.66 169.34 24.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.806 -1.184 . . . . 0.0 110.01 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.079 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -144.81 153.41 41.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.68 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 110' ' ' ILE . 4.5 tt -101.88 125.66 48.61 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.713 HD11 ' HB3' ' A' ' 147' ' ' ALA . 11.6 pt -114.01 152.12 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.048 -1.033 . . . . 0.0 111.117 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.2 t -147.47 140.31 24.91 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -147.61 160.0 43.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.04 130.16 32.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.73 138.68 84.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.851 1.034 . . . . 0.0 112.167 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.63 -160.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.119 1.213 . . . . 0.0 112.557 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.48 12.24 36.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 33.2 m -130.01 160.1 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 0.0 109.221 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 84.0 p -68.59 149.96 48.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 109.013 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.4 137.32 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -71.51 -53.5 13.66 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CE2' HG22 ' A' ' 139' ' ' THR . 26.4 p90 -167.37 170.32 11.56 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 3.5 m-85 -118.29 135.92 54.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.814 -1.179 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.592 ' NH2' ' CG ' ' A' ' 163' ' ' TYR . 28.5 ttp-105 -98.53 125.04 43.62 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.829 -1.17 . . . . 0.0 107.9 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.589 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 85.4 mt -111.17 133.46 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.075 -1.016 . . . . 0.0 110.135 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 137' ' ' GLU . 3.1 p -105.55 145.12 31.37 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.916 0.865 . . . . 0.0 111.282 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.698 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.3 m-85 -92.41 120.28 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.93 129.65 9.72 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.903 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 . . . . . 0 C--N 1.294 -1.819 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.388 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.489 1.477 0 CA-C-O 121.443 0.64 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 126' ' ' TYR . 96.8 mm-40 -117.49 138.08 52.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.734 ' HB3' HG22 ' A' ' 125' ' ' THR . 21.9 pt-20 -128.8 160.02 33.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.761 -1.212 . . . . 0.0 112.246 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 50.4 p90 -144.61 157.12 44.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.475 HG22 ' CE2' ' A' ' 121' ' ' TYR . 7.2 p -87.5 164.94 15.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.901 -1.124 . . . . 0.0 110.939 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 t -128.88 118.3 19.61 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.481 -0.762 . . . . 0.0 110.625 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.3 Cg_exo -59.04 130.47 36.61 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-N 119.273 0.776 . . . . 0.0 111.819 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.72 2.71 2.4 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 141' ' ' PRO . 52.5 m -89.98 -2.9 58.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -1.204 . . . . 0.0 110.113 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -128.81 138.73 52.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.02 -1.05 . . . . 0.0 109.728 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -94.36 -7.39 41.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.189 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.4 p -133.41 153.27 51.75 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.713 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -138.4 175.4 9.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.853 -1.154 . . . . 0.0 109.757 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 t -120.38 146.93 45.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.689 HD11 HD13 ' A' ' 110' ' ' ILE . 32.8 mm -113.16 120.74 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.149 -0.969 . . . . 0.0 109.44 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.698 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 35.6 m120 -123.76 177.51 5.68 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.245 -0.909 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 m120 59.97 46.52 10.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.493 HG12 ' CZ ' ' A' ' 158' ' ' TYR . 4.8 tt -107.68 153.67 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.43 ' N ' ' OH ' ' A' ' 158' ' ' TYR . 13.1 mmtt -97.66 109.97 53.08 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.008 -1.058 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.43 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.4 Cg_endo -68.42 173.16 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.305 1.336 . . . . 0.0 113.036 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.34 27.29 71.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -152.81 155.81 37.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.981 -1.305 . . . . 0.0 109.975 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 48.5 t0 -72.91 155.23 40.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.704 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-85 -142.43 160.02 41.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.858 -1.152 . . . . 0.0 110.774 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.473 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.7 m -135.09 120.5 19.13 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 108' ' ' LEU . 98.4 mt -105.58 121.58 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.228 -1.545 . . . . 0.0 108.901 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 125' ' ' THR . 50.8 m -129.97 142.05 50.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 162' ' ' LEU . 1.4 pp -136.45 152.4 50.53 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.678 -1.209 . . . . 0.0 111.42 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.2 m-85 -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.53 132.61 47.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.699 -1.251 . . . . 0.0 109.541 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.65 124.06 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.634 -0.666 . . . . 0.0 109.694 -179.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.259 0.552 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 85.0 p -79.34 170.0 17.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 108.807 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.454 ' HB2' HD11 ' A' ' 94' ' ' ILE . 6.2 mttm -56.2 129.06 73.54 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 108.756 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.3 Cg_endo -62.02 144.53 96.32 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.105 1.204 . . . . 0.0 113.217 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 94' ' ' ILE . 2.1 t -113.54 128.6 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 81.1 p -123.29 150.04 44.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 111.703 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.664 HD13 HD22 ' A' ' 98' ' ' LEU . 39.5 pt -133.85 159.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -104.84 139.33 39.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.947 -1.095 . . . . 0.0 109.002 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.604 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 62.4 t80 -135.33 130.38 34.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.593 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.1 139.99 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 108.946 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 109.479 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 N--CA 1.484 1.259 0 CA-C-O 121.49 0.662 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -74.41 149.22 40.56 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.424 -0.798 . . . . 0.0 108.982 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' THR . 47.5 t -82.5 132.17 53.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.989 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_endo -59.04 79.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.129 1.22 . . . . 0.0 111.591 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 4' ' ' SER . 1.0 OUTLIER -85.9 -159.56 0.47 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.787 -1.195 . . . . 0.0 110.241 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 79.24 19.05 72.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.572 ' HB2' HD21 ' A' ' 84' ' ' LEU . 57.3 t80 -59.97 134.83 57.41 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.643 0.735 . . . . 0.0 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 10' ' ' SER . 39.8 t0 -158.98 148.8 19.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 90.0 p -113.98 132.43 55.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.934 -1.104 . . . . 0.0 109.553 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 12' ' ' ASP . 37.3 p -149.22 -175.95 5.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.048 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 11' ' ' SER . 78.2 m-20 47.57 46.94 17.79 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.791 HG22 HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -82.64 127.92 39.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.152 -177.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.681 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.04 161.39 18.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.764 ' H ' ' HB1' ' A' ' 116' ' ' ALA . . . -63.32 -54.37 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.775 -1.203 . . . . 0.0 109.902 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.08 0.01 57.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.052 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 14' ' ' THR . 97.6 p -155.53 158.91 39.23 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.371 -0.831 . . . . 0.0 109.01 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CD1' ' NE2' ' A' ' 88' ' ' GLN . 30.4 p90 -163.02 151.03 13.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 109.529 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 m -95.36 157.1 16.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.54 -1.35 . . . . 0.0 111.518 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.65 ' C ' ' CD2' ' A' ' 21' ' ' HIS . 1.1 t -128.4 160.0 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.65 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.7 m-70 -150.87 154.11 36.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.84 -1.162 . . . . 0.0 110.589 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 47.4 p90 -153.69 160.01 42.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.509 -0.745 . . . . 0.0 109.19 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -84.63 157.83 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.995 -1.066 . . . . 0.0 109.768 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 23' ' ' VAL . . . -99.06 120.44 58.39 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.1 149.71 87.84 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.819 1.013 . . . . 0.0 112.19 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -78.83 -12.39 60.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.187 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -72.21 150.56 92.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.259 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.82 126.05 20.54 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.323 1.349 . . . . 0.0 112.719 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 28.4 pt -136.52 166.55 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.438 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 p -115.71 -3.31 12.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.9 -175.51 28.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.68 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 55.1 m-85 -131.57 151.36 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -1.199 . . . . 0.0 109.997 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 32' ' ' TYR . 1.4 mp -112.71 132.6 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 72' ' ' ILE . 2.2 mm -118.16 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.03 -1.044 . . . . 0.0 110.96 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -119.43 138.4 53.13 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.432 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 8.3 t60 -129.91 139.94 51.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.553 -1.342 . . . . 0.0 111.221 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.446 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 28.8 p-80 -163.61 153.19 14.8 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.3 0.572 . . . . 0.0 109.979 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.899 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 0.0 109.338 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 121.421 0.629 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -121.11 109.91 15.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.0 109.979 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' ILE . 91.7 m-20 -120.79 125.93 48.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.541 ' NH1' HG23 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -109.27 151.77 26.11 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.01 -1.056 . . . . 0.0 108.731 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.599 HG22 HD11 ' A' ' 34' ' ' ILE . 27.8 m -130.98 145.2 56.76 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.908 -1.12 . . . . 0.0 110.113 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.04 160.4 38.02 Favored 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 120.999 1.133 . . . . 0.0 111.837 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.14 -32.66 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.588 1.525 . . . . 0.0 112.298 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 m -74.84 -10.95 59.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.0 111.101 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.81 117.83 35.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.149 . . . . 0.0 109.872 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -104.14 -0.01 29.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.462 -0.774 . . . . 0.0 109.489 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.7 p -130.94 139.91 50.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.902 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 9.1 tt -130.04 130.22 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 m -98.94 120.88 40.13 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.173 -0.955 . . . . 0.0 109.979 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.9 mt -97.21 138.11 35.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.222 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -123.3 179.48 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 53.74 48.56 21.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.923 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 59' ' ' LEU . 55.5 mt -111.54 158.26 19.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.338 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.674 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 10.8 m120 -69.94 129.99 90.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.36 132.66 39.44 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.336 1.357 . . . . 0.0 113.505 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 67.08 65.84 2.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.602 ' N ' ' OG1' ' A' ' 90' ' ' THR . 1.2 m -149.86 151.85 34.15 Favored 'General case' 0 N--CA 1.506 2.341 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.188 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 49.6 mp0 -92.66 119.96 32.6 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.899 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 50.0 m-85 -111.23 140.51 45.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.117 -0.99 . . . . 0.0 110.799 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.446 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 15.2 t -92.7 121.42 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.99 125.6 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 109.708 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -99.59 135.33 41.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.673 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.662 HD13 HG23 ' A' ' 34' ' ' ILE . 48.5 mm -116.51 129.97 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 74' ' ' ALA . 80.4 mt -127.67 160.01 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 110.152 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.553 ' N ' HG22 ' A' ' 73' ' ' ILE . . . -128.54 131.94 48.25 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.1 m -128.31 151.21 34.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.222 -0.924 . . . . 0.0 109.295 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -126.25 33.84 4.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -0.945 . . . . 0.0 108.515 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.83 -89.33 1.27 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 40.7 ttm-85 -89.97 -19.38 24.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -1.061 . . . . 0.0 110.386 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -104.36 150.32 24.6 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 110.788 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -120.63 147.34 45.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.078 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -104.16 160.87 24.66 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.164 -0.96 . . . . 0.0 109.316 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.89 129.96 31.01 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.184 1.256 . . . . 0.0 112.298 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.91 145.25 98.77 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.294 1.329 . . . . 0.0 113.5 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 8' ' ' PHE . 13.3 tp -119.89 119.34 33.21 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -120.02 130.04 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.974 -1.078 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.15 168.79 22.86 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -121.88 147.77 45.58 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 109.889 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.798 ' NE2' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -142.29 159.27 42.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -119.08 135.36 54.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.083 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -73.84 133.6 43.21 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.791 HG23 HG22 ' A' ' 13' ' ' ILE . 39.7 t . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 122.008 0.909 . . . . 0.0 111.547 -178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 176' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.698 ' HD2' HG23 ' A' ' 94' ' ' ILE . 3.1 Cg_exo -61.7 -158.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 120.635 0.89 . . . . 0.0 111.205 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.555 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 40.5 ttp180 -154.14 166.69 32.29 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.098 -1.001 . . . . 0.0 109.812 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.555 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 15.7 t0 74.96 35.08 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.503 -0.748 . . . . 0.0 109.831 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.401 HD13 HD23 ' A' ' 162' ' ' LEU . 44.3 tp -67.6 107.0 2.36 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -158.51 163.55 36.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.58 139.96 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 pt -118.08 -16.0 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.115 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -140.67 130.04 23.83 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.468 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 6.2 m -117.42 119.76 36.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.019 . . . . 0.0 109.805 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.604 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -101.95 158.07 32.48 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.18 -35.56 52.72 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.312 1.341 . . . . 0.0 112.497 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.425 ' C ' HG22 ' A' ' 152' ' ' ILE . 68.4 p -130.14 18.4 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.031 -1.043 . . . . 0.0 110.245 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.607 ' O ' HD23 ' A' ' 108' ' ' LEU . 2.4 p -154.16 160.07 41.72 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.877 -1.139 . . . . 0.0 109.91 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.802 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -133.38 150.13 51.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 108.653 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 110' ' ' ILE . 4.7 tt -105.2 120.09 40.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 108.898 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.3 pt -99.97 138.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.683 ' HA ' HG22 ' A' ' 146' ' ' THR . 32.5 t -132.56 133.92 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -145.72 144.89 30.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 1.8 pt-20 -72.3 145.97 88.79 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.934 -1.103 . . . . 0.0 108.575 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.53 136.56 74.97 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 120.962 1.108 . . . . 0.0 111.744 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.31 -163.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 120.332 0.688 . . . . 0.0 111.364 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.764 ' HB1' ' H ' ' A' ' 15' ' ' ALA . . . -113.74 11.68 18.15 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.221 -0.924 . . . . 0.0 108.986 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 33.1 m -129.97 159.99 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -71.16 133.06 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.933 . . . . 0.0 108.789 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.666 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 14.6 t -122.78 134.59 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.074 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -72.3 -52.29 16.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 14.1 p90 -166.84 170.11 12.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.5 m-85 -122.15 143.87 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.963 . . . . 0.0 108.412 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.629 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 54.6 ttt-85 -103.71 126.04 50.58 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.692 -1.255 . . . . 0.0 107.906 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.674 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 50.2 mt -116.56 144.1 25.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.521 HG22 HH21 ' A' ' 123' ' ' ARG . 36.0 p -118.31 144.49 45.8 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.832 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.735 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.9 m-85 -87.9 131.36 34.61 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.52 115.25 4.66 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.922 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 34.2 mt-10 . . . . . 0 C--N 1.299 -1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.63 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 83.6 mt-30 -117.95 136.61 53.38 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.265 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.629 ' CD ' ' HE ' ' A' ' 123' ' ' ARG . 10.6 pt-20 -123.17 144.32 49.43 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.261 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.674 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 52.2 p90 -138.49 158.87 43.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 121' ' ' TYR . 4.0 p -94.25 167.0 11.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.905 -1.122 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 142' ' ' GLY . 98.0 t -135.17 85.64 33.1 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.5 Cg_exo -58.87 50.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 120.996 1.131 . . . . 0.0 113.162 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 34.95 24.54 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 141' ' ' PRO . 79.6 p -61.64 -39.98 93.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -1.18 . . . . 0.0 109.763 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -145.58 171.13 15.14 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.112 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 99.5 p -84.35 -1.17 55.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.581 -0.699 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 111' ' ' SER . 68.4 p -130.73 151.31 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 108.993 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -126.78 148.92 49.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.972 -1.08 . . . . 0.0 109.79 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.419 ' CG2' HD21 ' A' ' 150' ' ' ASN . 1.8 m -94.02 143.19 26.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.11 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.608 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 37.3 mm -115.19 121.33 66.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.735 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 14.3 m120 -127.11 170.0 12.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.703 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 19.0 m120 68.34 48.6 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.0 109.816 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.574 ' CD1' HD11 ' A' ' 108' ' ' LEU . 2.0 tt -113.74 147.34 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -95.45 111.13 54.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.848 -1.157 . . . . 0.0 109.654 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.429 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 2.8 Cg_endo -64.95 163.37 28.63 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.061 1.174 . . . . 0.0 112.705 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.96 72.49 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 184' ' ' THR . . . -146.36 146.79 30.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.31 . . . . 0.0 109.917 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 55.3 t0 -70.01 151.52 45.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.588 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.8 OUTLIER -138.1 173.16 11.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.86 -1.15 . . . . 0.0 111.225 -178.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -141.34 111.52 6.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.81 124.03 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.3 -1.5 . . . . 0.0 109.462 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -124.81 139.92 53.4 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.617 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 1.027 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -119.67 136.5 54.38 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -178.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 1.027 ' N ' HD12 ' A' ' 162' ' ' LEU . 51.0 m-85 -121.65 141.45 51.11 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.758 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -103.61 123.64 47.33 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 62.8 t -110.36 119.93 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.004 . . . . 0.0 109.84 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.453 -0.78 . . . . 0.0 108.949 179.367 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.2 p . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 121.563 0.697 . . . . 0.0 109.825 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.758 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 1.4 p -105.19 160.31 15.18 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.857 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -39.07 100.1 0.21 Allowed Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 121.088 -1.007 . . . . 0.0 110.148 -178.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.5 Cg_exo -62.69 159.27 37.85 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 121.818 1.679 . . . . 0.0 114.751 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.487 HG23 HG21 ' A' ' 94' ' ' ILE . 59.0 t -124.22 130.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 80.2 p -120.26 150.19 41.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.757 -1.215 . . . . 0.0 110.933 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.28 161.14 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.225 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -104.33 128.72 52.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 108.601 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.802 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 60.5 t80 -123.59 128.32 49.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 110.382 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -100.83 138.1 38.34 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.34 -0.85 . . . . 0.0 109.044 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.7 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.481 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.2 mt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -80.0 124.99 29.2 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 109.199 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.54 ' HG ' ' HG ' ' A' ' 81' ' ' SER . 53.5 m -78.75 146.9 69.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.783 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_exo -57.6 157.98 21.28 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 120.983 1.122 . . . . 0.0 111.681 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 5' ' ' PRO . 21.2 p -156.2 -144.36 0.13 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 109.646 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.14 19.47 24.01 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 105.249 -3.14 . . . . 0.0 105.249 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 6' ' ' THR . 59.6 t80 -54.91 130.03 39.8 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.83 0.824 . . . . 0.0 110.805 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 10' ' ' SER . 60.6 t0 -158.67 141.3 14.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 41.2 m -106.85 140.35 39.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.608 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 12' ' ' ASP . 60.8 p -152.98 -176.44 5.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' SER . 74.7 m-20 50.01 46.22 24.63 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.735 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -82.19 123.4 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.733 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.2 161.98 17.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.02 -57.61 12.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.813 -1.179 . . . . 0.0 110.049 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -91.1 -0.01 57.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.937 -1.102 . . . . 0.0 110.012 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 38.5 t -151.36 155.73 39.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.685 ' CZ ' ' OE1' ' A' ' 88' ' ' GLN . 20.5 p90 -162.9 145.76 10.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -94.78 151.11 19.52 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.463 -1.398 . . . . 0.0 111.531 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -120.1 134.83 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.417 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 49.9 m-70 -129.23 149.6 50.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.643 -1.286 . . . . 0.0 111.0 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 40.4 p90 -154.1 159.39 41.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -0.78 . . . . 0.0 109.175 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.36 155.66 3.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.044 -1.035 . . . . 0.0 109.941 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.14 135.41 34.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.849 -0.532 . . . . 0.0 109.751 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.79 -179.5 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 120.962 1.108 . . . . 0.0 112.139 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.53 12.46 26.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.722 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -113.2 158.33 38.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.015 . . . . 0.0 109.647 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.9 Cg_endo -56.54 130.3 39.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.777 1.651 . . . . 0.0 112.554 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 39.5 pt -138.92 170.02 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.395 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 p -117.98 0.27 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.715 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.43 -178.18 24.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 51.2 m-85 -130.14 151.29 50.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -1.13 . . . . 0.0 109.516 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.762 HG23 ' HD2' ' A' ' 49' ' ' ARG . 28.4 mm -110.01 129.99 63.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.671 HG21 HG21 ' A' ' 57' ' ' ILE . 1.9 mm -113.55 120.56 63.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.812 -1.18 . . . . 0.0 109.935 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -116.67 131.53 56.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -121.8 139.11 54.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.285 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -168.62 147.3 4.2 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.093 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.494 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 108.74 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 121.864 0.84 . . . . 0.0 111.404 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -112.83 113.51 25.62 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.519 ' O ' ' O ' ' A' ' 34' ' ' ILE . 85.6 m-20 -113.7 123.24 49.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.151 -0.968 . . . . 0.0 108.653 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.762 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -108.69 144.47 36.43 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.025 -1.047 . . . . 0.0 108.956 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.662 HG22 HD11 ' A' ' 34' ' ' ILE . 32.1 m -128.13 149.99 72.62 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.037 -1.04 . . . . 0.0 110.203 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.53 160.1 41.34 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.123 1.216 . . . . 0.0 111.724 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.92 -35.97 97.69 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.364 1.376 . . . . 0.0 112.38 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -70.23 -12.02 61.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 110.867 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -101.85 121.21 41.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.015 -1.053 . . . . 0.0 110.113 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -108.75 -0.0 20.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.61 -0.681 . . . . 0.0 109.699 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.417 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 57.3 p -130.34 139.95 50.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.183 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.671 HG21 HG21 ' A' ' 34' ' ' ILE . 6.4 tt -130.75 139.92 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.9 m -106.9 131.49 53.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.248 -0.908 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 62' ' ' LEU . 4.2 mt -112.07 148.08 34.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.806 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.4 p -135.06 179.66 6.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.862 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 57.47 40.72 26.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.368 -0.832 . . . . 0.0 109.539 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 59' ' ' LEU . 44.6 mt -107.31 156.83 18.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.4 -0.813 . . . . 0.0 109.409 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -69.99 120.21 76.46 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 108.618 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.695 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.9 Cg_endo -61.59 129.38 27.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 120.835 1.024 . . . . 0.0 112.966 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 76.17 60.76 3.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.2 m -145.47 152.02 39.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -1.125 . . . . 0.0 110.336 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 3.8 pt-20 -88.78 119.99 29.78 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.546 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 38.4 m-85 -112.72 139.98 47.88 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.057 -1.027 . . . . 0.0 110.617 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.99 121.35 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.0 121.59 67.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.405 ' CB ' HG12 ' A' ' 85' ' ' ILE . 13.0 p -100.88 140.99 34.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.623 ' CD1' HG23 ' A' ' 34' ' ' ILE . 49.7 mm -119.78 120.0 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.92 130.0 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.088 . . . . 0.0 109.612 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -93.4 139.42 30.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.91 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.0 139.45 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.135 -0.978 . . . . 0.0 109.615 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.448 HD21 ' HB2' ' A' ' 28' ' ' PRO . 41.7 t-20 -121.51 37.67 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 108.779 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.27 -100.66 2.58 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -91.63 -0.18 57.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.167 . . . . 0.0 110.325 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.26 141.57 48.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.06 . . . . 0.0 109.513 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.12 138.78 53.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.729 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -83.85 163.33 49.29 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' OG ' ' A' ' 4' ' ' SER . 3.1 Cg_exo -57.54 135.08 67.5 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 121.336 1.358 . . . . 0.0 111.945 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.93 130.93 40.75 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.251 1.301 . . . . 0.0 113.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 5' ' ' PRO . 19.5 tp -107.32 119.99 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.405 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -125.28 134.19 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.993 -1.067 . . . . 0.0 111.146 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.52 164.83 24.87 Favored Glycine 0 N--CA 1.479 1.542 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -114.69 131.11 56.85 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.921 -1.34 . . . . 0.0 110.084 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.685 ' OE1' ' CZ ' ' A' ' 18' ' ' PHE . 18.6 tm0? -123.87 128.32 49.3 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' O ' ' NE2' ' A' ' 88' ' ' GLN . . . -101.45 131.56 47.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.415 ' HA ' HE22 ' A' ' 88' ' ' GLN . 0.0 OUTLIER -74.43 136.65 42.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.735 HG23 HG22 ' A' ' 13' ' ' ILE . 3.9 t . . . . . 0 C--N 1.302 -1.471 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.447 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.514 HG21 HG23 ' A' ' 178' ' ' VAL . 6.7 mt . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HG2' HD21 ' A' ' 162' ' ' LEU . 3.3 Cg_exo -59.24 159.63 21.99 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 120.332 0.688 . . . . 0.0 110.541 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 24.0 mmt180 -120.57 172.5 7.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.826 -1.171 . . . . 0.0 110.959 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.59 39.99 29.59 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.668 HD13 HD23 ' A' ' 162' ' ' LEU . 41.7 tp -72.15 92.9 1.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.765 -1.209 . . . . 0.0 107.849 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.49 170.69 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.654 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -104.68 139.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 101' ' ' ILE . 1.1 pt -107.62 -15.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.258 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.3 134.79 34.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 99.87 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 110.334 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.704 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -81.93 156.8 69.67 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -49.03 -43.93 34.44 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.466 1.444 . . . . 0.0 112.95 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 152' ' ' ILE . 44.2 p -124.36 18.4 8.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.039 ' O ' HD23 ' A' ' 108' ' ' LEU . 37.7 p -153.76 165.77 34.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.862 -1.149 . . . . 0.0 109.898 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -140.69 154.22 46.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.561 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 109' ' ' LEU . 8.5 tt -104.96 119.99 40.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 147' ' ' ALA . 5.2 pt -106.68 145.99 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.987 . . . . 0.0 110.616 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 95.7 p -144.79 149.99 36.43 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.44 0.638 . . . . 0.0 109.778 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.606 ' CE2' ' O ' ' A' ' 145' ' ' SER . 43.8 p90 -149.84 154.87 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -76.0 134.67 71.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.065 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 127.92 26.17 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.771 0.981 . . . . 0.0 111.948 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.22 -178.22 0.19 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.058 1.172 . . . . 0.0 112.613 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 91' ' ' VAL . . . -100.37 10.26 41.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.84 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -71.7 138.73 48.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.01 135.9 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.468 -0.77 . . . . 0.0 109.079 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.691 ' NH1' ' O ' ' A' ' 166' ' ' THR . 80.6 mmt-85 -71.18 -51.45 24.73 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.774 -1.204 . . . . 0.0 107.947 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CE2' HG22 ' A' ' 139' ' ' THR . 6.5 p90 -167.52 174.57 7.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 17.4 m-85 -120.18 139.43 52.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.165 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 37.0 ttp-105 -100.46 129.96 46.48 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.72 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 16.6 mt -124.02 151.96 29.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.783 -1.198 . . . . 0.0 110.859 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 25.4 p -126.13 141.14 52.06 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.093 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.679 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.5 m-85 -84.11 129.54 34.9 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -109.17 131.01 10.3 Favored Glycine 0 N--CA 1.483 1.803 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.247 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 . . . . . 0 C--N 1.297 -1.715 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.51 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.485 1.323 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.627 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 22.2 mm100 -111.92 129.87 56.03 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.355 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 123' ' ' ARG . 65.4 tt0 -107.86 133.86 51.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.546 -0.721 . . . . 0.0 111.323 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.72 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 41.5 p90 -141.64 157.52 44.98 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.595 HG22 ' CE2' ' A' ' 121' ' ' TYR . 3.2 p -98.21 167.44 10.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.785 -1.197 . . . . 0.0 111.525 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 124' ' ' ILE . 88.1 t -132.18 118.68 16.3 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -57.6 127.99 27.53 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.507 0.804 . . . . 0.0 112.268 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.26 -4.55 0.83 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 141' ' ' PRO . 89.6 p -89.73 -0.05 57.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -1.233 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -124.88 132.96 53.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.889 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 97.7 p -93.13 0.05 57.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.477 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 15.1 p -139.12 158.12 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.661 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -139.95 169.95 16.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.819 -1.176 . . . . 0.0 109.916 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -118.92 142.59 47.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 109.391 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 31.4 mm -110.21 120.43 61.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.889 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.679 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 25.2 m120 -123.04 172.94 8.16 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -0.941 . . . . 0.0 110.283 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 61.1 49.82 5.38 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.728 0.775 . . . . 0.0 109.107 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 106' ' ' THR . 5.2 tt -108.98 153.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.75 110.02 55.63 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 110.147 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 2.5 Cg_endo -68.43 170.04 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.156 1.237 . . . . 0.0 112.492 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.98 20.03 75.89 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.547 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -146.48 150.8 36.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.043 -1.269 . . . . 0.0 109.701 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.643 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.3 t0 -70.02 153.12 43.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.728 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -140.89 159.89 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.611 -1.306 . . . . 0.0 110.55 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 46.9 m -132.94 119.99 20.86 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.815 HD11 HD12 ' A' ' 108' ' ' LEU . 79.6 mt -106.74 120.74 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.348 -1.47 . . . . 0.0 108.668 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 94.2 m -120.02 130.2 54.61 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.944 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.99 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -115.87 138.22 51.37 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.696 0.76 . . . . 0.0 110.83 -178.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.99 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.6 m-85 -117.47 157.38 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.56 135.79 54.99 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.795 -1.19 . . . . 0.0 110.176 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.59 HG21 ' CE1' ' A' ' 121' ' ' TYR . 63.2 t -110.06 120.0 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.691 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.8 p . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.5 p . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.338 0.589 . . . . 0.0 109.653 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 81.9 p -80.64 169.15 18.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.505 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -56.29 121.3 41.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.0 Cg_exo -61.38 154.02 61.74 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 120.929 1.086 . . . . 0.0 114.162 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.514 HG23 HG21 ' A' ' 94' ' ' ILE . 2.1 t -117.64 129.97 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 85.0 p -121.13 156.64 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.439 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.655 HG21 ' O ' ' A' ' 98' ' ' LEU . 47.0 pt -139.57 165.76 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.343 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -112.69 129.95 56.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.97 . . . . 0.0 108.963 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CE1' HG22 ' A' ' 184' ' ' THR . 54.7 t80 -124.98 118.52 26.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.026 . . . . 0.0 109.974 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.64 140.02 29.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.552 HG22 ' CE1' ' A' ' 182' ' ' TYR . 4.8 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.434 ' O ' ' CD ' ' A' ' 82' ' ' PRO . 86.0 mt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.409 0.623 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -79.97 130.11 35.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -84.83 149.79 54.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.02 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.75 146.19 86.7 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.173 1.249 . . . . 0.0 112.105 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' N ' ' A' ' 8' ' ' PHE . 17.8 p -143.54 -150.65 0.32 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.044 -1.035 . . . . 0.0 109.601 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.96 19.18 49.84 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 105.0 -3.24 . . . . 0.0 105.0 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.44 ' N ' ' C ' ' A' ' 6' ' ' THR . 63.6 t80 -54.51 134.93 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.478 -0.861 . . . . 0.0 110.863 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.9 t0 -157.97 147.57 19.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.7 m -116.81 135.23 53.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 12' ' ' ASP . 77.3 p -152.05 -171.02 3.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 11' ' ' SER . 81.5 m-20 50.0 41.62 23.45 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -78.39 130.84 35.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.051 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.56 162.73 24.27 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.749 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.81 -60.08 4.42 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.026 -1.046 . . . . 0.0 110.279 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -91.49 -0.0 57.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.896 -1.127 . . . . 0.0 109.993 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 98.4 p -148.92 155.81 41.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CE1' HG22 ' A' ' 20' ' ' VAL . 18.7 p90 -165.04 144.67 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 108.687 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -96.89 150.62 20.54 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.361 -1.462 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.628 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -120.01 132.4 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 63.4 m-70 -125.43 143.54 50.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.821 -1.175 . . . . 0.0 110.657 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 44.5 p90 -147.79 152.98 38.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -0.767 . . . . 0.0 109.211 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.01 142.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.108 -0.995 . . . . 0.0 110.492 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.03 137.06 79.28 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.838 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.58 -164.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.991 1.127 . . . . 0.0 112.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -112.38 17.86 19.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.939 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -119.73 150.21 49.9 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.909 -1.119 . . . . 0.0 109.951 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.48 127.1 23.42 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.485 1.456 . . . . 0.0 112.604 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 43.0 pt -133.4 170.02 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.2 p -106.08 -7.06 18.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 0.0 109.213 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.12 176.38 23.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 44.5 m-85 -119.99 145.54 46.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -1.199 . . . . 0.0 109.132 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.656 HG23 ' HG3' ' A' ' 49' ' ' ARG . 38.1 mm -102.04 128.87 54.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 120.953 -1.092 . . . . 0.0 108.304 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.8 mm -110.06 118.94 58.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.139 -0.975 . . . . 0.0 110.101 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.722 HH12 ' NE2' ' A' ' 47' ' ' GLN . 33.7 mmt180 -108.33 127.88 54.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.474 ' ND1' ' C ' ' A' ' 36' ' ' HIS . 2.2 t-80 -119.98 135.71 54.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.856 -1.152 . . . . 0.0 110.715 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.449 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 29.4 p-80 -167.94 149.96 5.49 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.618 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.059 179.481 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 121.586 0.708 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.722 ' NE2' HH12 ' A' ' 35' ' ' ARG . 97.5 mt-30 -105.64 116.51 32.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -117.87 127.53 53.95 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.656 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -121.45 148.55 44.27 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 109.693 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 34' ' ' ILE . 33.0 m -133.14 138.46 31.7 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.135 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 166.12 11.58 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 120.926 1.084 . . . . 0.0 111.709 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.45 -36.28 94.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.466 1.444 . . . . 0.0 112.428 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -70.37 -11.05 60.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 110.777 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -102.79 120.02 39.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.088 -1.007 . . . . 0.0 110.04 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -109.71 -4.9 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.515 -0.741 . . . . 0.0 109.465 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.461 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 59.7 p -130.16 138.76 50.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.592 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 9.2 tt -130.0 130.01 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.36 -0.838 . . . . 0.0 108.746 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.4 m -100.24 133.31 44.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.14 145.5 40.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -132.63 -178.73 5.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.726 -0.609 . . . . 0.0 109.85 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.1 m120 57.39 40.4 27.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.7 155.15 19.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.49 -0.756 . . . . 0.0 109.087 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.649 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 15.9 m120 -69.99 120.63 79.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.976 -1.078 . . . . 0.0 108.561 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.749 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -61.5 125.13 16.07 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 120.921 1.081 . . . . 0.0 112.889 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 83.4 58.68 2.25 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -146.1 154.01 41.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.957 -1.32 . . . . 0.0 110.96 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.445 ' N ' ' CG2' ' A' ' 66' ' ' THR . 98.0 mt-10 -89.96 118.72 29.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.649 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 43.2 m-85 -110.1 140.02 44.61 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 110.119 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.0 t -102.84 121.42 53.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.92 122.33 69.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 108.961 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -96.34 134.56 39.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 110.703 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 34' ' ' ILE . 50.3 mm -117.06 124.47 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.564 HG22 ' N ' ' A' ' 74' ' ' ALA . 60.3 mt -130.04 162.06 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -121.4 136.57 54.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.655 -0.653 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' OG1' ' A' ' 30' ' ' THR . 15.6 m -131.12 140.19 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 109.562 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 29' ' ' ILE . 23.5 t-20 -124.58 41.88 3.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.012 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.01 -103.68 2.53 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.23 -0.04 44.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -104.56 155.77 18.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -128.08 153.17 47.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -108.86 171.84 4.16 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.83 . . . . 0.0 109.088 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -61.85 126.35 18.7 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.21 1.273 . . . . 0.0 111.634 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.58 126.34 19.63 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.066 1.177 . . . . 0.0 113.472 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.02 HD22 ' O ' ' A' ' 5' ' ' PRO . 26.8 tp -106.15 120.04 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mt -125.01 139.3 51.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.998 -1.064 . . . . 0.0 110.36 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.21 152.49 21.47 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -109.75 129.93 55.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.429 -1.042 . . . . 0.0 109.54 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.54 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -123.55 129.79 51.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 88' ' ' GLN . . . -100.01 129.63 46.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.131 -0.981 . . . . 0.0 109.939 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.36 134.99 42.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.468 0.651 . . . . 0.0 109.975 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 94' ' ' ILE . 20.3 mt . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.58 178.2 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 N-CA-C 109.653 -0.941 . . . . 0.0 109.653 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -142.09 172.02 13.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.463 -1.398 . . . . 0.0 110.631 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.0 40.16 19.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.897 -0.502 . . . . 0.0 110.781 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.635 HD13 HD23 ' A' ' 162' ' ' LEU . 42.3 tp -72.7 93.29 1.63 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -147.92 169.97 18.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 51.2 t -96.98 133.83 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 110.711 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.414 HG12 ' N ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -98.19 -28.74 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.987 0.899 . . . . 0.0 108.664 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.414 ' N ' HG12 ' A' ' 101' ' ' ILE . . . -135.28 134.93 40.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.471 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -121.48 126.57 49.58 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.854 -1.154 . . . . 0.0 110.812 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -112.39 157.59 39.66 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.6 -40.05 46.2 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.602 1.534 . . . . 0.0 113.27 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -120.69 9.97 10.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.891 -1.131 . . . . 0.0 110.546 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.042 ' O ' HD23 ' A' ' 108' ' ' LEU . 80.1 p -154.01 162.27 41.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.658 -1.276 . . . . 0.0 110.77 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -144.61 152.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.474 -0.766 . . . . 0.0 109.01 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 109' ' ' LEU . 5.4 tt -102.81 120.19 40.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.224 -0.922 . . . . 0.0 108.548 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 147' ' ' ALA . 6.4 pt -102.81 146.95 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 110.707 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.3 p -139.96 149.23 43.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -154.06 160.02 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.544 -0.723 . . . . 0.0 109.614 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -86.22 143.96 37.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.13 137.49 75.73 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.054 1.17 . . . . 0.0 112.283 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.03 -166.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.016 1.144 . . . . 0.0 112.294 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.45 -1.68 24.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 109.606 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 34.6 m -130.05 164.19 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 109.707 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.7 m -68.76 150.01 48.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.363 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 166' ' ' THR . 19.9 t -134.56 141.54 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.822 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.405 ' HG2' ' O ' ' A' ' 166' ' ' THR . 61.3 mmt-85 -71.12 -51.03 27.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.731 ' CE2' HG22 ' A' ' 139' ' ' THR . 7.9 p90 -166.48 179.29 5.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -120.02 139.94 51.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.717 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.679 ' NE ' ' OE2' ' A' ' 137' ' ' GLU . 36.3 ttm180 -106.12 124.7 49.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 30.5 mt -119.98 146.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.008 -1.058 . . . . 0.0 110.65 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -118.52 149.47 41.25 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.005 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.627 ' HB2' ' H ' ' A' ' 136' ' ' GLN . 5.6 m-85 -93.12 136.37 33.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.55 118.41 5.5 Favored Glycine 0 N--CA 1.481 1.644 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.126 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--N 1.295 -1.798 0 O-C-N 121.411 -1.052 . . . . 0.0 108.786 177.473 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.476 0.864 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.627 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 10.7 mt-30 -102.45 123.03 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.951 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.679 ' OE2' ' NE ' ' A' ' 123' ' ' ARG . 80.4 tt0 -100.0 129.97 46.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 111.558 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 45.3 p90 -134.97 143.82 47.07 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.731 HG22 ' CE2' ' A' ' 121' ' ' TYR . 2.2 p -84.7 168.26 15.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.982 -1.074 . . . . 0.0 111.156 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 124' ' ' ILE . 79.3 t -142.78 128.74 10.44 Favored Pre-proline 0 N--CA 1.485 1.285 0 O-C-N 121.751 -0.593 . . . . 0.0 109.416 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.99 150.65 62.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 120.621 0.881 . . . . 0.0 112.287 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.14 -8.46 69.77 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -89.98 -0.04 57.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -1.213 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -106.96 125.09 50.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.943 -1.098 . . . . 0.0 110.282 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -93.26 -5.39 49.93 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.6 p -142.93 159.8 41.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -140.84 167.63 21.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.728 -1.233 . . . . 0.0 109.883 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -117.95 136.69 53.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.599 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 32.8 mm -109.46 123.21 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 108.625 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.565 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 68.0 m-20 -124.01 170.02 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.133 -0.979 . . . . 0.0 109.761 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 39.8 m-20 71.69 49.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.361 0.6 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.923 HG23 ' CE2' ' A' ' 158' ' ' TYR . 79.4 mt -115.58 130.72 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 0.0 109.393 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 184' ' ' THR . 22.4 mttm -73.95 118.86 72.82 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.056 -1.028 . . . . 0.0 109.795 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.0 167.28 16.31 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.31 1.34 . . . . 0.0 113.288 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 184' ' ' THR . . . 60.0 28.16 65.81 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 184' ' ' THR . . . -140.0 139.27 36.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.932 -1.334 . . . . 0.0 110.492 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 44.8 t0 -59.95 140.23 56.86 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.923 ' CE2' HG23 ' A' ' 152' ' ' ILE . 0.7 OUTLIER -134.74 159.16 42.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.315 -1.491 . . . . 0.0 110.058 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.624 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 66.9 m -130.22 119.99 23.78 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.26 123.63 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.194 -1.566 . . . . 0.0 108.273 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.525 HG22 ' CE1' ' A' ' 163' ' ' TYR . 86.6 m -127.61 140.02 52.37 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.172 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 1.077 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -122.37 137.77 54.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.683 0.754 . . . . 0.0 110.394 -178.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 1.077 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.4 m-85 -122.94 153.43 39.73 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.18 55.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.839 -1.163 . . . . 0.0 109.47 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.404 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 63.2 t -111.61 120.04 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.851 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 119' ' ' VAL . 41.1 p . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.728 0.775 . . . . 0.0 109.225 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.9 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 46.1 p -79.4 169.98 17.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 119.48 42.0 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.527 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.3 Cg_exo -61.14 148.12 93.76 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 120.779 0.986 . . . . 0.0 114.074 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.9 120.12 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 86.2 p -112.56 153.43 27.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 111.461 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 98' ' ' LEU . 42.2 pt -134.73 160.03 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -110.62 133.13 53.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 108.621 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.609 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 60.7 t80 -139.14 126.57 21.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.018 -1.051 . . . . 0.0 110.154 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.609 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 66.2 mttm -84.71 147.59 26.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.376 -0.828 . . . . 0.0 109.013 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 155' ' ' GLY . 1.1 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.395 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.9 mt . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 121.462 0.648 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.79 130.21 34.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.419 -0.8 . . . . 0.0 108.939 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.0 p -69.96 146.66 95.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.03 . . . . 0.0 109.735 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.862 ' O ' HD22 ' A' ' 84' ' ' LEU . 2.6 Cg_endo -60.75 116.31 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.179 1.253 . . . . 0.0 111.877 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -120.0 -155.75 0.63 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.923 -1.111 . . . . 0.0 109.66 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.66 20.02 75.35 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.512 ' HB2' HD21 ' A' ' 84' ' ' LEU . 64.4 t80 -53.07 133.18 38.8 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.755 0.788 . . . . 0.0 110.695 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 10' ' ' SER . 57.1 t0 -148.52 145.77 28.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 88' ' ' GLN . 47.6 t -129.11 145.2 51.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.979 -1.076 . . . . 0.0 110.295 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 12' ' ' ASP . 9.9 p -172.75 -162.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 11' ' ' SER . 72.6 m-20 49.39 40.08 17.84 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.514 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -80.12 132.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.938 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.683 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 164.09 20.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.51 -59.09 5.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.706 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.459 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 31.7 m120 -92.52 -0.51 57.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.969 -1.082 . . . . 0.0 109.817 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.683 ' O ' ' N ' ' A' ' 14' ' ' THR . 90.0 p -151.4 156.49 40.8 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.581 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 32.4 p90 -161.89 148.33 13.77 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -102.36 151.33 22.39 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.112 -1.617 . . . . 0.0 111.956 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.483 HG22 ' HE1' ' A' ' 18' ' ' PHE . 1.6 t -120.54 138.66 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.474 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 77.1 m-70 -127.49 141.22 51.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.844 -1.16 . . . . 0.0 110.838 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.498 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.8 p90 -149.97 156.24 41.36 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.91 159.39 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.03 -1.044 . . . . 0.0 109.842 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -88.69 140.19 29.65 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.69 179.28 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.921 1.081 . . . . 0.0 112.453 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.96 10.01 42.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.899 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -116.61 150.66 46.0 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.075 -1.015 . . . . 0.0 109.854 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.65 127.97 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.555 1.504 . . . . 0.0 112.684 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.737 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.2 pt -131.66 170.43 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.5 p -105.61 -3.29 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 109.855 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.34 174.29 14.21 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.737 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 13.0 m-85 -121.89 149.93 42.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.246 -1.15 . . . . 0.0 109.239 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.833 HG23 ' HG3' ' A' ' 49' ' ' ARG . 6.0 mt -115.15 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 120.984 -1.072 . . . . 0.0 108.579 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.8 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.3 mm -107.4 119.61 57.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.181 -0.949 . . . . 0.0 110.783 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -110.0 129.61 55.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.697 ' CE1' ' OD2' ' A' ' 48' ' ' ASP . 40.7 p-80 -134.13 148.61 50.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.51 -1.369 . . . . 0.0 111.339 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -162.85 151.14 14.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 109.457 179.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.508 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 84.3 mtt-85 . . . . . 0 N--CA 1.482 1.155 0 CA-C-O 121.394 0.616 . . . . 0.0 109.873 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 92.2 mm-40 -120.52 129.21 53.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.528 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.697 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 99.3 m-20 -141.29 117.56 10.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.833 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -109.43 142.06 40.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.891 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.583 HG11 ' HB ' ' A' ' 57' ' ' ILE . 35.4 m -126.3 137.03 29.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.12 160.18 31.42 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.772 0.981 . . . . 0.0 111.624 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.96 -33.8 96.1 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.502 1.468 . . . . 0.0 111.991 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.3 p -70.04 -10.35 58.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 110.354 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -103.88 120.59 41.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -106.92 -7.46 17.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.474 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 53.2 p -129.98 138.52 50.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 109.231 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.583 ' HB ' HG11 ' A' ' 50' ' ' VAL . 5.8 tt -130.01 132.83 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.5 m -99.73 120.0 39.03 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.491 HD21 ' OD2' ' A' ' 48' ' ' ASP . 7.6 mt -93.19 143.53 26.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.263 -0.898 . . . . 0.0 109.81 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.5 p -130.1 178.81 6.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.797 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.71 43.04 19.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.79 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 59' ' ' LEU . 43.3 mt -109.99 153.63 24.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.599 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.9 m-80 -69.98 126.72 92.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.998 . . . . 0.0 108.655 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.718 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.5 Cg_endo -64.76 132.16 31.75 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 120.709 0.939 . . . . 0.0 112.368 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.87 62.14 3.08 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -148.48 152.99 37.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.322 -1.105 . . . . 0.0 110.525 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' A' ' 66' ' ' THR . 98.7 mt-10 -91.45 120.0 31.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.599 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 30.8 m-85 -108.82 148.16 30.99 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 110.57 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -110.04 125.77 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.27 129.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.915 -1.115 . . . . 0.0 110.335 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' HG12 ' A' ' 85' ' ' ILE . 78.6 p -115.22 139.99 49.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 110.728 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 34' ' ' ILE . 6.6 mm -109.18 129.99 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 38.3 mm -119.9 123.15 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.047 . . . . 0.0 108.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -93.5 132.69 37.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.972 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 m -129.9 140.02 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -121.58 43.4 2.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.97 -97.09 1.88 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.646 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -102.17 0.01 33.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -1.195 . . . . 0.0 109.299 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -112.4 151.26 30.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -124.64 153.12 42.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 109.493 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -106.25 170.16 6.1 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 109.239 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.5 Cg_exo -59.74 125.39 17.65 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.223 1.282 . . . . 0.0 112.007 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 2.9 Cg_endo -60.76 143.32 99.37 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.223 1.282 . . . . 0.0 113.383 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 5' ' ' PRO . 24.9 tp -119.76 128.09 53.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.412 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -127.71 140.03 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 120.841 -1.162 . . . . 0.0 110.926 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.11 161.67 27.2 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -115.9 136.76 52.74 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.092 -1.24 . . . . 0.0 110.284 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.591 ' CD ' ' CB ' ' A' ' 10' ' ' SER . 98.2 mm-40 -130.2 139.03 50.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -110.77 137.47 48.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -79.68 140.11 37.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.1 t . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 121.504 0.669 . . . . 0.0 111.28 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.539 HG23 ' HD2' ' A' ' 95' ' ' PRO . 2.1 mt . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 120.473 0.178 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.7 Cg_endo -63.68 81.31 0.14 Allowed 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 120.798 0.998 . . . . 0.0 110.668 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.498 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 28.5 ttp-105 -62.76 165.78 6.22 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.501 -0.749 . . . . 0.0 111.118 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.1 m-20 64.96 42.28 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.062 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.523 ' O ' HG21 ' A' ' 180' ' ' ILE . 54.9 tp -79.86 103.6 9.87 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -150.06 170.03 19.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.939 -1.101 . . . . 0.0 110.255 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 54.0 t -103.85 139.14 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.369 -0.832 . . . . 0.0 109.643 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.67 -10.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -138.62 130.84 28.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 p -114.81 98.5 6.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.656 ' OG1' ' N ' ' A' ' 107' ' ' SER . 1.2 p -88.41 151.12 48.01 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.321 -0.862 . . . . 0.0 109.089 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.37 -30.7 53.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.348 1.365 . . . . 0.0 113.001 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.441 ' C ' HG22 ' A' ' 152' ' ' ILE . 27.8 p -129.02 12.89 6.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.906 -1.121 . . . . 0.0 110.718 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.944 ' O ' HD23 ' A' ' 108' ' ' LEU . 14.6 p -159.85 161.93 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.82 -1.175 . . . . 0.0 110.027 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.944 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -135.67 153.93 51.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.57 ' C ' HD23 ' A' ' 109' ' ' LEU . 5.4 tt -102.8 119.96 39.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 108.769 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 147' ' ' ALA . 2.6 pt -107.37 135.85 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 146' ' ' THR . 52.9 m -136.35 140.03 42.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -144.04 157.14 44.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.389 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.03 127.34 92.45 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.477 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.76 125.89 16.34 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 120.684 0.923 . . . . 0.0 111.654 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.03 176.39 0.74 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 120.831 1.021 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -108.39 24.92 12.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.651 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.0 160.1 41.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.1 m -67.63 130.02 41.73 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.0 109.029 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 166' ' ' THR . 57.5 t -126.31 132.08 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.609 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -71.71 -53.5 13.31 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.585 ' CE2' HG22 ' A' ' 139' ' ' THR . 8.1 p90 -167.27 170.29 11.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.5 m-85 -115.98 137.64 51.93 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 53.8 ttp180 -100.41 123.02 44.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.747 -1.221 . . . . 0.0 108.219 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.597 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 69.0 mt -110.26 139.82 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.005 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.794 HG22 ' HG2' ' A' ' 137' ' ' GLU . 19.5 p -115.59 137.22 52.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.375 -0.828 . . . . 0.0 110.796 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.715 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.9 m-85 -84.11 124.17 30.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.25 126.6 8.3 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.724 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 22.2 mt-10 . . . . . 0 C--N 1.295 -1.769 0 O-C-N 121.711 -0.876 . . . . 0.0 108.723 178.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.173 0 CA-C-O 121.38 0.61 . . . . 0.0 110.314 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.647 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 96.9 mt-30 -119.82 104.36 10.14 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.121 -1.031 . . . . 0.0 108.554 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.794 ' HG2' HG22 ' A' ' 125' ' ' THR . 98.9 mt-10 -86.89 140.79 29.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 0.0 112.084 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 39.8 p90 -143.9 150.01 37.76 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.585 HG22 ' CE2' ' A' ' 121' ' ' TYR . 16.7 p -89.56 168.72 11.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.933 -1.105 . . . . 0.0 111.459 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 19.6 t -134.14 126.81 18.75 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.747 -0.595 . . . . 0.0 109.649 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.64 155.7 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.291 0.782 . . . . 0.0 111.809 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.91 -0.31 81.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.7 p -99.96 2.29 43.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.059 -1.259 . . . . 0.0 110.422 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -112.48 128.57 56.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.821 -1.175 . . . . 0.0 110.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.2 m -94.74 -6.43 43.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 111' ' ' SER . 48.0 p -139.59 157.04 46.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -137.48 160.02 40.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.629 -1.294 . . . . 0.0 110.653 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.486 ' CG2' HD21 ' A' ' 150' ' ' ASN . 6.0 m -106.11 142.39 35.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.608 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 34.8 mm -114.47 120.07 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.715 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 8.8 m120 -122.05 173.81 7.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.236 -0.915 . . . . 0.0 109.798 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.3 46.26 2.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.037 . . . . 0.0 109.478 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 158' ' ' TYR . 2.7 tt -110.43 153.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -98.29 109.98 54.49 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.966 -1.084 . . . . 0.0 110.488 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.46 154.43 74.34 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.075 1.183 . . . . 0.0 112.546 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.02 15.46 78.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.496 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . -137.91 149.06 45.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 49.5 t0 -69.92 150.81 46.34 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.5 m-85 -139.34 164.11 30.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.895 -1.128 . . . . 0.0 110.929 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.9 m -136.48 115.4 12.26 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.75 121.98 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.363 -1.46 . . . . 0.0 108.612 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.428 HG23 ' HB3' ' A' ' 179' ' ' SER . 62.8 m -132.34 148.52 52.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.076 -1.015 . . . . 0.0 110.104 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 2.3 pp -140.65 152.51 45.45 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.973 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 2.5 m-85 -120.07 139.24 52.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -100.16 124.37 45.49 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 70.5 t -106.32 120.73 57.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 119' ' ' VAL . 19.0 p . . . . . 0 C--N 1.304 -1.404 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 85.5 p -74.31 162.15 29.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.199 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 94' ' ' ILE . 7.0 mttm -62.12 134.31 94.45 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.059 -1.026 . . . . 0.0 108.716 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 134.42 61.14 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.245 1.297 . . . . 0.0 113.424 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.83 129.99 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.428 ' HB3' HG23 ' A' ' 161' ' ' THR . 92.4 p -128.09 159.33 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.052 -1.03 . . . . 0.0 112.201 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.523 HG21 ' O ' ' A' ' 98' ' ' LEU . 44.4 pt -138.8 160.06 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -107.41 130.15 54.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.092 . . . . 0.0 109.195 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.503 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 65.7 t80 -122.5 129.94 52.53 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.95 139.23 35.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 3.2 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.184 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -83.39 109.99 17.77 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 109.073 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.9 p -70.02 150.05 96.28 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.256 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.592 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.77 149.7 67.16 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.077 1.185 . . . . 0.0 111.669 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -152.68 -158.16 0.87 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.96 21.54 76.83 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 105.93 -2.868 . . . . 0.0 105.93 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -50.41 130.07 22.92 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.712 0.768 . . . . 0.0 110.359 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 10' ' ' SER . 52.1 t0 -155.59 149.64 25.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.547 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.8 m -121.97 140.97 51.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.964 -1.085 . . . . 0.0 110.133 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 12' ' ' ASP . 78.0 p -157.2 -173.91 4.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.094 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.05 42.55 24.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.783 HG22 HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -78.01 124.83 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.935 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.692 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.89 162.45 17.32 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.756 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.34 -59.33 5.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.867 -1.146 . . . . 0.0 109.824 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.456 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 28.9 m120 -87.15 -10.79 51.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 14' ' ' THR . 48.8 m -139.96 155.26 47.21 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.636 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.688 ' CE1' HG22 ' A' ' 20' ' ' VAL . 15.1 p90 -161.46 142.01 10.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 108.779 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -91.16 154.02 19.63 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.443 -1.411 . . . . 0.0 111.777 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.688 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.8 t -124.35 139.31 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -129.68 141.25 50.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.819 -1.175 . . . . 0.0 110.93 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.4 p90 -148.44 160.02 43.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.02 156.11 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 120.81 -1.181 . . . . 0.0 110.346 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.21 124.4 45.2 Favored Pre-proline 0 C--N 1.299 -1.629 0 O-C-N 121.874 -0.516 . . . . 0.0 109.997 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.26 163.66 16.73 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.973 1.116 . . . . 0.0 112.244 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -92.06 -1.41 57.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -79.83 151.76 74.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.14 120.59 8.59 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.344 1.362 . . . . 0.0 112.332 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 27' ' ' ALA . 25.5 pt -135.74 164.4 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.91 -7.36 15.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.028 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.87 175.37 19.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 18.4 m-85 -120.0 139.99 51.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.24 . . . . 0.0 109.163 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.738 HG23 ' HG3' ' A' ' 49' ' ' ARG . 34.9 mm -91.17 120.09 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 57' ' ' ILE . 3.7 mm -97.15 107.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 110.12 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 68.3 mtm180 -105.46 120.0 40.5 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.697 -1.252 . . . . 0.0 107.673 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CD2' HD22 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -120.04 136.57 54.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.974 -1.079 . . . . 0.0 110.334 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -160.0 160.24 33.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.661 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.489 1.493 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 121.282 0.563 . . . . 0.0 109.895 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -102.09 120.5 40.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.878 . . . . 0.0 109.293 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -126.0 140.19 52.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.738 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -130.05 146.94 51.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.903 -1.123 . . . . 0.0 109.606 -178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 34' ' ' ILE . 29.0 m -139.5 145.79 45.33 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.94 162.56 25.25 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.032 1.155 . . . . 0.0 111.925 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.28 -34.09 97.95 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.576 1.518 . . . . 0.0 112.314 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.5 t -69.99 -19.73 63.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.589 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -96.06 115.19 27.05 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -107.62 0.48 22.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 p -129.98 134.39 47.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.403 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 34' ' ' ILE . 7.3 tt -130.26 136.11 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 109.723 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.2 m -99.97 122.23 42.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.309 -0.869 . . . . 0.0 109.649 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.829 ' HB3' HD11 ' A' ' 62' ' ' LEU . 12.6 mt -95.48 145.47 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.761 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -132.97 -178.66 5.06 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.434 0.635 . . . . 0.0 110.277 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 51.54 49.66 20.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.355 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.829 HD11 ' HB3' ' A' ' 59' ' ' LEU . 42.4 mt -116.5 153.68 31.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 109.286 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -70.0 123.32 88.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 108.598 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.756 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.6 Cg_endo -62.49 133.67 44.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.876 1.051 . . . . 0.0 112.717 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.66 62.26 2.9 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 m -147.42 148.92 31.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -1.12 . . . . 0.0 110.982 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' OE2' ' NE2' ' A' ' 87' ' ' GLN . 86.5 tt0 -90.13 119.0 30.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.661 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 37.9 m-85 -109.92 152.75 25.43 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.194 -0.941 . . . . 0.0 110.814 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.02 121.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.51 129.98 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.758 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 85' ' ' ILE . 93.8 p -116.84 137.88 51.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 0.0 110.741 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -112.77 121.85 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.3 mm -112.12 129.99 66.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.854 -1.154 . . . . 0.0 109.252 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -95.61 123.12 39.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.987 . . . . 0.0 109.026 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 75' ' ' VAL . 33.3 m -124.39 133.08 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.56 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -115.84 35.81 4.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.3 -103.06 2.49 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -90.33 0.03 57.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -1.141 . . . . 0.0 110.341 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.52 141.37 48.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.907 -1.121 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.98 140.5 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.814 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -94.05 167.87 12.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.837 . . . . 0.0 109.234 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -58.68 129.99 34.95 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.468 1.445 . . . . 0.0 112.085 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.0 151.9 68.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.396 1.397 . . . . 0.0 113.698 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 5' ' ' PRO . 28.2 tp -125.41 111.91 15.68 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.436 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.7 mt -120.41 129.92 75.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 120.868 -1.145 . . . . 0.0 110.91 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.68 175.98 19.42 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.605 ' NE2' ' OE2' ' A' ' 67' ' ' GLU . 27.7 mt-30 -125.94 137.25 53.69 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.483 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.627 ' OE1' ' CE2' ' A' ' 18' ' ' PHE . 12.4 tm0? -130.92 130.68 43.79 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.618 ' C ' ' NE2' ' A' ' 88' ' ' GLN . . . -99.04 131.6 44.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.918 -1.114 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.41 135.8 42.39 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.783 HG23 HG22 ' A' ' 13' ' ' ILE . 18.6 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 176' ' ' LYS . 8.5 mt . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 110.589 -0.152 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.6 Cg_endo -66.17 -166.34 0.1 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 109.926 -0.836 . . . . 0.0 109.926 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -152.74 162.17 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.594 -1.316 . . . . 0.0 110.513 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.61 40.04 20.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.812 -0.555 . . . . 0.0 110.902 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.782 ' O ' HG21 ' A' ' 180' ' ' ILE . 50.1 tp -73.08 96.79 2.24 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.73 -1.231 . . . . 0.0 107.792 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -151.76 169.81 21.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.679 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 43.2 t -96.23 139.38 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.165 -0.959 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.752 HD11 ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -108.6 -11.89 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.853 0.835 . . . . 0.0 108.768 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.605 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -147.18 150.7 35.44 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -129.83 130.01 44.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.838 -1.164 . . . . 0.0 110.271 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.43 157.97 39.78 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.26 -40.93 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 121.434 1.423 . . . . 0.0 112.656 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.501 ' C ' HG22 ' A' ' 152' ' ' ILE . 40.9 p -129.97 19.96 5.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.058 -1.026 . . . . 0.0 110.197 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.053 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.5 p -153.46 169.83 22.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.873 -1.142 . . . . 0.0 110.011 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -143.88 155.39 44.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.33 -0.857 . . . . 0.0 109.699 -179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.752 ' CD2' HD11 ' A' ' 101' ' ' ILE . 25.1 tp -103.99 120.51 41.21 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 147' ' ' ALA . 3.3 pt -107.59 146.95 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 111.321 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.8 p -141.11 144.22 34.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.468 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 42.3 p90 -150.74 159.99 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.73 140.58 22.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.2 134.52 56.33 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.028 1.152 . . . . 0.0 111.803 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.64 -171.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 120.954 1.103 . . . . 0.0 112.335 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.761 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -77.33 -1.44 29.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.09 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 23.4 m -129.96 160.04 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.476 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 152.28 44.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' A' ' 122' ' ' TYR . 48.9 t -130.04 133.81 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.916 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HD3' HG12 ' A' ' 165' ' ' VAL . 11.6 ptm180 -72.49 -48.04 43.81 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.417 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.698 ' CE1' HG22 ' A' ' 139' ' ' THR . 2.2 p90 -166.96 162.53 15.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.904 -1.122 . . . . 0.0 110.036 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.3 m-85 -122.52 151.11 41.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.527 ' NE ' ' HB2' ' A' ' 163' ' ' TYR . 17.2 ptt180 -109.85 129.64 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.794 -1.191 . . . . 0.0 108.193 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.623 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 83.9 mt -112.4 145.57 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.951 . . . . 0.0 109.546 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.621 HG22 ' HG2' ' A' ' 137' ' ' GLU . 1.1 p -122.07 142.7 50.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.68 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.1 m-85 -84.57 130.0 34.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.692 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.21 135.34 12.77 Favored Glycine 0 N--CA 1.479 1.566 0 C-N-CA 120.216 -0.993 . . . . 0.0 110.93 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 . . . . . 0 C--N 1.295 -1.786 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.702 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.3 m . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.567 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 15.7 mt-30 -99.61 115.28 29.04 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.561 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.621 ' HG2' HG22 ' A' ' 125' ' ' THR . 95.1 mt-10 -104.86 140.0 38.77 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.87 0.843 . . . . 0.0 111.979 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 42.8 p90 -145.91 151.96 38.69 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.698 HG22 ' CE1' ' A' ' 121' ' ' TYR . 2.7 p -84.33 160.16 20.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.941 -1.1 . . . . 0.0 111.453 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 122' ' ' TYR . 89.0 t -120.2 119.04 31.02 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.67 109.52 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.73 0.953 . . . . 0.0 111.821 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -50.09 -10.27 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.99 -19.22 63.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 110.136 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -122.03 140.74 52.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.7 m -90.02 -1.14 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.468 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 63.4 p -132.85 159.12 40.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.729 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -143.37 166.36 24.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.792 -1.192 . . . . 0.0 110.203 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.5 m -112.16 149.12 32.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.439 -0.788 . . . . 0.0 109.151 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.623 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 33.1 mm -117.62 123.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.68 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 31.2 m120 -125.49 170.08 11.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.024 -1.048 . . . . 0.0 110.013 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 80.8 m-20 65.64 46.7 2.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.589 0.709 . . . . 0.0 109.562 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.501 HG22 ' C ' ' A' ' 106' ' ' THR . 3.7 tt -108.32 149.79 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -98.02 110.04 54.15 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.411 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.4 Cg_endo -67.25 174.69 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.187 1.258 . . . . 0.0 112.853 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.97 26.42 74.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.448 ' O ' ' OG1' ' A' ' 184' ' ' THR . . . -157.21 159.08 37.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.927 -1.337 . . . . 0.0 110.068 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.8 t0 -77.94 144.39 36.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.692 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -130.77 158.17 40.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.828 -1.17 . . . . 0.0 110.272 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 63.7 m -130.24 118.92 22.1 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 108' ' ' LEU . 76.2 mt -100.91 119.79 49.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.364 -1.46 . . . . 0.0 108.775 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 179' ' ' SER . 21.5 m -127.08 140.85 51.99 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.661 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.825 ' C ' HD12 ' A' ' 162' ' ' LEU . 1.5 pp -139.09 152.42 47.49 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.335 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' HD12 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -119.96 141.82 49.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.46 137.17 38.34 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.582 -1.324 . . . . 0.0 110.19 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.662 HG12 ' HD3' ' A' ' 120' ' ' ARG . 62.2 t -110.02 120.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.3 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.435 0.636 . . . . 0.0 110.026 -179.41 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.1 p . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.42 0.628 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.5 p -83.02 172.77 12.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.181 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.673 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -59.26 133.33 87.97 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.024 -1.048 . . . . 0.0 108.464 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.02 145.77 97.59 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.338 1.359 . . . . 0.0 113.846 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.54 129.66 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 161' ' ' THR . 93.1 p -126.34 155.83 41.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.943 -1.098 . . . . 0.0 111.52 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 98' ' ' LEU . 27.2 pt -139.17 164.19 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -113.1 129.91 56.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 109.403 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 60.8 t80 -124.59 122.02 36.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.891 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 43.9 mmtt -84.61 149.54 25.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.907 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.526 ' OXT' ' OG1' ' A' ' 184' ' ' THR . 9.0 p . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.059 -1.025 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.0 mt . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.01 137.23 36.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.394 -0.816 . . . . 0.0 109.098 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 t -78.06 133.28 65.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.3 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.57 ' CD ' ' HB2' ' A' ' 74' ' ' ALA . 3.3 Cg_exo -57.22 90.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 120.967 1.111 . . . . 0.0 112.064 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -92.26 -158.54 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 109.904 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 22.11 66.82 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.468 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 56.0 t80 -57.75 132.4 53.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.82 0.819 . . . . 0.0 110.752 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.7 t0 -154.11 142.08 20.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 75.0 p -117.74 140.0 50.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.907 -1.121 . . . . 0.0 109.846 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 12' ' ' ASP . 58.7 p -158.6 -176.6 5.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.8 m-20 49.93 48.41 21.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -85.32 121.1 36.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.384 -177.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -112.76 162.7 15.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.04 -56.58 19.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.792 -1.193 . . . . 0.0 110.524 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -92.07 -0.03 57.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.85 -1.156 . . . . 0.0 109.93 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.7 ' O ' ' N ' ' A' ' 14' ' ' THR . 37.2 t -150.87 151.55 32.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.663 ' CD2' ' OH ' ' A' ' 68' ' ' TYR . 23.3 p90 -160.97 145.94 14.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 108.829 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 12' ' ' ASP . 3.6 m -93.16 148.03 22.37 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.507 -1.37 . . . . 0.0 111.489 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -121.52 142.56 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.438 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 72.3 m-70 -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.807 -1.183 . . . . 0.0 110.808 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.536 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 42.9 p90 -154.02 157.55 39.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.494 -0.754 . . . . 0.0 109.084 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.06 158.83 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 120.875 -1.141 . . . . 0.0 110.0 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -89.28 148.6 41.05 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 109.9 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.612 ' HG2' HG21 ' A' ' 29' ' ' ILE . 2.5 Cg_endo -61.58 178.72 0.61 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.279 1.319 . . . . 0.0 112.456 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -103.82 7.1 37.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.21 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -119.72 157.55 51.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.9 Cg_endo -56.85 136.29 75.6 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.676 1.584 . . . . 0.0 112.591 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 40.7 pt -139.97 170.06 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 p -106.42 -0.84 23.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -173.85 23.15 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 37.1 m-85 -128.36 151.15 49.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -1.207 . . . . 0.0 109.419 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.861 HG23 ' HE ' ' A' ' 49' ' ' ARG . 31.9 mm -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -0.949 . . . . 0.0 108.48 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.709 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.9 mm -113.91 123.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.008 -1.057 . . . . 0.0 110.315 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.582 HH12 ' NE2' ' A' ' 47' ' ' GLN . 83.0 mtt-85 -123.24 130.92 53.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.607 ' NE2' ' CB ' ' A' ' 46' ' ' ARG . 20.5 p-80 -130.76 129.4 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.559 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -159.99 159.92 32.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 109.32 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.422 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.607 ' CB ' ' NE2' ' A' ' 36' ' ' HIS . 22.5 mmm180 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.328 0.585 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.582 ' NE2' HH12 ' A' ' 35' ' ' ARG . 99.4 mt-30 -120.82 109.96 15.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.793 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' ILE . 94.5 m-20 -121.98 129.99 52.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.197 -0.94 . . . . 0.0 108.673 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.861 ' HE ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -113.56 141.22 47.43 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.325 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.795 ' CG1' HD12 ' A' ' 57' ' ' ILE . 33.1 m -120.95 147.66 46.82 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.28 159.98 44.54 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 120.844 1.029 . . . . 0.0 111.552 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.505 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 2.7 Cg_endo -57.96 -37.85 94.44 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.583 1.522 . . . . 0.0 112.563 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 m -70.05 -12.49 61.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.872 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -100.07 115.43 29.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.922 -1.112 . . . . 0.0 109.888 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -103.06 -4.11 25.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.486 -0.758 . . . . 0.0 108.983 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.438 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 19.4 p -130.33 135.92 48.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.772 . . . . 0.0 109.245 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.795 HD12 ' CG1' ' A' ' 50' ' ' VAL . 8.0 tt -132.43 133.75 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.096 -1.003 . . . . 0.0 110.361 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -95.74 109.99 22.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 17' ' ' SER . 5.6 mt -85.63 148.81 25.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.129 -0.982 . . . . 0.0 109.814 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.4 p -135.05 177.73 7.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.74 -0.6 . . . . 0.0 109.596 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m120 57.33 45.43 20.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 59' ' ' LEU . 48.5 mt -111.68 150.03 30.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.434 HD22 ' C ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -62.09 116.95 25.01 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.625 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.21 131.71 35.61 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 120.868 1.045 . . . . 0.0 112.932 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.45 62.91 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -142.38 130.72 22.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 110.887 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 67' ' ' GLU . 21.2 pt-20 -87.14 122.52 31.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.663 ' OH ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -139.82 175.45 9.56 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.615 -1.234 . . . . 0.0 110.863 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.446 HG22 ' HG2' ' A' ' 87' ' ' GLN . 62.4 t -109.12 129.08 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.71 123.19 68.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.419 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.1 p -111.19 142.36 43.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 0.0 111.586 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.709 ' CD1' HG23 ' A' ' 34' ' ' ILE . 49.3 mm -119.88 119.98 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.1 mm -113.66 119.97 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.91 -1.119 . . . . 0.0 108.809 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.821 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -85.67 130.13 34.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 108.686 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.8 147.55 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 110.061 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -128.51 40.05 3.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.06 -100.81 2.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 ptt-85 -90.34 -5.96 55.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -1.19 . . . . 0.0 110.242 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -112.31 143.48 43.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.97 -1.082 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -127.3 130.54 49.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 110.42 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.821 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 15.7 m -76.12 152.53 84.24 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.56 140.03 45.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 120.746 0.964 . . . . 0.0 111.765 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.89 146.22 80.2 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.561 1.508 . . . . 0.0 114.076 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 5' ' ' PRO . 20.0 tp -122.08 121.74 37.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.419 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -133.2 140.55 46.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 O-C-N 120.846 -1.159 . . . . 0.0 111.379 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.33 162.57 27.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.446 ' HG2' HG22 ' A' ' 69' ' ' VAL . 77.1 mt-30 -110.84 141.88 43.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.037 -1.273 . . . . 0.0 110.165 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.542 ' OE1' ' OG ' ' A' ' 10' ' ' SER . 67.5 tp60 -145.21 158.46 43.82 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.534 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . -124.19 127.12 47.26 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.858 -1.151 . . . . 0.0 111.03 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.638 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.11 142.57 45.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.523 0.677 . . . . 0.0 110.907 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 176' ' ' LYS . 10.3 mt . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.493 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.8 Cg_endo -64.42 -159.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 N-CA-C 109.896 -0.848 . . . . 0.0 109.896 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 15.9 ttp180 -160.01 160.57 33.45 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.664 -1.273 . . . . 0.0 111.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 98.2 m-20 59.95 43.84 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.631 HD22 ' CD2' ' A' ' 162' ' ' LEU . 41.2 tp -72.06 112.73 8.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 120.491 -1.381 . . . . 0.0 107.41 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -157.14 169.38 24.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 109' ' ' LEU . 53.4 t -104.95 133.41 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CG2' ' OG ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -98.39 -30.0 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.703 0.763 . . . . 0.0 109.427 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.97 144.55 47.46 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 p -122.32 119.06 29.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 110.164 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -97.18 156.58 36.13 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.1 -46.2 26.46 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.564 1.509 . . . . 0.0 112.918 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 154' ' ' PRO . 64.8 p -121.09 15.86 11.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.677 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.035 ' O ' HD23 ' A' ' 108' ' ' LEU . 4.8 p -149.97 164.29 35.87 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.093 -1.004 . . . . 0.0 109.669 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.035 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -139.43 150.0 44.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.628 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 110' ' ' ILE . 1.9 tt -99.02 122.64 42.55 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.109 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.506 ' N ' HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -106.99 141.26 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 0.0 110.872 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 101' ' ' ILE . 9.5 p -142.74 136.49 28.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.58 -0.7 . . . . 0.0 109.362 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.442 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 34.7 p90 -145.31 156.96 44.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.316 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.62 137.92 54.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.616 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.41 132.04 39.03 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 120.916 1.078 . . . . 0.0 112.099 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.94 -159.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 120.932 1.088 . . . . 0.0 112.256 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.44 2.92 45.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 24.0 m -130.01 160.0 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.098 -1.001 . . . . 0.0 109.819 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.4 t -74.55 135.36 42.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 122' ' ' TYR . 22.6 t -109.99 135.01 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -71.15 -45.94 62.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.496 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 12.1 p90 -166.29 162.37 17.27 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.424 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.7 m-85 -119.98 138.08 53.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 108.596 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 137' ' ' GLU . 13.6 tpt180 -95.46 121.58 37.29 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 89.9 mt -110.0 132.36 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.144 -0.973 . . . . 0.0 110.322 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 ' CG ' ' A' ' 137' ' ' GLU . 3.1 p -113.17 144.76 42.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.689 . . . . 0.0 111.436 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.776 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.7 m-85 -87.93 136.61 32.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.695 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.7 128.7 9.4 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.161 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 . . . . . 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.814 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.411 HG23 ' OE2' ' A' ' 137' ' ' GLU . 17.1 m . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.514 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 15.0 mt-30 -94.39 112.69 24.48 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.344 -1.342 . . . . 0.0 108.373 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.466 ' HB3' ' NE ' ' A' ' 123' ' ' ARG . 21.5 mp0 -102.41 140.17 37.04 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.988 0.899 . . . . 0.0 112.715 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 41.9 p90 -143.16 153.87 43.3 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 p -88.62 163.1 15.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.663 -1.273 . . . . 0.0 112.092 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.629 ' O ' ' N ' ' A' ' 142' ' ' GLY . 27.9 t -123.85 105.35 32.44 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.2 Cg_exo -59.86 35.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.672 0.915 . . . . 0.0 112.76 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 30.69 30.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.697 ' N ' ' O ' ' A' ' 141' ' ' PRO . 81.4 p -69.41 -33.6 73.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -1.21 . . . . 0.0 109.698 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -146.17 176.38 9.78 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.563 -0.711 . . . . 0.0 110.107 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 92.7 p -90.03 0.01 57.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.722 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.442 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 19.8 p -136.22 150.96 49.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.471 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -148.05 177.49 9.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 108.945 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.741 HG22 ' N ' ' A' ' 149' ' ' ILE . 43.8 m -122.61 167.07 13.86 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.062 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.776 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 85.8 mt -123.92 130.52 73.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 110.01 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.464 ' O ' ' OH ' ' A' ' 126' ' ' TYR . 30.3 m120 -123.32 172.67 8.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.6 m120 61.42 40.36 14.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.0 110.323 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.49 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 3.4 tt -97.78 168.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 108.707 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -110.73 100.08 44.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 120.925 -1.109 . . . . 0.0 109.36 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.534 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.8 Cg_endo -66.71 164.15 30.31 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.396 1.397 . . . . 0.0 113.015 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.98 19.52 69.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.688 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -149.72 156.76 42.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.29 . . . . 0.0 110.186 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.688 ' OD2' ' NZ ' ' A' ' 183' ' ' LYS . 61.9 t0 -70.0 151.14 45.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.6 OUTLIER -141.95 159.28 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.505 -1.372 . . . . 0.0 110.328 -179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 20.4 m -130.49 123.17 29.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -103.39 120.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.131 -1.606 . . . . 0.0 109.666 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 179' ' ' SER . 22.7 m -131.36 141.86 49.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.631 ' CD2' HD22 ' A' ' 98' ' ' LEU . 2.3 pt? -135.18 154.79 51.5 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.4 m-85 -120.02 140.6 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -108.04 125.74 51.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.752 -1.218 . . . . 0.0 109.768 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 90.1 t -114.5 127.54 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 121.524 0.678 . . . . 0.0 109.691 -179.877 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 79.2 p . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.3 p -66.34 152.6 44.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.066 -1.021 . . . . 0.0 108.458 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.67 ' HB2' HD11 ' A' ' 94' ' ' ILE . 1.8 mmtm -49.34 137.03 16.12 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.844 -1.16 . . . . 0.0 108.825 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.53 142.29 97.56 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.165 1.243 . . . . 0.0 112.916 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 129.23 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 161' ' ' THR . 64.8 p -126.06 150.82 47.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.034 -1.041 . . . . 0.0 111.992 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.575 HG23 HD23 ' A' ' 98' ' ' LEU . 48.0 pt -134.8 160.05 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -97.87 140.28 32.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.873 -1.142 . . . . 0.0 109.48 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.651 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 58.3 t80 -137.52 119.35 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 109.62 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.688 ' NZ ' ' OD2' ' A' ' 157' ' ' ASP . 71.3 mmtt -89.4 133.86 34.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.248 -0.907 . . . . 0.0 108.765 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.688 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 3.1 p . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 0.0 109.427 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 81' ' ' SER . 84.9 mt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.13 130.1 36.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.8 m -76.57 144.07 73.08 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 109.514 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.778 ' O ' HD22 ' A' ' 84' ' ' LEU . 2.6 Cg_endo -58.87 110.16 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.171 . . . . 0.0 111.377 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.1 -155.29 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 109.772 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.02 23.7 76.93 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 105.108 -3.197 . . . . 0.0 105.108 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 54.1 t80 -50.56 130.03 23.34 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.561 -0.819 . . . . 0.0 110.88 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.6 t0 -142.96 137.44 29.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.572 ' OG ' ' OE1' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -119.57 138.0 53.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 0.0 110.202 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' ASP . 91.5 p -167.2 -166.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.726 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.2 m-20 48.7 43.68 20.93 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.805 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -76.92 129.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.21 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.38 161.12 21.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.84 -59.99 4.5 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 110.218 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -90.06 0.02 57.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.869 -1.144 . . . . 0.0 109.062 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 14' ' ' THR . 86.0 p -149.47 159.2 44.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.093 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.494 ' CE1' HG22 ' A' ' 20' ' ' VAL . 16.9 p90 -163.77 148.27 10.49 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -101.37 150.29 23.17 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.115 -1.616 . . . . 0.0 112.286 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.494 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -119.18 139.06 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -129.33 139.99 51.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.773 -1.204 . . . . 0.0 110.816 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.416 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 35.9 p90 -150.25 155.45 39.74 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -87.32 157.24 3.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.868 -1.145 . . . . 0.0 109.985 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.401 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -93.12 137.02 23.87 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.95 176.01 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 120.827 1.018 . . . . 0.0 111.892 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -103.3 15.55 28.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.311 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.87 155.75 47.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.09 131.27 40.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.614 1.543 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.0 pt -140.01 170.64 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.246 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 46.9 p -108.41 -10.15 15.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 109.841 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.89 178.27 23.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.624 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 25.8 m-85 -123.14 145.14 48.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 109.232 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.67 HG23 ' HG3' ' A' ' 49' ' ' ARG . 42.3 mm -100.7 128.01 53.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 120.88 -1.138 . . . . 0.0 108.123 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.618 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.2 mm -109.29 110.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.112 -0.992 . . . . 0.0 110.421 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -105.69 121.49 44.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.494 ' CG ' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -118.76 135.09 54.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.808 -1.182 . . . . 0.0 110.861 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -160.05 159.0 31.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.597 -0.689 . . . . 0.0 109.586 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.404 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 108.547 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 mmt180 . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 121.427 0.632 . . . . 0.0 109.697 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -100.51 117.06 33.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.469 -0.769 . . . . 0.0 109.372 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -123.08 133.25 54.31 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.67 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -127.43 150.12 49.78 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.816 -1.177 . . . . 0.0 109.871 -178.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 HD11 ' A' ' 34' ' ' ILE . 34.4 m -135.15 145.96 56.33 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.17 160.08 46.58 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 120.924 1.083 . . . . 0.0 111.256 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.81 -31.5 91.83 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.243 1.296 . . . . 0.0 112.172 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.3 m -72.5 -11.42 60.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.546 -0.721 . . . . 0.0 111.255 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -103.94 120.0 40.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.839 -1.163 . . . . 0.0 109.461 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 55' ' ' ASN . 46.3 p-10 -102.49 -1.96 29.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.3 p -134.72 138.18 44.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.439 HD12 ' CG1' ' A' ' 50' ' ' VAL . 4.9 tt -131.55 134.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.705 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -102.5 119.8 39.45 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.339 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.5 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.1 mt -89.29 148.97 23.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 108.977 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -131.31 177.55 7.39 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.514 0.673 . . . . 0.0 110.019 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.4 m120 55.2 45.5 25.74 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.5 HD11 ' CB ' ' A' ' 59' ' ' LEU . 56.3 mt -109.94 152.87 25.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.473 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 95.1 m-20 -68.67 120.48 75.99 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.325 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.781 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.8 Cg_endo -60.95 133.99 50.66 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 121.068 1.179 . . . . 0.0 113.49 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.7 63.05 2.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.2 m -148.57 156.36 42.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -1.16 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.488 ' N ' ' CG2' ' A' ' 66' ' ' THR . 8.8 pt-20 -99.31 120.02 38.88 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.473 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 77.3 m-85 -110.19 153.77 24.3 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 111.039 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -109.97 120.73 61.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 36' ' ' HIS . 60.2 t -120.02 125.9 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.932 -1.105 . . . . 0.0 109.826 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 p -104.88 136.14 44.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 110.839 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.753 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.2 mm -112.05 121.03 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -119.11 129.98 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.965 -1.084 . . . . 0.0 109.594 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.74 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -91.65 132.54 36.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.339 -0.851 . . . . 0.0 109.543 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.559 HG12 ' HG2' ' A' ' 80' ' ' GLU . 16.5 m -128.6 137.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -119.96 41.93 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.63 -92.4 1.71 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.94 -0.0 40.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -1.106 . . . . 0.0 110.581 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.33 152.85 37.27 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.016 -1.053 . . . . 0.0 109.631 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.559 ' HG2' HG12 ' A' ' 75' ' ' VAL . 99.1 mt-10 -131.87 160.0 36.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 110.001 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.74 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -110.93 172.17 3.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.239 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.1 Cg_exo -61.78 132.74 41.39 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.391 1.394 . . . . 0.0 112.417 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.17 128.28 25.88 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.182 1.255 . . . . 0.0 113.074 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 5' ' ' PRO . 20.4 tp -106.9 121.37 44.3 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -119.98 133.39 66.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.932 -1.105 . . . . 0.0 110.868 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.82 155.39 21.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -110.99 136.17 50.4 Favored 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.204 -1.174 . . . . 0.0 110.054 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.792 HE21 ' CD1' ' A' ' 13' ' ' ILE . 51.6 tt0 -137.6 143.53 41.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.43 149.55 37.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.979 -1.076 . . . . 0.0 111.594 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 136.47 33.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.805 HG23 HG22 ' A' ' 13' ' ' ILE . 20.8 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.466 0.65 . . . . 0.0 110.045 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.769 HG21 HG23 ' A' ' 178' ' ' VAL . 3.1 mt . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.473 ' HD2' HG22 ' A' ' 94' ' ' ILE . 3.7 Cg_exo -57.42 -171.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.283 0.655 . . . . 0.0 110.988 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.491 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 53.0 ttt85 -146.67 160.65 41.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.725 -1.234 . . . . 0.0 110.92 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.491 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 25.0 t0 72.55 34.88 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.856 -0.527 . . . . 0.0 111.456 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.647 HD22 HD13 ' A' ' 180' ' ' ILE . 2.2 tt -65.28 102.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.498 -1.376 . . . . 0.0 107.663 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.466 ' N ' HD23 ' A' ' 98' ' ' LEU . 98.8 mt-10 -142.58 157.97 44.15 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.939 -1.101 . . . . 0.0 110.549 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 100' ' ' VAL . 3.2 p -89.96 137.3 21.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.61 HD11 ' CD2' ' A' ' 109' ' ' LEU . 47.3 pt -123.72 -13.21 6.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -142.63 130.01 21.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.5 t -115.03 117.67 31.24 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.687 ' CB ' ' HG ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -108.6 157.96 35.23 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.07 -40.74 33.98 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 121.509 1.473 . . . . 0.0 112.781 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.562 ' C ' HG22 ' A' ' 152' ' ' ILE . 69.6 p -130.01 20.02 5.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 110.22 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.065 ' O ' HD23 ' A' ' 108' ' ' LEU . 18.9 p -153.41 165.37 36.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.889 -1.132 . . . . 0.0 110.285 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.065 HD23 ' O ' ' A' ' 107' ' ' SER . 1.2 mt -141.49 157.26 45.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.61 ' CD2' HD11 ' A' ' 101' ' ' ILE . 23.9 tp -104.8 127.55 52.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.084 -1.01 . . . . 0.0 108.381 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.488 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.0 pt -109.77 135.3 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 110.703 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 146' ' ' THR . 52.6 m -126.86 132.51 50.94 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 42.5 p90 -143.02 157.5 44.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 109.596 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -95.11 142.06 24.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.368 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.29 136.44 68.34 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 120.952 1.101 . . . . 0.0 112.034 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.38 -163.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 120.984 1.123 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -91.24 1.6 56.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 109.187 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.632 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 33.1 m -129.98 160.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.702 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.4 p -69.63 157.38 37.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 108.584 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.602 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 23.8 t -129.91 130.0 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 110.146 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -73.16 -42.97 62.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.762 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 -166.57 163.45 16.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.117 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.602 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -120.0 142.76 48.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 108.771 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.48 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 1.2 mtp180 -99.36 127.34 45.37 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.7 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 35.7 mt -110.01 130.0 63.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.813 -1.179 . . . . 0.0 109.834 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.421 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 76.9 p -106.56 140.37 39.55 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.962 0.887 . . . . 0.0 111.58 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.702 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 5.8 m-85 -91.43 127.48 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.737 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -99.57 117.17 5.79 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.423 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 C--N 1.293 -1.855 0 O-C-N 121.541 -0.976 . . . . 0.0 109.197 179.319 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.5 m . . . . . 0 N--CA 1.479 1.02 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.624 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 93.3 mm-40 -109.38 121.53 45.38 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.611 -1.236 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 86.5 tt0 -109.77 140.57 43.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.865 . . . . 0.0 111.617 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.7 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 43.0 p90 -139.6 150.0 44.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.762 HG22 ' CE2' ' A' ' 121' ' ' TYR . 4.1 p -86.19 163.57 17.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.112 -0.993 . . . . 0.0 111.463 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 142' ' ' GLY . 7.2 t -129.99 112.45 17.27 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.703 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.35 35.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.728 0.952 . . . . 0.0 112.719 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.56 ' H ' HG12 ' A' ' 140' ' ' VAL . . . 35.03 24.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 141' ' ' PRO . 28.8 t -66.39 -40.02 89.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.059 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -134.3 175.64 9.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.841 0.829 . . . . 0.0 110.546 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 52.5 m -94.62 0.0 54.81 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 111' ' ' SER . 17.9 p -136.83 150.92 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 108.844 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.462 ' H ' HG13 ' A' ' 110' ' ' ILE . . . -141.73 162.92 34.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 109.847 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.4 t -100.56 148.37 24.89 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 108.98 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.702 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 48.5 mm -116.62 120.03 63.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.619 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 78.8 m-20 -120.06 173.91 6.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.19 -0.943 . . . . 0.0 110.306 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.7 t30 65.92 40.0 4.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 109.56 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.562 HG22 ' C ' ' A' ' 106' ' ' THR . 2.3 tt -100.66 146.54 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -99.95 109.43 56.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.987 -1.071 . . . . 0.0 110.123 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 2.5 Cg_endo -68.55 172.64 11.09 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.129 1.22 . . . . 0.0 112.485 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.608 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.34 20.86 77.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 184' ' ' THR . . . -148.65 156.75 42.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.317 . . . . 0.0 109.763 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.9 t0 -69.97 147.27 50.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.737 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -138.0 156.87 47.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.79 -1.194 . . . . 0.0 110.515 -178.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.5 m -134.58 118.03 16.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.18 124.91 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.343 -1.473 . . . . 0.0 109.357 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 178' ' ' VAL . 99.8 m -130.83 142.83 50.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.0 110.439 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 80.3 mt -107.83 142.13 38.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.645 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 24.7 m-85 -119.98 140.02 51.59 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.94 129.93 55.44 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.94 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 62.4 t -115.37 122.55 69.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . 0.55 HG22 ' HA ' ' A' ' 119' ' ' VAL . 9.7 p . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.51 0.672 . . . . 0.0 110.045 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 66.7 p . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.358 0.599 . . . . 0.0 109.722 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 49.1 p -72.07 160.69 32.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 94' ' ' ILE . 18.3 mmtm -57.73 130.57 82.12 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 108.435 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.435 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.1 Cg_endo -61.12 134.66 53.93 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.195 1.263 . . . . 0.0 113.664 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.901 ' O ' HG23 ' A' ' 161' ' ' THR . 2.0 t -100.29 126.83 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.438 ' CB ' ' OG1' ' A' ' 161' ' ' THR . 79.1 p -122.69 145.25 48.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.057 -1.027 . . . . 0.0 112.187 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.647 HD13 HD22 ' A' ' 98' ' ' LEU . 15.8 pt -130.61 159.97 42.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -104.13 135.78 44.98 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.85 -1.156 . . . . 0.0 109.502 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.442 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 65.7 t80 -130.2 109.67 10.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.39 136.22 33.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.077 -1.014 . . . . 0.0 108.99 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.371 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.976 ' N ' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.973 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -79.49 140.63 37.24 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' THR . 66.5 m -76.77 140.67 67.65 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.391 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 2.9 Cg_endo -57.76 78.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.133 1.222 . . . . 0.0 111.71 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -81.55 -152.02 0.09 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.0 22.95 77.31 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 106.207 -2.757 . . . . 0.0 106.207 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -57.78 130.0 44.44 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.623 0.725 . . . . 0.0 110.141 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.8 t0 -156.6 147.25 21.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 39.1 t -121.49 141.85 50.63 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.03 -1.043 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 12' ' ' ASP . 22.9 p -155.64 -171.54 3.81 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.4 m-20 49.63 39.94 18.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.45 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -76.49 130.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.42 160.81 27.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.598 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -59.67 -60.0 4.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 110.229 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -89.27 0.06 57.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.978 -1.076 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 14' ' ' THR . 47.5 t -149.33 154.62 39.26 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.802 ' CE1' HG22 ' A' ' 20' ' ' VAL . 12.6 p90 -165.12 141.01 5.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -91.24 150.09 21.49 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.449 -1.407 . . . . 0.0 111.301 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.802 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -119.98 138.44 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.436 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 68.9 m-70 -128.59 144.33 51.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.934 -1.104 . . . . 0.0 110.965 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.505 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 41.1 p90 -145.28 160.02 42.14 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.9 159.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.855 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -97.59 132.73 24.61 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.55 -178.46 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.003 1.135 . . . . 0.0 112.711 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -103.86 -0.75 28.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -103.15 151.68 38.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.088 -1.007 . . . . 0.0 109.729 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 2.9 Cg_endo -57.38 126.31 21.6 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.411 1.408 . . . . 0.0 112.29 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.56 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 19.6 pt -130.04 164.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.408 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -99.98 -1.79 36.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.515 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.9 -172.69 23.56 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 42.6 m-85 -128.45 156.84 42.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.739 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -114.24 128.08 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.739 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.6 mm -111.61 118.14 56.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.944 -1.098 . . . . 0.0 110.653 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -112.07 129.41 56.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.513 ' C ' ' CD2' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -124.01 141.29 52.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.781 -1.2 . . . . 0.0 110.982 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 46.9 p-80 -165.1 166.88 18.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.063 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.582 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 121.545 0.688 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.643 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -121.86 117.73 27.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.0 109.855 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' ILE . 85.9 m-20 -123.15 119.1 29.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.783 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -104.44 141.68 35.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.095 -1.003 . . . . 0.0 109.424 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 34' ' ' ILE . 30.9 m -125.33 147.85 59.0 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.46 159.92 45.38 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 120.853 1.035 . . . . 0.0 111.516 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.85 -35.17 99.05 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.488 1.459 . . . . 0.0 112.402 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -69.95 -16.75 63.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.894 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -100.03 117.19 33.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.031 -1.043 . . . . 0.0 109.478 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -104.31 -0.08 28.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.436 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 51.6 p -132.85 138.4 47.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.249 -0.907 . . . . 0.0 109.799 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.505 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 5.5 tt -130.05 134.9 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.048 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.8 m -99.81 120.27 39.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 62' ' ' LEU . 7.2 mt -97.45 140.75 31.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.274 -0.891 . . . . 0.0 109.568 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.1 p -132.63 179.42 6.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.686 . . . . 0.0 109.943 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.91 39.97 29.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.483 -0.761 . . . . 0.0 109.576 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 59' ' ' LEU . 21.0 mt -107.21 149.34 27.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 0.0 109.104 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.537 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 87.7 m-20 -60.82 116.4 18.33 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.96 -1.087 . . . . 0.0 108.363 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 131.97 37.2 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.035 1.157 . . . . 0.0 113.401 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.31 62.82 2.24 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -150.55 157.52 43.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -1.224 . . . . 0.0 110.662 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 66' ' ' THR . 99.0 mt-10 -92.24 120.05 32.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.537 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 44.2 m-85 -110.84 148.71 31.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.157 -0.964 . . . . 0.0 110.996 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.465 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 62.7 t -110.04 124.34 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.9 124.85 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 p -108.4 134.81 50.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 111.195 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.718 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.6 mm -114.5 117.3 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.5 mp -111.8 125.46 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 108.443 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -93.8 127.82 39.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 80' ' ' GLU . 3.1 m -117.46 129.96 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.876 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 52.3 t30 -111.64 34.82 3.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.865 . . . . 0.0 109.341 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.17 -87.05 1.52 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.79 -6.01 56.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -1.108 . . . . 0.0 110.393 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' HD11 ' A' ' 2' ' ' LEU . 100.0 mt-10 -131.12 150.05 52.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.495 ' HG3' HG12 ' A' ' 75' ' ' VAL . 60.0 mp0 -126.67 129.96 49.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.704 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -74.96 160.01 81.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.207 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.46 142.03 98.35 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.221 1.28 . . . . 0.0 111.969 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.99 136.99 78.61 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.239 1.293 . . . . 0.0 113.048 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 5' ' ' PRO . 26.2 tp -115.77 121.29 42.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.95 130.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.947 -1.096 . . . . 0.0 111.074 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.08 160.44 22.49 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.004 -2.439 . . . . 0.0 107.004 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.444 ' HG2' HG22 ' A' ' 69' ' ' VAL . 73.5 mt-30 -118.54 137.88 52.91 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.04 -1.27 . . . . 0.0 110.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -139.3 139.29 37.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -102.24 133.68 46.73 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 110.77 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.34 140.06 41.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.651 . . . . 0.0 110.484 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ARG . 2.0 mt . . . . . 0 N--CA 1.489 1.496 0 N-CA-C 110.496 -0.187 . . . . 0.0 110.496 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.591 ' HG2' HD21 ' A' ' 162' ' ' LEU . 2.5 Cg_endo -65.89 62.13 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.824 1.016 . . . . 0.0 111.124 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 44.5 ttm105 -40.58 163.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 110.367 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.525 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.9 m-20 63.1 40.62 8.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.904 -0.497 . . . . 0.0 111.246 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.554 HD13 HD23 ' A' ' 162' ' ' LEU . 49.0 tp -79.97 104.09 10.3 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.835 -1.166 . . . . 0.0 107.887 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -158.64 166.58 31.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.021 . . . . 0.0 110.121 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 25.3 t -89.07 140.02 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.773 HD11 ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -114.14 -9.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . . . -147.62 158.8 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.3 t -134.77 127.93 31.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.965 -1.084 . . . . 0.0 110.423 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.738 ' CB ' ' HG ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.55 158.68 38.0 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -48.92 -32.68 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.485 1.456 . . . . 0.0 112.914 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.595 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.0 p -139.21 20.26 2.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 109.862 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.07 ' O ' HD23 ' A' ' 108' ' ' LEU . 6.1 p -153.15 167.5 29.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.022 . . . . 0.0 110.067 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.07 HD23 ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.773 ' CD2' HD11 ' A' ' 101' ' ' ILE . 30.6 tp -105.27 121.63 44.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 108.795 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 147' ' ' ALA . 3.1 pt -102.95 143.94 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.482 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 146' ' ' THR . 36.3 t -136.73 140.0 42.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.704 -0.622 . . . . 0.0 109.756 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.695 ' CD2' ' O ' ' A' ' 145' ' ' SER . 48.8 p90 -144.37 156.99 44.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.564 -0.71 . . . . 0.0 109.303 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.96 130.45 89.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.67 118.59 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 120.937 1.091 . . . . 0.0 112.247 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.06 168.01 11.44 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 120.864 1.043 . . . . 0.0 111.995 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.49 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -107.01 28.12 8.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.829 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.97 159.99 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.5 t -70.86 129.96 40.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.326 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.713 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 39.9 t -129.98 130.44 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -70.95 -51.27 26.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 139' ' ' THR . 15.3 p90 -167.14 170.49 11.77 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.713 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 3.7 m-85 -120.03 139.86 51.86 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 108.47 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -98.7 126.85 44.44 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.607 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 44.9 mt -118.55 130.84 72.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.872 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 137' ' ' GLU . 12.5 p -101.55 146.54 27.53 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.088 0.947 . . . . 0.0 111.527 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.721 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 3.3 m-85 -92.05 128.07 37.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.727 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.27 122.99 7.08 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.873 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 . . . . . 0 C--N 1.295 -1.779 0 O-C-N 121.617 -0.931 . . . . 0.0 108.535 178.742 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.523 0.678 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.638 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 28.3 mt-30 -125.23 131.77 53.08 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 137' ' ' GLU . 1.1 pm0 -113.36 148.66 35.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.913 -1.117 . . . . 0.0 111.991 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 49.9 p90 -139.96 150.82 44.97 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.41 HG22 ' CE2' ' A' ' 121' ' ' TYR . 15.1 p -88.32 166.09 14.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.032 . . . . 0.0 111.634 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLY . 54.2 t -136.97 95.24 12.19 Favored Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.681 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -60.05 47.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 120.909 1.073 . . . . 0.0 113.243 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 33.98 26.98 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 141' ' ' PRO . 94.5 p -62.99 -39.98 96.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' A' ' 145' ' ' SER . 19.0 tttt -146.12 165.24 29.7 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.889 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.695 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 79.4 p -78.97 -2.85 42.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.68 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 111' ' ' SER . 58.7 p -129.45 150.58 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 108.831 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -132.39 161.57 33.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.101 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 m -104.24 147.1 27.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.437 -0.789 . . . . 0.0 109.437 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.599 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 40.5 mm -117.92 119.98 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.721 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 10.6 m120 -121.87 176.83 5.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 110.463 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.93 50.05 5.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.809 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.595 HG22 ' C ' ' A' ' 106' ' ' THR . 2.6 tt -114.81 149.22 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.087 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -94.18 111.96 55.47 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 109.974 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.24 156.37 63.46 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.171 1.247 . . . . 0.0 112.945 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.663 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.02 23.69 76.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 184' ' ' THR . . . -136.1 137.1 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.059 -1.26 . . . . 0.0 109.706 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 53.7 t0 -60.04 140.01 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.727 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -134.28 172.07 13.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.866 -1.146 . . . . 0.0 111.055 -178.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -146.44 124.63 12.18 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.815 HD11 HD12 ' A' ' 108' ' ' LEU . 69.9 mt -111.61 125.95 68.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 120.296 -1.502 . . . . 0.0 109.155 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.9 m -124.44 141.05 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.371 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 1.047 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -124.05 140.49 52.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 111.427 -177.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 1.047 ' N ' HD12 ' A' ' 162' ' ' LEU . 7.0 m-85 -124.78 152.49 43.78 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.64 131.49 54.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.816 -1.177 . . . . 0.0 109.875 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.02 130.02 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.549 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 2.8 p . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 109.945 -179.884 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 p . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.2 p -80.08 170.03 17.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 108.47 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -63.57 118.42 44.28 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.1 Cg_exo -61.98 150.59 85.72 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.034 1.156 . . . . 0.0 113.393 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.468 HG12 HD23 ' A' ' 98' ' ' LEU . 2.9 t -120.73 131.05 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 97.4 p -117.2 154.03 31.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.09 -1.006 . . . . 0.0 111.475 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 98' ' ' LEU . 48.3 pt -137.58 164.69 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -111.32 138.78 47.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.171 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.47 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 64.9 t80 -136.05 126.85 27.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.072 -1.017 . . . . 0.0 109.952 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -100.82 129.24 46.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.281 -0.887 . . . . 0.0 108.834 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.3 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.253 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.854 0 N-CA-C 119.456 2.542 . . . . 0.0 119.456 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt -125.98 139.63 53.28 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.24 -1.153 . . . . 0.0 109.327 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -79.69 135.99 36.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.311 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.0 t -85.25 139.97 36.52 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.127 -0.983 . . . . 0.0 109.667 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.687 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_exo -57.82 143.29 95.87 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 121.214 1.276 . . . . 0.0 111.943 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.9 p -150.57 -153.29 0.48 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.087 -1.008 . . . . 0.0 109.43 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 20.12 76.0 Favored Glycine 0 N--CA 1.485 1.918 0 N-CA-C 105.494 -3.043 . . . . 0.0 105.494 -177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 51.6 t80 -52.71 127.35 22.86 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-O 121.594 0.711 . . . . 0.0 110.09 -178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 10' ' ' SER . 53.2 t0 -147.83 141.15 25.21 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.624 ' CB ' ' OE1' ' A' ' 88' ' ' GLN . 81.9 p -111.46 145.89 38.2 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.956 -1.09 . . . . 0.0 110.255 -178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.43 ' O ' ' C ' ' A' ' 12' ' ' ASP . 80.2 p -169.45 -175.91 2.33 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.547 -0.721 . . . . 0.0 109.346 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 49.94 44.3 25.38 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 -178.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.66 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -80.03 129.99 36.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.764 -178.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.69 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.22 162.06 20.02 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.812 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.16 -60.01 4.5 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.999 -1.063 . . . . 0.0 110.287 -178.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -90.61 0.14 57.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.957 -1.089 . . . . 0.0 109.416 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.69 ' O ' ' N ' ' A' ' 14' ' ' THR . 80.0 p -149.64 158.67 44.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.429 -0.794 . . . . 0.0 109.368 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.684 ' CE2' HG22 ' A' ' 20' ' ' VAL . 26.0 p90 -165.54 148.28 7.76 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 m -97.26 149.86 21.58 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.289 -1.507 . . . . 0.0 111.607 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 18' ' ' PHE . 1.4 t -122.44 140.44 46.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 66.9 m-70 -129.83 145.59 51.58 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.743 -1.223 . . . . 0.0 111.086 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 46.8 p90 -149.66 158.42 44.15 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.02 158.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.879 -1.138 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.421 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -94.25 136.56 23.36 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.717 -0.614 . . . . 0.0 109.813 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.404 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 2.8 Cg_endo -59.17 176.15 0.56 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.012 1.141 . . . . 0.0 112.407 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -102.54 9.97 39.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.303 -0.873 . . . . 0.0 109.82 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -112.01 157.22 40.33 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.047 -1.033 . . . . 0.0 109.995 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.8 Cg_endo -57.48 122.09 11.18 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 121.74 1.627 . . . . 0.0 112.619 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.585 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 29.7 pt -130.03 165.91 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.295 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.489 HG23 ' HA ' ' A' ' 76' ' ' ASN . 70.4 p -106.66 -7.99 17.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.215 -0.928 . . . . 0.0 109.24 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.35 -179.18 22.62 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.585 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 16.3 m-85 -125.0 147.53 48.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.169 -1.194 . . . . 0.0 109.207 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.568 HG23 ' HG3' ' A' ' 49' ' ' ARG . 29.4 mm -102.1 126.38 56.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.589 HD11 HG22 ' A' ' 50' ' ' VAL . 3.2 mm -103.78 116.74 48.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 120.972 -1.08 . . . . 0.0 110.214 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -117.23 131.46 56.84 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 177.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.613 ' HB2' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -140.02 149.93 43.79 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.33 -1.481 . . . . 0.0 111.275 -178.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 39.2 p-80 -169.76 154.92 5.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.643 -0.661 . . . . 0.0 110.243 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.495 ' H ' ' HB3' ' A' ' 41' ' ' SER . . . -85.04 162.66 19.24 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.372 -0.83 . . . . 0.0 108.914 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -59.97 -39.98 87.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.937 -1.102 . . . . 0.0 108.697 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 44.0 m170 -90.75 21.32 4.14 Favored 'General case' 0 C--N 1.289 -2.05 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.385 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' A' ' 38' ' ' ALA . 85.2 p -74.3 168.77 18.99 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.342 -0.849 . . . . 0.0 109.31 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.679 ' O ' ' N ' ' A' ' 44' ' ' ARG . 49.0 t -74.35 149.98 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.353 -0.842 . . . . 0.0 109.797 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -47.94 -0.46 0.01 OUTLIER Glycine 0 N--CA 1.493 2.468 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.679 ' N ' ' O ' ' A' ' 42' ' ' VAL . 13.6 mtp180 -114.41 91.72 25.31 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.099 -1.236 . . . . 0.0 109.236 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -64.59 152.72 80.71 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 121.308 1.338 . . . . 0.0 112.334 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.477 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 42.9 mtt-85 -73.68 151.93 40.61 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.218 -0.926 . . . . 0.0 109.745 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.435 HE21 ' HD2' ' A' ' 49' ' ' ARG . 64.0 tt0 -117.85 112.56 20.54 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.587 0.708 . . . . 0.0 110.017 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.9 m-20 -124.11 129.96 51.74 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.697 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -118.77 145.18 45.79 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 120.859 -1.15 . . . . 0.0 109.664 -178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 HD11 ' A' ' 34' ' ' ILE . 27.1 m -131.52 149.07 72.49 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.249 -0.907 . . . . 0.0 109.963 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.17 157.76 51.93 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 120.889 1.059 . . . . 0.0 111.53 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -57.51 -35.4 98.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 C-N-CA 121.363 1.375 . . . . 0.0 112.05 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 75.5 m -70.35 -13.71 62.26 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.471 -0.768 . . . . 0.0 110.534 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -97.49 120.0 37.08 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.106 -0.996 . . . . 0.0 110.005 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.401 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 30.3 p-10 -108.87 -1.25 19.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.611 -0.681 . . . . 0.0 109.592 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 78.7 p -129.99 137.57 50.36 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.288 -0.883 . . . . 0.0 109.366 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.562 HD13 HG21 ' A' ' 34' ' ' ILE . 8.6 tt -129.99 130.13 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.188 -0.945 . . . . 0.0 109.543 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.4 m -95.85 119.16 33.84 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.316 -0.865 . . . . 0.0 109.137 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.753 ' HB3' HD11 ' A' ' 62' ' ' LEU . 12.2 mt -93.04 146.04 23.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 109.592 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.0 p -136.35 178.36 7.12 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.319 0.581 . . . . 0.0 109.932 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 56.18 44.19 25.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.301 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.753 HD11 ' HB3' ' A' ' 59' ' ' LEU . 14.6 mt -113.65 152.89 29.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.478 -0.764 . . . . 0.0 109.623 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.644 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 31.4 t-20 -70.11 120.02 75.45 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.117 -0.989 . . . . 0.0 108.733 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.812 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 138.82 75.35 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.988 1.125 . . . . 0.0 113.192 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.94 63.34 3.03 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.1 m -155.04 150.1 26.91 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.196 -1.179 . . . . 0.0 110.912 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' O ' ' CG ' ' A' ' 67' ' ' GLU . 11.5 pt-20 -85.73 122.28 29.59 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 178.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.644 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 34.6 m-85 -111.54 139.96 46.54 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.101 -1.0 . . . . 0.0 110.481 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.776 HG22 HE22 ' A' ' 87' ' ' GLN . 18.8 t -96.56 120.12 45.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.613 HG22 ' HB2' ' A' ' 36' ' ' HIS . 47.4 t -120.13 130.02 74.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.027 -1.046 . . . . 0.0 109.703 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.437 ' CB ' HG12 ' A' ' 85' ' ' ILE . 88.7 p -118.5 139.91 50.7 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.951 -1.093 . . . . 0.0 111.031 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.63 129.99 69.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.7 mm -119.46 129.26 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.741 -1.224 . . . . 0.0 109.21 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.756 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -96.62 127.36 42.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.099 -1.001 . . . . 0.0 109.01 179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.8 m -127.82 142.98 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.22 -0.925 . . . . 0.0 109.86 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.528 ' CG ' ' O ' ' A' ' 76' ' ' ASN . 6.7 t-20 -123.03 37.02 4.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.255 -0.903 . . . . 0.0 108.806 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.6 -94.82 1.82 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 13.1 tpp180 -94.71 -6.24 43.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -1.146 . . . . 0.0 110.042 -179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -114.55 140.01 49.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.938 -1.101 . . . . 0.0 109.724 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -118.6 139.96 50.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 0.0 109.405 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.756 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -92.54 169.55 10.52 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.256 -0.903 . . . . 0.0 109.389 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -62.19 133.6 44.57 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.225 1.283 . . . . 0.0 112.218 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.1 155.95 36.87 Favored 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 121.473 1.449 . . . . 0.0 113.655 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.687 HD22 ' O ' ' A' ' 5' ' ' PRO . 17.8 tp -131.82 121.14 23.62 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.437 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.4 mt -128.56 139.78 50.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.813 -1.179 . . . . 0.0 110.427 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.55 166.88 26.37 Favored Glycine 0 N--CA 1.482 1.726 0 N-CA-C 107.781 -2.127 . . . . 0.0 107.781 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.776 HE22 HG22 ' A' ' 69' ' ' VAL . 0.1 OUTLIER -119.54 137.81 53.58 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.062 -1.257 . . . . 0.0 110.039 -179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.624 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 62.1 tp60 -134.76 135.95 42.26 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -100.93 131.41 46.82 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.058 -1.026 . . . . 0.0 110.714 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.53 136.78 42.16 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.762 HG11 ' HB2' ' A' ' 116' ' ' ALA . 3.7 t -43.47 171.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-O 121.52 0.676 . . . . 0.0 110.884 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.569 ' H ' HG12 ' A' ' 91' ' ' VAL . 68.3 m -108.58 140.25 42.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.535 -0.728 . . . . 0.0 109.224 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -63.4 -40.04 96.14 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.0 110.738 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.479 HG21 HG23 ' A' ' 178' ' ' VAL . 6.4 mt -69.97 139.55 88.06 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.02 -1.05 . . . . 0.0 109.618 -179.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.45 -165.97 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.406 0 N-CA-C 109.57 -0.973 . . . . 0.0 109.57 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 20.6 ptt85 -157.54 165.6 35.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.51 -1.369 . . . . 0.0 110.328 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.3 t70 69.91 37.14 1.83 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.717 -0.614 . . . . 0.0 110.457 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.495 HD13 ' CD2' ' A' ' 162' ' ' LEU . 46.7 tp -73.05 102.43 3.52 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -150.62 170.04 20.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.606 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 24.6 t -100.86 135.86 35.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.191 -0.943 . . . . 0.0 110.625 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.484 HG12 HD12 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -104.04 -14.91 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.71 0.767 . . . . 0.0 109.055 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -139.72 148.23 42.02 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.437 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 28.5 t -132.38 119.7 21.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.928 -1.107 . . . . 0.0 110.793 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.607 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -118.39 153.53 51.83 Favored Pre-proline 0 C--N 1.306 -1.287 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -49.97 -42.04 46.38 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 C-N-CA 121.796 1.664 . . . . 0.0 113.479 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 33.0 p -119.1 10.39 12.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.908 -1.12 . . . . 0.0 110.298 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.073 ' O ' HD23 ' A' ' 108' ' ' LEU . 76.8 p -152.05 160.94 43.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.823 -1.173 . . . . 0.0 110.209 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.073 HD23 ' O ' ' A' ' 107' ' ' SER . 1.5 mt -143.8 155.26 44.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.346 -0.846 . . . . 0.0 109.376 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.827 HD13 ' N ' ' A' ' 110' ' ' ILE . 2.1 tm? -99.98 127.21 46.21 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.827 ' N ' HD13 ' A' ' 109' ' ' LEU . 5.8 pt -110.54 139.98 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.943 -1.098 . . . . 0.0 110.251 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.554 ' HA ' HG22 ' A' ' 146' ' ' THR . 53.3 m -138.25 141.94 39.9 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 120.169 -0.612 . . . . 0.0 109.612 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.603 ' CD2' ' O ' ' A' ' 145' ' ' SER . 43.5 p90 -154.63 159.97 41.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.368 -0.833 . . . . 0.0 109.138 179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -95.83 130.16 32.34 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 109.226 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.93 141.37 96.41 Favored 'Trans proline' 0 N--CA 1.49 1.302 0 C-N-CA 120.853 1.035 . . . . 0.0 112.074 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.87 -162.18 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.007 1.138 . . . . 0.0 112.379 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.762 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -104.2 17.12 24.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.341 -0.849 . . . . 0.0 109.147 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.99 160.0 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.289 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.6 t -69.97 130.66 42.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.208 -0.932 . . . . 0.0 109.331 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.645 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 41.1 t -115.93 130.01 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.412 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 166' ' ' THR . 26.9 mmt180 -71.71 -45.93 60.26 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.48 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 11.4 p90 -166.58 167.04 15.79 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.275 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.645 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -120.4 139.83 52.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.446 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 55.4 ttp180 -96.95 130.06 44.32 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.972 -1.08 . . . . 0.0 108.423 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.527 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 62.8 mt -119.25 130.25 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.178 -0.951 . . . . 0.0 109.606 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 18.1 p -106.22 146.89 29.73 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 121.848 0.832 . . . . 0.0 111.15 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.681 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.6 m-85 -94.6 132.21 39.54 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.73 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.38 117.67 5.46 Favored Glycine 0 C--O 1.206 -1.649 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.672 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.609 ' O ' ' C ' ' A' ' 129' ' ' THR . 40.9 mt-10 -108.67 142.3 39.37 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.913 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.1 p -21.37 -89.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.551 -0.718 . . . . 0.0 111.432 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.72 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . -79.76 -11.96 84.08 Favored Glycine 0 N--CA 1.495 2.594 0 O-C-N 120.918 -1.114 . . . . 0.0 110.679 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -66.12 47.6 0.18 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 130' ' ' GLY . 40.2 t30 -59.99 -40.03 87.77 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.511 -0.994 . . . . 0.0 109.584 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.605 ' O ' HG13 ' A' ' 135' ' ' VAL . 0.3 OUTLIER -99.22 -51.08 0.2 Allowed Pre-proline 0 C--N 1.296 -1.755 0 O-C-N 121.426 -0.796 . . . . 0.0 110.117 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.567 ' HD2' ' H ' ' A' ' 133' ' ' SER . 3.0 Cg_endo -65.91 44.33 0.18 Allowed 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 121.219 1.279 . . . . 0.0 112.674 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.605 HG13 ' O ' ' A' ' 133' ' ' SER . 0.8 OUTLIER -68.76 154.37 8.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 O-C-N 121.537 -0.727 . . . . 0.0 109.534 179.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.514 ' O ' ' N ' ' A' ' 126' ' ' TYR . 71.0 mt-30 -109.95 128.64 55.5 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 118.751 -1.179 . . . . 0.0 108.293 178.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -119.28 155.46 31.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.668 -1.27 . . . . 0.0 112.529 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.527 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 54.2 p90 -140.86 151.73 44.54 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.6 p -88.51 165.82 14.61 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.85 -1.156 . . . . 0.0 111.688 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.624 ' O ' ' N ' ' A' ' 142' ' ' GLY . 72.9 t -132.71 95.6 19.57 Favored Pre-proline 0 N--CA 1.485 1.323 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.686 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -59.8 44.23 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 120.787 0.991 . . . . 0.0 112.799 -179.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 35.63 23.45 0.01 OUTLIER Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.97 -35.93 74.82 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -1.152 . . . . 0.0 109.916 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.4 mmtp -139.92 153.68 47.02 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.522 -0.736 . . . . 0.0 109.832 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.603 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 88.6 p -79.9 -9.98 59.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.405 -0.809 . . . . 0.0 109.386 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.554 HG22 ' HA ' ' A' ' 111' ' ' SER . 45.5 p -128.15 152.31 48.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.345 -0.847 . . . . 0.0 109.311 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.733 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -141.01 169.4 17.68 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.169 -0.957 . . . . 0.0 109.642 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -112.72 139.98 47.87 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.235 -0.916 . . . . 0.0 108.943 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.674 HD11 HD13 ' A' ' 110' ' ' ILE . 32.9 mm -108.56 120.91 60.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.914 . . . . 0.0 108.725 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.681 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 73.2 m-20 -124.11 168.68 12.56 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.915 . . . . 0.0 109.852 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.49 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 32.2 t30 77.15 44.98 0.09 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.62 -0.675 . . . . 0.0 109.399 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.935 HG23 ' CE2' ' A' ' 158' ' ' TYR . 68.4 mt -113.01 130.04 67.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.462 -0.774 . . . . 0.0 109.266 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -72.85 121.87 86.14 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.021 -1.049 . . . . 0.0 109.941 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.03 159.41 42.71 Favored 'Trans proline' 0 N--CA 1.494 1.557 0 C-N-CA 121.27 1.313 . . . . 0.0 113.145 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.09 23.06 61.31 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.913 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . -127.89 133.26 49.3 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.114 -1.227 . . . . 0.0 109.936 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 54.8 t0 -59.96 140.07 56.98 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.935 ' CE2' HG23 ' A' ' 152' ' ' ILE . 1.4 m-85 -132.38 161.52 33.39 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.681 -1.262 . . . . 0.0 111.057 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.547 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 2.4 m -134.28 120.86 20.49 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.664 HD11 HD12 ' A' ' 108' ' ' LEU . 6.7 mt -107.16 120.18 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.154 -1.591 . . . . 0.0 108.97 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.415 HG23 ' HB3' ' A' ' 179' ' ' SER . 88.3 m -132.54 149.97 52.23 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.135 -0.978 . . . . 0.0 110.025 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.495 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.3 pp -143.13 151.22 40.46 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.615 -1.234 . . . . 0.0 111.602 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.0 OUTLIER -120.91 140.01 52.42 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -102.66 131.48 49.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.745 -1.222 . . . . 0.0 109.778 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 72.4 t -119.62 121.21 65.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.366 -0.834 . . . . 0.0 109.797 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.531 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 16.5 p -108.52 -65.3 1.14 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.531 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -73.9 140.82 28.4 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.281 -1.527 . . . . 0.0 109.281 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 69.9 mtp85 -150.02 153.68 36.9 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.22 -1.165 . . . . 0.0 109.404 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 90.66 -86.79 1.36 Allowed Glycine 0 N--CA 1.488 2.153 0 C-N-CA 120.018 -1.087 . . . . 0.0 110.572 179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -73.59 -46.42 47.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -1.14 . . . . 0.0 111.074 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.8 m -135.61 71.63 64.84 Favored Pre-proline 0 C--N 1.293 -1.874 0 O-C-N 121.295 -0.878 . . . . 0.0 110.489 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -66.34 99.03 0.41 Allowed 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 121.467 1.445 . . . . 0.0 111.828 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -123.0 147.6 46.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.02 -1.05 . . . . 0.0 110.165 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 24.4 p -123.1 149.37 44.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.416 -0.803 . . . . 0.0 109.185 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.1 p -79.94 170.13 16.91 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.072 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -57.03 124.59 66.35 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.065 -1.022 . . . . 0.0 108.383 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.482 ' HG3' ' CE2' ' A' ' 163' ' ' TYR . 2.7 Cg_endo -63.34 150.34 88.83 Favored 'Trans proline' 0 N--CA 1.492 1.384 0 C-N-CA 120.905 1.07 . . . . 0.0 113.641 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.479 HG23 HG21 ' A' ' 94' ' ' ILE . 1.9 t -116.18 131.87 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.415 ' HB3' HG23 ' A' ' 161' ' ' THR . 80.2 p -130.03 154.12 47.74 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.085 -1.009 . . . . 0.0 111.811 -177.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 37.9 pt -138.12 159.98 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -103.09 139.98 37.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.965 -1.084 . . . . 0.0 108.73 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 35.2 t80 -138.11 131.33 30.34 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.902 -1.124 . . . . 0.0 110.494 -179.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.635 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 19.8 pttp -94.09 138.41 32.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.396 -0.815 . . . . 0.0 108.93 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.439 HG23 ' O ' ' A' ' 156' ' ' ALA . 1.3 p . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.429 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.53 4.9 0 N-CA-C 119.456 2.543 . . . . 0.0 119.456 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.479 ' O ' ' OG ' ' A' ' 81' ' ' SER . 98.2 mt -133.14 143.5 49.29 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.252 -1.146 . . . . 0.0 109.234 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -77.96 159.27 28.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.357 -0.839 . . . . 0.0 109.602 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.523 ' O ' ' N ' ' A' ' 6' ' ' THR . 42.7 t -94.29 130.02 35.29 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.927 . . . . 0.0 109.886 -179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.549 ' CD ' ' HB2' ' A' ' 74' ' ' ALA . 2.8 Cg_endo -58.81 72.65 0.05 OUTLIER 'Trans proline' 0 N--CA 1.491 1.345 0 C-N-CA 121.106 1.204 . . . . 0.0 111.788 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.523 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.8 OUTLIER -79.55 -153.73 0.08 Allowed 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.013 -1.054 . . . . 0.0 109.611 -179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.94 22.62 78.4 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 106.063 -2.815 . . . . 0.0 106.063 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -58.21 130.28 45.91 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.505 0.669 . . . . 0.0 110.291 -178.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -147.5 123.91 10.99 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.739 ' CB ' HE21 ' A' ' 88' ' ' GLN . 0.3 OUTLIER -103.23 130.28 50.42 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.16 -0.963 . . . . 0.0 109.876 -179.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' ASP . 88.3 p -154.84 -172.4 4.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.311 -0.868 . . . . 0.0 109.159 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.0 49.89 19.5 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 -178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.535 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -88.48 126.3 41.73 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.905 -177.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -113.82 162.45 16.32 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 177.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.699 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -59.96 -51.57 69.11 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.751 -1.218 . . . . 0.0 110.416 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 18.8 m120 -97.7 -0.11 46.09 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.907 -1.121 . . . . 0.0 109.887 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.695 ' O ' ' N ' ' A' ' 14' ' ' THR . 18.1 m -150.47 155.01 38.71 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.165 -0.959 . . . . 0.0 109.257 179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.841 ' CE1' HG22 ' A' ' 20' ' ' VAL . 28.4 p90 -163.12 150.16 12.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.108 -0.995 . . . . 0.0 108.986 179.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.3 m -92.99 143.65 26.03 Favored 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.484 -1.385 . . . . 0.0 111.381 -178.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.841 HG22 ' CE1' ' A' ' 18' ' ' PHE . 2.0 t -116.14 137.19 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.482 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 77.6 m-70 -130.48 149.52 52.12 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.65 -1.281 . . . . 0.0 111.422 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.447 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 36.6 p90 -155.63 160.01 40.08 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.41 HG13 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.53 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 O-C-N 120.743 -1.223 . . . . 0.0 109.807 -179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' N ' HG13 ' A' ' 23' ' ' VAL . . . -94.54 132.58 28.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.793 -0.567 . . . . 0.0 109.915 -179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.642 ' HG2' HG21 ' A' ' 29' ' ' ILE . 2.9 Cg_endo -59.68 151.8 67.44 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 120.998 1.132 . . . . 0.0 112.201 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 47.8 mtm180 -65.78 -40.03 91.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.214 -0.929 . . . . 0.0 110.178 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -67.34 147.7 98.84 Favored Pre-proline 0 C--N 1.295 -1.766 0 O-C-N 121.537 -0.727 . . . . 0.0 110.174 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.66 138.36 85.3 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 121.426 1.418 . . . . 0.0 112.232 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.671 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 33.3 pt -132.6 168.04 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.148 -0.97 . . . . 0.0 109.733 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.5 p -103.66 -0.47 29.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.329 -0.857 . . . . 0.0 109.407 179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.56 -173.62 23.01 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.671 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 44.6 m-85 -130.01 157.06 43.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.226 -1.161 . . . . 0.0 109.506 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.611 ' C ' HD13 ' A' ' 34' ' ' ILE . 37.2 mm -110.03 130.0 64.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.689 HG23 ' CD1' ' A' ' 72' ' ' ILE . 2.0 mm -117.58 121.2 66.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 120.927 -1.108 . . . . 0.0 110.403 -178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.434 HH12 HG13 ' A' ' 73' ' ' ILE . 57.3 mtt180 -121.87 137.4 54.8 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 53.7 p-80 -138.08 138.77 39.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.618 -1.301 . . . . 0.0 110.849 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 41.4 p-80 -167.74 160.02 12.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.55 -0.719 . . . . 0.0 109.702 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' A' ' 41' ' ' SER . . . -83.33 154.56 24.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.17 -0.956 . . . . 0.0 109.849 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.492 ' HG3' ' CD2' ' A' ' 40' ' ' HIS . 13.3 pt-20 -64.54 -29.98 71.01 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.913 . . . . 0.0 109.051 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.492 ' CD2' ' HG3' ' A' ' 39' ' ' GLU . 90.4 m-70 -105.03 18.01 23.12 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.661 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 93.9 p -74.73 167.11 22.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.314 -0.866 . . . . 0.0 109.409 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.697 ' O ' ' N ' ' A' ' 44' ' ' ARG . 13.9 m -73.95 158.49 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.226 -0.921 . . . . 0.0 109.506 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.437 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -58.28 33.94 0.02 OUTLIER Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 -178.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.697 ' N ' ' O ' ' A' ' 42' ' ' VAL . 68.3 mtt180 -122.17 55.49 6.4 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.844 -1.386 . . . . 0.0 110.476 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.46 ' CD ' ' N ' ' A' ' 44' ' ' ARG . 2.7 Cg_endo -57.77 126.15 20.89 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 121.502 1.468 . . . . 0.0 112.355 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -74.2 149.99 40.59 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.136 -0.978 . . . . 0.0 110.177 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.559 ' NE2' HH12 ' A' ' 49' ' ' ARG . 14.6 pt20 -120.66 122.02 39.57 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.609 0.719 . . . . 0.0 109.538 179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -125.84 125.96 43.71 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.56 ' HD2' HG23 ' A' ' 33' ' ' ILE . 1.9 mmt-85 -108.94 147.3 32.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.985 -1.072 . . . . 0.0 109.108 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.701 ' CG1' HD12 ' A' ' 57' ' ' ILE . 28.2 m -127.24 147.44 61.96 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.13 -0.981 . . . . 0.0 110.175 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.03 159.52 46.14 Favored 'Trans proline' 0 N--CA 1.489 1.251 0 C-N-CA 120.955 1.103 . . . . 0.0 111.571 178.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.39 -33.65 97.51 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 121.383 1.389 . . . . 0.0 111.926 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.9 p -69.97 -12.76 61.85 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.574 -0.704 . . . . 0.0 110.471 -179.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -99.95 110.53 22.86 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.086 -1.009 . . . . 0.0 109.86 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.9 p30 -99.57 -1.5 38.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.337 -0.852 . . . . 0.0 108.788 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.482 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 78.5 p -138.24 136.07 36.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.701 HD12 ' CG1' ' A' ' 50' ' ' VAL . 7.2 tt -129.96 136.62 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.952 . . . . 0.0 109.823 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 m -100.48 114.63 28.39 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.204 -0.935 . . . . 0.0 109.237 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.478 ' HB3' HD11 ' A' ' 62' ' ' LEU . 11.1 mt -88.48 149.97 23.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.235 -0.916 . . . . 0.0 109.556 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.427 HG22 ' OG ' ' A' ' 17' ' ' SER . 27.3 p -136.01 177.89 7.48 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.743 -0.598 . . . . 0.0 109.96 -179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 13.9 m120 56.27 46.26 21.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.367 -0.833 . . . . 0.0 109.61 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 59' ' ' LEU . 44.0 mt -109.96 153.2 24.88 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.376 -0.827 . . . . 0.0 109.063 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.424 ' H ' HD22 ' A' ' 63' ' ' ASN . 2.3 m-80 -67.47 118.95 61.8 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 0.0 108.508 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.699 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.6 Cg_endo -62.84 129.83 27.4 Favored 'Trans proline' 0 C--N 1.316 -1.183 0 C-N-CA 120.893 1.062 . . . . 0.0 112.736 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.63 61.33 3.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -142.72 135.51 28.03 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.16 -1.2 . . . . 0.0 111.464 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.433 ' HG2' ' HB2' ' A' ' 89' ' ' ALA . 99.1 mt-10 -91.03 117.03 29.26 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.731 ' OH ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -133.61 173.78 11.14 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.084 -1.046 . . . . 0.0 111.308 -178.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -108.63 136.45 44.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.712 -0.617 . . . . 0.0 110.091 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.6 t -123.54 129.94 74.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 95.4 p -115.93 140.97 48.72 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.723 -1.235 . . . . 0.0 112.306 -178.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.689 ' CD1' HG23 ' A' ' 34' ' ' ILE . 48.6 mm -119.95 120.01 61.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.434 HG13 HH12 ' A' ' 35' ' ' ARG . 34.2 mm -115.36 129.95 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 120.718 -1.239 . . . . 0.0 108.666 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.562 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -92.84 129.91 38.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.035 -1.041 . . . . 0.0 109.751 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.01 159.99 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -140.49 38.45 1.87 Allowed 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.92 -97.61 1.62 Allowed Glycine 0 N--CA 1.488 2.132 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.4 mmt-85 -99.6 0.03 41.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.261 -1.141 . . . . 0.0 110.082 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -111.46 151.68 28.3 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.172 -0.955 . . . . 0.0 109.691 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -129.56 153.93 47.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 109.8 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -107.22 176.8 1.49 Allowed Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.384 -0.822 . . . . 0.0 108.977 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' CD ' ' CB ' ' A' ' 81' ' ' SER . 3.6 Cg_exo -65.75 131.44 27.53 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.035 1.157 . . . . 0.0 111.628 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.74 140.89 95.1 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 121.2 1.267 . . . . 0.0 113.384 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 20.1 tp -119.98 116.73 26.36 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -128.12 139.94 50.52 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 120.944 -1.097 . . . . 0.0 110.513 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.7 162.4 26.62 Favored Glycine 0 N--CA 1.483 1.789 0 N-CA-C 108.116 -1.993 . . . . 0.0 108.116 179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -110.36 149.61 29.98 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.155 -1.203 . . . . 0.0 109.671 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.739 HE21 ' CB ' ' A' ' 10' ' ' SER . 17.4 tt0 -148.46 156.48 42.53 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.379 -0.826 . . . . 0.0 108.98 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' N ' ' HG2' ' A' ' 88' ' ' GLN . . . -121.37 123.62 42.57 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.24 -0.913 . . . . 0.0 109.658 178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.731 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.32 142.89 47.12 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 179.695 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -61.77 154.42 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-O 121.48 0.657 . . . . 0.0 110.673 -179.322 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.8 p -83.51 151.62 25.32 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.425 -0.797 . . . . 0.0 109.815 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.54 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 53.2 t0 -81.16 -20.14 41.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.446 -0.784 . . . . 0.0 110.769 -179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.605 HG21 HG23 ' A' ' 178' ' ' VAL . 3.1 mt -81.53 140.84 48.24 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.876 -1.14 . . . . 0.0 109.527 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' HD2' HG22 ' A' ' 94' ' ' ILE . 3.6 Cg_exo -58.78 -170.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.291 0 N-CA-C 109.946 -0.828 . . . . 0.0 109.946 177.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 38.2 ttm180 -149.89 160.0 43.93 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.503 -1.373 . . . . 0.0 110.529 -179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.479 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 14.6 t0 72.6 36.22 1.01 Allowed 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.682 -0.636 . . . . 0.0 110.871 179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.664 HD22 HD13 ' A' ' 180' ' ' ILE . 2.2 tt -68.01 102.9 1.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 178.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.412 ' OE2' ' OD1' ' A' ' 97' ' ' ASP . 47.4 mt-10 -149.92 169.65 20.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.932 -1.105 . . . . 0.0 110.334 -178.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.9 t -110.16 131.74 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.44 -0.787 . . . . 0.0 109.605 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -99.6 -25.26 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.46 -0.775 . . . . 0.0 109.633 -179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.551 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -127.35 135.94 51.21 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.607 -0.683 . . . . 0.0 109.158 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.595 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 18.5 t -118.62 116.11 25.93 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.142 -0.974 . . . . 0.0 109.815 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.596 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -105.66 155.82 37.51 Favored Pre-proline 0 C--N 1.305 -1.347 0 O-C-N 121.313 -0.867 . . . . 0.0 108.903 179.173 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -51.61 -35.35 56.53 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 C-N-CA 121.661 1.574 . . . . 0.0 112.931 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.481 ' C ' HG22 ' A' ' 152' ' ' ILE . 56.4 p -128.75 16.36 6.38 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.992 -1.067 . . . . 0.0 110.412 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.079 ' O ' HD23 ' A' ' 108' ' ' LEU . 29.0 p -158.66 169.34 24.62 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.806 -1.184 . . . . 0.0 110.01 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.079 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -144.81 153.41 41.61 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.346 -0.846 . . . . 0.0 109.68 -179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.657 HD23 ' N ' ' A' ' 110' ' ' ILE . 4.5 tt -101.88 125.66 48.61 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.713 HD11 ' HB3' ' A' ' 147' ' ' ALA . 11.6 pt -114.01 152.12 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.048 -1.033 . . . . 0.0 111.117 -178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.2 t -147.47 140.31 24.91 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 48.5 p90 -147.61 160.0 43.14 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.374 -0.829 . . . . 0.0 109.052 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -96.04 130.16 32.03 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.347 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.73 138.68 84.58 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 120.851 1.034 . . . . 0.0 112.167 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -60.63 -160.65 0.02 OUTLIER 'Trans proline' 0 N--CA 1.49 1.282 0 C-N-CA 121.119 1.213 . . . . 0.0 112.557 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -102.48 12.24 36.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.285 179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.468 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 33.2 m -130.01 160.1 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 0.0 109.221 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 84.0 p -68.59 149.96 48.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.057 -1.027 . . . . 0.0 109.013 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 54.2 t -131.4 137.32 55.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 22.9 mtp180 -71.51 -53.5 13.66 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.475 ' CE2' HG22 ' A' ' 139' ' ' THR . 26.4 p90 -167.37 170.32 11.56 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.595 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 3.5 m-85 -118.29 135.92 54.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.814 -1.179 . . . . 0.0 108.666 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.592 ' NH2' ' CG ' ' A' ' 163' ' ' TYR . 28.5 ttp-105 -98.53 125.04 43.62 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 120.829 -1.17 . . . . 0.0 107.9 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.589 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 85.4 mt -111.17 133.46 56.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.075 -1.016 . . . . 0.0 110.135 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.734 HG22 ' HB3' ' A' ' 137' ' ' GLU . 3.1 p -105.55 145.12 31.37 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.916 0.865 . . . . 0.0 111.282 -179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.698 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.3 m-85 -92.41 120.28 32.76 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.704 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.93 129.65 9.72 Favored Glycine 0 N--CA 1.479 1.537 0 C-N-CA 119.359 -1.401 . . . . 0.0 110.903 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 130' ' ' GLY . 56.9 mt-10 -106.24 163.24 12.97 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.734 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 0.8 OUTLIER -28.91 -35.39 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.43 -0.794 . . . . 0.0 109.766 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . 104.32 31.77 4.52 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.33 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -78.58 -90.08 0.39 Allowed Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -133.29 22.45 4.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.234 -1.156 . . . . 0.0 109.497 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 47.6 t -106.84 119.25 51.99 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.194 -0.941 . . . . 0.0 109.885 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.1 155.74 54.19 Favored 'Trans proline' 0 N--CA 1.49 1.317 0 C-N-CA 120.879 1.052 . . . . 0.0 112.355 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.408 HG13 ' H ' ' A' ' 135' ' ' VAL . 1.4 m -73.62 150.33 7.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.246 -0.908 . . . . 0.0 109.754 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.54 ' O ' ' N ' ' A' ' 126' ' ' TYR . 96.8 mm-40 -117.49 138.08 52.12 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.734 ' HB3' HG22 ' A' ' 125' ' ' THR . 21.9 pt-20 -128.8 160.02 33.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.761 -1.212 . . . . 0.0 112.246 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.589 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 50.4 p90 -144.61 157.12 44.35 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.475 HG22 ' CE2' ' A' ' 121' ' ' TYR . 7.2 p -87.5 164.94 15.87 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.901 -1.124 . . . . 0.0 110.939 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.467 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 50.7 t -128.88 118.3 19.61 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.481 -0.762 . . . . 0.0 110.625 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.441 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.3 Cg_exo -59.04 130.47 36.61 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 CA-C-N 119.273 0.776 . . . . 0.0 111.819 179.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.72 2.71 2.4 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 141' ' ' PRO . 52.5 m -89.98 -2.9 58.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.153 -1.204 . . . . 0.0 110.113 -179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 48.5 mmtt -128.81 138.73 52.23 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.02 -1.05 . . . . 0.0 109.728 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.0 m -94.36 -7.39 41.83 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 109.189 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 32.4 p -133.41 153.27 51.75 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.713 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -138.4 175.4 9.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.853 -1.154 . . . . 0.0 109.757 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 3.1 t -120.38 146.93 45.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.689 HD11 HD13 ' A' ' 110' ' ' ILE . 32.8 mm -113.16 120.74 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.149 -0.969 . . . . 0.0 109.44 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.698 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 35.6 m120 -123.76 177.51 5.68 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.245 -0.909 . . . . 0.0 109.895 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 7.4 m120 59.97 46.52 10.9 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.252 -0.905 . . . . 0.0 109.484 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.493 HG12 ' CZ ' ' A' ' 158' ' ' TYR . 4.8 tt -107.68 153.67 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' N ' ' OH ' ' A' ' 158' ' ' TYR . 13.1 mmtt -97.66 109.97 53.08 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.008 -1.058 . . . . 0.0 109.954 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.43 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.4 Cg_endo -68.42 173.16 10.14 Favored 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.305 1.336 . . . . 0.0 113.036 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.34 27.29 71.43 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.734 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . -152.81 155.81 37.85 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.981 -1.305 . . . . 0.0 109.975 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 48.5 t0 -72.91 155.23 40.1 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.704 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.1 m-85 -142.43 160.02 41.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.858 -1.152 . . . . 0.0 110.774 -179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.473 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.7 m -135.09 120.5 19.13 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 178.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.706 HD11 HD12 ' A' ' 108' ' ' LEU . 98.4 mt -105.58 121.58 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.228 -1.545 . . . . 0.0 108.901 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.413 ' O ' ' OG1' ' A' ' 125' ' ' THR . 50.8 m -129.97 142.05 50.69 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 109.815 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.642 ' C ' HD12 ' A' ' 162' ' ' LEU . 1.4 pp -136.45 152.4 50.53 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.678 -1.209 . . . . 0.0 111.42 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.634 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.2 m-85 -121.01 139.98 52.55 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -101.53 132.61 47.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.699 -1.251 . . . . 0.0 109.541 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 47.1 t -115.65 124.06 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.284 -0.885 . . . . 0.0 109.48 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.617 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 2.8 p -123.13 -65.38 1.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.634 -0.666 . . . . 0.0 109.694 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.617 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -23.24 142.11 0.01 OUTLIER Glycine 0 N--CA 1.496 2.674 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 80.3 mtp85 -121.71 132.84 54.85 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.393 -1.063 . . . . 0.0 109.258 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 142.98 -151.68 23.37 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 31.5 p-10 -91.46 -0.44 57.62 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.326 -1.103 . . . . 0.0 109.382 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.0 m -131.76 74.32 77.74 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.196 -0.94 . . . . 0.0 109.975 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -65.13 108.66 1.18 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.581 1.521 . . . . 0.0 111.724 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.99 150.04 25.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.374 -0.829 . . . . 0.0 109.779 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.1 p -126.2 148.89 49.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.356 -0.84 . . . . 0.0 109.606 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 85.0 p -79.34 170.0 17.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 108.807 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.454 ' HB2' HD11 ' A' ' 94' ' ' ILE . 6.2 mttm -56.2 129.06 73.54 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.007 -1.058 . . . . 0.0 108.756 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.439 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.3 Cg_endo -62.02 144.53 96.32 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 121.105 1.204 . . . . 0.0 113.217 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.605 HG23 HG21 ' A' ' 94' ' ' ILE . 2.1 t -113.54 128.6 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 177.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 81.1 p -123.29 150.04 44.05 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.169 -0.957 . . . . 0.0 111.703 -177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.664 HD13 HD22 ' A' ' 98' ' ' LEU . 39.5 pt -133.85 159.98 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -104.84 139.33 39.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.947 -1.095 . . . . 0.0 109.002 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.604 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 62.4 t80 -135.33 130.38 34.94 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.202 -0.936 . . . . 0.0 110.593 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.0 ptpt -100.1 139.99 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.343 -0.848 . . . . 0.0 108.946 179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.492 1.631 0 O-C-N 120.951 -1.093 . . . . 0.0 109.479 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.867 0 N-CA-C 119.344 2.497 . . . . 0.0 119.344 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.1 mt -120.02 133.68 55.47 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.201 -1.176 . . . . 0.0 109.313 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -74.41 149.22 40.56 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.424 -0.798 . . . . 0.0 108.982 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' THR . 47.5 t -82.5 132.17 53.16 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.989 -179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.495 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_endo -59.04 79.91 0.05 OUTLIER 'Trans proline' 0 N--CA 1.492 1.415 0 C-N-CA 121.129 1.22 . . . . 0.0 111.591 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.426 ' N ' ' O ' ' A' ' 4' ' ' SER . 1.0 OUTLIER -85.9 -159.56 0.47 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.787 -1.195 . . . . 0.0 110.241 -179.094 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 79.24 19.05 72.91 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 106.01 -2.836 . . . . 0.0 106.01 -177.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.572 ' HB2' HD21 ' A' ' 84' ' ' LEU . 57.3 t80 -59.97 134.83 57.41 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.643 0.735 . . . . 0.0 110.146 -178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.421 ' OD1' ' N ' ' A' ' 10' ' ' SER . 39.8 t0 -158.98 148.8 19.12 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.421 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 90.0 p -113.98 132.43 55.98 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 120.934 -1.104 . . . . 0.0 109.553 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.495 ' O ' ' C ' ' A' ' 12' ' ' ASP . 37.3 p -149.22 -175.95 5.18 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.317 -0.864 . . . . 0.0 109.048 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.495 ' C ' ' O ' ' A' ' 11' ' ' SER . 78.2 m-20 47.57 46.94 17.79 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.791 HG22 HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -82.64 127.92 39.21 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.152 -177.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.681 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.04 161.39 18.41 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 177.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.764 ' H ' ' HB1' ' A' ' 116' ' ' ALA . . . -63.32 -54.37 38.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.775 -1.203 . . . . 0.0 109.902 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -91.08 0.01 57.63 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.018 -1.052 . . . . 0.0 109.528 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 14' ' ' THR . 97.6 p -155.53 158.91 39.23 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.371 -0.831 . . . . 0.0 109.01 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CD1' ' NE2' ' A' ' 88' ' ' GLN . 30.4 p90 -163.02 151.03 13.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.974 -1.079 . . . . 0.0 109.529 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.4 m -95.36 157.1 16.04 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.54 -1.35 . . . . 0.0 111.518 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.65 ' C ' ' CD2' ' A' ' 21' ' ' HIS . 1.1 t -128.4 160.0 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.65 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.7 m-70 -150.87 154.11 36.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.84 -1.162 . . . . 0.0 110.589 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.54 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 47.4 p90 -153.69 160.01 42.2 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.509 -0.745 . . . . 0.0 109.19 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -84.63 157.83 3.53 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 O-C-N 120.995 -1.066 . . . . 0.0 109.768 179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.4 ' N ' HG13 ' A' ' 23' ' ' VAL . . . -99.06 120.44 58.39 Favored Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -61.1 149.71 87.84 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.819 1.013 . . . . 0.0 112.19 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 59.2 mtt180 -78.83 -12.39 60.03 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.247 -0.908 . . . . 0.0 109.187 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.562 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -72.21 150.56 92.15 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.482 -0.761 . . . . 0.0 109.259 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.82 126.05 20.54 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 121.323 1.349 . . . . 0.0 112.719 179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.68 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 28.4 pt -136.52 166.55 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.205 -0.935 . . . . 0.0 109.438 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.6 p -115.71 -3.31 12.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.977 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.9 -175.51 28.99 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.68 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 55.1 m-85 -131.57 151.36 51.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.162 -1.199 . . . . 0.0 109.997 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.609 HD12 ' C ' ' A' ' 32' ' ' TYR . 1.4 mp -112.71 132.6 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.662 HG23 HD13 ' A' ' 72' ' ' ILE . 2.2 mm -118.16 131.23 71.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.03 -1.044 . . . . 0.0 110.96 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -119.43 138.4 53.13 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 177.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.432 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 8.3 t60 -129.91 139.94 51.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.553 -1.342 . . . . 0.0 111.221 -178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.446 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 28.8 p-80 -163.61 153.19 14.8 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.3 0.572 . . . . 0.0 109.979 179.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.899 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -95.93 149.68 21.28 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 0.0 109.338 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -60.03 -39.39 85.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.18 -0.95 . . . . 0.0 109.438 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 47.3 m-70 -83.17 0.08 46.93 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.511 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.524 ' OG ' ' O ' ' A' ' 38' ' ' ALA . 70.0 p -91.79 124.76 36.16 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.99 -1.069 . . . . 0.0 109.803 -179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' O ' HG12 ' A' ' 42' ' ' VAL . 39.6 t -99.96 -10.04 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.68 174.35 6.79 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.02 132.41 88.45 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.26 -1.141 . . . . 0.0 109.326 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.65 136.75 77.6 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 120.859 1.04 . . . . 0.0 111.889 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 82.8 mtt-85 -73.73 156.62 37.7 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.131 -0.981 . . . . 0.0 109.994 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 91.1 mt-30 -121.11 109.91 15.58 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.0 109.979 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.568 ' O ' ' O ' ' A' ' 34' ' ' ILE . 91.7 m-20 -120.79 125.93 48.83 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.541 ' NH1' HG23 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -109.27 151.77 26.11 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.01 -1.056 . . . . 0.0 108.731 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.599 HG22 HD11 ' A' ' 34' ' ' ILE . 27.8 m -130.98 145.2 56.76 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.908 -1.12 . . . . 0.0 110.113 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -64.04 160.4 38.02 Favored 'Trans proline' 0 N--CA 1.488 1.196 0 C-N-CA 120.999 1.133 . . . . 0.0 111.837 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.14 -32.66 97.62 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 121.588 1.525 . . . . 0.0 112.298 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.5 m -74.84 -10.95 59.99 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.491 -0.756 . . . . 0.0 111.101 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.81 117.83 35.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.861 -1.149 . . . . 0.0 109.872 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.1 p30 -104.14 -0.01 29.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.462 -0.774 . . . . 0.0 109.489 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 86.7 p -130.94 139.91 50.11 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.393 -0.817 . . . . 0.0 109.902 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.54 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 9.1 tt -130.04 130.22 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.14 178.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.6 m -98.94 120.88 40.13 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.173 -0.955 . . . . 0.0 109.979 -179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.661 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.9 mt -97.21 138.11 35.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.363 -0.836 . . . . 0.0 109.222 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.9 p -123.3 179.48 4.7 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.346 -0.846 . . . . 0.0 110.474 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 53.74 48.56 21.2 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.509 -0.744 . . . . 0.0 109.923 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.661 HD11 ' HB3' ' A' ' 59' ' ' LEU . 55.5 mt -111.54 158.26 19.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.338 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.674 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 10.8 m120 -69.94 129.99 90.4 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.245 -0.909 . . . . 0.0 109.296 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.36 132.66 39.44 Favored 'Trans proline' 0 N--CA 1.492 1.427 0 C-N-CA 121.336 1.357 . . . . 0.0 113.505 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 67.08 65.84 2.61 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.553 -1.819 . . . . 0.0 108.553 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.602 ' N ' ' OG1' ' A' ' 90' ' ' THR . 1.2 m -149.86 151.85 34.15 Favored 'General case' 0 N--CA 1.506 2.341 0 C-N-CA 118.354 -1.338 . . . . 0.0 112.188 -178.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 49.6 mp0 -92.66 119.96 32.6 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.899 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 50.0 m-85 -111.23 140.51 45.72 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.117 -0.99 . . . . 0.0 110.799 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.446 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 15.2 t -92.7 121.42 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.99 125.6 74.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.931 -1.106 . . . . 0.0 109.708 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.5 p -99.59 135.33 41.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.673 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.662 HD13 HG23 ' A' ' 34' ' ' ILE . 48.5 mm -116.51 129.97 72.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.553 HG22 ' N ' ' A' ' 74' ' ' ALA . 80.4 mt -127.67 160.01 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.992 -1.068 . . . . 0.0 110.152 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.553 ' N ' HG22 ' A' ' 73' ' ' ILE . . . -128.54 131.94 48.25 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 32.1 m -128.31 151.21 34.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.222 -0.924 . . . . 0.0 109.295 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -126.25 33.84 4.95 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.188 -0.945 . . . . 0.0 108.515 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.83 -89.33 1.27 Allowed Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.16 -1.576 . . . . 0.0 109.16 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 78' ' ' ARG . 40.7 ttm-85 -89.97 -19.38 24.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -1.061 . . . . 0.0 110.386 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -104.36 150.32 24.6 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 120.836 -1.165 . . . . 0.0 110.788 -178.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -120.63 147.34 45.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.447 -0.783 . . . . 0.0 109.078 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.8 OUTLIER -104.16 160.87 24.66 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.164 -0.96 . . . . 0.0 109.316 -179.622 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.89 129.96 31.01 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 121.184 1.256 . . . . 0.0 112.298 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.91 145.25 98.77 Favored 'Trans proline' 0 N--CA 1.491 1.351 0 C-N-CA 121.294 1.329 . . . . 0.0 113.5 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 8' ' ' PHE . 13.3 tp -119.89 119.34 33.21 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -120.02 130.04 74.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.974 -1.078 . . . . 0.0 110.568 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -133.15 168.79 22.86 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 107.871 -2.092 . . . . 0.0 107.871 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -121.88 147.77 45.58 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.08 -1.247 . . . . 0.0 109.889 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.798 ' NE2' ' CD1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -142.29 159.27 42.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -119.08 135.36 54.68 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.083 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 66' ' ' THR . 0.1 OUTLIER -73.84 133.6 43.21 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.136 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.791 HG23 HG22 ' A' ' 13' ' ' ILE . 39.7 t -37.21 171.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 CA-C-O 122.008 0.909 . . . . 0.0 111.547 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.744 ' N ' HG12 ' A' ' 91' ' ' VAL . 1.4 t -105.36 153.62 21.41 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 49.7 t0 -59.99 -40.02 87.72 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.473 -0.767 . . . . 0.0 110.243 -179.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.857 HD12 ' O ' ' A' ' 176' ' ' LYS . 0.5 OUTLIER -72.62 143.67 85.2 Favored Pre-proline 0 N--CA 1.485 1.315 0 C-N-CA 118.116 -1.434 . . . . 0.0 109.115 179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.698 ' HD2' HG23 ' A' ' 94' ' ' ILE . 3.1 Cg_exo -61.7 -158.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 120.635 0.89 . . . . 0.0 111.205 177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.555 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 40.5 ttp180 -154.14 166.69 32.29 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.098 -1.001 . . . . 0.0 109.812 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.555 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 15.7 t0 74.96 35.08 0.64 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.503 -0.748 . . . . 0.0 109.831 179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.401 HD13 HD23 ' A' ' 162' ' ' LEU . 44.3 tp -67.6 107.0 2.36 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -158.51 163.55 36.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.893 . . . . 0.0 109.902 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -93.58 139.96 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.428 -0.795 . . . . 0.0 109.605 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 30.4 pt -118.08 -16.0 8.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.313 -0.867 . . . . 0.0 109.115 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -140.67 130.04 23.83 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.468 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 6.2 m -117.42 119.76 36.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.07 -1.019 . . . . 0.0 109.805 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.604 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -101.95 158.07 32.48 Favored Pre-proline 0 C--N 1.302 -1.488 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -51.18 -35.56 52.72 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 C-N-CA 121.312 1.341 . . . . 0.0 112.497 -179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.425 ' C ' HG22 ' A' ' 152' ' ' ILE . 68.4 p -130.14 18.4 5.48 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.031 -1.043 . . . . 0.0 110.245 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.607 ' O ' HD23 ' A' ' 108' ' ' LEU . 2.4 p -154.16 160.07 41.72 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.877 -1.139 . . . . 0.0 109.91 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.802 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -133.38 150.13 51.83 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.274 -0.891 . . . . 0.0 108.653 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 110' ' ' ILE . 4.7 tt -105.2 120.09 40.66 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 108.898 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.74 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.3 pt -99.97 138.61 23.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.268 -0.895 . . . . 0.0 109.662 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.683 ' HA ' HG22 ' A' ' 146' ' ' THR . 32.5 t -132.56 133.92 44.31 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.46 -0.775 . . . . 0.0 110.1 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -145.72 144.89 30.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 95' ' ' PRO . 1.8 pt-20 -72.3 145.97 88.79 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.934 -1.103 . . . . 0.0 108.575 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.53 136.56 74.97 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 120.962 1.108 . . . . 0.0 111.744 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.31 -163.42 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 120.332 0.688 . . . . 0.0 111.364 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.764 ' HB1' ' H ' ' A' ' 15' ' ' ALA . . . -113.74 11.68 18.15 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.221 -0.924 . . . . 0.0 108.986 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.437 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 33.1 m -129.97 159.99 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.369 -0.832 . . . . 0.0 109.61 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 48.4 t -71.16 133.06 45.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.933 . . . . 0.0 108.789 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.666 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 14.6 t -122.78 134.59 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.074 . . . . 0.0 110.266 -179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.477 ' HD2' ' NH2' ' A' ' 168' ' ' ARG . 0.8 OUTLIER -72.3 -52.29 16.92 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 14.1 p90 -166.84 170.11 12.6 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.666 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.5 m-85 -122.15 143.87 49.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.158 -0.963 . . . . 0.0 108.412 179.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.629 ' HE ' ' CD ' ' A' ' 137' ' ' GLU . 54.6 ttt-85 -103.71 126.04 50.58 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.692 -1.255 . . . . 0.0 107.906 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.674 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 50.2 mt -116.56 144.1 25.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.099 -1.001 . . . . 0.0 109.895 -178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.521 HG22 HH21 ' A' ' 123' ' ' ARG . 36.0 p -118.31 144.49 45.8 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.832 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.735 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.9 m-85 -87.9 131.36 34.61 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.529 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.52 115.25 4.66 Favored Glycine 0 N--CA 1.482 1.701 0 C-N-CA 119.704 -1.236 . . . . 0.0 110.922 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.501 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 34.2 mt-10 -109.97 98.67 7.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.459 ' H ' HG23 ' A' ' 129' ' ' THR . 9.1 p -60.33 -39.62 87.7 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.653 -1.28 . . . . 0.0 109.765 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -50.95 -39.09 39.67 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 86.32 10.13 74.81 Favored Glycine 0 N--CA 1.491 2.318 0 O-C-N 121.139 -1.212 . . . . 0.0 110.494 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -60.0 -39.97 87.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.859 -1.377 . . . . 0.0 109.162 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 70.7 m -136.15 149.82 69.25 Favored Pre-proline 0 C--N 1.294 -1.836 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 179.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.25 166.79 6.86 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 121.106 1.204 . . . . 0.0 112.266 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.5 m -60.02 152.53 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.203 -0.935 . . . . 0.0 108.582 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.63 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 83.6 mt-30 -117.95 136.61 53.38 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 118.913 -1.115 . . . . 0.0 108.265 179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.629 ' CD ' ' HE ' ' A' ' 123' ' ' ARG . 10.6 pt-20 -123.17 144.32 49.43 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 118.872 -1.131 . . . . 0.0 111.261 -178.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.674 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 52.2 p90 -138.49 158.87 43.43 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.402 HG22 ' CE2' ' A' ' 121' ' ' TYR . 4.0 p -94.25 167.0 11.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.905 -1.122 . . . . 0.0 111.54 -177.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 142' ' ' GLY . 98.0 t -135.17 85.64 33.1 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.5 Cg_exo -58.87 50.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 120.996 1.131 . . . . 0.0 113.162 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 34.95 24.54 0.01 OUTLIER Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 141' ' ' PRO . 79.6 p -61.64 -39.98 93.23 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.193 -1.18 . . . . 0.0 109.763 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 53.5 mttt -145.58 171.13 15.14 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.58 -0.7 . . . . 0.0 110.112 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 99.5 p -84.35 -1.17 55.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.581 -0.699 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 111' ' ' SER . 68.4 p -130.73 151.31 51.31 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.382 -0.824 . . . . 0.0 108.993 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.74 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -126.78 148.92 49.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.972 -1.08 . . . . 0.0 109.79 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.419 ' CG2' HD21 ' A' ' 150' ' ' ASN . 1.8 m -94.02 143.19 26.58 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.224 -0.923 . . . . 0.0 109.11 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.608 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 37.3 mm -115.19 121.33 66.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.294 -0.879 . . . . 0.0 109.045 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.735 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 14.3 m120 -127.11 170.0 12.82 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.266 -0.896 . . . . 0.0 109.703 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.409 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 19.0 m120 68.34 48.6 0.87 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.567 -0.708 . . . . 0.0 109.816 -179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.574 ' CD1' HD11 ' A' ' 108' ' ' LEU . 2.0 tt -113.74 147.34 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt -95.45 111.13 54.28 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.848 -1.157 . . . . 0.0 109.654 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.429 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 2.8 Cg_endo -64.95 163.37 28.63 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 121.061 1.174 . . . . 0.0 112.705 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.86 25.96 72.49 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 110.373 -1.091 . . . . 0.0 110.373 179.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.405 ' O ' HG23 ' A' ' 184' ' ' THR . . . -146.36 146.79 30.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.973 -1.31 . . . . 0.0 109.917 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.588 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 55.3 t0 -70.01 151.52 45.46 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.734 -1.209 . . . . 0.0 107.734 178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.588 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.8 OUTLIER -138.1 173.16 11.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.86 -1.15 . . . . 0.0 111.225 -178.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.468 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -141.34 111.52 6.78 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 178.372 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 47.3 mm -102.81 124.03 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.3 -1.5 . . . . 0.0 109.462 -178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.9 m -124.81 139.92 53.4 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.617 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 1.027 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -119.67 136.5 54.38 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.419 -0.801 . . . . 0.0 110.36 -178.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 1.027 ' N ' HD12 ' A' ' 162' ' ' LEU . 51.0 m-85 -121.65 141.45 51.11 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.758 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -103.61 123.64 47.33 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.187 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 62.8 t -110.36 119.93 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.093 -1.004 . . . . 0.0 109.84 -179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 1.4 p -96.41 -43.62 7.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.453 -0.78 . . . . 0.0 108.949 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 165' ' ' VAL . . . -92.12 164.64 28.63 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.477 ' NH2' ' HD2' ' A' ' 120' ' ' ARG . 61.8 mtt180 -114.87 -109.98 0.36 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.093 -1.24 . . . . 0.0 110.337 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.41 -28.68 39.02 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.491 -1.044 . . . . 0.0 110.491 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -72.72 -44.46 61.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.981 -1.305 . . . . 0.0 109.871 -179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.463 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 75.6 m -141.47 66.31 23.03 Favored Pre-proline 0 C--N 1.295 -1.792 0 O-C-N 121.56 -0.713 . . . . 0.0 109.674 179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.463 ' HD3' ' N ' ' A' ' 171' ' ' SER . 2.8 Cg_endo -65.74 82.61 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 121.673 1.582 . . . . 0.0 112.421 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.86 139.66 52.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.212 -0.93 . . . . 0.0 109.28 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 15.2 p -101.9 167.04 10.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.142 -0.973 . . . . 0.0 109.825 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.758 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 1.4 p -105.19 160.31 15.18 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.857 ' O ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -39.07 100.1 0.21 Allowed Pre-proline 0 N--CA 1.506 2.345 0 O-C-N 121.088 -1.007 . . . . 0.0 110.148 -178.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.5 Cg_exo -62.69 159.27 37.85 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 121.818 1.679 . . . . 0.0 114.751 -178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.487 HG23 HG21 ' A' ' 94' ' ' ILE . 59.0 t -124.22 130.01 73.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 178.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 80.2 p -120.26 150.19 41.09 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.757 -1.215 . . . . 0.0 110.933 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 24.0 pt -138.28 161.14 31.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.225 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -104.33 128.72 52.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.115 -0.99 . . . . 0.0 108.601 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.802 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 60.5 t80 -123.59 128.32 49.54 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.983 -1.073 . . . . 0.0 110.382 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -100.83 138.1 38.34 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.34 -0.85 . . . . 0.0 109.044 179.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.429 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.7 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.481 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.865 0 N-CA-C 119.404 2.522 . . . . 0.0 119.404 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 89.2 mt -129.98 145.74 51.65 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.262 -1.14 . . . . 0.0 109.08 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -80.0 124.99 29.2 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.375 -0.828 . . . . 0.0 109.199 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.54 ' HG ' ' HG ' ' A' ' 81' ' ' SER . 53.5 m -78.75 146.9 69.88 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 0.0 109.202 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.783 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.0 Cg_exo -57.6 157.98 21.28 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 120.983 1.122 . . . . 0.0 111.681 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.604 HG23 ' O ' ' A' ' 5' ' ' PRO . 21.2 p -156.2 -144.36 0.13 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.108 -0.995 . . . . 0.0 109.646 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 56.14 19.47 24.01 Favored Glycine 0 N--CA 1.485 1.91 0 N-CA-C 105.249 -3.14 . . . . 0.0 105.249 -177.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.461 ' N ' ' C ' ' A' ' 6' ' ' THR . 59.6 t80 -54.91 130.03 39.8 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.83 0.824 . . . . 0.0 110.805 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' A' ' 10' ' ' SER . 60.6 t0 -158.67 141.3 14.35 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.564 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 41.2 m -106.85 140.35 39.82 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 120.948 -1.095 . . . . 0.0 109.608 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.437 ' O ' ' C ' ' A' ' 12' ' ' ASP . 60.8 p -152.98 -176.44 5.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.342 -0.849 . . . . 0.0 109.225 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 11' ' ' SER . 74.7 m-20 50.01 46.22 24.63 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.735 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -82.19 123.4 38.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.733 -178.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.2 161.98 17.69 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.695 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.02 -57.61 12.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.813 -1.179 . . . . 0.0 110.049 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -91.1 -0.01 57.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.937 -1.102 . . . . 0.0 110.012 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 38.5 t -151.36 155.73 39.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.222 -0.924 . . . . 0.0 109.363 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.685 ' CZ ' ' OE1' ' A' ' 88' ' ' GLN . 20.5 p90 -162.9 145.76 10.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.107 -0.996 . . . . 0.0 109.104 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -94.78 151.11 19.52 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.463 -1.398 . . . . 0.0 111.531 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.684 HG22 ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -120.1 134.83 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 178.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.417 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 49.9 m-70 -129.23 149.6 50.97 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.643 -1.286 . . . . 0.0 111.0 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 40.4 p90 -154.1 159.39 41.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.453 -0.78 . . . . 0.0 109.175 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.36 155.66 3.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 O-C-N 121.044 -1.035 . . . . 0.0 109.941 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -87.14 135.41 34.96 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.849 -0.532 . . . . 0.0 109.751 -179.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -59.79 -179.5 0.22 Allowed 'Trans proline' 0 N--CA 1.489 1.263 0 C-N-CA 120.962 1.108 . . . . 0.0 112.139 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -108.53 12.46 26.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.922 . . . . 0.0 109.722 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.524 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -113.2 158.33 38.44 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.077 -1.015 . . . . 0.0 109.647 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.9 Cg_endo -56.54 130.3 39.27 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.777 1.651 . . . . 0.0 112.554 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 32' ' ' TYR . 39.5 pt -138.92 170.02 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.257 -0.902 . . . . 0.0 109.395 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.1 p -117.98 0.27 11.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.894 . . . . 0.0 109.715 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.43 -178.18 24.28 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.846 -1.302 . . . . 0.0 109.846 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 51.2 m-85 -130.14 151.29 50.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.279 -1.13 . . . . 0.0 109.516 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.762 HG23 ' HD2' ' A' ' 49' ' ' ARG . 28.4 mm -110.01 129.99 63.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 178.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.671 HG21 HG21 ' A' ' 57' ' ' ILE . 1.9 mm -113.55 120.56 63.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 120.812 -1.18 . . . . 0.0 109.935 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 70.4 mtt180 -116.67 131.53 56.92 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.546 ' CE1' ' CD1' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -121.8 139.11 54.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.865 -1.147 . . . . 0.0 110.285 -178.805 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -168.62 147.3 4.2 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.093 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . -82.45 167.72 18.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.24 -0.913 . . . . 0.0 108.74 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -72.66 -97.27 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.399 0 O-C-N 120.959 -1.088 . . . . 0.0 110.59 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -73.49 -39.96 64.46 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-O 121.363 0.601 . . . . 0.0 111.386 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 38' ' ' ALA . 1.4 p -101.48 96.87 7.43 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.257 -0.902 . . . . 0.0 110.425 -178.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.49 ' CG2' ' H ' ' A' ' 38' ' ' ALA . 9.0 p -143.43 140.24 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.303 -0.873 . . . . 0.0 109.588 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -82.15 -87.36 0.71 Allowed Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.5 mtm180 -120.04 114.63 33.59 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.215 -1.168 . . . . 0.0 109.651 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.75 95.47 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 120.732 0.955 . . . . 0.0 111.614 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 41.5 mtt180 -75.35 155.0 36.97 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.299 -0.876 . . . . 0.0 111.404 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -112.83 113.51 25.62 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.519 ' O ' ' O ' ' A' ' 34' ' ' ILE . 85.6 m-20 -113.7 123.24 49.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.151 -0.968 . . . . 0.0 108.653 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.762 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.4 OUTLIER -108.69 144.47 36.43 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.025 -1.047 . . . . 0.0 108.956 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.662 HG22 HD11 ' A' ' 34' ' ' ILE . 32.1 m -128.13 149.99 72.62 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.037 -1.04 . . . . 0.0 110.203 -179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -64.53 160.1 41.34 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 C-N-CA 121.123 1.216 . . . . 0.0 111.724 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.92 -35.97 97.69 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.364 1.376 . . . . 0.0 112.38 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.3 p -70.23 -12.02 61.31 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.429 -0.794 . . . . 0.0 110.867 -179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 28.3 mmt180 -101.85 121.21 41.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.015 -1.053 . . . . 0.0 110.113 -179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 50.7 p-10 -108.75 -0.0 20.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.61 -0.681 . . . . 0.0 109.699 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.417 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 57.3 p -130.34 139.95 50.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.171 -0.956 . . . . 0.0 110.183 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.671 HG21 HG21 ' A' ' 34' ' ' ILE . 6.4 tt -130.75 139.92 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.0 109.737 179.05 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 38.9 m -106.9 131.49 53.93 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.248 -0.908 . . . . 0.0 109.66 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.533 ' HB3' HD11 ' A' ' 62' ' ' LEU . 4.2 mt -112.07 148.08 34.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.218 -0.926 . . . . 0.0 109.806 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 61.4 p -135.06 179.66 6.18 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.517 -0.74 . . . . 0.0 109.862 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 72.2 m-20 57.47 40.72 26.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.368 -0.832 . . . . 0.0 109.539 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.533 HD11 ' HB3' ' A' ' 59' ' ' LEU . 44.6 mt -107.31 156.83 18.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.4 -0.813 . . . . 0.0 109.409 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -69.99 120.21 76.46 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.166 -0.959 . . . . 0.0 108.618 179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.695 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.9 Cg_endo -61.59 129.38 27.71 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 120.835 1.024 . . . . 0.0 112.966 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 76.17 60.76 3.0 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.2 m -145.47 152.02 39.13 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.288 -1.125 . . . . 0.0 110.336 -179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 67' ' ' GLU . 3.8 pt-20 -88.78 119.99 29.78 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.546 ' CD1' ' CE1' ' A' ' 36' ' ' HIS . 38.4 m-85 -112.72 139.98 47.88 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.057 -1.027 . . . . 0.0 110.617 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.6 t -100.99 121.35 51.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.7 t -119.0 121.59 67.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.034 -1.041 . . . . 0.0 109.904 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.405 ' CB ' HG12 ' A' ' 85' ' ' ILE . 13.0 p -100.88 140.99 34.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 0.0 111.604 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.623 ' CD1' HG23 ' A' ' 34' ' ' ILE . 49.7 mm -119.78 120.0 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -116.92 130.0 72.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.959 -1.088 . . . . 0.0 109.612 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.764 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -93.4 139.42 30.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 108.91 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.0 139.45 51.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.135 -0.978 . . . . 0.0 109.615 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.448 HD21 ' HB2' ' A' ' 28' ' ' PRO . 41.7 t-20 -121.51 37.67 4.29 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.373 -0.829 . . . . 0.0 108.779 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 95.27 -100.66 2.58 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -91.63 -0.18 57.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.217 -1.167 . . . . 0.0 110.325 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.26 141.57 48.83 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.005 -1.06 . . . . 0.0 109.513 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -120.12 138.78 53.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.232 -0.917 . . . . 0.0 109.729 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.764 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -83.85 163.33 49.29 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.599 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' OG ' ' A' ' 4' ' ' SER . 3.1 Cg_exo -57.54 135.08 67.5 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 121.336 1.358 . . . . 0.0 111.945 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -57.93 130.93 40.75 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 121.251 1.301 . . . . 0.0 113.21 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.783 HD22 ' O ' ' A' ' 5' ' ' PRO . 19.5 tp -107.32 119.99 40.91 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.405 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -125.28 134.19 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 120.993 -1.067 . . . . 0.0 111.146 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -135.52 164.83 24.87 Favored Glycine 0 N--CA 1.479 1.542 0 N-CA-C 107.147 -2.381 . . . . 0.0 107.147 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -114.69 131.11 56.85 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.921 -1.34 . . . . 0.0 110.084 -179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.685 ' OE1' ' CZ ' ' A' ' 18' ' ' PHE . 18.6 tm0? -123.87 128.32 49.3 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' O ' ' NE2' ' A' ' 88' ' ' GLN . . . -101.45 131.56 47.5 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.173 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.415 ' HA ' HE22 ' A' ' 88' ' ' GLN . 0.0 OUTLIER -74.43 136.65 42.34 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.735 HG23 HG22 ' A' ' 13' ' ' ILE . 3.9 t -45.72 166.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 C-N-CA 120.061 -0.656 . . . . 0.0 109.447 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.46 ' N ' HG12 ' A' ' 91' ' ' VAL . 70.0 m -118.48 143.74 46.5 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -60.05 -39.91 87.61 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.277 -0.89 . . . . 0.0 108.656 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.514 HG21 HG23 ' A' ' 178' ' ' VAL . 6.7 mt -66.67 138.93 95.67 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.424 -0.797 . . . . 0.0 109.015 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.612 ' HG2' HD21 ' A' ' 162' ' ' LEU . 3.3 Cg_exo -59.24 159.63 21.99 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 120.332 0.688 . . . . 0.0 110.541 178.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HE ' ' HB2' ' A' ' 92' ' ' SER . 24.0 mmt180 -120.57 172.5 7.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.826 -1.171 . . . . 0.0 110.959 -178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 56.59 39.99 29.59 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.436 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.668 HD13 HD23 ' A' ' 162' ' ' LEU . 41.7 tp -72.15 92.9 1.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.765 -1.209 . . . . 0.0 107.849 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -148.49 170.69 17.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.654 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 42.0 t -104.68 139.49 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 O-C-N 121.137 -0.977 . . . . 0.0 110.388 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.412 HD13 HG21 ' A' ' 101' ' ' ILE . 1.1 pt -107.62 -15.42 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.529 -0.732 . . . . 0.0 109.258 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -138.3 134.79 34.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -116.87 99.87 7.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.025 -1.047 . . . . 0.0 110.334 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.704 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -81.93 156.8 69.67 Favored Pre-proline 0 C--N 1.305 -1.334 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -49.03 -43.93 34.44 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.466 1.444 . . . . 0.0 112.95 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.704 ' O ' HG22 ' A' ' 152' ' ' ILE . 44.2 p -124.36 18.4 8.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.987 -1.07 . . . . 0.0 110.175 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.039 ' O ' HD23 ' A' ' 108' ' ' LEU . 37.7 p -153.76 165.77 34.96 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.862 -1.149 . . . . 0.0 109.898 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -140.69 154.22 46.28 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.355 -0.841 . . . . 0.0 109.561 -179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.487 ' C ' HD23 ' A' ' 109' ' ' LEU . 8.5 tt -104.96 119.99 40.36 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.661 HD11 ' HB3' ' A' ' 147' ' ' ALA . 5.2 pt -106.68 145.99 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.122 -0.987 . . . . 0.0 110.616 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 95.7 p -144.79 149.99 36.43 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.44 0.638 . . . . 0.0 109.778 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.606 ' CE2' ' O ' ' A' ' 145' ' ' SER . 43.8 p90 -149.84 154.87 39.11 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -76.0 134.67 71.15 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.995 -1.065 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.82 127.92 26.17 Favored 'Trans proline' 0 C--N 1.315 -1.235 0 C-N-CA 120.771 0.981 . . . . 0.0 111.948 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.22 -178.22 0.19 Allowed 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 121.058 1.172 . . . . 0.0 112.613 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB2' HG21 ' A' ' 91' ' ' VAL . . . -100.37 10.26 41.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.355 -0.84 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.96 160.0 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 0.0 109.628 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 80.5 p -71.7 138.73 48.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.241 -0.912 . . . . 0.0 109.983 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 41.1 t -130.01 135.9 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.468 -0.77 . . . . 0.0 109.079 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.691 ' NH1' ' O ' ' A' ' 166' ' ' THR . 80.6 mmt-85 -71.18 -51.45 24.73 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.774 -1.204 . . . . 0.0 107.947 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CE2' HG22 ' A' ' 139' ' ' THR . 6.5 p90 -167.52 174.57 7.76 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.333 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 17.4 m-85 -120.18 139.43 52.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.078 -1.014 . . . . 0.0 109.165 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.403 ' HD2' ' OE2' ' A' ' 137' ' ' GLU . 37.0 ttp-105 -100.46 129.96 46.48 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.72 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 16.6 mt -124.02 151.96 29.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 120.783 -1.198 . . . . 0.0 110.859 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 25.4 p -126.13 141.14 52.06 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.093 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.679 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.5 m-85 -84.11 129.54 34.9 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.728 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -109.17 131.01 10.3 Favored Glycine 0 N--CA 1.483 1.803 0 C-N-CA 120.202 -0.999 . . . . 0.0 111.247 178.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.546 ' O ' ' C ' ' A' ' 129' ' ' THR . 61.4 mt-10 -105.78 158.1 16.97 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.84 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -31.37 -64.23 0.15 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.247 -0.908 . . . . 0.0 110.242 -179.596 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.602 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . -60.02 -40.01 96.44 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . 77.48 -33.12 1.59 Allowed Glycine 0 N--CA 1.489 2.178 0 N-CA-C 108.928 -1.669 . . . . 0.0 108.928 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.453 ' H ' ' C ' ' A' ' 130' ' ' GLY . 25.9 t-20 -71.1 -19.94 62.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.454 -1.027 . . . . 0.0 108.429 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.437 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -62.33 166.82 6.18 Favored Pre-proline 0 C--N 1.3 -1.55 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 3.0 Cg_exo -57.21 87.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 121.652 1.568 . . . . 0.0 112.796 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.418 ' H ' HG13 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -55.61 160.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 O-C-N 121.279 -0.888 . . . . 0.0 108.933 179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.627 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 22.2 mm100 -111.92 129.87 56.03 Favored 'General case' 0 N--CA 1.504 2.25 0 C-N-CA 118.539 -1.264 . . . . 0.0 109.355 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.403 ' OE2' ' HD2' ' A' ' 123' ' ' ARG . 65.4 tt0 -107.86 133.86 51.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.546 -0.721 . . . . 0.0 111.323 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.72 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 41.5 p90 -141.64 157.52 44.98 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.595 HG22 ' CE2' ' A' ' 121' ' ' TYR . 3.2 p -98.21 167.44 10.86 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.785 -1.197 . . . . 0.0 111.525 -177.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.669 HG21 HD11 ' A' ' 124' ' ' ILE . 88.1 t -132.18 118.68 16.3 Favored Pre-proline 0 N--CA 1.488 1.474 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.454 ' C ' ' H ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -57.6 127.99 27.53 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 120.507 0.804 . . . . 0.0 112.268 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -56.26 -4.55 0.83 Allowed Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 141' ' ' PRO . 89.6 p -89.73 -0.05 57.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.104 -1.233 . . . . 0.0 109.624 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 15.9 mmtm -124.88 132.96 53.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.113 -0.992 . . . . 0.0 109.889 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.606 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 97.7 p -93.13 0.05 57.11 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.327 -0.858 . . . . 0.0 109.077 179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.477 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 15.1 p -139.12 158.12 44.75 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.661 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -139.95 169.95 16.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.819 -1.176 . . . . 0.0 109.916 -179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.3 m -118.92 142.59 47.62 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.422 -0.799 . . . . 0.0 109.391 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.581 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 31.4 mm -110.21 120.43 61.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.323 -0.861 . . . . 0.0 108.889 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.679 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 25.2 m120 -123.04 172.94 8.16 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.194 -0.941 . . . . 0.0 110.283 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 14.3 m120 61.1 49.82 5.38 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.728 0.775 . . . . 0.0 109.107 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 106' ' ' THR . 5.2 tt -108.98 153.8 10.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.3 mttt -98.75 110.02 55.63 Favored Pre-proline 0 N--CA 1.495 1.8 0 O-C-N 120.96 -1.088 . . . . 0.0 110.147 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 2.5 Cg_endo -68.43 170.04 15.78 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.156 1.237 . . . . 0.0 112.492 179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.98 20.03 75.89 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.84 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . -146.48 150.8 36.28 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.043 -1.269 . . . . 0.0 109.701 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.643 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.3 t0 -70.02 153.12 43.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.728 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -140.89 159.89 41.25 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.611 -1.306 . . . . 0.0 110.55 -179.156 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.477 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 46.9 m -132.94 119.99 20.86 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 178.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.815 HD11 HD12 ' A' ' 108' ' ' LEU . 79.6 mt -106.74 120.74 58.46 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 O-C-N 120.348 -1.47 . . . . 0.0 108.668 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 94.2 m -120.02 130.2 54.61 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.944 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.99 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -115.87 138.22 51.37 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 121.696 0.76 . . . . 0.0 110.83 -178.436 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.99 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.6 m-85 -117.47 157.38 26.36 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.56 135.79 54.99 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.795 -1.19 . . . . 0.0 110.176 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.59 HG21 ' CE1' ' A' ' 121' ' ' TYR . 63.2 t -110.06 120.0 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.906 . . . . 0.0 108.765 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.691 ' O ' ' NH1' ' A' ' 120' ' ' ARG . 2.8 p -110.67 -42.58 4.02 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 -179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -54.06 -153.98 0.01 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.406 ' HG2' ' NE ' ' A' ' 120' ' ' ARG . 72.5 mtm180 -139.49 170.06 16.61 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.289 -1.124 . . . . 0.0 108.801 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -47.36 -32.02 6.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -72.36 -39.95 67.7 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.306 -1.114 . . . . 0.0 109.136 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.9 m -133.15 70.0 78.08 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 121.777 -0.577 . . . . 0.0 109.688 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -62.06 98.57 0.17 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.517 1.478 . . . . 0.0 112.279 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -114.2 148.36 37.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.125 -0.984 . . . . 0.0 109.602 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 78.5 p -133.77 146.3 50.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -0.934 . . . . 0.0 109.653 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 81.9 p -80.64 169.15 18.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.288 -0.882 . . . . 0.0 108.919 179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.505 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -56.29 121.3 41.44 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.506 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.0 Cg_exo -61.38 154.02 61.74 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 120.929 1.086 . . . . 0.0 114.162 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.514 HG23 HG21 ' A' ' 94' ' ' ILE . 2.1 t -117.64 129.97 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 178.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 85.0 p -121.13 156.64 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.091 -1.005 . . . . 0.0 111.439 -177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.655 HG21 ' O ' ' A' ' 98' ' ' LEU . 47.0 pt -139.57 165.76 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.626 -0.672 . . . . 0.0 109.343 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -112.69 129.95 56.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.149 -0.97 . . . . 0.0 108.963 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.552 ' CE1' HG22 ' A' ' 184' ' ' THR . 54.7 t80 -124.98 118.52 26.43 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.058 -1.026 . . . . 0.0 109.974 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.64 140.02 29.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 0.0 109.199 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.552 HG22 ' CE1' ' A' ' 182' ' ' TYR . 4.8 p . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.514 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.529 4.838 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.434 ' O ' ' CD ' ' A' ' 82' ' ' PRO . 86.0 mt -120.17 131.13 54.89 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.226 -1.161 . . . . 0.0 109.344 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -79.97 130.11 35.02 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.43 -0.794 . . . . 0.0 109.479 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 93.4 p -84.83 149.79 54.45 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.488 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.02 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.75 146.19 86.7 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.173 1.249 . . . . 0.0 112.105 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.44 ' C ' ' N ' ' A' ' 8' ' ' PHE . 17.8 p -143.54 -150.65 0.32 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.044 -1.035 . . . . 0.0 109.601 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.96 19.18 49.84 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 105.0 -3.24 . . . . 0.0 105.0 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.44 ' N ' ' C ' ' A' ' 6' ' ' THR . 63.6 t80 -54.51 134.93 46.39 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.478 -0.861 . . . . 0.0 110.863 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.9 t0 -157.97 147.57 19.9 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.7 m -116.81 135.23 53.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.422 ' O ' ' C ' ' A' ' 12' ' ' ASP . 77.3 p -152.05 -171.02 3.81 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.283 -0.886 . . . . 0.0 109.459 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 11' ' ' SER . 81.5 m-20 50.0 41.62 23.45 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 -178.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -78.39 130.84 35.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.051 -178.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -125.56 162.73 24.27 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 177.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.749 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.81 -60.08 4.42 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.026 -1.046 . . . . 0.0 110.279 -178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -91.49 -0.0 57.56 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.896 -1.127 . . . . 0.0 109.993 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.68 ' O ' ' N ' ' A' ' 14' ' ' THR . 98.4 p -148.92 155.81 41.38 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.222 -0.924 . . . . 0.0 109.43 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.628 ' CE1' HG22 ' A' ' 20' ' ' VAL . 18.7 p90 -165.04 144.67 6.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -0.885 . . . . 0.0 108.687 179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.1 m -96.89 150.62 20.54 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.361 -1.462 . . . . 0.0 111.706 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.628 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -120.01 132.4 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 178.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.461 ' HD1' ' HB3' ' A' ' 56' ' ' SER . 63.4 m-70 -125.43 143.54 50.94 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.821 -1.175 . . . . 0.0 110.657 -178.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.592 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 44.5 p90 -147.79 152.98 38.61 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.472 -0.767 . . . . 0.0 109.211 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.01 142.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 O-C-N 121.108 -0.995 . . . . 0.0 110.492 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.03 137.06 79.28 Favored Pre-proline 0 C--N 1.297 -1.675 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.838 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.58 -164.57 0.04 OUTLIER 'Trans proline' 0 N--CA 1.492 1.386 0 C-N-CA 120.991 1.127 . . . . 0.0 112.26 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 49.5 mtp180 -112.38 17.86 19.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.385 -0.822 . . . . 0.0 109.939 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -119.73 150.21 49.9 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.909 -1.119 . . . . 0.0 109.951 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -58.48 127.1 23.42 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 121.485 1.456 . . . . 0.0 112.604 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.709 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 43.0 pt -133.4 170.02 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.524 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.2 p -106.08 -7.06 18.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.244 -0.91 . . . . 0.0 109.213 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.12 176.38 23.14 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.709 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 44.5 m-85 -119.99 145.54 46.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.162 -1.199 . . . . 0.0 109.132 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.656 HG23 ' HG3' ' A' ' 49' ' ' ARG . 38.1 mm -102.04 128.87 54.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 120.953 -1.092 . . . . 0.0 108.304 178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.627 ' O ' ' O ' ' A' ' 48' ' ' ASP . 2.8 mm -110.06 118.94 58.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.139 -0.975 . . . . 0.0 110.101 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.722 HH12 ' NE2' ' A' ' 47' ' ' GLN . 33.7 mmt180 -108.33 127.88 54.26 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.435 -1.321 . . . . 0.0 107.435 178.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.474 ' ND1' ' C ' ' A' ' 36' ' ' HIS . 2.2 t-80 -119.98 135.71 54.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.856 -1.152 . . . . 0.0 110.715 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.449 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 29.4 p-80 -167.94 149.96 5.49 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.283 -0.567 . . . . 0.0 109.618 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.596 ' HB3' ' CB ' ' A' ' 41' ' ' SER . . . -86.61 168.48 13.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -0.945 . . . . 0.0 109.059 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.582 ' OE2' ' OE1' ' A' ' 67' ' ' GLU . 14.6 mt-10 -59.95 -48.28 82.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.948 . . . . 0.0 110.444 -179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -136.04 36.96 2.8 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.948 -0.701 . . . . 0.0 111.335 -178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.596 ' CB ' ' HB3' ' A' ' 38' ' ' ALA . 14.8 p -74.58 150.09 39.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.748 -1.22 . . . . 0.0 109.381 179.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.35 -39.95 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.27 -0.894 . . . . 0.0 109.867 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -51.35 139.92 25.09 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.96 151.08 96.27 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.33 -1.1 . . . . 0.0 109.463 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.19 119.13 6.02 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 121.352 1.368 . . . . 0.0 112.113 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.4 ptp180 -85.28 153.32 22.67 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.25 -0.906 . . . . 0.0 110.198 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.722 ' NE2' HH12 ' A' ' 35' ' ' ARG . 97.5 mt-30 -105.64 116.51 32.07 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -117.87 127.53 53.95 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.656 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -121.45 148.55 44.27 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 120.799 -1.188 . . . . 0.0 109.693 -178.566 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.598 HG22 HD11 ' A' ' 34' ' ' ILE . 33.0 m -133.14 138.46 31.7 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 110.135 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.26 166.12 11.58 Favored 'Trans proline' 0 N--CA 1.488 1.181 0 C-N-CA 120.926 1.084 . . . . 0.0 111.709 178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.45 -36.28 94.04 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 121.466 1.444 . . . . 0.0 112.428 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 82.8 p -70.37 -11.05 60.65 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.38 -0.825 . . . . 0.0 110.777 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -102.79 120.02 39.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.088 -1.007 . . . . 0.0 110.04 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.5 p30 -109.71 -4.9 15.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.515 -0.741 . . . . 0.0 109.465 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.461 ' HB3' ' HD1' ' A' ' 21' ' ' HIS . 59.7 p -130.16 138.76 50.79 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.277 -0.89 . . . . 0.0 109.781 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.592 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 9.2 tt -130.0 130.01 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.373 0 O-C-N 121.36 -0.838 . . . . 0.0 108.746 178.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.4 m -100.24 133.31 44.83 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.147 -0.971 . . . . 0.0 109.806 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.3 mt -113.14 145.5 40.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.354 -0.841 . . . . 0.0 109.745 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 66.5 p -132.63 -178.73 5.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.726 -0.609 . . . . 0.0 109.85 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 15.1 m120 57.39 40.4 27.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.427 -0.795 . . . . 0.0 109.383 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 54.4 mt -105.7 155.15 19.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.49 -0.756 . . . . 0.0 109.087 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.649 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 15.9 m120 -69.99 120.63 79.11 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 120.976 -1.078 . . . . 0.0 108.561 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.749 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -61.5 125.13 16.07 Favored 'Trans proline' 0 C--N 1.315 -1.207 0 C-N-CA 120.921 1.081 . . . . 0.0 112.889 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 83.4 58.68 2.25 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.445 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -146.1 154.01 41.34 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.957 -1.32 . . . . 0.0 110.96 -178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.582 ' OE1' ' OE2' ' A' ' 39' ' ' GLU . 98.0 mt-10 -89.96 118.72 29.74 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.649 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 43.2 m-85 -110.1 140.02 44.61 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.993 -1.067 . . . . 0.0 110.119 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.0 t -102.84 121.42 53.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.3 t -117.92 122.33 69.45 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.121 -0.987 . . . . 0.0 108.961 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.3 p -96.34 134.56 39.33 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.993 -1.067 . . . . 0.0 110.703 -178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.554 ' CD1' HG23 ' A' ' 34' ' ' ILE . 50.3 mm -117.06 124.47 73.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.004 -1.109 . . . . 0.0 108.004 178.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.564 HG22 ' N ' ' A' ' 74' ' ' ALA . 60.3 mt -130.04 162.06 38.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.982 -1.074 . . . . 0.0 109.96 -179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -121.4 136.57 54.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.655 -0.653 . . . . 0.0 109.387 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' O ' ' OG1' ' A' ' 30' ' ' THR . 15.6 m -131.12 140.19 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.182 -0.949 . . . . 0.0 109.562 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.457 HD22 ' HA ' ' A' ' 29' ' ' ILE . 23.5 t-20 -124.58 41.88 3.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.213 -0.929 . . . . 0.0 109.012 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.01 -103.68 2.53 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -98.23 -0.04 44.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -1.171 . . . . 0.0 109.553 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -104.56 155.77 18.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.16 -0.962 . . . . 0.0 109.541 -179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -128.08 153.17 47.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.216 -0.928 . . . . 0.0 109.802 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.684 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -108.86 171.84 4.16 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.371 -0.83 . . . . 0.0 109.088 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -61.85 126.35 18.7 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 121.21 1.273 . . . . 0.0 111.634 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.58 126.34 19.63 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 C-N-CA 121.066 1.177 . . . . 0.0 113.472 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.02 HD22 ' O ' ' A' ' 5' ' ' PRO . 26.8 tp -106.15 120.04 40.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.9 mt -125.01 139.3 51.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 120.998 -1.064 . . . . 0.0 110.36 -179.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -137.21 152.49 21.47 Favored Glycine 0 N--CA 1.481 1.667 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -109.75 129.93 55.57 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 121.429 -1.042 . . . . 0.0 109.54 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.54 ' OE1' ' O ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -123.55 129.79 51.72 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.403 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 88' ' ' GLN . . . -100.01 129.63 46.09 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.131 -0.981 . . . . 0.0 109.939 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.409 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.36 134.99 42.48 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.622 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.533 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.8 t -41.71 155.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 121.468 0.651 . . . . 0.0 109.975 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.424 ' O ' HG13 ' A' ' 94' ' ' ILE . 28.1 p -105.16 23.72 13.19 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 122.224 1.011 . . . . 0.0 109.155 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.427 ' OD1' HG13 ' A' ' 117' ' ' VAL . 96.1 m-20 58.62 14.61 3.18 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 94' ' ' ILE . 20.3 mt -104.46 138.44 19.52 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 120.724 -1.235 . . . . 0.0 109.774 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.58 178.2 0.5 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 N-CA-C 109.653 -0.941 . . . . 0.0 109.653 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 40.3 mtp-105 -142.09 172.02 13.26 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.463 -1.398 . . . . 0.0 110.631 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 60.0 40.16 19.13 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.897 -0.502 . . . . 0.0 110.781 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.635 HD13 HD23 ' A' ' 162' ' ' LEU . 42.3 tp -72.7 93.29 1.63 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -147.92 169.97 18.69 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.223 -0.923 . . . . 0.0 110.017 -178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 51.2 t -96.98 133.83 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.342 -0.849 . . . . 0.0 110.711 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.414 HG12 ' N ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -98.19 -28.74 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-O 121.987 0.899 . . . . 0.0 108.664 179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.414 ' N ' HG12 ' A' ' 101' ' ' ILE . . . -135.28 134.93 40.44 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.471 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -121.48 126.57 49.58 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.854 -1.154 . . . . 0.0 110.812 -178.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -112.39 157.59 39.66 Favored Pre-proline 0 C--N 1.303 -1.426 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.6 -40.05 46.2 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 C-N-CA 121.602 1.534 . . . . 0.0 113.27 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 69.5 p -120.69 9.97 10.9 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.891 -1.131 . . . . 0.0 110.546 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.042 ' O ' HD23 ' A' ' 108' ' ' LEU . 80.1 p -154.01 162.27 41.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.658 -1.276 . . . . 0.0 110.77 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.042 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -144.61 152.88 41.14 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.474 -0.766 . . . . 0.0 109.01 179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.531 ' C ' HD23 ' A' ' 109' ' ' LEU . 5.4 tt -102.81 120.19 40.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.224 -0.922 . . . . 0.0 108.548 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 147' ' ' ALA . 6.4 pt -102.81 146.95 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 120.998 -1.064 . . . . 0.0 110.707 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 92.3 p -139.96 149.23 43.03 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 37.8 p90 -154.06 160.02 41.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.544 -0.723 . . . . 0.0 109.614 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 61.8 mm-40 -86.22 143.96 37.74 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.13 137.49 75.73 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 121.054 1.17 . . . . 0.0 112.283 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.03 -166.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.016 1.144 . . . . 0.0 112.294 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -105.45 -1.68 24.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.931 . . . . 0.0 109.606 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.427 HG13 ' OD1' ' A' ' 93' ' ' ASP . 34.6 m -130.05 164.19 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.291 -0.881 . . . . 0.0 109.707 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 62.7 m -68.76 150.01 48.37 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 0.0 109.363 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.471 ' HA ' HG22 ' A' ' 166' ' ' THR . 19.9 t -134.56 141.54 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.822 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.735 HH21 ' HE ' ' A' ' 168' ' ' ARG . 61.3 mmt-85 -71.12 -51.03 27.39 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.731 ' CE2' HG22 ' A' ' 139' ' ' THR . 7.9 p90 -166.48 179.29 5.6 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -120.02 139.94 51.74 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.951 -1.093 . . . . 0.0 108.717 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.679 ' NE ' ' OE2' ' A' ' 137' ' ' GLU . 36.3 ttm180 -106.12 124.7 49.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.486 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 30.5 mt -119.98 146.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.008 -1.058 . . . . 0.0 110.65 -178.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 75.2 p -118.52 149.47 41.25 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.731 -0.788 . . . . 0.0 111.005 -178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.627 ' HB2' ' H ' ' A' ' 136' ' ' GLN . 5.6 m-85 -93.12 136.37 33.45 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.55 118.41 5.5 Favored Glycine 0 N--CA 1.481 1.644 0 C-N-CA 120.124 -1.036 . . . . 0.0 112.126 179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.584 ' O ' ' O ' ' A' ' 129' ' ' THR . 45.4 mt-10 -109.4 144.66 37.31 Favored 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.411 -1.052 . . . . 0.0 108.786 177.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.599 HG23 ' N ' ' A' ' 157' ' ' ASP . 0.8 OUTLIER -33.08 157.95 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.139 -0.975 . . . . 0.0 110.118 179.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.444 ' O ' ' N ' ' A' ' 133' ' ' SER . . . 69.23 90.65 0.07 OUTLIER Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . -45.05 -24.09 0.75 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 108.964 -1.654 . . . . 0.0 108.964 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.442 ' N ' ' O ' ' A' ' 130' ' ' GLY . 42.3 p-10 -76.66 -10.01 59.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.458 -1.025 . . . . 0.0 109.199 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.444 ' N ' ' O ' ' A' ' 130' ' ' GLY . 68.0 m -73.08 139.09 79.19 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.803 . . . . 0.0 109.425 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.37 146.08 91.25 Favored 'Trans proline' 0 N--CA 1.491 1.344 0 C-N-CA 121.166 1.244 . . . . 0.0 112.82 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.2 m -103.35 150.75 6.65 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.446 -0.784 . . . . 0.0 109.252 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.627 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 10.7 mt-30 -102.45 123.03 45.49 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 118.423 -1.311 . . . . 0.0 108.951 179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.679 ' OE2' ' NE ' ' A' ' 123' ' ' ARG . 80.4 tt0 -100.0 129.97 46.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.42 -0.8 . . . . 0.0 111.558 -178.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.486 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 45.3 p90 -134.97 143.82 47.07 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.731 HG22 ' CE2' ' A' ' 121' ' ' TYR . 2.2 p -84.7 168.26 15.4 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.982 -1.074 . . . . 0.0 111.156 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.444 HG21 ' CD1' ' A' ' 124' ' ' ILE . 79.3 t -142.78 128.74 10.44 Favored Pre-proline 0 N--CA 1.485 1.285 0 O-C-N 121.751 -0.593 . . . . 0.0 109.416 -179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -57.99 150.65 62.91 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 120.621 0.881 . . . . 0.0 112.287 179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.14 -8.46 69.77 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -89.98 -0.04 57.36 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.137 -1.213 . . . . 0.0 110.35 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -106.96 125.09 50.55 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.943 -1.098 . . . . 0.0 110.282 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 80.0 p -93.26 -5.39 49.93 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 34.6 p -142.93 159.8 41.55 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -140.84 167.63 21.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.728 -1.233 . . . . 0.0 109.883 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 1.3 t -117.95 136.69 53.33 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.599 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 32.8 mm -109.46 123.21 65.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.193 -0.942 . . . . 0.0 108.625 -179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.565 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 68.0 m-20 -124.01 170.02 11.07 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.133 -0.979 . . . . 0.0 109.761 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 39.8 m-20 71.69 49.74 0.27 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.361 0.6 . . . . 0.0 109.809 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.923 HG23 ' CE2' ' A' ' 158' ' ' TYR . 79.4 mt -115.58 130.72 69.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.348 -0.845 . . . . 0.0 109.393 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.5 ' O ' ' OG1' ' A' ' 184' ' ' THR . 22.4 mttm -73.95 118.86 72.82 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.056 -1.028 . . . . 0.0 109.795 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -65.0 167.28 16.31 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 121.31 1.34 . . . . 0.0 113.288 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.615 ' N ' ' O ' ' A' ' 184' ' ' THR . . . 60.0 28.16 65.81 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.527 ' N ' ' O ' ' A' ' 184' ' ' THR . . . -140.0 139.27 36.0 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.932 -1.334 . . . . 0.0 110.492 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.599 ' N ' HG23 ' A' ' 129' ' ' THR . 44.8 t0 -59.95 140.23 56.86 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 178.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.923 ' CE2' HG23 ' A' ' 152' ' ' ILE . 0.7 OUTLIER -134.74 159.16 42.18 Favored 'General case' 0 C--N 1.298 -1.665 0 O-C-N 120.315 -1.491 . . . . 0.0 110.058 -179.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.624 ' H ' ' HA3' ' A' ' 127' ' ' GLY . 66.9 m -130.22 119.99 23.78 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.5 mm -108.26 123.63 64.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 120.194 -1.566 . . . . 0.0 108.273 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.525 HG22 ' CE1' ' A' ' 163' ' ' TYR . 86.6 m -127.61 140.02 52.37 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 118.765 -1.174 . . . . 0.0 110.172 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 1.077 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -122.37 137.77 54.75 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.683 0.754 . . . . 0.0 110.394 -178.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 1.077 ' N ' HD12 ' A' ' 162' ' ' LEU . 1.4 m-85 -122.94 153.43 39.73 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.18 55.8 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.839 -1.163 . . . . 0.0 109.47 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.404 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 63.2 t -111.61 120.04 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.907 . . . . 0.0 109.851 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.471 HG22 ' HA ' ' A' ' 119' ' ' VAL . 41.1 p -104.69 -50.07 3.38 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.728 0.775 . . . . 0.0 109.225 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -57.75 -160.87 0.03 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.735 ' HE ' HH21 ' A' ' 120' ' ' ARG . 87.5 mtt180 -137.13 178.55 7.0 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.429 -1.042 . . . . 0.0 108.99 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -49.01 -29.61 8.64 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -71.46 -39.99 70.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.217 -1.167 . . . . 0.0 108.87 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 53.2 m -136.0 69.21 64.15 Favored Pre-proline 0 C--N 1.295 -1.784 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.02 87.66 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 121.684 1.589 . . . . 0.0 112.587 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -108.26 138.67 44.15 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.268 -0.895 . . . . 0.0 109.201 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 93.9 p -129.49 150.63 50.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.315 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 46.1 p -79.4 169.98 17.27 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.02 119.48 42.0 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.527 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.3 Cg_exo -61.14 148.12 93.76 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 120.779 0.986 . . . . 0.0 114.074 -178.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.0 t -112.9 120.12 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 177.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 86.2 p -112.56 153.43 27.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.355 -0.841 . . . . 0.0 111.461 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 98' ' ' LEU . 42.2 pt -134.73 160.03 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -110.62 133.13 53.59 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.09 -1.007 . . . . 0.0 108.621 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.609 ' CE1' ' O ' ' A' ' 183' ' ' LYS . 60.7 t80 -139.14 126.57 21.62 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.018 -1.051 . . . . 0.0 110.154 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.609 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 66.2 mttm -84.71 147.59 26.83 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.376 -0.828 . . . . 0.0 109.013 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.615 ' O ' ' N ' ' A' ' 155' ' ' GLY . 1.1 p . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.021 -1.049 . . . . 0.0 109.395 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.832 0 N-CA-C 119.388 2.515 . . . . 0.0 119.388 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.9 mt -119.99 130.6 54.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.236 -1.155 . . . . 0.0 109.565 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -84.79 130.21 34.71 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.419 -0.8 . . . . 0.0 108.939 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.0 p -69.96 146.66 95.4 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.052 -1.03 . . . . 0.0 109.735 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.862 ' O ' HD22 ' A' ' 84' ' ' LEU . 2.6 Cg_endo -60.75 116.31 3.26 Favored 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 121.179 1.253 . . . . 0.0 111.877 178.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.6 p -120.0 -155.75 0.63 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 120.923 -1.111 . . . . 0.0 109.66 179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.66 20.02 75.35 Favored Glycine 0 N--CA 1.485 1.937 0 N-CA-C 105.218 -3.153 . . . . 0.0 105.218 -176.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.512 ' HB2' HD21 ' A' ' 84' ' ' LEU . 64.4 t80 -53.07 133.18 38.8 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.755 0.788 . . . . 0.0 110.695 -178.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 10' ' ' SER . 57.1 t0 -148.52 145.77 28.04 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.591 ' CB ' ' CD ' ' A' ' 88' ' ' GLN . 47.6 t -129.11 145.2 51.34 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.979 -1.076 . . . . 0.0 110.295 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.467 ' O ' ' C ' ' A' ' 12' ' ' ASP . 9.9 p -172.75 -162.32 0.18 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.467 ' C ' ' O ' ' A' ' 11' ' ' SER . 72.6 m-20 49.39 40.08 17.84 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.514 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -80.12 132.26 32.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.938 -178.047 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.683 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.0 164.09 20.06 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.51 -59.09 5.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.073 -1.017 . . . . 0.0 110.706 -178.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.459 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 31.7 m120 -92.52 -0.51 57.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.969 -1.082 . . . . 0.0 109.817 -179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.683 ' O ' ' N ' ' A' ' 14' ' ' THR . 90.0 p -151.4 156.49 40.8 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.227 -0.921 . . . . 0.0 109.581 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.514 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 32.4 p90 -161.89 148.33 13.77 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.4 m -102.36 151.33 22.39 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.112 -1.617 . . . . 0.0 111.956 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.483 HG22 ' HE1' ' A' ' 18' ' ' PHE . 1.6 t -120.54 138.66 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.474 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 77.1 m-70 -127.49 141.22 51.72 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.844 -1.16 . . . . 0.0 110.838 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.498 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.8 p90 -149.97 156.24 41.36 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.431 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.91 159.39 2.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.03 -1.044 . . . . 0.0 109.842 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -88.69 140.19 29.65 Favored Pre-proline 0 C--N 1.299 -1.618 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -58.69 179.28 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 120.921 1.081 . . . . 0.0 112.453 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -99.96 10.01 42.0 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.877 . . . . 0.0 109.899 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -116.61 150.66 46.0 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.075 -1.015 . . . . 0.0 109.854 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.65 127.97 27.39 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.555 1.504 . . . . 0.0 112.684 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.737 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.2 pt -131.66 170.43 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.234 -0.916 . . . . 0.0 109.595 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 49.5 p -105.61 -3.29 22.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -0.84 . . . . 0.0 109.855 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.34 174.29 14.21 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 110.074 -1.211 . . . . 0.0 110.074 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.737 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 13.0 m-85 -121.89 149.93 42.68 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.246 -1.15 . . . . 0.0 109.239 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.833 HG23 ' HG3' ' A' ' 49' ' ' ARG . 6.0 mt -115.15 130.02 70.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 O-C-N 120.984 -1.072 . . . . 0.0 108.579 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.8 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.3 mm -107.4 119.61 57.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.181 -0.949 . . . . 0.0 110.783 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -110.0 129.61 55.65 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 176.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.697 ' CE1' ' OD2' ' A' ' 48' ' ' ASP . 40.7 p-80 -134.13 148.61 50.99 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.51 -1.369 . . . . 0.0 111.339 -178.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.9 p-80 -162.85 151.14 14.11 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -82.6 165.26 20.21 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.133 -0.979 . . . . 0.0 109.457 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -60.0 -36.73 77.82 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 121.967 0.889 . . . . 0.0 109.397 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -88.55 19.38 3.94 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.072 -179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 86.5 p -74.51 169.74 17.13 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.243 -0.911 . . . . 0.0 109.351 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.634 ' C ' ' H ' ' A' ' 44' ' ' ARG . 15.7 m -106.47 -177.58 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.59 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -59.66 14.6 0.03 OUTLIER Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.634 ' H ' ' C ' ' A' ' 42' ' ' VAL . 20.3 mtt180 -122.05 71.19 31.9 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.913 -1.345 . . . . 0.0 110.096 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -61.01 150.32 84.74 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.312 1.341 . . . . 0.0 112.222 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.508 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 84.3 mtt-85 -74.51 157.65 35.15 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.19 -0.944 . . . . 0.0 109.873 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 92.2 mm-40 -120.52 129.21 53.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 0.0 110.528 -179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.697 ' OD2' ' CE1' ' A' ' 36' ' ' HIS . 99.3 m-20 -141.29 117.56 10.72 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.833 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -109.43 142.06 40.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.197 -0.939 . . . . 0.0 109.891 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.583 HG11 ' HB ' ' A' ' 57' ' ' ILE . 35.4 m -126.3 137.03 29.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.213 -0.929 . . . . 0.0 109.82 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -62.12 160.18 31.42 Favored 'Trans proline' 0 N--CA 1.489 1.233 0 C-N-CA 120.772 0.981 . . . . 0.0 111.624 178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.96 -33.8 96.1 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 121.502 1.468 . . . . 0.0 111.991 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.3 p -70.04 -10.35 58.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.522 -0.736 . . . . 0.0 110.354 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -103.88 120.59 41.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.099 -1.001 . . . . 0.0 110.303 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 44.4 p-10 -106.92 -7.46 17.03 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.474 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 53.2 p -129.98 138.52 50.87 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.409 -0.807 . . . . 0.0 109.231 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.583 ' HB ' HG11 ' A' ' 50' ' ' VAL . 5.8 tt -130.01 132.83 65.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.208 -0.933 . . . . 0.0 109.432 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.5 m -99.73 120.0 39.03 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.284 -0.885 . . . . 0.0 109.573 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.491 HD21 ' OD2' ' A' ' 48' ' ' ASP . 7.6 mt -93.19 143.53 26.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.263 -0.898 . . . . 0.0 109.81 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 40.5 p -130.1 178.81 6.27 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.188 0.518 . . . . 0.0 109.797 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.1 m120 58.71 43.04 19.3 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.435 -0.79 . . . . 0.0 109.775 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 59' ' ' LEU . 43.3 mt -109.99 153.63 24.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.599 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.9 m-80 -69.98 126.72 92.58 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.102 -0.998 . . . . 0.0 108.655 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.718 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.5 Cg_endo -64.76 132.16 31.75 Favored 'Trans proline' 0 N--CA 1.488 1.183 0 C-N-CA 120.709 0.939 . . . . 0.0 112.368 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.87 62.14 3.08 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.578 -1.809 . . . . 0.0 108.578 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.422 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -148.48 152.99 37.85 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.322 -1.105 . . . . 0.0 110.525 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.422 ' N ' ' CG2' ' A' ' 66' ' ' THR . 98.7 mt-10 -91.45 120.0 31.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.599 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 30.8 m-85 -108.82 148.16 30.99 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.116 -0.99 . . . . 0.0 110.57 -178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.9 t -110.04 125.77 67.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.4 t -125.27 129.98 73.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 120.915 -1.115 . . . . 0.0 110.335 -178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.412 ' CB ' HG12 ' A' ' 85' ' ' ILE . 78.6 p -115.22 139.99 49.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.091 -1.006 . . . . 0.0 110.728 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.413 HD13 HG23 ' A' ' 34' ' ' ILE . 6.6 mm -109.18 129.99 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.403 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 38.3 mm -119.9 123.15 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.024 -1.047 . . . . 0.0 108.929 179.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.628 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -93.5 132.69 37.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.144 -0.972 . . . . 0.0 109.528 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 10.9 m -129.9 140.02 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -121.58 43.4 2.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.97 -97.09 1.88 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.03 -1.628 . . . . 0.0 109.03 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.646 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -102.17 0.01 33.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.169 -1.195 . . . . 0.0 109.299 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -112.4 151.26 30.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.278 -0.889 . . . . 0.0 109.886 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -124.64 153.12 42.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 0.0 109.493 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.628 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -106.25 170.16 6.1 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.284 -0.885 . . . . 0.0 109.239 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.5 Cg_exo -59.74 125.39 17.65 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 121.223 1.282 . . . . 0.0 112.007 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 2.9 Cg_endo -60.76 143.32 99.37 Favored 'Trans proline' 0 N--CA 1.493 1.446 0 C-N-CA 121.223 1.282 . . . . 0.0 113.383 -179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.862 HD22 ' O ' ' A' ' 5' ' ' PRO . 24.9 tp -119.76 128.09 53.42 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.412 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -127.71 140.03 50.27 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 O-C-N 120.841 -1.162 . . . . 0.0 110.926 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -142.11 161.67 27.2 Favored Glycine 0 N--CA 1.483 1.81 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.8 tt0 -115.9 136.76 52.74 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 121.092 -1.24 . . . . 0.0 110.284 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.591 ' CD ' ' CB ' ' A' ' 10' ' ' SER . 98.2 mm-40 -130.2 139.03 50.87 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -110.77 137.47 48.38 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.082 -1.011 . . . . 0.0 110.288 -179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.6 OUTLIER -79.68 140.11 37.14 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.1 t -55.33 170.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 CA-C-O 121.504 0.669 . . . . 0.0 111.28 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 22.8 t -97.69 138.5 34.99 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.525 -0.734 . . . . 0.0 110.007 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' OD2' ' CB ' ' A' ' 64' ' ' PRO . 95.9 m-20 -69.95 -40.08 75.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.361 -0.837 . . . . 0.0 112.244 -179.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.539 HG23 ' HD2' ' A' ' 95' ' ' PRO . 2.1 mt -72.8 140.23 80.95 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.635 -1.29 . . . . 0.0 110.71 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.539 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.7 Cg_endo -63.68 81.31 0.14 Allowed 'Trans proline' 0 N--CA 1.486 1.068 0 C-N-CA 120.798 0.998 . . . . 0.0 110.668 177.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.498 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 28.5 ttp-105 -62.76 165.78 6.22 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.501 -0.749 . . . . 0.0 111.118 -178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.498 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.1 m-20 64.96 42.28 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.062 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.523 ' O ' HG21 ' A' ' 180' ' ' ILE . 54.9 tp -79.86 103.6 9.87 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 177.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -150.06 170.03 19.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.939 -1.101 . . . . 0.0 110.255 -178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 54.0 t -103.85 139.14 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.369 -0.832 . . . . 0.0 109.643 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.2 pt -113.67 -10.48 12.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.42 -0.8 . . . . 0.0 109.654 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -138.62 130.84 28.47 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.4 p -114.81 98.5 6.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.334 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.656 ' OG1' ' N ' ' A' ' 107' ' ' SER . 1.2 p -88.41 151.12 48.01 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.321 -0.862 . . . . 0.0 109.089 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -53.37 -30.7 53.91 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.348 1.365 . . . . 0.0 113.001 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.441 ' C ' HG22 ' A' ' 152' ' ' ILE . 27.8 p -129.02 12.89 6.21 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.906 -1.121 . . . . 0.0 110.718 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.944 ' O ' HD23 ' A' ' 108' ' ' LEU . 14.6 p -159.85 161.93 34.56 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.82 -1.175 . . . . 0.0 110.027 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.944 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -135.67 153.93 51.45 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.614 -179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.57 ' C ' HD23 ' A' ' 109' ' ' LEU . 5.4 tt -102.8 119.96 39.76 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.318 -0.864 . . . . 0.0 108.769 179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.637 HD11 ' HB3' ' A' ' 147' ' ' ALA . 2.6 pt -107.37 135.85 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.173 -0.954 . . . . 0.0 110.434 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 146' ' ' THR . 52.9 m -136.35 140.03 42.97 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 47.5 p90 -144.04 157.14 44.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.865 . . . . 0.0 109.389 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.03 127.34 92.45 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.237 -0.915 . . . . 0.0 109.477 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -63.76 125.89 16.34 Favored 'Trans proline' 0 N--CA 1.488 1.19 0 C-N-CA 120.684 0.923 . . . . 0.0 111.654 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -60.03 176.39 0.74 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 120.831 1.021 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.523 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -108.39 24.92 12.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 0.0 109.651 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 35.5 m -130.0 160.1 41.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.343 -0.848 . . . . 0.0 109.4 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 54.1 m -67.63 130.02 41.73 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.251 -0.906 . . . . 0.0 109.029 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.482 ' HA ' HG22 ' A' ' 166' ' ' THR . 57.5 t -126.31 132.08 70.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.447 -0.783 . . . . 0.0 109.609 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 13.9 mmt180 -71.71 -53.5 13.31 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.585 ' CE2' HG22 ' A' ' 139' ' ' THR . 8.1 p90 -167.27 170.29 11.74 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.564 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.5 m-85 -115.98 137.64 51.93 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.461 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 53.8 ttp180 -100.41 123.02 44.09 Favored 'General case' 0 C--N 1.306 -1.303 0 O-C-N 120.747 -1.221 . . . . 0.0 108.219 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.597 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 69.0 mt -110.26 139.82 32.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.005 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.794 HG22 ' HG2' ' A' ' 137' ' ' GLU . 19.5 p -115.59 137.22 52.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.375 -0.828 . . . . 0.0 110.796 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.715 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 6.9 m-85 -84.11 124.17 30.83 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.724 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.25 126.6 8.3 Favored Glycine 0 N--CA 1.481 1.66 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.724 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.617 ' O ' ' C ' ' A' ' 129' ' ' THR . 22.2 mt-10 -106.85 161.17 14.93 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.711 -0.876 . . . . 0.0 108.723 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.633 HG22 ' HB1' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -17.26 -64.68 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.949 -0.47 . . . . 0.0 110.831 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.564 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . 138.12 13.96 0.76 Allowed Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.799 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -61.95 -72.86 0.58 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.351 -1.9 . . . . 0.0 108.351 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.0 m120 -100.52 0.01 38.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.366 -1.079 . . . . 0.0 108.269 178.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.657 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 1.1 t 66.78 40.17 0.24 Allowed Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.708 -0.62 . . . . 0.0 111.035 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 133' ' ' SER . 2.4 Cg_endo -59.25 86.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.49 1.311 0 C-N-CA 120.742 0.961 . . . . 0.0 111.573 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.524 HG22 ' O ' ' A' ' 133' ' ' SER . 0.0 OUTLIER -93.24 138.03 21.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 120.871 -1.143 . . . . 0.0 110.314 -179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.647 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 96.9 mt-30 -119.82 104.36 10.14 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.121 -1.031 . . . . 0.0 108.554 178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.794 ' HG2' HG22 ' A' ' 125' ' ' THR . 98.9 mt-10 -86.89 140.79 29.29 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 0.0 112.084 -178.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.597 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 39.8 p90 -143.9 150.01 37.76 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.585 HG22 ' CE2' ' A' ' 121' ' ' TYR . 16.7 p -89.56 168.72 11.94 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.933 -1.105 . . . . 0.0 111.459 -177.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 19.6 t -134.14 126.81 18.75 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.747 -0.595 . . . . 0.0 109.649 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -56.64 155.7 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 CA-C-N 119.291 0.782 . . . . 0.0 111.809 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -78.91 -0.31 81.2 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 110.189 -1.164 . . . . 0.0 110.189 -179.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 87.7 p -99.96 2.29 43.42 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.059 -1.259 . . . . 0.0 110.422 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -112.48 128.57 56.37 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.821 -1.175 . . . . 0.0 110.259 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 25.2 m -94.74 -6.43 43.1 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 111' ' ' SER . 48.0 p -139.59 157.04 46.48 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -137.48 160.02 40.31 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.629 -1.294 . . . . 0.0 110.653 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.486 ' CG2' HD21 ' A' ' 150' ' ' ASN . 6.0 m -106.11 142.39 35.88 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.608 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 34.8 mm -114.47 120.07 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.184 -0.947 . . . . 0.0 109.44 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.715 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 8.8 m120 -122.05 173.81 7.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.236 -0.915 . . . . 0.0 109.798 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 65.3 46.26 2.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.04 -1.037 . . . . 0.0 109.478 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.51 HG12 ' CZ ' ' A' ' 158' ' ' TYR . 2.7 tt -110.43 153.06 12.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -98.29 109.98 54.49 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 120.966 -1.084 . . . . 0.0 110.488 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.46 154.43 74.34 Favored 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.075 1.183 . . . . 0.0 112.546 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 80.02 15.46 78.87 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.633 ' HB1' HG22 ' A' ' 129' ' ' THR . . . -137.91 149.06 45.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.856 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 49.5 t0 -69.92 150.81 46.34 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.724 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 1.5 m-85 -139.34 164.11 30.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.895 -1.128 . . . . 0.0 110.929 -178.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.476 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.9 m -136.48 115.4 12.26 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.9 mm -102.75 121.98 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.363 -1.46 . . . . 0.0 108.612 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.428 HG23 ' HB3' ' A' ' 179' ' ' SER . 62.8 m -132.34 148.52 52.43 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.076 -1.015 . . . . 0.0 110.104 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.461 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 2.3 pp -140.65 152.51 45.45 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 118.51 -1.276 . . . . 0.0 111.973 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.511 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 2.5 m-85 -120.07 139.24 52.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -100.16 124.37 45.49 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.829 -1.169 . . . . 0.0 108.586 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 70.5 t -106.32 120.73 57.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.175 -0.953 . . . . 0.0 110.213 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 119' ' ' VAL . 19.0 p -121.85 136.58 54.94 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -94.35 126.41 8.67 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.499 -1.334 . . . . 0.0 109.981 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.636 ' H ' ' HA ' ' A' ' 172' ' ' PRO . 78.1 mtt180 -103.98 7.9 36.65 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.4 -1.059 . . . . 0.0 109.255 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 122.5 -124.49 5.72 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -73.7 -15.23 61.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.286 -1.126 . . . . 0.0 109.354 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 50.4 m -128.05 88.51 52.77 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.543 -0.723 . . . . 0.0 109.156 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.636 ' HA ' ' H ' ' A' ' 168' ' ' ARG . 3.2 Cg_exo -62.24 -174.94 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.09 1.193 . . . . 0.0 111.954 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -156.26 159.99 39.38 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.275 -0.89 . . . . 0.0 110.607 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 3.3 p -134.74 140.12 45.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.424 -0.798 . . . . 0.0 109.013 178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 85.5 p -74.31 162.15 29.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.154 -0.966 . . . . 0.0 109.199 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.434 ' HB2' HD11 ' A' ' 94' ' ' ILE . 7.0 mttm -62.12 134.31 94.45 Favored Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.059 -1.026 . . . . 0.0 108.716 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -58.44 134.42 61.14 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 121.245 1.297 . . . . 0.0 113.424 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.83 129.99 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.428 ' HB3' HG23 ' A' ' 161' ' ' THR . 92.4 p -128.09 159.33 35.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.052 -1.03 . . . . 0.0 112.201 -177.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.523 HG21 ' O ' ' A' ' 98' ' ' LEU . 44.4 pt -138.8 160.06 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -107.41 130.15 54.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.092 . . . . 0.0 109.195 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.503 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 65.7 t80 -122.5 129.94 52.53 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.196 -0.94 . . . . 0.0 109.518 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -99.95 139.23 35.92 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.201 -0.937 . . . . 0.0 109.411 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.496 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 3.2 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.184 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.83 0 N-CA-C 119.367 2.507 . . . . 0.0 119.367 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.7 mt -117.99 136.75 53.32 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.276 -1.132 . . . . 0.0 108.933 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -83.39 109.99 17.77 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.4 -0.813 . . . . 0.0 109.073 179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 91.9 p -70.02 150.05 96.28 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.256 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.592 ' O ' HD22 ' A' ' 84' ' ' LEU . 3.1 Cg_exo -57.77 149.7 67.16 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 121.077 1.185 . . . . 0.0 111.669 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -152.68 -158.16 0.87 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.198 -0.939 . . . . 0.0 109.617 179.672 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.96 21.54 76.83 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 105.93 -2.868 . . . . 0.0 105.93 -177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -50.41 130.07 22.92 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 121.712 0.768 . . . . 0.0 110.359 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 10' ' ' SER . 52.1 t0 -155.59 149.64 25.58 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.547 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 58.8 m -121.97 140.97 51.81 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.964 -1.085 . . . . 0.0 110.133 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.432 ' O ' ' C ' ' A' ' 12' ' ' ASP . 78.0 p -157.2 -173.91 4.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.417 -0.802 . . . . 0.0 109.094 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 11' ' ' SER . 96.0 m-20 50.05 42.55 24.95 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -177.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.783 HG22 HG23 ' A' ' 91' ' ' VAL . 0.9 OUTLIER -78.01 124.83 37.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 CA-C-N 115.155 -0.93 . . . . 0.0 110.935 -177.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.692 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.89 162.45 17.32 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 177.552 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.756 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.34 -59.33 5.57 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 120.867 -1.146 . . . . 0.0 109.824 -179.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.456 ' ND2' ' HD3' ' A' ' 64' ' ' PRO . 28.9 m120 -87.15 -10.79 51.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.987 . . . . 0.0 109.859 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.692 ' O ' ' N ' ' A' ' 14' ' ' THR . 48.8 m -139.96 155.26 47.21 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.636 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.688 ' CE1' HG22 ' A' ' 20' ' ' VAL . 15.1 p90 -161.46 142.01 10.9 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.199 -0.938 . . . . 0.0 108.779 178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 4.0 m -91.16 154.02 19.63 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.443 -1.411 . . . . 0.0 111.777 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.688 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.8 t -124.35 139.31 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -129.68 141.25 50.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.819 -1.175 . . . . 0.0 110.93 -178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.482 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.4 p90 -148.44 160.02 43.46 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -89.02 156.11 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 120.81 -1.181 . . . . 0.0 110.346 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.21 124.4 45.2 Favored Pre-proline 0 C--N 1.299 -1.629 0 O-C-N 121.874 -0.516 . . . . 0.0 109.997 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -61.26 163.66 16.73 Favored 'Trans proline' 0 N--CA 1.49 1.299 0 C-N-CA 120.973 1.116 . . . . 0.0 112.244 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt180 -92.06 -1.41 57.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -79.83 151.76 74.01 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 109.636 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -58.14 120.59 8.59 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.344 1.362 . . . . 0.0 112.332 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.629 HG23 ' O ' ' A' ' 27' ' ' ALA . 25.5 pt -135.74 164.4 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 109.506 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -108.91 -7.36 15.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.896 . . . . 0.0 109.028 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 146.87 175.37 19.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 18.4 m-85 -120.0 139.99 51.64 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.093 -1.24 . . . . 0.0 109.163 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.738 HG23 ' HG3' ' A' ' 49' ' ' ARG . 34.9 mm -91.17 120.09 39.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 57' ' ' ILE . 3.7 mm -97.15 107.06 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.127 -0.983 . . . . 0.0 110.12 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.4 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 68.3 mtm180 -105.46 120.0 40.5 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.697 -1.252 . . . . 0.0 107.673 177.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.551 ' CD2' HD22 ' A' ' 59' ' ' LEU . 0.1 OUTLIER -120.04 136.57 54.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.974 -1.079 . . . . 0.0 110.334 -178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 54.6 p-80 -160.0 160.24 33.06 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.661 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -88.71 -171.71 3.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.092 -1.005 . . . . 0.0 109.298 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -50.98 -87.13 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.086 -1.009 . . . . 0.0 109.104 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -141.17 27.6 1.93 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.463 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.1 p -74.37 -13.51 60.74 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.668 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.934 HG22 ' H ' ' A' ' 44' ' ' ARG . 11.7 p -137.57 139.98 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.563 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -88.99 -3.34 76.59 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.934 ' H ' HG22 ' A' ' 42' ' ' VAL . 3.2 mmm180 -120.1 96.91 49.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.316 -1.108 . . . . 0.0 109.701 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -63.04 137.88 64.48 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 120.869 1.046 . . . . 0.0 111.881 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.8 mmt180 -76.15 134.79 39.85 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.251 -0.905 . . . . 0.0 109.895 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -102.09 120.5 40.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.296 -0.878 . . . . 0.0 109.293 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.627 ' O ' ' O ' ' A' ' 34' ' ' ILE . 95.8 m-20 -126.0 140.19 52.82 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.738 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -130.05 146.94 51.74 Favored 'General case' 0 C--N 1.294 -1.845 0 O-C-N 120.903 -1.123 . . . . 0.0 109.606 -178.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 34' ' ' ILE . 29.0 m -139.5 145.79 45.33 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.313 -0.867 . . . . 0.0 109.885 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -62.94 162.56 25.25 Favored 'Trans proline' 0 N--CA 1.49 1.307 0 C-N-CA 121.032 1.155 . . . . 0.0 111.925 178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -59.28 -34.09 97.95 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.576 1.518 . . . . 0.0 112.314 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 42.5 t -69.99 -19.73 63.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.482 -0.761 . . . . 0.0 110.589 -179.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 83.6 mmt-85 -96.06 115.19 27.05 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.22 -0.925 . . . . 0.0 109.495 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -107.62 0.48 22.55 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.538 -0.726 . . . . 0.0 109.871 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.2 p -129.98 134.39 47.41 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.29 -0.881 . . . . 0.0 109.403 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.654 HG21 HG21 ' A' ' 34' ' ' ILE . 7.3 tt -130.26 136.11 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.141 -0.974 . . . . 0.0 109.723 179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.2 m -99.97 122.23 42.56 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.309 -0.869 . . . . 0.0 109.649 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.829 ' HB3' HD11 ' A' ' 62' ' ' LEU . 12.6 mt -95.48 145.47 25.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.212 -0.93 . . . . 0.0 109.761 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 72.8 p -132.97 -178.66 5.06 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.434 0.635 . . . . 0.0 110.277 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 51.54 49.66 20.44 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.355 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.829 HD11 ' HB3' ' A' ' 59' ' ' LEU . 42.4 mt -116.5 153.68 31.72 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.542 -0.724 . . . . 0.0 109.286 -179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -70.0 123.32 88.51 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.102 -0.999 . . . . 0.0 108.598 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.756 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.6 Cg_endo -62.49 133.67 44.04 Favored 'Trans proline' 0 N--CA 1.488 1.205 0 C-N-CA 120.876 1.051 . . . . 0.0 112.717 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.66 62.26 2.9 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.586 -1.805 . . . . 0.0 108.586 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 m -147.42 148.92 31.8 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.297 -1.12 . . . . 0.0 110.982 -179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' OE2' ' NE2' ' A' ' 87' ' ' GLN . 86.5 tt0 -90.13 119.0 30.09 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.661 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 37.9 m-85 -109.92 152.75 25.43 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.194 -0.941 . . . . 0.0 110.814 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.7 t -110.02 121.3 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 62.5 t -118.51 129.98 74.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.758 -178.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.436 ' CB ' HG12 ' A' ' 85' ' ' ILE . 93.8 p -116.84 137.88 51.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.079 -1.013 . . . . 0.0 110.741 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -112.77 121.85 65.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.3 mm -112.12 129.99 66.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 120.854 -1.154 . . . . 0.0 109.252 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.652 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -95.61 123.12 39.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.12 -0.987 . . . . 0.0 109.026 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.41 ' O ' HG23 ' A' ' 75' ' ' VAL . 33.3 m -124.39 133.08 70.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.299 -0.876 . . . . 0.0 109.56 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -115.84 35.81 4.29 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.3 -103.06 2.49 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.3 ttt-85 -90.33 0.03 57.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -1.141 . . . . 0.0 110.341 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -117.52 141.37 48.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.907 -1.121 . . . . 0.0 109.906 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -119.98 140.5 50.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.251 -0.905 . . . . 0.0 109.814 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.0 OUTLIER -94.05 167.87 12.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.362 -0.837 . . . . 0.0 109.234 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.2 Cg_exo -58.68 129.99 34.95 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 121.468 1.445 . . . . 0.0 112.085 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.0 151.9 68.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 121.396 1.397 . . . . 0.0 113.698 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.592 HD22 ' O ' ' A' ' 5' ' ' PRO . 28.2 tp -125.41 111.91 15.68 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.436 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.7 mt -120.41 129.92 75.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 O-C-N 120.868 -1.145 . . . . 0.0 110.91 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.68 175.98 19.42 Favored Glycine 0 N--CA 1.482 1.713 0 N-CA-C 107.395 -2.282 . . . . 0.0 107.395 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.605 ' NE2' ' OE2' ' A' ' 67' ' ' GLU . 27.7 mt-30 -125.94 137.25 53.69 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 120.866 -1.373 . . . . 0.0 110.483 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.627 ' OE1' ' CE2' ' A' ' 18' ' ' PHE . 12.4 tm0? -130.92 130.68 43.79 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.618 ' C ' ' NE2' ' A' ' 88' ' ' GLN . . . -99.04 131.6 44.97 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.918 -1.114 . . . . 0.0 110.323 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.478 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.41 135.8 42.39 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.783 HG23 HG22 ' A' ' 13' ' ' ILE . 18.6 t -43.8 171.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 CA-C-O 121.504 0.669 . . . . 0.0 110.144 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.63 ' N ' HG12 ' A' ' 91' ' ' VAL . 58.2 m -113.59 149.67 34.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.56 -0.713 . . . . 0.0 109.377 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.706 ' OD2' HG21 ' A' ' 166' ' ' THR . 57.4 t0 -69.99 -16.02 63.12 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.323 -0.86 . . . . 0.0 109.774 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.673 HD11 ' HB2' ' A' ' 176' ' ' LYS . 8.5 mt -59.14 140.35 87.49 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.17 -0.956 . . . . 0.0 110.589 -179.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.427 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.6 Cg_endo -66.17 -166.34 0.1 Allowed 'Trans proline' 0 C--N 1.318 -1.05 0 N-CA-C 109.926 -0.836 . . . . 0.0 109.926 176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 84.2 mtt85 -152.74 162.17 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.594 -1.316 . . . . 0.0 110.513 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 59.61 40.04 20.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.812 -0.555 . . . . 0.0 110.902 178.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.782 ' O ' HG21 ' A' ' 180' ' ' ILE . 50.1 tp -73.08 96.79 2.24 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.73 -1.231 . . . . 0.0 107.792 178.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -151.76 169.81 21.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.145 -0.972 . . . . 0.0 109.679 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.605 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 43.2 t -96.23 139.38 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.401 0 O-C-N 121.165 -0.959 . . . . 0.0 110.352 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.752 HD11 ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -108.6 -11.89 10.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 121.853 0.835 . . . . 0.0 108.768 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.605 ' O ' ' CG1' ' A' ' 100' ' ' VAL . . . -147.18 150.7 35.44 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 53.0 m -129.83 130.01 44.72 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.838 -1.164 . . . . 0.0 110.271 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.43 157.97 39.78 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 178.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.26 -40.93 35.42 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 121.434 1.423 . . . . 0.0 112.656 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.501 ' C ' HG22 ' A' ' 152' ' ' ILE . 40.9 p -129.97 19.96 5.46 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.058 -1.026 . . . . 0.0 110.197 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.053 ' O ' HD23 ' A' ' 108' ' ' LEU . 5.5 p -153.46 169.83 22.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.873 -1.142 . . . . 0.0 110.011 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -143.88 155.39 44.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.33 -0.857 . . . . 0.0 109.699 -179.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.752 ' CD2' HD11 ' A' ' 101' ' ' ILE . 25.1 tp -103.99 120.51 41.21 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.729 HD11 ' HB3' ' A' ' 147' ' ' ALA . 3.3 pt -107.59 146.95 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.155 -0.966 . . . . 0.0 111.321 -177.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.8 p -141.11 144.22 34.75 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.468 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 42.3 p90 -150.74 159.99 44.16 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -96.73 140.58 22.22 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.914 -1.116 . . . . 0.0 109.926 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.2 134.52 56.33 Favored 'Trans proline' 0 N--CA 1.489 1.209 0 C-N-CA 121.028 1.152 . . . . 0.0 111.803 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.64 -171.93 0.06 OUTLIER 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 120.954 1.103 . . . . 0.0 112.335 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.761 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -77.33 -1.44 29.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.329 -0.857 . . . . 0.0 109.09 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.506 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 23.4 m -129.96 160.04 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.0 109.476 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 91.7 p -70.1 152.28 44.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.207 -0.933 . . . . 0.0 109.042 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.477 HG11 ' CE2' ' A' ' 122' ' ' TYR . 48.9 t -130.04 133.81 63.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.061 -1.024 . . . . 0.0 109.916 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.662 ' HD3' HG12 ' A' ' 165' ' ' VAL . 11.6 ptm180 -72.49 -48.04 43.81 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.127 -1.029 . . . . 0.0 108.417 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.698 ' CE1' HG22 ' A' ' 139' ' ' THR . 2.2 p90 -166.96 162.53 15.72 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.904 -1.122 . . . . 0.0 110.036 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.607 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.3 m-85 -122.52 151.11 41.69 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 108.903 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.527 ' NE ' ' HB2' ' A' ' 163' ' ' TYR . 17.2 ptt180 -109.85 129.64 55.62 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.794 -1.191 . . . . 0.0 108.193 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.623 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 83.9 mt -112.4 145.57 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.179 -0.951 . . . . 0.0 109.546 -178.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.621 HG22 ' HG2' ' A' ' 137' ' ' GLU . 1.1 p -122.07 142.7 50.09 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.241 -0.912 . . . . 0.0 110.967 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.68 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 4.1 m-85 -84.57 130.0 34.78 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.692 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -108.21 135.34 12.77 Favored Glycine 0 N--CA 1.479 1.566 0 C-N-CA 120.216 -0.993 . . . . 0.0 110.93 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.603 ' O ' ' C ' ' A' ' 129' ' ' THR . 60.0 mt-10 -105.79 151.83 23.98 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.798 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -25.31 -86.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.583 -0.698 . . . . 0.0 110.355 -179.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.739 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . -83.52 -80.02 1.03 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.085 -1.606 . . . . 0.0 109.085 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.672 ' O ' ' N ' ' A' ' 133' ' ' SER . . . 161.01 -85.33 0.11 Allowed Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.494 ' C ' ' O ' ' A' ' 131' ' ' GLY . 12.7 m120 39.95 19.79 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.338 -1.096 . . . . 0.0 108.709 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.672 ' N ' ' O ' ' A' ' 131' ' ' GLY . 0.7 OUTLIER -168.18 148.95 4.55 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.471 -0.768 . . . . 0.0 109.186 179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.12 155.28 40.45 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.183 1.255 . . . . 0.0 112.57 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 135' ' ' VAL . 31.3 m -86.96 166.09 2.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.567 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 15.7 mt-30 -99.61 115.28 29.04 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 117.887 -1.525 . . . . 0.0 108.561 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.621 ' HG2' HG22 ' A' ' 125' ' ' THR . 95.1 mt-10 -104.86 140.0 38.77 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.87 0.843 . . . . 0.0 111.979 -178.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 42.8 p90 -145.91 151.96 38.69 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.698 HG22 ' CE1' ' A' ' 121' ' ' TYR . 2.7 p -84.33 160.16 20.75 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.941 -1.1 . . . . 0.0 111.453 -177.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.429 ' N ' ' O ' ' A' ' 122' ' ' TYR . 89.0 t -120.2 119.04 31.02 Favored Pre-proline 0 N--CA 1.487 1.412 0 O-C-N 121.745 -0.597 . . . . 0.0 110.324 -179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.494 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.67 109.52 0.91 Allowed 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 120.73 0.953 . . . . 0.0 111.821 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -50.09 -10.27 0.29 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 141' ' ' PRO . 80.1 p -69.99 -19.22 63.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -1.169 . . . . 0.0 110.136 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 67.1 mmtt -122.03 140.74 52.12 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.256 -0.903 . . . . 0.0 110.03 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.7 m -90.02 -1.14 57.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.506 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.468 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 63.4 p -132.85 159.12 40.75 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.729 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -143.37 166.36 24.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.792 -1.192 . . . . 0.0 110.203 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 2.5 m -112.16 149.12 32.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.439 -0.788 . . . . 0.0 109.151 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.623 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 33.1 mm -117.62 123.33 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.68 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 31.2 m120 -125.49 170.08 11.77 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.024 -1.048 . . . . 0.0 110.013 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 80.8 m-20 65.64 46.7 2.35 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.589 0.709 . . . . 0.0 109.562 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.501 HG22 ' C ' ' A' ' 106' ' ' THR . 3.7 tt -108.32 149.79 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 9.8 mtpt -98.02 110.04 54.15 Favored Pre-proline 0 N--CA 1.497 1.9 0 O-C-N 120.928 -1.108 . . . . 0.0 110.182 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.411 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.4 Cg_endo -67.25 174.69 6.72 Favored 'Trans proline' 0 N--CA 1.492 1.396 0 C-N-CA 121.187 1.258 . . . . 0.0 112.853 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 69.97 26.42 74.35 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.798 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . -157.21 159.08 37.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.927 -1.337 . . . . 0.0 110.068 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.622 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.8 t0 -77.94 144.39 36.86 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.692 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.7 OUTLIER -130.77 158.17 40.86 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.828 -1.17 . . . . 0.0 110.272 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.465 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 63.7 m -130.24 118.92 22.1 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.821 HD11 HD12 ' A' ' 108' ' ' LEU . 76.2 mt -100.91 119.79 49.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 120.364 -1.46 . . . . 0.0 108.775 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.5 HG23 ' HB3' ' A' ' 179' ' ' SER . 21.5 m -127.08 140.85 51.99 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.333 -0.947 . . . . 0.0 109.661 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.825 ' C ' HD12 ' A' ' 162' ' ' LEU . 1.5 pp -139.09 152.42 47.49 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.335 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.608 ' N ' HD12 ' A' ' 162' ' ' LEU . 0.8 OUTLIER -119.96 141.82 49.31 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -99.46 137.17 38.34 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 120.582 -1.324 . . . . 0.0 110.19 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.662 HG12 ' HD3' ' A' ' 120' ' ' ARG . 62.2 t -110.02 120.11 60.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.706 HG21 ' OD2' ' A' ' 93' ' ' ASP . 24.3 p -115.21 -48.86 2.79 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.435 0.636 . . . . 0.0 110.026 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -49.91 157.87 1.66 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 94.2 mtt180 -130.02 130.43 44.95 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.391 -1.064 . . . . 0.0 109.406 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 147.82 -165.31 28.85 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -73.13 -30.78 63.85 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.408 -1.054 . . . . 0.0 109.179 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 52.5 m -129.98 76.06 78.64 Favored Pre-proline 0 C--N 1.297 -1.706 0 O-C-N 121.7 -0.625 . . . . 0.0 109.352 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -63.93 -160.15 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.658 1.572 . . . . 0.0 112.486 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -136.15 158.95 43.18 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.281 -0.887 . . . . 0.0 109.354 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 80.1 p -133.39 149.65 51.82 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.132 -0.98 . . . . 0.0 109.89 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 23.5 p -83.02 172.77 12.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.181 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.673 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -59.26 133.33 87.97 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.024 -1.048 . . . . 0.0 108.464 -179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -60.02 145.77 97.59 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 121.338 1.359 . . . . 0.0 113.846 -179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -119.54 129.66 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.5 ' HB3' HG23 ' A' ' 161' ' ' THR . 93.1 p -126.34 155.83 41.42 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.943 -1.098 . . . . 0.0 111.52 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.782 HG21 ' O ' ' A' ' 98' ' ' LEU . 27.2 pt -139.17 164.19 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -113.1 129.91 56.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.018 -1.051 . . . . 0.0 109.403 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.528 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 60.8 t80 -124.59 122.02 36.39 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.209 -0.932 . . . . 0.0 109.891 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.47 ' O ' ' CE1' ' A' ' 182' ' ' TYR . 43.9 mmtt -84.61 149.54 25.79 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.229 -0.919 . . . . 0.0 108.907 179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.526 ' OXT' ' OG1' ' A' ' 184' ' ' THR . 9.0 p . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.059 -1.025 . . . . 0.0 109.396 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.797 0 N-CA-C 119.392 2.517 . . . . 0.0 119.392 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.0 mt -129.96 143.94 51.07 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.213 -1.169 . . . . 0.0 109.159 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -80.01 137.23 36.77 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.394 -0.816 . . . . 0.0 109.098 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.4 t -78.06 133.28 65.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.131 -0.981 . . . . 0.0 109.3 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' CD ' ' HB2' ' A' ' 74' ' ' ALA . 3.3 Cg_exo -57.22 90.34 0.05 OUTLIER 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 120.967 1.111 . . . . 0.0 112.064 179.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -92.26 -158.54 0.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.248 -0.908 . . . . 0.0 109.904 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.92 22.11 66.82 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 105.64 -2.984 . . . . 0.0 105.64 -177.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.468 ' CZ ' ' CG1' ' A' ' 20' ' ' VAL . 56.0 t80 -57.75 132.4 53.2 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-O 121.82 0.819 . . . . 0.0 110.752 -178.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.597 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.7 t0 -154.11 142.08 20.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.597 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 75.0 p -117.74 140.0 50.27 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 120.907 -1.121 . . . . 0.0 109.846 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' C ' ' A' ' 12' ' ' ASP . 58.7 p -158.6 -176.6 5.98 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.463 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.8 m-20 49.93 48.41 21.87 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.506 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -85.32 121.1 36.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.69 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.384 -177.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.7 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -112.76 162.7 15.46 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.379 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.04 -56.58 19.94 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.792 -1.193 . . . . 0.0 110.524 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 65.8 m-80 -92.07 -0.03 57.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.85 -1.156 . . . . 0.0 109.93 -179.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.7 ' O ' ' N ' ' A' ' 14' ' ' THR . 37.2 t -150.87 151.55 32.39 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.256 -0.903 . . . . 0.0 109.234 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.663 ' CD2' ' OH ' ' A' ' 68' ' ' TYR . 23.3 p90 -160.97 145.94 14.05 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.293 -0.88 . . . . 0.0 108.829 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.407 ' OG1' ' HB2' ' A' ' 12' ' ' ASP . 3.6 m -93.16 148.03 22.37 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.507 -1.37 . . . . 0.0 111.489 -178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.568 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -121.52 142.56 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 178.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.438 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 72.3 m-70 -130.04 143.11 50.62 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.807 -1.183 . . . . 0.0 110.808 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.536 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 42.9 p90 -154.02 157.55 39.23 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.494 -0.754 . . . . 0.0 109.084 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -90.06 158.83 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 120.875 -1.141 . . . . 0.0 110.0 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -89.28 148.6 41.05 Favored Pre-proline 0 C--N 1.301 -1.538 0 O-C-N 121.668 -0.645 . . . . 0.0 109.9 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.612 ' HG2' HG21 ' A' ' 29' ' ' ILE . 2.5 Cg_endo -61.58 178.72 0.61 Allowed 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 121.279 1.319 . . . . 0.0 112.456 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -103.82 7.1 37.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.351 -0.843 . . . . 0.0 109.21 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.486 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -119.72 157.55 51.89 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 109.57 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.486 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 2.9 Cg_endo -56.85 136.29 75.6 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 121.676 1.584 . . . . 0.0 112.591 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.719 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 40.7 pt -139.97 170.06 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 109.614 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.4 p -106.42 -0.84 23.82 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.335 -0.853 . . . . 0.0 109.657 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 141.29 -173.85 23.15 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.719 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 37.1 m-85 -128.36 151.15 49.68 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.148 -1.207 . . . . 0.0 109.419 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.861 HG23 ' HE ' ' A' ' 49' ' ' ARG . 31.9 mm -110.02 130.02 63.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.182 -0.949 . . . . 0.0 108.48 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.709 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.9 mm -113.91 123.39 69.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.008 -1.057 . . . . 0.0 110.315 -179.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.582 HH12 ' NE2' ' A' ' 47' ' ' GLN . 83.0 mtt-85 -123.24 130.92 53.4 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.607 ' NE2' ' CB ' ' A' ' 46' ' ' ARG . 20.5 p-80 -130.76 129.4 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.776 -1.202 . . . . 0.0 110.559 -179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -159.99 159.92 32.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.5 -0.75 . . . . 0.0 109.32 179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.546 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -82.38 157.94 23.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.545 ' HG2' HG23 ' A' ' 69' ' ' VAL . 12.9 mt-10 -59.99 -40.04 87.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.214 -0.929 . . . . 0.0 109.402 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -86.25 -0.02 54.83 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.329 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.546 ' OG ' ' N ' ' A' ' 38' ' ' ALA . 88.9 p -110.04 116.65 31.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.996 -1.065 . . . . 0.0 109.695 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.0 m -138.8 1.33 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.218 -0.927 . . . . 0.0 109.509 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.35 -65.28 2.73 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 18.8 mtt85 -121.51 79.99 38.23 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.172 -1.193 . . . . 0.0 109.853 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.07 140.65 79.78 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.412 1.408 . . . . 0.0 112.29 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.607 ' CB ' ' NE2' ' A' ' 36' ' ' HIS . 22.5 mmm180 -81.3 135.96 35.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.339 -0.851 . . . . 0.0 109.785 -179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.582 ' NE2' HH12 ' A' ' 35' ' ' ARG . 99.4 mt-30 -120.82 109.96 15.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.793 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' ILE . 94.5 m-20 -121.98 129.99 52.94 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.197 -0.94 . . . . 0.0 108.673 178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.861 ' HE ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -113.56 141.22 47.43 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.217 -0.927 . . . . 0.0 109.325 -178.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.795 ' CG1' HD12 ' A' ' 57' ' ' ILE . 33.1 m -120.95 147.66 46.82 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.013 -1.054 . . . . 0.0 109.931 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.28 159.98 44.54 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 120.844 1.029 . . . . 0.0 111.552 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.505 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 2.7 Cg_endo -57.96 -37.85 94.44 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 121.583 1.522 . . . . 0.0 112.563 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.4 m -70.05 -12.49 61.64 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.371 -0.83 . . . . 0.0 110.872 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 -100.07 115.43 29.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.922 -1.112 . . . . 0.0 109.888 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.7 p-10 -103.06 -4.11 25.01 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.486 -0.758 . . . . 0.0 108.983 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.438 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 19.4 p -130.33 135.92 48.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.464 -0.772 . . . . 0.0 109.245 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.795 HD12 ' CG1' ' A' ' 50' ' ' VAL . 8.0 tt -132.43 133.75 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 O-C-N 121.096 -1.003 . . . . 0.0 110.361 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.8 m -95.74 109.99 22.2 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 17' ' ' SER . 5.6 mt -85.63 148.81 25.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.129 -0.982 . . . . 0.0 109.814 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 39.4 p -135.05 177.73 7.58 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.74 -0.6 . . . . 0.0 109.596 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 22.3 m120 57.33 45.43 20.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 109.866 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD11 ' HB3' ' A' ' 59' ' ' LEU . 48.5 mt -111.68 150.03 30.75 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.221 -0.924 . . . . 0.0 109.435 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.434 HD22 ' C ' ' A' ' 63' ' ' ASN . 0.4 OUTLIER -62.09 116.95 25.01 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.172 -1.048 . . . . 0.0 108.172 179.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.625 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.21 131.71 35.61 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 120.868 1.045 . . . . 0.0 112.932 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.45 62.91 3.26 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 108.602 -1.799 . . . . 0.0 108.602 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 m -142.38 130.72 22.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -1.147 . . . . 0.0 110.887 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 67' ' ' GLU . 21.2 pt-20 -87.14 122.52 31.06 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 177.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.663 ' OH ' ' CD2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -139.82 175.45 9.56 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.615 -1.234 . . . . 0.0 110.863 -177.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.545 HG23 ' HG2' ' A' ' 39' ' ' GLU . 62.4 t -109.12 129.08 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.573 -0.704 . . . . 0.0 109.449 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.7 t -112.71 123.19 68.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.419 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.1 p -111.19 142.36 43.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 0.0 111.586 -178.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.709 ' CD1' HG23 ' A' ' 34' ' ' ILE . 49.3 mm -119.88 119.98 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 36.1 mm -113.66 119.97 62.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.91 -1.119 . . . . 0.0 108.809 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.821 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -85.67 130.13 34.65 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 108.686 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.2 m -126.8 147.55 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.083 -1.011 . . . . 0.0 110.061 -179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -128.51 40.05 3.72 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.06 -100.81 2.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.109 -1.597 . . . . 0.0 109.109 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.9 ptt-85 -90.34 -5.96 55.61 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.177 -1.19 . . . . 0.0 110.242 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -112.31 143.48 43.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.97 -1.082 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -127.3 130.54 49.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 110.42 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.821 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 15.7 m -76.12 152.53 84.24 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -51.56 140.03 45.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 120.746 0.964 . . . . 0.0 111.765 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.89 146.22 80.2 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 121.561 1.508 . . . . 0.0 114.076 -178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 5' ' ' PRO . 20.0 tp -122.08 121.74 37.64 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.419 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.5 mt -133.2 140.55 46.82 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 O-C-N 120.846 -1.159 . . . . 0.0 111.379 -178.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -144.33 162.57 27.9 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.446 ' HG2' HG22 ' A' ' 69' ' ' VAL . 77.1 mt-30 -110.84 141.88 43.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.037 -1.273 . . . . 0.0 110.165 -179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.542 ' OE1' ' OG ' ' A' ' 10' ' ' SER . 67.5 tp60 -145.21 158.46 43.82 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.534 ' H ' ' NE2' ' A' ' 88' ' ' GLN . . . -124.19 127.12 47.26 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.858 -1.151 . . . . 0.0 111.03 -179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.638 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.11 142.57 45.57 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.591 ' O ' ' N ' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -62.62 161.07 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-O 121.523 0.677 . . . . 0.0 110.907 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.5 m -88.87 138.5 31.36 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.576 -0.702 . . . . 0.0 110.016 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.563 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 54.1 t0 -70.23 -27.03 64.13 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.524 -0.735 . . . . 0.0 110.542 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.67 HD11 ' HB2' ' A' ' 176' ' ' LYS . 10.3 mt -60.06 140.53 90.65 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.0 -1.062 . . . . 0.0 110.067 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.493 ' HD2' HG23 ' A' ' 94' ' ' ILE . 2.8 Cg_endo -64.42 -159.03 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.151 0 N-CA-C 109.896 -0.848 . . . . 0.0 109.896 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 15.9 ttp180 -160.01 160.57 33.45 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 120.664 -1.273 . . . . 0.0 111.259 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 98.2 m-20 59.95 43.84 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.932 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.631 HD22 ' CD2' ' A' ' 162' ' ' LEU . 41.2 tp -72.06 112.73 8.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 120.491 -1.381 . . . . 0.0 107.41 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 20.3 pt-20 -157.14 169.38 24.93 Favored 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 109' ' ' LEU . 53.4 t -104.95 133.41 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.226 -0.921 . . . . 0.0 109.917 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.446 ' CG2' ' OG ' ' A' ' 111' ' ' SER . 0.6 OUTLIER -98.39 -30.0 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 121.703 0.763 . . . . 0.0 109.427 -179.459 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -134.97 144.55 47.46 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.2 p -122.32 119.06 29.99 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.034 -1.041 . . . . 0.0 110.164 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -97.18 156.58 36.13 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -49.1 -46.2 26.46 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 121.564 1.509 . . . . 0.0 112.918 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 154' ' ' PRO . 64.8 p -121.09 15.86 11.56 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.677 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.035 ' O ' HD23 ' A' ' 108' ' ' LEU . 4.8 p -149.97 164.29 35.87 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.093 -1.004 . . . . 0.0 109.669 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.035 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -139.43 150.0 44.72 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.628 -179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 110' ' ' ILE . 1.9 tt -99.02 122.64 42.55 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.301 -0.874 . . . . 0.0 109.109 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.506 ' N ' HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -106.99 141.26 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.483 -0.761 . . . . 0.0 110.872 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.446 ' OG ' ' CG2' ' A' ' 101' ' ' ILE . 9.5 p -142.74 136.49 28.98 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.58 -0.7 . . . . 0.0 109.362 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.442 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 34.7 p90 -145.31 156.96 44.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.203 -0.936 . . . . 0.0 109.316 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.62 137.92 54.84 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.616 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -61.41 132.04 39.03 Favored 'Trans proline' 0 N--CA 1.491 1.34 0 C-N-CA 120.916 1.078 . . . . 0.0 112.099 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -59.94 -159.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 120.932 1.088 . . . . 0.0 112.256 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -99.44 2.92 45.51 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.507 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 24.0 m -130.01 160.0 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.098 -1.001 . . . . 0.0 109.819 -179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.4 t -74.55 135.36 42.13 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.451 ' HB ' ' CZ ' ' A' ' 122' ' ' TYR . 22.6 t -109.99 135.01 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.988 -1.07 . . . . 0.0 109.927 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.596 ' CB ' ' HE ' ' A' ' 168' ' ' ARG . 23.9 mmt180 -71.15 -45.94 62.5 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.496 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 12.1 p90 -166.29 162.37 17.27 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 119.652 -0.819 . . . . 0.0 109.424 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.582 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.7 m-85 -119.98 138.08 53.69 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.224 -0.922 . . . . 0.0 108.596 179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.466 ' NE ' ' HB3' ' A' ' 137' ' ' GLU . 13.6 tpt180 -95.46 121.58 37.29 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 89.9 mt -110.0 132.36 58.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.144 -0.973 . . . . 0.0 110.322 -178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.46 HG22 ' CG ' ' A' ' 137' ' ' GLU . 3.1 p -113.17 144.76 42.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.597 -0.689 . . . . 0.0 111.436 -178.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.776 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.7 m-85 -87.93 136.61 32.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.695 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.7 128.7 9.4 Favored Glycine 0 N--CA 1.478 1.475 0 C-N-CA 119.771 -1.204 . . . . 0.0 110.161 178.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.679 ' O ' ' N ' ' A' ' 130' ' ' GLY . 55.6 mt-10 -108.92 147.66 31.86 Favored 'General case' 0 C--N 1.294 -1.846 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.656 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -39.56 -20.01 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.413 0 O-C-N 120.885 -1.134 . . . . 0.0 109.057 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.679 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . -108.04 58.57 0.4 Allowed Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.479 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . -39.96 -20.04 0.02 OUTLIER Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.649 ' N ' ' O ' ' A' ' 130' ' ' GLY . 47.0 t-20 -59.98 -40.03 87.71 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.168 -1.195 . . . . 0.0 108.88 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.9 m -70.41 150.98 95.75 Favored Pre-proline 0 C--N 1.296 -1.74 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -54.93 124.18 15.62 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.334 1.356 . . . . 0.0 112.99 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.411 HG23 ' OE2' ' A' ' 137' ' ' GLU . 17.1 m -69.02 162.75 3.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 121.404 -0.81 . . . . 0.0 108.853 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.514 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 15.0 mt-30 -94.39 112.69 24.48 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 118.344 -1.342 . . . . 0.0 108.373 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.466 ' HB3' ' NE ' ' A' ' 123' ' ' ARG . 21.5 mp0 -102.41 140.17 37.04 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.988 0.899 . . . . 0.0 112.715 -177.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 41.9 p90 -143.16 153.87 43.3 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.3 p -88.62 163.1 15.98 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.663 -1.273 . . . . 0.0 112.092 -177.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.629 ' O ' ' N ' ' A' ' 142' ' ' GLY . 27.9 t -123.85 105.35 32.44 Favored Pre-proline 0 N--CA 1.488 1.457 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.697 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.2 Cg_exo -59.86 35.65 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 120.672 0.915 . . . . 0.0 112.76 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.629 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 30.69 30.54 0.01 OUTLIER Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.988 -1.245 . . . . 0.0 109.988 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.697 ' N ' ' O ' ' A' ' 141' ' ' PRO . 81.4 p -69.41 -33.6 73.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -1.21 . . . . 0.0 109.698 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -146.17 176.38 9.78 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.563 -0.711 . . . . 0.0 110.107 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 92.7 p -90.03 0.01 57.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.545 -0.722 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.442 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 19.8 p -136.22 150.96 49.22 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.198 -0.939 . . . . 0.0 109.392 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.471 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -148.05 177.49 9.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.084 -1.01 . . . . 0.0 108.945 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.741 HG22 ' N ' ' A' ' 149' ' ' ILE . 43.8 m -122.61 167.07 13.86 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.022 -1.049 . . . . 0.0 110.062 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.776 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 85.8 mt -123.92 130.52 73.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.819 -0.55 . . . . 0.0 110.01 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.464 ' O ' ' OH ' ' A' ' 126' ' ' TYR . 30.3 m120 -123.32 172.67 8.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.256 -0.902 . . . . 0.0 109.696 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 10.6 m120 61.42 40.36 14.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.0 110.323 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.49 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 3.4 tt -97.78 168.04 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 108.707 179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 5.2 tptm -110.73 100.08 44.42 Favored Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 120.925 -1.109 . . . . 0.0 109.36 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.534 ' HG3' HG22 ' A' ' 106' ' ' THR . 2.8 Cg_endo -66.71 164.15 30.31 Favored 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.396 1.397 . . . . 0.0 113.015 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 79.98 19.52 69.87 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.129 -1.189 . . . . 0.0 110.129 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.688 ' H ' ' HG1' ' A' ' 184' ' ' THR . . . -149.72 156.76 42.4 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.007 -1.29 . . . . 0.0 110.186 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.688 ' OD2' ' NZ ' ' A' ' 183' ' ' LYS . 61.9 t0 -70.0 151.14 45.91 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.695 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.6 OUTLIER -141.95 159.28 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.505 -1.372 . . . . 0.0 110.328 -179.188 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.508 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 20.4 m -130.49 123.17 29.09 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 48.6 mm -103.39 120.56 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.131 -1.606 . . . . 0.0 109.666 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.441 HG23 ' HB3' ' A' ' 179' ' ' SER . 22.7 m -131.36 141.86 49.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.0 110.001 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.631 ' CD2' HD22 ' A' ' 98' ' ' LEU . 2.3 pt? -135.18 154.79 51.5 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.919 -1.112 . . . . 0.0 111.434 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.53 ' N ' ' CD1' ' A' ' 163' ' ' TYR . 1.4 m-85 -120.02 140.6 50.73 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -108.04 125.74 51.91 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.752 -1.218 . . . . 0.0 109.768 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.496 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 90.1 t -114.5 127.54 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.418 -0.801 . . . . 0.0 109.597 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.662 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 1.4 p -121.29 -69.3 0.85 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.524 0.678 . . . . 0.0 109.691 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.662 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -57.21 121.37 25.13 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.596 ' HE ' ' CB ' ' A' ' 120' ' ' ARG . 53.9 mtt180 -119.89 12.9 12.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.425 -1.044 . . . . 0.0 109.394 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -77.28 -133.7 0.62 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.01 0.63 57.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.396 -1.061 . . . . 0.0 109.546 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 67.0 m -130.01 71.2 82.26 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.214 -0.929 . . . . 0.0 109.787 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.58 105.19 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 121.67 1.58 . . . . 0.0 111.903 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -119.96 140.75 50.44 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.177 -0.952 . . . . 0.0 109.912 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 79.2 p -119.89 144.1 47.58 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.394 -0.816 . . . . 0.0 108.956 179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 16.3 p -66.34 152.6 44.66 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.066 -1.021 . . . . 0.0 108.458 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.67 ' HB2' HD11 ' A' ' 94' ' ' ILE . 1.8 mmtm -49.34 137.03 16.12 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.844 -1.16 . . . . 0.0 108.825 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.53 142.29 97.56 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 121.165 1.243 . . . . 0.0 112.916 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.01 129.23 72.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.441 ' HB3' HG23 ' A' ' 161' ' ' THR . 64.8 p -126.06 150.82 47.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.034 -1.041 . . . . 0.0 111.992 -177.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.575 HG23 HD23 ' A' ' 98' ' ' LEU . 48.0 pt -134.8 160.05 41.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -97.87 140.28 32.47 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.873 -1.142 . . . . 0.0 109.48 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.651 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 58.3 t80 -137.52 119.35 15.22 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.102 -0.999 . . . . 0.0 109.62 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.688 ' NZ ' ' OD2' ' A' ' 157' ' ' ASP . 71.3 mmtt -89.4 133.86 34.34 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.248 -0.907 . . . . 0.0 108.765 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.688 ' HG1' ' H ' ' A' ' 156' ' ' ALA . 3.1 p . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.021 . . . . 0.0 109.427 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 1 N--CA 1.528 4.811 0 N-CA-C 119.384 2.514 . . . . 0.0 119.384 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.556 ' O ' ' OG ' ' A' ' 81' ' ' SER . 84.9 mt -123.72 136.81 54.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.262 -1.14 . . . . 0.0 109.241 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -77.13 130.1 36.9 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.363 -0.836 . . . . 0.0 109.05 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.8 m -76.57 144.07 73.08 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.154 -0.966 . . . . 0.0 109.514 -179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.778 ' O ' HD22 ' A' ' 84' ' ' LEU . 2.6 Cg_endo -58.87 110.16 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.057 1.171 . . . . 0.0 111.377 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.1 p -115.1 -155.29 0.57 Allowed 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.935 -1.103 . . . . 0.0 109.772 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.02 23.7 76.93 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 105.108 -3.197 . . . . 0.0 105.108 -176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.476 ' CZ ' HG12 ' A' ' 20' ' ' VAL . 54.1 t80 -50.56 130.03 23.34 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.561 -0.819 . . . . 0.0 110.88 -178.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 10' ' ' SER . 49.6 t0 -142.96 137.44 29.38 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.572 ' OG ' ' OE1' ' A' ' 88' ' ' GLN . 0.6 OUTLIER -119.57 138.0 53.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.003 -1.06 . . . . 0.0 110.202 -179.045 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.431 ' O ' ' C ' ' A' ' 12' ' ' ASP . 91.5 p -167.2 -166.03 0.75 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.37 -0.831 . . . . 0.0 109.726 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.2 m-20 48.7 43.68 20.93 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.805 HG22 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -76.92 129.99 36.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.21 -178.562 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.682 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -120.38 161.12 21.73 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.781 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -60.84 -59.99 4.5 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.9 -1.125 . . . . 0.0 110.218 -178.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 42.6 p-10 -90.06 0.02 57.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.869 -1.144 . . . . 0.0 109.062 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.682 ' O ' ' N ' ' A' ' 14' ' ' THR . 86.0 p -149.47 159.2 44.5 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.441 -0.787 . . . . 0.0 109.093 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.494 ' CE1' HG22 ' A' ' 20' ' ' VAL . 16.9 p90 -163.77 148.27 10.49 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.0 m -101.37 150.29 23.17 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.115 -1.616 . . . . 0.0 112.286 -178.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.494 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -119.18 139.06 47.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.472 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 75.9 m-70 -129.33 139.99 51.55 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.773 -1.204 . . . . 0.0 110.816 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.416 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 35.9 p90 -150.25 155.45 39.74 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -87.32 157.24 3.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 120.868 -1.145 . . . . 0.0 109.985 179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -93.12 137.02 23.87 Favored Pre-proline 0 C--N 1.298 -1.671 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.95 176.01 0.4 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 120.827 1.018 . . . . 0.0 111.892 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -103.3 15.55 28.87 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.165 -0.959 . . . . 0.0 109.311 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.87 155.75 47.37 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.521 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -59.09 131.27 40.48 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 121.614 1.543 . . . . 0.0 112.828 179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.624 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 44.0 pt -140.01 170.64 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.282 -0.886 . . . . 0.0 109.246 179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 46.9 p -108.41 -10.15 15.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.147 -0.971 . . . . 0.0 109.841 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.89 178.27 23.8 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.624 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 25.8 m-85 -123.14 145.14 48.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -1.129 . . . . 0.0 109.232 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.67 HG23 ' HG3' ' A' ' 49' ' ' ARG . 42.3 mm -100.7 128.01 53.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 120.88 -1.138 . . . . 0.0 108.123 178.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.618 ' O ' ' O ' ' A' ' 48' ' ' ASP . 3.2 mm -109.29 110.59 32.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.112 -0.992 . . . . 0.0 110.421 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -105.69 121.49 44.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.494 ' CG ' HD22 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -118.76 135.09 54.7 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.808 -1.182 . . . . 0.0 110.861 -178.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -160.05 159.0 31.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.597 -0.689 . . . . 0.0 109.586 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 41' ' ' SER . . . -94.39 139.6 30.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -0.943 . . . . 0.0 108.547 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.576 ' OE2' ' OE1' ' A' ' 67' ' ' GLU . 21.9 pt-20 -62.12 -26.19 68.16 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.022 -1.049 . . . . 0.0 109.79 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.523 ' NE2' HG23 ' A' ' 66' ' ' THR . 18.6 p80 -93.25 2.14 56.75 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.505 -0.747 . . . . 0.0 110.029 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 98.1 p -78.99 158.4 27.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.099 -1.0 . . . . 0.0 109.833 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.1 m -130.53 -0.99 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -0.839 . . . . 0.0 109.362 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.24 -177.37 50.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.721 -1.352 . . . . 0.0 109.721 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -70.02 133.04 88.09 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.252 -1.146 . . . . 0.0 109.476 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -57.86 135.56 69.77 Favored 'Trans proline' 0 N--CA 1.491 1.35 0 C-N-CA 121.202 1.268 . . . . 0.0 112.649 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 mmt180 -73.51 136.73 44.14 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.161 -0.962 . . . . 0.0 109.697 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -100.51 117.06 33.9 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.469 -0.769 . . . . 0.0 109.372 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ILE . 96.0 m-20 -123.08 133.25 54.31 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.67 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -127.43 150.12 49.78 Favored 'General case' 0 C--N 1.295 -1.764 0 O-C-N 120.816 -1.177 . . . . 0.0 109.871 -178.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 HD11 ' A' ' 34' ' ' ILE . 34.4 m -135.15 145.96 56.33 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 110.464 -179.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -66.17 160.08 46.58 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 C-N-CA 120.924 1.083 . . . . 0.0 111.256 177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -60.81 -31.5 91.83 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.243 1.296 . . . . 0.0 112.172 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.3 m -72.5 -11.42 60.66 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.546 -0.721 . . . . 0.0 111.255 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -103.94 120.0 40.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.839 -1.163 . . . . 0.0 109.461 -179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.431 ' OD1' ' C ' ' A' ' 55' ' ' ASN . 46.3 p-10 -102.49 -1.96 29.56 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.454 -0.779 . . . . 0.0 110.177 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.3 p -134.72 138.18 44.15 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.439 HD12 ' CG1' ' A' ' 50' ' ' VAL . 4.9 tt -131.55 134.66 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 0.0 109.705 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 25.9 m -102.5 119.8 39.45 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.182 -0.949 . . . . 0.0 109.339 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.5 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.1 mt -89.29 148.97 23.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 108.977 179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 73.1 p -131.31 177.55 7.39 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-O 121.514 0.673 . . . . 0.0 110.019 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 19.4 m120 55.2 45.5 25.74 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.42 -0.8 . . . . 0.0 109.698 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.5 HD11 ' CB ' ' A' ' 59' ' ' LEU . 56.3 mt -109.94 152.87 25.3 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.175 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.473 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 95.1 m-20 -68.67 120.48 75.99 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.059 -1.026 . . . . 0.0 108.325 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.781 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.8 Cg_endo -60.95 133.99 50.66 Favored 'Trans proline' 0 N--CA 1.489 1.254 0 C-N-CA 121.068 1.179 . . . . 0.0 113.49 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.7 63.05 2.67 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.523 HG23 ' NE2' ' A' ' 40' ' ' HIS . 1.2 m -148.57 156.36 42.32 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.228 -1.16 . . . . 0.0 110.495 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.576 ' OE1' ' OE2' ' A' ' 39' ' ' GLU . 8.8 pt-20 -99.31 120.02 38.88 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.473 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 77.3 m-85 -110.19 153.77 24.3 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.049 -1.032 . . . . 0.0 111.039 -178.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 62.2 t -109.97 120.73 61.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.434 HG22 ' HB2' ' A' ' 36' ' ' HIS . 60.2 t -120.02 125.9 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 120.932 -1.105 . . . . 0.0 109.826 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 59.9 p -104.88 136.14 44.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -0.941 . . . . 0.0 110.839 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.753 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.2 mm -112.05 121.03 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.753 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -119.11 129.98 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.965 -1.084 . . . . 0.0 109.594 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.74 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -91.65 132.54 36.28 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.339 -0.851 . . . . 0.0 109.543 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.559 HG12 ' HG2' ' A' ' 80' ' ' GLU . 16.5 m -128.6 137.2 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -119.96 41.93 3.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.266 -0.896 . . . . 0.0 109.17 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 91.63 -92.4 1.71 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -99.94 -0.0 40.32 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -1.106 . . . . 0.0 110.581 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -120.33 152.85 37.27 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.016 -1.053 . . . . 0.0 109.631 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.559 ' HG2' HG12 ' A' ' 75' ' ' VAL . 99.1 mt-10 -131.87 160.0 36.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 110.001 -179.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.74 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -110.93 172.17 3.76 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.239 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.447 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 3.1 Cg_exo -61.78 132.74 41.39 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 121.391 1.394 . . . . 0.0 112.417 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.17 128.28 25.88 Favored 'Trans proline' 0 N--CA 1.491 1.356 0 C-N-CA 121.182 1.255 . . . . 0.0 113.074 -179.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.778 HD22 ' O ' ' A' ' 5' ' ' PRO . 20.4 tp -106.9 121.37 44.3 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 mt -119.98 133.39 66.89 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 O-C-N 120.932 -1.105 . . . . 0.0 110.868 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -134.82 155.39 21.96 Favored Glycine 0 N--CA 1.48 1.604 0 N-CA-C 107.552 -2.219 . . . . 0.0 107.552 178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -110.99 136.17 50.4 Favored 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.204 -1.174 . . . . 0.0 110.054 -179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.792 HE21 ' CD1' ' A' ' 13' ' ' ILE . 51.6 tt0 -137.6 143.53 41.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -115.43 149.55 37.83 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.979 -1.076 . . . . 0.0 111.594 -178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.77 136.47 33.32 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.805 HG23 HG22 ' A' ' 13' ' ' ILE . 20.8 t -51.13 173.07 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-O 121.466 0.65 . . . . 0.0 110.045 179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.635 ' N ' HG12 ' A' ' 91' ' ' VAL . 68.6 m -100.86 141.35 33.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.413 -0.805 . . . . 0.0 109.158 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.568 ' OD1' ' O ' ' A' ' 93' ' ' ASP . 57.9 t0 -71.47 -12.05 61.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.9 . . . . 0.0 110.092 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.769 HG21 HG23 ' A' ' 178' ' ' VAL . 3.1 mt -77.87 139.26 61.77 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.003 . . . . 0.0 109.017 -179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.473 ' HD2' HG22 ' A' ' 94' ' ' ILE . 3.7 Cg_exo -57.42 -171.39 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 120.283 0.655 . . . . 0.0 110.988 178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.491 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 53.0 ttt85 -146.67 160.65 41.94 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.725 -1.234 . . . . 0.0 110.92 -178.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.491 ' N ' ' CG ' ' A' ' 96' ' ' ARG . 25.0 t0 72.55 34.88 1.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.856 -0.527 . . . . 0.0 111.456 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.647 HD22 HD13 ' A' ' 180' ' ' ILE . 2.2 tt -65.28 102.6 0.68 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.498 -1.376 . . . . 0.0 107.663 178.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.466 ' N ' HD23 ' A' ' 98' ' ' LEU . 98.8 mt-10 -142.58 157.97 44.15 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.939 -1.101 . . . . 0.0 110.549 -178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 100' ' ' VAL . 3.2 p -89.96 137.3 21.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.61 HD11 ' CD2' ' A' ' 109' ' ' LEU . 47.3 pt -123.72 -13.21 6.21 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.122 -0.986 . . . . 0.0 109.739 -179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.556 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -142.63 130.01 21.14 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.5 t -115.03 117.67 31.24 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.687 ' CB ' ' HG ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -108.6 157.96 35.23 Favored Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.026 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -48.07 -40.74 33.98 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 121.509 1.473 . . . . 0.0 112.781 -178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.562 ' C ' HG22 ' A' ' 152' ' ' ILE . 69.6 p -130.01 20.02 5.44 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.044 -1.035 . . . . 0.0 110.22 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.065 ' O ' HD23 ' A' ' 108' ' ' LEU . 18.9 p -153.41 165.37 36.01 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.889 -1.132 . . . . 0.0 110.285 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.065 HD23 ' O ' ' A' ' 107' ' ' SER . 1.2 mt -141.49 157.26 45.36 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.61 ' CD2' HD11 ' A' ' 101' ' ' ILE . 23.9 tp -104.8 127.55 52.64 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.084 -1.01 . . . . 0.0 108.381 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.488 ' CD1' HD11 ' A' ' 149' ' ' ILE . 2.0 pt -109.77 135.3 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.188 -0.945 . . . . 0.0 110.703 -178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.525 ' HA ' HG22 ' A' ' 146' ' ' THR . 52.6 m -126.86 132.51 50.94 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD2' ' O ' ' A' ' 145' ' ' SER . 42.5 p90 -143.02 157.5 44.48 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.153 -0.967 . . . . 0.0 109.596 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -95.11 142.06 24.09 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.313 -0.867 . . . . 0.0 109.368 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.29 136.44 68.34 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 120.952 1.101 . . . . 0.0 112.034 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.38 -163.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 120.984 1.123 . . . . 0.0 112.362 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 15' ' ' ALA . . . -91.24 1.6 56.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 0.0 109.187 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.632 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 33.1 m -129.98 160.03 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.881 . . . . 0.0 109.702 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 82.4 p -69.63 157.38 37.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.195 -0.941 . . . . 0.0 108.584 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.602 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 23.8 t -129.91 130.0 66.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.037 -1.039 . . . . 0.0 110.146 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -73.16 -42.97 62.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 106.265 -1.754 . . . . 0.0 106.265 177.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.762 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 -166.57 163.45 16.96 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.117 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.602 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -120.0 142.76 48.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.2 -0.937 . . . . 0.0 108.771 179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.48 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 1.2 mtp180 -99.36 127.34 45.37 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.7 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 35.7 mt -110.01 130.0 63.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 120.813 -1.179 . . . . 0.0 109.834 -178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.421 ' CG2' ' CE1' ' A' ' 163' ' ' TYR . 76.9 p -106.56 140.37 39.55 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.962 0.887 . . . . 0.0 111.58 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.702 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 5.8 m-85 -91.43 127.48 36.89 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.737 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -99.57 117.17 5.79 Favored Glycine 0 N--CA 1.485 1.95 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.423 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' OE1' ' HB2' ' A' ' 133' ' ' SER . 42.7 mt-10 -109.21 64.86 0.61 Allowed 'General case' 0 C--N 1.293 -1.855 0 O-C-N 121.541 -0.976 . . . . 0.0 109.197 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.483 ' O ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -74.08 146.72 43.41 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 120.982 -1.074 . . . . 0.0 109.839 -179.5 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 89.94 -9.96 75.52 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -119.67 -8.47 9.02 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.7 m120 52.07 29.44 6.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.274 -1.133 . . . . 0.0 108.801 -179.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.403 ' HB2' ' OE1' ' A' ' 128' ' ' GLU . 17.7 m -97.77 151.51 37.63 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.371 -0.831 . . . . 0.0 109.35 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -56.36 140.11 87.89 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.327 1.351 . . . . 0.0 112.475 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.412 ' H ' HG13 ' A' ' 135' ' ' VAL . 2.5 m -69.76 150.2 10.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.341 -0.85 . . . . 0.0 109.156 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.624 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 93.3 mm-40 -109.38 121.53 45.38 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 118.611 -1.236 . . . . 0.0 108.699 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 86.5 tt0 -109.77 140.57 43.53 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.317 -0.865 . . . . 0.0 111.617 -178.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.7 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 43.0 p90 -139.6 150.0 44.48 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.762 HG22 ' CE2' ' A' ' 121' ' ' TYR . 4.1 p -86.19 163.57 17.72 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.112 -0.993 . . . . 0.0 111.463 -177.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 142' ' ' GLY . 7.2 t -129.99 112.45 17.27 Favored Pre-proline 0 N--CA 1.488 1.463 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.703 ' O ' ' N ' ' A' ' 143' ' ' SER . 2.9 Cg_endo -62.35 35.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 120.728 0.952 . . . . 0.0 112.719 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.56 ' H ' HG12 ' A' ' 140' ' ' VAL . . . 35.03 24.1 0.01 OUTLIER Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 141' ' ' PRO . 28.8 t -66.39 -40.02 89.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.232 -1.158 . . . . 0.0 110.059 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -134.3 175.64 9.32 Favored 'General case' 0 C--N 1.294 -1.807 0 CA-C-O 121.841 0.829 . . . . 0.0 110.546 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.511 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 52.5 m -94.62 0.0 54.81 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.525 HG22 ' HA ' ' A' ' 111' ' ' SER . 17.9 p -136.83 150.92 48.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 108.844 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' H ' HG13 ' A' ' 110' ' ' ILE . . . -141.73 162.92 34.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.872 -1.142 . . . . 0.0 109.847 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.4 t -100.56 148.37 24.89 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.32 -0.863 . . . . 0.0 108.98 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.702 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 48.5 mm -116.62 120.03 63.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 O-C-N 121.23 -0.919 . . . . 0.0 108.77 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.619 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 78.8 m-20 -120.06 173.91 6.8 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.19 -0.943 . . . . 0.0 110.306 -178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 42.7 t30 65.92 40.0 4.33 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.337 -0.852 . . . . 0.0 109.56 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.562 HG22 ' C ' ' A' ' 106' ' ' THR . 2.3 tt -100.66 146.54 9.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -99.95 109.43 56.01 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 120.987 -1.071 . . . . 0.0 110.123 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 2.5 Cg_endo -68.55 172.64 11.09 Favored 'Trans proline' 0 N--CA 1.491 1.364 0 C-N-CA 121.129 1.22 . . . . 0.0 112.485 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.608 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.34 20.86 77.13 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.408 ' O ' HG23 ' A' ' 184' ' ' THR . . . -148.65 156.75 42.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.317 . . . . 0.0 109.763 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 57.9 t0 -69.97 147.27 50.38 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.737 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -138.0 156.87 47.39 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.79 -1.194 . . . . 0.0 110.515 -178.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.5 m -134.58 118.03 16.8 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 6.6 mm -104.18 124.91 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.343 -1.473 . . . . 0.0 109.357 -179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.901 HG23 ' O ' ' A' ' 178' ' ' VAL . 99.8 m -130.83 142.83 50.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.114 -0.991 . . . . 0.0 110.439 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 80.3 mt -107.83 142.13 38.35 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.489 -0.757 . . . . 0.0 109.645 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.435 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 24.7 m-85 -119.98 140.02 51.59 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -118.94 129.93 55.44 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.569 -1.252 . . . . 0.0 110.94 -179.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.429 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 62.4 t -115.37 122.55 69.51 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.57 ' O ' ' C ' ' A' ' 167' ' ' GLY . 9.7 p -129.82 -61.73 0.99 Allowed 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.51 0.672 . . . . 0.0 110.045 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.57 ' C ' ' O ' ' A' ' 166' ' ' THR . . . -25.4 131.77 0.02 OUTLIER Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 89.4 mtm-85 -111.22 124.96 53.26 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.45 -1.029 . . . . 0.0 109.271 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 157.24 -168.72 34.16 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -76.42 -5.13 45.99 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.429 -1.042 . . . . 0.0 109.31 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 54.4 m -130.04 76.45 78.03 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.345 -0.847 . . . . 0.0 109.536 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.03 106.59 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.563 1.509 . . . . 0.0 112.172 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.97 154.79 23.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.464 -0.773 . . . . 0.0 109.692 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 66.7 p -125.63 147.27 49.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.722 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 49.1 p -72.07 160.69 32.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.548 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 94' ' ' ILE . 18.3 mmtm -57.73 130.57 82.12 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.028 -1.045 . . . . 0.0 108.435 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.435 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 2.1 Cg_endo -61.12 134.66 53.93 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 121.195 1.263 . . . . 0.0 113.664 -179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.901 ' O ' HG23 ' A' ' 161' ' ' THR . 2.0 t -100.29 126.83 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 176.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.438 ' CB ' ' OG1' ' A' ' 161' ' ' THR . 79.1 p -122.69 145.25 48.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.057 -1.027 . . . . 0.0 112.187 -177.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.647 HD13 HD22 ' A' ' 98' ' ' LEU . 15.8 pt -130.61 159.97 42.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -104.13 135.78 44.98 Favored 'General case' 0 C--N 1.297 -1.674 0 O-C-N 120.85 -1.156 . . . . 0.0 109.502 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.442 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 65.7 t80 -130.2 109.67 10.98 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.447 -0.783 . . . . 0.0 109.572 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -88.39 136.22 33.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.077 -1.014 . . . . 0.0 108.99 179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.608 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.371 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.945 ' C ' HD13 ' A' ' 2' ' ' LEU . . . . . . . . 1 N--CA 1.529 4.835 0 N-CA-C 119.396 2.518 . . . . 0.0 119.396 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 1.019 HD22 ' H ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -112.95 157.64 21.23 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.246 -1.149 . . . . 0.0 108.809 179.952 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -79.49 140.63 37.24 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.467 ' O ' ' N ' ' A' ' 6' ' ' THR . 66.5 m -76.77 140.67 67.65 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.391 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 2.9 Cg_endo -57.76 78.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.133 1.222 . . . . 0.0 111.71 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 4' ' ' SER . 0.9 OUTLIER -81.55 -152.02 0.09 Allowed 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.194 -0.941 . . . . 0.0 109.548 -179.397 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 6' ' ' THR . . . 70.0 22.95 77.31 Favored Glycine 0 N--CA 1.484 1.876 0 N-CA-C 106.207 -2.757 . . . . 0.0 106.207 -177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -57.78 130.0 44.44 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.623 0.725 . . . . 0.0 110.141 -178.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 10' ' ' SER . 51.8 t0 -156.6 147.25 21.67 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.529 ' N ' ' OD1' ' A' ' 9' ' ' ASP . 39.1 t -121.49 141.85 50.63 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.03 -1.043 . . . . 0.0 109.911 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.476 ' O ' ' C ' ' A' ' 12' ' ' ASP . 22.9 p -155.64 -171.54 3.81 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 11' ' ' SER . 95.4 m-20 49.63 39.94 18.52 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 -178.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.45 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -76.49 130.02 36.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.207 -177.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.42 160.81 27.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.652 ' CB ' ' OD1' ' A' ' 93' ' ' ASP . . . -59.67 -60.0 4.54 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.921 -1.112 . . . . 0.0 110.229 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.8 p-10 -89.27 0.06 57.08 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.978 -1.076 . . . . 0.0 109.625 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.685 ' O ' ' N ' ' A' ' 14' ' ' THR . 47.5 t -149.33 154.62 39.26 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.354 -0.841 . . . . 0.0 109.212 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.802 ' CE1' HG22 ' A' ' 20' ' ' VAL . 12.6 p90 -165.12 141.01 5.46 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.1 m -91.24 150.09 21.49 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 120.449 -1.407 . . . . 0.0 111.301 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.802 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -119.98 138.44 50.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.436 ' ND1' ' HB3' ' A' ' 56' ' ' SER . 68.9 m-70 -128.59 144.33 51.13 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.934 -1.104 . . . . 0.0 110.965 -178.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.505 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 41.1 p90 -145.28 160.02 42.14 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -89.9 159.95 2.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 O-C-N 120.907 -1.121 . . . . 0.0 109.855 -179.982 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -97.59 132.73 24.61 Favored Pre-proline 0 C--N 1.298 -1.654 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.55 -178.46 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 C-N-CA 121.003 1.135 . . . . 0.0 112.711 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -103.86 -0.75 28.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.947 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.55 ' O ' HG23 ' A' ' 29' ' ' ILE . . . -103.15 151.68 38.52 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.088 -1.007 . . . . 0.0 109.729 -179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 2.9 Cg_endo -57.38 126.31 21.6 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 121.411 1.408 . . . . 0.0 112.29 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.56 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 19.6 pt -130.04 164.4 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.217 -0.927 . . . . 0.0 109.408 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -99.98 -1.79 36.2 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.515 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 140.9 -172.69 23.56 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.56 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 42.6 m-85 -128.45 156.84 42.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.19 -1.182 . . . . 0.0 109.459 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.739 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.8 OUTLIER -114.24 128.08 71.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.739 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.6 mm -111.61 118.14 56.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 120.944 -1.098 . . . . 0.0 110.653 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -112.07 129.41 56.23 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.513 ' C ' ' CD2' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -124.01 141.29 52.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.781 -1.2 . . . . 0.0 110.982 -178.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 46.9 p-80 -165.1 166.88 18.78 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.063 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -100.83 138.56 37.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.319 -0.863 . . . . 0.0 109.26 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -63.43 -20.34 65.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.146 -0.971 . . . . 0.0 109.431 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -75.8 -10.01 59.07 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.597 -0.689 . . . . 0.0 109.776 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 82.2 p -138.71 150.01 45.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 0.0 110.025 -179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.485 ' O ' ' O ' ' A' ' 43' ' ' GLY . 12.7 t -136.79 2.96 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.436 -0.79 . . . . 0.0 109.384 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.485 ' O ' ' O ' ' A' ' 42' ' ' VAL . . . -44.81 -99.15 0.01 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.452 HH21 ' HB2' ' A' ' 44' ' ' ARG . 32.9 mtm-85 -117.06 100.43 53.3 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.2 -1.176 . . . . 0.0 109.68 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -64.85 138.22 56.88 Favored 'Trans proline' 0 N--CA 1.49 1.32 0 C-N-CA 121.166 1.244 . . . . 0.0 112.196 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -73.61 152.86 40.4 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 121.097 -1.002 . . . . 0.0 110.155 -179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.643 ' N ' ' CD ' ' A' ' 47' ' ' GLN . 0.1 OUTLIER -121.86 117.73 27.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.0 109.855 179.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' ILE . 85.9 m-20 -123.15 119.1 29.26 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.783 ' HE ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -104.44 141.68 35.94 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.095 -1.003 . . . . 0.0 109.424 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 34' ' ' ILE . 30.9 m -125.33 147.85 59.0 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -65.46 159.92 45.38 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 120.853 1.035 . . . . 0.0 111.516 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.85 -35.17 99.05 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 121.488 1.459 . . . . 0.0 112.402 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 39.9 t -69.95 -16.75 63.25 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 110.894 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 -100.03 117.19 33.78 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.031 -1.043 . . . . 0.0 109.478 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -104.31 -0.08 28.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.351 -0.843 . . . . 0.0 110.066 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.436 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 51.6 p -132.85 138.4 47.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.249 -0.907 . . . . 0.0 109.799 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.505 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 5.5 tt -130.05 134.9 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 109.048 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.8 m -99.81 120.27 39.48 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.231 -0.918 . . . . 0.0 109.746 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.787 ' HB3' HD11 ' A' ' 62' ' ' LEU . 7.2 mt -97.45 140.75 31.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.274 -0.891 . . . . 0.0 109.568 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 68.1 p -132.63 179.42 6.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.602 -0.686 . . . . 0.0 109.943 -179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 56.91 39.97 29.14 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.483 -0.761 . . . . 0.0 109.576 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 59' ' ' LEU . 21.0 mt -107.21 149.34 27.84 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.383 -0.823 . . . . 0.0 109.104 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.537 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 87.7 m-20 -60.82 116.4 18.33 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 120.96 -1.087 . . . . 0.0 108.363 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.598 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 2.7 Cg_endo -62.04 131.97 37.2 Favored 'Trans proline' 0 N--CA 1.489 1.234 0 C-N-CA 121.035 1.157 . . . . 0.0 113.401 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 78.31 62.82 2.24 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.485 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 1.1 m -150.55 157.52 43.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.12 -1.224 . . . . 0.0 110.662 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.485 ' N ' ' CG2' ' A' ' 66' ' ' THR . 99.0 mt-10 -92.24 120.05 32.43 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 178.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.537 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 44.2 m-85 -110.84 148.71 31.83 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.157 -0.964 . . . . 0.0 110.996 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.465 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 62.7 t -110.04 124.34 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.1 t -119.9 124.85 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.025 -1.047 . . . . 0.0 110.215 -178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.7 p -108.4 134.81 50.68 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.115 -0.991 . . . . 0.0 111.195 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.718 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.6 mm -114.5 117.3 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.718 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.5 mp -111.8 125.46 69.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.063 -1.023 . . . . 0.0 108.443 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.704 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -93.8 127.82 39.73 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.208 -0.932 . . . . 0.0 109.595 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.495 HG12 ' HG3' ' A' ' 80' ' ' GLU . 3.1 m -117.46 129.96 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.298 -0.876 . . . . 0.0 109.116 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.495 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 52.3 t30 -111.64 34.82 3.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.317 -0.865 . . . . 0.0 109.341 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 84.17 -87.05 1.52 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -89.79 -6.01 56.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.317 -1.108 . . . . 0.0 110.393 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' HD11 ' A' ' 2' ' ' LEU . 100.0 mt-10 -131.12 150.05 52.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.05 -1.031 . . . . 0.0 110.371 -179.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.495 ' HG3' HG12 ' A' ' 75' ' ' VAL . 60.0 mp0 -126.67 129.96 49.49 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.392 -0.817 . . . . 0.0 109.521 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.704 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -74.96 160.01 81.6 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.251 -0.906 . . . . 0.0 109.207 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -59.46 142.03 98.35 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.221 1.28 . . . . 0.0 111.969 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.99 136.99 78.61 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 121.239 1.293 . . . . 0.0 113.048 -179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.401 HD22 ' O ' ' A' ' 5' ' ' PRO . 26.2 tp -115.77 121.29 42.01 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 mt -127.95 130.25 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 120.947 -1.096 . . . . 0.0 111.074 -179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.08 160.44 22.49 Favored Glycine 0 N--CA 1.479 1.538 0 N-CA-C 107.004 -2.439 . . . . 0.0 107.004 178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.444 ' HG2' HG22 ' A' ' 69' ' ' VAL . 73.5 mt-30 -118.54 137.88 52.91 Favored 'General case' 0 C--N 1.292 -1.929 0 O-C-N 121.04 -1.27 . . . . 0.0 110.033 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -139.3 139.29 37.28 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -102.24 133.68 46.73 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.154 -0.966 . . . . 0.0 110.77 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.34 140.06 41.29 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.49 HG11 ' HB2' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -60.19 153.16 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-O 121.468 0.651 . . . . 0.0 110.484 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.9 p -84.11 159.97 21.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.418 -0.801 . . . . 0.0 109.079 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.652 ' OD1' ' CB ' ' A' ' 15' ' ' ALA . 89.1 m-20 -105.62 -13.77 15.48 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.135 -0.978 . . . . 0.0 111.28 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.496 ' O ' ' N ' ' A' ' 96' ' ' ARG . 2.0 mt -80.05 138.13 53.17 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 120.662 -1.274 . . . . 0.0 110.496 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.591 ' HG2' HD21 ' A' ' 162' ' ' LEU . 2.5 Cg_endo -65.89 62.13 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 120.824 1.016 . . . . 0.0 111.124 178.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.525 ' HG2' ' N ' ' A' ' 97' ' ' ASP . 44.5 ttm105 -40.58 163.93 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.417 -0.802 . . . . 0.0 110.367 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.525 ' N ' ' HG2' ' A' ' 96' ' ' ARG . 95.9 m-20 63.1 40.62 8.87 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.904 -0.497 . . . . 0.0 111.246 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.554 HD13 HD23 ' A' ' 162' ' ' LEU . 49.0 tp -79.97 104.09 10.3 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.835 -1.166 . . . . 0.0 107.887 178.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -158.64 166.58 31.71 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.067 -1.021 . . . . 0.0 110.121 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.418 ' CG1' ' O ' ' A' ' 102' ' ' ALA . 25.3 t -89.07 140.02 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.278 -0.889 . . . . 0.0 109.441 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.773 HD11 ' CD2' ' A' ' 109' ' ' LEU . 2.1 pt -114.14 -9.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 0.0 109.57 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.483 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . . . -147.62 158.8 44.17 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.3 t -134.77 127.93 31.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.965 -1.084 . . . . 0.0 110.423 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.738 ' CB ' ' HG ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -113.55 158.68 38.0 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -48.92 -32.68 23.59 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 C-N-CA 121.485 1.456 . . . . 0.0 112.914 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.595 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.0 p -139.21 20.26 2.6 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 0.0 109.862 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.07 ' O ' HD23 ' A' ' 108' ' ' LEU . 6.1 p -153.15 167.5 29.07 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.064 -1.022 . . . . 0.0 110.067 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.07 HD23 ' O ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -142.15 155.58 45.32 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.773 ' CD2' HD11 ' A' ' 101' ' ' ILE . 30.6 tp -105.27 121.63 44.26 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.139 -0.976 . . . . 0.0 108.795 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 147' ' ' ALA . 3.1 pt -102.95 143.94 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.482 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.478 ' HA ' HG22 ' A' ' 146' ' ' THR . 36.3 t -136.73 140.0 42.3 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.704 -0.622 . . . . 0.0 109.756 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.695 ' CD2' ' O ' ' A' ' 145' ' ' SER . 48.8 p90 -144.37 156.99 44.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.564 -0.71 . . . . 0.0 109.303 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.96 130.45 89.93 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.157 -0.964 . . . . 0.0 109.885 -179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -61.67 118.59 5.47 Favored 'Trans proline' 0 N--CA 1.491 1.348 0 C-N-CA 120.937 1.091 . . . . 0.0 112.247 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -63.06 168.01 11.44 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 120.864 1.043 . . . . 0.0 111.995 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.49 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -107.01 28.12 8.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.191 -0.943 . . . . 0.0 109.829 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.97 159.99 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.146 -0.971 . . . . 0.0 108.974 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 47.5 t -70.86 129.96 40.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.938 . . . . 0.0 109.326 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.713 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 39.9 t -129.98 130.44 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 0.0 109.224 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 25.8 mmt180 -70.95 -51.27 26.83 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 139' ' ' THR . 15.3 p90 -167.14 170.49 11.77 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 119.627 -0.829 . . . . 0.0 109.178 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.713 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 3.7 m-85 -120.03 139.86 51.86 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 108.47 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 25.2 ttm180 -98.7 126.85 44.44 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.607 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 44.9 mt -118.55 130.84 72.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.984 -1.073 . . . . 0.0 109.872 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 137' ' ' GLU . 12.5 p -101.55 146.54 27.53 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 122.088 0.947 . . . . 0.0 111.527 -178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.721 ' OH ' ' N ' ' A' ' 150' ' ' ASN . 3.3 m-85 -92.05 128.07 37.75 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.727 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -107.27 122.99 7.08 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.843 -1.17 . . . . 0.0 110.873 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.591 ' O ' ' C ' ' A' ' 129' ' ' THR . 43.4 mt-10 -105.75 157.45 17.43 Favored 'General case' 0 C--N 1.295 -1.779 0 O-C-N 121.617 -0.931 . . . . 0.0 108.535 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.591 ' C ' ' O ' ' A' ' 128' ' ' GLU . 1.0 OUTLIER -22.8 -62.27 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.7 -0.625 . . . . 0.0 110.709 -179.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.539 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . 142.91 24.28 0.18 Allowed Glycine 0 N--CA 1.49 2.286 0 C-N-CA 119.334 -1.412 . . . . 0.0 110.675 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -62.21 -81.68 0.09 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.335 -1.906 . . . . 0.0 108.335 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.473 ' O ' ' CB ' ' A' ' 133' ' ' SER . 80.8 m-20 -102.96 -1.98 28.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.3 -1.118 . . . . 0.0 108.549 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.687 ' N ' ' CD ' ' A' ' 134' ' ' PRO . 1.6 p 75.51 35.04 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.657 -0.652 . . . . 0.0 111.668 179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 133' ' ' SER . 2.5 Cg_endo -60.17 50.94 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.388 0 C-N-CA 120.724 0.949 . . . . 0.0 112.464 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.601 ' N ' ' O ' ' A' ' 133' ' ' SER . 1.7 m -57.11 143.47 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.804 -1.185 . . . . 0.0 109.517 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.638 ' H ' ' HB2' ' A' ' 126' ' ' TYR . 28.3 mt-30 -125.23 131.77 53.08 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 137' ' ' GLU . 1.1 pm0 -113.36 148.66 35.32 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.913 -1.117 . . . . 0.0 111.991 -178.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.607 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 49.9 p90 -139.96 150.82 44.97 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.41 HG22 ' CE2' ' A' ' 121' ' ' TYR . 15.1 p -88.32 166.09 14.53 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.048 -1.032 . . . . 0.0 111.634 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.582 ' O ' ' N ' ' A' ' 142' ' ' GLY . 54.2 t -136.97 95.24 12.19 Favored Pre-proline 0 N--CA 1.487 1.381 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.681 ' O ' ' N ' ' A' ' 143' ' ' SER . 3.4 Cg_exo -60.05 47.53 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 120.909 1.073 . . . . 0.0 113.243 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 140' ' ' VAL . . . 33.98 26.98 0.01 OUTLIER Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 141' ' ' PRO . 94.5 p -62.99 -39.98 96.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.28 -1.129 . . . . 0.0 110.169 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HG2' ' N ' ' A' ' 145' ' ' SER . 19.0 tttt -146.12 165.24 29.7 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.503 -0.748 . . . . 0.0 109.889 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.695 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 79.4 p -78.97 -2.85 42.1 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.388 -0.82 . . . . 0.0 109.68 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 111' ' ' SER . 58.7 p -129.45 150.58 50.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 0.0 108.831 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.73 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -132.39 161.57 33.29 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.101 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 5.7 m -104.24 147.1 27.87 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.437 -0.789 . . . . 0.0 109.437 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.599 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 40.5 mm -117.92 119.98 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.246 -0.909 . . . . 0.0 109.181 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.721 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 10.6 m120 -121.87 176.83 5.56 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.146 -0.971 . . . . 0.0 110.463 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 60.93 50.05 5.46 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.405 -0.809 . . . . 0.0 109.896 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.595 HG22 ' C ' ' A' ' 106' ' ' THR . 2.6 tt -114.81 149.22 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.087 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -94.18 111.96 55.47 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.046 -1.034 . . . . 0.0 109.974 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -65.24 156.37 63.46 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.171 1.247 . . . . 0.0 112.945 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.663 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 70.02 23.69 76.93 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 110.245 -1.142 . . . . 0.0 110.245 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.574 ' O ' HG23 ' A' ' 184' ' ' THR . . . -136.1 137.1 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.059 -1.26 . . . . 0.0 109.706 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 53.7 t0 -60.04 140.01 57.09 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.727 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.8 OUTLIER -134.28 172.07 13.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.866 -1.146 . . . . 0.0 111.055 -178.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.497 ' O ' ' N ' ' A' ' 127' ' ' GLY . 1.0 OUTLIER -146.44 124.63 12.18 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.815 HD11 HD12 ' A' ' 108' ' ' LEU . 69.9 mt -111.61 125.95 68.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 120.296 -1.502 . . . . 0.0 109.155 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.9 m -124.44 141.05 52.38 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.12 -0.987 . . . . 0.0 109.371 179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 1.047 HD12 ' N ' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -124.05 140.49 52.92 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.383 -0.823 . . . . 0.0 111.427 -177.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 1.047 ' N ' HD12 ' A' ' 162' ' ' LEU . 7.0 m-85 -124.78 152.49 43.78 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -120.64 131.49 54.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.816 -1.177 . . . . 0.0 109.875 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 62.8 t -120.02 130.02 74.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 109.549 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.633 ' OG1' ' N ' ' A' ' 167' ' ' GLY . 2.8 p -116.73 -70.75 0.77 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.446 -0.784 . . . . 0.0 109.945 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.633 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -70.58 143.01 36.23 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.138 -1.185 . . . . 0.0 110.138 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.484 HH11 ' HG2' ' A' ' 168' ' ' ARG . 75.9 mtp85 -134.3 136.33 43.44 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -1.08 . . . . 0.0 109.088 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 149.67 -148.65 20.16 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -74.35 -14.3 60.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -1.138 . . . . 0.0 109.116 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 70.9 m -132.44 75.23 74.29 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.555 -0.716 . . . . 0.0 109.496 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -64.4 -177.68 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.74 0 C-N-CA 121.429 1.419 . . . . 0.0 111.905 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -155.45 126.9 7.29 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.472 -0.768 . . . . 0.0 109.962 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 20.3 p -132.55 141.93 48.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.373 -0.829 . . . . 0.0 108.991 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 83.2 p -80.08 170.03 17.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.143 -0.973 . . . . 0.0 108.47 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -63.57 118.42 44.28 Favored Pre-proline 0 C--N 1.304 -1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 3.1 Cg_exo -61.98 150.59 85.72 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 121.034 1.156 . . . . 0.0 113.393 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.468 HG12 HD23 ' A' ' 98' ' ' LEU . 2.9 t -120.73 131.05 73.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . . . . . . . . . 97.4 p -117.2 154.03 31.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.09 -1.006 . . . . 0.0 111.475 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 98' ' ' LEU . 48.3 pt -137.58 164.69 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -111.32 138.78 47.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.171 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.47 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 64.9 t80 -136.05 126.85 27.43 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.072 -1.017 . . . . 0.0 109.952 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -100.82 129.24 46.67 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.281 -0.887 . . . . 0.0 108.834 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.663 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 1.3 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.253 -179.658 . . . . . . . . 1 1 . 1 stop_ save_